<SEC-DOCUMENT>0001193125-13-165186.txt : 20130422
<SEC-HEADER>0001193125-13-165186.hdr.sgml : 20130422
<ACCEPTANCE-DATETIME>20130422171621
ACCESSION NUMBER:		0001193125-13-165186
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130524
FILED AS OF DATE:		20130422
DATE AS OF CHANGE:		20130422
EFFECTIVENESS DATE:		20130422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOGENEX PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-80623
		FILM NUMBER:		13774513

	BUSINESS ADDRESS:	
		STREET 1:		1522 217TH PLACE S.E.
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		4254879500

	MAIL ADDRESS:	
		STREET 1:		1522 217TH PLACE S.E.
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d511574ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549
</B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section 14(a) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>of the Securities Exchange Act
of 1934 </B></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed&nbsp;by&nbsp;the&nbsp;Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed&nbsp;by&nbsp;a&nbsp;Party&nbsp;other&nbsp;than&nbsp;the&nbsp;Registrant&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to Rule 14a-12</FONT></TD></TR>
<TR>
<TD HEIGHT="32" COLSPAN="5"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>ONCOGENEX PHARMACEUTICALS, INC.</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified in its Charter)</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR>
<TD COLSPAN="5" VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</B></FONT></TD></TR>
<TR>
<TD HEIGHT="32" COLSPAN="5"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box):</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid:</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials.</FONT></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-before:always">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
</TABLE>  <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

   <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">ONCOGENEX PHARMACEUTICALS, INC. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">1522&#151;217th Place S.E., Suite 100 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bothell, Washington 98021 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">April 22, 2013 </FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear Stockholder:
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">You are cordially invited to attend the Annual Meeting of Stockholders of OncoGenex Pharmaceuticals, Inc. on May&nbsp;24,
2013, at 9:00 a.m. local time. The Annual Meeting will be held at the offices of Fenwick&nbsp;&amp; West LLP, 1191 Second Avenue, 10</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Floor, Seattle, Washington 98101. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The matters to be acted upon are described in the accompanying Notice of Annual Meeting and Proxy Statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Your vote is very important. Whether or not you plan to attend the Annual Meeting, we urge you to vote and submit your proxy by telephone, via the Internet or by mail in order to ensure the presence of a
quorum. If you attend the Annual Meeting, you may, of course, revoke your proxy and vote your shares in person. If you hold your shares through an account with a brokerage firm, bank or other nominee, please follow the instructions you receive from
them to vote your shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We look forward to seeing you at the Annual Meeting. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Sincerely, </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>/s/ SCOTT
CORMACK&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ONCOGENEX PHARMACEUTICALS, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1522 &#151; 217th Place S.E., Suite 100 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Bothell, Washington 98021 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE IS HEREBY GIVEN that the Annual
Meeting of Stockholders of OncoGenex Pharmaceuticals, Inc., a Delaware corporation, will be held on May&nbsp;24, 2013, at 9:00 a.m. local time. The Annual Meeting will be held at the offices of Fenwick&nbsp;&amp; West LLP, 1191 Second Avenue,
10</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Floor, Seattle, Washington 98101, for the following
purposes: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect six directors to serve until our next annual meeting of stockholders or until their successors are duly elected and qualified; </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ratify the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2013;
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment to our 2010 Performance Incentive Plan that will increase the total shares of common stock available for issuance under the 2010 Performance
Incentive Plan from 1,050,000 to 2,050,000; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment to our certificate of incorporation to eliminate cumulative voting for the election of directors; </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment to our certificate of incorporation to increase our authorized shares of common stock from 25,000,000 to 50,000,000; and
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To transact such other business as may properly come before the Annual Meeting. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on March&nbsp;28, 2013 are entitled to notice of, and to vote at, the Annual Meeting. For 10 days prior to the Annual Meeting, a complete list of
stockholders entitled to vote at the Annual Meeting will be available for examination by any stockholder, for any purpose relating to the Annual Meeting, during ordinary business hours at our headquarters at the above address. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors, </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>/s/ SCOTT
CORMACK&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">President&nbsp;&amp; CEO </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bothell, Washington </FONT></P>  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;22, 2013
</FONT></P>  <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>YOUR VOTE IS IMPORTANT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING, WE ENCOURAGE YOU TO VOTE AND SUBMIT YOUR PROXY BY TELEPHONE, VIA THE INTERNET OR BY MAIL. FOR ADDITIONAL INSTRUCTIONS ON VOTING BY TELEPHONE OR VIA
THE INTERNET, PLEASE REFER TO YOUR PROXY CARD. TO VOTE AND SUBMIT YOUR PROXY BY MAIL, PLEASE COMPLETE, SIGN AND DATE THE ENCLOSED PROXY CARD AND RETURN IT IN THE ENCLOSED ENVELOPE. IF YOU ATTEND THE ANNUAL MEETING, YOU MAY REVOKE YOUR PROXY AND VOTE
IN PERSON. IF YOU HOLD YOUR SHARES THROUGH AN ACCOUNT WITH A BROKERAGE FIRM, BANK OR OTHER NOMINEE, PLEASE FOLLOW THE INSTRUCTIONS YOU RECEIVE FROM THEM TO VOTE YOUR SHARES. </B></FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 24, 2013
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Company&#146;s Proxy Statement and Annual Report on Form&nbsp;10-K for the year ended </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>December&nbsp;31, 2012 are available at <U>http://www.oncogenex.com</U>. </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_1">PROXY STATEMENT FOR 2013 ANNUAL MEETING OF STOCKHOLDERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_2">BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_3">General</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_4">Director Independence</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_5">Relationships Among Directors, Executive Officers and Director Nominees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_6">Stockholder Communication With the Board of Directors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_7">Related-Party Transactions Policy and Procedure</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_8">Board of Directors&#146; Committees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_9">Audit Committee Responsibilities</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_10">Board of Directors Leadership Structure</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_11">Board of Directors&#146; Role in Risk Oversight</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_12">Risk Assessment of Compensation Programs</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_13">Director Nomination Process</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_14">Code of Ethics</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_15">PROPOSAL ONE: ELECTION OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_16">Nominees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_17">Director Compensation Overview</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_18">Peer Group Used for Benchmarking 2012 Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_19">Director Compensation Policy</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_20">REPORT OF THE AUDIT COMMITTEE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_21">PROPOSAL TWO: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_22">Fees Billed by Independent Registered Public Accounting Firm</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_23">Policy on Audit Committee Pre-Approval of Audit Services and Permissible Non-Audit
Services</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_24">PROPOSAL THREE: APPROVAL OF AN AMENDMENT TO OUR 2010 PERFORMANCE INCENTIVE PLAN</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_25">Description of the 2010 Plan</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_26">Vote Required</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_27">PROPOSAL FOUR: APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO ELIMINATE CUMULATIVE VOTING FOR
 THE ELECTION OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_28">PROPOSAL FIVE: APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE OUR AUTHORIZED SHARES
 OF COMMON STOCK</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_29">COMPENSATION DISCUSSION AND ANALYSIS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_30">Compensation Objectives and Philosophy</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_31">Compensation Determination Process and the Role of Executive Officers in Compensation
Decisions</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_32">Benchmarking of Executive Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_33">Elements of Executive Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_34">Stock Ownership Guidelines</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_35">Perquisites</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_36">2012 Officer Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_37">Other Policies and Considerations</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_38">Compensation Committee Interlocks and Insider Participation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_39">Compensation Committee Report</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_40">EXECUTIVE COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_41">Summary Compensation Table</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_42">Fiscal 2012 Grants of Plan-Based Awards</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_43">Outstanding Equity Awards at Fiscal Year-End</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_44">Option Exercises and Stock Vested</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_45">Pension Benefits/Nonqualified Deferred Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_46">Potential Payments Upon Termination/Change of Control</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_47">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_48">OTHER MATTERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_49">Section&nbsp;16(a) Beneficial Ownership Reporting Compliance</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_50">Delivery of Documents to Stockholders Sharing an Address</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_51">Stockholder Proposals to Be Presented at 2014 Annual Meeting</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc511574_52">Transaction of Other Business</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_1"></A>ONCOGENEX PHARMACEUTICALS, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1522&#151;217th Place S.E., Suite 100 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Bothell, Washington 98021 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY STATEMENT FOR </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013 ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">This Proxy Statement is furnished in connection with the solicitation of proxies on behalf of the Board of Directors of OncoGenex Pharmaceuticals, Inc., a Delaware corporation, for use at the Annual
Meeting of Stockholders, or the Annual Meeting, to be held on May&nbsp;24, 2013, at 9:00 a.m. local time, or at any adjournment or postponement of the Annual Meeting, for the purposes set forth in this proxy statement and in the accompanying Notice
of Annual Meeting. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Annual Meeting will be held on May&nbsp;24, 2013 at the offices of Fenwick&nbsp;&amp; West LLP, 1191 Second
Avenue, 10th Floor, Seattle, Washington 98101. This Proxy Statement and accompanying proxy card will first be mailed on or about April&nbsp;22, 2013 to all stockholders entitled to vote at the Annual Meeting. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting Rights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of
record at the close of business on March&nbsp;28, 2013, the record date, are entitled to notice of and to vote at the Annual Meeting and any adjournment or postponement of the Annual Meeting. At the close of business on March&nbsp;28, 2013, we had
14,670,020 shares of common stock outstanding. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each stockholder of record is entitled to one vote for each share of common stock held on the
record date on all matters. Dissenters&#146; rights are not applicable to any of the matters being voted on. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All stockholders entitled to
vote at the Annual Meeting may cumulate votes in the election of directors. With cumulative voting, each stockholder is entitled to as many votes as shall be equal to the number of votes that the stockholder would be entitled to cast for the
election of directors multiplied by the number of directors to be elected by the stockholders, and each stockholder may cast all of his, her or its votes for a single director or may distribute them among the number to be voted for or for any two or
more of them. No stockholder, however, will be entitled to cumulate votes unless the name of the candidate or candidates for whom the votes would be cast has been placed in nomination prior to voting, and such stockholder has given notice, at the
Annual Meeting and prior to commencement of voting, of the stockholder&#146;s intention to cumulate votes. Otherwise, the proxies solicited by the Board of Directors confer discretionary authority in the proxy holders to cumulate votes so as to
elect the maximum number of nominees. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How to Vote Your Shares </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>YOUR VOTE IS IMPORTANT</B>. Your shares can be voted at the Annual Meeting only if you are present in person or represented by proxy. Whether or not you expect to attend the Annual Meeting, please take
the time to vote your proxy. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders of record, or &#147;registered stockholders,&#148; can vote by proxy in the following three ways:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="95%%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>By Telephone:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Call the toll-free number indicated on the enclosed proxy card and follow the recorded instructions.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Via the Internet:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Go to the website indicated on the enclosed proxy card and follow the instructions provided.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>By Mail:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mark your vote, date, sign and return the enclosed proxy card in the postage-paid return envelope provided.</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are held beneficially in &#147;street&#148; name through a nominee such as a financial
institution, brokerage firm, or other holder of record, your vote is controlled by that institution, firm or holder. Your vote by proxy may also be cast by telephone or via the Internet, as well as by mail, if your financial institution or brokerage
firm offers such voting alternatives. Please follow the specific instructions provided by your nominee on your voting instruction card. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Even
if you have given your proxy, you still may vote in person if you attend the Annual Meeting. Please note, however, that if your shares are held beneficially through a bank, broker or other nominee and you wish to vote at the Annual Meeting, you must
obtain a proxy issued in your name from the record holder. Should you wish to attend the Annual Meeting, directions to Fenwick&nbsp;&amp; West LLP at 1191 Second Avenue, 10th Floor, Seattle, Washington 98101 can be found on its website at:
http://www.fenwick.com/fenwickfocus/1.5.4.asp. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Voting of Proxies </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">All shares represented by a valid proxy received prior to the Annual Meeting will be voted, and, if you provide specific instructions, your shares will be voted as you instruct. If you sign your proxy
card with no further instructions and do not hold your shares beneficially through a broker, bank or other nominee, your shares will be voted: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR each of the nominees for the Board of Directors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR the ratification of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31,
2013; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR the approval of an amendment to our 2010 Performance Incentive Plan that will increase the total shares of common stock available for issuance
under the 2010 Performance Incentive Plan from 1,050,000 to 2,050,000; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR the approval of an amendment to our certificate of incorporation to eliminate cumulative voting for the election of directors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">FOR the approval of an amendment to our certificate of incorporation to increase our authorized shares of common stock from 25,000,000 to 50,000,000;
and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">in the discretion of the proxy holders with respect to any other matters that properly come before the Annual Meeting or any adjournment or
postponement of the Annual Meeting. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Revocability of Proxies </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">You may revoke or change any previously delivered proxy that does not state that it is irrevocable at any time before the Annual Meeting by delivering a written notice of revocation or another proxy with
a later date to our Secretary at our headquarters at 1522&#151;217th Place S.E., Suite 100, Bothell, Washington 98021. You may also revoke your proxy by attending the Annual Meeting and voting in person, although attendance at the Annual Meeting
will not, by itself, revoke a proxy. If you hold shares in street name through a broker, bank or other nominee, you must contact that bank, broker or other nominee to revoke any prior voting instructions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Quorum </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The presence, in person or by
proxy, of at least a majority of the shares of common stock outstanding on the record date will constitute a quorum. Both abstentions and broker non-votes are counted for the purpose of determining the presence of a quorum. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Votes Required to Approve Matters Presented at the Annual Meeting </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our directors are elected by a plurality of the votes of shares of common stock present in person or represented by proxy and entitled to vote at the Annual Meeting. Ratification of the selection of
Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm and the approval of an amendment to our 2010 Performance Incentive Plan requires the affirmative vote of a majority of the shares of common stock properly cast at the
Annual Meeting. The approval of each of the amendments to our certificate of incorporation requires the affirmative of the majority of the outstanding shares of common stock entitled to vote at the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Broker Non-Votes </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Banks, brokers or other nominees are entitled to vote shares held for a beneficial owner on &#147;routine&#148; matters without instructions from the beneficial owner of those shares. Absent instructions
from the beneficial owner of such shares, a bank, broker or other nominee is not, however, entitled to vote shares held for a beneficial owner on certain &#147;non-routine&#148; matters. The election of our directors, the approval of an amendment to
our 2010 Performance Incentive Plan and the approval of each of the amendments to our certificate of incorporation will each be treated as a non-routine matter. The ratification of the selection of Ernst&nbsp;&amp; Young LLP as our independent
public accounting firm will be treated as a routine matter, and, therefore, no broker non-votes are expected to exist with respect to this proposal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you hold your shares in street name, it is critical that you cast your vote if you want it to count on all matters to be decided at the Annual Meeting. If you hold your shares in street name and you do
not instruct your bank, broker or other nominee how to vote in the election of directors, the approval of an amendment to our 2010 Performance Incentive Plan and the approval of each of the amendments to our certificate of incorporation, no votes
will be cast on your behalf with respect to these proposals. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As noted above, broker non-votes are counted for purposes of determining whether
or not a quorum exists for the transaction of business at the Annual Meeting. Broker non-votes, as well as abstentions from voting, will not, however, be treated as votes cast and, therefore, will have no effect on the election of directors, the
ratification of the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm or the approval of the amendment to our 2010 Performance Incentive Plan. Because approval of each of the amendments to our certificate
of incorporation requires the affirmative vote of the majority of shares of common stock entitled to vote on the proposal, as opposed to shares cast at the Annual Meeting, broker non-votes and abstentions will have the effect of votes against each
of the amendments to our certificate of incorporation. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Solicitation of Proxies </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have engaged The Proxy Advisory Group, LLC, to assist in the solicitation of proxies and provide related advice and informational support, for a
services fee and the reimbursement of customary disbursements that, collectively, are not expected to exceed $15,000. We will bear the cost of soliciting proxies, including preparing, assembling, printing and mailing this Proxy Statement, the proxy
card and any additional information furnished to stockholders. Copies of solicitation materials will be furnished to banks, brokerage houses, fiduciaries and custodians holding in their names shares of common stock beneficially owned by others to
forward to such beneficial owners. We may reimburse persons representing beneficial owners of common stock for their costs of forwarding solicitation materials to such beneficial owners. Original solicitation of proxies by mail may be supplemented
by telephone, telegram, via the Internet or by personal solicitation by our directors, officers or other regular employees. No additional compensation will be paid to these individuals for such services. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Availability of Proxy Statement and Annual Report on Form 10-K </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Proxy Statement and Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2012 are available at www.sec.gov and on our website at http://ir.oncogenex.com/financials.cfm. We have
provided to each stockholder of record as of March&nbsp;28, 2013 , a copy of our consolidated financial statements and related information, which are included in our Annual Report on Form 10-K for fiscal year 2012. We will mail without charge, upon
written request, a copy of our Annual Report on Form 10-K for fiscal year 2012, including the consolidated financial statements, schedules and list of exhibits, and any particular exhibit specifically requested. Requests should be sent to: OncoGenex
Pharmaceuticals, Inc., 1522&#151;217th Place S.E., Suite 100, Bothell, Washington 98021, Attention: President. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_2"></A>BOARD OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_3"></A>General </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors are elected at each annual stockholders meeting to hold office until the next annual meeting or until their successors are elected and have
qualified. Currently, there are six members of the Board of Directors. The following table sets forth information with respect to our current directors. The ages of such persons are shown as of December&nbsp;31, 2012. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Municipality of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:89pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Residence</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Director&nbsp;Since</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vancouver, Canada</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, President and Chief Executive Officer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2008</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neil Clendeninn</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Hanalei, Hawaii</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, Chairperson of the Compensation Committee and Member of the Nominating and Governance Committee</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2008</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kamuela, Hawaii</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chairperson of the Board of Directors, Member of the Compensation Committee, Member of the Nominating and Governance Committee and Member of the Audit Committee</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin Mattingly</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Diego, California</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">55</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, Member of the Compensation Committee and Member of the Audit Committee</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Parker</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Seattle, Washington</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, Chairperson of the Nominating and Governance Committee and Member of the Audit Committee</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David Smith</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alamo, California</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, Chairperson of the Audit Committee and Member of the Nominating and Governance Committee</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors held a total of six meetings during fiscal year 2012. During fiscal year 2012, each of our
incumbent directors attended at least 75&nbsp;% of the aggregate of (i)&nbsp;the total number of meetings of the Board of Directors held during the period he or she was a director and (ii)&nbsp;the total number of meetings held by all committees on
which the director served during the period he or she was a member. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we do not have a formal policy regarding attendance by directors
at annual meetings of stockholders, we encourage directors to attend and, historically, most have done so. All of our current directors were in attendance at the 2012 annual meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our Corporate Governance Guidelines, the Board of Directors is required to hold at least four regularly scheduled meetings each year. At least one of these meetings must include budgeting and
long-term strategic planning. Each director is expected to attend no fewer than 75% of the total of all meetings of the Board of Directors and meetings of the committees on which he or she serves. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Set forth below are the names of, and information concerning, our current directors. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Scott Cormack</I>, 47, has been our President, Chief Executive Officer and a director since August 2008. He was a co-founder of OncoGenex Technologies Inc., which is our wholly owned subsidiary, and
has been its President since May 2000, its Chief Executive Officer since February 2002 and a member of its Board of Directors since May 2000. Mr.&nbsp;Cormack served as interim President, Chief Executive Officer and Chairman of the Board of
Directors of Salpep Biotechnology Inc., an asthma and inflammation biotechnology company, from 2000 to 2001. From 1998 to 2001, Mr.&nbsp;Cormack served as Vice President of Milestone Medica Corporation, a seed venture capital firm investing in life
sciences opportunities. Mr.&nbsp;Cormack holds a B.S. degree from the University of Alberta. The determination was made that Mr.&nbsp;Cormack should serve on our Board of Directors due to our belief that it is of importance that the Board of
Directors have the benefit of management&#146;s perspective and, in particular, that of the Chief Executive Officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Neil Clendeninn</I>,
M.D., Ph.D., 63, has served as a director since August 2008. Additionally, he has served as a member of OncoGenex Technologies Inc.&#146;s Board of Directors since September 2004. Dr.&nbsp;Clendeninn served as Corporate Vice President, Head of
Clinical Affairs of Agouron Pharmaceuticals, Inc., a biopharmaceutical company and a subsidiary of Pfizer Inc., a pharmaceutical company, from 1993 until his retirement in 2001. Dr.&nbsp;Clendeninn holds a B.A. degree in biology/chemistry from
Wesleyan University, and a Ph.D. degree in microbiology/pharmacology and an M.D. degree from New York University. The determination was made that Dr.&nbsp;Clendeninn should serve on our Board of Directors due to his training and experience as a
medical oncologist and his executive-level experience in public development-stage oncology-focused companies. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Jack Goldstein</I>, Ph.D., 65, has served as our Chairman of the Board of Directors since March 2010.
Dr.&nbsp;Goldstein was President and Chief Operating Officer of Chiron Corporation, a biotechnology company, from November 2004 until its acquisition by Novartis AG in April 2006, prior to which he served as Vice President and President, Chiron
Blood Testing Division beginning in 2002. From 2000 to 2002, Dr.&nbsp;Goldstein was General Partner at Windamere Venture Partners, L.L.C., a venture capital fund. From 1997 to 2001, he served as President and Chief Executive Officer of Applied
Imaging Corporation, a supplier of instrument systems for prenatal and cancer genetics, where he also served as Chairman of the Board of Directors from 1999 to 2002. Dr.&nbsp;Goldstein currently serves on the Board of Directors of Accuray
Incorporated and has served as a director of Orasure Technologies Inc. from May 2006 to May 2011, Illumina, Inc. from June 2006 to May 2010, and Immucor, Inc. from December 2007 to February 2009. Dr.&nbsp;Goldstein holds a B.A. degree in biology
from Rider University, and a M.S. degree in immunology and a Ph.D. degree in microbiology from St. John&#146;s University. The determination was made that Dr.&nbsp;Goldstein should serve on our Board of Directors as a result of his extensive
experience as a senior executive and as a chair of the board of directors of both publicly held and privately held biotechnology or pharmaceutical companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Martin Mattingly</I><B></B>, Pharm.D., 55, has served as a director since June 2010. Since August 2012, Dr.&nbsp;Mattingly has served as a member of Tech Coast Angles. Previously,
Dr.&nbsp;Mattingly served as the Chief Executive Officer of Trimeris, Inc., a biopharmaceutical company, from November 2007 until its merger with Synageva in November 2011. He also served on the Board of Directors of Trimeris, Inc. from November
2007 until November 2011. From 2005 to 2007, Dr.&nbsp;Mattingly was employed at Ambrx, Inc., a biopharmaceutical company, where he served as President and Chief Executive Officer. From 2003 to 2005, Dr.&nbsp;Mattingly served as Executive Vice
President and Chief Operating Officer of CancerVax Corporation, a biotechnology company. From 1996 to 2003, he provided senior leadership in various management positions at Agouron Pharmaceuticals, Inc. and Pfizer, Inc., including serving as General
Manager of the Agouron HIV division, Vice President, Product Development Group at Pfizer and Vice President, Global Marketing Planning at Pfizer. Dr.&nbsp;Mattingly holds a Pharm.D. degree from the University of Kentucky. The determination was made
that Dr.&nbsp;Mattingly should serve on the Board of Directors as a result of his executive leadership experience in late-stage clinical development, public company expertise, and commercialization and business development experience with
pharmaceuticals and biologics. <B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stewart Parker</I>, 57, has served as a director since March 2010. Ms.&nbsp;Parker has served as
the Chief Executive Officer of the Infectious Disease Research Institute, or IDRI, a nonprofit research organization focused on the development of products for the diagnosis, prevention, and treatment of neglected diseases since March 2011. Prior to
IDRI, Ms.&nbsp;Parker managed the formation of Targeted Genetics Corporation, a biotechnology company, as a wholly owned subsidiary of Immunex Corporation, a biotechnology company, and served as its President and Chief Executive Officer and as a
director from its spinout from Immunex Corporation in 1992 to November 2008. She served in various capacities at Immunex Corporation from August 1981 through December 1991, most recently as Vice President, Corporate Development. She served on the
Board of Directors and the executive committee of BIO, the primary trade organization for the biotechnology industry. Ms.&nbsp;Parker has also served as a director of Targeted Genetics Corporation from 1992 to November 2008 and Neose Technologies,
Inc. from May 2005 to January 2009. Ms.&nbsp;Parker received her B.A. and M.B.A. degrees from the University of Washington. The determination was made that Ms.&nbsp;Parker should serve on our Board of Directors due to her executive leadership
experience in development-stage clinical development, public company expertise, and business development experience for pharmaceuticals and biologics. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>David Smith</I>, 53, has served as a director since August 2010. Since June 2012 Mr.&nbsp;Smith has served as Chief Operating Officer of IntegenX, Inc., an applied genomics company. From December 2006
to July 2011, Mr.&nbsp;Smith was the Executive Vice President and Chief Financial Officer of Thoratec Corporation, a medical device company. Mr.&nbsp;Smith served as the Vice President and Chief Financial Officer of Chiron Corporation from April
2003 to April 2006, as its Vice President, Finance from February 2002 to April 2003 and as its Vice President and Principal Accounting Officer from February 1999 to February 2002. Mr.&nbsp;Smith earned a B.A degree in economics and history from
Willamette University and a M.B.A degree in finance from Golden Gate University. In the past five years, he served as a director and chair of the audit committee of Perlegen Sciences, Inc. from May 2006 to November 2009. The determination was made
that Mr.&nbsp;Smith should serve on our Board of Directors due to his financial expertise and extensive experience as a senior executive at publicly held biotechnology companies. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_4"></A>Director Independence </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors has determined that
each of our nominees for director, other than Mr.&nbsp;Cormack, is &#147;independent&#148; under the applicable Securities and Exchange Commission, or the SEC, rules and the criteria established by The Nasdaq Stock Market LLC., or NASDAQ.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_5"></A>Relationships Among Directors, Executive Officers and Director Nominees </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no family relationships among any of our directors, executive officers or director nominees. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_6"></A>Stockholder Communication With the Board of Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders who are interested in communicating directly with members of the Board of Directors, or the Board of Directors as a group, may do so by
writing directly to the member(s) c/o President, OncoGenex Pharmaceuticals, Inc., 1522&#151;217th Place S.E., Suite&nbsp;100, Bothell, Washington 98021. The President will promptly forward to the Board of Directors or the individually named
directors all written communications received at the above address that the Secretary considers appropriate. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_7"></A>Related-Party Transactions Policy and Procedure </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Audit Committee is responsible for reviewing and approving all related-party transactions and conflict of interest situations involving a principal stockholder, a member of the Board of Directors or
senior management. Our Code of Conduct and Business Ethics requires our executive officers and directors to report any conflicts of interest with our interests to our Audit Committee, and generally prohibits our executive officers and directors from
conflicts of interest with our interests. Waivers of our Code of Conduct and Business Ethics with respect to an executive officer or director may only be granted by the Board of Directors or, if permitted by NASDAQ and any other applicable stock
exchange&#146;s rules, our Nominating and Governance Committee. We do not have a specific policy concerning approval of transactions with stockholders who own more than five percent of our outstanding shares. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have determined that there were no reportable related-party transactions in fiscal year 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_8"></A>Board of Directors&#146; Committees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has established separately designated Audit, Compensation and Nominating and Governance Committees to assist it in performing its responsibilities. The Board of Directors designates
the members of these committees and the committee chairs annually, based on the recommendations of the Nominating and Governance Committee in consultation with the Chief Executive Officer and the Chairperson of the Board of Directors. The Nominating
and Governance Committee reviews committee assignments from time to time and considers the rotation of committee chairpersons and members with a view towards balancing the benefits derived from the diversity of experience and viewpoints of the
directors. The Board of Directors has adopted written charters for each of these committees, which are available on our website at http://ir.oncogenex.com under &#147;Corporate Governance.&#148; The chairperson of each committee develops the agenda
for that committee and determines the frequency and length of committee meetings. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><A NAME="toc511574_9"></A>Audit Committee and Audit
Committee Financial Expert </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has been established in accordance with Section&nbsp;3(a)(58)(A) of the Securities
Exchange Act of 1934, as amended, or the Exchange Act, and is currently comprised of David Smith (Chairperson), Jack Goldstein, Martin Mattingly and Stewart Parker, each of whom the Board of Directors has determined satisfies the applicable SEC and
NASDAQ independence requirements for audit committee members. The Board of Directors has also determined that Mr.&nbsp;Smith is an &#147;audit committee financial expert,&#148; as defined by the applicable rules of the SEC. The Audit Committee held
six meetings during fiscal year 2012. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Audit Committee Responsibilities </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee is responsible for, among other things: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing the independence, qualifications, services, fees and performance of our independent registered public accounting firm;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">appointing, replacing and discharging our independent registered public accounting firm; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">pre-approving the professional services provided by our independent registered public accounting firm; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing the scope of the annual audit and reports and recommendations submitted by our independent registered public accounting firm; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewing our financial reporting and accounting policies, including any significant changes, with our management and our independent registered public
accounting firm. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please see the sections entitled &#147;Report of the Audit Committee&#148; and &#147;Proposal Two:
Ratification of Appointment of Independent Registered Public Accounting Firm&#148; for further matters related to the Audit Committee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Committee </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee currently consists of Neil Clendeninn (Chairperson), Jack Goldstein and Martin Mattingly, each of whom the Board of Directors has determined satisfies the applicable SEC and
NASDAQ independence requirements. In addition, each member of the Compensation Committee has been determined to be an outside director under Section&nbsp;162(m), of the Internal Revenue Code of 1986, as amended, or the Code, and a non-employee
director under Rule 16b-3 as promulgated under the Exchange Act. The Compensation Committee reviews and recommends to the Board of Directors the compensation for our executive officers and our non-employee directors for their services as members of
the Board of Directors. The Compensation Committee does not have any explicit authority to delegate its duties. The Compensation Committee held six meetings during fiscal year 2012. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In 2011, the Compensation Committee retained Radford, an Aon Consulting company, to provide a report summarizing relevant benchmark data relating to industry-appropriate peers and make recommendations
regarding base salary, target total cash (base salary plus target cash incentives) and the amounts and terms of long-term equity incentive awards for our executives as well as to benchmark and make recommendations regarding the initial and annual
cash retainer amounts for directors and chairpersons of the Board of Directors and the various committees, as well as the amounts and terms of initial and annual long-term equity incentive awards for directors. The Chief Executive Officer then made
recommendations to the Compensation Committee regarding compensation levels for the directors, committee members and executive officers, excluding himself, based on Radford&#146;s recommendations for each. The Compensation Committee, in turn, made
recommendations to the Board of Directors regarding compensation levels effective January&nbsp;1, 2012. A further detailed evaluation by Radford for the executive officers occurred in 2012 and the same process was followed for recommendations
regarding compensation levels for the executive officers effective January&nbsp;1, 2013. No work performed by Radford during fiscal year 2012 raised a conflict of interest. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Please see the sections entitled &#147;Compensation Discussion and Analysis&#148; and &#147;Director Compensation&#148; for further matters related to the Compensation Committee and director and executive
officer compensation matters. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Nominating and Governance Committee </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Governance Committee currently consists of Stewart Parker (Chairperson), Neil Clendeninn, Jack Goldstein and David Smith, each of whom the Board of Directors has determined satisfies
the applicable SEC and NASDAQ independence requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Governance Committee reviews, evaluates and proposes candidates
for election to our Board of Directors, and considers any nominees properly recommended by stockholders. The Nominating and Governance Committee promotes the proper constitution of our Board of Directors in order to meet its fiduciary obligations to
our stockholders, and oversees the establishment of, and compliance with, appropriate governance standards. The Nominating and Governance Committee held four meetings during fiscal year 2012. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_10"></A>Board of Directors Leadership Structure </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein, a
non-employee independent director, has served as the Chairperson of the Board of Directors since March 2010. We do not currently have a policy mandating the separation of the roles of Chairperson and Chief Executive Officer. This allows the Board of
Directors flexibility to determine whether the two roles should be combined or separated based on our needs and the Board of Directors&#146; assessment of its leadership from time to time. The Board of Directors, however, believes such separation is
currently appropriate, as it enhances the accountability of the Chief Executive Officer to the Board of Directors and strengthens the independence of the Board of Directors from management. In addition, by separating these roles, Mr.&nbsp;Cormack
can focus his efforts on running our business and managing the day-to-day challenges that we are faced with, while allowing the Board of Directors to benefit from Dr.&nbsp;Goldstein&#146;s extensive experience as a director of various public
companies. The Board of Directors believes Dr.&nbsp;Goldstein is best suited to be Chairperson of the Board of Directors because of his extensive experience as a senior executive and as a chair of biotechnology and pharmaceutical company Boards of
Directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Chairperson of the Board of Directors is responsible for managing the Board of Directors&#146; business, including setting the
agenda (with the input of directors and management), facilitating communication among directors, presiding at meetings of the Board of Directors and stockholders, serving as chairperson at each regularly scheduled Board of Directors meeting and
providing support and counsel to the Chief Executive Officer. Pursuant to our Corporate Governance Guidelines, the Board of Directors is free to choose the Chairperson of the Board of Directors in any manner that is in our best interests at the
time. The Corporate Governance Guidelines identify a number of non-exclusive factors for the Board of Directors to consider in the selection process, including the current size of our business, the composition of the Board of Directors, the current
candidates for the position, applicable regulations and our succession planning goals. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_11"></A>Board of Directors&#146; Role in Risk Oversight </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with our leadership structure, our management is charged with the day-to-day management of risks that we face or may face and provides our
Board of Directors with quarterly risk assessment and mitigation strategy updates, while our Board of Directors and its committees are responsible for oversight of risk management. The Audit Committee has responsibility for oversight of financial
reporting related risks, including those related to our accounting, auditing and financial reporting practices. In addition, the Audit Committee annually reviews and assesses the adequacy of our risk management policies and procedures with regard to
identifying our management of financial risks, reviews the quarterly updates on these risks that are received from management, and assesses the adequacy of management&#146;s implementation of appropriate systems to mitigate and manage financial
risks. Furthermore, under our Code of Business Conduct and Ethics, the Audit Committee is responsible for considering reports of conflicts of interest involving officers and directors. The Nominating and Governance Committee oversees corporate
governance risks, including implementing procedures to ensure that the Board of Directors operates independently of management and without conflicts of interest. In addition, the Nominating and Governance Committee oversees compliance with our Code
of Business Conduct and Ethics. The Compensation Committee oversees risks associated with our compensation policies, plans and practices. The Audit Committee, the Nominating and Governance Committee and the Compensation Committee each report to the
Board of Directors regarding the foregoing matters, and the Board of Directors approves any changes in corporate policies, including those pertaining to risk management </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has also adopted a Whistle Blowing Policy, which provides a means by which concerns about actual and suspected violations of our Code of Business Conduct and Ethics and other public
interest matters are to be reported. We recognize that individuals may not feel comfortable reporting a matter directly to the appropriate persons at the company and therefore the Whistle Blowing Policy provides a mechanism by which a person may
report a matter to NASDAQ OMX Group Corporate Services, Inc., a third party retained by us. Under the policy, the Chairperson of the Audit Committee determines whether and, if so, how an investigation is to be conducted and, together with the full
Audit Committee in certain instances, resolves reported violations. In all cases, a report of the outcome is to be made to the Board of Directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_12"></A>Risk Assessment of Compensation Programs </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have determined
that our compensation policies, plans and practices are appropriately balanced and do not create risks that are reasonably likely to have a material adverse effect on our company. To make this determination, our management reviewed the compensation
policies, plans and practices for our executive officers, as well as for all other employees. We assessed the following features of our compensation, plans and practices: design, payment methodology, potential payment volatility, relationship to our
financial results, length of performance period, risk-mitigating features, performance measures and goals, oversight and controls, and plan features and values compared to market practices. Based on this review, we believe that our compensation
policies, plans and practices do not create risks that are reasonably likely to have a material adverse effect on our company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_13">
</A>Director Nomination Process </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Director Qualifications </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Members of our Board of Directors must have broad experience and business acumen, a record of professional accomplishment in his or her field, and demonstrated honesty and integrity consistent with our
values. In evaluating director nominees, the Nominating and Governance Committee considers a variety of factors, including, without limitation, the director nominee&#146;s skills, expertise and experience, wisdom, integrity, the ability to make
independent analytical inquiries, the ability to understand our business environment, the willingness to devote adequate time to Board of Directors duties, the interplay of the director nominee&#146;s experience and skills with those of other
directors, and the extent to which the director nominee would be a desirable addition to the Board of Directors and any committees of the Board of Directors. The Nominating and Governance Committee may also consider such other factors as it may deem
are in the best interests of us and our stockholders. Additionally, in accordance with the applicable securities laws and NASDAQ requirements, a majority of the members of the Board of Directors must be &#147;independent.&#148; We do not have a
policy regarding diversity, but the Nominating and Governance committee does and will continue to consider each candidate&#146;s experiences and qualities as described above and how these experiences and qualities complement the diversity of the
Board of Directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Identification of Nominees by the Board of Directors </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Governance Committee identifies nominees by first determining the desired skills and experience of a new nominee based on the
qualifications discussed above. The Nominating and Governance Committee will solicit names for possible candidates from other directors, our senior level executives and individuals personally known to the directors, as well as third-party search
firms. The Nominating and Governance Committee evaluates all possible candidates, including individuals recommended by stockholders, using the same criteria. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stockholder Nominations </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our bylaws contain provisions that address the process by which a stockholder may nominate an individual to stand for election to the Board of Directors. The Nominating and Governance Committee will
consider nominees properly recommended by stockholders. Stockholders wishing to submit nominations must provide timely written notice to our Corporate Secretary containing the following information: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the name and address of the stockholder proposing such business, which we refer to as a Nominating Person; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the class and number of our shares that are owned beneficially by the Nominating Person; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">description of any agreement, arrangement or understanding with respect to Nominating Person and their respective affiliates or associates and each
director nominee proposed by the Nominating Person; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">description of any agreement, arrangement or understanding that has been entered into as of the date of the notice by the Nominating Person, whether or
not such instrument or right is subject to settlement in underlying shares of capital stock of ours, the effect or intent of which is to mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease the voting power
of, the Nominating Person, with respect to securities of the corporation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the Nominating Person is a holder of record of stock of ours entitled to vote at the Annual Meeting and intends to appear in person or by proxy at the
meeting to propose such nomination; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the Nominating Person intends to deliver a proxy statement and/or form of proxy to holders of a sufficient number of holders of our voting shares to
elect such nominee or nominees; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">with respect to each director nominee proposed by the Nominating Person, such nominee&#146;s written consent to being named in our proxy statement as a
nominee and to serving as a director, if elected; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">such other information regarding the Nominating Person and each nominee proposed by the Nominating Person as would be required to be disclosed in a
proxy statement or other filings required to be made in connection with the solicitations or proxies for election of directors, or would be otherwise required, in each case pursuant to Regulation 14A under the Exchange Act and the rules and
regulations promulgated under the Exchange Act. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To be timely, a Nominating Person&#146;s notice in respect of a director
nomination must be delivered to or mailed and received by our Corporate Secretary at our principal executive offices, OncoGenex Pharmaceuticals, Inc., 1522&#151;217th Place S.E., Suite 100, Bothell, Washington 98021, not less than 90 nor more than
120 calendar days prior to the first anniversary of the previous year&#146;s annual meeting. In the event, however, that the date of the annual meeting is more than 30 days before or more than 60 days after the anniversary date, notice must be
delivered no more than 120 and not less than 90 days prior to the annual meeting or the close of business on the tenth day following the date which public disclosure of the date of such meeting is made. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_14"></A>Code of Ethics </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that sound corporate governance policies are essential to earning and retaining the trust of investors. We are committed to maintaining the
highest standards of integrity. We have adopted a Code of Business Conduct and Ethics that is applicable to our principal executive officer, our principal financial officer and our principal accounting officer, as well as to all of our other
employees and directors, and have posted such code on our website at http://ir.oncogenex.com/governance.cfm. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_15"></A>PROPOSAL ONE: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_16"></A>Nominees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
following persons are our 2013 director nominees, each of whom was recommended by the Nominating and Governance Committee and approved by the Board of Directors for nomination at the Annual Meeting: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neil Clendeninn </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin Mattingly </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Parker </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">David Smith </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless
otherwise instructed, the proxy holders will vote the proxies received by them for the nominees named above. If a nominee is unable or declines to serve as a director at the time of the Annual Meeting, the proxies will be voted for any nominee who
is designated by the present Board of Directors to fill the vacancy. Each nominee has consented to being named in this Proxy Statement and to serve if elected. We do not expect that any nominee will be unable or decline to serve as a director. Each
director is elected annually to serve until the next annual meeting of stockholders or until a successor has been duly elected and has qualified. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our current directors are Neil Clendeninn, Scott Cormack, Jack Goldstein, Martin Mattingly, Stewart Parker and David Smith, all of whom served on the Board of Directors throughout 2012. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Biographies of our 2013 director nominees are located above under the heading &#147;Board of Directors &#150; General.&#148; </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_17"></A>Director Compensation Overview </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The charter of the Compensation Committee provides that the Compensation Committee is to recommend to the Board of Directors matters related to director compensation. The director compensation package for
non-employee directors consists of annual cash compensation and an award of restricted stock units and stock options exercisable to purchase shares of our common stock. None of our employees is entitled to receive compensation for service as a
director. Our current director compensation policy was adopted in 2011, went into effect as of January&nbsp;1, 2012, and is set forth below under the heading &#147;Director Compensation Policy &#150; 2012 Director Compensation&#148;. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_18"></A>Peer Group Used for Benchmarking 2012 Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our management regularly reviews peer group data to determine whether total direct compensation and each component of the compensation package are approximately equal to the targeted 50th percentile for
director compensation of our peer company list. Based on this review, management makes recommendations to the Compensation Committee that they deem necessary to align director compensation with the foregoing peer group target. The peer group
companies are amended from time to time at the discretion of the Board of Directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our most recent evaluation of peer group companies for
purposes of establishing director compensation occurred in 2011, when we were establishing our director compensation policy for 2012. At that time, in consideration of our market capitalization and number of employees, the Compensation Committee
recommended, and the Board of Directors approved, a peer group based on the following characteristics: </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commercial life sciences companies in late stages of product development; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies located in biotechnology hub markets (Seattle, San Francisco, San Diego and Boston) to reflect the recruiting market for executive talent;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies with market values between $100 million and $500 million; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies with generally less than 100 employees. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development spending, available cash and enterprise value were also examined as additional
metrics to help determine appropriate peer companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the foregoing criteria, and the recommendations of Radford, the Compensation
Committee recommended, and the Board of Directors approved, the following peer group for purposes of establishing our current director compensation policy: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alnylam Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Keryx Biopharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amicus Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medivation, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ardea Biosciences, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Micromet, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arqule Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Omeros Corporation</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aveo Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Oncothyreon Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cell Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peregrine Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Celldex Therapeutics, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rigel Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cytokinetics, Incorporated</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo Biosciences, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CytRx Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Synta Pharmaceuticals Corp.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vical Incorporated</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Infinity Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_19"></A>Director Compensation Policy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>2012 Director Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As part of its evaluation of compensation levels for the 2012
fiscal year, the Compensation Committee recommended and the Board of Directors approved the retention of Radford to review compensation levels of our independent directors and committee members. Radford is a provider of compensation market
intelligence to the technology and life sciences industries. Radford was instructed to benchmark and make recommendations regarding the initial and annual retainer amounts for directors and chairpersons of the Board of Directors and the various
committees, as well as the amounts and terms of initial and annual long-term equity incentive awards for directors. The Chief Executive Officer then made recommendations to the Compensation Committee regarding compensation levels for the directors,
excluding himself, and committee members based on Radford&#146;s recommendations for each. The Compensation Committee, in turn, made recommendations to the Board of Directors. In November 2011, the Board of Directors approved changes to the
compensation for non-employee directors in connection with their service on the Board of Directors and its committees for the 2012 fiscal year consistent with Radford&#146;s recommendations, as follows: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An annual retainer of $65,000 is paid to the Chairperson of the Board of Directors or the lead director and $40,000 is paid to all other non-employee
directors, together with an excess meeting fee of $2,000 for each meeting held over 10 annual meetings. These retainers are paid in four quarterly installments. Each quarterly payment is conditioned on the director remaining a director on the date
of actual payment, which is typically within 10 days following the completion of the respective calendar quarter. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional annual cash compensation for the chairpersons and members of each committee as set forth in the following table and paid on the same
schedule and on the same terms as the non-employee director compensation described above: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Chairperson</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Other&nbsp;Members</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Committee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Compensation Committee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Nominating and Governance Committee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">New directors receive a one-time initial grant of stock options to acquire 8,000 shares of our common stock upon becoming a director, which initial
grant vests over three years, with 1/3 vesting at each of the first, second and third anniversaries of the date of grant. In addition, new directors also receive an initial grant of restricted stock units, or RSUs, to acquire 4,000 shares of our
common stock, or the cash settlement equivalent, which RSUs will vest upon achievement of specified performance goals outlined in an award agreement based on performance criteria set out in the 2010 Performance Incentive Plan.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each director that is re-elected by our stockholders at an annual meeting receives a grant of stock options to acquire 4,000 shares of common stock and
RSUs to acquire 2,000 shares of common stock, or the cash settlement equivalent, promptly following re-election. Any director who is appointed or elected to the Board of Directors for the first time subsequent to
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
December&nbsp;31, 2011, and who receives an initial stock option and RSU grant, will receive a first annual stock option and RSU grant in an amount equal to the product of the number of shares of
common stock that would otherwise be subject to such annual stock option and RSU grant multiplied by the fraction of a year during which the director serves on the Board of Directors immediately preceding the date of the annual meeting. Each annual
stock option grant will vest in full on the first anniversary of the date of grant. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">These cash compensation changes to our
director compensation policy became effective as of January&nbsp;1, 2012 and the equity compensation changes became effective as of May&nbsp;31, 2012, the date of our 2012 Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Director Compensation Paid for 2012 </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table summarizes all compensation paid
to or earned by our non-employee directors for fulfilling their duties as directors during the 2012 fiscal year. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($) <SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> (2)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Restricted<BR>Stock&nbsp;Units<BR>($)
<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"> (2)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neil Clendeninn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">143,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin Mattingly</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Parker</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">116,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David Smith</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The dollar amounts reflect the aggregate grant date fair value of equity awards granted within the fiscal year in accordance with the Financial Accounting Standards
Board, or FASB, Accounting Standards Codification Topic 718 for stock-based compensation. These amounts do not correspond to the actual cash value that will be recognized by the directors when received. Assumptions used in the calculation of the
amounts in this column are included in note 11 to our audited consolidated financial statements included in our 2012 Annual Report on Form 10-K. As of December&nbsp;31, 2012, the following directors had the following number of options and RSUs
outstanding: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neil Clendeninn: 39,308 options, of which 35,308 were vested as of December&nbsp;31, 2012, and 2,000 RSUs. In addition, 4,000 options and 2,000 RSUs
vest on May&nbsp;23, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein: 12,961 options, of which 8,567 were vested as of December&nbsp;31, 2012, and 2,000 RSUs. In addition, 394 options vest on
March&nbsp;23, 2013, and 4,000 options and 2,000 RSUs vest on May&nbsp;23, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin Mattingly: 13,000 options, of which 7,166 were vested as of December&nbsp;31, 2012, and 2,000 RSUs. In addition, 4,000 options and 2,000 RSUs
vest on May&nbsp;23, 2013 and 1,834 options vest on June&nbsp;8, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Parker: 12,961 options, of which 8,567 were vested as of December&nbsp;31, 2012, and 2,000 RSUs. In addition, 394 options vest on
March&nbsp;23, 2013, and 4,000 options and 2,000 RSUs vest on May&nbsp;23, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">David Smith: 13,000 options, of which 7,166 were vested as of December&nbsp;31, 2012, and 2,000 RSUs. In addition, 4,000 options and 2,000 RSUs vest on
May&nbsp;23, 2013 and 1,834 options vest August&nbsp;9, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These options and RSUs were granted on May&nbsp;31, 2012 under our 2010 Performance Incentive Plan and vest 100% on the earlier of the one-year anniversary of the date
of grant or the day immediately prior to the 2013 Annual Meeting of Stockholders. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS UNANIMOUSLY
RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE ELECTION OF ALL OF THE NOMINEES. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_20"></A>REPORT OF THE AUDIT COMMITTEE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with the consolidated financial statements for the fiscal year ended December&nbsp;31, 2012, the Audit Committee has: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewed and discussed the audited consolidated financial statements with management; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>discussed with Ernst&nbsp;&amp; Young LLP, our independent registered public accounting firm, the matters required to be discussed by the
statement on Auditing Standards No.&nbsp;61, Communication with Audit Committees, as amended; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>received the written disclosures and letter from Ernst&nbsp;&amp; Young LLP required by applicable requirements of the Public Company Accounting
Oversight Board regarding the independent registered public accounting firm&#146;s communications with the audit committee concerning independence, and has discussed with Ernst&nbsp;&amp; Young LLP its independence from us.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the Audit Committee&#146;s review of the audited consolidated financial statements and its discussions with
management and Ernst&nbsp;&amp; Young LLP, the Audit Committee recommended to the Board of Directors at the March&nbsp;5, 2013 meeting of the Board of Directors that the audited consolidated financial statements for the 2012 fiscal year be included
in our Annual Report on Form 10-K filed with the SEC. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">AUDIT COMMITTEE OF THE BOARD OF DIRECTORS </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">David Smith, Chairperson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin Mattingly </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Parker </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>The information contained in the report above shall not be deemed to be &#147;soliciting material&#148; or to be &#147;filed&#148; with the SEC, nor
shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference in such filing. </I></B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_21"></A>PROPOSAL TWO: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has appointed Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending
December&nbsp;31, 2013. A representative of Ernst&nbsp;&amp; Young LLP will be present at the Annual Meeting, will be given the opportunity to make a statement, if he or she desires, and will be available to respond to appropriate questions.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has conditioned its appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm upon
the receipt of an affirmative vote of a majority of the shares properly cast at the Annual Meeting. Proxies solicited by management for which no specific direction is included will be voted &#147;FOR&#148; the ratification of the appointment of
Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2013. In the event that the stockholders do not ratify the appointment of Ernst&nbsp;&amp; Young LLP, the Audit Committee
will reconsider its selection. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_22"></A>Fees Billed by Independent Registered Public Accounting Firm </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of the fees billed by our independent registered public accounting firm for the fiscal years ended December&nbsp;31, 2012 and
December&nbsp;31, 2011 for professional services rendered to us: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fee Category</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fiscal<BR>2012&nbsp;Fees<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fiscal&nbsp;2011<BR>Fees<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">210,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit-Related Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,000</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Other Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total Fees</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>260,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>222,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accountant fees and services charged by Ernst&nbsp;&amp; Young LLP are paid in Canadian dollars, and thus the amounts shown in the columns above have been translated
into U.S. dollars based on average exchange rates. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accountant fees and services charged by Ernst&nbsp;&amp; Young LLP in relation to our filing of a Form S-3 registration statement in 2012, and procedures with respect
to our public offering completed in March 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accountant fees and services charged by Ernst&nbsp;&amp; Young LLP in relation to our filing of a Form S-3 registration statement in 2011. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit Fees</I></B>. Consists of fees billed for professional services rendered for the audit of our consolidated financial statements and review of
the interim consolidated financial statements included in quarterly reports on Form 10-Q that are filed with the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit-Related
Fees</I></B>. Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements, including accounting consultations and fees related to
registration of securities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Tax Fees</I></B>. Consists of fees billed for professional services for tax compliance, tax advice and tax
planning. These services include assistance related to state tax incentives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>All Other Fees</I></B>. Consists of fees billed for all
other non-audit services. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_23"></A>Policy on Audit Committee Pre-Approval of Audit Services and Permissible Non-Audit
Services </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee&#146;s policy is to pre-approve all audit and permissible non-audit services performed by our independent
registered public accounting firm. These services may include audit services, audit-related services, tax services and other services. For audit services, our independent registered public accounting firm typically provides audit service detail in
advance of the first quarter meeting of the Audit Committee, which outlines the scope of the audit and related audit fees. If agreed to by the Audit Committee, an engagement letter is formally accepted by the Audit Committee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For non-audit services, our senior management will submit from time to time to the Audit Committee for
approval non-audit services that it recommends the Audit Committee engage our independent registered public accounting firm to provide for the fiscal year. Our senior management and our independent registered public accounting firm will each confirm
to the Audit Committee that each non-audit service is permissible under all applicable legal requirements. A budget, estimating non-audit service spending for the fiscal year, will be provided to the Audit Committee along with the request. The Audit
Committee must approve both permissible non-audit services and the budget for such services. The Audit Committee will be informed routinely as to the non-audit services actually provided by our independent registered public accounting firm pursuant
to this pre-approval process. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the 2011 and 2012 fiscal years, the Audit Committee approved all of the services provided by
Ernst&nbsp;&amp; Young LLP described above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE
RATIFICATION OF THE APPOINTMENT OF ERNST&nbsp;&amp; YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2013. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_24"></A>PROPOSAL THREE: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT TO OUR 2010 PERFORMANCE INCENTIVE PLAN </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors is asking our stockholders to approve an amendment, referred to in this Proxy Statement as the Amendment, to the 2010 Performance Incentive Plan, or the 2010 Plan, that will
increase the total shares of common stock available for issuance under the 2010 Plan from 1,050,000 to 2,050,000. Subject to adjustments for our awards that are not exercised or that are cancelled or forfeited as set forth below, the increase of
1,000,000 shares represents approximately 7% of the 14,670,020 shares of common stock outstanding as of March&nbsp;28, 2013. The Amendment will also increase the number of shares that may be issued pursuant to the exercise of &#147;incentive stock
options&#148; during the term of the 2010 Plan to 2,050,000. The Amendment was unanimously approved by our Board of Directors on March&nbsp;19, 2013 and requires stockholder approval. Of the 1,050,000 shares previously approved, only 53,799 remained
available for grant as of March&nbsp;28, 2013. As of March&nbsp;28, 2013, the closing price of our common stock was $11.33 per share as reported on the NASDAQ Capital Market. If approved, we expect to use the additional authorized shares for
continued periodic equity grants to employees, including executive officers, directors and consultants. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_25"></A>Description of the 2010 Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of the principal features of the 2010 Plan. This summary is qualified in its entirety by reference to the 2010 Plan as amended as described herein, which is attached as Appendix
A to this Proxy Statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Purposes of the 2010 Plan.</I></B> The purposes of the 2010 Plan are to enhance our ability and the ability
of any parent or subsidiary corporation, whether now existing or hereafter created or acquired, which we refer to as an Affiliated Company, to attract and retain the services of officers, qualified employees, directors and outside consultants and
service providers, upon whose judgment, initiative and efforts the successful conduct and development of our businesses largely depends, and to provide additional incentives to such persons to devote their utmost effort and skill to our advancement
and betterment, by providing them an opportunity to participate in our ownership and thereby have an interest in our success and increased value that coincides with the financial interests of our stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Shares Reserved for Issuance.</I></B> Assuming the Amendment is approved by the stockholders, we will be authorized to issue up to an aggregate of
2,050,000 shares of common stock pursuant to awards granted under the 2010 Plan. In addition, the 2010 Plan provides that if an option granted under any of our other equity compensation plans is outstanding on the date of stockholder approval of the
2010 Plan and such option subsequently terminates or expires in accordance with its terms, the shares underlying such option that remain unexercised and unissued at the time of termination or expiration will become available for grant or issuance
under the 2010 Plan; provided, however, that not more than 2,050,000 shares of common stock may be issued pursuant to the exercise of options that are designated &#147;incentive stock options&#148;. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event that all or any portion of any shares underlying an award other than restricted shares granted under the 2010 Plan can no longer under any
circumstances be exercised or purchased due to the forfeiture or cancellation of all or any portion of such award, the shares of common stock allocable to the unexercised or forfeited portion of such award will become available for grant or issuance
under the 2010 Plan. In the event that all or any portion of any shares subject to an award other than restricted shares under the 2010 Plan are reacquired by us for any reason other than cancellation or forfeiture, the shares allocable to the
reacquired portion of such award will not become available for grant or issuance under the 2010 Plan. In the event that restricted shares awarded under the 2010 Plan are reacquired by us, for any reason, the shares so reacquired will become
available for grant or issuance under the 2010 Plan. Shares that are withheld to pay the exercise or purchase price of an award or to satisfy any tax withholding obligations in connection with an award, shares that are not issued or delivered as a
result of the net settlement of an outstanding award and shares that are repurchased on the open market with the proceeds of an award exercise or purchase price will not be available again for grant and issuance under the 2010 Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additionally, the number of shares available for issuance under the 2010 Plan will be subject to adjustment in the event of a recapitalization, stock
split, reverse stock split, combination of shares, reclassification, stock dividend, or other similar change in our capital structure. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Administration.</I></B> The 2010 Plan is to be administered by an &#147;Administrator,&#148; which, under the 2010 Plan, shall be either the Board
of Directors or a committee appointed by the Board of Directors, or the Chief Executive Officer to the extent permitted under applicable law. Subject to the provisions of the 2010 Plan, the Administrator has full authority to implement, administer
and make all determinations necessary under the 2010 Plan. The 2010 Plan is administered by our Compensation Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to the terms
and limitations expressly set forth in the 2010 Plan, the Compensation Committee or the Chief Executive Officer have the authority to (i)&nbsp;designate new employees of ours or an Affiliated Company to be the recipient of awards and
(ii)&nbsp;determine the type of the equity award and the number of shares of common stock to be subject to such options, restricted stock units or restricted share awards. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to applicable law, the Board of Directors may from time to time alter, amend, suspend or terminate
the 2010 Plan in such respects as the Board of Directors may deem advisable; provided, however, that no such alteration, amendment, suspension or termination shall be made that would substantially affect or impair the rights of any person under any
outstanding award without his or her consent. Unless previously terminated by the Board of Directors, the 2010 Plan will terminate on March&nbsp;23, 2020. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Eligibility.</I></B> The 2010 Plan provides that awards may be granted to our employees, officers, directors, consultants, independent contractors and advisors or those of an Affiliated Company, as
may be determined by the Administrator. Assuming the Amendment is approved by the stockholders, in no event may any individual be granted equity awards under the 2010 Plan for more than 1,050,000 shares of our common stock in any one calendar year.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The actual number of individuals who will receive awards under the 2010 Plan cannot be determined in advance because the Administrator has
discretion to select the participants. Nevertheless, as of March&nbsp;28, 2013, 9 of our officers and directors and approximately 40 other employees would be eligible to participate in the 2010 Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Terms of Options.</I></B> As discussed above, the Administrator determines many of the terms and conditions of awards granted under the 2010 Plan,
including whether an option will be an &#147;incentive stock option,&#148; or ISO, or a &#147;non-qualified stock option,&#148; or NQSO. Each option is evidenced by an agreement in such form as the Administrator approves and is subject to the
following conditions, which are described in further detail in the 2010 Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vesting and Exercisability.</I> Options become vested and exercisable within such periods and subject to such conditions as determined by the
Administrator and as set forth in the related stock option agreement, provided that options must expire no later than 10 years from the date of grant (five years with respect to an ISO granted to an optionee who owns stock possessing more than 10%
of the total combined voting power of all classes of our stock or the stock of an Affiliated Company, which individual is referred to as a 10% Stockholder). </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Exercise Price.</I> The exercise price of options shall not be less than the fair market value of a share of common stock, as such term is defined
in the 2010 Plan, at the time the option is granted. The exercise price of any ISO granted to a 10% Stockholder shall not be less than 110% of the fair market value of a share of common stock at the time of grant, subject to limited exceptions.
However, an option may be granted with an exercise price lower than fair market value in connection with the assumption or substitution for another option upon certain changes in control. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Repricing Prohibited.</I> Repricing, or reducing the exercise price of outstanding options is not permitted under the 2010 Plan without shareholder
approval under the 2010 Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cancellation and Rescission</I>. Any unexpired, unpaid or deferred options may be cancelled, rescinded, suspended, withheld or otherwise limited or
restricted by the Administrator at any time, unless otherwise specified in the related stock option agreement, if the optionee is not in compliance with all applicable provisions of the related stock option agreement and the 2010 Plan, or if the
optionee engages in any (i)&nbsp;unauthorized disclosure to anyone outside of the company, or unauthorized use in other than our business, of any confidential information or material relating to our business that was acquired by the optionee either
during or after employment with us; (ii)&nbsp;failure or refusal to promptly disclose and assign to us all right, title and interest in any invention or idea made or conceived by the optionee during employment with us that relates in any manner to
our actual or anticipated business, research or development work; or (iii)&nbsp;activity that results in termination of the optionee&#146;s employment for cause. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Terms of Restricted Stock Awards.</I></B> Each restricted share award is evidenced by a restricted stock purchase agreement in such form as the Administrator approves and is subject to the following
conditions, which are described in further detail in the 2010 Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vesting.</I> Shares subject to a restricted share award may become vested over time or upon completion of performance goals set out in advance.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Purchase Price.</I> Each restricted stock purchase agreement states the purchase price, which may not be less than the minimum lawful amount under
applicable state law. Without limiting the generality of the foregoing, the Administrator may determine to issue restricted shares as consideration for continued employment or the achievement of specified performance goals or objectives.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Termination of Service.</I> Restricted stock awards shall cease to vest immediately if a participant is terminated for any reason, unless otherwise
provided in the applicable restricted stock purchase agreement or unless otherwise determined by the Administrator, and we will generally have the right to repurchase any unvested shares subject to such award for the original purchase price paid by
the participant. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Additional Restrictions.</I> Restricted shares are nontransferable except as specifically provided in the restricted stock purchase agreement and in
certain limited circumstances provided in the 2010 Plan. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Terms of Restricted Stock Units.</I></B> Each restricted stock unit award is evidenced by a restricted
stock unit purchase agreement in such form as the Administrator approves and is subject to the following conditions, which are described in further detail in the 2010 Plan: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vesting.</I> Shares subject to a restricted stock unit award may become vested over time or upon completion of performance goals set out in advance.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Settlement.</I> At the Administrator&#146;s discretion, earned restricted stock units may be settled in cash, shares of common stock or a
combination of both, and no purchase price will apply to a restricted stock unit settled in common stock. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Termination of Service.</I> Restricted stock awards shall cease to vest immediately if a participant is terminated for any reason, unless otherwise
provided in the applicable restricted stock purchase agreement or unless otherwise determined by the Administrator. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Additional Restrictions.</I> Restricted stock units are nontransferable for as long as they are subject to any restrictions pursuant to the 2010
Plan or the application award agreement. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Change in Control</I></B><I>.</I> Under the 2010 Plan, the Administrator has
the discretion to provide in each award agreement the terms and conditions with respect to a change in control that relate to the vesting of an award and the assumption of an award or issuance of comparable securities under an incentive program, and
individual employment agreements may contain similar provisions. If the terms of an option or employment agreement provide for accelerated vesting in the event of a change in control, or to the extent that an option is vested and not yet exercised,
the Administrator may provide for the purchase or exchange of each option for an amount of cash or other property. Outstanding unexercised options shall terminate and cease to be exercisable upon a change in control except to the extent that the
options are assumed by the successor entity, or the parent of the successor entity, pursuant to the terms of the change in control transaction. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Section&nbsp;162(m)</I></B>. In general, under Section&nbsp;162(m) of the Code, income tax deductions of publicly-held corporations may be limited
to the extent total compensation (including base salary, annual bonus, stock option exercises and non-qualified benefits paid) for specified executive officers exceeds $1 million in any one year. Under Section&nbsp;162(m), however, the deduction
limit does not apply to certain &#147;performance-based compensation&#148; established by an independent compensation committee which is adequately disclosed to, and approved by, stockholders. In particular, stock options will satisfy the
&#147;performance-based compensation&#148; exception if the awards are made by a qualifying compensation committee, the underlying plan sets the maximum number of shares that can be granted to any person within a specified period and the
compensation is based solely on an increase in the stock price after the grant date (in other words, the option exercise price is equal to or greater than the fair market value of the stock subject to the award on the grant date). To meet the
maximum number of shares requirement, the 2010 Plan limits awards to individual participants as set forth below. Other awards granted under the 2010 Plan may qualify as &#147;qualified performance-based compensation&#148; for purposes of
Section&nbsp;162(m)&nbsp;if such awards are granted or vest upon pre-established objective performance goals based on one or more of the following business criteria: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net revenue and/or net revenue growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings per share and/or earnings per share growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings before income taxes and amortization and/or earnings before income taxes and amortization growth; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating income and/or operating income growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income and/or net income growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholder return and/or total stockholder return growth; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on equity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating cash flow return on income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted operating cash flow return on income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Economic value added; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Individual business objectives; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company-specific operational metrics; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Appreciation in and/or maintenance of the price of the shares of the company; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reductions in costs; cash flow or cash flow per share (before or after dividends); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Drug development milestones; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regulatory achievements (including submitting or filing applications or other documents with regulatory authorities), successfully executing an
advisory committee meeting, or receiving approval of any such applications or other documents and passing pre-approval inspections and validation of manufacturing processes; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Initiation or completion of pre-clinical studies; clinical achievements (including initiating clinical studies; initiating enrollment, completing
enrollment or enrolling particular numbers of subjects in clinical studies; completing phases of a clinical study (including the treatment phase); or announcing or presenting preliminary or final data from clinical studies; in each case, whether on
particular timelines or generally); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Implementation, completion or attainment of measurable objectives with respect to research (including nominating a development candidate or initiating
a new full discovery program), development, manufacturing, commercialization, development candidates, products or projects, safety, and production volume levels. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding satisfaction of any performance criteria described above, to the extent specified at the time of grant of an award, the number of shares of common stock or other benefits granted, issued,
and/or vested under an award on account of satisfaction of performance criteria may be reduced by the Compensation Committee on the basis of such further considerations as the Compensation Committee in its sole discretion determines. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary of Federal Income Tax Consequences of the 2010 Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following is a general summary as of the date of this Proxy Statement of the United States federal income tax consequences to us and to the participants in the 2010 Plan. The federal tax laws may
change and the federal, state and local tax consequences for any participant will depend upon his or her individual circumstances. The summary does not purport to be complete and does not discuss the tax consequences arising in the context of the
participant&#146;s death or the income tax laws of any municipality, state or foreign country in which the participant&#146;s income or gain may be taxable. Each participant has been, and is, encouraged to seek the advice of a qualified tax advisor
regarding the tax consequences of participation in the 2010 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Incentive Stock Options. </I></B>No taxable income will be recognized
by a US optionee under the 2010 Plan upon either the grant or the exercise of an ISO. Instead, a taxable event will occur upon the sale or other disposition of the shares acquired upon exercise of an ISO, and the tax treatment of the gain or loss
realized will depend on how long the shares were held before their sale or disposition. If a sale or other disposition of the shares received upon the exercise of an ISO occurs more than (i)&nbsp;one year after the date of exercise of the option and
(ii)&nbsp;two years after the date of grant of the option, the holder will recognize long-term capital gain or loss at the time of sale equal to the full amount of the difference between the proceeds realized and the exercise price paid. Generally,
any gain realized by a participant will be taxed as long-term capital gain and any loss sustained will be long-term capital loss, and we will not be entitled to a deduction in respect to such disposition. However, except in the event of death, if
shares acquired by a participant upon the exercise of an incentive stock option are disposed of by such participant before the expiration of the statutory holding periods (i.e. a &#147;disqualifying disposition&#148;), such participant will be
considered to have realized as compensation taxed as ordinary income in the year of such disposition an amount, not exceeding the gain realized on such disposition, equal to the difference between the exercise price and the fair market value of such
shares on the date of exercise of such stock option. Generally, any gain recognized on the disposition in excess of the amount treated as compensation or any loss realized on the disposition will constitute capital gain or loss, respectively. If a
participant makes a &#147;disqualifying disposition,&#148; generally in the fiscal year of such &#147;disqualifying disposition&#148; we will be allowed a deduction for federal income tax purposes in an amount equal to the compensation realized by
such participant. The exercise of an ISO may result in an &#147;adjustment&#148; for purposes of the &#147;alternative minimum tax.&#148; Alternative minimum tax is imposed on an individual&#146;s income only if the amount of the alternative minimum
tax exceeds the individual&#146;s regular tax for the year. For purposes of computing alternative minimum tax, the excess of the fair market value on the date of exercise of the shares received on exercise of an ISO over the exercise price paid is
included in alternative minimum taxable income in the year the option is exercised. An optionee who is subject to alternative minimum tax in the year of exercise of an ISO may claim as a credit against the optionee&#146;s regular tax liability in
future years the amount of alternative minimum tax paid that is attributable to the exercise of the ISO. This credit is available in the first year following the year of exercise in which the optionee has regular tax liability. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Non-qualified Stock Options. </I></B>No taxable income is recognized by an optionee upon the grant of an NQSO. Upon exercise, however, the optionee
will recognize ordinary income in the amount by which the fair market value of the shares purchased, on the date of exercise, exceeds the exercise price paid for such shares. The income recognized by the optionee who is an employee will be subject
to income tax withholding. We will be entitled to a tax deduction equal to the amount of ordinary income recognized by the optionee, provided that certain reporting requirements are satisfied. Upon the sale or disposition of shares acquired pursuant
to the exercise of an NQSO, the difference between the proceeds realized and the optionee&#146;s basis in the shares will be a capital gain or loss and will be treated as long-term capital gain or loss if the shares have been held for more than the
applicable statutory holding period (which is currently more than one year for long-term capital gains). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Restricted Shares. </I></B>In
general, a taxable event will occur on each date the participant&#146;s ownership rights vest (e.g., when our repurchase rights expire) as to the number of shares that vest on that date, and the holding period for capital gain purposes will not
commence until the date the shares vest. The participant will recognize ordinary income on each date shares vest in an amount equal to the excess of the fair market value of such shares on that date over the amount paid for such shares. Any income
recognized by a participant who is an employee will be subject to income tax withholding. We are entitled to a tax deduction in an amount equal to the ordinary income recognized by the participant. The participant&#146;s basis in the shares will be
equal to the purchase price, if any, increased by the amount of ordinary income recognized. If a Section&nbsp;83(b) election is made within 30 days after the date of transfer, or if no repurchase rights are retained by us, then the participant will
recognize ordinary income on the date of purchase in an amount equal to the excess of the fair market value of such shares on the date of purchase over the purchase price paid for such shares and this amount will be subject to income tax
withholding. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Restricted Stock Units.</I></B><I> </I>In general, no taxable income is realized upon the grant of a
restricted stock unit award. The participant will generally include in ordinary income the fair market value of the award of stock at the time shares of stock are delivered to the participant or at the time the restricted stock unit vests. We
generally will be entitled to a tax deduction at the time and in the amount that the participant recognizes ordinary income. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Tax
Withholding. </I></B>Under the 2010 Plan, we have the power to withhold, or require a participant to remit to us, an amount sufficient to satisfy federal, state, local or foreign withholding tax requirements with respect to any options exercised or
restricted shares granted under the 2010 Plan. To the extent permissible under applicable tax, securities, and other laws, the Administrator may, in its sole discretion, permit a participant to satisfy an obligation to pay any tax to any
governmental entity in respect of any option or restricted shares up to an amount determined on the basis of the lowest marginal tax rate applicable to such participant, in whole or in part, by (i)&nbsp;directing us to apply shares of common stock
to which the participant is entitled as a result of the exercise of an option or as a result of the lapse of restrictions on restricted shares, or (ii)&nbsp;delivering to us shares of common stock owned by the participant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>New Plan Benefits</I></B>. All awards to directors, executive officers, employees and consultants are made at the discretion of the Administrator.
Therefore, the benefits and amounts that will be received or allocated under the 2010 Plan, as amended, are not determinable at this time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Equity Compensation Plan Information</I></B>. The following table sets forth information regarding our equity compensation plans as of
December&nbsp;31, 2012. The table does not include information with respect to shares we are proposing to add to the 2010 Plan in Proposal Three. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:46pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;securities&nbsp;to<BR>be&nbsp;issued&nbsp;upon&nbsp;exercise<BR>of outstanding
options,<BR>warrants and rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted-average<BR>exercise price of<BR>outstanding&nbsp;options,<BR>warrants and rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;securities&nbsp;remaining&nbsp;available<BR>for future issuance under
equity<BR>compensation plans (excluding securities<BR>reflected in column (a))</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans approved by security holders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">966,148</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.41</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">461,076</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans not approved by security holders</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,718</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">976,866</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">461,076</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2012, we maintained the following equity compensation plans, which were adopted by Sonus Pharmaceuticals, Inc., our predecessor, prior to the
its acquisition of OncoGenex Technologies: (a)&nbsp;Incentive Stock Option, Nonqualified Stock Option and Restricted Stock Purchase Plan &#150; 1991, (b)&nbsp;1999 Nonqualified Stock Incentive Plan, or the 1999 Plan, (c)&nbsp;the 2000 Stock
Incentive Plan, (d)&nbsp;the 2007 Performance Incentive Plan, (e)&nbsp;the OncoGenex Technologies Amended and Restated Stock Option Plan, and (f)&nbsp;the 2010 Performance Incentive Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 1999 Plan is a broad-based plan for which stockholder approval was not required or obtained. On February&nbsp;11, 2010, the 1999 Plan terminated in accordance with
its terms. All stock options, rights to purchase, and restricted stock outstanding as of the termination date will continue in effect in accordance with their respective terms. Stock options granted under the 1999 Plan were generally granted with an
exercise price equal to the fair market value on the date of grant. Pursuant to the 1999 Plan, upon a change of control, the vesting period for outstanding options, rights to purchase, and restricted stock granted under the 1999 Plan will accelerate
and the administrator of the 1999 Plan may provide for the purchase or exchange of each option or right to purchase, adjust the terms of each option or right to purchase, cause the options and rights to purchase to be assumed, or new rights
substituted for such rights, or make such other provision as the administrator determines is equitable. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_26">
</A>Vote Required </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of the Amendment will require the affirmative vote of the majority of shares properly cast upon the proposal at
the Annual Meeting. Proxies solicited by management for which no specific direction is included will be voted &#147;FOR&#148; the approval of the amendment of the 2010 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; APPROVAL OF THE AMENDMENT TO THE 2010 PERFORMANCE INCENTIVE PLAN. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_27"></A>PROPOSAL FOUR: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO ELIMINATE CUMULATIVE VOTING FOR THE ELECTION OF DIRECTORS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;19, 2013, our Board of Directors unanimously approved, subject to stockholder approval, an amendment to our certificate of
incorporation to eliminate cumulative voting for the election of directors by removing Article X from our certificate of incorporation. The text of the proposed amendment is set forth on Appendix B to this Proxy Statement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our stockholders currently elect directors by a procedure called &#147;cumulative voting.&#148; Cumulative voting enables a stockholder to cumulate votes
for the election of a nominee by casting a number of votes for such nominee equal to the number of directors to be elected multiplied by the number of votes to which the stockholder is entitled. The stockholder also may distribute his or her votes
among two or more nominees on the same basis. This procedure allows a stockholder to cumulate his or her votes for one or more of the nominees for director, meaning that his or her votes may be cast for one or more of the nominees. For example, in
an election of three directors, if a stockholder held one vote, the stockholder would have three votes. He or she could cast those three votes for one of the directors, or cast two votes for one director and one vote for another, or cast one vote
for each of the three nominees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors believes this procedure is overly complicated to implement and seldom if ever used by
stockholders and is no longer in the best interests of our company and our stockholders, particularly in view of our large number of stockholders and broad-based ownership. In addition, a stockholder or group of stockholders holding a relatively
small number of shares that cumulatively votes its shares in an election of directors could elect one or more directors whose loyalty may primarily be to the minority group responsible for their election rather than to our company and all of our
stockholders. Our Board of Directors believes that each director is responsible to, and should represent the interests of all stockholders as opposed to a minority stockholder group that may have special interests and goals inconsistent with those
of the majority of stockholders. The election of directors who view themselves as representing a particular minority stockholder group could result in partisanship and discord on our Board of Directors, and may impair the ability of our directors to
act in the best interests of our company and all of our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accordingly, our Board of Directors is proposing to eliminate
cumulative voting by removing Article X of our certificate of incorporation. If this proposal is accepted by the stockholders, our directors will then be elected by plurality vote as provided by our bylaws, without the right to cumulate votes.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The elimination of cumulative voting might under certain circumstances render more difficult or discourage a merger, tender offer or proxy
contest, the assumption of control by a holder of a large block of our common shares or the removal of incumbent management. Neither management nor our Board of Directors is aware of any attempt by any stockholder to accumulate sufficient shares to
obtain control of our company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the amendment is approved by the requisite vote of the stockholders, we will file an amended and restated
certificate of incorporation with the Delaware Secretary of State as soon as reasonably practicable after the Annual Meeting. The amendment shall become effective upon filing with the Delaware Secretary of State. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of the amendment
to our certificate of incorporation will require the affirmative vote of the majority of the outstanding shares of common stock entitled to vote at the Annual Meeting. Proxies solicited by management for which no specific direction is included will
be voted &#147;for&#148; the approval of the amendment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE
&#147;FOR&#148; THE APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO ELIMINATE CUMULATIVE VOTING FOR THE ELECTION OF DIRECTORS. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_28"></A>PROPOSAL FIVE: </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE OUR AUTHORIZED SHARES OF COMMON STOCK </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;19, 2013, our Board of Directors unanimously approved, subject to stockholder approval, an amendment to our certificate of incorporation to
increase our authorized shares of common stock from 25,000,000 to 50,000,000 and to make a corresponding change to the number of authorized shares of capital stock. The text of the proposed amendment is set forth on Appendix B to this Proxy
Statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We currently have a total of 30,000,000 shares of capital stock authorized under of certificate of incorporation, consisting of
25,000,000 shares of common stock and 5,000,000 shares of preferred stock. Our Board of Directors is asking our stockholders to approve an amendment that will increase the number of authorized shares of common stock from 25,000,000 to 50,000,000,
and increase the number of authorized shares of all classes of stock from 30,000,000 to 55,000,000. The number of shares of authorized preferred stock would remain unchanged. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors has determined that it would be in our best interests to increase the number of authorized shares of common stock in order to provide our company with the flexibility to pursue all
finance and corporate opportunities involving our common stock, which may include private or public offerings of our equity securities, or to issue stock dividends, without the need to obtain additional stockholder approvals. There are currently no
formal proposals or agreements that would require an increase in our authorized shares of common stock. Each additional authorized share of common stock would have the same rights and privileges as each share of currently authorized common stock.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of March&nbsp;28, 2013, 14,670,020 shares of common stock, $0.001 par value, were outstanding, leaving 9,819,166 shares of common stock
available for issuance. As of December&nbsp;31, 2012, we had reserved, pursuant to varies equity award plans, 1,265,857 shares of common stock, of which 804,781 were reserved for options currently outstanding and 461,076 were available for future
option grants. Additionally, as of December&nbsp;31, 2012, we had warrants outstanding to purchase 1,587,301 shares of common stock. We have no shares of preferred stock outstanding. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At present, our Board of Directors has no immediate plans, arrangements or understandings to issue the additional shares of common stock. However, it desires to have the shares available to provide
additional flexibility to use our common stock for business and financial purposes in the future as well to have sufficient shares available to provide appropriate equity incentives for our employees. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The issuance of additional shares of common stock in the future will have the effect of diluting earnings per share, voting power and common
shareholdings of stockholders. It could also have the effect of making it more difficult for a third party to acquire control of our company. The shares will be available for issuance by our Board of Directors for proper corporate purposes,
including but not limited to, stock dividends, acquisitions, financings and equity compensation plans. Our management believes the increase in authorized share capital is in the best interests of our company and our stockholders and recommends that
the stockholders approve the increase in authorized share capital. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the amendment is approved by the requisite vote of the stockholders, we
will file an amended and restated certificate of incorporation with the Delaware Secretary of State as soon as reasonably practicable after the Annual Meeting. The amendment shall become effective upon filing with the Delaware Secretary of State.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of
the amendment to our certificate of incorporation will require the affirmative vote of the majority of the outstanding shares of common stock entitled to vote at the Annual Meeting. Proxies solicited by management for which no specific direction is
included will be voted &#147;for&#148; the approval of the amendment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE
&#147;FOR&#148; THE APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE OUR AUTHORIZED SHARES OF COMMON STOCK. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_29"></A>COMPENSATION DISCUSSION AND ANALYSIS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_30"></A>Compensation Objectives and Philosophy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our executive compensation program is designed to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">attract and retain the most talented and dedicated executives possible; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">align our executive officers&#146; incentives with stockholder value creation; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">correlate annual and long-term cash and stock incentives to achievement of measurable strategic performance objectives; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increase the percentage of executive compensation that is performance-based, and therefore at-risk, as an executive&#146;s experience, unique expertise
and criticality of role increases. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To achieve these objectives we have established compensation programs that tie a
substantial portion of each executive&#146;s overall compensation to key strategic operational and financial goals such as the development of our product candidates, the establishment and maintenance of key strategic relationships, and the
identification and advancement of additional product candidates. The Compensation Committee&#146;s approach emphasizes the setting of compensation at levels the committee believes are competitive with executives in other companies of similar size
and stage of development operating in the biotechnology industry while taking into account our relative performance and our own strategic goals. Our annual cash incentives and a portion of our longer term incentives, such as our performance-based
equity awards, are tied to our achievement of corporate operating goals. We believe that successful execution against goals is the best way to enhance long-term stockholder value. Overall, our pay programs attempt to balance cash and equity to
reward both short- and long-term performance. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_31"></A>Compensation Determination Process and the Role of Executive
Officers in Compensation Decisions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation review process was conducted subsequent to the end of the 2012 fiscal year in order to
facilitate the comparison of corporate objectives against our full year performance. The Chief Executive Officer provided a presentation regarding our current compensation philosophies and programs to the Compensation Committee with the remaining
members of the Board of Directors invited to attend. Typically, the Chief Executive Officer produces an executive compensation review for each Named Executive Officer, excluding the Chief Executive Officer, which includes recommendations for:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">base salary for the upcoming year; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">year-end cash incentive award, if any, under the terms of our discretionary short-term incentive awards program, or STIP, based on the achievement of
corporate objectives; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annual equity awards of stock options and restricted stock units, or RSUs. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Chief Executive Officer may also recommend other changes to an executive&#146;s compensation package, such as changes in the executive&#146;s eligibility for cash incentives. The Compensation
Committee evaluates and, if determined appropriate or advisable, revises the Chief Executive Officer&#146;s recommendations and forwards its own recommendations to the Board of Directors, which may in turn suggest further revisions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee also meets in executive sessions without the Chief Executive Officer present to discuss the Chief Executive Officer&#146;s
compensation, including base salary, year-end cash incentive award and annual stock option grant, and to make recommendations regarding such compensation to the Board of Directors. The Board of Directors considers the Compensation Committee&#146;s
recommendations with respect to the Chief Executive Officer in executive session and provides feedback to the Compensation Committee. With the exception of executive sessions of the Compensation Committee and the Board of Directors to review,
recommend and approve the Chief Executive Officer&#146;s compensation, the Chief Executive Officer is generally present at all deliberations of the Compensation Committee and the Board of Directors related to executive compensation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the fourth quarter of the fiscal year, the Chief Executive Officer recommends to the Compensation Committee the corporate objectives to be adopted
under the terms of the STIP for the upcoming year. The Compensation Committee evaluates and may revise the Chief Executive Officer&#146;s recommendations and forwards its own recommendations to the Board of Directors, which may in turn suggest
further revisions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee makes final determinations with respect to the award of cash incentives under the STIP and all
annual equity awards. The Board of Directors, after reviewing the recommendations of the Compensation Committee, makes final determinations with respect to the cash incentives to the executive officers and the Chief Executive Officer, as well as the
corporate </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
objectives under the STIP. From time to time at the request of the Compensation Committee, members of our executive management team, including representatives from finance, legal and human
resources, may provide information to the Compensation Committee and attend all or a portion of certain of the committee&#146;s meetings. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_32">
</A>Benchmarking of Executive Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Every year or at the direction of the Compensation Committee, our management reviews peer group
data to determine whether total direct compensation and each component of the compensation package are approximately equal to the targeted 50th percentile for executive officer compensation of our peer group. The peer group companies are amended
from time to time at the discretion of the Board of Directors and based on Radford recommendations. In 2011, Radford was retained to review compensation levels and executive agreements of our executive officers and to provide a report summarizing
relevant benchmark data and making recommendations as to executive compensation levels. Radford&#146;s review included benchmarking the base salary, target total cash (base salary plus target cash incentives) and long-term incentives of our
executives with industry-appropriate peers based on the following characteristics: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commercial life sciences companies in late stages of product development; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies located in biotechnology hub markets (Seattle, San Francisco, San Diego and Boston) to reflect the recruiting market for executive talent;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies with market values between $100 million and $500 million; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Companies with generally less than 100 employees. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition, Radford also examined research and development spending, cash on-hand and enterprise value as additional metrics to help determine appropriate peer companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The peer group recommended by Radford in 2011 and approved by the Compensation Committee and the Board of Directors for the evaluation of compensation
levels for the 2012 fiscal year, after a comprehensive review, analysis and discussion regarding Radford&#146;s recommendations, is comprised of the companies set forth below. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alnylam Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Keryx Biopharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amicus Therapeutics, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medivation, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ardea Biosciences, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Micromet Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arqule Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Omeros Corporation</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aveo Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Oncothyreon Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cell Therapeutics, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peregrine Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Celldex Therapeutics, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rigel Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cytokinetics, Incorporated</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo Biosciences, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">CytRx Corporation</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Synta Pharmaceuticals Corp.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vical Incorporated</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Infinity Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Benchmarking in the Context of Our Other Executive Compensation Principles </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In establishing executive compensation, the Compensation Committee focuses on a range around the 50th percentile of peer group benchmarking for each of
base salary, target total cash (base salary plus target cash incentives) and long-term incentives for each similarly situated executive, which the Compensation Committee believes provides the tools to allow a company of our size to attract, compete
for and retain the type of executives necessary for us to our achieve our goals but conserve our cash and equity as much as possible. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee realizes, however, that using a peer benchmark is neither the only means for gathering and validating market data nor the only criteria for establishing executive pay. In instances where an executive officer is uniquely
critical to our success, the Compensation Committee may provide compensation in excess of the benchmark. Upward or downward variations for base salary and long-term incentives may also occur as a result of the individual&#146;s experience level, the
balance of the individual&#146;s different elements of compensation, market factors and other strategic considerations, which we refer to below as compensation factors. Additional market surveys, such as the Radford Global Life Sciences Survey,
which reports compensation practices of a broad range of life science companies, are also utilized in determining market competitive compensation. The Compensation Committee believes that, given the competitiveness of our industry and our company
culture, our base compensation, cash incentives and equity programs are flexible, reward the achievement of clearly defined corporate goals and are generally sufficient to retain our existing executive officers and to hire new executive officers
when necessary. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_33"></A>Elements of Executive Compensation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have designed and implemented compensation policies that have historically allowed us to recruit both in our geographic areas of operation (i.e.,
Seattle, Washington and Vancouver, British Columbia) and other areas. We seek to implement and utilize compensation policies that balance fixed and variable pay costs for a long-term, sustainable approach to talent acquisition and retention. Our
executive compensation consists of base salary, cash incentives and stock option and RSU grants, each of which is discussed in detail below. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Base Salary </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We provide an annual
salary based on comparable market data for level of responsibility, expertise, skills, knowledge, experience, our unique organizational requirements and desire to maintain internal equity. When establishing executive compensation for 2012, the
Compensation Committee focused on the respective peer group market survey as well as the Radford Global Life Sciences Survey for base salaries and incentive compensation. The executive base salary program targets a range around the 50th percentile
of salaries for executives with the requisite skills in similar positions with similar responsibilities at comparable companies. In reviewing base salaries annually, the Compensation Committee also considers the role, overall value and contribution
each executive makes to the achievement of our objectives. Executives may be compensated below or above that range based on the compensation factors described above. The Compensation Committee reviews base salaries in the first quarter of each year
and may make adjustments from time to time to realign salaries with market levels after taking into account the compensation factors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Cash Incentives </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The STIP
provides an annual opportunity for our Named Executive Officers to receive a discretionary cash bonus (stated as a percentage of each officer&#146;s salary) based on performance related to corporate objectives established by the Board of Directors.
The STIP, when combined with each executive&#146;s base salary, is designed to provide total target cash compensation within a range around the 50th percentile of our peer group, subject to adjustment for the compensation factors described above.
For any given year, these objectives may relate to operational, strategic or financial factors such as developing our product candidates, establishing and maintaining key strategic relationships, raising or maintaining certain levels of capital,
improving our results of operations or increasing the price per share of our common stock. The Compensation Committee alone determines achievement level of corporate objectives as it relates to incentive compensation for executive officers. If
corporate objectives are not achieved at a 100% level, the Compensation Committee may determine that the corporate objectives were not achieved or, in its sole discretion, may determine that such objectives were partially achieved. The Compensation
Committee may award bonuses based on the foregoing determinations or, after considering market conditions, our financial position or other factors, the Compensation Committee may, in its sole discretion, determine not to award any bonuses or to
award bonuses at less than maximum eligibility. Cash bonuses paid do not exceed the maximum eligibility amount. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Equity Awards
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our 2010 Performance Incentive Plan provides alternative forms of long-term incentives for our executive officers, including stock
options with time-based vesting, which require the market value of our common stock to increase before they are valuable; performance-based RSUs, the right to which depends on successful completion of corporate performance goals; or RSUs with
time-based vesting. We do not use a targeted split of cash and equity when setting compensation for our executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The number of
stock options granted is discretionary and the value earned on any grant varies with the stock price over the option term. In large part due to the length of product development cycles, it is critical for our business to align the interests of
executive officers and stockholders, and to retain executive officers by means of what we hope will be long-term wealth creation in the value of their stock options and RSUs, which have vesting provisions that encourage continued employment. We have
historically elected to use stock options as the primary long-term equity incentive vehicle. Stock option grants are made at the commencement of employment, may be made annually and, occasionally, may be made following a significant change in job
responsibilities or to meet other special objectives, including strategic goals and retention. Historically, annual stock option grants have generally occurred at or near the end of the year, as part of our annual evaluation of executive
compensation, and are targeted around the 50th percentile of our peer group (in terms of market value), subject to adjustment for the compensation factors described above and the availability of equity under our equity-based compensation plans.
Commencing in 2012, annual stock option grants occur subsequent to the filing of our annual report on Form 10-K for the most recently completed year. We expect to continue to use stock options as a long-term incentive vehicle because: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock options align the interests of executives with those of the stockholders, support a pay-for-performance culture, foster employee stock ownership
and focus the management team on increasing value for our stockholders. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock options help to provide a balance to the overall executive compensation program as base salary and our cash incentive compensation program focus
on nearer-term achievements, while the grant and vesting of stock options is intended to focus executive efforts towards increasing stockholder value over the longer term. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The vesting period of stock options encourages executive retention as long as the options remain in the money. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe the use of stock options assists us in making our compensation package attractive to current and potential executive candidates, while
conserving cash. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beginning in 2012, we awarded RSUs, including performance-based RSUs pursuant to the terms of our 2010
Performance Incentive Plan. Our decision to use RSUs for annual replenishment equity awards was based on a desire to reduce short-term dilution and stock plan share usage. RSUs provide the right to receive a specified number of shares of our common
stock at no cost to the employee if the employee remains employed by us on the date the RSUs vest. The compensation value of RSUs does not depend solely on future stock price increases. While unvested, the value of RSUs provides a significant
retention inventive and maintains alignment between the interests of stockholders and of management. Although its value may increase or decrease with changes in the stock price during the period before vesting, an RSU will have value in the long
term, while the entire compensation value of a stock option depends on future stock price appreciation. Accordingly, RSUs can deliver significantly greater share-for-share compensation value at grant than stock options, and we can offer comparable
compensation value with fewer shares and less dilution for our stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_34"></A>Stock Ownership Guidelines
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although stock option grants encourage equity ownership, we currently do not require our directors or executive officers to own a
particular number of shares of our common stock. The Compensation Committee believes that stock and option holdings among our directors and executive officers are sufficient at this time to align this group&#146;s interests with those of our
stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_35"></A>Perquisites </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our executive officers located in Canada participate in the same group insurance and employee benefit plans as our other salaried employees in Canada and our executive officers located in the United
States participate in the same group insurance and employee benefit plans as our other salaried employees in the United States. Tax preparation services are paid for executive officers who owe additional tax liabilities incurred by working in
non-resident countries. At this time, we do not provide other special benefits or other perquisites to our executive officers. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_36">
</A>2012 Officer Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>Salary</I></B><B> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack became our Chief Executive Officer and President in 2008. Since 2008, the Board of Directors has successively increased his salary based on performance, which has brought his compensation
more in line with the 50th percentile of peer public company chief executive officers. His leadership has driven our performance, leading our predecessor from its early start-up phase through development to proof of scientific concept in humans, the
merger in 2008 that resulted in a public entity and the licensing of our lead product candidate. With respect to the 2012 fiscal year, based on Mr.&nbsp;Cormack&#146;s instrumental role as our Chief Executive Officer in achieving our 2011
objectives, as well as a comprehensive review, analysis and discussion of the salaries of executives as reported by Radford Executive Compensation Report in 2011, Mr.&nbsp;Cormack&#146;s base salary for 2012 was increased 3% to approximately
CDN$520,150, which was consistent with the 50th percentile of the peer company survey, as converted to Canadian dollars, and warranted based on his performance and contribution to the achievement of company objectives. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Burris was our Chief Financial Officer from January 2011 to January 2013 and our Executive Vice President Operations from January 2011 to
March&nbsp;31, 2013. In determining her base salary for 2012, the Compensation Committee considered Ms.&nbsp;Burris&#146; extensive financial and operations management expertise as a public biotechnology company executive. Based on a comprehensive
review, analysis and discussion of the salaries of executives in similar roles reported in the Radford Global Life Sciences Survey report, Ms.&nbsp;Burris&#146; base salary for 2012 was increased 3% and set at $375,950, which is approximately equal
to 95% of the 50th percentile of the survey based on a combination of the survey data for the CFO/COO job descriptions. On March&nbsp;31, 2013, Ms.&nbsp;Burris began serving as a consultant to our company, as which she will receive a monthly
retainer of approximately $34,000 and will be eligible to receive an incentive payment of up to 40% of the aggregate amounts paid to Ms.&nbsp;Burris during the 2013 fiscal year, which will be based on a percentage according to our achievement of
corporate objectives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Cindy Jacobs is our Executive Vice President and Chief Medical Officer. In determining her base salary for
2012, the Compensation Committee considered Dr.&nbsp;Jacobs&#146; important role in furthering the development of our clinical assets and extensive experience in obtaining U.S. Food and Drug Administration approval for product candidates, as well as
her instrumental role in partnering, alliance management and strategic discussions. Based on a comprehensive review, analysis and discussion of the salaries of executives as reported by Radford in 2011, Dr.&nbsp;Jacobs&#146; base salary for 2012 was
increased 3% and set at $391,400, which is approximately equal to 105% of the 50th percentile of the peer company survey from 2011. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2011 and until May&nbsp;31, 2012, Cameron Lawrence served as our Principal
Accounting Officer. In determining Mr.&nbsp;Lawrence&#146;s base salary for 2012, the Compensation Committee took into account his finance and accounting background and his contributions to us in his role as Principal Accounting Officer. Based on a
comprehensive review, analysis and discussion of the salaries as reported by Radford in 2011 and consistent with our compensation policies that allow us to recruit both in our geographic areas of operation (i.e., Seattle, Washington and Vancouver,
British Columbia) and other areas, Mr.&nbsp;Lawrence&#146;s base salary for 2012 was increased approximately 13% and was set at CDN$158,500, which was approximately equal to 95% of the 50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile for financial executives. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:59pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012&nbsp;Base&nbsp;Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011&nbsp;Base&nbsp;Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage<BR>increase&nbsp;from<BR>2011 (%)</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">CDN$520,150</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">CDN$505,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.0%</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Medical Officer and Executive Vice President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$391,400</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$380,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.0%</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Former Executive Vice President, Operations, Chief</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Financial Officer and Secretary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$375,950</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">365,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.0%</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cameron Lawrence</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Former Principal Accounting Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">CDN$158,500</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">CDN$139,500</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Cash Incentives </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In accordance with the Compensation Committee&#146;s goal to target compensation around the 50th percentile of our peer group as described further in the section entitled &#147;Benchmarking of Executive
Compensation&#148; and based on a comprehensive review, analysis and discussion of the recommendations set forth in the Radford report, the Compensation Committee recommended, and the Board of Directors approved, an increase in each Named Executive
Officer&#146;s bonus potential for 2012, as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="21%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:59pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Short-term&nbsp;Incentive<BR>Award Eligibility</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55%&nbsp;of&nbsp;salary</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Medical Officer and Executive Vice President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40%&nbsp;of&nbsp;salary</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President, Operations, Chief Financial</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Officer and Secretary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40%&nbsp;of&nbsp;salary</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cameron Lawrence,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Former Principal Accounting Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25%&nbsp;of&nbsp;salary</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result, each Named Executive Officer&#146;s bonus potential for 2012 was approximately equal to the 50th percentile
of our peer group. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the fourth quarter of 2011, the Board of Directors adopted the following 2012 corporate objectives under the STIP:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:73pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate Objectives</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ensure that the Company has sufficient working capital at the end of 2012 to complete its publicly announced clinical development
activities and strive to achieve our corporate objectives ahead of schedule or achieve additional advancements within budgetary constraints.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Advance our partnered program (OGX-011) through clinical development and increase awareness of the product candidate through data
presentation and publication.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Advance our proprietary product candidates and increase awareness through data presentation and publication.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors selected these particular corporate objectives based on its judgment that they
represented areas over which the Named Executive Officers have significant operational control and on which the Board of Directors believed they should focus to move our strategic plan forward and enhance stockholder value during 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance Against 2012 Corporate Objectives </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee determined that the corporate objectives for 2012 were achieved at the 90th percentile. This represented the Committee&#146;s assessment that the first and second objectives
were fully met but that the third was only partially met given that Borealis-1 accrued patients more slowly at its initiation than was originally anticipated. Accordingly, all persons eligible for a bonus under the STIP for 2012 were paid 90% of
their 2012 bonus eligibility attributable to corporate objectives. Mr.&nbsp;Lawrence was not eligible to receive a bonus under the STIP as his employment with our company terminated as of May&nbsp;31, 2012. For Mr.&nbsp;Cormack, Ms.&nbsp;Burris and
Dr.&nbsp;Jacobs, 100% of their STIP eligibility was attributable to the achievement of the corporate objectives and, therefore, the final amount awarded to each is as set forth below: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:59pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Dollar&nbsp;Value&nbsp;of<BR>Incentive&nbsp;Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;Award&nbsp;as&nbsp;a<BR>Percentage&nbsp;of&nbsp;Target&nbsp;(%)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">CDN$257,475</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Medical Officer and Executive Vice President</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$140,904</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President, Operations, Chief</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Financial Officer and Secretary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">$135,342</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Incentive Awards </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Stock option grants are discretionary based on the Compensation Committee&#146;s analysis of employee achievement of company-wide and individual objectives. The Compensation Committee determined to award
each Named Executive Officer non-qualified stock options to acquire shares of our common stock and RSUs pursuant to the terms and conditions of the 2010 Performance Incentive Plan. In each case, the Compensation Committee considered and evaluated
the Radford report, the compensation factors described above and the amount of equity available for grant under our 2010 Performance Incentive Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The number of stock options granted was calculated using an option grant dollar value (based on a Black-Scholes model) benchmarked to the 50th percentile based upon the comprehensive review conducted by
Radford in 2011. Each option was granted with a 10-year term and an exercise price equal to the closing price of our common stock on NASDAQ on the date of grant. Consistent with the recommendations in the Radford report, vesting occurs monthly over
four years, which represented a change from some of our prior practices of vesting stock option awards annually over four years. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The number
of time-based RSUs and performance-based RSUs granted were calculated using a 30-day average stock price and a Black-Sholes value. Based on a comprehensive review, analysis and discussion of the equity awards reported in the Radford 2011 Report, the
aggregate value of the time-based RSUs and performance-based RSUs granted to each Named Executive Officer, other than Cameron Lawrence, was benchmarked at the 75th percentile, with 50% of the total award consisting of time-based RSUs and 25% of the
total award consisting of performance-based RSUs. The Compensation Committee determined the relative mix of time-based and performance-based RSUs was appropriate because such mix is consistent with our primary intent to retain our executive
officers, while at the same time aligning long-term interests and encouraging long-term stockholder value. The time-based RSUs will vest annually over four years beginning on January&nbsp;1, 2012. The performance-based RSUs will vest with respect to
100% of the award upon the achievement of both the successful enrollment and release of data from our Synergy trial and the completion of enrollment of our Borealis-1 trial. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Advisory Vote on Executive Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2011, we held an advisory say-on-pay vote to
approve the compensation of our executive officers, with approximately 98% of the votes cast in favor of our executive compensation program. In light of the support by our stockholders of our 2011 executive compensation program, the Compensation
Committee has not made significant changes to our 2012 executive compensation program </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, at our 2011 annual meeting of
stockholders, a majority of our stockholders voted in favor of an advisory vote on executive compensation&nbsp;every three years, and, accordingly, our Board of Directors determined that we will hold an advisory vote on executive compensation at our
annual meeting of stockholders every three years.&nbsp;We expect to hold the next vote on executive compensation at the 2014 annual meeting of stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_37"></A>Other Policies and Considerations </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Internal Pay Equity </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Committee reviewed the 2011 Radford report compensation and concluded that total compensation for a company&#146;s chief executive officer is generally higher than the total compensation for either its chief financial officer or chief
medical officer, and that the total compensation of the chief medical officer is generally higher than the total compensation of the chief financial officer. The relative total compensation for our executive officers for 2012 followed the same
pattern observed in the Radford report, with our Chief Executive Officer receiving the highest total compensation, followed by our Chief Medical Officer and our Chief Financial Officer. Our ordinal pay ranking is consistent with comparable
companies, and as each component of compensation for each executive officer is determined in relation to the 50th percentile of officers holding positions having similar responsibilities at comparable companies, the Compensation Committee believes
that relative compensation among our executive officers is appropriate and consistent with maintaining internal pay equity. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Relationship Between Compensation Elements </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each element of executive officer compensation was determined with reference to the 50th percentile of the same element paid to executive officers holding the similar position at comparable companies.
Therefore, no objective formula was utilized when determining the relative proportion of salary, cash incentive or equity awards relative to each other or to total compensation. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Employment Agreements and Termination Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The employment agreement for each
executive officer contains provisions related to termination and change of control. When establishing the termination and change of control provisions of the employment agreements, the Compensation Committee and the Board of Directors considered the
Radford report, which provided recommendations to the Compensation Committee regarding the termination and change of control provisions for each executive officer based on publicly available information regarding the practices of our peer group,
policy statements made by significant investor groups and an analysis of current market trends. We provide change in control protections to our officers to alleviate concerns regarding the possible occurrence of such a transaction, allowing them to
focus their attention on our business. In addition, these protections encourage executives to remain with the Company during the threat or negotiation of a change in control transaction, which preserves our value and the potential benefit to be
received by our stockholders in the transaction. The specific terms of the termination and change of control arrangements, as well as an estimate of the compensation that would have been payable had they been triggered as of the end of 2012, are
described in detail in the section below entitled &#147;Executive Compensation &#150; Potential Payments Upon Termination/Change of Control.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_38"></A>Compensation Committee Interlocks and Insider Participation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">No
member of the Compensation Committee during fiscal year 2012 served as one of our officers, former officers or employees nor received directly or indirectly compensation from the Company, other than in the capacity as a member of our Board and
Compensation Committee. There was no direct or indirect control by the members of the Compensation Committee of the Company. No member of the Compensation Committee, directly or indirectly, is the beneficial owner of more than 10% of the
Company&#146;s equity, nor are they an executive officer, employee, director, general partner or a managing member of one or more entities that are together the beneficial owners of more than 10% of the Company&#146;s equity. The Compensation
Committee members are not aware of any business or personal relationship between (i)&nbsp;a member of the Compensation Committee and any person who has provided or is providing advice to the Compensation Committee; and (ii)&nbsp;an executive officer
of the company and any firm or other person who is employed or is employing such person to provide advice to the Compensation Committee. During fiscal year 2012, none of our executive officers served as a member of the compensation committee of any
other entity, one of whose executive officers served as a member of our Board of Directors or Compensation Committee, and none of our executive officers served as a member of the board of directors of any other entity, one of whose executive
officers served as a member of our Compensation Committee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_39"></A>Compensation Committee Report </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee of the Board of Directors has reviewed and discussed &#147;Compensation Discussion and Analysis&#148; required by
Item&nbsp;402(b) of Regulation S-K with management and, based on such review and discussions, the Compensation Committee recommended to the Board of Directors that the &#147;Compensation Discussion and Analysis&#148; be included in the our 2012
Annual Report on Form 10-K and this Proxy Statement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neil Clendeninn, Chairperson </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin Mattingly </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>The information contained in the report above shall not be deemed to be &#147;soliciting
material&#148; or to be &#147;filed&#148; with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference in such
filing. </I></B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_40"></A>EXECUTIVE COMPENSATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the 2012 fiscal year, our Named Executive Officers and their respective positions were as follows: Scott Cormack, Chief Executive Officer and
President; Michelle Burris, Executive Vice President Operations, Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary; Cindy Jacobs, Ph.D., M.D., Executive Vice President and Chief Medical Officer; and Cameron Lawrence,
former Principal Accounting Officer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Cormack, Ms.&nbsp;Burris, Dr.&nbsp;Jacobs and Mr.&nbsp;Lawrence are referred to as our Named
Executive Officers for purposes of this Proxy Statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information regarding our current executive officers as
of April&nbsp;22, 2013. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Municipality</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of Residence</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position With the Company</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Executive Officers</I></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vancouver, Canada</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">President, Chief Executive Officer and Director</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fall City, Washington</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">55</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President and Chief Medical Officer</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Susan Wyrick,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Seattle, Washington</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Principal Accounting Officer, and Senior Director, Finance</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following are the biographies of the foregoing persons, except the biography of Mr.&nbsp;Cormack, which is located above
under the heading &#147;Board of Directors &#150; General.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cindy Jacobs</I>, Ph.D., M.D., 55, has served as our Executive Vice
President and Chief Medical Officer since August 2008, and had been Executive Vice President and Chief Medical Officer of OncoGenex Technologies Inc. from September 2005 to August 2008. From 1999 to July 2005, Dr.&nbsp;Jacobs served as Chief Medical
Officer and Senior Vice President, Clinical Development of Corixa Corporation. Prior to 1999, Dr.&nbsp;Jacobs held Vice President, Clinical Research positions at two other biopharmaceutical companies. Dr.&nbsp;Jacobs received her Ph.D. degree in
Veterinary Pathology/Microbiology from Washington State University and an M.D. degree from the University of Washington Medical School. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Susan Wyrick, 40</I>, has served as our Principal Accounting Officer since February 2013, and as Senior Director, Finance since June 2012.
Ms.&nbsp;Wyrick served as the Director, Site Controller at Emergent BioSolutions Inc., a biopharmaceutical company, from November 2010 to June 2012, where her duties included managing the accounting department and preparing operating plans and
forecasts. From March 2006 to October 2010, Ms.&nbsp;Wyrick served as the Controller at Trubion Pharmaceuticals, Inc., a biopharmaceutical company, which was acquired by Emergent BioSolutions Inc. in October 2010. As Controller,
Ms.&nbsp;Wyrick&#146;s responsibilities included managing the accounting department and the annual financial audit. Prior to March 2006, Ms.&nbsp;Wyrick served in senior financial positions at publicly-held biotechnology companies. Ms.&nbsp;Wyrick
received a B.A. in Business Administration from the University of Washington and has passed the CPA exam. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_41"></A>Summary Compensation Table </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information regarding the compensation of our Named Executive Officers for each of the fiscal years ended December&nbsp;31,
2012, 2011 and 2010. The components of the compensation reported in the Summary Compensation Table are described below. Additional information on the components of the total compensation package, including a discussion of the proportion of each
element to total compensation, is discussed in &#147;Compensation Discussion and Analysis.&#148; </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)(2)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)(2)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity<BR>Incentive</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation<BR>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Other<BR>Compensation</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Officer&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)&nbsp;(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">520,358</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">487,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">374,148</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">257,577</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,639,584</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">499,480</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,859</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">683,339</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">475,825</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">453,600</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">214,078</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,143,503</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs, Executive</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President and Chief</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medical Officer </FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">391,400</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268,125</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">149,659</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,904</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">950,088</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">380,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,750</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">497,750</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">369,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">226,800</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">116,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">712,300</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Former Executive Vice</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President Operations and</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer </FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD ROWSPAN="2" VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,949</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">365,000</FONT></P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"></TD>
<TD ROWSPAN="2" VALIGN="top"></TD>
<TD ROWSPAN="2" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268,125</FONT></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD ROWSPAN="2" VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">149,659</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">417,550</FONT></P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD ROWSPAN="2" VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">135,342</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">95,813</FONT></P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD ROWSPAN="2" VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT><BR>
<P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ROWSPAN="2" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD ROWSPAN="2" VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">929,076</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">878,363</FONT></P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cameron Lawrence,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Former Principal Accounting</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Officer&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,966</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,617</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,638</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">126,609</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">215,830</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,975</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,146</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">155,121</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">98,069</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,476</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,360</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,505</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">177,410</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes amounts earned but deferred at the election of our Named Executive Officer, such as salary deferrals under our 401(k) Plan established under
Section&nbsp;401(k) of the Code. During 2009, Mr.&nbsp;Cormack and Dr.&nbsp;Jacobs and, during 2010, Ms.&nbsp;Burris entered into employment agreements with us, which provided for base salaries of not less than CDN$345,000, $360,000 and $365,000,
respectively. Additionally, the agreements provide that such officers are eligible to receive a discretionary annual incentive bonus and the opportunity to participate in our equity compensation plans. The termination benefits under each of these
agreements are described below under the heading &#147;Potential Payments Upon Termination/Change of Control.&#148; </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The dollar amounts in this column reflect the aggregate grant date fair value of equity awards granted during the fiscal year in accordance with FASB Accounting
Standards Codification Topic 718 for stock-based compensation. These amounts do not correspond to the actual cash value that will be recognized by each of the Named Executive Officers when received. For a discussion of the assumptions and
methodologies used to value the awards reported in this column, see note 10 to our audited consolidated financial statements, which are included in our 2011 Annual Report on Form 10-K. During 2011 and 2010, no option awards were forfeited by our
Named Executive Officers. During 2012, 4,541 option awards were forfeited by Cameron Lawrence in connection with his departure from the Company. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Burris resigned as our Principal Accounting Officer, Chief Financial Officer, Secretary and Treasurer as of February&nbsp;1, 2013 and resigned as our Executive
Vice President, Operations as of March&nbsp;31, 2013. Since March&nbsp;31, 2013, she has served as a consultant for our company. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts payable to Mr.&nbsp;Cormack and Mr.&nbsp;Lawrence are denominated in Canadian dollars and have been translated into U.S. dollars based on the May&nbsp;31, 2012
and December&nbsp;31, 2012 average annual exchange rate of US$1.00 = CDN$0.9987 and US$100=CDN$0.9996, respectively. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount paid to Mr.&nbsp;Lawrence in connection with his departure from the Company effective May&nbsp;31, 2012. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_42"></A>Fiscal 2012 Grants of Plan-Based Awards </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information related to grants of plan-based awards to our Named Executive Officers during the 2012 fiscal year. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Payouts</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Under&nbsp;Non-Equity</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive Plan Awards (1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Payouts<BR>Under&nbsp;Equity</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;Plan&nbsp;Awards&nbsp;(2)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Stock<BR>Awards:&nbsp;#&nbsp;of<BR>Securities<BR>Underlying<BR>RSUs (3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Option</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards:&nbsp;#&nbsp;of<BR>Securities<BR>Underlying</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Options&nbsp;(4)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise&nbsp;or&nbsp;Base<BR>Price of Option<BR>Awards ($/Sh)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date<BR>Fair&nbsp;Value&nbsp;of<BR>Stock&nbsp;and</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards&nbsp;(5)($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">374,148</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">243,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">CD257,475</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">CD286,083</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">243,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">149,659</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">97,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,904</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">156,560</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">149,659</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">97,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">135,342</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cameron Lawrence</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,932</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,663</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">39,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,688</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This amounts shown in this column represent the non-equity incentive plan awards granted to our Named Executive Officers during the 2012 fiscal year, which were earned
based our performance during the year. For a description of the performance-based vesting criteria associated with these awards, see &#147;Compensation Discussion and Analysis.&#148; There is no threshold value for these awards.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts shown in this column represent performance-based RSUs granted under our 2010 Performance Incentive Plan. For a description of the performance-based vesting
criteria associated with these awards, see &#147;Compensation Discussion and Analysis.&#148; There is no threshold value for these awards. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts shown in this column represent RSUs granted under our 2010 Performance Incentive Plan, which vest annually over four years. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts shown in this column represent stock options granted under our 2010 Performance Incentive Plan, which vest monthly over four years.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts represent the grant date fair value of stock option and RSU awards measured in accordance with the guidance in FASB ASC Topic 718. For performance-based RSUs,
represents the value at the grant date based upon the probable outcome of such conditions. These amounts do not correspond to the actual cash value that will be recognized by each of the Named Executive Officers when received. For a discussion of
the assumptions and methodologies used to value the awards reported in this column, see note 10 to our audited consolidated financial statements, which are included in our 2012 Annual Report on Form 10-K. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_43"></A>Outstanding Equity Awards at Fiscal Year-End </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information regarding the outstanding equity awards held by the Named Executive Officers as of December&nbsp;31, 2012.
Mr.&nbsp;Lawrence did not have any outstanding equity awards as of December&nbsp;31, 2012. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>OPTION AWARDS</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>STOCK AWARDS</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Securities&nbsp;Underlying<BR>Unexercised Options<BR>(#) Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities&nbsp;Underlying<BR>Unexercised Options<BR>(#) Unexercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights&nbsp;that<BR>Have Not<BR>Vested&nbsp;(#)(5)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive&nbsp;Plan<BR>Awards:<BR>Market or<BR>Payout Value<BR>of Unearned<BR>Shares, Units<BR>or
Other<BR>Rights that<BR>Have Not<BR>Vested ($)(6)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Shares or<BR>Units or<BR>Other&nbsp;Rights<BR>that Have<BR>Not<BR>Vested(#)(7)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Value<BR>of Shares or<BR>Units or<BR>Other Rights<BR>that Have<BR>Not
Vested<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="4"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/31/15</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22.28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/31/19</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/14/20</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,906</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">05/08/22</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">243,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">243,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="5"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">President and Chief</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medical Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/31/15</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22.28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/31/19</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15.97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/14/20</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,562</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">05/08/22</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">97,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="8"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">President Operations</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">and Chief Financial</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,359</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10/28/15</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,641</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10/28/15</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,260</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/12/16</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/8/20</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,771</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16.83</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/3/21</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,562</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">05/08/22</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">97,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2000 Stock Incentive Plan and were fully vested on December&nbsp;31, 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2007 Performance Incentive Plan and vest monthly over a 48-month period beginning January&nbsp;31, 2010.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2010 Performance Incentive Plan and vest monthly over a 48-month period beginning January&nbsp;14, 2011.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2010 Performance Incentive Plan and vest monthly over a 48-month period beginning January&nbsp;1, 2012.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These performance-based RSUs were granted under the 2010 Performance Incentive Plan and vest with respect to 100% of the award upon the achievement of both the
successful enrollment and release of data from our Synergy trial and of the completion of enrollment of our Borealis-1 trial. For more information regarding these awards, see &#147;Compensation Discussion and Analysis.&#148;
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents market value if both performance criteria are met and target amount of award is received. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These RSUs were granted under the 2010 Performance Incentive Plan and vest annually over four years beginning January&nbsp;1, 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 1999 Stock Incentive Plan and were fully vested on October&nbsp;28, 2009. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2000 Stock Incentive Plan and were fully vested on October&nbsp;28, 2009. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2007 Performance Incentive Plan and were fully vested on May&nbsp;12, 2010. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2010 Performance Incentive Plan and were fully vested on June&nbsp;8, 2011. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These stock options were granted under the 2010 Performance Incentive Plan and vest monthly over a 48-month period beginning February&nbsp;3, 2011.
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_44"></A>Option Exercises and Stock Vested </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information related to exercised options held by the Named Executive Officers during the 2012 fiscal year. No RSUs vested
during the 2012 fiscal year. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized&nbsp;on<BR>Exercise</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack, President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41,167&nbsp;</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">408,278</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs, Executive Vice President and Chief Medical Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris, Former Executive Vice President Operations and Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cameron Lawrence, former Principal Accounting Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">813</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,198</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">These are owned directly by Mr.&nbsp;Cormack. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_45"></A>Pension Benefits/Nonqualified Deferred Compensation </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We do not have any plan that provides for payments or other benefits at, following, or in connection with retirement. We also do not have a plan that provides for the deferral of compensation for any
employee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_46"></A>Potential Payments Upon Termination/Change of Control </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Change of Control Under Our Equity Compensation Plans </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following discussion sets forth the change of control provisions provided for in our various equity compensation plans. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><U>1999 Nonqualified Stock Incentive Plan and 2000 Stock Incentive Plan </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under our 1999
Nonqualified Stock Incentive Plan, or the 1999 Plan, the vesting period for all outstanding awards will automatically accelerate in connection with a change of control. Under our 2000 Stock Incentive Plan, or the 2000 Plan, the vesting period for
all outstanding awards will automatically accelerate in connection with a change of control unless the administrator of the 2000 Plan causes such awards to be assumed or new rights substituted for such rights. In addition, under both plans, the
administrator of such plans may take one of the following actions in connection with a change of control, as applicable: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">provide for the purchase of each outstanding award, or, in the case of the 1999 Plan only, the exchange of each such award;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">adjust the terms of such awards in a manner to be determined by the administrator to reflect the change of control; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cause such awards to be assumed, or new rights substituted for such awards, by another entity; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">make such changes to the applicable plan as the administrator considers equitable. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the administrator does not take any of the foregoing actions, all awards will terminate upon the consummation of the change of control. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As used in the 1999 Plan and the 2000 Plan, the term &#147;change of control&#148; means the occurrence of any of the following events, as applicable:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">acquisitions of our securities representing 50% or more of our outstanding securities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a merger or consolidation in which we are not the surviving entity, except for a transaction, the principal purpose of which is to change the state of
our incorporation; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">under the 1999 Plan, sales, transfers or other dispositions of 50% or more of the value of our assets, or, under the 2000 Plan, sales transfers or
other disposition of all or substantially all of our assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any reverse merger in which we are a surviving entity but in which securities possessing more than 50% of the total combined voting power of our
outstanding securities are transferred to a person or persons different from the persons holding those securities immediately prior to such reverse merger; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">our dissolution; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">under the 1999 Plan, a liquidation of more than 50% of our value, or, under of the 2000 Plan, our complete liquidation; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">under the 1999 Plan only, at least a majority of our directors constitute persons who were not, at the time of their first election to the Board of
Directors, candidates proposed by a majority of the Board of Directors in office prior to the time of such first election. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>2007 Performance Incentive Plan </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under
the 2007 Performance Incentive Plan, or the 2007 Plan, the administrator has the discretion to provide in each award agreement the terms and conditions with respect to a change of control that relate to (1)&nbsp;the vesting of an award and
(2)&nbsp;the assumption of an award or issuance of comparable securities under an incentive program. If the terms of an option agreement provide for accelerated vesting in the event of a change of control, or to the extent that an option is vested
and not yet exercised, the administrator may provide for the purchase or exchange of each option for an amount of cash or other property. Outstanding options shall terminate and cease to be exercisable upon a change of control except to the extent
that the options are assumed by the successor entity, or parent of the successor entity, pursuant to the terms of the change of control transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As used in the 2007 Plan, the term &#147;change of control&#148; means the occurrence of any of the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">acquisitions of our securities possessing more than 50% of the total combined voting power of all of our outstanding securities;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a merger or consolidation with any other entity, whether or not we are the surviving entity in such transaction, except for a transaction in which the
holders of our outstanding voting securities immediately prior to such merger or consolidation hold, as a result of holding our securities prior to such transaction, in the aggregate, securities possessing more than 50% of the total combined voting
power of all of our outstanding voting securities or the voting securities of the surviving entity, or the parent of the surviving entity, immediately after such merger or consolidation; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the sale, transfer or other disposition, in one transaction or a series of related transactions, of all or substantially all of our assets; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the approval by our stockholders of a plan or proposal for our liquidation or dissolution. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>2010 Performance Incentive Plan </U></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under
the 2010 Plan, the administrator has the discretion to provide in each award agreement the terms and conditions with respect to a change of control that relate to the vesting of an award and the assumption of an award or issuance of comparable
securities under an incentive program. If the terms of an option agreement provide for accelerated vesting in the event of a change of control, or to the extent that an option is vested and not yet exercised, the administrator may provide for the
purchase or exchange of each option for an amount of cash or other property. Outstanding options shall terminate and cease to be exercisable upon a change of control except to the extent that the options are assumed by the successor entity (or
parent of the successor entity) pursuant to the terms of the change of control transaction. As used in the 2010 Plan, the term &#147;change of control&#148; means the occurrence of any of the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">acquisitions of our securities possessing more than 50% of the total combined voting power of all of our outstanding securities;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a merger or consolidation with any other entity, whether or not we are the surviving entity in such transaction, except for a transaction in which the
holders of our outstanding voting securities immediately prior to such merger or consolidation hold, as a result of holding our securities prior to such transaction, in the aggregate, securities possessing more than 50% of the total combined voting
power of all of our outstanding voting securities or the voting securities of the surviving entity, or the parent of the surviving entity, immediately after such merger or consolidation; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the sale, transfer or other disposition, in one transaction or a series of related transactions, of all or substantially all of our assets; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the approval by the stockholders of a plan or proposal for our liquidation or dissolution. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Termination and Change of Control Provisions Under Employment Agreements </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2012, we have employment agreements in place with each of our Named Executive Officers that provide for compensation upon the termination of their employment under certain
circumstances, as described below. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Cormack Agreement </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The agreement between us, OncoGenex Technologies Inc. and Mr.&nbsp;Cormack, which is referred to as the Cormack Agreement, provides Mr.&nbsp;Cormack with termination benefits in the event Mr.&nbsp;Cormack
is terminated without cause or for disability, or if Mr.&nbsp;Cormack resigns for good reason, or Good Reason, which means due to (i)&nbsp;the relocation of the officer&#146;s primary work location by more than 40 miles from the current office
location; (ii)&nbsp;a material reduction of the officer&#146;s base salary or employee benefits; (iii)&nbsp;any material reduction or diminution of the officer&#146;s duties, authority or responsibilities; (iv)&nbsp;a fundamental breach by us of the
Cormack Agreement; or (v)&nbsp;the failure of any successor to assume expressly in writing our obligations under the Cormack Agreement, in each case, provided that Mr.&nbsp;Cormack has provided us with two months&#146; advance written notice and an
opportunity to cure such breach during such two-month period. Any termination that occurs without cause, due to disability or for Good Reason is referred to as an Involuntary Termination. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Cormack Agreement provides that if an Involuntary Termination occurs, we will be obligated to pay Mr.&nbsp;Cormack a lump sum equal to 18&nbsp;months of his then-current base salary. In addition,
Mr.&nbsp;Cormack will receive continued entitlement under group medical, dental and insurance plans, excluding short- and long-term disability plans and pension plans, to which Mr.&nbsp;Cormack and his family are entitled at Mr.&nbsp;Cormack&#146;s
termination date, to the extent such benefit plans permit for 18&nbsp;months or until Mr.&nbsp;Cormack becomes employed elsewhere where comparable benefits are provided, whichever date comes first (this period is referred to as the Cormack Benefit
Plan Severance Period). To the extent continuance of a benefit plan, excluding short- and long-term disability plans and pension plans, is not permitted, OncoGenex Technologies Inc. will be obligated to pay Mr.&nbsp;Cormack an amount equal to the
sum Mr.&nbsp;Cormack would be required to pay to receive comparable benefits for the Cormack Benefit Plan Severance Period. Notwithstanding the terms of any of our equity compensation plans or any agreement in connection with such plans, if there is
an Involuntary Termination, then the time-based vesting restrictions, if any, will immediately lapse on an additional number of shares under all of Mr.&nbsp;Cormack&#146;s outstanding compensatory equity awards, which includes any outstanding stock
options granted to Mr.&nbsp;Cormack under our equity compensation plans, that would have time-vested if Mr.&nbsp;Cormack had continued his employment for 18&nbsp;months following his Involuntary Termination. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Cormack Agreement provides for additional termination benefits if an Involuntary Termination occurs during the period beginning three months before
and ending 12&nbsp;months after a change in control or if such Involuntary Termination is required by the merger agreement, purchase agreement or other instrument relating to such change in control or such Involuntary Termination is made at the
express request of the other party or parties to the transaction constituting such change in control, each of which events is referred to as a Change in Control Termination. Upon a Change in Control Termination, we will be obligated to pay
Mr.&nbsp;Cormack 24 months of his then-current base salary, plus a sum equal to 12&nbsp;months of his average monthly bonus earnings, where such average is calculated over the 24-month period immediately preceding Mr.&nbsp;Cormack&#146;s termination
date and based on Mr.&nbsp;Cormack&#146;s bonuses paid in such 24-month period. In addition, Mr.&nbsp;Cormack will receive continued entitlement under our benefit plans as described above, or an amount equal to the sum Mr.&nbsp;Cormack would be
required to pay to receive comparable benefits if such continued entitlement is not permitted as described above, except that the Cormack Benefit Plan Severance Period will be 24&nbsp;months instead of 18&nbsp;months. Notwithstanding the terms of
any of our equity compensation plans or any agreement in connection with such plans, upon a Change in Control Termination, all vesting restrictions, if any, will immediately lapse on all of Mr.&nbsp;Cormack&#146;s compensatory equity awards
effective as of his termination date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All termination benefits in the event of an Involuntary Termination or Change in Control Termination
are subject to Mr.&nbsp;Cormack&#146;s execution, delivery and non-revocation of a general release of all litigation and other claims against us and our affiliates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><U>Burris Agreement </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective March&nbsp;31, 2013 Michelle Burris resigned as the
Company&#146;s Executive Vice President of Operations and on April&nbsp;1, 2013 became a consultant of the Company for a period of one year. The term of the consultancy may be extended by mutual agreement of the parties. Pursuant to our previous
employment agreement with Ms.&nbsp;Burris, referred to as the Burris Agreement, which was effective as of December&nbsp;31, 2012, if an Involuntary Termination occurred, we would be obligated to pay Ms.&nbsp;Burris a lump sum payment equal to
12&nbsp;months of her then-current base salary. In addition, if Ms.&nbsp;Burris elected to continue her and her dependents&#146; health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, or COBRA, we would pay up to
12&nbsp;months of Ms.&nbsp;Burris&#146; monthly premium under COBRA, provided that our obligation to pay the monthly premium would cease </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
when Ms.&nbsp;Burris became eligible to receive substantially equivalent health coverage in connection with new employment. Notwithstanding the terms of any of our equity compensation plans or
any agreement in connection with such plans, if there was an Involuntary Termination, then the time-based vesting restrictions, if any, would immediately lapse on an additional number of shares under all of Ms.&nbsp;Burris&#146; outstanding
compensatory equity awards, which included outstanding stock options granted to Ms.&nbsp;Burris under our equity compensation plans, that would have time-vested if Ms.&nbsp;Burris had continued in employment for 12&nbsp;months following her
Involuntary Termination. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Burris Agreement provided for additional termination benefits if an Involuntary Termination occurs during the
period beginning three months before and ending 12&nbsp;months after a change in control or if such Involuntary Termination was required by the merger agreement, purchase agreement or other instrument relating to such change in control, or such
Involuntary Termination was made at the express request of the other party or parties to the transaction constituting such change in control, each of which events was referred to as a Change in Control Termination. Upon such a Change in Control
Termination, we would be obligated to pay Ms.&nbsp;Burris 15&nbsp;months of her then-current base salary, plus a sum equal to 12&nbsp;months of her average monthly bonus earnings, where such average would be calculated over the 24-month period
immediately preceding Ms.&nbsp;Burris separation from services and based on Ms.&nbsp;Burris bonuses paid in such 24-month period. In addition, our payment of monthly COBRA premiums as described above would be for up to 15&nbsp;months instead of up
to 12&nbsp;months. Notwithstanding the terms of any of our equity compensation plans or any agreement in connection with such plans, upon a Change in Control Termination, all vesting restrictions, if any, would immediately lapse on all of
Ms.&nbsp;Burris compensatory equity effective as of her separation from service. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All termination benefits in the event of an Involuntary
Termination or Change in Control Termination were subject to Ms.&nbsp;Burris execution, delivery and non-revocation of a general release of all litigation and other claims against us and our affiliates. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a consultant to the Company effective as of April&nbsp;1, 2013, Ms.&nbsp;Burris will receive a monthly retainer of approximately $34,000 and
reimbursement of health insurance coverage. Ms.&nbsp;Burris will also be eligible to receive an incentive payment of up to 40% of the aggregate amounts paid to Ms.&nbsp;Burris from the Company during the 2013 fiscal year. Following the end of the
consultancy, the Company will pay Ms.&nbsp;Burris a lump sum payment of approximately $410,000 which is consistent with the terms of the Burris Agreement. In addition, notwithstanding the terms of any of our equity compensation plans or any
agreement in connection with such plans, following the end of the consultancy, the time-based vesting restrictions, if any, would immediately lapse on an additional number of shares under all of Ms.&nbsp;Burris&#146; outstanding compensatory equity
awards, which included outstanding stock options granted to Ms.&nbsp;Burris under our equity compensation plans, that would have time-vested if Ms.&nbsp;Burris had continued in service for 12&nbsp;months following her consultancy, which is
consistent with the terms of the Burris Agreement. If the consultancy ends within three months before or within 12 months after a change of control of the Company, the Company will pay a lump sum payment of approximately $511,000, plus a bonus, and
notwithstanding the terms of any of our equity compensation plans or any agreement in connection with such plans, all vesting restrictions, if any, would immediately lapse on all of Ms.&nbsp;Burris compensatory equity effective as of her separation
from service, which is consistent with the change in control provisions in the Burris Agreement. All termination benefits in the event of the end of the consultancy are subject to Ms.&nbsp;Burris execution, delivery and non-revocation of a general
release of all litigation and other claims against us and our affiliates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Jacobs Agreement </U></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our agreement with Cindy Jacobs, referred to as the Jacobs Agreement, provides Dr.&nbsp;Jacobs with termination benefits in the event of an Involuntary
Termination, provided that, in the case of termination for good reason, Dr.&nbsp;Jacobs has provided us with 30&nbsp;days&#146; advance written notice and an opportunity to cure such breach during such 30-day period. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Jacobs Agreement provides that if an Involuntary Termination occurs, we will be obligated to pay Dr.&nbsp;Jacobs a lump sum payment equal to
12&nbsp;months of her then-current base salary. In addition, if Dr.&nbsp;Jacobs elects to continue her and her dependents&#146; health insurance coverage under COBRA, we must pay up to 12&nbsp;months of Dr.&nbsp;Jacobs&#146; monthly premium under
COBRA, provided that our obligation to pay the monthly premium will cease when Dr.&nbsp;Jacobs becomes eligible to receive substantially equivalent health coverage in connection with new employment. Notwithstanding the terms of any of our equity
compensation plans or any agreement in connection with such plans, if there is an Involuntary Termination, then the time-based vesting restrictions, if any, will immediately lapse on an additional number of shares under all of Dr.&nbsp;Jacobs&#146;
outstanding compensatory equity awards, which includes outstanding stock options granted to Dr.&nbsp;Jacobs under our equity compensation plans, that would have time-vested if Dr.&nbsp;Jacobs had continued in employment for 12&nbsp;months following
her Involuntary Termination. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Jacobs Agreement provides for additional termination benefits if an Involuntary Termination occurs during
the period beginning three months before and ending 12&nbsp;months after a change in control or if such Involuntary Termination is required by the merger agreement, purchase agreement or other instrument relating to such change in control, or such
Involuntary Termination is made at the express request of the other party or parties to the transaction constituting such change in control, each of which events is referred to as a Change in Control Termination. Upon such a Change in Control
Termination, we will be obligated to pay Dr.&nbsp;Jacobs 15&nbsp;months of her then-current base salary, plus a sum equal to 12&nbsp;months of her average monthly bonus earnings, where such average is calculated over the 24-month period immediately
preceding Dr.&nbsp;Jacobs&#146; separation from services and based on Dr.&nbsp;Jacobs&#146; bonuses </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
paid in such 24-month period. In addition, our payment of monthly COBRA premiums as described above will be for up to 15&nbsp;months instead of up to 12&nbsp;months. Notwithstanding the terms of
any of our equity compensation plans or any agreement in connection with such plans, upon a Change in Control Termination, all vesting restrictions, if any, will immediately lapse on all of Dr.&nbsp;Jacobs&#146; compensatory equity effective as of
her separation from service. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">All termination benefits in the event of an Involuntary Termination or Change in Control Termination are subject
to Dr.&nbsp;Jacobs&#146; execution, delivery and non-revocation of a general release of all litigation and other claims against us and our affiliates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><U>Lawrence Agreement </U></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective May&nbsp;31, 2012, Mr.&nbsp;Lawrence ceased to be an
employee of OncoGenex Technologies Inc. Prior to his departure, Mr.&nbsp;Lawrence&#146;s employment relationship was governed by an employment agreement with OncoGenex Technologies Inc., referred to as the Lawrence Agreement. The Lawrence Agreement
provided Mr.&nbsp;Lawrence with termination benefits in the event Mr.&nbsp;Lawrence was terminated without cause, or if Mr.&nbsp;Lawrence resigned for Good Reason. The Lawrence Agreement provided that in the event of an Involuntary Termination or
Mr.&nbsp;Lawrence&#146;s resignation as a result of a material adverse change, without his consent, in his title, position, job function or compensation, we would be obligated to provide Mr.&nbsp;Lawrence four weeks&#146; notice plus an additional
two weeks&#146; notice for each full year of Mr.&nbsp;Lawrence&#146;s employment at the date such termination notice is given, which is referred to as the Severance Period, to a maximum of 26 weeks, or pay in lieu of notice in an amount determined
by multiplying Mr.&nbsp;Lawrence&#146;s average weekly earnings (inclusive of his base salary and bonus) where such average is calculated over the 104-week period immediately preceding the Severance Period) by the number of weeks in the Severance
Period. Such severance would be paid to Mr.&nbsp;Lawrence either in a lump sum or by equal weekly, bi-weekly or monthly installments for the duration of the Severance Period, at our sole discretion. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any payment to Mr.&nbsp;Lawrence would be deemed to include all required termination and/or severance payments pursuant to the provisions of the
<I>Employment Standards Act</I> (British Columbia), as amended from time to time, and, to the extent that such insurance plans permit, continued entitlement under all group medical, dental and insurance plans, excluding short- and long-term
disability plans and pension plan, to which Mr.&nbsp;Lawrence is entitled at the time of termination of employment. Such continuation of benefit entitlement would be for a period equal to the Severance Period or until the date Mr.&nbsp;Lawrence is
employed where comparable benefits are provided, whichever date comes first. To the extent the continuance of certain benefit plans, excluding short- and long-term disability, is not permitted, we would pay to Mr.&nbsp;Lawrence, no later than 30
days after his date of termination, an amount equal to ten percent of his weekly base salary in effect immediately prior to the such termination date, which equaled his base salary divided by 52, multiplied by the number of weeks in the Severance
Period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Lawrence Agreement would terminate when Mr.&nbsp;Lawrence retired. Mr.&nbsp;Lawrence was able to, by providing us with one
month&#146;s notice, terminate the Lawrence Agreement and his employment with us. In such circumstance, we were able to request that Mr.&nbsp;Lawrence cease his duties prior to the expiration of such one-month notice period, in which event we would
pay Mr.&nbsp;Lawrence an amount equal to the difference between what he would have received had his employment continued for such one-month and the amount actually paid during such one-month. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In connection with Mr.&nbsp;Cameron&#146;s departure from the Company in May 2012, he received a payroll check consisting of (i)&nbsp;amounts earned prior to May&nbsp;31, 2012, (ii)&nbsp;an amount for
accrued but untaken vacation time and (iii)&nbsp;a lump-sum of CDN$30,098.59. He was entitled to continued coverage under all group medical, dental and insurance plans, excluding short and long term disability plans and pension plan, to which he was
entitled prior to his departure until the earlier of August&nbsp;9, 2012 or the date he became employed elsewhere and provided comparable coverage. Additionally, in recognition of his duties as an executive officer, Mr.&nbsp;Lawrence received, on
release of all claims against OncoGenex Technologies Inc., its affiliates, the Company and its affiliates, (i)&nbsp;a lump-sum payment of CDN$88,394.23, (ii)&nbsp;continued coverage under all group medical, dental and insurance plans, excluding
short and long term disability plans and pension plan, until November&nbsp;30, 2012 and (iii)&nbsp;an opportunity to immediately exercise any of his outstanding stock options that would have vested between May&nbsp;31, 2012 and February&nbsp;28,
2013. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Potential Cost of Termination Payments </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the table below, we have estimated the potential cost to us of the compensation to which each Named Executive Officer, except for Mr.&nbsp;Lawrence,
would have been entitled if he or she experienced an Involuntary Termination or a Change in Control Termination effective as of December&nbsp;31, 2012. For a description of the amounts paid to Mr.&nbsp;Lawrence upon his departure from our company in
May 2012, see &#147;&#151;Lawrence Agreement&#148; above. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="15" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Involuntary Termination</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Involuntary Termination in Connection</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>with a Change in Control</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Payments&nbsp;($)<BR>(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Benefits<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Compensation<BR>($) (2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total&nbsp;($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash<BR>Payments&nbsp;($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Benefits&nbsp;($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Compensation<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">780,537</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,411</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">394,783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,188,731</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,224,576</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,882</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">613,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,855,723</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">391,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,098</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,537</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">543,035</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">589,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,827</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">882,449</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris(8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,950</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,978</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">138,165</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">543,093</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">565,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">36,222</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">332,860</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">934,833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts payable to Mr.&nbsp;Cormack are denominated in Canadian dollars and have been translated into U.S. dollars based on the December&nbsp;31, 2012 annual average
exchange rate of US$1.00 = CDN$0.9996. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The employment agreements for each of Mr.&nbsp;Cormack, Dr.&nbsp;Jacobs, and Ms.&nbsp;Burris state that the time-based vesting restrictions associated with unvested
options immediately lapse on any shares of common stock that would have time-vested if they had had continued in employment throughout their respective severance period as defined in their employment agreements. The amounts above represent the stock
option expense that would be incurred by us in accordance with the guidance of FASB ASC Topic 718 in relation to options vested immediately upon termination in accordance with the terms of the individual&#146;s employment agreement.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents stock option expense associated with the accelerated vesting of 6,250 options with an exercise price of $22.28 per share, 20,000 options with an exercise
price of $15.97 per share, and 28,906 options with an exercise price of $13.00 per share. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents stock option expense associated with the accelerated vesting of 3,000 options at an exercise price of $22.28 per share, 5,000 options with an exercise price
of $15.97 per share, and 3,384 options with an exercise price of $13.00 per share. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents stock option expense associated with the accelerated vesting of 8,750 options at an exercise price of $16.83 per share and 3,384 options with an exercise
price of $13.00 per share. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents stock option expense associated with the accelerated vesting of 3,000 options at an exercise price of $22.28 per share, 10,000 options with an exercise price
of $15.97 per share, and 11,562 options with an exercise price of $13.00 per share. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents stock option expense associated with the accelerated vesting of 18,229 options at an exercise price of $16.83 per share and 11,562 options with an exercise
price of $13.00 per share. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents amounts Ms.&nbsp;Burris would have received under her employment agreement in effect as of December&nbsp;31, 2012. As described above, subsequent to
year-end, Ms.&nbsp;Burris entered into a consulting agreement that superseded the terms of her prior employment agreement. Assuming Ms.&nbsp;Burris&#146;s consulting agreement was in effect as of December&nbsp;31, 2012, Ms.&nbsp;Burris would have
been entitled to the same payments upon involuntary termination or a change in control as of December&nbsp;31, 2012. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_47"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information with respect to the beneficial ownership of our common stock by the following persons
as of March&nbsp;28, 2013, except as otherwise noted in the footnotes to the table: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">each person, entity or group who we know to beneficially own five percent or more of our voting securities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">each of our directors and director nominees; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">each of our Named Executive Officers identified in the Summary Compensation Table; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">all of our directors and executive officers as a group. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise indicated below, the address of each beneficial owner listed in the table is c/o OncoGenex Pharmaceuticals, Inc., 1522&#151;217th Place S.E., Suite 100, Bothell, Washington 98021. The
percentages in the table below are based on 14,670,020 shares of our common stock outstanding as of March&nbsp;28, 2013. Except as indicated in the footnotes to the table and pursuant to applicable community property laws, to our knowledge, each
stockholder named in the table has sole voting and investment power with respect to the shares set forth opposite such stockholder&#146;s name. The information provided in the table is based on our records and information filed with the SEC, unless
otherwise noted. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name of Beneficial</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Business Address of Beneficial Owner</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount&nbsp;and&nbsp;Nature&nbsp;of<BR>Beneficial&nbsp;Ownership(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent of<BR>Class(%)<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fidelity Management&nbsp;&amp; Research Company</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">82 Devonshire Street</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02109</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,670,255</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.4</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">RA Capital Management, LLC</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 Park Plaza, Suite 1200</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02116</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,099,232</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.5</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Great Point Partners, LLC</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">165 Mason Street, 3</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">rd</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Floor</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Greenwich, CT 06830</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,039,793</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.1</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tang Capital Partners, LP</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">4747 Executive Drive, Suite 510, San Diego, CA 92121</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">869,231</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.9</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 East 52</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">nd</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Street</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">New
York, NY 10022</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">824,925</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.6</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Named Executive</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Officers and Directors:</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">274,845</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cindy Jacobs</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">121,301</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michelle Burris</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,185</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Susan Wyrick</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,146</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cameron Lawrence</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neil Clendeninn</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,870</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Parker</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jack Goldstein</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,961</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin Mattingly</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David Smith</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All current officers and directors as a group (10 persons)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">572,001</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than 1% </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of
common stock subject to options and warrants currently exercisable, or exercisable within 60 days of March&nbsp;28, 2013, are deemed outstanding for computing the percentage of the person holding such options or warrants but are not deemed
outstanding for computing the percentage of any other person. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Schedule 13G filed on February&nbsp;14, 2013 FMR LLC (&#147;FMR&#148;), Scott C. Goebel reported that FMR is the beneficial owner of 1,670,255 shares of our common
stock as a result of acting as investment adviser to various investment companies registered under Section&nbsp;8 of the Investment Company Act of 1940. Edward C. Johnson 3d and FMR, through its control of Fidelity, and the funds each has sole power
to dispose of the 1,670,255 shares owned by the funds. Members of the family of Edward C. Johnson 3d, Chairman of FMR, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR, representing 49% of the voting
power of FMR. The Johnson family group and all other Series B shareholders have entered into a shareholders&#146; voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting
common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#146; voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling
group with respect to FMR. Neither FMR nor Edward C. Johnson 3d, Chairman of FMR has the sole power to vote or direct the voting of the shares owned directly by the Fidelity Funds, which power resides with the Funds&#146; Boards of Trustees.
Fidelity carries out the voting of the shares under written guidelines established by the Funds&#146; Boards of Trustees. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Schedule 13G filed on February&nbsp;14, 2013 by RA Capital Healthcare Fund, L.P. (&#147;Fund&#148;), RA Capital Management, LLC (&#147;Capital&#148;) and Peter
Kolchinsky (the &#147;Reporting Persons&#148;) reported that as of January&nbsp;31, 2013, they, in the aggregate, beneficially owned 894,232 shares of our common stock. The Reporting Persons have the right to purchase an additional 205,000 shares of
our common stock pursuant to the terms of common stock purchase warrants issued on October&nbsp;22, 2010, which are not exercisable except upon 61 days prior written notice to us. The beneficial ownership of each Reporting Person is as follows:
(i)&nbsp;Fund beneficially owns 526,713 shares of common stock representing approximately 3.6% of the class and (ii)&nbsp;Capital, as the investment adviser and sole general partner of the Fund and investment adviser to an account owned by a
separate investment vehicle which holds shares of our common stock, and Mr.&nbsp;Kolchinsky as the manager of Capital, each beneficially own 894,232 shares of common stock of ours representing approximately 6.1% of the class. The percentage of
common stock beneficially owned by each Reporting Person is based on a total of 14,656,916 shares of common stock of our issued outstanding as reported in our Form 10-Q filed with the SEC on November&nbsp;8, 2012. The Fund has the power to vote and
dispose of the shares of common stock beneficially owned by such entity. Capital, as the investment adviser and sole general partner of the Fund and as the investment adviser to an account owned by a separate investment vehicle which holds shares of
our common stock, has the sole authority to vote and dispose of all of the shares of common stock reported in the Schedule 13G. The Manager, by virtue of his position as manager of Capital, has the sole authority to vote and dispose of all of the
shares of common stock reported in the Schedule 13G. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Schedule 13G filed on February&nbsp;14, 2013 by Great Point Partners, LLC (&#147;Great Point&#148;), Jeffrey R. Jay, M.D. and David Kroin reported that Great Point,
Dr.&nbsp;Jay and Mr.&nbsp;Kroin beneficially owned 1,039,793 shares of our common stock and warrants to purchase common stock, consisting of 266,661 shares owned by Biomedical Value Fund, LP (&#147;BVF&#148;), 179,588 shares owned by Biomedical
Offshore Value Fund, Ltd.(&#147;BOVF&#148;), 97,955 shares owned by Biomedical Institutional Value Fund, LP (&#147;BIVF&#148;), 75,028 shares owned by Lyrical Multi-Manager Fund, LP (&#147;Lyrical&#148;), 32,377 shares owned by Lyrical Multi-Manager
Offshore Fund Ltd. (&#147;Lyrical Offshore&#148;), 143,711 shares owned by Class D Series of GEF-PS, LP (&#147;GEF-PS&#148;), 5,395 shares owned by David J. Morrison (&#147;Morrison&#148;), 21,777 shares owned by WS Investments III, LLC
(&#147;WS&#148;), and an aggregate of 217,301 shares of common stock underlying warrants collectively held by BVF, BOVF, BIVF, Lyrical, Lyrical Offshore, GEF-PS, Morrison and WS. Each of BVF, BOVF, BIVF, Lyrical, Lyrical Offshore, GEF-PS, Morrison
and WS holds warrants to purchase 55,590 shares, 49,252 shares, 25,604 shares, 19,324 shares, 8,396 shares, 46,199 shares, 1,848 shares and 11,088 shares, respectively. Great Point is the investment manager of BVF, BOVF, BIVF, Lyrical, Lyrical
Offshore, GEF-PS, Morrison and WS, and by virtue of such status may be deemed to be the beneficial owner of such shares. Each of Dr.&nbsp;Jay, as senior managing member of Great Point, and Mr.&nbsp;Kroin, as special managing member of Great Point,
has voting and investment power with respect to such shares, and therefore may be deemed to be the beneficial owner of such shares. Great Point, Dr.&nbsp;Jay and Mr.&nbsp;Kroin disclaim beneficial ownership of the shares and the shares underlying
the warrants described above, except to the extent of their respective pecuniary interests. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Schedule 13G filed on February&nbsp;14, 2013 by Tang Capital Partners, LP (&#147;Tang Capital Partners&#148;), Tang Capital Management, LLC (&#147;Tang Capital
Management&#148;) and Kevin C. Tang reported that Tang Capital Partners beneficially owned 869,231 shares of our common stock and shared voting and dispositive power over such shares with Tang Capital Management and Mr.&nbsp;Tang. Tang Capital
Management, as the general partner of Tang Capital Partners, may be deemed to beneficially own the shares of our common stock owned by Tang Capital Partners. Mr.&nbsp;Tang, as the manager of Tang Capital Management, may be deemed to beneficially own
the shares of our common stock beneficially owned by Tang Capital Partners. Mr.&nbsp;Tang disclaims beneficial ownership of the shares described above except to the extent of his pecuniary interest therein. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Schedule 13G filed on February&nbsp;11, 2013 by BlackRock, Inc. reported that it beneficially owned 824,925 shares of our common stock, with sole power to vote or
direct the vote. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 56,788 shares owned directly, 49,340 shares owned indirectly through Trycor Investment Trust, 8,092 shares owned indirectly through Mr.&nbsp;Cormack&#146;s
spouse, and 160,625 options exercisable within 60&nbsp;days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 22,551 shares owned directly and 98,750 representing options exercisable within 60&nbsp;days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 1,341 shares owned directly and 55,844 options exercisable within 60&nbsp;days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 1,146 options exercisable within 60&nbsp;days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beneficial ownership calculated as of May&nbsp;31, 2012 which is the effective date of Mr.&nbsp;Lawrence&#146;s departure from the Company. Represents 4,450 shares
owned directly through Mr.&nbsp;Lawrence&#146;s Registered Retirement Savings Plan, 950 shares owned indirectly through his spouse&#146;s Registered Retirement Savings Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 7,562 shares owned directly and 39,308 representing options and 2,000 RSUs exercisable within 60&nbsp;days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 3,000 shares owned directly and 12,961 shares representing options and 2,000 RSUs exercisable within 60&nbsp;days of March&nbsp;28, 2013.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 1,000 shares owned directly, 14,961 options and 2,000 RSUs exercisable within 60 days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 1,000 shares owned directly and 11,166 options and 2,000 RSUs exercisable within 60 days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents 11,166 options and 2,000 RSUs exercisable within 60 days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents for the current officers and directors as a group, 156,074 shares owned directly or indirectly as indicated above, and 405,927 options and 10,000 RSUs
exercisable within 60&nbsp;days of March&nbsp;28, 2013. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_48"></A>OTHER MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_49"></A>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Exchange Act requires that our executive officers and directors, and persons who own more than 10% of a registered class of our equity securities, file reports of ownership and
changes in ownership with the SEC. Executive officers, directors and greater than 10% stockholders are required by SEC rules to furnish us with copies of all forms they file. Based solely on our review of the copies of such forms we received and
written representations from certain reporting persons, we believe that all of our executive officers, directors and 10% stockholders timely filed all reports required to be filed under Section&nbsp;16(a) during fiscal year 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_50"></A>Delivery of Documents to Stockholders Sharing an Address </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have adopted a process for delivering documents to stockholders that has been approved by the SEC called &#147;householding.&#148; Under this process, stockholders of record who have the same address
and last name will receive only one copy of our Annual Report and this Proxy Statement, unless we or one of our mailing agents has received contrary instructions from any stockholder at that address. We will continue to mail a proxy card to each
stockholder of record. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you prefer to receive multiple copies of the Annual Report and this Proxy Statement at the same address, additional
copies will be provided to you promptly upon either written or oral request. If you are a stockholder of record, you may contact us by writing to OncoGenex Pharmaceuticals, Inc., Attention: Secretary, 1522&#151;217th Place S.E., Bothell, Washington
98021 or calling (425)&nbsp;686-1500. Eligible stockholders of record receiving multiple copies of our Annual Report and this Proxy Statement who wish to only receive one copy in the future, can request householding by contacting us in the same
manner. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner holding shares through your broker, bank or other nominee, you may request additional copies of the
Annual Report or this Proxy Statement, or you may request householding, by notifying your broker, bank or other nominee. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_51">
</A>Stockholder Proposals to Be Presented at 2014 Annual Meeting </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our bylaws provide that, for stockholder nominations to the Board of
Director or other proposals to be considered at an annual meeting, the stockholder must give timely notice thereof in writing to our Secretary at 1522&#151;217th Place S.E., Bothell, Washington 98021, Attn: Secretary. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To be timely for our 2014 annual meeting of stockholders, a stockholder&#146;s notice must be delivered to or mailed and received by our Secretary at our
principal executive offices not earlier than the close of business on January&nbsp;24, 2014 and not later than the close of business on February&nbsp;23, 2014. A stockholder&#146;s notice to our Secretary must set forth as to each matter the
stockholder proposes to bring before the annual meeting the information required by our bylaws. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholder proposals submitted pursuant to
Rule 14a-8 under the Exchange Act and intended to be presented at our 2014 annual meeting must be received by us not later than December&nbsp;23, 2013 in order to be considered for inclusion in our proxy materials for our 2014 annual meeting of
stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc511574_52"></A>Transaction of Other Business </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At the date of this Proxy Statement, the only business that the Board of Directors intends to present or knows that others will present at the Annual Meeting is as set forth above. If any other matter or
matters are properly brought before the Annual Meeting, or any adjournment or postponement of the Annual Meeting, it is the intention of the persons named in the accompanying form of proxy to vote the proxy on such matters in accordance with their
best judgment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors, </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Scott Cormack </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">President&nbsp;&amp; CEO </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Bothell, Washington </FONT></P>  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">April 22, 2013 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Appendix A </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ONCOGENEX PHARMACEUTICALS, INC. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2010 PERFORMANCE INCENTIVE PLAN
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This 2010 PERFORMANCE INCENTIVE PLAN (the &#147;Plan&#148;) established by OncoGenex Pharmaceuticals, Inc., a Delaware
corporation (the &#147;Company&#148;), was adopted by its Board of Directors on March&nbsp;24, 2010 (the &#147;Effective Date&#148;) and approved by the Company&#146;s stockholders at the 2010 Annual Meeting of Stockholders (the &#147;Approved
Date&#148;). The Plan was amended on March&nbsp;22, 2011 and November&nbsp;1, 2011. An amendment and restatement of the Plan was approved by the Board and the Compensation Committee of the Board on March&nbsp;19, 2013 to be effective on the date of
the 2013 Annual Meeting of Stockholders assuming the Plan is approved by the Company&#146;s stockholders at such meeting. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 1 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PURPOSES OF THE PLAN </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>1.1 Purposes.</B> The purposes of the Plan are (a)&nbsp;to enhance the ability of the Company and its Affiliated Companies to attract and retain the services of officers, qualified employees, directors
and outside consultants and service providers to the Company, upon whose judgment, initiative and efforts the successful conduct and development of the Company&#146;s businesses largely depends, and (b)&nbsp;to provide additional incentives to such
persons to devote their utmost effort and skill to the advancement and betterment of the Company, by providing them an opportunity to participate in the ownership of the Company and thereby have an interest in the success and increased value of the
Company that coincides with the financial interests of the Company&#146;s stockholders. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 2 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DEFINITIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For purposes of this Plan, in addition to other capitalized terms defined herein, the following terms shall have the meanings indicated: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.1 Administrator.</B> &#147;Administrator&#148; means the Board, subject to the Board&#146;s authority to delegate responsibility for
any matter to the Committee or to the Chief Executive Officer of the Company as set forth in Section&nbsp;8.1 of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.2 Affiliated Company.</B> &#147;Affiliated Company&#148; means any &#147;parent corporation&#148; or &#147;subsidiary
corporation&#148; of the Company, whether now existing or hereafter created or acquired, as those terms are defined in Sections 424(e) and 424(f) of the Code, respectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.3 Award.</B> &#147;Award&#148; means an Option, Restricted Share or Restricted Stock Unit issued to a Participant under the Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.4 Award Agreement.</B> &#147;Award Agreement&#148; means an Option Agreement or Stock
Purchase Agreement issued to a Participant pursuant to the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.5 Board.</B> &#147;Board&#148; means the Board of
Directors of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.6 Cause.</B> &#147;Cause&#148; means, with respect to the termination of a Participant&#146;s
employment, termination of such employment by the Company for any of the following reasons: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The
continued refusal or omission by the Participant to perform any material duties required of him by the Company if such duties are consistent with duties customary for the position held with the Company; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>Any material act or omission by the Participant involving malfeasance or gross negligence in the performance of
Participant&#146;s duties to, or material deviation from any of the policies or directives of, the Company; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>Conduct on the part of Participant which constitutes the breach of any statutory or common law duty of loyalty
to the Company; or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B>Any illegal act by Participant which materially and adversely affects the
business of the Company or any felony committed by Participant, as evidenced by conviction thereof, provided that the Company may suspend Participant with pay while any allegation of such illegal or felonious act is investigated. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.7 Change in Control.</B> &#147;Change in Control&#148; shall mean the occurrence of any of the following events: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The acquisition, directly or indirectly, in one transaction or a series of related transactions, by any person
or group (within the meaning of Section&nbsp;13(d)(3) of the Exchange Act) of the beneficial ownership of securities of the Company possessing more than fifty percent (50%)&nbsp;of the total combined voting power of all outstanding securities of the
Company; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>A merger or consolidation of the Company with any other entity, whether or not the Company
is the surviving entity in such transaction, except for a transaction in which the holders of the outstanding voting securities of the Company immediately prior to such merger or consolidation hold as a result of holding Company securities prior to
such transaction, in the aggregate, securities possessing more than fifty percent (50%)&nbsp;of the total combined voting power of all outstanding voting securities of the Company or of the surviving entity (or the parent of the surviving entity)
immediately after such merger or consolidation; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>The sale, transfer or other disposition (in one
transaction or a series of related transactions) of all or substantially all of the assets of the Company; or </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B>The approval by the stockholders of a plan or proposal for the liquidation or dissolution of the Company.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.8 Code.</B> &#147;Code&#148; means the Internal Revenue Code of 1986, as amended from
time to time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.9 Committee.</B> &#147;Committee&#148; means a committee of two or more members of the Board appointed to
administer the Plan, as set forth in Section&nbsp;8.1 hereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.10 Common Stock.</B> &#147;Common Stock&#148; means the
Common Stock of the Company, $0.001 par value, subject to adjustment pursuant to Section&nbsp;4.2 hereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.11
Consultant.</B> &#147;Consultant&#148; means any consultant or advisor if: (i)&nbsp;the consultant or advisor renders bona fide services to the Company or any Affiliated Company; (ii)&nbsp;the services rendered by the consultant or advisor are not
in connection with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company&#146;s securities; and (iii)&nbsp;the consultant or advisor is a natural person who
has contracted directly with the Company or any Affiliated Company to render such services. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.12 Disability.</B>
&#147;Disability&#148; means permanent and total disability as defined in Section&nbsp;22(e)(3) of the Code. The Administrator&#146;s determination of a Disability or the absence thereof shall be conclusive and binding on all interested parties.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.13 DRO.</B> &#147;DRO&#148; means a domestic relations order as defined in the Code or Title I of the Employee
Retirement Income Security Act of 1974, as amended, or the regulations thereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.14 Employee.</B> &#147;Employee&#148;
means any officer or other employee (as defined in accordance with Section&nbsp;3401(c) of the Code) of the Company, or any Affiliated Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.15 Effective Date.</B> &#147;Effective Date&#148; means the date on which the Plan is adopted by the Board, as set forth on the first page hereof. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.16 Exchange Act.</B> &#147;Exchange Act&#148; means the Securities and Exchange Act of 1934, as amended. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.17 Exercise Price.</B> &#147;Exercise Price&#148; means the purchase price per share of Common Stock payable upon exercise of an
Option. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.18 Fair Market Value.</B> &#147;Fair Market Value&#148; on any given date means the value of one share of Common
Stock, determined as follows: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>If the Common Stock is then listed or admitted to trading on a Nasdaq
market system or a stock exchange which reports closing sale prices, the Fair Market Value shall be the closing sale price on the date of valuation on such Nasdaq market system or principal stock exchange on which the Common Stock is then listed or
admitted to trading, or, if no closing sale price is reported on such day, then the Fair Market Value shall be the closing sale price of the Common Stock on such Nasdaq market system or such exchange on the next preceding day for which a closing
sale price is reported. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>If the Common Stock is not then listed or admitted to trading on
a Nasdaq market system or a stock exchange which reports closing sale prices, the Fair Market Value shall be the average of the closing bid and asked prices of the Common Stock in the over-the-counter market on the date of valuation. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>If neither clause (a)&nbsp;nor (b)&nbsp;of this Section&nbsp;2.18 is applicable as of the date of valuation,
then the Fair Market Value shall be determined by the Administrator in good faith using any reasonable method of valuation, which determination shall be conclusive and binding on all interested parties. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.19 FINRA Dealer.</B> &#147;FINRA Dealer&#148; means a broker-dealer that is a member of the Financial Industry Regulatory Authority,
Inc. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.20 Incentive Option.</B> &#147;Incentive Option&#148; means any Option so designated by the Administrator and
intended to qualify as an &#147;incentive stock option&#148; as defined in Section&nbsp;422 of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.21 Incentive
Option Agreement.</B> &#147;Incentive Option Agreement&#148; means an Option Agreement with respect to an Incentive Option. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.22 Nonqualified Option.</B> &#147;Nonqualified Option&#148; means any Option that is not an Incentive Option. To the extent that any
Option designated as an Incentive Option fails in whole or in part to qualify as an Incentive Option, including, without limitation, for failure to meet the limitations applicable to a 10% Stockholder or because it exceeds the annual limit provided
for in Section&nbsp;5.6 below, it shall to that extent constitute a Nonqualified Option. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.23 Nonqualified Option
Agreement.</B> &#147;Nonqualified Option Agreement&#148; means an Option Agreement with respect to a Nonqualified Option. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.24 Option.</B> &#147;Option&#148; means any option to purchase Common Stock granted pursuant to the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.25 Option Agreement.</B> &#147;Option Agreement&#148; means the written agreement entered into between the Company and the Optionee
with respect to an Option granted under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.26 Optionee.</B> &#147;Optionee&#148; means a Participant who holds an
Option. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.27 Participant.</B> &#147;Participant&#148; means an individual or entity that holds an Award under the Plan.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.28 Purchase Price.</B> &#147;Purchase Price&#148; means the purchase price per Restricted Share. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.29 Restricted Shares.</B> &#147;Restricted Shares&#148; means shares of Common Stock issued pursuant to Article 6 hereof, subject to
any restrictions and conditions as are established pursuant to such Article 6. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.30 Restricted Stock Unit.</B> &#147;Restricted Stock Unit&#148; means an award made
pursuant to Article 7 hereof, subject to any restrictions and conditions as are established pursuant to such Article 7. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.31 Rule 16b-3 Covered Person.</B> &#147;Rule 16b-3 Covered Person&#148; means any key Employee or member of the Board designated by
the Administrator with respect to which any transaction involving Common Stock may be eligible for the exemption from Section&nbsp;16(b) of the Exchange Act set forth in Rule 16b-3. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.32 Section&nbsp;162(m) Covered Employee.</B> &#147;Section 162(m) Covered Employee&#148; means (i)&nbsp;an employee of the Company
if, as of the close of the taxable year, such employee is the Principal Executive Officer of the Company (or an individual acting in such a capacity) and the three (3)&nbsp;officers of the Company (other than the Principal Financial Officer and the
Principal Executive Officer) for whom total compensation is required to be reported to stockholders under the Exchange Act by reason of such individuals being among the three (3)&nbsp;highest compensated officers for the relevant taxable year and
(ii)&nbsp;any other key Employee designated by the Administrator as a key Employee whose compensation for the fiscal year in which the key Employee is so designated or a future fiscal year may be subject to the limit on deductible compensation
imposed by Section&nbsp;162(m) of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.33 Service Provider.</B> &#147;Service Provider&#148; means a Consultant,
Employee, member of the Board or other natural person the Administrator authorizes to become a Participant in the Plan and who provides services to (i)&nbsp;the Company, (ii)&nbsp;an Affiliated Company, or (iii)&nbsp;any other business venture
designated by the Administrator in which the Company (or any entity that is a successor to the Company) or an Affiliated Company has a significant ownership interest. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.34 Stock Purchase Agreement.</B> &#147;Stock Purchase Agreement&#148; means the written agreement entered into between the Company and a Participant with respect to the purchase of Restricted Shares
under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.35 10% Stockholder.</B> &#147;10% Stockholder&#148; means a person who, as of a relevant date, owns or
is deemed to own (by reason of the attribution rules applicable under Section&nbsp;424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or of an Affiliated Company. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 3 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELIGIBILITY </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>3.1 Incentive Options. </B>Only Employees of the Company or of an Affiliated Company (including officers of the Company and members of the Board if they are Employees of the Company or of an Affiliated
Company) are eligible to receive Incentive Options under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.2 Nonqualified Options and Restricted Shares.</B>
Employees of the Company or of an Affiliated Company, officers of the Company and members of the Board (whether or not employed by the Company or an Affiliated Company), and Service Providers are eligible to receive Nonqualified Options or acquire
Restricted Shares. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.3 Section&nbsp;162(m) Limitation for Options.</B> The aggregate number of shares of
Common Stock with respect to which Options may be granted to any Employee shall not exceed 1,050,000 shares of Common Stock during any calendar year. Any shares subject to an Option granted during a calendar year to an Employee that can no longer
under any circumstances be exercised or purchased for any reason under the Plan shall continue to count against the applicable limitations set forth above for such Employee during such calendar year. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 4 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>GRANTING OF AWARDS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>4.1 Shares Subject to the Plan.</B> The shares of stock available as a basis for Awards shall be Common Stock. Such shares may be issued from either previously authorized but unissued shares or
treasury shares, subject to adjustment as to the number and kind of shares pursuant to Section&nbsp;4.2 hereof. Subject to the foregoing, a total of 2,050,000 shares of Common Stock may be issued under the Plan. Notwithstanding the limitation
described in the preceding sentence, if an option granted pursuant to an equity compensation plan of the Company other than the Plan is outstanding as of the Approved Date and such option subsequently terminates or expires in accordance with its
terms, the shares of Common Stock underlying such option which remain unexercised and unissued at the time of such termination or expiration, shall become available for grant or issuance under the Plan, subject to adjustment pursuant to
Section&nbsp;4.2 hereof. In no event will there be available greater than 2,050,000 shares of Common Stock for purposes of the issuance of Incentive Options under the Plan, subject to adjustment pursuant to Section&nbsp;4.2 hereof. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B><U>Cancelled or Forfeited Awards other than Restricted Shares</U>. For purposes of the limitation set forth in this
Section&nbsp;4.1, if all or any portion of any Award, other than Restricted Shares, granted or offered under the Plan can no longer under any circumstances be exercised or purchased due to the forfeiture or cancellation of all or any portion of such
Award, then the shares of Common Stock allocable to such unexercised or forfeited portions of such Award shall not count against such limitation and shall again become available for grant or issuance under the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B><U>Non-Replenishment of Reacquired Shares; Awards other than Restricted Shares for Reasons other than Cancellation or
Forfeiture of Award</U>. For purposes of the limitation set forth in this Section&nbsp;4.1, any shares of Common Stock subject to an Award, other than Restricted Shares, and which are reacquired by the Company for any reason, including without
limitation pursuant to Section&nbsp;11.1, other than the cancellation or forfeiture of such Award as described in Section&nbsp;4.1(a) shall count against such limitation. The Company shall hold all such shares of Common Stock that it reacquires as
treasury shares, which shall not again become available for grant or issuance under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B><U>Replenishment of
Reacquired Shares; Awards of Restricted Shares</U>. For purposes of the limitation set forth in this Section&nbsp;4.1, any shares of Common Stock that were initially the subject of a Stock Purchase Agreement, and which are reacquired by the Company
for any reason, including without limitation pursuant to Section&nbsp;11.1, shall not count against such limitation and shall again become available for grant or issuance under the Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.2 Changes in Capital Structure.</B> In the event that the outstanding shares of Common
Stock are hereafter increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of a recapitalization, stock split, reverse stock split, combination of shares,
reclassification, stock dividend, or other similar change in the capital structure of the Company, then appropriate adjustments shall be made by the Administrator to the aggregate number and kind of shares issuable thereafter under this Plan, the
number and kind of shares and the price per share subject to outstanding Award Agreements and the limit on the number of shares under Sections 3.3 and 6.6, all in order to preserve, as nearly as practical, but not to increase, the benefits to
Participants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.3 Award Agreement.</B> Each Award shall be evidenced by an Award Agreement. Award Agreements evidencing
Incentive Options shall contain such terms and conditions as may be necessary to meet the applicable provisions of Section&nbsp;422 of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>4.4 Rule 16b-3 Covered Persons.</B> Notwithstanding any other provision of the Plan, the Plan and any Award granted or awarded to a Rule 16b-3 Covered Person shall be subject to any additional
limitations set forth in any applicable exemptive rule under Section&nbsp;16 of the Exchange Act (including Rule 16b-3 under the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable
law, the Plan and Awards granted or awarded hereunder shall be deemed amended to the extent necessary to conform to such applicable exemptive rule(s). </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 5 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OPTIONS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1 Option Agreement.</B> Each Option granted pursuant to this Plan shall be evidenced by an Option Agreement that shall specify the
number of shares subject thereto, the Exercise Price per share, and whether the Option is an Incentive Option or Nonqualified Option. As soon as is practical following the grant of an Option, an Option Agreement shall be duly executed and delivered
by or on behalf of the Company to the Optionee to whom such Option was granted. Each Option Agreement shall be in such form and contain such additional terms and conditions, not inconsistent with the provisions of this Plan, as the Administrator
shall, from time to time, deem desirable, including, without limitation, the imposition of any rights of first refusal and resale obligations upon any shares of Common Stock acquired pursuant to an Option Agreement. Each Option Agreement may be
different from each other Option Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2 Exercise Price.</B> The Exercise Price per share of Common Stock covered
by each Option shall be determined by the Administrator, subject to the following: (a)&nbsp;the Exercise Price of an Option shall not be less than 100% of Fair Market Value on the date the Option is granted and (b)&nbsp;if the person to whom an
Incentive Option is granted is a 10% Stockholder on the date of grant, the Exercise Price shall not be less than 110% of Fair Market Value on the date the Option is granted. However, an Option may be granted with an Exercise Price lower than that
set forth in the preceding sentence if such Incentive Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section&nbsp;424 of the Code. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.3 Payment of Exercise Price.</B> Payment of the Exercise Price shall be made upon
exercise of an Option and may be made, in the discretion of the Administrator, subject to any legal restrictions, by: (a)&nbsp;cash; (b)&nbsp;check; (c)&nbsp;the surrender of shares of Common Stock acquired pursuant to the exercise of an Option
(provided that shares acquired pursuant to the exercise of Options must have been held by the Optionee for the requisite period necessary to avoid a charge to the Company&#146;s earnings for financial reporting purposes), which surrendered shares
shall be valued at Fair Market Value as of the date of such exercise; (d)&nbsp;the waiver of compensation due or accrued to the Optionee for services rendered; (e)&nbsp;a &#147;same day sale&#148; commitment from the Optionee and a FINRA Dealer
whereby the Optionee irrevocably elects to exercise the Option and to sell a portion of the shares so purchased to pay for the Exercise Price and whereby the FINRA Dealer irrevocably commits upon receipt of such shares to forward the Exercise Price
directly to the Company; or (f)&nbsp;any combination of the foregoing methods of payment or any other consideration or method of payment as shall be permitted by applicable law, including the Sarbanes-Oxley Act of 2002, as amended. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.4 Term and Termination of Options.</B> The term and provisions for termination of each Option shall be as fixed by the
Administrator, but no Option may be exercisable more than ten (10)&nbsp;years after the date it is granted. An Incentive Option granted to a person who is a 10% Stockholder on the date of grant shall not be exercisable more than five (5)&nbsp;years
after the date it is granted. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.5 Vesting and Exercise of Options.</B> Each Option shall vest and become exercisable in
one or more installments at such time or times and subject to such conditions, including without limitation the achievement of specified performance goal(s) or objectives, as shall be determined by the Administrator. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.6 Annual Limit on Incentive Options.</B> To the extent required for &#147;incentive stock option&#148; treatment under
Section&nbsp;422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the Common Stock, with respect to which Incentive Options granted under this Plan and any other plan of the Company or any Affiliated Company
become exercisable for the first time by an Optionee during any calendar year, shall not exceed $100,000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.7
Nontransferability of Options.</B> Except as otherwise provided by the Administrator in an Option Agreement and as permissible under applicable law, no Option shall be assignable or transferable except by will or the laws of descent and
distribution, and during the life of the Optionee shall be exercisable only by such Optionee unless it has been disposed of with the consent of the Administrator (which consent may be withheld in the Administrator&#146;s sole and absolute
discretion) pursuant to a DRO. Notwithstanding the foregoing, no Option shall be assignable or transferable in exchange for consideration. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>5.8 Rights as Stockholder.</B> An Optionee or permitted transferee of an Option shall have no rights or privileges as a stockholder with respect to any shares covered by an Option until such Option has
been duly exercised and certificates representing shares purchased upon such exercise have been issued to such person. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 6 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>RESTRICTED SHARES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.1 Issuance and Sale of Restricted Shares.</B> The
Administrator shall have the right to grant Restricted Shares subject to such terms, restrictions and conditions as the Administrator may determine at the time of grant (&#147;Restricted Share Awards&#148;). Such conditions shall include the
Purchase Price to be paid by the grantee for such an Award, if any (but not less than the minimum lawful amount under applicable state law). Such conditions may also include, but are not limited to, continued employment or the achievement of
specified performance goal(s) or objectives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.2 Stock Purchase Agreements.</B> A Participant shall have no rights with
respect to the Restricted Shares covered by a Stock Purchase Agreement until the Participant has paid the full Purchase Price (if applicable) to the Company in the manner set forth in Section&nbsp;6.3 hereof and has executed and delivered to the
Company the Stock Purchase Agreement. Each Stock Purchase Agreement shall be in such form, and shall set forth the Purchase Price and such other terms, conditions and restrictions of the Restricted Shares, not inconsistent with the provisions of
this Plan, as the Administrator shall, from time to time, deem desirable. Each Stock Purchase Agreement may be different from each other Stock Purchase Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>6.3 Payment of Purchase Price.</B> Subject to any legal restrictions, payment of the Purchase Price, if any, may be made, in the discretion of the Administrator, by: (a)&nbsp;cash; (b)&nbsp;check;
(c)&nbsp;the surrender of shares of Common Stock owned by the Participant that have been held by the Participant for the requisite period necessary to avoid a charge to the Company&#146;s earnings for financial reporting purposes, which surrendered
shares shall be valued at Fair Market Value as of the date of such acceptance; (d)&nbsp;the waiver of compensation due or accrued to the Participant for services rendered; or (e)&nbsp;any combination of the foregoing methods of payment or any other
consideration or method of payment as shall be permitted by applicable corporate law, including the Sarbanes-Oxley Act of 2002, as amended. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>6.4 Rights as a Stockholder.</B> Upon complying with the provisions of Section&nbsp;6.2 hereof, a Participant shall have the rights of a stockholder with respect to the Restricted Shares purchased
pursuant to a Stock Purchase Agreement, including voting and dividend rights, subject to the terms, restrictions and conditions as are set forth in such Stock Purchase Agreement. Unless the Administrator shall determine otherwise, certificates
evidencing Restricted Shares shall remain in the possession of the Company until such shares have vested in accordance with the terms of the Stock Purchase Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>6.5 Restrictions.</B> Restricted Shares may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided in the Stock Purchase Agreement. In the
event of termination of a Participant&#146;s employment, service as a director of the Company or Service Provider status for any reason whatsoever (including death or disability), the Stock Purchase Agreement may provide, in the discretion of the
Administrator, that the Company shall have the right, exercisable at the discretion of the Administrator, to repurchase, at the original Purchase Price, any Restricted Shares which have not vested as of the date of termination. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.6 Vesting of Restricted Shares.</B> Subject to Section&nbsp;6.5 above, the Stock
Purchase Agreement shall specify the date or dates, the performance goal(s) or objectives that must be achieved, and any other conditions on which the Restricted Shares may vest. The Administrator may include among such conditions the requirement
that the performance of the Company or a business unit of the Company for a specified period of one or more fiscal years equal or exceed a target determined in advance by the Administrator.&nbsp;The Administrator shall determine such
performance.&nbsp;Such target shall be based on one or more of the criteria set forth in <B>Appendix&nbsp;A</B>.&nbsp;The Administrator shall identify such target not later than the 90th&nbsp;day of such period.&nbsp;Subject to adjustment in
accordance with Section&nbsp;4.2, in no event shall more than 1,050,000 Restricted Shares that are subject to performance-based vesting conditions be granted to any Participant in a single fiscal year of the Company. A Restricted Stock Agreement may
provide for accelerated vesting in the event of a Change in Control, the Participant&#146;s death, disability or retirement or other events. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 7 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RESTRICTED STOCK UNITS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.1 Awards of Restricted Stock Units.</B> A Restricted Stock Unit (&#147;<B><I>RSU</I></B>&#148;) is an award to a Participant
covering a number of shares of Common Stock that may be settled in cash, or by issuance of those shares of Common Stock (which may consist of Restricted Stock). All RSUs shall be made pursuant to an Award Agreement. Subject to adjustment in
accordance with Section&nbsp;4.2, in no event shall RSUs for more than 1,050,000 shares of Common Stock that are subject to performance-based vesting conditions be granted to any Participant in a single fiscal year of the Company.</FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.2 Terms of RSUs.</B> The Administrator will determine the terms of an RSU including, without limitation: (a)&nbsp;the number of
shares of Common Stock subject to the RSU; (b)&nbsp;the time or times during which the RSU may be settled; and (c)&nbsp;the consideration to be distributed on settlement, and the effect of the Participant&#146;s Termination on each RSU. An RSU may
be awarded upon satisfaction of such performance goals as are set out in advance in the Participant&#146;s Award Agreement. If the RSU is being earned upon satisfaction of performance goals or objectives, then the Administrator will:
(x)&nbsp;determine the nature, length and starting date of any performance period for the RSU; (y)&nbsp;select from among the criteria set forth in <B>Appendix&nbsp;A </B>to be used to measure the performance, if any; and (z)&nbsp;determine the
number of shares of Common Stock deemed subject to the RSU. Performance periods may overlap and participants may participate simultaneously with respect to RSUs that are subject to different performance periods and different performance goals and
other criteria. The Administrator shall determine such performance.&nbsp;Such target shall be based on one or more of the criteria set forth in <B>Appendix&nbsp;A</B>.&nbsp;The Administrator shall identify such target not later than the
90th&nbsp;day of such period.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.3 Form and Timing of Settlement.</B> Payment of earned RSUs shall be made as soon as
practicable after the date(s) determined by the Administrator and set forth in the Award Agreement. The Administrator, in its sole discretion, may settle earned RSUs in cash, shares of Common Stock, or a combination of both. No Purchase Price shall
apply to an RSU settled in shares of Common Stock. The Administrator may also permit a Participant to defer payment under a RSU to a date or dates after the RSU is earned provided that the terms of the RSU and any deferral satisfy the requirements
of Section&nbsp;409A of the Code. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.4 Termination of Participant.</B> Except as may be set forth in the Participant&#146;s
Award Agreement, vesting ceases on such Participant&#146;s termination of service (unless determined otherwise by the Administrator). </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 8 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADMINISTRATION OF THE PLAN </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.1 Administrator.</B> Authority to control and manage the operation and administration of the Plan shall be vested in the Board,
which may delegate such responsibilities in whole or in part to one or more Committees. Members of the Committee may be appointed from time to time by, and shall serve at the pleasure of, the Board. Without limiting the foregoing, the Board may
limit the composition of the Committee to those persons necessary to comply with the requirements of Section&nbsp;162(m) of the Code and the regulations promulgated thereunder, and Section&nbsp;16 of the Exchange Act and Rule 16b-3 under the
Exchange Act. The Board (or the Committee, as applicable) may delegate to the Chief Executive Officer of the Company such responsibilities to administer the Plan as it shall deem advisable and as permitted by applicable law. As used herein, the term
&#147;Administrator&#148; means the Board or, with respect to any matter as to which responsibility has been delegated to the Committee or the Chief Executive Officer, the term Administrator shall mean the Committee or the Chief Executive Officer,
as the case may be. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.2 Powers of the Administrator.</B> In addition to any other powers or authority conferred upon the
Administrator elsewhere in the Plan or by law, the Administrator shall have full power and authority: (a)&nbsp;to determine the persons to whom, and the time or times at which, Awards shall be granted, the number of shares to be represented by each
Option, the number of Restricted Shares to be offered, and the consideration to be received by the Company upon the exercise of or sale of such Awards; (b)&nbsp;to interpret the Plan; (c)&nbsp;to create, amend or rescind rules and regulations
relating to the Plan; (d)&nbsp;to determine the terms, conditions and restrictions contained in, and the form of, Award Agreements; (e)&nbsp;to determine the identity or capacity of any persons who may be entitled to exercise a Participant&#146;s
rights under any Award Agreement under the Plan; (f)&nbsp;to correct any defect or supply any omission or reconcile any inconsistency in the Plan or in any Award Agreement; (g)&nbsp;to accelerate the vesting of any Award or release or waive any
repurchase rights of the Company with respect to any Award; (h)&nbsp;to extend the exercise date of any Award or acceptance date of any Award; (i)&nbsp;to provide for rights of first refusal and/or repurchase rights; (j)&nbsp;to amend outstanding
Award Agreements to provide for, among other things, any change or modification which the Administrator could have included in the original Award Agreement or in furtherance of the powers provided for herein; and (k)&nbsp;to make all other
determinations necessary or advisable for the administration of the Plan, but only to the extent not contrary to the express provisions of the Plan. Any action, decision, interpretation or determination made in good faith by the Administrator in the
exercise of its authority conferred upon it under the Plan shall be final and binding on the Company and all Participants. In making any determination or in taking or not taking any action under the Plan, the Administrator may obtain and rely upon
the advice of experts, including advisors to the Company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.3 Limitation on Liability.</B> No Employee of the Company or member of the Board or
Committee shall be subject to any liability with respect to duties under the Plan unless the person acts fraudulently or in bad faith. To the extent permitted by law, the Company shall indemnify each member of the Board or Committee, and any
Employee of the Company with duties under the Plan, who was or is a party, or is threatened to be made a party, to any threatened, pending or completed proceeding, whether civil, criminal, administrative or investigative, by reason of such
person&#146;s conduct in the performance of duties under the Plan. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 9 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CHANGE IN CONTROL </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>9.1 Change in Control.</B> In order to preserve a Participant&#146;s rights in the event of a Change in Control of the Company: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The Administrator shall have the discretion to provide in each Award Agreement the terms and conditions that
relate to (i)&nbsp;vesting of such Award in the event of a Change in Control, and (ii)&nbsp;assumption of such Awards or issuance of comparable securities under an incentive program in the event of a Change in Control. The aforementioned terms and
conditions may vary in each Award Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>If the terms of an outstanding Option Agreement
provide for accelerated vesting in the event of a Change in Control, or to the extent that an Option is vested and not yet exercised, the Administrator in its discretion may provide, in connection with the Change in Control transaction, for the
purchase or exchange of each Option for an amount of cash or other property having a value equal to the difference (or &#147;spread&#148;) between: (x)&nbsp;the value of the cash or other property that the Participant would have received pursuant to
the Change in Control transaction in exchange for the shares issuable upon exercise of the Option had the Option been exercised immediately prior to the Change in Control, and (y)&nbsp;the Exercise Price of the Option. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>Outstanding Options shall terminate and cease to be exercisable upon consummation of a Change in Control except
to the extent that the Options are assumed by the successor entity (or parent thereof) pursuant to the terms of the Change in Control transaction. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B>The Administrator shall cause written notice of a proposed Change in Control transaction to be given to Participants not less than fifteen (15)&nbsp;days prior to the anticipated effective date
of the proposed transaction. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 10 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>AMENDMENT AND TERMINATION OF THE PLAN </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10.1 Amendments.</B> Subject to
applicable law, including Nasdaq stockholder approval requirements, the Board may from time to time alter, amend, suspend or terminate the Plan in such respects as the Board may deem advisable. No such alteration, amendment, suspension or
termination shall be made which shall substantially affect or impair the rights of any Participant under an outstanding Award Agreement without such Participant&#146;s consent. The Board may alter or amend the Plan to comply with requirements under
the Code relating to Incentive Options or other types of options which give Optionees more favorable tax treatment than that applicable to Options granted under this Plan as of the date of its adoption. Upon any such alteration or amendment, any
outstanding Option granted hereunder may, if the Administrator so determines and if permitted by applicable law, be subject to the more favorable tax treatment afforded to an Optionee pursuant to such terms and conditions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10.2 Plan Termination.</B> Unless the Plan shall theretofore have been terminated, the Plan shall terminate on the tenth
(10th)&nbsp;anniversary of the earlier of the Effective Date and the Approved Date and no Awards may be granted under the Plan thereafter, but Award Agreements then outstanding shall continue in effect in accordance with their respective terms.
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 11 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CANCELLATION&nbsp;&amp; RESCISSION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11.1 Non-Competition.</B> Unless an
Option Agreement specifies otherwise, the Administrator may cancel, rescind, suspend, withhold or otherwise limit or restrict any unexpired, unpaid or deferred Options at any time if the Participant is not in compliance with all applicable
provisions of the Option Agreement and the Plan or if the Participant engages in any &#147;Adverse Activity.&#148; For purposes of this Section&nbsp;11.1, &#147;Adverse Activity&#148; shall include: (i)&nbsp;the disclosure to anyone outside the
Company, or the use in other than the Company&#146;s business, without prior written authorization from the Company, of any confidential information or material relating to the business of the Company, acquired by the Participant either during or
after employment with the Company; (ii)&nbsp;the failure or refusal to disclose promptly and to assign to the Company all right, title and interest in any invention or idea, patentable or not, made or conceived by the Participant during employment
by the Company, relating in any manner to the actual or anticipated business, research or development work of the Company; or (iii)&nbsp;activity that results in termination of the Participant&#146;s employment for Cause. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11.2 Agreement Upon Exercise.</B> Upon exercise, payment or delivery pursuant to an Option Agreement, the Participant shall certify in
a manner acceptable to the Company that he or she is in compliance with the terms and conditions of the Plan. In the event a Participant fails to comply with the provisions of clauses (i)&nbsp;through (iii)&nbsp;of Section&nbsp;11.1 hereof prior to,
or during the six (6)&nbsp;months after, any exercise, payment or delivery pursuant to an Option Agreement, such exercise, payment or delivery may be rescinded within two years thereafter. In the event of any such rescission, the Participant shall
pay to the Company the amount of any gain realized or payment received as a result of the exercise, payment or delivery, in such manner and on such terms and conditions as may be required, and the Company shall be entitled to set-off against the
amount of any such gain any amount owed to the Participant by the Company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 12 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>TAX WITHHOLDING </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12.1 Withholding.</B> The Company shall have the power
to withhold, or require a Participant to remit to the Company in cash, an amount sufficient to satisfy any applicable federal, state, local or foreign tax withholding requirements with respect to any Options exercised, any Restricted Shares issued,
or any other Award issued under the Plan. To the extent permissible under applicable tax, securities and other laws, the Administrator may, in its sole discretion and upon such terms and conditions as it may deem appropriate, permit a Participant to
satisfy his or her obligation to pay any such tax, in whole or in part, in an amount determined on the basis of the lowest rate of withholding applicable to such Participant, by (a)&nbsp;directing the Company to apply shares of Common Stock to which
the Participant is entitled as a result of the exercise of an Award or as a result of the purchase of or lapse of restrictions on an Award, or (b)&nbsp;delivering to the Company shares of Common Stock owned by the Participant. The shares of Common
Stock so applied or delivered in satisfaction of the Participant&#146;s tax withholding obligation shall be valued at their Fair Market Value as of the date of withholding based on the minimum statutory withholding rates for income tax and payroll
tax purposes that are applicable to such supplemental taxable income. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARTICLE 13 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>MISCELLANEOUS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>13.1 Repricings Not Permitted.</B> Notwithstanding anything herein to the contrary, the Administrator shall not have the authority to cause the repricing of any outstanding Options either through an
adjustment to the Exercise Price or through the cancellation of an Option and regrant of a new Option or other Award in exchange for the cancelled Option (a &#147;Repricing&#148;), unless such Repricing is approved by a majority of the
Company&#146;s stockholders entitled to vote on such matter. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.2 Benefits Not Alienable.</B> For so long as it is subject
to any restrictions pursuant to this Plan or an Award Agreement, no Award or interest or right therein or part thereof shall be liable for the debts, contracts, or engagements of the Participant or his or her successors in interest or shall be
subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment, or any other means whether such disposition be voluntary or involuntary or by operation of law, by judgment, levy, attachment, garnishment, or any other
legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect; provided, however, that nothing in this Plan shall prevent transfers by will or the applicable laws of descent and
distribution or assignments pursuant to a DRO entered by a court of competent jurisdiction. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.3 No Enlargement of Employee Rights.</B> This Plan is strictly a voluntary undertaking
on the part of the Company and shall not be deemed to constitute a contract between the Company and any Participant to be consideration for, or an inducement to, or a condition of, the employment of any Participant. Nothing contained in the Plan
shall be deemed to give the right to any Participant to be retained as an employee of the Company or any Affiliated Company or to interfere with the right of the Company or any Affiliated Company to discharge any Participant at any time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.4 Application of Funds.</B> The proceeds received by the Company from the sale of Common Stock pursuant to Award Agreements, except
as otherwise provided herein, will be used for general corporate purposes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.5 Annual Reports.</B> During the term of
this Plan, the Company will furnish to each Participant who does not otherwise receive such materials, copies of all reports, proxy statements and other communications that the Company distributes generally to its stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.6 Applicable Law.</B> The validity, construction, interpretation and effect of this Plan and all Award Agreements hereunder shall
be governed by and determined in accordance with the laws of the State of Washington except for matters of corporate law, in which case the provisions of the Delaware General Corporation Law shall govern. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Appendix&nbsp;A </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PERFORMANCE CRITERIA </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>FOR RESTRICTED SHARES AND RESTRICTED STOCK UNITS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The performance goals that may be used
by the Administrator for restricted share awards shall consist of: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net revenue and/or net revenue growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings per share and/or earnings per share growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings before income taxes and amortization and/or earnings before income taxes and amortization growth; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating income and/or operating income growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income and/or net income growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholder return and/or total stockholder return growth; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on equity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating cash flow return on income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted operating cash flow return on income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Economic value added; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Individual business objectives; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company-specific operational metrics. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">appreciation in and/or maintenance of the price of the Shares of the Company; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reductions in costs; cash flow or cash flow per share (before or after dividends); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">drug development milestones; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">regulatory achievements (including submitting or filing applications or other documents with regulatory authorities, successfully executing an advisory
committee meeting, or receiving approval of any such applications or other documents and passing pre-approval inspections and validation of manufacturing processes; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">initiation or completion of pre-clinical studies; clinical achievements (including initiating clinical studies; initiating enrollment, completing
enrollment or enrolling particular numbers of subjects in clinical studies; completing phases of a clinical study (including the treatment phase); or announcing or presenting preliminary or final data from clinical studies; in each case, whether on
particular timelines or generally); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">implementation, completion or attainment of measurable objectives with respect to research (including nominating a development candidate or initiating
a new full discovery program), development, manufacturing, commercialization, development candidates, products or projects, safety, production volume levels; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the extent that an award under the Plan is designated as a &#147;performance award,&#148;
but is not intended to qualify as performance-based compensation under Section&nbsp;162(m), the performance criteria can include the achievement of strategic objectives as determined by the Administrator. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding satisfaction of any performance criteria described above, to the extent specified at the time of grant of an award, the
number of shares of Common Stock or other benefits granted, issued, and/or vested under an award on account of satisfaction of performance criteria may be reduced by the Administrator on the basis of such further considerations as the Administrator
in its sole discretion determines. To the extent consistent with section&nbsp;162(m)&nbsp;of the Code, the Administrator may adjust the results under any performance criterion to exclude any of the following events that occurs during a performance
measurement period: (a)&nbsp;asset write-downs, (b)&nbsp;litigation, claims, judgments or settlements, (c)&nbsp;the effect of changes in tax law, accounting principles or other such laws or provisions affecting reported results, (d)&nbsp;accruals
for reorganization and restructuring programs and (e)&nbsp;any extraordinary, unusual or non-recurring items. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Appendix B </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">PROPOSED AMENDMENTS TO THE </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">CERTIFICATE OF INCORPORATION </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Proposal Four: Text of Amendment to Certificate of Incorporation to Eliminate Cumulative Voting </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Article X &#150; Cumulative Voting would be deleted in its entirety as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">ARTICLE X &#150; CUMULATIVE VOTING </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At all elections of directors of the
Corporation, each stockholder of the Corporation shall be entitled to as many votes as shall equal the number of votes which the stockholder would be entitled to cast for the election of directors with respect to the stockholder&#146;s shares of
stock multiplied by the number of directors to be elected by the stockholders, and each stockholder may cast all of such votes for a single director or may distribute them among the number to be voted for, or for any two or more of them as the
stockholder may see fit. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Article XI &#150; Amendment of Certificate of Incorporation and Article XIII &#150; Perpetual Existence would be
renumbered as Article X &#150; Amendment of Certificate and Article XI &#150; Perpetual Existence. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Proposal Five: Text of Amendment to
Certificate of Incorporation to Increase Shares of Authorized Common Stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Article IV &#150; Authorized Capital would be amended as
follows: </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">ARTICLE IV &#150; AUTHORIZED CAPITAL </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">This Corporation is authorized to issue two classes of stock to be designated respectively, &#147;Common Stock&#148; and &#147;Preferred Stock.&#148; The total number of shares of all classes of stock
which the Corporation shall have authority to issue is 55,000,000, of which (i) 50,000,000 shares shall be designated Common Stock and shall have a par value of $.001 per share; and (ii)&nbsp;5,000,000 shares shall be designated Preferred Stock and
shall have a par value of $.001 per share.&#148; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g511574pc1.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ONCOGENEX PHARMACEUTICALS, INC. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1522-217TH PLACE SE, SUITE 100 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">BOTHELL, WA 98021 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY INTERNET -
www.proxyvote.com </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Use the Internet to transmit your voting instructions and for electronic delivery of
information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction
form. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all
future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to
receive or access proxy materials electronically in future years. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY PHONE - 1-800-690-6903 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the
cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY MAIL </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">M58007-P36799 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">KEEP THIS PORTION FOR YOUR RECORDS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">THIS PROXY
CARD IS VALID ONLY WHEN SIGNED AND DATED. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">DETACH AND RETURN THIS PORTION ONLY </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ONCOGENEX PHARMACEUTICALS, INC. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The Board of Directors recommends you vote FOR the following: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1. Election of Directors </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Nominees: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">01) Scott Cormack </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">02) Neil Clendeninn </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">03) Jack Goldstein
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">04) Martin Mattingly </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">05) Stewart Parker </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">06) David Smith </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For All </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Withhold All </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For All Except </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">To withhold authority to vote for any individual nominee(s), mark &#147;For All Except&#148; and write the number(s) of
the nominee(s) on the line below. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The Board of Directors recommends you vote FOR the following proposal:
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2. To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for
the fiscal year ending December 31, 2013. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">3. To approve an amendment to our 2010 Performance Incentive Plan
that will increase the total shares of common stock available for issuance under the 2010 Performance Incentive Plan from 1,050,000 to 2,050,000. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">4. To approve an amendment to our certificate of incorporation to eliminate cumulative voting for the election of directors. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">5. To approve an amendment to our certificate of incorporation to increase our authorized shares of common stock from
25,000,000 to 50,000,000. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For Against Abstain </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">To cumulate votes as to a particular nominee as explained in the Proxy Statement, check box to the right then indicate the
name(s) and the number of votes to be given to such nominee(s) on the reverse side of this card. Please do not check box unless you want to exercise cumulative voting. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please indicate if you plan to attend this meeting. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Yes No </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NOTE: Please sign exactly as your name or names appear(s) on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee
or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person and
state your title. PLEASE COMPLETE, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY USING THE ENCLOSED ENVELOPE. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NOTE: In their discretion, the proxies may transact such other business as properly comes before the meeting or any
adjournment thereof. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Signature [PLEASE SIGN WITHIN BOX] Date </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Signature (Joint Owners) Date </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g511574pc2.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">M58008-P36799 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ONCOGENEX PHARMACEUTICALS, INC. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Annual Meeting of
Stockholders </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">May&nbsp;24, 2013 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">This proxy is solicited by the Board of Directors </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The undersigned hereby nominates and appoints Scott Cormack and Susan Wyrick, and each of them individually, the attorney,
agent and proxy of the undersigned, with full power of substitution, to vote all stock of ONCOGENEX PHARMACEUTICALS, INC. which the undersigned is entitled to represent and vote at the Annual Meeting of Stockholders to be held at the offices of
Fenwick&nbsp;&amp; West LLP at 1191 Second Avenue, 10th Floor, Seattle, Washington, on May&nbsp;24, 2013 at 9:00 a.m. local time, and at any and all adjournments or postponements thereof, as fully as if the undersigned were present and voting on the
matters listed on the reverse side. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">This proxy, when properly executed, will be voted in the manner directed
herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors&#146; recommendations. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Cumulative voting </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NAME OF CANDIDATE </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1.1 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1.2 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1.3 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1.4 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1.5 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1.6 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF"># OF VOTES CAST </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">(If you exercised cumulative voting, please mark corresponding box on the reverse side.) </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">(Continued and to be signed on reverse side) </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g511574pc1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g511574pc1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@#*@)Q`P$1``(1`0,1`?_$`+4``0`"`@,!`0$`````
M```````'"`4&`P0)"@(!`0$!`0$``````````````````0(#$```!@,``0,"
M`@4&"@8'!`L"`P0%!@<``0@)$1(3%!4A%B(7EU@9,2,8>'DZM-35-K;6F-B9
MV3(D5]=9"D%A,S0EMSA"M98G=[@Y)C=:4:%#1#41`0`"``4"!04``@(#`0$!
M```!$2$Q40(209'P87&A(H'1X3(#L<'Q$T)28C.2HO_:``P#`0`"$0,1`#\`
M^_C`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`H[V-V
M_&.,!Q%;/86Z/4<G44N$V)NS6](4BR06W6]?.=E1*DVAJ6)-A52JVH_&7@IH
M.$H++TX(BTWQF&*2_::C;:IR[RQOADAES+&>7UKPE"/HZ)U&YNMQ,D<W95N\
M@-ZUPZ,@;ZA-A;B=6[+&BVI6!D?%`G`#Z,C?N2HM#!L1>'CU;!RKY/I1TC>=
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MY1G*NO9&C01<=>F?,JF;ZYQXUH."MV2-`[G'B_\`<1`/'"+J\;B.Z#;/_P#,
M5M]2*YVDD7)"B2*X%#:WDQ[)7EWK7N4R=39<)C$X;Q1)DD]'0DI9%6!#)RT[
MFO6J4#B2HT'XFP\!FAZEM?\`7?59J)>:J+VC?E:T94]&'OQEC6C8=:E2J5V;
MJ+IFA96%;<O3>7I%;2PUY.E!<Q9I!TB;'E34J.1ID;E%EWS+P;-)!JL\*BYT
M7#Y6[;>;KBMX32]JQA?+D:IN^IESV!YD%]1F9-4FF,!DAT/D1PG0Z+P=`P)C
MY($I.VEFF''N'S!WH(!>@!$G;66.#"WEY3N3><;K)Y_MYYFD5LAQD"R/QUO.
MB)Q[?*AIJUC=DI7=C<RENT_Y??-24+`W*U7TI:V3HE;<7ZF$;$(1MF8N,D3,
MWFUX;<I.@@;F[6C$+$/C\$D3U7TMKA>V2R&D3R<(X.4V3!$0N7)6A^B(EH7B
M0(M'FGL[``:\_6B@"]"\-U7T3'SAY0^3^L*WL2W*0?Y9*J[JROI%8LTDVXL:
MC1M*&+N<O;W:.FEFK-J03$M-##UY:`8`"-;E*4\(MA/UZ$G;,34YH(:?-WR&
M]H:_-00[H\;W/D+BJ%#3*D*+EL)6##1),"8IZV"D_P`#&^7(]=/UVV1,DH]4
M%Q<)BW%FB3!$<83+7A,:>/\`B6ZQGR_<OOL>L62/$1OROD5/)9"LMTBP*T3,
M:JLR(=86ZNF8I9]-)G-(GU$9B$2=PVG-4A(`$1GJ(&O7*D[9B:'GS#<C1I"I
M4RA+;T;<3+&5U]%HT[P`DN2V$E$Z%1F*V9`VI,_*AOM26-.ER&.L#[L1)"Y[
M<DI`@E!,V8%9QEH2_P`UO.C3+%+"\5A>C&WLD#>'>:GOL:CK3(X';;=;-<TR
MBYZE,=52<+>@LIUG-J,B`!GW/;44L<TA8U/QG".*+PE8&8^4#E&(,T'DY;]+
M)=$9OSU&NI=2V&1<;NP1.DY^L$S5=+9DH/6H%+3JU904<T,*<HI0>H<DYI9P
M2``V9A.,^Z"VSS5<TO=AKJ=9J<ZU<[E97%BB<FJ=+33=N:Q:U))#+`LIHI=]
M3F3<MH)L]36E9.L@^D)6'(M-98!_5?(/16AQGRKQ]WIG2EP0CH&HZXNZM5RE
MR@-JPYBG,07+49C>M4L,B0$N+>-8A-V(Q(JT0=K1A>][V`>MZ]=^GKA)BIJ4
MGX0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P*:]9$<WRTI@A_1-7!M!OK)D?^Q(JB
M5H"%B1B?^872,OK>_MOO>&LS4M;7.1)S&\L?JD.UHT!XM%[V$9803$]>-]]M
M,ZY6.%%EV?U(\S6C5KVJ@ER%-[\^[`>Q3Y']M4M(H%`AS!20:@6RE,2V$2M6
M5LG3DO-#K6%N:KHBJN;2\:L&ZW%%XU75FU+<'/T.@_*[9/7&$]"Q2I$<#KB/
M'%P.%R5_]WZKR8O%6V7FIH^]3(I,F7J%IQ;2M5&_-[2SRF,<IFW2BE?^**E8
M"79L(IAW3P!TGSS(W%S%%;^?GV%2?E9[<NC-$M=<S(U9:#&V1J=0W3TACT;9
M1)'5U"G-+0J0C`/(3NWS@VV=WIXU[8NF"3RQZVG4DL=QAU?/,3FDEYTZ-(,2
M)X?8_0-:Q6%2:-*(,F<XI)XK*)).]JF>0M*(T+<O4J5`!I"_D)J?*(KHUJ(J
M?$"ZH&_G>,P5J10Q@K.X^7&UO4U+T!&ZB9JBN22-\HLV")[.>(JV5H@@UFRN
M/$?;7#3P%(ZK$>TC0J,&6,G19G=_MK33!?$W:$,M^L$-#V)/H/%8[`^J;(#)
MX!U2O=7MWHXX^MX486XSW15CRBPX.379:$;*4(Y1LI,6%22/?NUHE[LTDU%6
MWB^MNPF*W*PJ%TCUI-YTOZT;'B.0[H"M%*]_LQAII]M5Y;E4;)88;9CXXAC\
M0+E$>;S7D`7=*64K1_6[.T(3.ZJG)E*RZ0\;\ZI.4/C96,B-IVP+K<I[9S;8
M7*-Y2&%-UV3)8=8#[+["-DE8R"&Q=0E>FW2E:ZJ%!#2RNFBDYAZ96(LG8GE?
MFH1TM6WC([<M1?TC8'3O=\9?+"C<#CB.)QRFK1@J"/P^AG&+VI!=)(3..0G"
M>1B/%3BPD4D;W!R,T4^.[_HI*>I),)1EQJ-V[;''!#YO._C=;#Y9U5'>O_)C
M(I='IE8%HR23)8`F13I5.[`HZ=,<VD:>"3KCQC6RD<SJ.%.[,L"D:U;6C`6+
M9X$@_4_57ENGXU&C,(O%]XW>4HE9//%6=N=_4:-TF;K/'F"1Q<XR,,AMMKI"
M)/R=Y''6WG)4]6T-%5D^:/DCJ%8J0..]FH_I]N"10%,R.>Z<9B'8@7C%\=5;
M4M%F)'W=W-(&9%!EU,+E<%6D/CJ\:F$PY?:IRUM3&AYWGME,J[]9I]:B#ZKU
M3U#3&Q&22N1EM"P1`G?NF<H8VY_&-PQ4P+*J6*=Z>0N%VW.H#OF&0)@QJ1].
M-ZV%S&)"MERBL\KR-\\N)<L:Y)$=*%Z][4KDR\Y>+U4N@EP=E;$;YSJ*8Y^Y
MQ\;(&TE\E/8WDI-8*VJI?Q_$9&*)ML@>SZ/C,3IJU"(%7+#'>1W:T)/$DC3+
M&%V0OK<W*%R4YK.6EKR=I]GB'+=I'CZMD??%OXQ[4B=BU:Z=<=X6+'>;JOL(
M^719WE+.6D%!942R2NQ4*B;RCG5H26^\*5QC6H7GK'E[=&=S`D$,Y&I))V7$
MC?,8Q$>/J-7`'C9D%A+H,C[+\FH)K&W(GGTAA6M<W9F1V1QUE7U>FA,-(7<D
M(8/8=;1=%51Z-.J9ON<;;75"-<4>4Z*AJU%.<Z0Q/+_%'C3?'1RGU+=F^2B!
MS2H4+G:KP]S?:UDE+-NH45M50JE#E)K'Y=6%3V61**VS)$!Y)JUW>4S7(TX5
M90=;;=$Q9W353$5X\WK-1_3W'_*D7YOXMKIRN]\CD:)1T!7DYE=46:&*.0*^
MAQ3EIV770^02(5K.B5#2G]1N4?4K4AZSW%`T$>M@U6)N9G=*6_XE7'`-&F*K
M(E3:D1M3@^O+D\4C>S*SQ=D0LZB0)WF9O3K6J-JA35(V9/\`4,:AV.1DR`LT
MG[:)5M01HPE2E-1UY2"2J*YN]8NL='6%I;3&1N3JZ)O1*%K0+$RA6F?;$:5%
M<EOE21@U,FV/3K*DS,W>@R_4_P#G2_>*0X'R8<J+8=$)FQNML.Z>=SEOKZ+L
M2KGN]H9*5+PXI(@ZDN[PP6)7</7Q""_8YVUK02-Y"WL*DE66%.L-.&`H0XS$
MTW1W[IHZ,W=/Z*E95BQF05\HJY$NDCE6LQ40QX66JFE"QM/9WAI:G(\,6C">
M+B^^R180DC#48K3E'..C1B`$5A;90]G<[BK)GN'<ND15>R":JH$QO:FKK62J
M'5X1O8V!0[(&)1"2I"I@8%X/=J3A2;C8D@P*@KMI3`'"%2U#^G]S:F)=`.[[
M-&][:&Z3.9T5;:MLB=2)S*B=@N=;NC;$T-;1:9%SN6EO;;I0)@8S'%_(;%2=
M8>B*3G`,V*EKD4\D_+<N<)PSHUUQ(GZ`2)7&GR.N'-W089$:X)GE*REE-;$D
MK-6ZN2U3M6%9]O+*VZ)VL!BY0F)2$FG`$Q,,U'/(?RI,%#F7%IQ(75(RNL=:
MW-Z4UE9D:C@OS4SR]X95D<D4NB+`R3],HW!G%$(,=/=CRG,KZ,985._CP5+:
MY1VC2L6A]+3)63:)R:_IC$8974?'2UL,DWTKE\K;HBE>YS")3#F&559%&MP<
MRAK7.3)&A(26,O6AB,/3EG"IND4@\GG(ZE(L?4$ODZV$-Q5:'K9[N`3%LCVT
MMOR!3'Z[<VE*]LS9))1')4844L0/#2@7-"UL5DK$ZDU.+9@14_5DYKY,N-J_
M;W)SDEB3/29K3RI2>4PT-T#+W!0&#RZ20F9$M+5$JN>W-\6Q=XB:P]>G1DGG
MI6GX'0P`6U6E5G%XS=+:5S:4$MEL?'F`/GW]MCDODD$>%6FUV;0I95$5VVV0
M-@`.Z%`:K"@6ZV7]02$Q,;O7J68/7XX92!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"@G:Q?/LB7US`[D
M)O,I>^%O*P3O1:V>L2AMK?3M&&&=$VS)($M;STE).:Q^;2WY*O&-N4EZ!LXL
M02_718>?J62<1DQCF#L^P.>NJV^6FW-=UA<]M;T=.YO<[ZZ&Z5ITC@37S8^+
M'!]C4RC)07"/,1X326U*,&PEEBUO>1<<NC;&.T^+Y+T/TE]\J7J@:'I)VY;7
M2^;2DN?O%.R!>WQFO94Q'1J,F.RA!5<7@P[*AJ*5JBDR1*L>Y`6F/T886=O*
M3E&6#38;:'CDJ2E&BFX[0'9#34<25V%)F@2RIKE<"PJ+@BDZ5S@TN2+%JAR6
MA%"RW99LL9H@H$0`F%^W00>D6;F;N+<'4Y_CPLB>,4<M:ENHY2G@W1U@ZF9L
M?,L2.UI%)]"9?#KU0V[<.FR1(6I94B%VZ#$YQA_5@4($I;VJ3D``%4,&Q'*(
MPT3ONR^""C&"I3*QO4\-LSROHBMCAU?V&<G96N'VJ);6MAS?WF^R*TS(+`G^
MBT#V=L*%S*4A+W[BPZUJIC+FCC+P7P_"6=BKIGOL;0XM5L<@1FO80KM.QG^3
M+XK/9/(IHU,L;^Y+5CO."I)(UP$+SZ[7#2>TDHWXBP!T+F<VZ5(?Q3RO&S[6
MC4DN@F/UG1\',^V3^5V3."*\@UDR1/!#4J2+R1Q<BV*:.\SJ#94HT6#2[;D@
M,,5;V8(6Q$QEYGV*V^-935M%P62<[=Y3&$UY9%O=!0U1/WBY8^=7]GNEE(X$
M^M=POTGE1#BQHI.]/8`15O=OJ&]40,!:4`-"#DP:CEC4QXQ>FMO<ST:"Z>>(
M*&MK@D)2B+RZW(XCC]Z2&+U^.9\V0>D857C-.(7M\3I)H\.,>1MZ=N5J2CDR
M`Q&I-/\`TU>Q"J7@@6W7+G5NY;C%I"H&PDK/:[?J$R3[I>(JG:ZS9YI%+M@L
MH=W"YU:\;,RN$6:)=($H%*403PN2]#\(PF[(&`92U.1/54V;..P>H[0B\@:0
M5'S1!8=`8W&K2"VV>?7[#)93(6>[G.PVE20NIVTI*X.9B`83S@.S<SH@#4BW
MH>PY%QPB-41Q*YN+JZ+776;5/1;2Z.'';MU/&JT_7[(932<@E\,MV)JFBO*X
M2'OA$!/O6\)_1S2YI7<E*4*2D%+#SA"+^K]PKIAFN?Y`6OGR`1:!]WS.O9J"
MW)*FIFAV)[C-^K^?WN&,UK35N5#,,G*5<2U,JTH;B)`Z*2BQ*W)K]S=[]D#]
MF$C'X]$9N3CX_H]8CW&QUKTTMGL5(O5>V0Q2GL=0Q,K147-D3K"4NT=")Z41
MJ-16P*QA2%"PG^XD+X]`4*"@;4[/,P8^2(*UM?D&+RWI2SY,T7NWPBZHPSU.
MOH-'`;I62^&-LHA;=([>D<EC#P\.R*'.3*Q,J-3*5\>"B1D)22E2O1IV@#"7
M&NBR]C/E/.-4MG1%1\YW=.W^N;KCJ.;U'+;(<>;YE&E<DM!^L=.OL",V"N3H
MGN/*I3<6WI.T*-"`O;W%.(L.RRRP:)&=(1-0\&19O,JMZAO;S2)\G-A6Y-9=
M%9-=<K8&Q7<$HFJ*V:UD5R,#Z-*KJ9)JDG5Y=8QHW;,A9F3ZSX`E@UK*8YX-
MYFY/#@:VLKH5F0=;6I&>-+Y664W5S$9U:;E'T$@=8<A82&JN(4.1EQQ5SNY1
M]>!P"V%ATP%C&:MV1HW0M[&-TU&L+4\=;2T)*K61WJR"3_I0$#"HCEE#M7]:
MI<-K66PEGK>T6J2NCL>Y(:>BDKF#"S,$B0G?2"(TD))#\!.O9%F)\JA_;[B/
MC\GNXIS]9=0]>VC$>*)!)[*8YVU.EJN:%WLQMG,=@,S1G2S4H0.=R/\`&ULX
M"H>`JAJB&]&`0Q:WZ:UH1,QC'5ODB=>!9S"5EEU_!N@K-WSN9"'8EBJM18:6
M02I$W6`S<G,T03H"G9`7/TCD?SHV.7V-2(0'9L3-[K[!A7$F#)C=33]7;T7Q
M/9*B9W`P5ST1;5K,;%6#HN@E:)IC%9!8FTMM?J,;Z-?D6W-M;%B)OL6;DD2Z
M/.`?HP$B*4JP&@)#[:E2ZE@VIXY;HJ:`T]/*QO\`%77,;4P]#QCZB$V/'10B
M.UT0E=*[DSG*4JY*<JC]C$K2P,)"@\Q/(PZ]F@BT'(L7G#1[GA7!T)EPK<C5
M"]@.,]O&B4DI(L7GU?9;-.61K5]*PMF6L\$7L4F;UT>OMMG%ZGB5$-FRG33,
MG4(]FB)T67E6.4Q6%6FV`-/!DHG-YI(9..@VZ16"K;NII=9Q5GVBU%,3\PL&
MV60M-9S4+_I9!G=(Q)CB9)'VS24LX(SM*`#V(6&9MH;Q*>":ZYO438-"=/)F
M:`V)"*1:ZA5PNQ&NZ0S5]<)I)X*%CACHY$NQB@:>[W%]:UNC`BV4H2F%BT,D
M@(8N-U@GRPD/*K:/GBK91(^I9Y(Z74M$Q9I4U3ZTYM-MOK`]I99%ZIZ-L-"_
M*':5OLZF#.E3HHK(U"C[PY(R"1%[V`&\J7.;SYX[K_Q]QOEV_I8P\5=/4U7;
M<=7+\HJN5O$KFU@6&^V-6.[B9XE3\3(DC@M/W%2[.4H4"1(,E,68FT--H!)!
M>PQK=<SC,2DQL#P!5<ECE]1*@;P8;LBE0\QUHR?G)!/'F+(X/-HTWU[%IG.D
MA$@5MLDBM<)[2`DL!]$4)=\PMA.$<?\`'O!C.&%/2/QL-=8QKCNJ815#S(9%
M'J^*?8.[2"61M9%)(^3)@?%Q$N=G9G<#E*PLY<]C-,+,,--$80(`O=O*S.:]
MF$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,"F_3`N3@3FGA="J')/+Q.)X*]$V*[=2(1)/S)$!.09Z*M#2H
MX*N-24+-MP_-_K&]&Z*^I_1]<*AV96IX[&&BN<K9EYXDE+L2E2?SNX[@UZ'+
M6X1C:>WJES?$VR.&SDIM`TB%H2ET0?2ED#"9[]!$`6RU-TT59,_%NM:X++E+
M@-`UQY$BLJ)J"$'1D<`:&/2B*42Q,CTSI$;:;(GMQF55-#4TPQW3JE[VXLA*
ME&V*C2-*-0J<FKG='>+;Z6QXX>TR@4=KV.5\9)ST=4]$.@5K=;Z1XJ.)-<;C
M[)'W">RA4O22U8UJ--[8>%#M2+9XRC"_<72(W2S-24OXH9),I)6541ML'*))
M+T79\P:2'J_&=MD$DFT(@KJ;*I.]/KJ@C;LVO$(.CJIVARM48W`)TB.7M(1A
M*%H7NKRR86%W5XO&][?D4=8+)&-DL1`Q*)8Y51UK)T1LV=9FUV`U,Z9_=(V^
M.C?%DLSK]N/8]J?I(N:;HI,R#.+/.)%,$J7*JIO@+O:2M4DABR=-$ZL!HK"]
MY(F"Z]'ULI7P*3(R7[Z6/I$4KA46J^Q)DT*B3WA9&C$<J+`9I0M]VCO>,ORV
MMGM%)XVY78S)0U@LOW2Q:@*=:U35:RV)-/SJKA3!5JVY%$GE%5P:Q@3ZX(0G
M;`*=(G5W9WQ2.4*3@)O5<J,--&.;`N4X\3]W1UDGBI8=*&5F_.%@H"&YEZ8:
M%KB)PLYHJ>2G/,#:&YK>9>:3:BI&G2M3BW+1)'`(5Z-,7\6U0*?*%Q+;Z)Y,
MJV81>0V?-6YOF,/C4=,B*M"SSB3JR(YT`=*T$9VT)X@T/2=[!/U5'.1*;0`*
M3M'-@`:^,:I-I02I5YM2<>.-SY\6QF=S*0HJ-D3"S(5<7A\CZ:C3F[-$G;)Z
M[-\:+CU9K6NQ#UDD0IWW2IG+(^L7&E;(4IQF@(+T6.5X9NY+'WQP<DN%E5I+
MR@P1RZ$,#T#9^G*/WI,E4X5R5\4I&IT?)U]ME`T#FX/47,3,T;"Y)E`?I?@0
M(`E^@-DQEC)_-_&5;Y1JVTE;?+BTSC!S-K9\RW>`1[P]P^RG>!DI54A;DQCD
MZDM-EOC6D)*$:<@?G9*R>TEX,;$.#')O,GF?"O07/SVO<IE*GZEX,IK*\E#G
M#Y1T?")2R+'E`DL&LG*)N<$<(S;`EBM#\1B=@93!F:]VT1J+0A"3[&,2J14T
M1\-->6J)WKBNY%`;)F$TE=UN32^UOV=$&Z52VP*SF$@E=H2B$SV/ML/?4QE?
M.3V48ZN2$U"T'K5"$!B9<I$G,C4\LI9VH(WXFH34<WO2OZP=X]6]G2.UC)]/
M9(U7LYS><J:XJ6;AF\DD3=+G1XNEY`"KC79&B*4(A.9R798$Z;0=)1:J?*9K
MJL_*.A.*45)(+E=$\I<:AZ)N")PUV<TU:W,%Y46,P?''6,^:P-5'T-DPQ)&C
MZN(2K#5#4E)1Z1@-5!"2(P[9*FZZPTN<V%XV8M(WV)S7T0O/YOC5?N^MPN^%
M38H=[@A%UR!@6II$U,"E@6PM_A<OFQQDD2JAQY"$Y2`]<0:24$L1$]&BQU1X
MM"H=VY0,:CFHI4[T![LCKYP;4-S0"%/JZ>N&F)Z?8_/BE3"[NNG0U,$6G2$*
M1M16O39*H!ON#HORPE&UENWAHD]L\O!G;`V3VQ:/4)(_0DK0L][31;4JFC[$
MFM"M`)$YL.W%V;6=#/(')&\QZ?RSV56-D.5N"W8!(3U!?E%L38T5\)/14AE2
M2R4)-I;OB6)3Y"E=%G5[K6;^ZK)FS2I-/FY.F4ZJR(PQVF432*/S>WZ;X^M-
M2;#M>87\@=D^4)+.B_`U`H^H*2MF;;4%WQ=#9N65W6T1O9B=6!14E&\^+:]@
M446U6ID5DG/T9IEOAKTL<&YV"-V=EJY404G]RI"EA<X3'1--`\Z>.$F8.#E0
M\,B:V<2"(L34]/"1]L9Z?'V.4[8T:M5L"_/,F>EQ[LZ1*R9XW+E)ZLTQR&K5
M_3J1F!+-)!4N:\D3I6KQ3F0.V(0XQAQ40ZXJZE$>N*(V)$>H53@JJ^-O*I$N
MC\J8+":C9+`8HF<M#(8$0RFL@\@("V<`R`EAT)ME)%<7BV9)#14&>G50T/-4
M(HC1M+0]!$ND6]%'_P`QG5//H_79T?9&`EF<GU@3PV)/:U,\DJ'",-NB%B[Z
M%&L-,4%K=7J[$0)\9%;";>LZVJ\H+ATT='^1RK&8*QMPQSL!KW(E32UQIV32
M!I2A21,+P2<+[\J)(2JP@T(M8?K9>MDQE'%80OQ16C%:5?8XCLY>EM1L6QN$
M()U..SCI*UK79$I?2%5G%RV6+5T"F3>B?0IXW)Y0:C6IDH$:5@<OIDZ`LLLW
M?FD=9./$W3ME/B#<AJRO["YY2RR23YF95,Y9R6%04\5I!I5/[>9&/XX[.Y8F
M>)_'=[DDF)='8D2C;B4K"%.J5$CY2[T`LCQTWJHF?'T3:Y:F*F;0R(G1D517
MH.L-.)43A[+%VY`V66H21EYKF>1I@:B6S3<:ZL4I]4I@RTYA8MGF#&,5;V1A
M\+E?O<^E4,KI9ISM2P:[IFRYNQLO2`PRV84+;M+02*-[[*7=6F^[QR#V`5'2
MG5^).-851*)40Y+5`1J4YXO<],>,V'EN&TPF@?(,?)A]0P^2RAN3Q$+'/HT:
MR/JAZ5KG[>V6S$:&6%HG%S/,/2J!%[1*R!Z,2#&1L`L),S,W.:V&$,!@,!@,
M!@,!@,!@,!@,#H.K@6TM;DZFDJ5!38@6.!B=&2)0K/+1)S%(R4I`/49ZDT)>
MP@!K\1"WK6OY<#Y_JQ\F'0;RIY[M]]?*PDU<]2<ZWC?SA1D:8P`D_*<0KF#Z
MDT!?)A.RW(2J3*I7(CBV)V3KT:`E,X?(!&([98M:-S$1<:*SUMY?^V$$!;6N
MV&>I5%ZTE7\59NMF%&QJ66+1"V^O+;YM2\H2=T4EKE;A%:TKVHK9>S7X8`'C
M=7!J_`16M"]"SMB\,IR^B\-@]+=0UU92KG%YZ[IA"X-//$LZUE74<@IAE;HL
MVQF+2I)#0T]%(2FF)K))##G->6J7/`UP5B5%Z:"G$<,(<,U%7YTB22^4*^)7
M"ZZV_J@<>NC?QMS%T_=KZDI&4='S4J5=)2=]BS)!X#4*$*%S60V.K(N,;Z[G
MBT<V?=D10@!-]WJ7C%ZQ;3W7N_OM]4=AVO%YA&(Q2,"DI-#\I.CS6M7N,1LR
MXY[NM*CK)QER7]8Y5[,[CJZK0+7J$?Y>"T&)&[:'ZK1Q@O2+QVU&O5'Q?E;[
M?MNI5J.G&J))^B6BQ^7.2YQ`VZ,PY1^5.FED'U8G7!\;>+%F$5A#E^2D;DF;
M$:)V7HVY(>4(1JG8QZ#@XQ$XY5:TSAV3US%NK:+XKW;%=R:4W9`JI-E5LOU>
M15KWSY9S0*Q[0LVMI:TPR6OL#E]H6_4C2F1Q9F;7,TE(&/N;MLTQ,(O8B5%7
M#<KE[/ZZ5>1!SYWYP8CI97E(IJ(!=C>OJ)Q4UZ>W62I_--CR24]$_6E,-92"
M"5648N:H_LLY6]*]E@"'T%K*1$<;E3Y5YHN@ZO9*CF_0%;HX-5\P;>NNBV6R
MB5U8.[+?-`PR=[CG.-=5^P1^;.DT@K^\(K,B`7-[?4"7Y_I%RHLO:;1HBHO"
M)_7/!^FGRT]'S#@8%@L<V@3]T*\=ZLW-">=<_P!5*[]9"*L"X1NR)]+Z\JMD
M=1++2=H-2(WPK>DQ_M5+F<XX.MA#Z95X1&ZIRIC&'R\]9Q"P^1I!:_ZK7KGF
M84HS/MH/<+C^E$GM.P>B);,R^.$\2"E<U:6&/,TK1L8W>0-)>U0&U2ZF@]_P
MDZ'D9XQCG:!*W\[_`$8F!5$'M.Q.<C+=5=7@-NQA0H43>-@H*3=#07GA@H&`
MHR7DTR5W)%%CS)Y$].Y?N`C9HG[S0:"O3C,-<.O3Q+V"M3K:\)'>W7\2@]KU
MYSY`.(8]"G=W12V$(IY,+Z7S>LR+&1G(2G-Z9"XE""Q*RVQ.N1:6J5"S1GJ`
M(=:UEZL5A<]5;>?^QO(*FJWC:6])O$9C,V[)ZCJRO_R\_P`*J9'&JXJA51-D
MWA.G.,OU8V3,#EZB0&,[<R-Y,I"T/2(Q.88<D]YX0Y&IC;<UE$/W)>LNX+?;
MJ-D5'=%UG6C5TWWM9U,TB4LH=DL)-*.78P)4ZFV`G7KY>UFCE41AL(D*\L6@
M"2N!P2P'?$6#8MDK;$XQA$>[&<O=Q=C]-6!+:4<+UJ>ED\"06':""]Y;4+6%
MRMRJX[T5<M"PO4;KYTE:&,(T;TT4Q^8GAS)<#M(]OQ!"8)I0`F;I,1$6VWDS
MS`).B>Y+@K)-/*P>.;8E2=R/</\`LVB`V:&4<UR6O&J=6'.4H5HQ1F+6FEES
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M-4$LOY!EZ]_IJLS71>7"&`P&`P&`P&`P&`P&!1GKE!R7J55,X=)WDAIQU=QO
ML,BK,OM=OK=ON!B<%\<D$JK1^;5YQ.IM&74V.(A+4`-A$,K6P[%H(]^I8OHB
MUWEOCKD]9\U0LF\87)(0^O[CS/SV*)663(%$QE3JW)HLZPIH7LJA<>]O#6WM
M@0J1[W_U()>QF;#K\<&-JJW;SAX?KIO.Z:EMVR/MUQHH7'N>9\RKK?DT(VB5
MW':R_I&%,\54#6-S,=;C7/'DMV;5+>(UX92'%&#U++5$Z,+>Z(\F]5'$O&16
MCI%+;:NAWR((TT2A=)0]CM^YG2,,2HKDJ7I9(%\:HW.-M*QRDJ-_0:V^/&A&
M:<BQ#T9O>A;W@Q;U4E%T!`.@[<N:*VM"W*E*ZH5WA4A@S5:SM/3$YM>@.HJV
M)A/H8<AVSQ9ZCP>=#8DM5HU:E0O41M0F5EDJ$8P[&-56*L<5J_Q(7-*$]M(^
MVYU+72AG2L.@#U#_`-8/C0UL,-B$YB4JJ1S>V10J9TCK3#+*#4#6U:4E&M_J
M:8@"8(S8PZ+\HZ+)0^K_`!P\52@CII=T&?"E\HI^@(D;<UIWRH41"85Q'-CA
M]1%FR!_6%0]>NF(&P*0PY/[%;P6F!K>Q!#K"?+=@REZ2/Q?K!NTELGH"L8<\
MVC8,CVHLY@M)CCDI02@_G$1+TUIK$;#/ND59TM(*2G0*<:LE(4-6G5AUHT\H
M0H1RG)#3OP[XE:]Y9<HE+[=2-7/TRAG.S]J?2;I%4A&=%J9?DB:JY<QV)IY1
M*DJ>1R\THQR6IS]%OCF9H1VQ&;UE(G=RP_9L-@.'#?3EMUO<ZGI*JXO4U8P^
MT^6H8YLD[,A,L?;J;YI"WX9D<>W(+>U%N=#;KPA1&EJ`:Q00K>W+8@%E;+$;
M#&,.N;9(+6/C5F]IT@Z0SJ9)/Y>)R1-540A!T>VR%MGMCT*X/4F?9B3%D:L9
MLMLYE%)UHWY:#W&;(5CT:``=X)OK#@M1FXHZZZI(,F/6B0PZ(22*TPGYYC5Q
M_DLQZZ&YWM6?R09,KA`RRU$J=XZZ.XBT@`#_`)"3/0(P"T+*8Q#FZ-KCQKM+
MS92.\^@#8^KC\O@T\DL(%=`TA=,NS],H^U0B0M461"-6P)D3WK,HQ,"CS`?3
M)9FV,SJ(0?I0A$(OHU?G]=Q'%Z5M6C)#U=61$GLOH.32A8_U99^F5?#+1M71
MUJP"%4G/'+XG1T?X/$O@4,IA!0E!`"_7X`^GMW";G&L')SGS?XT&*9]#W)".
MF9-<$T<:#<X[T8\VATXY6(OB%3R=#(I/(Y#,FMX<0ZKY0ZIG)>L7*Q$H@E[+
M%O80?%Z:I,S."9V&!>/YF@$>HX[H-HDB9&?<+^B5RB]F]YGCP:LK`R/6<O<7
MXQ<4O</RQ6DP($8+8=?;TIJ8W?IKVBV3%/2J.\J2IP=:3U8C$MDS5++$Z*>8
M8AL--^:6\]]EMB1.<25>@)5[<$T30S%<_-@P#!I,E6)#"-[T,C8=#'-2NNJ1
M\734?=-D1?I5OEB&RH/#II/G-VZ7*E$=C]9Q:%V?RU&7B/E'NQK?$83M-/WU
MI]Y'L2'/>@B_%05K619N,)A)4:A?CM82;<83NBX_*V&Y1[Y97PV97NTR".PP
M+JW.#NAHJL&A2L`&'&DHEQJU(V$[,4E_@:'_`*.MY4B\X:?QQ2?C!<EBK^BM
M9#-,Y!95*N['LM!:*A_E,MIJ+,D-Y5=IFB1K3]NJZ-+76A@`$]%E[2KY$:Y.
M&AC4+U`QEW3NG]D=\U\V^(/G=E>ZVI.]XCIJZI>9I13%&'+H\B4CD3SM\*.D
MM458D<GE2>WJ&![)V`#2WZW]"88,`2P['O63!9W;MV><,W*T/&UOS;J+OIXZ
M786FGX0V5'4I=O4?-'EI/K>6UF9("9).QV`F0',Q,Q>3+E+B[D-K^O2_9VA$
M0H."H).()J8_KU6-YJJCBJ*N=TVM0UX#ES.E87EAGOT=T)I9!ZB1OC4P2"8+
M&E(0H&D@;C*=11*\N:@9GN/4E"4?HZWO6B3,Y2J%4G.GB:HF+2.(P#KM6VL<
MS+21^7A?.NS)&X2@^QTVK`A2=Z=9&\N+HL6E)'G3M'=?+K9!"G1A6ME#UD69
MW3C+74%0>(5UNJR;KC_93@;9,YBY,UN:7L/4PCV%[8N?W2MH!+GV<JB5!\;8
MUS@M/C#3)30"0JG8I*E3F[V45L.59Y54KKN%;\>597E/<ZS#IN2-1]EVZ@NR
MI7&:W\27:-J2YKDB:P2D<=?5IB=5)HH/82RAMB(GZ;;9O1.M:#OUPF,W*,$7
M.?C$F+/47=39:4:?:\Y[7H)7%+N:[W,.JCXHS!(C43;J:NZ!ZU$Y6RLC+$4(
M227`1I1+@(9X?0PS>"]WZM#G/'/B4O3J.V>C9XZ1I?=MP4W:M22]"\V0JCK%
M):M;*K51NVY3'(>>J0M[JA*K6Q"S'"0$!4$`+$G4:,",D`PB-VZ(J,F#Y+C/
MB>I%T;3J,[%V_,53O;W'%<?EW3>YE`GZR81"F*3/DOD&G]883-+)@$*DB,Q4
MYZ4FFMQ*K6CO0?\`()Y3G"1?R/XXK#=YDS$=6+K)F%CJ6&9KF]FZ$3265)HM
M,KHIV0-#;%V9@&,QGKEYG,-86TPE.F^`Q`K4$F#WI289DP/DMOPM2O*]!U"]
M5]R1)P2VODUB3)R?74RQEMI.),W<G,1\B:%\I<G%T7!VT*M_"4B$;[41>M%@
M"$.O3*DS,S<YKHX0P&`P&`P&`P&`P&`P&`P&!XP.?:'C`A4`[-E[=1;"&)PR
MXH925_)D7/<*B0.A;<LI$UNK%&T1$R*A[?:J]::\$E'*'DP@C2KU#\@O3W;C
M5;L$NQGI7E)=:;#$9IR-/Z7L;L&'.3(<NM.@(&UGW`"IHW)G9-4LTD$5>Y:&
M5.S#7C:K<FQ&L-5-)34K+`4H`<HTGW2;K.XAL?-_]!+HY@=:XAO*4&@YO'EA
M":0TE9'/,`BCC1LQ>D6I"VOD/C2)O=XO&U$J;!Z6D*FA0%2(`M;/T49OVX2;
MC&>J+KD[-\?DE;KGL/IJB'-3*>&-1BP%S-<G.+7-++C:.3`?G*N9]4B0*.7J
M"`3`Z++1-:@E2WK"S"-#4`3!&4,98C=TZM!=+<\?]+VS5;=&_&G*")AUJGB%
MJ0.PJUX_I@LFS)JV-!O1;40\/J-Z:Y(;9-?J8F4_'J'!/HMK>B$QH%GU7Q"P
MORK/)HB;K#Q:W=`D\IN;A,N%57,NN`05%)>G^6J-8H-*.I9W))+#I_-Q*7Y]
M>T)DC8GF#*BI1*%82C#`E%[+4+-;#A>.^)PG&NFBTNNB^"X5S38-^0FD&-XI
MFH.D6B,L#?5M.0)R'8E_&R*$4G%)I1[2TGIF66O;H_S)#'FU^)4)CQ@3G%!-
M"G)UL1FINNK=Z#["X[N:;G1^L(K]FGMV06>VA::=SKIGC3L2W5!)"*BF)%XN
M)(QEG2".O9P6@(5)R\L16MA+-V3KUPDQ-6CJL>DO&7:U(+^EX]"*J;ZFXIF_
MZJX5+Y#3D9:QUDXQ-O94D&W2"0+.I<&>.R:/V`W"B9C,!-I>WO)/TP`@/]-E
MF-UUUE&\L[^X]C-MU6SR7BRZ$?0]JO#]8E91Y\H:G&"V'P29O)K)QM)E7RRQ
M&0X]4ZL\R"Q%C3K1ORE&XC2_3;*&:#18VS,34X+#3^0\4T?;E.<U-7,D8D=G
M2A-%;#AD!JJCJ]5"@4:K<L->1"SUI:K4>0LC172#W-:%0V[5+VA"6(LDDI/[
M?<9QS:1QG<W#/12R_:-YGY>9V"IH]/9J?:+Z@J"FHU1MB6=')[^69&J6L<9?
MUKV[2YRE<?4*2%;\P(C7`#2:H+-'\0-B-;HW14S.+=.@I!Q%)>FZ_H"V.:8A
M?]\.U8KY`6);2-=V*IK2D'IX,ASG(92]S,)*YFKMS=RA(E13>%;K?MW\Y&B_
M06&8NKC)79XZ-\656<M0A(=S1!8[SA;<_N8^,TXU\X5NABC_`"&D)L;6DJL(
M^LR$Z:,&(GF6HFU"SNPBA'+Q.K9_[/2@'M+\IF[Q9MK\C')RQ\LD<LY(OVM6
M[@>O)'9$KL&R>?H&QQ:@8^KJ5[?/HHF\)IDZN+(]SRMBE;:F2,R?6U!)_P!&
MJV26;[1%X[L*ZLPWV!XZ+RXP7=!6_P`@0V.\K\^-KXLC3+=//-03EFCL6;4:
M?;H]UA#:\46VSD,8CW`Q":!!HD\M42H+/)+T6,6$K=&ZHG%_#.Z/'B],'-;6
M]UHB)A=IUM'F6'`DE/Q$$3H^I+ZVJJ^OF.RB5!YR&M(3?!K?J/M;<F+4$.A0
M@%*"0)="$`5+J\?-OBQN2;N;=SKQS3E4S*+L"&VX+(`<P5Q4+[+ZZFOUL2:+
MTJ-Y8F5))"HO(C&TY`0Z"^V.6_A]NR@AT'>"9W54S</1B)4#3,)KV%56Q5S%
MOR%7;PEDD-C[PV$R,EDE2-Z6R4F8)U,@TYK3)C^9')0XB=C#!N!B]08H$=LX
MP0]F;ERME`T4R.<&>F:F*I:7BL2)2EK9U;:]B2%RK]-.=*=35/"ER9I*4Q8B
M7:6':<P(1$!7Z-'\^A^[?J+ECX=S7SK7;FG>X!0U-0=Y2/K[*$CM$:RA<<<T
MTEE")`VR60IUS.RHU1+W(&]J2D+501:/5$IB@&B$$L.M%N4UX0P&`P&`P&`P
M&`P&`P///O/E"O\`JMOA,?LKK*Y>>8G'%"5U>H;6=HQ6`1FT$89]7IR)-8C7
M)6AT*DK0&2IF]I*!OV`T8]?`'?SJ2=X6)J<K1]+ZKY*.O>M9^W=;H(%,WQ\K
MFT$\08YE3:MIN>%T^CW$V5HT1((T^N`H4A?$)BAQ<8\I0.!:OW`-6ED>A6AC
MHD&:T11%H31!-V#ID^.KKU?)=\*"(2VHGENN*+N+!4[!85=QD,ACTD5+F=0W
MTDVB6*F$TIZ0#VIV6L(T+6@#'LKPZ\(\3?EDVBG?HLU'"T15@$V55$DF%0C_
M`#S$TLT;+!=&67I)/&#9(AC4"E;*D5;5-QJ$0BR=%K3SR1C"(MS?)(7('-_%
M-%ZMZ&5KT.DMR46-"8%6EBJY5:\*DDQ.10FK(RUOKD48Q!;%!+M9#O.3YU)E
M)0-EK9=-%SC_`#9B[V8)F9QZ(LMKAKDMUK(ZD+*[4G4;GLP51T<:LIHM"I*Z
MO)NE2R[:6>J>ED$#$8LPD()%#+%IZ,-3$K2-GH-01OZCYU9IAVXL3,3<1@L1
M'Z?Y29HU5BQ-T6C$UTY!:>JU`^N=EP5,H6%,ACRNA&Y>K4$I1D2F:&R,T>R=
MZ2C5BT'1)(=ZWZU+E#M@\H\TQ!36]%2SL285W(F>RX+UK&HXO=*5:S54)YW;
M(76[JU.C8\5P;'&VOY$[2-I`]/1I*:0N#BL**(=-:+"46(GJS*_F&C89,5A[
M3WC(JVG$84-4<J!&=*.9U3G0<8<GH$V45W%&*;5V\ADJ*7)?DU\TL(?G?2(W
M9B124+0#0B/3!D"/&764NCMCG-G1]P/48O:Q[;LUS7L^Z67-JR`WH9!W=SJR
M.NJ.L3@&U^@7P!I6-KKHTZ2"^+8374\DT8!$OR6"0\3Q1GO>%7M'K'GL=<8G
M%8A#W"+M#=729NF3)"6)P96ALD4IW!AV02Q*C5P5J]J0/2-J<5R8@U0F,V2#
M6A>%,,+A9G_6I+[!)NVV"(S.9>1)Y)4P6^JS(:L;RY2Z6$IB1;X=7)ECI&1;
M93\O?!G%/8'$!RO:4M2!`62E+%X.K:/"#=9$P?YBCONX(&H6V5&[GB3;%VVH
MEC?7MM1Y?7HS9NP#EE92->\FOC!7I34J;7HYT:`I5R@PE*4J^!02(FD`2#Q$
M0F016&P0/5W6L=A,745\<]1.&S2$P]ALTF!07<(,:;3;H[`6Y/.(Y*=[^Y+6
MQ;HQ`2X:UM(2F*UHK4I>7E"U=<<:UU343B+/%@O<TU75;W#`V9DEJ]E3I9BV
MVV\,TC>VR4N"*/`T$)JV/DI"3@$[+(3'&>\HW?IZ5+5'K'Q4,X:'C$`M2TYR
MFECLQOZRX11)7%W=OG%CKG1>XP>=N3Y,8@]2!6_U208B3H=$G)6QT`WE!<D2
MLC^9R+,XX+@TYR&@JUAF2&0V_95N2:P8M,8Q,9S-$%;,+P\_G6PK(L9S>?LE
M9P."PMO=B7.S%:<O:5L)*VF3D>\`S=&&&5)FT5$>-^OFR=RBPHY<-W1]Z?*T
MJ"OV%O*?HR\Q2OW:F9A")NQ61#(?)(J\1M#-9`]5TS_>OF3'MKD4B+":EW[=
M;T+PIEV7QYUJA=3'9_L&R9B<D:YA&XN4\BA2`F(Q&8,Y;>?&6S4;B#(8XIVI
MS*^XI5;B)8X_4[V`Q08F_F,%L_0_%)-'S%DG6[YMBP7]LK&95RZGR9FIZ/@F
M*N96>\V@*<3#5;UC"1/DBC"U[.0,B8S?V=H1G*1)D9:E>O4*1,VB*FO%U`:H
M<)&^OW0_3]XRB32AJDBV7WE8K?/94G)9;!;K#;(TA?ED=)<4\80KFT"(A)\F
MP$-XME%^W?H+19W7HEZMN&HC6_/T_P"?R+0LZ2()V>U'@GD@'"1S6,BBD<B$
M6@/VC[9#VZ-.`H2U0-JT0)S;UPUYB;8W#:L1IVQDF;=RL^*H[`:VMVMGRU;)
MLI+<$#!7#N_RM-7K2],<6`AF1>TK$7!8/$F?Z@;U8+PY;.5I51FE"SXM;TE*
M)(+%H1OOQ=0KHL,%=)ST9TFTSN%3<<S.L.!2>'01^EA+C6$;JB4P^3M49A+=
M$E4,F<>B:$UR0DMQ`351`1!V`.M`T6-TQIBT8WQ$1MQKV=U_(^S>UI2.PE$W
M6O,^>[.C!MK(E\O<N;79N6Q^RDT'32]@-A"[F9K&U:2JR@!^ZN&C]'Z$F^F'
M+T6,M'A)GLMYYI4I^@NBZ_B7-B^%N26LX).&YL@-MJX.]-;VW&W$SK6!Q-EH
MUBAKT!0()J<0@G&;#L(Q>[1(FG7F7CZK>7<[SOG=)9EUP5#-ED&=4]FUQ-@P
MBV(:^P&O(-6C6_0^7,+<C&V.BV/P4K:HP91ORG+%.]:T$0`@%U-HV0>*>D6N
M7)Y2VV5=Z-+JO+6@+E$`3!O,AK\?;,#35\ZSQ[8CF(Q.OL)D:-*S$+H+^>^=
MS5_/\P#M@T.6%)(5\(('UTL)_F=_W',)!8#5I(:[+VVH6@;`\?D*OH**2M*"
M+UBQM2EQW^KE&XZ(7$*T`%IQP0D:3""0`6ZC5X[:O1Q6/QUVG=BR-P9^B">G
M'&5N6X6C?9+9(C`*W7[H4R1!J94C$].?R*34B%(D`4,W82-E%Z``(M:*CJD_
M4C`D%=)9O)YLQ,1QY$7,E22*)ET<COOWMMBZ4Z*QV.`<6]G*W\92A<%2X&A_
M$Y0:+]+")@P&`P&`P&`P&`P&`P&`P&`P/,R2^/1V?*HNVL]7)''@SH#HNT;O
ML!]LRB8U:1`8Y83NL4,E>QN//\K3(61?6<?.(0,;]\AQZ828)^DVM[^/1KEC
M<:(3JGQ;WO3LBE#O%^ZECLG:^?DW/'-JR;\_-\OFG,,7:VB+L34Z0J4.=M?:
MI`\JD<?,5NZA:T`5.KHH`;L\A(3I",L[HGIU2_2'C=*K2D8O#9W;"6S;\KN8
M3JQZ_P"D$$.F-=.1=E2].8!-85EU^RW.Z--P25N6#T>>6\KAM:K8`EE(TI>O
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MEL1H(C>XX&VVU;-;)LPN`%_E*2L*NNFMLL":-BU$K;5!AZ--'R$Y(0;,T:2.
M<\N75'MR^)ETGD_?]U+TH;SE0<UHN,<V3"JZYI]$?8Q=.MT@'(YBQ0.^'"P2
MW.'/=@+Q[^N=5#&[*]>NQ"V:/?NT.45EC;,Q'P_UG#Z;Z(HLJ]+CDT/N^843
M8\?>)AN*+YK5\]YW8ZW8ZV=&EU8F.-1]Y969#44=2EMPFI(#3<WZ3B,&(?SZ
M$[YF8GK#8$OCZO%]ZAJGIZX^F:<N1^KZ*,T.<623\8QWU$V-TN0S!<X5@]+[
MF>QU%)75Q:4@MN*=,Y'D'$_(7_+H`8<HJHBOJF;HOB^1]&7/5=BO-U!B,/IV
M1(YY"8Y%*V0H+*;YTVQ][94F_P!=1<J)=1UPXJ'GZIWC(FH2=T$G*",\OVZ%
MJI$U%(EY,X7O7D"*Q>"0^WJ$DS>Y6LBD=L3UDYI0TW8<BKI.FL63.[*O4,TT
MGOZQIM)[)DZ+_P"*.BUO`U-(ENR"SCC`%B+,Q*8[:XQ=+HZ;KB\IA;)*6%U1
MO3C#8)%J[11VP27HQL5-C@VN]X)9.8[/59/.E8U"R,',^TIZKT,V=K>M:PD3
M44IX?X;&F0PRMJ^L#HZ33")TB@BT#IM#JO&9J4QJF&FYJXNZ5PN3J]R1RU,I
MC8,EIV+IW&2_&@,^D:O:%'[SC!X6-\PG2R_'0X3RC.T*E17H8W/_`&3=3M9K
M_-I#6:*7(8M"W`^,)D]0F0_\X,1<HC2&-,![=I08X(S#`KS#/C#[=`V.6,3H
MGAIY=?$W'DJY=4SF"QM]F4%GT*=;"IJD&&GHJ@%8&W@AS?(W3[1)WEG9%X4#
MP/0_1S-V>K]RD0M"'L.B7C:D\]\,=56,L5QN06Q+2J0DU`T?3%@U8U1]L;W.
M4/?-]<V)6U-3QMGX'$:V+`BR2SG!X&V$(#=GR%&W+0JROI1E'FN<_6_\K=\F
M<9_T='R66#.+-4W1;DJB4"K$N9F0]!`6:+5)5K4%I@U?1*)(7B1_:D)/H->Y
MG#7G_<78\U2$M.$>B0F9F_1>#"&`P&`P&`P&`P&`P&`P&`P*.]@\.0OK]PKY
M;)I(HC1<1;9[&I&F3L"!]#.(;+V4AU9HTL&O5)_M`(9>4/A<\2*2=#.$Z0]*
M3^@`X1H"Q-*Q2_Q/-$W9*Y;WBS8(D=(X.5@FKRQ<Y1-I$\-D@L97:"..581J
M7J%%)Q<N1+S271O2*'-.]-PM)S0E^FQ[E+R9*2\..<'ZWYSG-.0EK,K5!<TH
MLV:_%7]1)X+2$9:Z=<84RQ2LM+[!8)S7CQ-98]FK58XK&G1&Z@$=IR$BV208
MKI>$VRUF>+>&3Z5758),MAAL\MF43F0(7BPJ49+'01=MG%>NL&6PQ0C,E<:>
M7^'!4N0'(]`!R0)UJ@@(30[UZBP<FL,'BL4QQ[OF6(+F@.YG;-6T7"H?+/Z+
M\%;'>N9G5+7$"9E8"H4=EK&3*B+;?(8C6+F=.%E)2E%$IMGJ0$%"T.6%,^C\
M9SHB,;?_`,W*S>!-RZK9@3(I5S!%Y)8J6RH-?<:NF2NC//EL_`YLU=RI(S*6
MU!&"BM@85JL+D4L4#)$F.E')C81XGH;'FM7'99/XU/(T%XC;LUM[E2463K5!
MK%)I1,Q*9RY+']ZU.WQ+(I29IG<#B4JAC;TY"4CW:+^38M-5S\#LEL-=6'E3
M1D13JI:;'4;1+)E5K#92"4IS54$-.6V%'7AX;3IBR[##C3P,ZA?I,!S5%K??
MLU*'1E2^S1$OBQI8E/.!K%+%('Z91:9,(9?**SB4BE;4YRF1HGQ#*`O;IM0N
M7/,3;TQC6VF#&`Q*WF_$486`/MV+7BI*JATS$%T&2OB-UC9,OFC]$&]%'$\;
M3Q*/RZ4NTK)AR9*C<%B(YKC:MZ-2H/@*1DIV\LA.`@`"M>H3!A#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&MS)U<V*(2I\9&E6_O+
M-&WQU:&)`5\ZYZ<VYK5+$#2B(]Y?S*W%42`DL'N#[ACUKUU@?(5R7QEVU4M-
M2!4T0'I$BK)W*.8G/IF*R!D;:GZ,F$=9G]U<.DH=!H7#'%(3/QN*5826.4K%
M&I1)4GO2"4_$'TU'29VS.*Y5H\9SFP>3>X6&/<H2..4W>$]YS8>4^2G(M"9(
MZL5*)"WP6WNG$<>(5Z!4,C/8[$6N9S>6?L]M)BGUFM[-5;]U2)QC'&$5VGXZ
M^@(]_2`A?+;//JAYTM*]N5>67[G&.597Y<2FE%LJME8[VO\`33!Q2G3J',;R
MA<5CBL<&9:DVX'I0F*2CA?I:C4;HSG/'%$#!SG;7ZANT[I5<Z]?J>D>AKX9R
M90WG<H0R,6S"*BL?I]XMJ7LM3V6T+4]CVU#4E8Q1K9UR%P<QHFGT3$)"@%"T
M'0O&(PJM<'I+5?2SO7G9/2-SV-RYVO&(19T3Y9I'G\+W1KT5%&TAH72-C.:S
ME!3RM+C3U.9]/6M*,*@D'I](4(P>@`WL-9G]8C#.6_>4VJ>K;%N3A-RY<BCR
MM5*'OH6H+*L1&8'[71<,O2NXXP*[3?D>SRAK0,Z5C4IDP0!&,"M4`8=:V'6\
M)MFHEY`4ER-Y`(E144HZ.\QVXJ5-A]R<I0W4ML1@KY9#N"X[TG*+)MB5%VL]
M`?"V*[.SF64Q6-IBU*=0>&.198N*$2:(&]&[B\\/'_+U3C,`Z3(\)[+0-B1R
M]ZZZ))IX5$.8*W81V?9+.Y)'%1'F][*"UN2%2_1Q8RD%`6N28\LTQ&:8<#TW
MO6L,8<\/UMYF@XW\BAG]"2D)Q3[BACU</[K;$9;ZP<7]535;NEI]4OEF/\*W
M+U;Q]71Q?+U'QQB8X0=\:AU7HI&^-&CMIO:'#<[MN,QXP_V[JNM>KX#%+=F]
MC<)7KTC+KH8EU"W9!GN)ZF40M2[=VZ[3)AZ<G$<:Y`VOTNI2CJJ8&]I9-HCR
M5#W]S4(4P"AC&/)9A,U?C1Z0PGC2P6SH7Q*>KQTC/:[YAYJL0RRYK:DD>&YD
M638F+Q5JJPR:5L:ZG,3=;YB]U>/JE!9`E29`G*2".$467H-9O"<KF7N?A@P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(-O#I>AN;$L'67I9\8K0BRYHBKN`_F(
M]0`^6S=P1+7))&V-*C3*U2UR,;FU0H$$(/:602,8]A"'>]!'+KWIQPR16@YN
MY]$UHFB?4A@RN>7S[ULY%;NRDJ9:H,AFTY!ICDG1HUA1IYOM"6G+'H1@@Z_'
M`CAP\J'CQ:Y&RQ-=UG4Q+_);'7U%&T6G1><"0V4V'LB99$&)<0VFM[PZEF2)
M%L.DQIA9H#]#`(0`C$$,HG\F_`"NI7J]4?65-+*DCLV35P\3A')P*VI'-UH3
MS$D=^-.0:O4+E*=*<<7LHD98DY!IVA?$68,(;F]=[\71Y3)4;STY32%3#Y%&
MHG)B1S9I-&SR"954Y7C$V]7H@XW6MR2HF=7(41H?<2I;$QIH!BT`6M!M$2Z^
MYEGECHJCA=U0:46.X5LVV^EBC&YB<5^ZV>&]O=FN6'FIR!HDB!<U.J546`XT
M!XDZ@LSX_8,(MA$C+Y-^`I+&JOF$=ZOJ!^C=U3MUK&J7-FD(G,,[GC&6@4.T
M:8$R),<L5+D"-T3*![V6$K2506?H>R1A'L)%6=N\CM^H2)=T)6"0%CR"<16"
M&J)(E*(E,CK6YHOSO/&5H/'Z$J7"+7C-FF+*B_=K8'EP(3Z]1#U@:58_DBX3
MJ)Y6Q^R>HJGB#TVH;$='%N=7X>E#>UU,Z#9+(<UVDZ8\*-MASP6)*M4&;"2!
M1KX]"V+\,#:(-W?QS9B-E7P+HZJI2GD6X>%BTU29,<I=C9Z\S..1).A0CT!:
MH5O#]7;ZC"2$OY2E+2J+-"`1(]:#/O'8G+\?O-+S2]7?`FR]EC2)[3UJK=OB
M?A-^DQRW0A[V5]O)5&)4XS`)AGA4F!UZA+WZZ]0C]/Y&.'E5),/2"?I:M#:,
ME4\;:PB]F!<EGY:DM@/`E`6B*Q]1M#H]Z=73Z0T2<*8LT)P"Q"!O8=;W@=:2
M^23A&'P%DM*2=2U*UU[)(K-9RQRTV0;-9W&'5Q93%3L]DI*A,G/V%FB%H29`
MQN!XM!`E7J0ECWK\=Z#@;_)=P0Z5<T74AZMIXVJWXVSD[1-AR4"=G7*:78#)
M3:R0H2D@E2%7`8Z4)8Y%"+"8G(U[MAP-D@G?O&5H3JL:RKOHNMII/KE@YUDU
MG%HZZG.CK*X*F?9=&%$E2%)DHP)&]/)("]-X_JA$#`M:U).PZ,*$'01]87E4
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M1IR!4,.BQDA^06P@V$6PC!P\M_C8:D`W-Q[&IM*@*B\+F9R@QY7;`1&;'6EM
M\!=5`0-HAIRYDL-"!M+'H)RSW:V4`6M^N!-R+N'D%R<8RT(.C*F6.,TGL!JZ
M(I4\N;31R6PK2JQENZNHDR;"9L#D\3*I)&@D"`LK8M'MJLHW6_08=;#L33M7
ME&NV.622:7S7;`S0:XR>>Y8J5/03#&:[SV=CD0*N4(TI2A<;,M1^2(5PT911
MAA:-1H\7H5H0@A9TLP!I8#2Q:$68`)@!:_D$`>M""+7_`*MAW@?O`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`\U_(5RLBZ1>>4YL#H2'T&\\D7:X])_53$B:C:I1&$%:S2L
M)4@<'*M;^YRF\7:D""R0J#7$M^-:MF`+2.J%P;E2E$H"BL>\*=I_J3X/J"3]
MC0N1-?#!5GQ.%/T4H6U:U5SJF[7@C7"7&/OZZ"]C-SYJ<-Z1&8H*=ON*B.+]
MG!+<(ZL*!L(PMW`O'78\<K[B*I91T1%'ZO\`Q_7Q6T_H@J,T6LA,J<J>JCFB
MW.;8I5]DO7ZXI"QOTV,:;-*<%LI:FEC0GB;A$`8BM*?E("H-)^#&2\X1.O=T
M[U9'TEN5),-SBO[&GM`/<]9MO4NIVTJ,ME)-(<?T"T.3]&G*#V>=^3FIN>V5
M!"52<7QEKTJI2E,"*G'_`,NC43&Y15LA?5+S$'1$YQ)(R)7JOH\\OTYJNGO'
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M9CCI:X2<`3/I3"=B$&NW9X'7>T837L*8.MU,>+8>`YMPU8,CD593U]D=AG3]
MZ42.1W6>*#]&U4PJ9.XO:LTXQIDR"6-(!"T80`A0`M0`+3\[^+6%5)9')=C)
MK2C,\3\?+.Y&-B(+KH`GR6D]*V\1-H7J;SAQL"5/+S9//A6WQK52!R^O>)$X
MOSFX*!(5:Q<%4&PS7QJODLM*8&I[T;FSFVPNGH=VC,*E.K-\<+6.Z-@:F%ND
M?<&"]0VXA9V2JAO-=LYRR,BAJDQ022>GTX%EJC,"/X5XH:R#Q9PIR`R7S))!
M&^,[>H&VI9.6J464J>+2>ZG@CDA<&N-.B>ZULMH%KFYLH(=4"%@?1MC`@$!&
MB2;0&Z!@:"U^%Q>DA%_ULLZ;"?#YKR+W%QYS_P#04\8W2.IH+WM:2>Z+8?K8
M>3+47HKS?X]/6E`!CTVHH,G)9RU"54!6>H"L)#4;W\(P;=17)%)!U@GCM:68
MZ]/3*O&PVI=FSB(W]V=`T-<VC))).E%MI&^PH6F(^I-C$;1LS`Z(#SRM*'E?
MLGU,"2^7/$P]\J]:5K>S'TM''R.Q6F9G2XJP5U[:<>E,JB!O2'2U_P`>?7&6
M,?4J2.3^:,0.DR&I\>YK$YFM=U;4)W`-O<'56/`TJ<>!.FK)N!\N:6V]-R);
M)NN.DNE'B0P1SM*LINBB%\4[**X9Z<A4T@UT,JVO4$/ECVBD3LY,Y*4J:&-)
M"-W0&E>A@`Y:F\-=H553=;\]-W5]<AJ&I9:_W9!&ABY66L#VV=&S5@E;%,94
MH4'=#O,/6TJ(-AR`QG@`F(*5L+4I$QK@L2(0D&AOM5^)RM:$B'&-7+KPCKS6
M_!?0DQZ)I]MG%>1M/+SJ8U3<DB3W74TDP96A;'(B.WG-D%@&20II2-[>I:VA
M`4UI=(T2PH-;ZA\)L=Z?Z?N/HUTZ$=8HVWT]URDM&NFNMFIU;I[3L!I=OK8-
M+RY]<)3LYUBKK,&\$G^5.F1B)4;^#V&#"6J"$'5%_P"7X=ZLB,^V?W78DKM*
MY>-[-XJN-_7U'$6^LI%7,FH&O>>ZV>HW7Z&1_GMD?:VBU/QE3LEUFD@;5"PM
MU&W)F83TL%@;W>_@R7WI:<VESGU2O88+9:+A9--8NRPRV&*8C.XI<HBL)4QJ
M8POIV'1)F76.1%]@TZJ8JX26.&*/<W.@0!$6:$.)/_+IN*ZSH[:TE[HEC.^U
M<Q<_.](L=.4#7M=0>&7;3'-E"<UOMF26(R9^LYKDK#.8SSZU'IV1JU'%+`%2
MI3I7,8#!#V%K[&\45T355T8C9NJZUB;'>74R'KN&R=OYPL%)?/.EQ+*OA-3R
MV6TQ<<6ZRB)#4_J(U$3=-`UK$L;2`.*E$\H9`UGJ6]0'MB@3&(D")&<L4N!J
M1(F3&KUGP_6+C""0%#6*OIRB"/J5(@;&/V``#W"WZ!UKTU@?L"M(8I/1%JDY
MBQ*4G/5)`'%B4IB5>SPI#CR`BV:24J$E-T6(6M:'LL7IZ^W?H'8P,&\R>-1T
MQN*D$A8V(UX5Z0-);R[(&PQT7;UK>D;<!:H($M5[UOU^,K0A_P#JP,Y@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,"AW9/%C1UZLC+;,"XD]0!&Q(&*60N7(W18W2=$EOSG^X#DBH
MMM.3_*@5-M.*40RACT$PQ87[]"*T9K8424\,6U8%Y]:2)I9X\&JB;<;T=/5G
M=ZVS(Y7%AH9FY:N"[Y:^EQPS\RK5C%T"_.2R(K$80H3$A99`=_2:!O06;YNX
MNN^O6&ZJKNZU(_,:MF-"1JD(-+8F^SM+;!PG13;+G8\GE_WO06!E>RW.S@)F
M-2TG&'B2H2A*-@,``.@\Y^>?#=V97M1.L<O?KN%=(VLKNV>3UG>)*99+,Q5Y
M&K/3[->7QF6-RD3[([%C,J965_8`N!)3:C6MFR-;T2<,6!9^P?'#TU9K[<ZV
M3VG4QS$]Q&[Z]JUC,56<N*=HA:%X@MU,5:AP]I%#6K<F@]1'W0+$9L)3?\7T
MH]^S0=!O4O\`&[/9%S96M),\U@$3<(31#Q49@&Q))5$6;C'BZ*NLX""/#5A$
M]FQ9G88&>SD;5;^K.+-*&;Z[^3`Y*5\?_1E:W]RM8$AO^'R:N.>ZGLBNY@A%
M&WXZS;<ELCE3R\H+=<)4L7:;X_)+"3KB#YF@*)/1GK"M@1#`1L/H&+Y]\<-B
MTCU`5:#>;2;+6+/;%JSMG-B+E:7ZR71GL@ZPY*])G]I>A'0DEVG,RM#_`..Z
M3&?2A1PQC,3AV>:KT4$3VGXH+_<BH"32]]0&OTC5471[;8Z9Q9ILK>IU?%WN
MRAZ_60@FZ9V,>HTU/QPRT4D)*(&:H;-#(2A*T/\``-@KOQS=10MGB\+8Y5SW
M5%>$#LN2R**U6\W*>D025]N?J"QHU$XL7($Q`3H-)X]?21%)U*H0''YDAWT8
M-E@3>T))X^X`M>FK&L&0VPZ4$UU',.7HW1C7SY2J>Q38I7BPAZ<UTI1I);.U
MA,AE,%7)E`SV[:TI,O0*7)P+#OX1E^T*T!\/EV,W/LABE86!0=-7?,Z8K:I)
MH]QMBL>65C*F:K*;K"KX;&)&SR%S1O3W$H\KAK@M0C_ZNO(VJ(V(9@@"UL+C
MW]Q!;%G.?/1K0XU+*"ZMJ-Q@3Q([+>+,12B(/X*^7QA<\5<5$P#;G%+=`58H
M_,!O`BU:>-GFF(![5_H""J$K\2MDR8B1JW)HYFD[NH@=(?9&&72WH!?'?S+2
M4I!)8C4S<K(/"ZUM0\5-U[4JUI+52)Q4A"I6:]_J#`L2C\<<EDW+-)<Y6.]5
MNX,,"AEA02;QIC56`KB<BC<GOZJK/8FPM_<5Z6:O:]LB-<#0.+JM.)6.;LJ&
MK&$`33"]!IB?@OJ>`6HRVY`7[FZ53F!U[N,16TK3?[M3SEU9'-0],+C2TM1Q
MXM1&2J9AL0>2W5E6$@->S)"U)0J/:E$</81*X^'B:I:JL(R+VW6Z7I.95LOA
M2"UYFWSF;19WD[S,E9<C*FD0<9"G3/3!)*B9(Y&U!)(2U)?Y>(,+]-Z'L831
M1GC7M2MY9T9(9G8M<2:079S`[T818;:DF)$U<%SQ"8)'$)$F9G-2KCC9`:R=
M8PN%'4[9OZG2)Z,)5;&(@H6PB"E.!+@I_H+EF(D,L;BE9QQEF#];<7IE1:@Z
M(@K57;XOE_/YM?R*PSM+%%@R6X7=4[2AL,,.,-3&:"$'T(`BV$EM?C_ZM@S]
M-I96DUH5F>I?&I/5KPA<'FY!M$PCL[='I;,.@92,LM0I2=%+21M^BTR,/V/0
MRS?0T`-%!P)`DWCLD39PXT\W0M%4%C34^4&3JUF6Z'NU&^H+WFCVJ!N3R"P'
M6'*5MB)%(]E$.*8"+VD[<$1(1EZ(V/6!"C;XD'Y_01@-JKZ?,U"$#R@9F:.N
M=L+6%VDS\GJEHD]UOASLZ-:PBT;)CD+7MCV05HQN`G-3;3[^79X]A"3GXT^S
MI65U*SP:4<[P1^>'84`K"U[BCUL60[S>N2GF+N@:UF-?.2U'"UM,Q2%;V7&U
M;<=MX3R-H*--%L@O>]AN5F>.^_*;IZ?SZO9,&P^O+$<:L$3*8LBGZU',[7B=
MHOQ\,=K"2GKCFIBK*,U9)3VE0::!*B2_3E&*!B"$.]A:ZVO&:78%N5=,6^4M
M?Y'H^OJ#CU31Z1.,R4N\8FU&SQD<&R>G+&YP3$.[N;7!;JS@&KV?[C',8S0"
MUO>]!W^A/'.*W[OLGH2*.\,8;*E+8RAA\N7'S;[M'W>%U8[1JO5Q^FIW`T"*
MBEC*T[V5HI-O8M$[T/WBWK6!4JM/$_U`U((V&=6QSJP*HMUNY=#-;-2<,G,4
MAI,<=XW313HT$L[VK<U!$I<IE!WUP4'_`##3&?=P[UH'J,L`:_TAXV)K4]7,
MC30K:S.+K-;VA,I?H5'&6]7=ED5E/Z&YXJ\VY)7:('OJF'O$0(LEJ>FUS<Q(
MXRF=(Z1]Q$6G%[M!.=]\%6[T[UA=S\YI('&*D51ZJHTGG4@<;0#9<G;FEB@K
MW+*LCS6T*$=?G4A+U[8,#RIT>%\+>$X]`U\/IL01);?B4LJ62N6RQWDE:I*X
M.D<J%.H_$5]YKYQ=%#RV4.AUB064(FA<3[)8Y0=]0.S:0TA.".955"@`$!(<
MY;"'IWX\JXM:N>5H'J^OG*O2?JY#:MPH1F*?I&F?3]W4/3LS-2)4:<)H:VH@
MPD@I&'?L3[`(.M:P+MX#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`HCU_S=:O0,FJ\4.LN?0*(Q+9:N0I*^
MNZTJ8<'EP46?4ZEP^X**P=V-3(48:H;96E)(6'#(+7+"!!`$?H<4'EM*^*?)
M,X3V-%RV00B4TM6<;YP6Q@HKN'KV&VS<5I5$:AV4V361.LBE$!ANECR,9QSR
MR,(':4Z``E\^X[&(6!*,$XF\AP8OT;(K<M=LF5KN;PZ!H"-MG2'1B>G!,RV[
M4$Y<5LIC#W('C<9>Y'%X>T;(-2:4FQ(U8X(8Z8UH3?BP-8Y:XO\`(G7#C&Y9
M;ZQDT](NS6:?KF*$]G]-S1FWS0P19S9"&F>2.U5$EMF\WLC;LH-:XN]R4$>2
M.?P'J/J4A8D(PE#I=)U+T!>E%1RK'&T*I<K"Y/CEVWA2H;AFM=*:FE-?2L:^
M!UJZSFN5VVAD77>;9DRBTA>6XEP-`9"&Y2$H84R46@G^A:@[9AUNU(38#RG5
MTTP1!J=I>N6]`S2P)$1(TL<NUA*K$UDD$13*9XB;1SF.JE$L<74"IU4L0#34
M030@'H*'7OR/Y.I%:C>Y5HK9(3&"[X1O5E7=(_)!V@4[3&L'4X#=+9!`>=H^
MZ,5!5"(<9(*3H8F-`ZMR)>(:Q,J(4CV9L/1I3SM>L3@<=K^+RJ:3N(0OIUOE
MC*UR3I>VF.PGFA-P;:8+!*KT-%(K,D:YAM1R.>AMSDL6E.S>D+;3E`$HPEE!
M5!JY"[6DL1TZ@N&5M#_'I1*YQ`UK'V3=TG:);+C:O>V%CF#RJV2E93H%)INK
M2+M01P1/458]$[,((.%^&PKN1POY3G&=4BW,5U*&3FL$`4QRQ4CMW'U!.[R:
MUY]Q6%)'^:-MKH5D:9K'?+DJV;-J4XX]J0)X8='DA46`T$C.^8+;1/A>X6QO
MONN)+)Y(^$WEPJOY^2V0\]8WO(Y7'9#%W2;1Z+@41U]<U3L^/CQ&K!*6+;%"
M[$2A*H;@I!C4:4!/*#H5/SOUVR5O<\)L&7KJFD]OUNVPNNV@_MVX+F=TLB,D
M3NZ+2X1,I6S16105TK^KW!+'/NC`46O?%39][/TG5J!>T.1-ROW+&.@K*D"^
MQ2I7RRV632*JK(,7U/TA$K#=*H@]6N,7?M6;.'R23$A(Z1*:@2OAP&LM(.=Z
M$J!(U*L6TYB<*>U#X^/+=M`X[O7HMK/ECD__`*IG::UWTKT"B='BCIQ*0M]F
M76@`Z*SS87=3?"P:=6!@9C449:GW6M("D(/46PF^T^0.HJE@_6ETH+BGZ!]F
MKM=TD''VKI_J,$+35NKL.EYI7L1KR!1/\V,5'2EV96*7MBY_A46+>4@WD*C8
ME>Q&^@:OTA07?M[<V<-QZN%40C3P>PL*.ZG6X^L^EH3+"&^7/[(E>XE^6X;(
M6:%]%.:JMUBY*7^?FAS,-6Z*.TE(4#'[0MS?O"EDVQ2E91IH?4S19M1=HR_J
M*&.2*PYS&6,A,ILZRINP)'$J-FH4[XXJV24)D`BG!*K2MXU!QA83/9Z&A#QM
M'=]./0T#ZU;62(+YXS,EX"E%$@[;LXRMDT:G3C4,>K^K482:V-A*MN3*(M(Y
M*9(=Q=.>0X-)3<!.;]6-6C#*USRQW="I3QPD4W<B?28Q>=P6_P!:-\HZ+OB5
M2=QB4L=W$^&(Z^2.4B^QR*(`(/+:CHV[MNHVT`)^5I(2*?4>!HL`YQ[3N.>V
M)/M3RPZW@R:]K]7QUP4]?7J]FV8%F0WQ7E5N@*I1;8HU2L5K"5NB4DZ+HU+H
MRRPK25V7%?5-B$L`01:W-?DJIULD=[1^46`L;H2R'3&#<\HNS^G;F<I%?4$`
MF?J(;W!T4(VY?.*_FSXC,@<FBJD*!@<TDF_,3L(\UF)*$%S^Q><['6T-6D/5
M76J.K:L^=3ZQM>TK*ZWGE(II1,HJZU@)J>9+)XT-"M-L6</\$/0G2YT=SS&$
MY>H$!`J-4GA$%-87R)Y*I\ZR^VDRJL8]MX4/THYK717R*]FWA"8*JG_(_3%;
M*Y2_!GK^^-4V2MMF2V"@2IF';"W"(+7/","-86`HX)SC/C^[3>Z[0.DTZ0GR
M&Z3X^SHW557W875@*UCTBBE4P>,L[.PL#Q/W/[FS1RRV5V,7*73ZIYD18OF>
MU*U4<=O`R%/<2>1$Z5"E_0%^Z"Z,5LVBXQEOJ'HKI]MA3M`YW.Z43K)#+X;*
MYZ^H'"2/M7,<K`E80B#&H4X&IAQE*UGJ%BH8;;Q#4_4G)=HP"&VU`7\RGYC5
M<8K'<V>>WI[>[17MB1TI_>$#>WP*R&B%MR%MF"@2=J*<RBWR4O#L>5LX\E(`
M1>PB6#<K=W6B9;#DHF%HU-$%-^3"51!,]=F=%O,IEAD0OGKTE8MTW&A8E=30
M*95]*H<V-\40JEL;2I42=:6E$-`DV,(BN2A/)!59$POVMIE*],\`)(>HYS<E
M[2Z/OUQ>+OAH&224%#7)U<FK:Z4QJ6S%&;7<GCRHML;7ULL@$C>5.AQ5#H07
M\O+GWKU!"6V.\^2`FVI1"^3$M1QEPN'JCH6L6P-U)!@$KFEJD5"^-\VG+C,X
M^I3;V[F/29Z:3D_S)S1"4C'@5:DG"W=3_09J*T9\Y3NU)PXQ9AFT8:>X>E*R
MJF+MD:BB-H@CXS*PGOBR5LC)('=Z3/\`%UY`=6,0O1CD2U><WIO:'J!P75ES
M4QSE'Z\O=8O<)PQR*7Z(7/-R3"^I&LC"E]5'QE1)K*F3:PJ75^-;!AV>G0-C
M6T(?T2$:0DDO6MA<O`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8'D_Y/./>I>LPTDGYLE=%00^`2<3V_P`R
MM!WNQHG#`6ID$2+<%%8G56Z)H^-R60A.])!A?T;@FVH4)_8`K>A'`"&G7QB6
MFP]*TY*(`JK=^YLJ^=4;/HS"K%N[H8<NJ*60J7N,MMR:0!I`W2ACGS[9)Z_9
M9:22.@$*4/X%Z("$(=!CH[XU^K)9<DZL2_+4IM?&471Z^]:,B50R#H"&(HNK
M3697;M'9#.T*J3')9+.1U?&W9J<4X1[C9RIP`(#?K6AF[#:H9X]^G:4>8(FI
MNRH.IK_<NKE=8,.FMJW@(IF1H+,'9]JS6#JUK7-G*0RB:."5,A"R.*MO:1(M
MFEA4I2_0H08;G'QR=4LU56O$NI[-I"8R&RT=>M@6ZEUMW1"!,K7$[Z<K?>FY
ML,?'X^P6Q(])7,T`@%.XM#5&F%_S:06B]!5BN/&IWY"+_*:K#LBMKDC#I9UD
M6/$+3'8_3$+65K#$<[;7.!SM];FM&^Q&<]11])+-HD#"K,;H:XL3$#1P]&D#
M$H"<'_Q,6;.HC;8)H35I[ROKYM8:0KE+T1U"LK:'3@QZ:C9S-'V2G-K?(QGS
M]L:BU!@!-CH%L6ZT!.'9?O,&$X6EPGUA*J<H2NZYN&L*]65QU5(+9FJ1]<;>
ML!.Y5<[6`[2ML''9KMUBDE57+'2%GS(3W-(9&R3U1J4:$Y,02,04UKSQ)=P0
M@CI-@G=L43T95]@/:,ZLZFF%G](5$FD$3=I8-_6PZWY[7#2Z.4?;:@3B`"&B
MBK628L``2=TV(LW8P!+58>)VUJQ;H@>T?JL"^13::N61`3T+U'J-Q&L8(.%I
MZDL^/)U"%04Y6VQ.+/().J85J3[*)VE2AN,<E:!(E-T&_1WQBW3`F)X8(W:#
M!*8^MA3$F7Q*5V3<C<CF\]47@SV;:[D^2X!<IE\/8[:CK$0@6`:S3P(#!"`E
M3`)UZ""KUL^+CK%VD-U6G9\[J%97K1:,YN2I:MY_2=&*Y@/Z<L3M7:5V)7N,
MGD+E8:I^:&=$[GL2AM;52$@W>DQ8##`X%J)SX^NA+RY?Y0BCK9QT2L7<"F(N
MKV^232?IRU;W;RMJZ7>T4)-C:A2/3O!^PX#$TB+ZP?TJ:`!>&T'REJ/HU`1&
MQ^-?R`D\^]/U@*W^5X++K=OZDK6@.X69TF_0!-'HD0U#MQKFZ:32U+,4#M/'
M)"(XDIB<$[9KVAULHD(Q@T%C+0\:=F7))Y#,+;O%)8\O51]EA,:F+*LMJC7!
MJK]C(Z+.:HT[,%?V0ZL#N_('>SHRH52$H*18[G,IQAA*8O29-H-$KCQX=;D7
MG(;&M2SJ64Q`CJ?F2ZX<T0UXM]Q=W")4Q6S_`!.;#FA,V*7M":P9<_K$"DO[
M1M,UFEH_D.T`_?J().JKQ\V2U]-1>W;5DD==83`Y!)IDE01ZV[L<'JS;5&XN
M!L2N^=1AQ*8HE'Y,2U/"E,KCJ,YQCQ7NT(L)OM+T4%96_P`.MB0X704GI>25
M92=MSN=RE9";);)[T-/2)E"WN+7R<=NX80_R!G9&5=*)A;Z-N<6>/F#1H61I
M$L0+2W`_0"@G"/>,RR9$R\N-=[6%%9?JF^>Y!7E@HX/)K<A;:^V7][,D=?NT
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M1CE:V^?!%U/[Y/!ZXB+4V1>]+Z@D3LQWA4L;9"&76$Y1Z%`D%3HD+<W?:QL,
M,*VG>VTXX@]6CV8`TD($=N$KC>NEY%4LC84TF;;.AM^*)'<#))>R(?%ZNB,_
MCL,_+]4-*],PL=-/[:\/;:L/$L0R$^6MJH\6_:'6QBP+?WORIV"RT](HK4=@
ML#PQJ*H515[,536T"[,B++4]E619%5(Z:1MD>=P3:72*'29OB[C]V7-ANPM*
M??U"W9@MA"+8_P",:R[%YXJACLYOJ^%V!7\UG5NP:*,%L]!3V*5U/Y+5KU%8
MU+VZ93QNCT]42Q3*'8IY<DRY"8C8ENC`MH![+`+83E`."[DB\3Z%<4DSAL&L
MNT.?OU/U,T-<]N>SJ[I4266VG*"H^2MF2J.ODHAS^XS-,L<5^T:)_`-4K1IS
MP)4J#T"B+AXD/(.FC?,S-$^JZG9#(-^M[=[D%O-W(DKL[STR`.<=G=4N#>:%
MX!+V34)41H6I$8O(+BKTL`#9BOXS0A/ZGQ530^X9U;[+&J?@;_+J'31@E='N
MANJ'18FGR"&0JNV^O5*-:0VL"FJTD=A@U`92)(*5:4NZ@O2+6B2U!@;RV^-F
MWR'VMIV58D>C,QCIM(,4A0M5CW)*8TCJ>N[9M"TWVIF4B5^]'(VU"HD4:2-3
MRX-R9[5EL.OK#P`%HL0>@/)-.S"CZN-A<Z+C2F2:D;RY+Y+')G.9F.;&+3_?
MN8/YDZ;T*J/R-\WKY5;:AV<VI#=["G,V7Z:T%H<!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@4`[GI^\K<5
M<[):K3R1ZBD9ORII98[#%[L<*0-2L\5LZ$2I3,9*I0)%8+8B$>CS$Y%J(2IT
M!*]JE:<8Q:^GU@>?%4<:>3=P1(7Z[;59V*S`5#T1"QRJO;CGLA7-<ID$R4R.
MJW=GD,V-<I(C2O?TY7U24!^D4?3J1I$)0$Y808$31'C3RO/5C6*7T]T?.(#S
M7-6X^TY!-J>ZZN5KLNH5$\A0[!G5-0PI`Z$E$PWGB]!.)<=>4):=P>HBK):E
M1AC<B1HDH6_Y_L[JUY\?O14JM*.6Y&+K<ZME-O1%^6O;@O)3+Y_&I"HC<%JE
M>>:?)F[]7B2/(?F">'1A*]SV8#U]=ZT%>U7+7E1_*<;D]=.":-/CN[4HC>:]
MMGKJSYS8\/A,6G<^D4Q*<>DX28PO]I+D:R0B<T;<X?(QN#:XE,RL@Q.WEZV'
MZ@E`^8K[Y/G&2*F>*+QQ_K1LJLI-V7<\\K)M=I_7;X34DQG$=DZY;-WF6CLE
M,U:0(B'$N,PAJ4+C&M"2JTE$4%M)1R1T]:W(/'L5LB7_`$73E'6165L2A:S6
MU83O$4LCB*=X$K;G"2/S@JDEOI6C2P!"%5(QK%1JK0%QPA'E^[80!KD'N9:G
M>920.:LJL%CT6]1>)2/KB1S>V&NLX1#K:8[2A1/0BEOT[IWJ8N-A*Q-[AH/N
M0%NFO3T^D#ZAJ#URGYAUO6?-+Y#.@E<2XX.ARI-T%7,RNZ23"PX,!TC;C6BJ
M.1N;-I2-XLR>LT5<OS"ADJ\?T_YL3EJS"O<6'8@M5V9Q;;E[]<55:D/D-UL\
M*::Q-9W1TK;KVT:(C\/ED%;[M61@]VJB$N")LL=ZG3W;+>02[C$6:R(F926;
MHXM66`(8J@:&\C:&-]Q,'1,ZAKZJL&O28ISP\1^SK%DA;X_&UXY,XY4^Q^9K
MG)@IM4A=S2$YR2,D)4+F;LU>I+&?[-Z#E3\G=:12U]2Z/6==$BCT\NX^9SJ/
M/_6UF*H;%HX.V[-4H$L4B+HM5@C$%:ZC=V0O\JQL;6C4+R`A,]0D:WL*_P!&
M\N>1FB(?:2QE'94N?Y;,>@*DB4&G_<,GF[1$JKE,D#*Z6Z/97*3M3BV-$TC:
M]_?271H)3A>E9)R(`UPBD1`0!EI/R;W0[7O2]D$)[,<'B"]2_<["ES[VU+G.
MIY-53C6VV%59\(YP7)542@R%K>#_`(P0U,22:-47M<%1\@_709*(<C^08^*V
M'()+;MWQB=,$>CB:EHRW]>2B4IE<G=0&QZZW^5*GM.JBCX&0I3%;W#T;VB7H
M(JJ5)2"B0!1:U@2C;=/][IO&`BIRDF=Z7]<DH&YJ9W"P>R;2#,V0222C<2)7
M+>EVA4CF$XDB=.6`]4DT(EI<`BVWC*TA]2L"'&'F7R%,$]N3;(GL%BJIWN"5
M3"-QDGM>3*%<F?9-TE;4X:K'C2D;<,ZIJU9*Z?V<3K7:<7V]YWL2+>M?#LPP
M-/(Y2\P#'U+2TP!>PYK1L>L\R$6@VO%^V"R&/%61>9,5J13H)'!VA:FC;A-)
M.&<S6`.\06%*6HV/HF-68`Q4WH#T06&Z+YE[`7=76%8U(++-%";,05N[[>V?
MKJ5UM$HC*(@PMT,:T9M+%I5C4Z-C$H0&O[P!,,E/*4ZD+>H!L8-F;"5>RZ!Z
M\LBY(S(J/LN<L]4E0R.R.612*7=(JB<%,^J28.Z!LK]F/9?<00Q]`5G><GV^
MN1P1A;W>!Q@_V",)*$6%,IQR=Y*D.Y:]4P[RAME5G,_//UBN?]H6:Z)ZVBE9
MS0MO?:Z)&TC3*9=:R:/.1SZIF8A`1RHE%ME=DZ@A0+>!>#KN-]K/=HM+-1$:
MD[W4LOB<:(E\PB/0[#3DAKMVB9-M#>4D>C[S$Y`<\.MB;E#$4!P).(*0C;"S
M#@&:*#K85>JOE'R!-L0K26O%ERVL+/B?YV6*8^X=,SRW(D'<PEM)MNE%P:=?
M:U7T_,%81Z3&D+G1,8)`Y'@"WZ3E"*T6&)Y+8+4ZMX,Z^C;'*K=-;+(E\K:J
M/D;_`-:V':\G7)FUN9?O"F#='NR)AFT39W^9-JT"`DI.4&,_-\!>AED_B&GM
MW'GDSK>J*;AU$S%Q;FHZV(%9%F1"\NQ+QLJ=0(,AL*T9+9!35=K<[(Y#9Q,.
MC2V-IAQYS$*)RAP^M4'HM?(+W!</I/D;H"UK%FLGA-DV%!T*DQHD<=75??,^
MI1Q?99$:5D$=BZ*;AK]:U"D4.U9"I*H4M*T1[><3[QC*%^(=A5%GX\\CVK!9
MXDVSJ35_S<F!;9CTJ_I@7$_76Y.S[W;,;8;5">0(%Z)L`VSJ@W%K!]4<`;Y'
M2TQS(G4_2*E/R!U>F>1?*HC15:OY6O&1OBJ16+)I%TG%[,Z:LYM2";#W-^CU
M;G5"_-Z\MR@S=7S(]))"L86\U,S21<T@1N:980:848$^S;GOLB-\*7'3]1,$
MCDUXN_1EW2&$+9?VK<<*?G6OI3;TQF$0F`;Z@*]JLN)!5LJY"+4:`J&4B)&-
M$8,PL._4(/?^.O(DHY($P.]AV9/[BMB@'EOZ0KA)V!.HTF4V]L+.UQ)@HFW'
M,MQ5T[&&U,Y+E#RL;"4^I"G0_3K`&#5>\(>R]$/\D>8)ILE,"D]?N4%>G2N2
MTLI5)ERB4(H0(EC2SMH7)S3!+HW+0IMJD)QOM/-)%H1@0BWZ8$S8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`\SO("/R$-KY4#QQ`@3RAG`AGJBS8H<ZP./?([UV5'[XKQ$>\S-*L.`UWF
MY5"JII:-&6,QF26>8^^@1-(#`!Y[26MO-'3]#6+*H#++1ORZ96^P!Z>JKU.^
M=(4A0($=P/0;.3\\2N80N2(*[DDUK<U$LUN3"D;*B'HX"-"E&()(0NS0*#N2
MK:FZ,L+I:RYL_P`B6\_BG4>1R[5/*8Q55FQ5);"5W9X(@K2)-CN-B5,+1''A
M9IY5ONS%JHP*<TL`1I@A7*I47DMET`2V*[R7L%KBJJ"1<35!Y&X<-ZOYZ6OU
MJ15=9+Z2&/,ZZHP.B:O-K-P'YGE(G):S!@>TYCA\>PASSFO/*$BK^?V7_2`O
M6)/#4R/4E8X>-1RPL8VE@A59T@=$DLC3$U2[+OS3)7/4O.F7T;HL1FO:=1MH
M$E;QH`;",F,SRBR2"1F[8,@["E#L\4E>K5!Z\G]@\6PI:YSZ71YFF4;EL_6Q
M9JE,/9*_6(XR)LJUQ2(GE_9WYY3BE+4<V[6;)"<*4<^Z89TCS[+^HFOJ5Z87
M:&L-73)J9AT9)>=F6P)\PMI;%*4K-5VD5M`DS*J;3R)H]OY0HHA5F?(T%%DF
M^_`L#:57]JOE[[EL"L^V837<5ME3*D$.B3U2XX5:D65+N16($<L-'/H5,IDF
MC#?'$]CK"B8^XQI9]22/8S3!G)-""HU2P'R?-#I<$KGROI0\<H<H(!2'\Z<Q
M.\V1I4EFE"G[=S^T?.@JAGB:>";WJ/F2-"0\FI]C^XFFJ_:+88%T3^7:2BLA
MU#6_0D0-KSK"0.%'1Q1T;RC*B[:J9;6=RM9#S.7UEIV``@U6ENZ1A&SLAB"0
M2!G?G-,>M->T1*@"8)[N&`]\SKB/E!0I4WXU=+LVE&KSA]26#1C;+'1TFU9S
M^!H$=AR=V3Q.`2&#PF6REJ=9$IC0VEU&D;3E3.0)8$A&,(_>HIY2HY(ZUHAK
M-Z(L6M`UWTPV3_K57<?*C).OE52JPBJ92+JS3TRU:?+4'%4;&-HD+>K9F9']
M;LMS:SSBAJL#<^@I7VK$Z^X`JZHIM,8Q=%QTXZUG/(U,%]3O=DQNQX%4L4O-
M1;=@FI6Z7L+P$ISI1SK=[6-9OY>`Z6@G-^I+-VVG!#<Z4?O(8U2"+Q"<0B\W
MJ)R^XXG(V^Q;)<N6S7ZM*-C:G2680J["JXD;<F63Z:>T9Z,<4:W=(%/L'O5)
M#/<7@54[3NSR'UI9W64C6LMW4;R*PM[<=7ENQ+H/B!;+Y:O:JDE)Z=!04`NJ
M`1)'7[LZV,2CTN;98]R]8]%DC&VA1;%]+L)H90^48-ITS(80MF$ZIZ>M%OS6
M6.MES>CV9I@ABJN86?3D8=8)&JI1RZ1,S^Y[<@EZ2/B96TO)^U2PY6A)+0'!
MG%4:\B4K\>=)O$S+O:*=>0^TVR?3N#UE8?.[Q;#S&D$BEZ1L@#M-'>-PJB)J
MU`;G=K->1%I&#2]N1&C("2K]B<83K"8WV=).1)S%'^5W+"+MD-DQYCC,WD)_
M/9]SP^N7:15PWV#*FLV,LTCI,2QB2'RE;&@K&Y>;IK+0!7)CUGRE""O,=WY4
M/LUDBF+%8Z=V;^D;335LDBDYYQ>026MF^`%)JID#LYN\1C@8Q2DGGA9BAP:_
MI'&:-))H2]*%H0;$((BJR*^9E\(I=UG*N6UFXS5K9H-9K.XV!0UF.-5&M]E3
MVUTUE3F5M,$A\<GP=,%7-\#7$1B+M!YK+:1>PE&+6,;L2%HZX-\ACCPHL4VV
MP6Q%>F%=PKU#I&H!,N=9G<C130K+3[.0P"9OL<AE$.TGW`]'";#7=N1@++&`
MM5H1X!&#"<J6:.LX[5M[2:X7*Q)O93Q%80.OH`@?*=:BFE[;.>:^;I0DKET2
M10IO8G)]N(#TH//D:EY2EN`A&$%A;_A38%)*<-\HKI1<%677'^G(G:QM20$J
M11V(2WC"5/;8X$WQ(06F2_2E6VQR*/\`?RBE0MPX^L;V]!"Q#&9]402?KVX&
MJ1T7F`6RYP4S)ANZ*QE'T+-6YG01*;\C6"7)JH4P'2=BL!W.>HY6ZV"PIG>R
MBS6Z&D??W]Q>SCOK)"B;BR_D"=;IFW93:AX%K^-AZ&)M"71"0/%P-4!7\QK9
M#I^A0JI2E2*_W:=)6N';K!.ND9P9:E@.AOGR.&BV<)X"OG"&B-46\G,7(E!K
M_+.F9[+GZ*/TL:RV%PXW35;%W%^B[F<^5VQ_=&2/S4N71F5%IBX2:L"X-(4X
M]_>ERCTV+0?WDJ>>0U\MFZ:LO2:'NMAU1SR38LF;F,-8JZ\WT%<+(*$H:LAZ
MEB:-N31`X3+:)<Y]#2I`X$20<'M9GT_$?4%A"2&B63"_+=5=962ZU](>B^GY
ML\L@VV)0H5M<<TJ[L+ON<TPZ(Y!'9VX\\RR/HOI&(Z5I5*9R9W(*ML(V06).
ML-3K0A_($Q^6QEE=?,"AKNLYFD]PWK,[LF$KL[FA9&H0U6###Y7`8K53&EC3
MU*9%5\/=WQ.RH25AS2ZLLF;%AAFGED-2BV&OKHAY7F:T8K7R:/\`2U@5N[P:
M;LL_MAZOOEAFB#@O?>17+38YO\$8JU9;._/J'HQA0H$KA&'R-LR;3F,_;8,@
M`C]!ZI\$)>B$'.$=;NHAV6KMIMD,N0N#Q;JFIQ3N1,:9\4@CK^ZM=*'N4`C1
M+FV>P:=L(<GA0D(T$*E>I.V,6!<W`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'F-Y,+/[/@$1JYFX]KB<S
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M6?`K>UIA278?0W`J]![N\I=R3BUX.P(.NX['&WG5`OJJY;\Y/@U`,*ZX7^60
MN(M[R9"VI0>H=$B5&QK90XL,@+1J6U$YJ$)Y0"@AW@6YKN]NU[JX\9;?@H5Z
M";2V8=$M$'TRUPTJG&+1VM*.M"O(.[2*%[5:8G\4AZ/@`7EO3".+2*D;L@2>
M[0/TMAN-YD>0-VYKIIQ@<VES=>E7=.,P;"W%:WCS<+H"I8)+WQO7*Y)'E1YZ
M2&QJP8NWE.*A.V&#T,P\M.2+81:W@1@Z]3]H"O\`K6ZD%;=0%\HK`WD&3T87
MR,\BL,N"L+?0S="Y0ZI3"_U@(;+<+#ECH6ULFR-#71]&Z+0`V4B/$$,A`+L\
MEQ#GR5J:5[.I`WW/U%9R>XE2>FXI&F^CJ)0*CMPE@G:8QV%(&]G61_6CD4A)
M+$X'NN@D*RP$;WO`TN7=7>1A-95AQROJY>+-8:F[8BO.LQ-@->19S,2PQ^4.
M?0A-@K`+W4I<;69'-MRPJ(N[BB"8Y(9C&5)Q9>PK%(2@U)OZ'\H4IJZU+'3Q
M^_Z['!+'NN/0^"RGCB+OEI6;%V.\Z(05XM8XRR.PDZ0;]6K[*T+*Y&[TUFE%
M?=W0PHE$9O8>^S&[Z>D(E?T#JW")6KV\U.\-RAL5;/;%AR`]040H`#9[>J-3
M[,3*`>I*D@032]B`(.]AWQHD9BLA>8D3&+DI*A.F6C(*$K3IU8B!JB"%(@;.
M))4C2E;,"'>@CV6'>];]NO0.S@8YT9VE[3:1/36W.Z/1I9^DCHB3+TVCRO7X
MCM$*RC2M&E^[?M%Z>NO7\,#OA"$`0@`$(``#H(0AUH(0A#KT"$(=>F@A#K7I
MK6OY,#]8#`8#`8#`8#`XA$$".+4")*$H)`:44>(L&SBBSMEB.++-WKW@`;LD
M&Q:UO6A;#KU_DU@<N!UB42-.>K4ITB8A2O-+.7*"2"BCUIQ)!24HU6:``3%)
MI24@!81#V+82P!#K\-:U@=G`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'66HD;DC5MSBD3
M+V]>F/1+D*T@I4C6HU10R%216E/`80I3*2#!`,+&$0!@%O6];UO`ZC(QLL9:
M&Z/QQG:X^PM"0I`TLC(WI&IH:T)`?80C;FU`20C1)"0:]`%E`"`.OPUK`RF`
MP&!@8]%8Q$4JU#%(XPQA$Y/+S(W%)'F=O94J^0R-R4O,A?EJ=M3IBE3R_.ZP
MY6M5&:$>J4FC--$(8A"V&>P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P/+_`,E,@[$@C94<JY$06'*W2:O$PYWF4:A+&1)4U?[O*)+V&N>G'5E$
MWG#4(J`M)`SKG(PU20C(CZMQ,-"9[0^TUMKJHF>D\C4DNZ[Z_6SKKUE$!FZI
M;Y>Z1Z*%L53QJK8@RJU'$4RYBLMPKM9$95>5CKR$P9>A0K7QQ",PX*]M;/0O
M0C7QB(G#QG;.<1B[D9.M.=(Y?<R[!DM;N?`//$XD2JTV*Q$T2-Z6G"*T)'>S
M#-W*)\Y'5HFE<37JFE#MIDLJB2YE(3HB4:5R,,5?"-W&IJOV]E+^8IIYDI#$
MI2DE<GZT02L=XUU&"76PZ)G12.)PN[;,=:/L12K13ZH:J%)EE0QN3IK*:%L7
MW((6QM[#LEP?#!'?'N+NC;>%57CQFO?WY7?DPE724D:N1+BMNNZNJO@QHE""
M5?,XKF61WEJ3WPWKR62'H:@D[)?=Q.D>9&(!K`I?XP!MVJ0N!>E`C-)S*FV=
MM8U=JXHY]Y6UWV,'32;I>NJA60/C(VUWOC:$V!:-OL#$XT=TPXR=V@:1WH@B
M8FW6]]`-\"0V:TL\<?TS`T'A]1IR35"DDOP_\<\<_&C6S+&\WB&:QPR3Q^Y5
M;-,7SAJ/3I!":[1&MM52AKY/!..@I&SK0M2LM]KRQ+7=-,+V6WC<4;%(F\81
MK4Y9@0BA\.GG_EZ5^-JR^JVGA+G]\N>K^EKNON4S.)1JYD5EJ#J^L6OM/C"S
M[F=@R%MZ;@G*2XV%0MR+&)2V1MM?C!G'F%LYSN`L8RZSNB.4UDW:V9EV+7';
MEAOD$@MT=!48KXYCJN%4]!4%:PZ,MMU&7<DCKTO0V5:LF@T$7S)%!E8W90@7
MOR-1MJ3B"E2J#-A]1''CCA-O%U@LKSG%<^Q=4QM?0CU<(;)NHV(%3VJCVH#[
M:R&"\XJ*VA]LE+(@TJV/FE6_.]IB/7*T[;'BGEN1(D$A<&PII<GF8M3&RY\>
M.BT"V\_*=#*0O!NJ>C^E;A2O*6HED<N6WF='$IE4,K.7$:Z^:"*T7QYBZ*G\
M/CZ(TS=<FPBOYAM5L&OIAK_36A5(C9,XSX\9J]PVV?,TK?[0)C4`ZD;X8GY0
ME[O%U-BQ]WD@T(D:N",49<(TZS:IJGGDJZ7EKT3,9&@:U,=2.C?&%3,@=&A&
MZ)S4XYBM;+Z9K86!?GE!0<=U"4T<R=$KI9'KZC['.)B4ZQEON*[^<50;?=8$
M]QQEA338%E598;B%E@K5+#YG"HV%&Y/"H:\IM:PN3BVF8C;>>"JT7LWS;*::
M?E#Y'^B$LL;>CI(U11PW6A&Y!+Y^TTV0KBR0R/G1Q.ZLG$,HZ($)$)R=4K>$
MB/@$)0Y$)MA5X:K^=_3Q]7L%Q%(>A'OISN4J?*KR6T*BE\/_`%*FW'%)Y'F]
M+)C7FR2[0:JY5V;5%.R5PA3<!.R@0:;43_%_H-ISV^0.)RE:2BK$U4:O3_#)
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@44[*Z*D?.A9#\)ZU'XK(:EMQ@B
M*W\K*Y,)TZ34ABVJ-C!13<TNRD"A\,V[:+*/"6A/&7H)PO7V86(M3J`^2*['
M>]ZSI5TAL1F`);TO(Z8D4LKRK[C/BD88&.)E/IJ)YGKRK0L""?M`!:5.*O2(
M3$,P>VU/ZJ"]GB+QPMLUU]\WFR=7V]RY2C1"7R11JN&%^B:R<T'?`8O&Y6HL
M.@(RY[E]G,LM1Q*?,JJ.70<K(1,9*!:C-;3=G&F%DG:P1$5<I<Y,Z\O>_+2M
M6N)S6<4A0ZN@P)<]&H4LE(6)#;*>!*Z`0Z`\+S0.8I!7["[N#SLLLK:92%,4
M#0="%[B3$5:HM6^36_D</;W2V"Z7E3K$6YG;[::X36-[Q=^8--:N$-]K6ZIT
M]"=6HN"55(7AWCKLW)23UZA\:QGHA#0[UK"UBD=?WCT#;S0QG\]K*?CI\O(J
M.05RXS6L[BDJ6>1B7='BKF02<"9,IC*E#"VV"-_N6EF`3.I"ER+4@$625Z#A
M53BRUU]]7PQ0BD[-AE:G52R.3NIC=F-E\55/U[;-)%):WCLF@Z2HW*"N1KP8
MTZ?G-64)R7$$$&_0'$#``?L%ND1TZL6H[_ZA:&C\_F53"I]6I52F.03ZYKVW
M398_3C:CH->ELJ*M+P\%B<JB6P^E$SB5'S"R9(9MZ3E?5A&87K8KIU2<B[%O
M"5<C<E]'(F>/P5=;-NTZP6,SS"J;);'=R@TXE@&!9J,5^>[.<IK9_?1C+T26
M^G+M-Q9F_G,UOT,U"HN85)C?E1Z:=JD@5V*J"EY2:P))1<%3PC=#62G<F=SL
M2W;OB4F=7"&FO?YV9BVA'!&QF.<53B:UI33`/0D_T2D"?&*\8NF4@'D@ZMM1
MI2R:&M=)R%+7\P7/-H(H;7UQ+6)[A:6O.@I*\TRT/#VL)5);EB[M4S<D^^IA
M'L"A:X@#],(!@2]DJ(U2VZ=V]9/#DO:X!6U6;-9K&=M2T^00RX%9<!A\;610
MF0TV_@0.;9]VOM(CDFU`'=",49$`'Z)`]A'K0J&U\Y]SWWTW`O(&8T5*JK>Q
M>;7*TX55+%**YF[28HG,=#:"6%HW(Y]<=M]L-[LCC$?>PNC!I$@4$/WT.BPG
MIAFCI,1$QHVOBGLZSNA9DGCDI75/+&TR)+W-6KK&#6Y#5[()H<!-S?.7DRRU
M`T)\.LP10C&9$G!IQ2:_]X$/7KL(F*5'GOD:ZQIF+]=R:P%M*N**B[..BD+;
M8IS)TM.YD0)YF=RN\<A,Y9HM-FY-('DZFX.RN);NR?&@)^^I!*`#&8(&%K;@
MVTKR&=>(6;G22R^&4-$F+HPV*39G`O@M\*91&*\<EB%B6UXIBR%Q4*7FZ7MZ
M=DQZ8T9S8UM+6!0>K)/V3Z"B5'9ME>=>]Z.MB\^1FPH129,8M)]B[/)W6!UY
M;[:X,:N3TE$+92'J?S=)7I"WQUM<9B%H7;,]BH2E":$LPD>]A`*CHWI;V?T#
M$.-:<O)6PP"Q)_+[HE%'S@]HBDYCL7;IE+YY9E'T$%HC#DO225(T.G0ZF",3
MN<J/'H+0X+59(]B^$S!6-(K3^3NWV&MS)1,X!!W&2.K]*HA&&N*0^WTR4ZS6
MVM&^9HZ96IW`EQ6G3*.R-0<SNKB$9#0H.)]R80=[]N"K6ALOI/I>K>.*_OMR
M@U?2BS9*XMA4BBD7C5AFL[03;:61QVC&Y,PB=U4KVO;K3E$';I:I,-^G3MHW
MA84`@!9/Q5(B)FE.+V\BG4T&IVSIPF9*LAKS5-E4NR3U%^KNVI6NA"672>-Q
MB5U6XA3[6)7ZQ'!6ZF+6]Y;4ZED3-/\`[<&C_P"=U%C;$S3:[A[WZ[I*-6S+
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MPHV[&N"-(VN:ER*TJ3;-.`$M1E*Q\D6,GD;Z=95=],LE#44M?JOZ<.JQ&XME
M57*SQ!>PCKS4UC$%C*8)QKRLG-BK0A;FMV/6+6=,J/!]1O>M;!N%+%L':'22
M.R&6&6%"*R;VB4]#+8E'G-CB=K?=U%3*)U=$$8F4IH4KEA#A::<ZJ27-Q==J
M$K`4V.19H$_Z1?NJ5#H=I>1B3\U6%+*TC[1!R75D)K9ZW(IQ';,=8['('-&R
M8)GRP9**'IR@.+3%Y<TMJ7:%`IVXJ`JQ``7LP1>\+$6E]^[865WR95W2UEEQ
M1M97Y_;6N;RY!'[$!"1QI<DD1;?9$5CA;>]6`VQB7+FU">VIG`@Y8G2.(`J/
MYS6Q82KFH5J>.X^M-I3)$./U#$J_=YASPXQV2'UY<#HY-M=2N2<JM%F-$A(V
MX&DK9+)5'11A;`O3)2$K<E:56UI`S2QFDEJ/JO%P[;=H772R^<6VC/;Y.99=
MBLZ)$H8-QP:>,,TA/11P(4(DJ0PXL3<`.PJ!AV([6_=O>\).:XF$,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,"OG1,]G=<,=;O\)/C8$Z^\*AA<T1R%I7N9SC#;#FS5!'$F/'H7=K"T/Z1;
M(DRLI2>%63HI.87LG>S-#`%2;'Z=O2+<S]0SU)+.?X_8E=6-TW':X?IZJ:(5
M%&N.UC*#TD$&^,MA6K`HO+5S>R>P+VL63.(-XS=:.T8E`/182QFU2C^XIW8'
M2E.TTMD<.EI4^HMCL)UB$?KD3/-&]D-9S1K;_D3XRV_9$7@T$?IRC41YJCN]
MNNEX@!<&Y]<D(M&868K%JL`NZYX$H\F5GK:[K:.IHO/[7*IB2N38!D?K7?JD
MBAIC4WN``718[[83.T(4IWU"G:.#:;@`$4D:321F+`PPP23QWVY8?05RRB#S
M]JA,&9X!2]2QV9-6D[RB=C.P]RFRF&^(K#)$\+"6J85JPK(L2WLHTR?ZU0J;
MEYHQ"+]@04F(B,/$(?Z>\FCARKTMU3'K"F-.M%.4'S-2]GLS#,`%L[LLFMJV
M8&!E*9%):[G%P=``85*Q2F1I0MM(+V0E0?[UC^GWH)`BQMN,-?'BVOL_EMDL
MA=&61)H3S^T5>":SMK?2Q=!.,HL11#T%7MLXK4U.TQFL%,=9;BL%>J-VD@`W
M%9(A-A(AF%D+0&(0$X]W=K_RGW9<-%(;UJKG.E7N.O,DVQQ\<AZ/L2-H'Y#%
MJ;LJ[+,?T1P>6G5\3(4<6A[8&-EJVU,H>3G,\*XMGVD#I4.,1-2N;>MHWTGE
MG*RBHIQ6\)A]F;E3S8[)-JH>['>G9EC=:N-C`:8K(VRUZY2Q)<N`V[1;5J&Y
MW"7LW1OP"]OQ")%5-J@5WY1[ADJ:,2B0<X0-)6#K%/S,X2QJNF1*9M]&GC=Y
M*#U"6M=TUM!I0HE-"N9`4@9"<,"%40<$PT__`*ML3$?5(T"[2^H\;5:]845!
MJHB4==G>O1)6RQK!G,2IF/P&46XRQ^=2YQLB7URQS6/QJ.1YW<%IS@\QIO`B
M4)3=FE:2%A/&6OE2NBWS(3.K(U1)-[TO7K3+;SN!EK*'N\9LF=JX8_MTBK&M
MK,B)YIB:F7I9%+2GC;8?PML=5B,80J&U2$Z2`U\>S"QMNZZ+)==>2#^C9T$W
M4]_^1;*R,,236#/GBT[3D+!,G&..M1=/SUOW`JVAU>3B4OS$QN_/P-2!V2%+
MU+<A6[VF:UQWH#1(BW#Q?Y/4_94WA,2B%;,06N5P@5F!FK#-)@XQYQK=,Q?;
M%T\B":95)7<@=&#5R@,BY!3JB8W,PL&UIB0G7JGT28I70_S2D0AV<8C8$:I5
M^?B+U;*O0OM:6G/)A'R$,KZ'O*F8S$9N@AM,S=ZKV^CD-/B/)87`'V)6<8(2
MA[;B_3T+Q9N.^46_X[#I6ZVA4W/SI,_H)9,X17<9NR41Z<KHFXIY6JK<@<17
M5;)'5]88T&*BU/I.BWM/'R3A'ID"X).P#A4?1>VB.R#;LZ(Z@YT(AK*TRKF=
M#!2GT\F22E3I1)I<T*EHVAV+>:WCB1"UF&I0JFQ>V*7H"YG5$*#@(U>SD!-2
M8J+>8<>\E$HL*IY9=/3-,<_2ZLZ5NFXVB)2*I+NL*6M45OCGEFETH^V6;#V6
MLG(:R&06-,HG14]Z`[NJ!ST4>3%]*4251LLQ%U#T2G'="A@Y,I+I%ICM3L:^
M[6.'O#63>%UFTU34>-D[04[E-;_<BRO)(J1N+OHS21A)%'PG/"\PHCV)Q#_1
M$1<TAQA\H37)IS7BE$VUHBI\Q9:D5MQ<DFLHG]J,]DP:HZ3LXBKJXK2M(!*Y
M#/+?:%-AO:-WAP""G\E%'U:\!/L2J"0CCW=M?WS;D_="62F()5;>)+T+1\*?
M%TQF<H=W^.59/YRR1^0-]BU^WPUB<ZKOU8W.&S6^,.2P[29$+:U0<(1(D0R5
M".;PZ:L=1X^Z;L7H:$4`NL:XM_GLUF7W_95#4*S)"UZB6P2'FV6@9RY;-9T?
M&%S<E)C)R9O13!Q2KB1&)$_IZ%B,<$%A\W"G5=3Z:0R(\[3-GY\DD,16HDBU
MLV0T!61&3T7<\[8XG'"YK1$*0,M\2B?U2GCD=BR<Y[:G5Q<DZ$EY^I.*ULO&
MY]5UH;Y*&VP>'87V3$V.IE#5.YP.',2]^MZ20NE!HM25V8D\S6VM,Z@892RQ
M9P(:=C(&XQ%&JVJ/*3C)+V+WZ)QK=QG--4%ZRF$RI#HFZC*PCS.CJ-B.>8+'
MU$^>#'"8F$T'";C&BFYHJ[(#`!A=YEIKV)""1;^F(^K]OR"^C"2H4TF_EEEU
M/1`QVN2BX#'9&KF4:B#`DB%P3V:Q!P7K)NP0&0MSC)]<]LCPQOJE_D)),<`<
MT;;74?\`[\N:`^HM%C;>3%./EGD;_:SG#X'"JN;(="^F[8YFF[[/9E/(Y)%4
ML@TTK*+1U@A#!)JRB+=*[8D**2.[MJ.(%ZQ$8QIRE:=W/.)7(TPXX>;LVIY+
M')JJ=J>K:H"LDCCN]H^A0-BWH1W;(,)D8?UFV55LE03I?4S"Y'VT]/E$?3MD
M5$U@3J9`K0HRG(_1NS-0K'!/_7??JGG.\JJIY""EFM-)44$F4R>+4L]?&)*K
MADK>K#8U2"J8`RQ.0OE@/[0?`]GN`B!Z&@1'Z,`F5F>A.ZE8*-N'G894M1PG
MH1.P40LI^65=:[TE?T=DWLH1.E@5Q95,Q,U4T)#.7$MNCJ$AFM(L"AX%!=N8
M'M2F3&MR=*+2TR-<<:ZO>*LIZV6;!8U-FP`$Y;\U(5JML^K3JU+(X*$I)ZQE
M<=IQ;VG<6TTWXSB30E'E"U[32RQ^X`:PWS`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8%">T.SA<GB1:-IV
MRK<3.-16_8B))5M<2VSG9KD58[B*AD'*6J)(5I\:@BDQ^'I:]GZT2B/"G!ZZ
M$;K>BQ%JARSS`46D66S#A5,VVF]URZ3.-N3#7=BU3.B'B9H8VF=HW7S^E*<1
M[@MFVP\@5M;9''H)3GM4C%\X-!V'>18VI"K+RG438',L?Z^A%:FK8%(K)!2Z
M1TCDC@#H%&)36"^>5PE=I(U+=MC89)9@>SP<3,8;I6QS%Z`@5EEC3G^VD[9B
M>,MF8/)+!7!F3.4XH^0044@KV76U%4#I**Y>A/43CL&=I,\;=CVMV-2168+W
M!M$T`9UXBW$\\SY/9LD(]ZA4W20YKV,?"*H*MDGG58X&K.B++IMM8-6-4S$J
M6,]8NMJEO-JB?W=X2,J1,N35JXJD[.8=I[&8J`5LKYA#UE2H]D!)?(XT3F!-
M]NLO';H_))<QL[@R&RBQ:-C;L_PZ8O['':<7&JI,]$[*;)M.EYR522</TC`$
M6UKCHDDPH8BU'6<&V\R^0VG.E)G&XM$J#?8XT3=D>[BB#\YD0HU0OJ-HB#(Z
M,5POT3;#CI%$37N5.2^*@;EY);NA>VE40>`&M:]1.V8]6/EGDEB5;I:\0O="
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MD$D0%C9$"A24%:,K8MZT7CV;4S=Y*)19]!5`Y\NDQ&5S:6N31:".33ZLGT-+
M.,>G,[K1O2MA$=5KCK!='-YKQ2$E8S!,1MA'M^J,*W[0[%9XH7GWEQJU3,'&
M#0SF>2S^[D-@EU,RQ>1CB#,>XRECG$QA]HQA5(G`2@$5#"&E5"#5:I;L"$G]
M;\9^3^:/5[+'&>N7CQ]'%_3PI*N[RF;\DY[E8NIBN<IQN354IM*O"7*!$TP\
M:4/-.Q`I2[DQ='$W^6&[.42=N$*.J7?6OF/T=^&H5,QY6L5:G=E7TS6]<V*\
M\^/9BRU"+4&&,MI<'*<R+AI6:,S#*JOVY".+;I%-1)E$L>VY4E&:0L;HBY'E
MF>II/OJ4SD4[CKM[E!<6EU,FPVPB!0E"%M-D%<2@G;%:MD0ZNHH8SRIA<5+8
M\#<4\V^Y+VY(88H0I4YA:@&C!@T(5+J7GY!(KSV?:4J?ZG;2(7$;0J:HB9TY
M6U4D+=["F<WE9T*?&QJB4A>$<M$I@JOZ<:8I44$Q_(/]6S1NBQ86(OU:P1WA
M#81RCT-T794"J>%L%-7O.:P4LSQ8$+JR)2)0@ES3#1O#G-;'VSQ9H?)`%X'L
M12D?N6&:TF`(9AH=;A5S4-3WY-XA+F1^`Q\RNTHARA5"6JBUCU.:E:8Q<<@>
MI@Z0HQ,22\N>RJU:8M(V,T.G%[*(3J"PA,2^_P!0ZP57JSLZ[4GD'B//\GB'
M*$2E;W=%#1KH),V)[2KJ(@#9LJG=!P)ZKYD<GC101NQ;+=B@[\RG:"WG:2EE
M",WH_?I2(\VH*_*]6CA/GNL*9H55:UO'(*P>=5XV6%5$,F"R3SF;(H28&7I)
M0Y(38FS,"HX8D4C<=Z;GLXL*9O,,.-*T*''6<$I6AVG(&Q1R;MCYQ:9I6W1-
M2/\`8"5.^S2%M;JR6*C0099"*V0%.9HHRA"(J4+!KI"K-*:4^DI8"3!&'AUE
M2(SU1]$N_6V3J`-[9S2Q*ULJD]DQR.PHF00AJ6N<OJ"95?'3"WV8N^TU>HR$
MADQ=UB=>)4(D[:!.6D$,U4#6Q3H4QY8:`NB=0:B&RB9ZPN\VFP:Z0Q=W9HP-
M"@E9$C?%:Y*>TI#S2!MJ&H4C58FEA8-D&Q>0H3P;V8,0=&N$U;>W?R#22&6]
M*X)-.<`M58Q2Q+0A,XF#)8T(D3ZQ,$10<V(X7.%,#;C=NK^EGCM?!:(;4C`:
MYMA*4DT\O96Q["2L,W19O)=4$[Y8D74,5KEJET8C%U)JH6-$>E,)FZ%U6[E2
M=H"L:)='CED8V]%'F%&J$1IH5#6J_FE7QF!W@K&FN/WD5=TB2)D*>-CV:7NY
M6Y.^MDOM>E$S?&)2P](#YYL1`V/"1V5@G<EK\HY(\KE;1HXL"9W1$;-^8X00
MBHU<5J=6TY;L";VBWZDL2'I&Q8HL_<$C-AP_6IU':_9;GFB!,_F1AT&DDT2>
MR:>4EK&T>]@*-<4X%'L_G/053*R/OYX9[;502PN36Y,ZDG1Z/5FKU:-4RETE
M$V?ZSB$\!$1N*94<W05G;E4J4)3)(O4%L1FR/:`W9@MAP5@PCEY'$"2)R20M
M7#TMD+%&9!**K9`M<QI#Z5YN&,GE.DZ@)(SWLI$PQ5BC#&L?5LI4B+8!(6D0
M_E$+XM;%>;UFA#\V2F)L$E:2VTI(_M:)X^)I<&YV1$G."8I2>26Z-`S&YQ$2
M89L&SR1"`9L/NUO>MZPRVK`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&$=(S&WPP9SU'V1W.-9W6/&&NC4
M@<##&!]TFT^,8S%:<T0V=YTC)^K3;W\"CX@?($7M#Z!';7SW0;(Y+WEEH^H&
MAX=94T3IS=6NM(8@<G&;L!QRAAF2]<D92E2R5,BA088D<3!"5IAC$(LP.Q;W
MLMRTJ6\F4G(Z[9:D8X>R5A6#=:L0M]V@M51B&PB.RR4PB7-UALOWU&VQOU3@
M'83"UO2E4VB0.:E8V$A&JVG&H)/%SGU=^1\C\I3!M=6:6\Q\]2EH?9>18+VU
M2.EZW>VUYGJ4DY.EF[JA<XTJ2N$O3)U!@"W(X(UH`#$'1FM;WK8B9C)W+<YI
MI>\&.&Q2R(#%)+#X7915K)(8[16*O,1=Y<!))TQRM^CKZR.C4O\`K%$O6JSC
M-%%J3%AGR[-]VQ^X1,PR;WSCSU)D$9:I)0],R!LA;,YQR'-SW5\(=4$3CST4
M`AX8HRC7L9Z=A9G8@L(%*5*$H@\`=:&$6M81B(=S96$%NJ8WM&VHMLE\RBOY
M.4(6ULCC+'VII6S1^LJ3GMZ!@8VI2L>IQ8TG<'UY<'`]<M7.2L9@C=:WH.BW
M-4_C?RCRVTO7YD:N:Z!;)%^89?+OO[?3E=HGK\UV$U[8Y])_NB:.%KOS#.&0
M6T;PM^3ZES2[^)2,PO\`1P7+?452U4VSA\LUNK.OD%DR:,M\*DE@HH9'$LXD
M$-:!_(U1)\EA#:6_.T9;!Z]R=`>H,2D[_$!>L([K36U=L"%0V,4!A;*VJV<<
M>5M[3%F-M0JF`U2X+36-0D1H24YS.8L=U9PDP@[)V:J-%L/N,'L0:JNY]H5T
MD3=+W.D:A<98T(7ML:90NK:&*Y$V-LF9_P`NR1O;GM0RF.2)#((__P!17%%F
MA+5H_P"9-T,O]'"W+-**@J97*F*=*JOKM3-HNH>E<9F*B$QHZ51U5)51RZ1J
M6*0F-@G=H4/ZU28<M&G.+$J-,$,W8A"WO9'%^IFG_O"N1?JIK;\P+WETD2Y\
M_(L7^\+9`]CAYKT^JW/[7]:I>7<RO6`2I4,>SU`F-OV8(6T2;XQ;^JZ;J%>]
MFR9=5=;K9(<WO+2=(%<'C"A[-:I&L^XR%L-=CFL:\QO?G#^?6D[,V6J._3-T
M(7XX&J3OGJOK"DE/O;VF.3M-*S:4V5%X4THH^@B;A8$JC<EB9\L?2`L@WA0O
M1,<ZD!6B4ZQ,C6C?51BXE69I.(@MND#D[E@I1!51?-//Y:JKI*LF=9J04W70
M%%=3!Q6IG)PE<%.#'-&1&2KG%$2H.7-^TZHT\D`Q#V((=Z%R[TIYAYKG,H>Y
MO-N>:-F$TDIT24R.7RFIH%()0_J(`;\\$/>W]V8%;JZG0H_]-H$>:8)M'^*?
M9>\%RV9]I6G)1&'>$2:IJSD4,?WDR1OL1?8'%G>,/<A.4@6'/SNP.#4H:G)Y
M-6%A-$J.*&>(P.A;%[M>N$8EZYVY^DD8'")%1=.O\+&$@(XB]5E"G6,#"E<3
M7=*$;`N9#VH04SL>-47K97Z"@8C->@][%@N69-IFGS_R-\U4UL=^K!CW&*T^
M6"Q<S]7D:V*.#W'H-[VO?Y28]CA[1OZ1!].G]6M'OV?]6)]A;E^D=.U$W/FY
M.WU97"&2"1L[<*0HX/&4KX)OCSE]X8$.W8AK`OVC8W?7U2,KY/8F4_SI>@C_
M`$L([#[5%6RF.%P^35K`)%$BF)1%RHL^PZ.N\<+C*L2`:J.ELC@W*&P#$I$U
M)=F)-%:3CVF*]0;^,'H&!5<_4,NC!T)6TE42R&*$WT:B(JJVAJB,'I/N#0[?
M2G,!S*-J-3?=(^@4^P16P_4(4YGI[R2]A#*LU-U#'7=+((_55;L3\A4E+$+V
MS0:,-CNC5D1AOA)*I*Y(FLA:G4DPQI2M`1@'H06M,4EUOX"P%Z#D)J&ID[X_
MR8BKZ[(DDK=2'V42$F$QHM\DCVF+C9*9Y?W8#8%>\.J<F&LX`*%!AAP`M2/6
MA:TE(]@N7X0TY439%S8.VU77#?"SWHZ1GQ!#!XPDBYTA4+-.*A^-8$[66TF/
M1[AKYQJMD[/$=^GL6Q?C@89[YYH&2KW!UD='4^_NCNS#CKJY/=9PMU7N<?,E
MH9^8Q."Q<R'J%K,.=@T][2F"$1MWUI9[?J-?)@N78<J%HQZ>(Q(7BEZG=G^$
M,LAC<+?'*NH>O>(C'9<C5-\L8(PYJF<U:P,LG0+CR'%*D&40M).&`X(PC%K8
MN6)_HS\X?&H)_H_4C\*N"!JY45^JF"?&IK,"T3D"NE`/L/M.@@'$8E&F@6MM
M^CM['\7NWZX+=MSYVY^>H9^KAYHNG':O-*RW#4#<ZQA2^&?7E)`H"EOY75,A
MK']64A!HD)GP>\)6M`UOVZ],%RDQDC[#&4/VR-LC1'VWYSE/V]D;434A^I4B
M]ZA1](@)3D?.>/\`$8_;[A;_`!WO>!E\!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>>G>/<:SB$BO7UV@;
M?*XK9S?:$+B!XG]0SN;OT:UP)UFU'U*7LQK/9D22Y5D7<60A<I5$C*>#D)!1
M1PE.]!-1%J@KO*1?ZN63./QNA*D+3*5W6<`JC<HM"9H7C=K\2-BESN;=O-+3
M7+J;#JXE`$)H8NN;]N;D;L9.W!&C^4.%XQ_CW;=QUY%NC.C+[J>HYS1]8P]E
MF?'=%]8RR2P5WO>P$K$GZ(!9#K!H<3)2J2;Z[CJYKCT+2[5"DSPR'.:U0J+:
M2EP$1P]#=MB(F?.E4:9\Y-X6-$ULB>^0F="O56"P0F%1YMG,M97&=([5E3U4
M5-2Z)BLJ`0@B504=_?9(I)Y&UB61]L4/`3$JM9HH0<+NV1$TM9U]Y5GWCGJ5
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M13E3!#X9)0C3``O^-L&%,8`X0!:+MQFH44>^W>#8-=_4UBN/,:-4\(K4B?(-
MA=&P.L8/(W^ZWEQ@J!W6PZ2KS"F*8/,2C\@<11@H!ACHD5N(!?'[2-^_#534
M=UF>:#N0;DN&0R."<J1*OKEY8CE?4@BEKQ4L*89[5,+<JIAT_BM-)WI"BV\0
M;<6BUB`2FQQ*<-"W_P`X`L8M"$'1)OKE*I,"O_Q?UFSR1Z@_$:&LT4AN!E=I
M`TQSEN#1J5NLXJ\,@N%+<4QBK6F1KFY#6FX@=(TSROW]R1FE:5%%%F^P0HLS
MNG.5F3;RX^ORK;?ZFEW,#]*@4H;%4ST*S*/A@K.D<>KX&K4K"4P8F3N0_O,0
M;2;)52"-J#%R79(UZH\DLHXT?OK..5JT']$>-=5S?8A,:X342:M90FDE]QNC
MR.6X$C1]..+^V*5-@V57\64!%'9BH0D+30R=W6Z)/)*,-$/YP^NA%QO/%8R=
M7!RG0W1X)RS<DG.=URFE7-ZL.^ZYJVNTCZT1J!PUC=HW3\FLUT7QIP<96X1I
M6BTT,QRP"0*$`1?*6$(0;&,Q5X/W$?+#SK*K&8ZW'%;=8ETQFZ.&P.0.T69B
MXM+RP)Z?2RN1-;N5)AA/:*YF5Y1QA?M$`4'I%[B4,L!Z;Y#RAQFK;BU>37G%
MU"<,MNM=(6RIHNYS\U?`#R"ZHC\F:G)S,DEEB"XFZCC/%C6W:-ZV'YU#<N.*
M)&5O8_71*;RB[MJ-VDLEC+'%K=?3(92(;\EKRUP$XU@CT-6P%AL>.MCDX'N2
M<0)=+V!\V!K0`+'M0L0JR1#+V3ZB%(]1>2RI'-7$V1LI_IMPF<M*DQ95?)ZD
M+U-6)[B>X0H=(K)6D^2DDM4D$RS]"YE$_.86-O`>;LP.RO;L<6-9_*KRZ_..
MVEI2VNL<BR5I:E&77Y_S(Y!I!#9%'(4IT)ST'4UGT!L!HDS"W@V,UQ8%@5&M
MA&$PH(XRVBUO(K5%..$E',*POT,$BTJ11)=;Z""L0ZO7+3U2MJ<U["]+YDWO
M#\T1B1I@-+D<E;S=IW)225H(]#]VA3)0#O2(619D(KAGIB^X^&8PR1RP<MG\
M(1Q"--#I%F03R_5H:J4/:PQ5:3!^B6Y->M%E(M"]^U`]:]-B8J+:I%_)U0<G
M-8`ZAMX,::219S>F]S?*^2%M.I:WV%9-8I*>.<VR1NB3];DAEE3O)3:V%B,(
M5%D@'I3KWZUHO%D`^1BL6ZM*KL:8U;>$/%:-?S^R/RFXP]M&_P!?LD"6J&K[
M?91@Y`E:(M()3(-HVAK3B4F%G/#@0G&:`.Q&A)3A@ODLHB:MEZ/ZF-VO#H]1
M$4@5A.[Q+8:6A)EE=V,Q,[Q&YC$"4SHL/<$!I[F8G,`/19@=IA#]-Z%K6A3L
MUYY&JJLHRQB&ZK[^B`JXJ:<6XM7V971<,87EJ@!+8N>V!E=Q/;I]1)@LL@:W
M,*?96@_;'1,?L7J/981,>C\+?(C`VF%1N:/-.7N@/F%OVA2\6K\$,1K+0DDJ
MK5:N1A$PQ).\"+7II7MO&-!ZJR]^STV/TP5C3#6EY)X37CE122/T'T=;2:]&
M&6/+3NMH&A='EE=(6YA8))7ZIA7/C>H665'GT)Y;DU@,`%(G0J3M'F_%H`Q$
M6W(GR*<^.*"V7".$V!+RZ=ITNZI`EBL6(=W%Y8/F,1+XY%VT#N6M<)RT.H-(
MU+<H`E]%(]!+,,#[A:%-1,\GE&$QR:RLVN.BPLE?O+]"Y.I+J10J&BM>-.[:
MSO5,@(1O2@T^S4(W+2@:,.OI0HB#SQ*=%E"W@IPG^3FHF90U)9C5=]0]3)[)
MG]4PM&YPQC4.$KFL(@S).FR/MJ!!*U"HQVLM,\_11H!832'!<2(LPXC0@"%+
M7C_AM4*\D'.4M?F6,.YDSJY^<(G,),^-ENL[/`E$`7P5T&U2*#V!IRD0PQR;
MIQAT:6FWLU,<2/7L4;'[@:J<9:^I\FU'(8JBE3Q";EB13H%U5-C;/(BSP]U4
ML1,;62**S+[6Y2<3J="K"&@-0LZ]*G5",6EB`>40'VC$*EVF3R1U$\CLIT'!
M;49X%75:M5E(+$?&%L:8S;34^/22/M&Z84.#PF!,6Y<\*])`KE(VPC2O82]Z
MUH6QA'&6#1>57FE6Y%MYS'<K:0N5-S6Q/KC7H"HW)Y`HJ<^VWF-QY])?%#>O
M=X@@TE97/U&!,"1.2)&0<HTI+-VM>/HT^NO,#S/;>F=36\6N&6))'#3)A%V]
MMAZ,V92\H+TA:!-T5AY3T:L6K&LLIY4NA:LY"H;26!7L9(O4K8Q.V8S2"_>4
M+FZ/`=%RYKM74;!+FZ"PR:"AJ)##[:E*ET4-3PTU8^.\@;2),IB`THSG4(])
M=IR/38-&BWH.$J6:F?DUY+@%BNU82N8/C7(V-W`QNAQL97;:TJ]6OH%*S`VI
MT+Z@P,D0=#MSDW>PD6U;6P2)2'7QLJO81QFK6&Y[Z,K_`*6B+K,:^+?$J%FD
MCM&'!#(DS8F<BEC6H&46L#IG=GQN-;G5/H*A*,*G9@B!AV8`L?J#1)BLT]8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`J9T;>?/4%EU/4W?3:^+@W)*&D4'&3`I?-HB"9QJ;0A-%2)BKA[
M4]AB")3+Y"VZ(<7HI+']':T2K5%B-**.+$3+SOFT<\+_`-LK@%B5H)O,YW?:
MYD$"CLPJ'JYEG,!?29&JI^N)`NA;O$T4\4GJ'ID&C3K71$H"I3!+6F#&E-*4
MCF#5[L9U61LV><(UC/*HON02Z:U7);$=W2[_`,TQ"(W4D9I^BC$50T^YI^AD
M[3"G9FC#0QFV4T)/H)6!D7IWY.D)![3TRA/NLQ=>2J$YKSQFVA&(9!8"_`K-
M!/KVK>V)$[3&J.J3)E/Y?9<@%#$S$V3.9N\*<X]9,M-<_HG),\">0-32=LQV
M9?MXM#U%QO%(+O>7BQNNG5=+/4'D<KH:^JI=[`F#2"K;R#&%]?4\"'5DQ-LL
M-:&LJ1MTR<&HMG3M41+UJ5GI`DF'MI?O#L=*W1CU;TVMWC/O`M#Q\S0)6[P>
MM:$E20*A,SW'7L!KRKH4_5HLE$`+MM2HB)B"1MJV0M!CLU(W,QT1)P'$.>B`
M;-),A>[]NKN3B.>,/LV8Q]CL&%J;.DLHIVQXAJ.R2$=&QEJ*J-CV0BF`+,CZ
MMGC<9BQ:TIK*+:'"4D(W%V3DA^T'J"M:RIC$>2MQ\?\`"HQ/'-]AM-'NCF^Q
M2352CYP5-]+=3DH8;(3)XHJV$JF(I^CK9$(F\Z6/PEBH"W:9P=8VG2.AI:ML
M3MJ@)?EDVU(]>-*F$IQ-P3!?:DQF-NS[JY0OB5']#O9"J0VZJ6.PRU40JJ,S
M3ZJ+NA:7Z1L8GLQ>2YK@!+)3G*QEEX,92`\1_P`?O*='/VZVBU@1F+=LUL6@
M)DT9;KSMF5.L:G"6(UU'%BEGEKV]S>(-#$EM%!L"0P+2D9R0C*-^D,"$&Y@?
M+=/G#K,\3\:M4K7_`)2?(E,6=_KET@##(9$XL_1VG!PD5H)&B2%RY!:Z5:[2
M9MC)Y]5(-O$D$\$1]KV22B4N``FC)'3'-H]O5GQ+3-E0T])5\MJYIYVZ5J>3
MRG<3ARZ7NE@/CA&W:P:]L5M4F6"YR%;6=?/EC+6EY4DL#H];.+2,R$LE`C1Z
MPL7WAAI_#_#;TC:LHDEIU!*9U+0R2I94J=Y=7W68(XBD\N?7\IB?&.'&(B&N
MODD=D55C_-[F%I:&AI7$$:?%`#A>FB?*,DJRFX?'W$>V+5K::5G,&NY`0BO*
M[>IPU+'RP8Q(VN\(W](U,395]73Z;3F!?=6$6R'*6.L,CS4I'K8-O)YN"IKR
M9*KVGQ40"G8;!JO@A<?JE$;+(W#XRWUET3I:TEQX$GL)W<`-[A&C9BS-6Q=&
M+'-H?%`24BX^5I!M:HXU2@U@GE.,H[77EX@?U3:YN.9GB7P!OK61T6=5[U3O
M4;\I2Q-[1K;%DU535]FT/VJC,G^AC)CNXII,YH79K3)_JU8TQ'H9DP)Y7?5P
MR]?X>].DW+D\'F1+I6$D:8G*6=!3O:I>G,ROF-%12<+"P1N'?1W'6,#:ZV+;
ME[DRD/D3:CD@EJM04>H&J.I6[#\+\26/<C5['8_(7B-(RF.Z&Y?6S"8Q1V?R
MU5+66T(>PE/+6%KBR%\=DK(Z0:O4)R]::20F;V]LV>><06`PS"8H-YXF7!]U
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M;U6T]5HT"MX3/#P7NP(VJ3O4]+_^$A;Q:#]Z&C4!`9#Y.:3UQXG[;?/O<"9(
M@GO%OF<UI^JIY)JPZ6E##7UJVU!=T2-^1QQ,Z0-%^0W%OA)#*2^M[LS,.W!&
M62A>4CF<4<*D7]'&?S?Q?R_.^;^?9YSXRW;>EHUZ\U,1>;^"H$$:0LTHE;D_
MKB5$7Z;Z"%++"`5,SS%B)B9OU@RU*1H`C!&E[V<(7,XVU99SMXQJZY%K;IZY
M>7I1*6B@[*?8*DDUC*G:06I%93.[KCW+MD64,UPMZ2(XY`GIV9B9&K1$/)B9
MGC@33"$9"G1J3<P6]UU:039EXF#-=:0B85Z8@BDGFZSG>]D,HB5LS*`S,Q(S
M)I&-JC[*S&S!LA];J=B+`@6)$C$SN#KL!*(1ZH0`B)6[!O?WGQ4FP=G@BF!C
M::Y:TE+I&I"[T5TC%XBSIW-%62NN$0WEV@;4U-!D/(IF*II"2<I*,B)Z!(CD
M06\Y7HE13Y1-]5=6J6>$*!O/0S,EK`ZJ1/4B>K,MU[)IOIB!GO2]QDS<NEEE
M-^VF.M\NB<)5S!&W(=R-.G:8V^+'!.@;U:[ZWX#)@3RF(O)T.B(_XOZ(I>3=
M"7YS_-[WKF\44_ZY).>(#,&$ID9:C?V"=P]F;:BMZ8P4-93!F;ITF+;BTK.Q
MJW<MN-$XAT8$.C&"QRNHPZ+6K)YXW9_;R>WY[6"EOL"3R7G!UAMO3"I;,4P*
MS753%U]=T`\0FRV5H>:BD2]J;^P7Q@VATO"YH2G)Q/<$I:!&%843Y571</D*
ML.8:NH^/).0H+'8!2,S7/%C,35&6%]C*!P<9DN,<GE_-99,G1OJ%8[KMB,,`
MH))'K?\`(`.O365F;ZK.X#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`\UNW+%HR)6_SG#K=B@7)19P)4U)Y
M>OM-MK9IAD6A<JK2SWE>!*N4E*YD]%2&%,ZLIN0AVK,2HU.];T5\@1%B)>6<
M*HWQ&LM5HZZD/.O5\6KZ4S:_X6_%V4ANYS.B[99SXLIU\FMQOZYV6KZ]ALG?
M&`8XFI=CRM-ZHP*E+HDTWUR-WNSPO!MTSM#QA7LAJ:L)18]Z5/3//]=SWGQQ
MIUP_6O5R]TTVS?BMP9";)<$:H*I_:2CII'5J$#@,T3P`+NM+&,#.Y;`2MU>Z
MPT\<O'W;3M8L*GT*Z@0II[!$L?FK.YQJW8O%ZTADAT;&4G0*310DZ*KQRI.C
MV7J<I=D*E11?NV;Z:WO*F+%(Z0X<ZPY_Z@M)GICHH=6,4`NJ)/\`2;A*YU53
M?;[;+F:(W^X2=CKE0\-Z1!()=HIH31=_/"2H`SE)/IQ@1#+U@QB>B-:/M'DR
M%O228T51=^34F[:.987#JC=KA4NL`77#?L>BYZOG,RM9&]*6&N[`<8K1IJR3
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M`<4TM;6:NX:@@4.71N:R./R%ECK=(Z^E!)*>0-JXES$K,<JQ:@FGB'LTU.`X
MH6]@/-T*I<PPT\XKI>Q[6=;BDI]CBE+^F@[9(4#99<N:8C((]`PO0$,5>8FA
M<2F5?%W[[X9MY0C*V0[;)(VHT/X0>@O"F9M7C^B;EL+5KS:,N)EBDU-(*5;Y
M:S2)Z87=H@DE>4D@<$[0<V+$X&]X)>4!*A,O`'2M,86'98P^F"ZBE?)IXIN/
MK'>8(_SZ/V-+W2NG:O)%'5+[;<_5_))JWE,_FC;)GH'WL`'U^D<DLIS4ORA5
MHP3V+X-*]&:3E:"7E,9+8//.M3/TE?)>Y1S9C_(Y=`IL\+RERI.:K>ZU:R6>
M):'LDP`M-B%"0$(TGK].<+U$(.][WO#-H#,\=7.9\%W72P5JKXXH(FC8[?6V
M[.CW60Q>=12'0EUA,A>-NVG!WA3?&J\8$S<VFCVG;],J,1.@B(#O%+<W:(&W
MP\\;,[##H>UEW@B@<$CD>BL=KXB_K0#"2&6-O09(E)61_;_M*YJ'&0$$+5YZ
MCY#EQZ4G9PA:+T'"\ISZMIZBX);;.B24JECR858ZE_5MSC.W.R;:B+JS5M.+
M"EMCVRT1EXK=W1.XE<M?9>I^5N5"VSKT_L3*P"()*"$D3255'%L3E/.D!YZM
M*R[9G15?IWA&W6<US!?6]DJ4;NTRN*&(A/\``S&<U&C+@4N4,8BR?;HU!K6A
M>H_46"\;AOT,Y7JJ"3.2S1D_.)QLC3R$@J,/$UD+O!8H;+U)BR8+X)#URPUE
MA[E+%)HAN)Z(LHQ5O?Z>]X+0+7?C&Y<JR,V;'H41:;4LMA^C<FDTVW;LY46(
MB>X<U;C<37Q6:&NHGJ*G1V'^C(DVB,*^-G#I+^)?KZB9F<VGI_$5QFUNEX/\
M99K6ADDZ"<T+K8$DA]UV2POI)R4*8I:FA[@D?]&PEND21.).Z)FWZ<EP(/.`
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M3V#,4JLO37'ET91EO*@AV`9("BVQ>/U"LV=ZG!`;O],`1:+$S$5&3;[1\;G,
M=SRP<HLI#9$G2%V)%+5:(*KM6<%5I&9O%T[LG4.T9@B9V)8&8$VV\FFR,@HK
M1#X>$LQ4`8BP[T(W3&$(ODOB`X[F-E0ZY9.&[WJV:]<7=;"+$77Y9QTKC*)T
M";])&FQRV_>H(C&%`BE#.V#"-(V*4J<T@`1D@WJ4O*:F.DK#RCAKGN<5%5%)
M3-BDDKA--25#+H>*03.1NDB4/Z%G?V3:V3R54N&[RK2]')50E9:TPTI2=L!A
M@=B+!L-2)F)N%)+`\)/(^X*)LI>-O,)G3)S.+DJN7N0V/9#Y&(!5SF!U:W)_
M;XIM^,;5UC,2.5.;NV.AQ>U`Y!\!QYFR]"]"\]U_6WJ%3E9**DB:F(#F+U+V
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MEV1(%@E[?&9&A>;&7H)3!&U4+W)8ZY%*V)-K6@E)`!UK6B6RM2\74?1XYZVU
MPDF31`;&A#7!Y!53C/I7)H$4F;C)*2>]LQ$G<WB2,[VYQZ0$LIGP.042=E9V
MY(D3IBTH?<+END.Y=H*OI*YS"%5HR1J2/<R:;">'1J4.Z<QUFS'7RRJFV2N)
M.G':58ZDU\O,;!F&%B^<G81&Z&:``PBYE(SG7,+>7]VE#FQDJGY\A)U<NKB)
M4O+,5PL]:K<36,11*LM.62-8O-'\H`!4:V/TT9Z:UK1&J(*!J%L:)DQ(H8E*
M;+`A,>K>7$#<GQ0:[0.)Q]?%XW%/K%+F:M0,S,RNRP!!*4PG035B@_\`]N>:
M:,,LS4_7<=<'UV8F$UJ=9._QV2R%R0ODB3KWASB20A!'"W!8!VTH4,S2@3`(
M*;1"^W?!ZE[(V`0@["2\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#S!ZN@]\_KO=+!@=G=4
M-%=,]&%#?X;41Z!UC.CE,QTT3)YA<-)KJ2/\JNEI@WO6,3>G6"$:L]HPICM^
MA8BQE3&ZE'243Y(9K7K]!TA;CE3]GBF4%KF<QP<4Z6Z5IL+$Y1,F%6Y&YI&(
M<Y1F3&266'NX0J&UI6;1L"$TTHL1II0BX74TAT$2ZA7R]DJZ3W-VV&REL8"S
M*)##8JICU'BI9\)6NCS.UMI"J5[@;'U1%0.1J)&B&Y"4#5H4N@-IQ!AA^#*+
MPS8V`6%=W/M^\X.?0EB])**/9>!82ZVA)K';+.=(L=T)-+$4-#R7/5\*YV45
M8.PT:Y\;D12-VED;<T*/9>TS6N+^<\HN$[<*NV3Z"DWD<03?I:'U+NP3V"SY
M<C449-D-?%.#;04;I"*1Z=3Q$8H,2?+*M]-".41B.C++4;;7;0S=^X`1>PF"
MN;U97E2M1JMM.UU+TY5Y]AWK35S46YR!?$("W,E`$/VF>5TR>9!6"X)K`W@$
M0:RWAW13%E9G=<O5F)=`2[%KV1?C&DX+H<VS7L9[AU[+[F)N0F8N4#MF0<OZ
M/K)7&6QPA90U0XP.QF18V`/B'0::3*RM)F!T,1@,834ND?UQA#H)'4FL*5;H
MR\NZ(M1QC--8_P!2R2Q9A7%]L%4OKA2%XS4T%HJI<VN-<&3MUFU"T](H,-AC
M9*M.0XRYBCL;.,&`M(N7%^U1L;HB\,D^M#Y=8E<0;W:9=UAYPW=;Z7')X74,
MUUT:[A3P:C%4/9[-CI=4&V"T5"OL9QGR98X+8NV)?I4:79RPA,!(H6D1XX3O
MM!LJ6U5ER'=4(ILW3?;Q3;31E63E\43^D&ZTB4;)%7EZ@E460[0.ZGC1Q93F
MI<VLA`%C&`X.PH0N#DA+AT<O4TR[G:.K;J(JDF_#ZW_HO/A,):HK%[*<HRDF
M+A%(X-!(8^K:J-?ZT52]BDVG+Y]@EJB7_I!`AC"XL!9AI8JO.W;KNX[[=J`E
MU>337;+2ZI':)2F16-'Z&Z-<;6:J!5Q*--#PIIV63OFF`/,WM\NSBCOJ&$^)
MDRPAG-5K`L^R0$#&2L<*5VLJQ_*A7EHT6^5/&>FKBJ%/9E.3MXC4AA06J53+
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MIEBA<&FZYI%%8U.N;J]L$<>':0&%*8:QQ%[;2D)AA:-P6H?F<2J35X,OS`O[
MO*Z,=7B\C;7W6TNYPKANCJ!Q;U2QC07,R5N!UFNG:)((2G8:Y6K''8#1.PI*
MX`='40V[25,8'>M$FJ0=RKT5VA5<402._P"`=;VJ4.0WX2B84M+WI,']\EBJ
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MR874DRZ*6V\[]%LZ6IK,GX)U3BQ)%I/:<(V\1^`;>Z!6R:!U_`(7]8B->6N/
M3-L4(_>O2KE)QBE.BI%7$SDU"PICV/"7NX5S:LZM>95$V"Y_N$<8*MD$ZJX-
M<1JKW533C]3[LT0#_P#,:VY#/TZ,HY*UG+WY=L8]*&=($>_C&$]T@3/H.UK'
M%:[''FCM>$PT%U5/)ULE8.6;LB4Y9>:IE1+.X+0529*ZHVL?)DVVVF$2]LS>
M@=I(R[-.*5H2`B]Q0JM%1"YEY9FE(_-B,B]'I.U'OJAK?'2MFH;N_`[*=A4C
MS6223I$F`F0<3A:M6#9.M@VJ0IE@1+"R@C,*)+6WQXZO3[FI;:;=>/0$;ETL
MO>7QHRUW]:P/ME5W,6N$%MNF1*)/!JZ6/L`@[:R1J'FBT$EW;EDG9Y0+>S2G
M`E5\R,DST7_PA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?D00CUL(PA$'?IZA%K0M;]-^NO76
M_76_3>L#]8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8%/KH[IYYH236Y#;$D#VCE-+\X2/JB5LC9''!T6KZHBZP;:XF1;2</
MQ2&5'NOQI$K22+2M4H/+"6$7NWO2UB)GNA"4>5CFZ%D6(NE,9NID:*\M!%46
MWE;`V\*"9RQ9*5D/$9!P@DXU[FS)'I`<`:I40B";H&_@T:+]'!QEMED^2WG*
MJPNILG06T<F3.*Y%&U;)6;T[D6*CC4-E$_LF05[],9\T@8*@B<+=5,H/$`@3
M8)$,G0#3Q`+&(B9P2A`>PH38%HV=5J2M[QCAU9P<NR`3R7UR:RUG8D+//^!&
M]UE+=.BHN2E+O38R2S24APR@B%[/0.\$Q6B'J[\G_-=BQ^*RQ.DLN)Q:60E\
MFI$AG$4;F%J9PLB=,XBC+\I#(ENT,G<6-Q1KTY8-&I-)UI`3E!1XMDA$[9A_
M7SR65+%6J&R.5T]TW'(C.*FL6WVJ:+:G(6Q)*R5A`IE94BCSL^,<G=TB&8J8
ME!U9R%'ZC*5&FIR0G:-."'!7HD6L.ZJ?M68Q^$,\?M)A=WA4\Q]V43"$B86N
M"V,QN*QO55%.EPW-0%BL\\*$Q20VA">$Y+K1@3?Q],$Q2Y^$,!@,!@,!@,"A
M"CR.<]GH&!SB:2QK"12&Q_U1DJ87$B%:5NLA(I5ER"'NZYX>61`B?(BC0G*W
M0CY1&)TY>_;H9FPE[+QEB$GDRY^/FS%"%4=MUI/D=ZVQ0#9('*%MX(V.4TTN
M86>72$Y4DDBMQ(A1S](B$*%6)+I2I/T,7TP"0_+LO&:M(!?<U3(KCF--3>+V
MI5"V'2=IBAEAVM$D4(J.0N#_`!J42MA4Q>P'-^^V.;<]-4+=-)31A)V:H2")
MT'Y-@"(E86_M9]UTM<-N16GJY;K#DSK*JT:;9+ER*)A_5VRQ&1,B=_C9CU+!
MN84X'*0(5&OI4Z4M4+8M?I[`'81"%35M!WY**25O-F1F,0&^IY+:PF1$07Q"
M"UL5))1)T^ETE:WF9PYE22#2QT@\5<XDM3N:T\*4Q.:$K023-'D;,'%@I+Y2
M^?F5UMEKCT'OZT`TXQM,FDKE5E8AE[<Y,"Y_11IX=8X,F0)53BDACHNUIWV:
M2G$046885HX`!;PL;9G1*IO>%,D.+$VGL5JE"6KT[?+E8H"LV@J8Q=9,GJ!J
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MX-<$*I-W3SI3+9M.I'7J98UQ?2J/L;]&8O6LL6CD#@8XIU*=`I;K89P)S$Q"
MH0SC#="`$!(QZ%3,6C*S_)M0-53>W:^=HK<S](:<-AB1[#%80VKV^1.DVGL/
MKA"SQ%>X2=J(7.#7)9VW:6Z5[1%%IS!FEC-"6/T+&V92VK[*KT@FREJ6"W*[
MM%=N*J-HWQH@!BQKM&?MKVNBSQ650F_<RU$XGS-+&E8U*4199)85J,X(31@!
M[]DI#;[Y0>?(V],T9=XE>*:3+ZYF]A/L:W6^MR"!'P*%3>P':O9VS_?=.#)9
M2V.5\Y#1MP"SRCC-$`$>#:DCWEX]DNPOM"`39SJZ.):\NU@FEENCBUKH'+*]
M^P2^J1MR/;A]5;[4I>!`B"-P0[`<DV6:L&H*,",`-@W[M$I<#"&`P&`P*EVQ
MTC:E<3=?$HMPUU5>#*C1-BLBQJL?.1T,+<SEZ?YU+<A36UU/5LY`M9S/YI3M
M0RD$;,_]B8<#]/#41%9Q[LC370=F6C+CXU+^+^FN?VHEC7.X)U;[SRPX112M
M2+&U*3&R"*8Z8MZ7Z>W$E<8H)$8U`0:)2':-4EF;)+.),1'6)[HP6]AWBD7+
MTA/C+[D<2$:]:C(<D<EX'"B<R$BHU.2YH0K>X4:X*%Q*+T<3H\D@_10PZ,*+
M'[@!+QC6/?[)7C%^V0_U1.K&<N.NDH;*8@L,2LE(25XY@.M*RB0)&I2%PA"Z
M+](22IDR,TUQ-(#I^E+(=\J(_>R]%[(&<2HNKCW0_P#TRKU_\,#NW_\`$_C^
M_P!^K"\8UCW^R7S;]LDNE$]K!XYZ3.F1[]MG,YW*>.7]7(D0Z>CVK4G4.)O2
M)5);8A(R0N&@%S(QP^C,#KZ7ZGW)PDJ+JX]T.F]FWN6688'Q>=X'"``8PDER
MCQ]:,-$$.]Z++V;W:65H8]Z]->X00^N_QWK7XX7C&L>_V3+<-]V/6*F*)XEQ
M[TA?94C9#W9T65(\<Q($T(6E&)``CDI#<?1U2JCWI2%2,8!-);HAT$@?N4!W
MLO0R1$3UB$6-77UWN+JTMRKQI=OLJ5R=6QN5/;I)>#!M;&E7KDZ12]NH&KMQ
MS=AM;.0<)2I"D2JE8B"A:)(.-]A8BU&L>_V2%<'1-H5E,]Q:)<3]0WTSZ9FY
MTU8-2/7**"'B6+CEQ2B/Z3W'T_4LT^[M($@#%`ML^D6P*2_A4&BT:$LD1$]8
MCNXJBZ-M*RYJGBDKXAZEHEF.:W)P,L2UWODQ=#4JE!]/],RGIZ@ZCM:;[<W?
MYQ?3"+9C$NOB'\QQ/Z'O$Q$=8]_LT9[Z[NQI>WMI1^-CMN1(FEY=FI%(V62<
M(ELLB1MK@I1)9`REOG;#,^%L[XG("J2A7(D2T*<X&CTY!WO*`6HUCW^R3(3?
MMDRRN[&F[SQSTG74@@Q!YT>JB:/'+ZBP+:&4U?<0)J]5P?I&9URD/4*O^I`W
M))!'B]*OQ$()'\]A*B\X]T0?TRKU_P##`[M__$_C^_WZL+QC6/?[)A1WY9"J
MEG2U3N.^D6^8M[X!H2\\K'CF$5R/2(3NWMNY(V."+I!928&0M(M,7["KF*5?
M](E-UI-M1LD@TE1=7"'#.S+V``8P^+WN\T00"%HL$G\?>AF;#K>]`!LSNP`-
M"'O7IKW"UKU_EWK"\8UCW^R9K5OJQJ[:X"X1?C_HZ[%,R9E#J^LU7N_,B)RK
M!82G9CRX_.AVOT96#6J>%1CH<46*/J7U%HQO4>]0`&TPU!(B)ZPB%/V+>1ZE
M,09XQ^YTA9ZE.08K42;@3:=&6><`HQ8ITG[E/4[3)`#V89HHLPW8`[]@!B]`
M[+QC6/?[-ULSINVH%.7Z(QS@OK6X65G,0`0V16[]QTCA,F"L:D#B>:Q)K.ZS
MKB=%%MBI8-$?]P94(MJDQNRM&D;*/-%1K'O]G9JKI2UK$G#5$I1PMU;2;*XI
MW,Y59%H/G(:V%,IB!`<L3)7--5'5=GSH:AX/*"F3;2,JHO1Y@=G")*]QH1,1
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M_,>NTNE)*BZN$-[[*O7_`,+_`+MW_P"K4G\?OX_^K\>ZM:PO&-8]_LF6Q[YL
M:"Q"MY+'N0.CK;=ITTEN4B@E=N_,J265&J&U-;B)CL0^R>C*\AZMT*5.!J$0
MHT[2))]4B.WH_9&R#SB1$:PAG?9=[:UO>O%_W=OTUO?IJ3^/WUWZ?^C7KW5K
M7KO_`->\+QC6/?[)#M+I6UZ]FCA%8SPGU?=#.B1M2HBPZR?>044-=#G%`2L5
M($">U.K:SFP5;(>;M,JVH9DY(CRQ;(,/*]IHA$16<>_V=>M.G+:GDY8(C(^"
M>MJ@97DU<6OLBQW[CE9"HN%(U+W$@]^35EUI8TZ-*<E2,"(C[>RKQZ5*2MFA
M+(T:>428C6/?[,;-NJKCB<PDL89O'EV/8K2PNZEL;9[#)#Q.GB,P2$:!\;['
M")QV+#)B2TJ_=OXPN;2W+->W?O(!^'J6HUCW^S?*IOJQ[%;IZNE''W1])*(<
MRIW5C:;1>.8UKA9JP\AX.,CT&%4_1MH-R9Y2C:R2S!/ZAC0[&O3^Q0,.E`DY
M)B-80R7V9>XRP#%XO.[RA#`$0BC)/X^]C+V+6M[+'LONPPO8P;WZ;]HA:]?Y
M-[UA>,:Q[_9,44OVR9'5D^L-TXYZ2A$GAJ@XEBI:4O',!]G6>`M`WK`*H*MB
M?2,HJI*0>>M,2@_,$G8C/G2F[$$)6R3325%YQ[H?_IE7K_X8'=O_`.)_']_O
MU87C&L>_V3!-;]LF*5S7,X9N.>D[$D,X)(,D-30UXY?3V%4PSFH3B,BPE<VZ
M1AM;JS4RH.D0_P`MR&0`VJWK81"(]3M$J+SCW0X;V;>Y91A@?%YW@<(`!C"2
M7*/'UHPT00[WHLO9O=I16ACWKTU[A!#Z[_'>M?CA>,:Q[_9(=F=+6O`I(G8H
MYPCUA<#<?'6-[,EU</O("..I'!W).-6Q1039W5U<R7<@C8RM%K1EMQC<(9@?
MI52D/N$$1$:Q[_9C8%U+<$QFD:BK[X^NPJQ9GYQVA<;#G4@XL4PZ()])%*C[
MM(T\`Z_G,V.;]FD!(]&QG<5/RG`W\7QZ&,`J-8]_LY+"ZBMZ%3:21-@\?_7U
MJ,S$M)2-UBP%_P",$L,EI)J!&L&XQU/8G7D"G!*).>J&E'IR9FX_YTYFPEB*
MV6:8(B-8]_LW&G;[L>SUDJ32[CWI"@B8\R$.S6OMUXYC7I)JM--5%CCL8#37
M1UMK"'E.%.$8Q.I+8AV$X'M4"%H80$F(CK'NADKLV]S"RQB\7G>!(A@`,11D
MG\?>S"A"#K>RS-E=VF%[&#>_3?M$(/KK\-[U^.%XQK'O]DQP2_;(F$!LB9/G
M'725:/L%1G*H[6$X>.8%,[MPXII.<@-]=JH%TA-Z_2+%"HK2$&Y*^QXG2HP.
MQ&!(]QX25%U<>Z'_`.F5>O\`X8'=O_XG\?W^_5A>,:Q[_9"/4U%Q"]X3#;PG
M'''8<PG\U<HNG?Z2KF=<NQVTZZ31:,V>VLJF<N4AO]BJ]>Q(54J$I,2,TN?0
MFNPFL\2<9:=1LL935PIG,N<R)T]S"62GQX^3IXE<K?6=X&^B5>'8IQ;VI@E*
MJ7M</*)!>)+3*&I&YJQ:2+Y(0]2%NW_/HW-,K$-2*+A'6/=-?1W,K.ZKFIO2
M\I^2B?M[W&BYC'E=+7!QHP(J$,M"'3>!W/3#4LL[H6%R0]XGL>EKA^<3S=R=
M&<M7DK6=Y+6D`/3TC6X]_LE")-!,UG;:URKQR]]PU-+K$K=Z5V#+;>Y.;(I7
MXJ^CPH;"ULB1U)VTYRF25_#V(X?U#0<SR0*_8Q#4(EH]^F#+K'O]D;VSS7"8
M1-FFNHQP1V5;-2U121%'5ZFJ`KQO1^D!,T@:6]UD4HCR2PK;JRY%4D6/)H-/
M:-Z(+C+D\-WU`FE47[%!PSC./=(?,/.\??FMPK!]Y>[2Y^;F+FNQ*08K'NZ0
M\5'L0X_:,@85<P*B<$YWM"S8,UV(O4M21848?"T<>3ID`RBR@_.>G5$GUB<?
M-7&C:-:.?)I54PAWC;\ID@,IIAF+?%F>>W5P+,6AWFD]E+I*Y?<\V6.?:@97
M.K<>U[N>4!T=7%02A1BT2D3)M:PLXYS'O]GKQ6=\6-/8Q8S_`"3D'HVGG*#M
M`7*/0ZR'?F99);95B;GE=MBKTZL>B['BZ1V`H:R4FQ21RCR/ZAP3[T?LG2@U
M.9J-80QKLN]MZUO?B_[N#O>M;V'<G\?OKKUU_)OT[KWKUU_ZM[UA>,:Q[_9,
MSQ?-C-E,QJTDG('1S],'YX$V.7/K2[\R%W!#TFECVET_R-P>.C&FECF@1+22
MHT%LF#BL^%Q3:V1\FE):<E1=7"&P]DWKL0=;\8/=@="$$.Q"D_C_`/:'6]ZU
ML0O;W2(7M#K?KOTUO?I_)K>\+QC6/?[)BNN^K'JF1-+'#>/ND.B&]Q9-.JJ6
M4T\<QMT>9%FURI'N.NA5W='4W(QO.B$X5/N2-ZI#\!P-?4?+H98"1$3UB$<1
MGK2Z'^21YB<O''VG#FY[?6AH<)=))'PT='(HA<W!.B5R60$QCM"224UC84YX
ME2L+<W."\2<H>DZ8\[V%#+4:Q[_9M=L=(VI7$W<(E%N&NJKO942-L5)['JQ\
MY&0PMU.7I=*%+>@36UU15LY`L9S=_"IVH92"=FZ]23#@?IX2(B8SCW^S)4ST
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MM:6$L"50)`U64G3*48B]*&@P\.TQ9.N<>N*)'R.O!;$O#6GC7\DU%SYQF$MF
M[W<M)27Q<QJYI4?-7A>]RB.R66O_`%7(D,C9'@2LM*'Z]*:L2)D:72=40-.`
MW1<.LQ/?[)4M#F>K:2>G-757#'4-I+;OK:51NS7^@'_DN/&-[(^O[:_%0JP%
MEQ7G4[N]O+*[>]0S'HPO2=O)">1I6$D821DC'.8]VB*XP^3&<MJQ1P%Y-(0U
M2N:)%5B(T]E^/4F"RM`X75*+E0;L-*DZUD4M#$X#/K!='0`8[M*[&H][3C^O
MT$H@0J-8]_LV2T>=:_J&?6^P0OA3LN_6>\*#_5%9,TK";\C:K61Q^32"3/+^
ME_*]V]%5:\$6$(QRV6[.'Y>"C<4@TA9ABP2?^9+&/6/=FJUJ!HM>WD+8Z\6]
MJ<K5EII0O1L6D,EXD:N9RI/`H2VUQ"#OR52MZVQ8C6^((646B;4+:D(C&RD>
M]K4_N]NS"3K<3/U8J.)3:BI"Q>/X7XQ>ZG:@'(B9U^TL[0_^.XB'(84Z-((@
MX!K9I7=<1PYIB4J$D42`@ET:P+=+WA0:H))$/Z4@5&=Q?U^SMHZ\76R\6U+9
MOR!Y`H7$&6"&RQ#S=,IKPB=6=MV@45]$0_U^UPJ_)@ZH[RT!(4>4JD4D8(KH
M[V'"WH[0MZ&$81,>Z'"8`O/45C))3XYO)M/[6J63/TUB5Y32:>,1PMDF8R51
M"TSS)QO2#JMK9$+PMA<$11@PQ`W(@F1\1I`PB/'I2$OUBOK]F\7+Q]6M^5/:
M%\/7'G7<`NB>SAHW*ZRCQW!;MT#.&QEM.MYHQJ%_ZP;`L[F24P.//L)1N2)+
M(GU0XHFTA80G)`8HTF.$34U<5]6//W9Y;98;4BX:\KR-FF#POFL99&^PO%Z$
MJH+-<WMRE;O9M0JEG4IK@RS-XE3RM7C`Z*G5G)-6&%$HB4OM(`*B\X]_LRM[
M\?U\S,<*?R>5>UN@[=GM>OZ&4W76\IXN0WY7KN_5_+J_DQ\^E-I6C5<4-F<T
MC-OKTJPB-I'F+G*(\C.$07M"@,.)$^<1'U8M"W6*I>Z9<';B3RI.#E6UHMUF
MO<AD$Z\7RI3:4K2(T[`Q.]MKF_I?[J)IAK,6`HA/%@L(AHB?@-+5`_F1%PUC
MW^SW`PP8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`\3?(?<O8]2=04[
M&Z3Z59:]K6Q*(ZELMQA#K1\%FAZ5^YKK!).41*:7/:HITTWS):OT4M#L.Q)"
MBO4G?J+\#>VIB;C&'GU'?,+V58<WY9CL$801A=9U*<7+7QCOZFUU2M4_MJXN
M>.^YO,Y3'GIU,(6IZ-F=ATC$OHGY#H21,B:G+288@#-%J-3LB+F?/_,+*)O(
M#T;%/&KWK9[W;!LC[+Y687`Z5(Y%3D);(O5,O>F<+Q'&Z)"A*U5"[HA8$(]J
M&UR`H$8M+"$"GVF;WK*S$1.Z/_695U9/)OY$H;T[4]660D//*+K]<[N5:3.A
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M)E:U"PPU#&VB`Z4.ZMO$8O1"DB+9(-@!O#,1A>;R0K;S=73;/)?E#LMCG-8(
M+7IJ/O%V<M1YNB.G*65_23F_$0UO;[-B"[X$DIE42E`1!*,]=$NQ1Y8O7TR7
MW;X5NBXPEV&KR5=NO`Y-)U?257PQOH+E.77@97$OIN)MDLZ?E<-[2ZNY_;Z_
ME[:<O!):8M260REF9$X1QG*-.8Y<I.2F:T$(_0<=NF<_9>/K/M/LALM"/0&@
MDL8AQTHX/BG1;S'I2UQ@Z7PMZ=^E*"A$_=H^?,E:"/R&906JIR_`:8ZM&!*\
MOH$Q(M^\0`BK,1MJYU_TW&\_(/(:1Y+X>[C9YJY63SG-6R.H[V>'6KDL0E4M
M06I6AAU;V0MC8=A65J:CL5O((6-24(@:.>BR!?H%:W@C;<SMREY7P'S>='?G
M3H>MIQ8]7_F*.<%=#2NLTBJ#MS7+6/L:IJ-6=3(@.[>E,_+C]#DM>2)7&S4`
M#A#^\5VMV;H(UAFM2VN$83TN%G^PO))TVPROE.&TM=U9UXS]`TMRN\RBRQP>
M)3]!#9?:W2,>JZ?R1(6\N!;(,E''URA,%"I,"0E5:]^]^\/IEZIMVQC,QE:S
M(N]+\B?#'4]EJ7*#V/8W.W33!S!&+]3,(FJM+,89/-*1B:OH3<;91*6].@KP
M-O+R71(C,&VB>(LJ+T9I-O8M$C;$[HC52B^_*=V!RW8;%7`IE$NCH14%HR55
M<E^,5;L387;5(M'+]IWO89\5C<14JV9!->?B8,%0N3M!AVW/W$I]AT(T61=N
MV-WK^:;]1GD?["L[F*];8+G-:/UI<[4WP3U"HKH$:BD?4VO6LZX7HWH3I>$I
MOJW`(X]^:93.'=6TNY01::#/IT>M[)_'!NVQ$QI,S_FDC]0=R]F<Y^.R'=Z2
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MV'5L<AQ$O<V6UKM9M],(^@:G#7\99HK#K$CT%X[?X%&JTL.$*EZ.Q*9KI/T`
MLD!DF3C,5N[.,1*GV'I-Y%XQ.673W^S*N?E+Z*JJRJPKANOA-T\YPOH1*?UR
MI=.:TE0M+;SZ5S3=]_2\5#N;6H&18S2U1.J')U978@1BU8<SZ1J0Z^JWBSC$
MQ=5%?[:9P]Y4^PK]?;9?K!M%6H35YP?`KRC,)C'-[`&KG^>RKEJ.6JO?Y[<1
M*HQRASR*8N@SFN.%AT2N2B]FA^T&M;J[MD1&&O\`M<GC[R16NS4=T'->F+%A
M%_H:+X7YB[,4V;"(RT5^J,EO0$"LN2N_.KVR,!RJ)$R1D=X$@+9AIC!+%)#\
M2%6'1OLULS.V+J-:5(KCS!=96%X^878\%D],6SUZS=STA14Y9HA'OHX[)*\N
M28:>8@P'L:\1)D0F,AK<[214/7\XB7DB&7K>Q:UD:G9\JRBI:M77EEZQNZ*G
M7Y$.D:S@U>Q/E&S.KXM5\MIR-)G'HHE)WYV125=52)<X+2IA#W]VIZGXPU%!
M;2C%HG\W9IX0_,;K0G9$8=;_`-0N1W;Y!.G:?L!BD->3N!4_&X+XW9OW$_TK
M94+;GQ9<UD1N9UHT-M!'R<9I4JBZQU32U2VDC92C%HG,9.]AT#0LJ;=L3%=;
MI7QD\O%U]`6[Y&:NK&\JMJH-<5K8E@<A$D0AFG<Z(6<KHG9)=Z>2MCV,E@FT
M'L[Z%"\LKH29LQ(D<1$@V(1.O4<*B)F/$M66^1'N6&ORIKD71SI)5C)XAF+N
M9`7'^3H,LA3[;\WI/IZQBT=ES5O6!#64-C#C7#*!H+`'8GH],)*:/W*1BPO'
M;_\`ZIZ8<`]871*K174E>%UP3HQ&MYYIV^$-XQ6)QBN4D4FEKK0-HN>Y&SQA
M8JC2J4D:WIP:]DF[7*$`]?,#Y,C&ZNF#V*RLF`P&`P/)/ICE2TK-ZHGMDP&I
MVQMDSSSU#X'6O5IE@MK:[5FN;3;N-G<!30LE6&2')9TCE+4C,6%DB3`TJ^?8
MM&(@8:O"O-4!J\<=WDTK"W6%T+74`Z9:Z/L"AF>8R.21*)KJR7658C"SNMKM
MZBC'4]CT>QUDJ=EJ<ULW][4C]"S-A5&[PLSCCDG*!<J].M+)3T?O.CJ]M]VK
M*D7^BJW?X3:IR.)T4IB#G:;'#;,8$MA+BI>[+;(J9UB+6XJ@_.]EKF8X:GU*
MT2/9)KHD%@YK[I@=!=&PPFUFNW;DMJM:5K&N9])`,M6H:X0+"'V%SI2-/78]
M'G;IF.RHYV2.I'H]OQR0!8=[.`3O!\;TA4L/!'D%05PV(6USKAIL.(\^-G'R
MA!'+,F*FM9W1K7;4H>HK+6@V3GFRUHMBOX4K2*$[@Y;V:X+E"@D\P100;R+R
MC+HM)S_R-:##SKU;7A=,-/.AMN4$=4[77R6?,$Z2S*X],5N-4VZ)6JV1<JC[
M2.VQS=GV8G/,+<#--6_KP@T$G*DSC>:GD/\`&1>X`S>K[3J>*6'%S.3'.CHE
M/C%U8-T5-E4<9OC9W!G:$[J"R:H89<^""H2,3-H3.D$5LU:/Y-ZUDI>76,,5
MI;IXYNZ4,E@\PU37""`46JG-963!+'1S>-JHJTQ:/UE`*C>:-(JAP6[?U)*!
M$TN+GOZT6F-Q3``E,%[SS-ZJ7C<YHUH;Q_\`6]%R:IAL;U&#XLVOG+%?7*S?
MFE2A8'BM^>K!LBPF^SJPC28\]-$9*';JVLRMD&+296U."P(=B$E2X6=T3"=+
M$X!G;:Y7RZ<L+HYS3+[<Z9@=ICLR-1Z-S=P519MJ8QMF1KG#)PK,C:Q2]V&N
M6&"3F:!Z#5"5@U[M!]"1,?\`EC#\4GS)?=>]`4-*I=6J69!CQ;VCE]N/,YBC
MFVPAB-YSJF%*M12)J%OYG;9E+K+AAX336LH2`;:8?M5O\4V$O!%L@\>5FQV<
MVK:2B)I^@&&VNG+DLV4<]?F6-5Q'U+'+"CT583-P=CUQ39,Y5!E91"X"AT&6
MN1$#&0E+WL`?6+ROLT]N\8ENO#U>!5V-$-N9AO"(\SH78IR<DR31$KHB+\Z1
M:9NTI?!+R)3/@6,D9I1ML$KT68SA2*]"]=O/KE7EA%83"0(=P_=$)D=2-#?5
MC()'"B::00:R4-H`2ET%"*\LETD%GUXTL!ZT3TY([@A)X6WT0!-3FZ-]BX00
M`R),WBY*9XM[#KNB[,I)_DC=(6./\P\_4W1#@HL%U-ECDU0]4HE,_KJ<OHS!
M>P]I&[+(FV/01;^X,A*4Y4+Y=G>E-TQ./69:0_<-=8_1[GU(QEDI%X0PZ^X'
M#:%=;1V[PF.59>KES4S/];N*J/JE+,E=V<%=R"9,BYN$-.B>BTR88PE+EF")
MBJE,O-W(5NDS&D9%:M=.=>?JU&T1ZXDJJS8U.&*_WREHNSD<^7PG3L"T;BR/
MD7=D0T91"S0%VV\)9*H`RRP[V)E['X9,!@,!@:K,IU":Y85,JL*8Q6"1A$,H
MM9(YE(6B+L*0P_>PDEJ7A[5H6\@9PM;T'0C-;%O^3`KQ_3TX=W^/],;ES]OE
M6:__`+;E7KK"UNTGL_O]//A[]\;EO]OM5_ZU8*W:3V/Z>?#W[XW+?[?:K_UJ
MP5NTGL?T\^'OWQN6_P!OM5_ZU8*W:3V/Z>?#W[XW+?[?:K_UJP5NTGL?T\^'
MOWQN6_V^U7_K5@K=I/8_IY\/?OC<M_M]JO\`UJP5NTGL?T\^'OWQN6_V^U7_
M`*U8*W:3V/Z>?#W[XW+?[?:K_P!:L%;M)[']//A[]\;EO]OM5_ZU8*W:3V/Z
M>?#W[XW+?[?:K_UJP5NTGL?T\^'OWQN6_P!OM5_ZU8*W:3V/Z>?#W[XW+?[?
M:K_UJP5NTGL?T\^'OWQN6_V^U7_K5@K=I/8_IY\/?OC<M_M]JO\`UJP5NTGL
M?T\^'OWQN6_V^U7_`*U8*W:3V/Z>?#W[XW+?[?:K_P!:L%;M)[']//A[]\;E
MO]OM5_ZU8*W:3V/Z>?#W[XW+?[?:K_UJP5NTGL?T\^'OWQN6_P!OM5_ZU8*W
M:3V/Z>?#W[XW+?[?:K_UJP5NTGLU*0]:^..7.#6[2OI'BZ3NK&@D34R.<AMJ
MDWIP9VN7MY;3+&UK6N3\I4MZ"4-104SB22(!:U.'19VA@UK6"MVD]I:8IN_Q
M0K!,XU=K>/Q4..Q^/Q./B4S+G@\3%%HDQRZ,16-,XC7`6VR/QF-6`_-S>C(]
MB9$A>UY!(`%+%`#"_+2?=UXQ<GB6A-;O=.0RS/'I$:ADQCF=)*KC$LYS8*WD
M!SV((WDU[@[4M21AU,=Q@UM4(]*9M1O6MC]WI@^=WC?U;6[]/^,Z0R(,O?[_
M`.'WR6`'%S0RAWLVBG*1!-@ZM_7PHP+VM>3G+0X>NE;H<U[^7U;S7)4,CXQ*
M#MC)6[2>TM-0VSXC6Q+,T+;8GCL;T5CRQBGMA(T,FYO2)9Y.8N\IY%&9G,TY
M"LLF42R.R!(4O0N*[1ZQ(L*`<48`P.A:+\_/W;2/I/QAF+CW0R].%C'-5.6^
MT%+B.QJ&$N466THOMK58AZL3OM0=.6QNW\"=W$+;@23^@`W0?PPE;HZ3VEAK
M=N_Q0]`M[6T7S:WC\NUJ8U)RUE;+=F7/%DM[.L4E?`H5M:*9.#TF;U*@C]`9
MA00"&#\-[WK"Q&Z,HGW=M[Z`\6,F+**D=R<$2`HB#CK$DI[G?/SJ636QAZ12
M97I0%[F>$N#C4H"#-M.M:0;&26+XO4`=Z)6[2?=J3K8'AU?)NTV:]R_QM/%D
M,#LO?F*P75XYE<)NROCJ^.LG<WIIE:LXY^;G9QDCZN<#U)*@!QRY8>>,6S33
M!B+\\L:^K9[*O?Q47.4K)N&W>`K7)7LA,97$V5-N>YT4MCB>1M$P3Q]67*'%
MT`I9");'T#H!(/0B`N*%.IT'1Q)8PB.<97[MG?>K?&Y*(@"OI-T7Q3(H$6G:
MTA<(?;5I!WB`$K&<E4,J8$:<'Q0S!3LYZ(D:4&B?:G&2#9>@[`'>B5NTGM+4
MEMW>*!RB:*!.-K>/Q?!6UZD<E;H6MF7.ZJ)H)%,4<D;I<_HHX>X&,Z5ZE3?,
MG<AR5`)">N)=5@#A#"I.T,M;M)]V@!=_"<"(#KT*SQ>A@(R-I1P</]%740&E
M%(]S`28<:T'3*(@4N%MUV#9'MVX[^I]/F_3P?//Y7]4ULG5?C9C,%(J^-]$\
M3Q^M$S(IC*:NV2U*/:H*GC:P@Y*KCY$20/A#`4R*DR@PLQ(%/H@8#!!$#>A;
MULE;M)[2TI@N+Q*Q2-QR&Q:R_'G&HA#OS/\`E&*L$KYS9XW%OSJS+H[,ORXQ
MMRU,V,?YMC[HI0.?TI17UZ-0:2?\A9@P[+\_/W8=NL#PZL\D_.31+_&TUR_\
MA$U7^:FYXYE0R3]5Z>.-\/3UO]\3'%.GY"(B32E:P,_R_;PMR8I-HG1)8`:'
MS_\`KW22^=3>-23P$VJ9+T)Q'(:N/9$,:/K9\M&C7:`G1QL+3%-K`;#E[THC
MQC(WE(B0D)=IMD%!*!H(=:"'T)6Z[J;^K$H.A_%PU-Z1I:[KX-;6IOG>K20-
MB"P*!1MZ*S0J35H;&2(T[H6F33O2PX9NG<`0N'RC$+Y?=O>\+\M)]VHZL?P]
MAFT=LL,T\;^K'B"EV61*P-/?-&IM%U;\]2.2/BJ.RO2C[ZR*7F13!W7JQICR
MA*%KHL/,V(U2<(8^>6-?5M\;Z)\7,-6IW.'W9P=%'))#0URE<(W8%!,2U-7H
M'$UW!!$ZMK=4IY,-`['C5::PBTATH&(SXO?O8L%;ISB?=@X1</B4K-M8&:M[
M*\>5?-$4!+"HLU0B5<Y11MC1<]*0$SHM@0L*U`E9@30EJ2@=M)PEZ<0IBM*/
MDT6#T$\YSOW8^#V7X?ZR^/=;3CQQ5[LE]<Y25^1W[FJ)_%)GIA>HL\R(O["I
M0>Q]=HQ)7%N5+->B@]`X*4XQB*/-`(3SG._=TV>=^'"/2E#.6"5>-=CFK9$B
MX`VS!G=>8VR4M\$*9BHZ5"D,@1&D.R2)%Q\@"`+:6<%'I&`).B_CUH.*/G.O
MNS,=M[Q(P^NCZ?B5D>/"+U*J=T$@4U='91SBR5TI?FIV;']K>SX2V+$T:.=V
MU]9$2TA2)+LXE6D).`+1A0!!'SN\;^K97#I+Q@N\B6R]UO/A5SECD\0^0N$H
M<+%H5;(E[_7A@CH`^+7M2[&.2IX@QHMB9U(S1'-@M[VF$7O"5NTGW1V.9^&D
MQ\ADF,DGC1')*X&K'7DA&X<P"?(&-PD;Y,%XX8[",VOBXULMDSDZ';0F$;,<
M7!2I%ZG'FC&7Y_\`U[MXF'0/BRL*90VQI_<O!,XL*N1FF5[.YA/.?Y-,H(8>
M>2J/,ALG>G-:]Q<9RI.68/:$\C8C"PBW^(=;T*W5537U<)-\>*I,S0V.)[>X
M#(CU=,SY':^829OSV4S02/R=OTTR5BAK6!Q"AC#-(6K7TRY*B+((5I_YLT(P
M?A@K=I/NU5^GWASE3XPR>3RWQLR22Q:$@K6,2%^=N97A\CE<EL[M'BX`PNS@
M<H7M$)`P/RY#IJ3F%H-(UIY.BOC.,"(?/_Z]V1AUJ^(BNXZVP^O[`\=,%B3-
M-&RR&B+PZ1\VQF.M5B,I_P!4SSUM9&14B;$,T:5/\XF="B@KB!_I`-#O\<'S
MSQ]TY?T\^'OWQN6_V^U7_K5A*W:3V/Z>?#W[XW+?[?:K_P!:L%;M)[']//A[
M]\;EO]OM5_ZU8*W:3V/Z>?#W[XW+?[?:K_UJP5NTGL?T\^'OWQN6_P!OM5_Z
MU8*W:3V/Z>?#W[XW+?[?:K_UJP5NTGL?T\^'OWQN6_V^U7_K5@K=I/8_IY\/
M?OC<M_M]JO\`UJP5NTGL?T\^'OWQN6_V^U7_`*U8*W:3V/Z>?#W[XW+?[?:K
M_P!:L%;M)[']//A[]\;EO]OM5_ZU8*W:3V/Z>?#W[XW+?[?:K_UJP5NTGL?T
M\^'OWQN6_P!OM5_ZU8*W:3V/Z>?#W[XW+?[?:K_UJP5NTGL?T\^'OWQN6_V^
MU7_K5@K=I/8_IY\/?OC<M_M]JO\`UJP5NTGL?T\^'OWQN6_V^U7_`*U8*W:3
MV/Z>?#W[XW+?[?:K_P!:L%;M)[']//A[]\;EO]OM5_ZU8*W:3V/Z>?#W[XW+
M?[?:K_UJP5NTGL?T\^'OWQN6_P!OM5_ZU8*W:3V3)6UTT[<J1>OJ&V*UM1"U
MC(*=%=<SF,39,V&JB]G)BG$Z-.CF6A-4%:V(`3=@$(.O76L$Q,9I,PA@,!@,
M#YM+-J"N?(]YM^@N7.NX^;:O./&G*%)6)6='.CNY$UD_V'=+@M,D$TG\:1'I
M")0[,R9$`AN`>(9)&M:%L.]^H=FXF=NW#.?'^D2=E1WBKF%'UO9$9\7?&<NI
M'BW[-%+,!(VY>P7#,+!E]71ZPX@=641:Z\?(\\UTF,G#2G=7)2YD*DY:5U,)
M3G;1>T98N:BYN42TO.>&^AGU)4]?^*7CZ)WN^N%%U^CCEF@)1PR!W/.*.G5Z
MVI![7D<4A$B7LR>'1Z'$IV8UO2+SG92YD`-+3"]0X)N,;FFVVL;Q?1K(\6S8
M/BPXR<:31=!23C]"FA:%>MN4?0,5EJRN'"3NL2>Z\9XRU<^*ILT*3RGX;KMP
M+8#DBTU$'9_QZ)<ZS;@@R;D*5WI0U`!\9?$;I+Y=(^CVR^5$8I_I@TFHP4&]
MT:B^Q%,[_P`Q,LB2.C\RW&!?I_D"5DA(B-(AIW<\M>2/<6;JXF:52B_5/$\^
MC%>IXSX>N46NU97&>:7:0PAU8I1,SX\?TE=$I@T/=FMAJ*I9Y/Y?&I)6;&EE
M3,6W-![PH)7:*4(T^BAF:6UQF/\`REZA\X4MPE=?7MX<HR#QM\:1M;SDR#=K
M#EK.G;7<,F,E$=K635\CKV.KHLUO6W!H1R=T)F:%Z+;'".GZ:-_":6ZEC!6)
MY1%W.+RUBO5G')<#G\ULOPETDQ($_)UN=)U"^0VH[5F,1FBZO)^&'IFB8NQ%
M'IU%=U<W)323'FPUQ(8;H\\'VY<N(T,[4MTXS=<I[IR:>@/%M/Z9\A-CU5XX
M^.)%(N/[(A<4K.,')D;NIMF&2RP8[4^[#>8]"(?)Y^SH`3@QX&A1M;2[K'=N
M3(QHP&GK`$Z,Q&ZXB9F+0E8'6W#==Q6V5[IX;>6%DHA_,$`N6OFU&J9RVR?V
M2^36PT<WKY28KAQ+U&V^)5+5K_--B4(_O!*!F6HUJ%*O*TGW5C;NF8QFK67J
MJ^/$/9\9\@DL:O'7RZ\(>,3&95#VB*HX,[22VHTO6MD*6R]8TJTJ`Z(1A/9R
MHY.4N,^9,<S``MT/U'\6$K?AC.+-6I$*/HVRKRK2PO%)X_GURY]X2>^Q9B\5
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M4CBET:$C&N;Y')9@L3IGLY40#?TQ!FBME'[&`D\HSF<VX"I[Q]H/'=).RSO'
MQQI))_#%!K-+:VC\(E4<9(],6VV4%8RF#/V[+K*&V3&I9"5JDY.ZHG*/I3T[
MFD,(]OL]#=B.4[N-RHA#NAO',^OSI#I!XG.9X[,6TB_1@9_M[,NTK;(SV54'
M'7.EA:&5&`FI*TM253]\5/:L\):MD#$UOPD*R]A,PLQNJXF?$6]XJC\6W$KI
M"&HRYN&.)6RS0`'N3M=1QL4NA"(9Q@S6_P"U/4JB<1D"D"A!L`][4-Z?]+>_
M;H0?06S$[IZ3-)-_A1>-C]R/G+]FC#_B^$Y;M9/X47C8_<CYR_9HP_XO@Y;M
M9/X47C8_<CYR_9HP_P"+X.6[63^%%XV/W(^<OV:,/^+X.6[63^%%XV/W(^<O
MV:,/^+X.6[63^%%XV/W(^<OV:,/^+X.6[63^%%XV/W(^<OV:,/\`B^#ENUD_
MA1>-C]R/G+]FC#_B^#ENUD_A1>-C]R/G+]FC#_B^#ENUD_A1>-C]R/G+]FC#
M_B^#ENUEY%22?>#>!W3T]3E@\`P-D/Y8=G5#-W>)4A&KF?E3+&H7$)U,;(44
M]2IT_N^$TY$VF;(254PD<=:8X-=L:8I8,X.P8;B-\Q$Q.:Y<RY7\4$8YYB/3
MK?X^JR?JNE!L&<E)ZJCVJ"2**0&9.:)*KL>5Q>R2(B^L\=B;0L^YKR#"-..T
M1>]D)S1["`1F]UU<O-E/TIX-G"#,,^9_&@S/K0ZJW?3HE9*<K)S=8VQ?!TDX
MP.6.#>DDIIRZ.VFQ<R/+FS'HM*?1M6I5*G1!7U`B3=;[JY\5]V]M=O\`@U=$
M4L]OC>VDDL3M:IZX'!5O*1Q4PDK-:TSI.!)[#@C4!"9N<M$3D=\,I#JT-0E<
ME*&8`);<8)6ATI)QWZ^[;%]F?^7P,.J$<.Y4I^<L%TV+'Z^AL\;^>E,<K1T$
MM9GQ^FSTP6--F6-PN;AIE`PFZFC8Q+7)ZC1XP$K4A1N]@T*W]9]UL^1^;/$3
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MN?YQ7UM71\,?6^H)/4T:7K654U/"]S/32?\`6\A6-HQI@!&E3G;-V4/903"3
MSB+F97W_`(47C8_<CYR_9HP_XOAGENUE3GK/QM\GP5QHD^F.6.6HXW/UD/C;
M8D=4<DQ.WY'.(Q'ZPG=D;C4/-73&'`BDA?CX%II3J@A5;"8YZ,T#8B@`&6-T
M]9GNK2X5YX^XUR7)NHG?QO<AS5C@%GLD5FSM43&3+H$&%.[P0SN,IC#X?$4+
MP^N\)<'),A>V\*'7TK@%06`P82O?N+'*9J)FU:[/_HL1[FF97BA\9?#E0+*Y
M3SY%/3KGB(SXHS/5-2KGBJ+G/:G%(R-XER6-7A8TNCC'M:%$B?BH^F<?J"B%
M98!58NZN4KL]*4NFM*MX!,?&-X\#TX4E7R"YUD(9Y,X-XH9=\L8V*O7VGG=S
MK](H>I.UH739CRRNR9O0%;%[D[F>$&O?$N<<9:,]IN,2:B=[-:_']XZ6LMM8
M+94J9&](3W.E8B[1>"59.HX=:5CI8RA=(>"&+9JKC4M1$MRH1$E)TC+-U[=F
M:6MS=7*?[UK+QO467P6B>^+N%U\DZW<ZC9W=G.K:>!5N1UEO5;Q(]UJ@Z'UC
M,HK]$WR*Q"#@ZDSHR$#0^FP'#'H6M5(G=-XS:L<IWR!-'WFQOYPX1\8"A%?-
MG)Z7;S+-TO4)I';8JM9)V[0>/OD0B+F0C2Q)S=CT#JJ3$N+FG/2:UI#O6QZR
M+%Q^TRE5GA_&DGDID/C_`(U.!QR[5AQFJ5$*6'KS9G'W<5F5S7LRM>4Q]JK9
MP6MM""52=Q3,3R$(U2UV+0IU"=,$Y08FJ7.LM6>(WRQ&)TQQ]W\;'C_=T$_C
M%;-U<1M&P/#!9ZBTK40N$8A!K['-Q%\1"J*4W@!%%OOJ<\0FE0KU]07L6_;H
M7NUE.'2E*</\_P#24DIT[@[Q\'QC\A4O.82;*T!\8EJ\$TE=D1>4,3H`J(.2
M(Z72U?#BTD';DNC2'-8D6A4J2!!T`,+FLY9KH:C.)*9MYNK-J\8'*:U$[58=
M=(I!+XYJ.D1"L&B,2!JFTVGIB*'NS<R,U=W4_09J>``4'*"6-Z7N("QB0A).
MI$[JNY51G+GQ#6K<ZR62>/GQY/L8/3U6@A8:WCD[L15)%LQOVRJ4?+%1J8G5
MCLZ.5/KQP,`V5Q2-IQ8CSPB5FIR]BV`7.LK7=:\N\H\^V7!ALW!7`S333_14
MOETB76Y#38V=$K*13FJVEE4V#/61A>V6$U\WLDD<&_0TQ3DH<Y`O1$[`22'1
MVQ$S,9S;9&GG;@9)SEU+T_9_CPY&JVN*1!,#XB4YU])Y+)CFZO680Y4ZV3%H
ME7#N^MQ!S\#>VY/'2'Y8J;1!,^()XO@P3,Y1,VJC!">+IK"GFZ$GBXXR44BR
M5.XV">\HV"5))NKW7*BDY)=$B(B3_5+3M)`6.IK.<GEG^J.)?EJEG^E4-Z81
M@A%Q<<KFUBY?S#S+^2*<5U[XS^&AV)<L#B$M8F"?QYZ:80@/G=WUO7L>&[RZ
M-P.0R=&F_(T[TZ#(TQB,TL#HHP198!&:J7-XS-*BR\SE)LL2',3!XT^#1,HH
M-6LPGL151=X7V.0@DM51BUYY+$R<<,;B6BM(RQN3H0RN185JQY=&@Y(>E1B`
M+61<:SE(KK%..M$4H,/CPX&KL%RS#FHQD<K,C:A(SN,`OZY99'6)AAYY4?3J
MI3=LWIQ&T/S2Q*"FTI$8<OT:<9]&'1Q/EK*/;*M[Q/1MGAJN%<3\*RU]?)M&
M*Z=HRPQ9_L1S(L!WJY+-Y%7R==6M>R6)12<0MZ4[2JTTQ<XTB,(*%_UH!V_B
MTL^>LO:VI/&1X\)M5-93.1</\SE2"6U["Y.^E(*K9$:`IX?HVVNKF6B1FEG&
MI4@%JL>BRQ#&(`-:#O>]Z]<J3NW:RD+^%%XV/W(^<OV:,/\`B^$Y;M9/X47C
M8_<CYR_9HP_XO@Y;M9/X47C8_<CYR_9HP_XO@Y;M9/X47C8_<CYR_9HP_P"+
MX.6[63^%%XV/W(^<OV:,/^+X.6[63^%%XV/W(^<OV:,/^+X.6[63^%%XV/W(
M^<OV:,/^+X.6[63^%%XV/W(^<OV:,/\`B^#ENUD_A1>-C]R/G+]FC#_B^#EN
MUD_A1>-C]R/G+]FC#_B^#ENUD_A1>-C]R/G+]FC#_B^#ENUD_A1>-C]R/G+]
MFC#_`(O@Y;M9/X47C8_<CYR_9HP_XO@Y;M9/X47C8_<CYR_9HP_XO@Y;M9/X
M47C8_<CYR_9HP_XO@Y;M9>5W9O'%&>.GJ3@'KGBN#,G.B^<]<PN@^C(969![
M-%+KK2X0*6@Y*_14*PN/#?V-Q*`>D7[*":0#U"'_`-'I/-K;,[HF)]7TK96#
M`8#`8'S^\R_WC#R=?U(>,/\`"7G#4_K'C5["S[E3F2U9N39=F\^4O8-B)XR[
M0HB<S2M(?)9:3$'YL=&1[BY<@>&A8Z!8'=G?%J52DT;\!R=6<6,.P&#ULES&
M#B?N3>792RR^-R7G6DG^/V"GAR2=LCQ6$,<6J9):\;Q-$"3R=`K9C4SX3"VH
M6TS6%2$S2`C>P$^P/X8+F'$V\C\KL\U6V2U<XT<VV$Y1`%?.$W0U;"DLK704
MMK2L8(<K?R68#FHC(&9"2DTB$;M/I.4`OV>P.M:%SET:PR<(\3QHZOU,=Y(Y
MO8E%4/[[*ZP/:*7KQO.KR3R=6SKY)(86:DCY0XT]/RV/(#5BE'LDY28B($8(
M6R@;".4SU=U_XBXVE3(CC4FY4YXD$>;XS!H6@8WBG8`XM2*(5BYFO5<1=*@5
ML)J8A@@3N<-4SI`AT0VJ!;,3A+%O>\'+=K*0XIS]14%=8X^0JG*QB3U#TTO1
M11WCD&C3*Y1M)8*ME7SM*QKF]M3J6LB9+8VWG.8"1`"N,0D".T/90-A%SDP@
M^6>:#(V9#C.?Z9'$S:N?:0-C(ZUAXF$RFI0X%NTDJD;3MHVA%7;^Z$@4+&;8
M/MZD\.AF%"%K6\%SG<VYA<Q<X":(TP"H6GML<-C#+"HBS[KB(_;(S#XV^M$H
MCT6847VGZ9JC[')6!"X)$9`0$)UJ,DX`0F%@%H7.?5K1O%_(1Y+HG/Y>H`XA
M["[`>23:B@9A3J!_8I_%WP#B`3%L*P+Q&[7DZ!3HS0M'HY"Y$C]2UJ@)@Y;M
M6YL7.E`1AJC+%&Z3JEA987!7&L(@TL\`BS:W1BMW<H)#K`F!&D:R4[3#W(D.
M@GMI`0)#0Z]!%[P7,YH[A?#'%U<2-BF%?\G<YPF61B-ND.CDEBM-5^POK%$W
MO3V%XC+0ZMC`F6M["Z:DSCI0D*&$@[2]1[@[^8SW"9F<Y;5`N4>8JL;8ZSUG
MSS2U?M41D,OEL5;8;6<.C:&.2BP653&YW(F-*T,Z0EK>YE'EAJ%S5$Z`<N2&
MB*.$,L6P[%RQQ7'/)9$JK&=$<S4,3-*49&6-4]+"JG@X)%5L=CC<:T1]CK]X
M"R:7Q%I8VH\:9(G0&$%)R![++"$._3!<]W4EG%7'T\6,#C-N6^?I:OBJN8+X
MRMD=0P-Y51Y;82I&NGBIE/7L1YK8HF2UN3FN@B=@VN,(`([W[`'>A<Y='[C_
M`!KRO%4#ZR,%"5>VQ>11&+P)RA)$09_R'J%0MY4R2,Q=!"!)119K8VF2+3G$
MM,G2%%?7FB4;ULW>QX+G.\6S)N8N<$8M#24-3Z4>HQ.(3H:>N8D2+4.LV3AF
MUC17W%M(=_EZ=S$.G5W1_P#N[BXZ^H/",W]/!<LE47/E$4`A=6RC*;K"GFY]
M^S_>D-9P:-PA([?EYM"SL/W)/'&YN*6_9FD&DR7Y-"^`C7L!Z!_#!,S.:8,(
M8#`8#`8#`8#`8'S!=+69XU)ST#VOSE(:;L]?/HQ9E?#LR45ITE/:GD-Q._7T
MRY%Y9Z5A21U@$S9I:WUI`XY-:G72:-*#"X_(5'P;(3;6)%!X#K'*HGI]K_+V
M1Y_<*:[[\?T*3R&JSVBBK\II=!7>HW]\-=CTT!$4XP53&5\A;AHU*H1C8V;U
MI24,!VO=H7N]^O=AB;V[O.):7'?$KP1%6IS96.D=)&YZ552J>B!3>?*=N^Z5
MY_D7,=>IG,U3)335R!KI^7.B-0G,$(EP7+SW%4$YP,$IV.>[QW>/*&Q_&#5?
M2UH4Q$*$L^8V1S1TYS'#6V5OO2$_E+K+9;8?5_*()/,@FR28R!\$R<]W)%JT
MTH1NHMEN2,G3:BUI$)64(W\IVW/GX^N*\_&?C5\=%R\U<@7S%^>I;%H:Y5S6
M=\5'3\NNZU9Q$*@=YY7@CWTQEC+E,%$,)DLV;)6>5,G!,A*',57_`%ATVJ,T
M$6C.[=NC=,3G;TKYAY*I'CZ(R>#T8QR)E89A,3)T_:E,\F]B.BI]_+4:AB$L
ME\GK_(GA$QL<0AS6UMK:2<6@;D"$DA.466#0<,S,SF\`*=N[QQ](1.HK%N+F
M:RZGWTMT9=4>KQCB-OV3-6R[)59,T76I:U57@!D/@+1*88ND2-3)54!="I##
MD!)/U*?]+]#1TW<HPCI3>+@Z"\+)%,50DOJDIY(N?62*=#=*Q)@MB.+Y1731
M7/2DVF5@?TBWN$2V=+BWMBOF;)WDNL';[>O<F\2LY.@+:4Z@>A1(C?=1FE?@
M&TN`TW:C-3W-_-_2]?W:X<]V?;4C>KB534Q;":UMF9U9(TBV7,TMGDJ`F9;9
M6Q=M,CRTL9QB0#9M$`M*6<(.R;N58S%/H$RL*&=CWYT934AK%/0];Q>QFU0$
M^2V*QO3#+W6321A3S^LH$1"*S<8Z[M;+')Z^'V*)4G6O`%C>2G0'",($`(A!
M+%=5-X]W+V5.PSLROH_SX_L%8Q-KF\@D^ZCZ`3-DOV^.7V@VNH<TKI>VN)$S
MA3H+0'14;M4F4:`(11!6M_HQ:AFX3VAVJ[2:SCG>GZ_<H;2LW8HM-V)/![':
MI9:(GY_U71:BCW)6[B9FEH*EC6<]C$\D.Y@6M:`D1NA`T=@J$%./EDZ--K^N
M7U#0+X@73VO^M)8HD*Z@;396-D!1#QMJC)SR6\RY6.`+@H-F.1B%TTOW(0)-
MDH!I]G@&`O%:RI.WY(KZ4CE*VS,Z^3(99>'5%!PLEKALD9TDS<J2;*PE4`-1
MRMY3)F]_L1_B,P7FO_V\E+'Q.#>H1MA8MMYYY]2NL.Y9G5/7T8O]Y98]7E3J
MJ&C-@,4>6C<():SI9ZZ,I)[2D4E[JSO#5)$L0VM4MMKJ%C7OZ$91068\1VC0
MZ%["85YJ<0/R?=?6W7,NM"NZ4$_1^MI#!41+$;SG;5/V%::F06?)HT_[:(E8
M\LEXXM%HM$FPE0O'LX]>M^`U2E/3EGDE`C7&(PZO5NT72[W*OH)=]56K'44:
MBM-65/)[$VBL=O!=R/2^ISW&N3HL.0B42N'MS',@!<0(M;,6+B1`2'BWOW;W
M68IY52F\^KTK#!8G<L(CMFW?5S*SW!"H98#=*I0_/D[&QJI-'KA?EG/+/2]%
M2JOJ3=AE'C9#(^%]3J419Z12!>`M0,UA>&2XW9_6UZ4;>W,<+@%;V=/86W'L
MDSZT=JJI7<\:4,*G#FX5S`D1DD=WHD4'913)`[O2\Y&4Z.J=N8PZ%HLHX0C2
M1%QC,('M#K+J9H\?5IW,IEKO"[/8NK&:N6F8HH?$XXM;ZB6W3#8P<XIDTSIZ
MUXTD0J8>YJ=_=5L6=0EEB^;8/<#0PEVQ'*(;6J\AEXDW%,JU2P.%EQN(/DY0
M1"7/->VNIW>K=$T*A0B2P1>V";F5G?#9H6N@YZA:2!&HD4;<7!,3IN5H2M$J
M*A5&I/+QU3?T:VEC%<0*&V;(*TFCO"ZDF5$7S';7E$Q*BKX`I*SL[S(G&.,3
M;3D^;QEO!SR=HJ6M[8<:TZ3[4E@)BSMB/1[`<^O%Q2QE(Z'E]\QZQ:JG5!P%
MV8ZXA51#BL:99\WM)R^=3N-J9`0"V5[7+C_T4S(\*AFH@`T#7H8+>\K,X8/*
MEC[_`+UZYJ%S7J:-TX\]K(Q/$=IL;[4/0]"6Q9R#<3N>711GAK,&?+G.",)W
MZITS1)TCD>[!>TKMLDKXR58211:Z=4_0_N.\(;X][LZE981"+Z6T79QB-I@%
M25W9-=-6Z$B.J\/E$>A$6EI"F:.TPA,.<70M*9L!Z=>YHP@+!LKT!JE7,0T_
MGON[N^_Z[AUEO=%16H$<TKBJ3VV"NE9V,GLE':+VPVK&+)V]:?G]8SIJY3VM
M76SV`GX"G,^-KD1RD\(U&0W1MC+5MG`'D$Z%ZGM*VZ.G$+BR5_J6J$[JDLYO
MI.X8-6LTFH4L2;T4G87>:O\`\3['%TT<I`SKF)&6E<FE5%#S?JCD[@E$33=M
MJ(E`-6^2+M!GY1?.C+`B=?W&SN::VFV*&5ISY<R&91"9U(Y*4LF=YI7RA[9G
M*7P%>J!I,S(VPIN=A$AT,Q8L%[ABBSMCE3WSJ^2NLTK.NYB^M86-\ED%B,E>
M64)2@@+.ZOK`WNCBUA)6>JLD+>K5#*T$W^<#[/07Z7KE8;U@,!@,!@,!@,!@
M,!@,!@,!@>*WFE_S9X'_`+1WF#_2-7DEO^><^CVIRL&`P&`P/G]YE_O&'DZ_
MJ0\8?X2\X:G]8\:OH"PR\]/(U;G1%)UE4LNYYG]90=VE'2_.])24-F5&\6NC
M<&>_[?AM.EKV9.SVS51K2[153,=.8`C-6`<-IM)/0CY?J"S6V(F<=)>83QYP
MY[1<;Z[!?E:5J[KZ&MR>1ZOK+CSQ9$?K0^MT'8'2_+S%)^AFR+UW<DXJ)#&G
M3G544XN3"@F9"LQ:C,^!&8H-2I34[(PKQ@V[N'R]6=7WC\XO[1YR9H9%3^G+
M(5,2ICMR-+)`D.9VZD[ZGJ9MCB5SF]./0PR^852A+;E0254A5,JWU01QQ>#D
MK0:-NR]TQ/1(4^\TC?727K\4MJZ(0O\`HMC0I@/D\L&;-L<<7(JPGFME;+9!
M4.IN>RZKG^;K6$U]A*0#4]?F"*K$3D>8@`>,!1.&7FK59GG<MPU`U+*ZHBIX
M%&)M9O/4,KR>VC;3LZ.SV*>(^#IU8L'%7C9"&-D66N?`.W4>XRU()6L$M2QY
M[=S=@(;"TJZ+PCK/C'[?X7]\E/DMEW#2M"P06G8/9$J5U#,+;:FVS[;=:@)M
M!9&'5(R(Z.Y^"S5I9CC</2#^I6Z6I(D20@,.:B35`5&Q!T7NIMVQNSGQ]FCO
M/=G1++X:(9W?)':C8A=4\@M,SX4D-8WQSI&`1>\+;A;*UR1^9G>811P7H(16
M,X)5.6S'Q`D,7)33-*BTV]"T(VQSX]+4ZC/FROR*W!<5>22KZ[Z(B5>6-"8/
M"9Y4HGJ&FW17C9S=U!TC8=]5(RMBVYDL\+GK+00VF'1M*M+2GN1"C0WLTH>C
M"XO&*OK^8AM_.7GD7=<I9I'*4K&F=S**U?:$U;Y<]6W:#=5=I2>+,SLZ,-:<
MW&3/GJ`V#>EHQTENT=,F/[(PZ9`"#],K7E&`/RF[^?'/)IJ;S[S]!7]/N(*-
MHFRIO8KES358V"'=&.B"2F6=>J2I!+K>75^CJ67.D9Y!87ZS#(H=,`+75619
M#<?%]H##2]KMCA$WCX^_^ES:^\KLDD_%7;O43_4E4%SKC0F<:=ZMKJ_EEGPY
MW<XHP#>D3*[7JS54DKXES7[#H"XN/#D_V;>_B6;+5A$EU+P3CC$:H>MOS@K:
MAZV_H826A(NRV>436:-]FLPM*8PNCZ]4S*(1*8O%B67:3W2935&Z"/4R@R+Q
MN1$%K7-XF34J;UC0UD#1+598V7MY.H;YNY<N$ZM\4YSK^1R-VL"LX-#&!/?K
MF);`'"P.DJ^YO2QSK8A#3SBLY[LJ0K9Z"3Q5B3DR4<CBR4:P)Z<7\WJG"L]/
M]7@BQ-_Y@.;.5?1:8-?)L-,<GU(?+%S2MZ#<4R!#7C]2W.5V5PY(G8BF5AJ^
M5NS%TRQIWEO&F(1MAZ92),N<"]$".'_7C5^,?LC\?_F6D!MAL=0(N;(]JV7R
MR8Q1Y,`=+/LQN<";%<>ADU!/]B[D6N<U,%5\PE/)2PAHDZ=V-D3D^$`;C8ZC
M]YBDDO\`U^/I_EG;<\]MN1=XD41:Z>YO@4YI3KJ$<SV[%[%Z51M:^T5^Y@HC
M]B.W.9T]B=3M3K4L>`7I*XSN1*F4,=<PC)5,QN]:]9:1LB=:IZ3RKR9AAGCO
MK?R%N5?15^K]P-)<+@1Q":S1<T0R*?<Y9#U3W7;N_5+&W^TS1V*V-34@_P#@
MS4A>"'/:Y"J4)=)1K*SQ^7%``/,\[-LCLV/S#G%-%_U6RNEVF8."NT#RDD%B
M=A794]5RJ?6H-RK]K#7$<2QJUP2J+'K=[3R-G9'0Q0:UEI-F"G5>&%VFV0>4
M!?%N+>1>V'RFD1,"Z:@L#6.[0AFST[N4$M*YF>,;I>&(1-=>JA26(R:5/2A"
MYR`XMLTTIR"E&DJC9_PEU..,[>L*=2;S572H3@0,5%TE!GUMLVJ&6Q_SC>#X
M^[YOBAO4U0\Z6NV=A-J&M&`'-TH?#;$4/<./5JW1(X0M$JD)N@?2?:SXUPC7
MQY+<^-_RRP[R%VMT'5C#`PQ1TI$MK=504:R?KG"/H'9Z=6`N%6ZDG%65J@A]
MQH5;0-2I:&%7*V@"`THT+L,8ME:K.[;Q>OF&3`8#`8%)7#QP<-NBUI=5O-==
MF/S//S;0)E)2=U2S%QG!MEM]PA>)+,4KH1*)>2ELAI2.:9$ZJUJ!*-(0420!
M.264$URW:K+U15%>4=7D6J>J(NBA=>0EO&UQ:+MQJT]$SMYBM0N&F3G.*I:N
M,")6K,'O9AHQ>H]_CZ829F9N<TAX11,_QE<&J'2OW[?-$!(D593LNRXO)D(Y
M"W2@^;D2LJ=)'R925`]IGVR1-TO3E.*5/(U#JE2*B2ADE`^,OVFN>[5;2LZV
M@].5W!JFK./)(E7=:Q1A@T&BZ`U6>BCT4B[8F9F%E2'."E8N-3MK8C+)`(XT
MPS80:V(0M^N\,S-S<YMXP*'1?QD\.0]LBK*QT4DTTP.1BED`;G>>6E)$=>OX
MU*A48LKXB23AV+@I1PU9H#$[3I&F,(,$2(O96]@PO*9Q0Q?/A>\>EZ0-1&G/
MGB#(9:Q0ZU(U4%@.X)5,5].K;0:79&8LBS0]2X"0V,Q5V==KFF.;,*9&LP.P
M("481[WA8WS$IKYR\<O+/-1U6RF&5^!1;]9Q04:_7$LD<\53*4?<(LEC$AU(
M5;W,GY2[QMP+($>A85YZYI8SAZ&WDD&`"9@G=,YY+VX94LZ<G7349L:D&FBD
MK)J&+'MN<[>4.]522Q53O&SK0JF#*8NPN[+-(BA@3O\`EZ=.;UMS5E.P"DK*
M<+Z,0`F&`+%=5)(_U;WQ;R:4OU?PXFN6&O:XBLA7)K!Y(NL3W94^4GE,,SA$
M3;)=-:L=6I.PO.S%9"T*5R`J1`ULL(RQ:/R+41FAQ7VUY#("5U>2?75AW%)J
M^2V8KB$8C'$UIM!K2?`9+S%!8Z\UV\R.?1>`7BT6BU3>72=#'4,A(<$`FPY*
M-S4%)Q'A+48-YN?I3N1OC1,A=G&/UDK?ILM;X%7:SEZS;77R>.,<9*1S6)/5
M=0V0O$MM*3OS6YJ)(SZ0&QMF:3VL21P<3D>CENJ12:Y9;-KHZTC\JBD53S]P
MC?2<OCS!.GZB72V'ID1M;TLVUUVU06N%FG6`*F!Y?WF#;E8E1Z*-`8AG.(E/
MSB$(RR2^5=G0VK9]*Y#/9&JDIG>]8(RFQ!SXZ2Y0R\URB6TVP/U<PQAA[@N=
ME#(S$O+I]7-!Z="B20*UAA1*8O8DY<)RT1?4_37?\>F?(E16?7$DL`J=R5J0
M6S=B'G601=B#''6MFV9*D\S3`L-434;[#E[AIOV[?$\H7]Q*-)$E:!AV'!43
M<MEL#HGNR%+B5SHF9VV$3^6VR6U/T?Y!NNTGRBHO6;W*6.+D2R'06?K)!:ZV
MWU!348B5HR6$#>G,,/T2J)WLPHF#09O?/E&(87.5ML=C+8E62)Q&"MFSFF;N
MLQ88J"TF*"I6=#/";7<VMW>U,2<3G\#L)@+)*)+WK:$02QCR+4-AL7ICR%U6
M0_N9D!56V@E/0T$C$(;JUY6DX7^M*F?[TO6O74V7$.M\DH9^4CAU?1YS720@
MYC"UH'X"\+2L+&40*E;9[*PM_?GD.F41F;I,(`^<OSV#V_((Q&&.8<J6O.6R
MP53,EF*=_@5?PB$2"03?HQC(@1()2P29M.AR98Y(-D.13<@*/4BBSMB)PQA?
M=XZ&OAKJEV?8H[/3@$-]SR.JK(7T)+;G<V!O)&I=4]<F4K3[RFDQ/V&9'J(8
M8Z;7*"&/;5]0O&?O>Q;K+!4/,.TYW7?45@V!%8["[LEW.#*ZTJ)FI>4Q%TB$
MJ0([O0QJOY4.6V$]M=I.D6F!9+L3LM/']EIWO1!H!@-`?HLU]%3'OL+R3551
M]AW`DB<RZ)9G%7"E4*;(]Q#9<9N"+1]5<)$)L67HZ:D=DP]]G'Q1'Y'AHB"P
M<><DB;\37)67H(Q3%8C;=3A*U$[MKNM=-HPE@3>OB!LTY0IM_/7OM*OT_KNO
M[SEMF0AEFQCC%TC]!WIW/CT4D3B><SF25`8G*1:-,,UHHSWDPZY6V*B.C^QI
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M8U7.Y8YM4(13,;B4H:T,],9DA9K@A+5",`(?R`+^'81;),1T6PPA@,!@,!@,
M!@,!@0+T[6-K7)1D\K:D+]?.7[1DQ#$7%;VC<,CMA/<"-;)0QO3J>AA\L.(C
M[SM^8FU4U#TH'K1)2X1P/YPL&L+$Q$XXP\??X7?EE_\`Y@>]O]BKG#_*^,73
MG_/_`-?>3^%WY9?_`.8'O;_8JYP_ROC$Y_S_`/7WD_A=^67_`/F![V_V*N</
M\KXQ.?\`/_U]Y0]XUU7?C!Y;NS^5>B_(I8W4U7\@TG2+\6S2FFJG@*.Q)#TA
M'-R9N>5&H6C*<XN=6H6(Y.26!6O+=-+=C'I/\6@#E]#?QX1NB*M]+N5R>*WF
ME_S9X'_M'>8/](U>26_YYSZ/:G*P8#`8#`^?WF7^\8>3K^I#QA_A+SAJ?UCQ
MJ^@+#+SE\H-J7_4_/$*7\S@-%:TVZ:YFJIM$ECD/DKB4TV5<$9BCZ-G(L%,K
M@[2\Z;G`>DKD[`VA;C]A/-]`@]<-;:O'*GC?=O=_<\7-Z9B\.7L\EM)D(N6)
MR6F0T+"%#_S2&%=*0BLN:)ZXOJMK%'IXO[:A$J6RI+I[$?'TBP[YD@0)"CO6
M-QMVX3X\^R5.K>].O:C\97._04?%4!U@+'GHZ$6V^S6I7%T21.<UM5/39=7)
MT4/84)L>;9:MMRN&)@").3IH<Y0N2$I=Z:E@_4D;8G?73Q_IJ%G>9CH&A+N9
M^>;OY1B,OE9\VJ!NDDTJNJKGDT*O,-J0J,RUBKFN59C0H(AMPPMBD9:QT5RH
M[;!I*6()`PBUZ:$;(F,,D@WGY$>J:&OGI]@?*VH-_JF"7R;!:3W)X/,V9I6.
MU;4+1-G)J>C<A9V\]5(^E.G`WB0V0C9WM9D:R$NI0Q;`),5E(VQACT^_M"%X
MKY9NO2I[VWJV:_K5FBE4]IQRIZCEG0,!>HY7/-T*65&NL#3/9+[`FE1*Y++9
MK)2"XDQ+D^C-?F%05HT7P#]N#C#8;$\Q_98666U.EX**K^<+*>D9#*;+VJ2/
M$8K.]I+4KCTM3-1SJ,`:=D.PV7G#Z,Z1+$V_M9$S(.;"]Z+]NL2L;(SMFH9Y
M<^B8ZFDJ*;<Y5@8TQ^+PM+%;5%'YK'T43TRN_($&M"V[V:T+(%"S0!B(ZQ<'
M_P"EC/R')6A@7$^GJ/?M).R.DX_\_9ZG^-SI@[L2CHO;TBCU(1QV=(%2TY!!
M*R3OBEWKIRM>GXO.GI')U;^WI4VOOBE[&K9C4/KLYA.3?5;TI^4.C.Z*FNCT
M#*BD7(-`<3&V`DXHDI,6:4SMQ9I:<A:%Q)(`8!/H0"27`.CPAUOVA.UH>M>[
M\<,NR0PL:5&I;DS*TIV]:(T:Q`0W(R4:L9^_4\:E*62$@\1V]_I[&'>Q?^G`
M*V!B<##SE[*TK35))292:K;D:DQ0G(,T<0G/&<2,1I))P=#``6]A"+7KK7K@
M?DN/,!)BHXIC9RC5JE*M6FEMB(!BM8A$`2)6J&$C0E"E&(L.RC![V,O8=>W>
MO3`_.HW'0AT`+"RZ`$`2P@TUH=!"6`E,F`7H.B/30`)T9)>M?R:`4`/\@0ZT
M'X_*\9V>%5N.L6U(/;[%'VAO^<'L6;<`>TWZ?Y`^Q>+9^O3?X';]_P#TOQP.
M-7$8HO-V>NC$>6G"$<,1RME;5)NQJ3=GJ![,.3#'L1YV_>/?KZB%^._7>!'U
MPT37MY0)/6,Z1.?Y%*?XP_JX['GA=&D#QN).Z9\:V1[*:#$P7.,&N2(DQ2WF
M:VF4_$'0P[UKTP9)+_+[#\:HK;*TB+7)TR1<`3>D$%:E1EZ*2)UFA$[^J)2E
MZ]I83/=H&OPUZ8'8VUM@D9#<)N0";TOP:3(=HT^T:?278=IM$)ME_"3]/L.O
MC]H=>STUZ>F!U11V/CVYB&Q,PMO8BQO.Q-B(6W81/I\(G/>R-[7B*]->W9OO
MV'T_#`[")H:6TY4H;FMN0'KC/E6GHD29*<L-U_\`Y%1A!18U!G_K'O>\#(X#
M`8#`8#`8#`8#`8#`8#`8#`8#`X#$J8XU.H.3D&GHQF&)#C"BQFI3#2AD&C3F
M"#L9`S2#!`%L.];$`6];_#>\#^D)DZ4`BTI!*8L9RA0,L@H!(!*%9YBI4>()
M80A$<I4G#,,%O](9@MBWO>][W@<V`P&`P&!P&IDQQJ8XY.0:<C,&<D--*+,-
M2G&$&IC#4Q@P[$088F/&7L0=ZWL`Q!W^&]ZP!"9,E","5.0F`8>>I,`0462$
MQ2J.&H5*!A+"'0CU*@P0S![_`$AC%L6][WO>\#GP&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P/`+C7^\#^9W_\`0!X[/_EE)<G5TW?_`);?67O[E<WBMYI?\V>!
M_P"T=Y@_TC5Y);_GG/H]J<K!@,!@,#Y_>9?[QAY.OZD/&'^$O.&I_6/&KZ`L
M,M"LNSX+3\263NQWX$:B;>L:D*YY-0.CB0D4/3DE:&[Z@EG0N"LI.:X+2P#.
MV7HD@(MC-$`L(A:#?<##2*0,T2C[[*I&X$M,>C+,YR!]=%/R;3MK,S(CW%T<
M#]%`,-V2C0IAF"]H1"]H=^FM[_#`AF)]2T+,6=A?4-A(V%ODS8T.[)JQ6635
M.XK44AD"N*Q_U9;198>\I5;_`"!`:E0ICDY:E8,/J26,(@BV6ING*7U+S8HG
MB6KT5[U,YV(J72ULU"VB>1MXD2-Q@:="KFB!V;&MP5J617%DSD0-<6L"0-,$
MT/OUKUP5-7T;2R7C2LF=(HR1NX*ND#U.VYX>(.T,E@1-U=)DTQT_Z:0.D4;T
M#LH5R)N8E/\`-K#T8#BDH_T3!!W^&$:I/>I^;ZQ(<CIS=]9L0V>8Q"O79O'+
MFA>]-LYG[J8R0N)+F%J4KGI*_P`E<R32TB4:?1INB#1ZU["C!!"+++O_`),M
M&4S/DB=V,_HI2L4LT8?VEC5W95)QKX[&HW!KC,3N^$%0Y+J;;!\2@Q`PR/3N
MG2Z$::6`C0Q86IC'HD.OK0Y1KZOX]$*WM.BH[6]?UFA>(ZTQZQH27'(S4D=(
M+:D<A3C*?#$Z2#M9*<)/W$0_I`[#Z"-]?7!CU;#%.D^>IT865#;QJ:3C4.KP
MQHOLE@Q9Q"Z.L>BS'-W]&S&)G0PMZ&QP^2H'-8))LX"9$K+-,V$`O7!4QFSU
M;W73=QEO!U16U65J$QU20BD!M;SR*S@MB6*BQG)DCP.,.KH%L4J"BQ"`6?L`
MQA#O>M;UK!,3&:3<(8#`8#`8#`8#`8#`8#`8&,>E!J1F=E2<?QGIFQ>H),]`
MB]AI*4TPL?M'H0!>T8=;]-ZWK?\`Z<#P,E-:(8'RK5G;<6L"_P!3T,\=.<XI
MW>3.'3W1<B@;BUVUVU7M*SAK/H]PM);1`6197,R6MY*0J-EI4(MEJ"`%*2@'
M!C<8SQG*O]/H&RL&!Y>]&PM%?_?-*\ZV%(;22T^3R->MX&QZL+FN.BU:ZRHQ
M<-"U^PNSQ*Z0G5>2IX1((O/W4H#:J7&MXC3M'[(V<468`U&&V^MIKXC1"C,8
MN2MT<CELCC%77Y94)A@IQ-Y/9$E9XRWNNCT#$X3F</$BFTBTV;4B++-=7!:L
M"7K01&[T'7H2<UU\(C^V7=PC]6V0^M*D2)T9H)+71N6`"`0T:Y`PKU256`)H
M1E;$F.*"/7NUL/J'\=;U^&!XR5U53%4D#\8?1,-L2^E%I]"3RB&NVG69=0="
M69$;%0VUSO/9].4@ZNL6T955#2![E;4G<4_V5D0";?@T6@VF2^\D1N9F;C"O
M1[MX8,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>`7&
MO]X'\SO_`.@#QV?_`"RDN3JZ;O\`\MOK+W]RN;Q6\TO^;/`_]H[S!_I&KR2W
M_/.?1[4Y6#`8#`8'S^\R_P!XP\G7]2'C#_"7G#4_K'C5]`6&4:W'6J*XJMG=
M7.+D>SH9W&G.-J75*F(5JF\IR($0)6F3J-A),/(]WN#H6]?CK^7`W=J3.:4A
M2!U<RW4\QS=5*8\M`6W:3-BIP4J&IL$46<?H\QJ;S"TXE&]A$HV7LS80[%L.
M@UVR86FLFNI]72U<H;$<^A4JA:MR2%EFJF]-*6)>QGKDQ1W\R:H2%+MF`"+]
M$0@ZUO\`#`\JY)XDT4PJRJZZ=^AY)'%E;(8['E;O6<`:(BS2R&,EA.$X6QAP
MB[Y(IJ)"%]3+0HC5A:\:I.,OZE.(H8M@U*:Y8SYL^\^+Q7(Y;7#^\7LT$-M=
MO'1J4*.,<_0"+2:35S>-=MT#CT2D4Z;W<;VMD]?&I3W!3)!!VLDAQP`JR2]E
M:,'3EW2;7WCOCD3>X),G^?)9#.X5(B)(7(&.L(A`T>E.K+C5A+V^,LK&:>7"
M61Z(C);:L1H3O@4DG&F&!$(>]82^SOMOC^80VHAL.1SI!(VJ,W.X7/!XP*KH
MD@6-KN^2*PI0]H);*_G6.<^V4Z3\>FA6K*)/9"DV@I_Q-,%@M^9=P@[S>WU$
MV?;W=OU9(+XB?3$-J=O@#"C51ZX&%O1Q]X<7*PONISM)(P_Q8M0E"UC1IM)%
M!^E&CC-E!+V+5MWX=6=HM-\M"%='2R/EJZ8K^`QZMG>LH%*:K8;,KNO(U5S7
M;:V(*--Y4A0N\/BJ4ESBAQQ;*M-#L\?\]L0]EY352WU9XMTKL]SQ>YW2C3--
MEFJ%4J9HK24'B1R%<94$/KL"F"O#:XC60;YY3&CWI;I)H0G%"K+9SQ"2I2S1
M#EBM)S!R.R<OR*WET2=XLEB5FR%OD+;`H1542K)ECJ\A`!*[/#PICAARR<2R
M1*0?,J<E>R?3_H%D@#Z^I)FUP<(8#`8#`8#`8#`8#`8#`8'\$'0M;"+6A!%K
M81!%K6]"UO7IO6];_#>MZP*5LWCIXGC]L)KO:.>X:CLY'*U4X22'2J2')DLM
M6B4FGOR:-J'PZ*D+_J%9AP!!0ZT4H%\H-!,UH6C7+=5=%U<,F!7;H#DSG7J5
M+&DE^58PV,"'K%BZ,J'%2\M;BSGN";:1<%(ZQYS9W/2581O7R)Q'"(&((1;!
ML0`BT6)F,F^5#3584)!&JLZ?AK5!(,R#5FMS`T?5&$EGKU1JU<J/5KU"QQ7+
M%:L\8S#E!QIHQ;_$6\),WC*3<#A4)R%9!Z5424H3*23$ZA.>6$TD\@X`BSB3
MBAZ$`PHTL6PB#O6];UOTW@4VJ_QX\74O8Z*VJQH"(12P&LYU4-#\E5R1<%E4
M/032W`YC9W9\7L3(:,@\PHH21*3M.0,117L+%L.S4[MTQ4S@N?ADP*BW:X]Y
M)9L`KG"'<BOM<?86X9BZ[;)N2*3;4G$J<M.Z<#5!*IF;%MA*1!1[3';6Z4#-
M$=H90`A!L9J.-8W:(_O7EL_[-?'3^V[I?_=]P?#S/O7EL_[-?'3^V[I?_=]P
M?#S/O7EL_P"S7QT_MNZ7_P!WW!\/,^]>6S_LU\=/[;NE_P#=]P?#S/O7EL_[
M-?'3^V[I?_=]P?#S/O7EL_[-?'3^V[I?_=]P?#S/O7EL_P"S7QT_MNZ7_P!W
MW!\/,^]>6S_LU\=/[;NE_P#=]P?#S/O7EL_[-?'3^V[I?_=]P?#S/O7EL_[-
M?'3^V[I?_=]P?#S/O7EL_P"S7QT_MNZ7_P!WW!\/,^]>6S_LU\=/[;NE_P#=
M]P?#S/O7EL_[-?'3^V[I?_=]P?#S/O7EL_[-?'3^V[I?_=]P?#S/O7EL_P"S
M7QT_MNZ7_P!WW!\/,^]>6S_LU\=/[;NE_P#=]P?#S/O7EL_[-?'3^V[I?_=]
MP?#S/O7EL_[-?'3^V[I?_=]P?#S74JDZUU$`CIUX-M>M%IC*7?FQNJEZDDB@
M"8_3HN"VZCKS+F"+R):48R:3#/VI0)]@5"-`#0BP@&(DU>&20L(8#`8#`8#`
M8#`8#`8#`\!>-BS`_P#F!/,V8(LP)8Z!\=V@&"+&$LS8:RDONT`S8=`'L.]_
MCZ;WZ9.KIN__`#V^LO?K*YO%;S2_YL\#_P!H[S!_I&KR2W_/.?1[4Y6#`8#`
M8'S^\R_WC#R=?U(>,/\`"7G#4_K'C5]`6&3`8%;.S$=H./'_`%:WT@&4#NE?
MS9>:.H00=T,8YJ.T%57R@B`!B#T4N:S6>4"E8TFF]4%2G$G5_&9HTO8??HNV
MN47E;PAC!GFAJHNTVR4#OZ0M;=9M/01NLN"HZJN"QIM$(+S?"&.+V)"*XM+2
MZMHG&[BN$E<=;&BD29S:!"-/;S!J-[59&_A.GB?%(XFC[_YA*1<B=*OCVJLI
MHZ(14JWND"J^L(+STTLK[:%CWUT%44[KR`39$S)[!21VHZ79(I,XT\DO*&0B
M.7IU"A>I$(U(6Q6.$3&G_'^<DLO]E^="`,E\ZB%>6%:#80V*_P!6;,N:*%;)
MQ$8Y"+5K*)@(J:5O[$^%3RRY[4S@_/)!L^*?DQCBE^0S00_S!E2MGU<%K7]Y
MYB+#:VENHN31J&KZ.H:1O+]3D.I.QDF[3<ZZKA?8==Q9+8`BW*%RI7<JF8M[
MZ_O9DCCS+$TK*:@:AKQ+%!XK^=>;WIY==K!?*"K5VM4-EEV*N9E1TN3W`QU_
M'+&1O'WES"<WR)KJML9:_P!?;@!"0D4-B1,2M0EDJ1%A--'K#$U>&2?<(8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`\5O-+_`)L\#_VCO,'^D:O)+?\`/.?1
M[4Y6#`8#`8'S^\R_WC#R=?U(>,/\)><-3^L>-7T!89,!@=5<N1MB)8Y.*I.A
M;V]*H7+URLXM.D1HTA0SU2I4H-$$HA.G(+$,8Q;T$(=;WO?IK`K,Q]F<]2($
M2VVRR2!.F^[&TP(7*K+89'06JH:"G^:C>&EZA"!SC1:1D/`K1"<BD@7A.+0V
M_:H/XX6EC&!^9I4PLDGCCFC>H](VAM?F%X;S@*4#LS/",EP:W-"H+WL!Z->A
M4`-*&'\!`'K>OY<(A%HZKH)V?YQ'#+#1QQ97]BIJC>G">L\CKF+NME*DXE.H
M9`YG/6>.1&SWQ+H.RU)4;6NNTBC^9/V6;^AA:EJ4[[PXOK-E9Y+..HZ+88V_
MN,J9V>1'65%53"X/4&7QUMF+(G>4#DJ;1/<86RQO"N1[-TI3:4Z$8`(0CV$5
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M[]!*D)B@@HW6RQC"9K8<(EK`8#`UJ92^/0"+/LSE:X3;'HXW'N;JK*1+W-2%
M.1K7H2A:FI*N=G=R5FB"2E1I"#U:M08`DDLPT8`;"O;KVOS2QH*]7N]AJ$&[
M1B$TG<0:SX18(9&;%:\1Z6S-TD$5U%=R2%_8O7Z<PAZ2-Z@:[_J@"QJM;)PM
M2M0$01A",`M""+6A!$'>A!$$6O70@[UZZWK>M_AO"*I-?<?*+S^4A(+IBXB)
MM/[9J]B7*27E`V`G-%1&1SNW&1_=%[8F;HEJ"Q2)KU:U2ZFHD@=$Z``T1AI0
M!EJ<W>D';'(<87Q!I=.EJ2&]3\^%$PIA:+'BTA?Y278XE0(&O8V*/N3F[N+/
M+MH3OMZXLD2-5HH6P&[UK>"I90_KSE_5<77;31?-6S2`<XM,N>+S?*UF#/:`
MZP3P-M=W:6HI8T5VID[VW/S*B85FS&S:;;B(:8PL!`C`[#@J;KJXU'7_`"^A
MD<GBKM>M:L#O"V^M'&4[DLG;XRU,A5R`+,JI,MD#\:W,('6P`'`VU(M*=K%F
MC`_&5OW!]14M;9.\>-9'+9'`V7I:GE\RAOYGW,(X7-6<#I$B80X3AKFBN4)C
ME!8H\@B"VN'D+HH6?"0WA1^\\98#21&#C.C/R'LKDN+L45DCQTI1X&F>Q1VG
M5>FH+.A[RKL:&L)8C7J35RV,SNO=)^R-18=B4*&<E:65K6_=O7I@J4QPJQ:^
MLEN$\5U.X;/FD!#"J&Z0J3LDI;@)I3%V2;QA0):QKER8)$CA<F;7=`/8O:L:
MW!,J*V,@\HP9*K-N6`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&!XK>:7_-G@?^T=Y@_TC5Y);_GG/H]J<K!@
M,!@,#Y_>9?[QAY.OZD/&'^$O.&I_6/&KZ`L,F`P-.L1OB;O7\Z:IZ:G(@SG#
MI.WS0]4IVC2DQ-:R+DTC-4JP[")*G+9S#MC,UO6P!UL7_HP/&MDG=51])7KH
M]N_5DKL:52.U8V;8\FYQ''TC!)I=7H*R@[7;K5'VIJ;8.F2P)$A/CPMEEC>$
M6BU0]F;._2-='J[S<S-<=YWH2/L<RW8K*Q4O5K,T6#M$4V[G36UP=B1-\RVW
M$@+)0;DZ0@"WX0!"$KY_;K6M:],,SF\LE+US7)KOMVY3NHY#"GRN^C+1A<T1
M+ZB@D:C,+74[6SF"Q6"5@51G1LL3+X.<H.:)@O\`J'0Q*+9:)1L'J'#6,,`P
M\Y\[3BJG!GC/5<I7I8`B/GRRTC*RK!P:G&K5J1FI6(1IH0N45/BZ_P"W2#F)
MD&6Y)B?NSJ>UB">884YGA,A>-M]D,EJ:7ER&:V+>UV\SLEQ40JK6ZXE>5-1R
MLE%B-<26)J;CUC:1RAD-<:Y5+)#;>AH2FH2=&XA/T(9>B4WZ(1\I_H"M,-LV
MYI_V6R6:,$ZKB%6?*VIBA)"9?.&V12(<`BC=`H=&BFA$K<RIF2B$!`F^%8-,
M!2<+9XCC-TQNJQ1_;W-_%3Z\5O#_`.)).ZFB0K:>J;7TO"9;$&2&W!<.Z[K*
MI10^7,A;`88YR1EU&$9Q.RQ%Z"XN1H-CW[@@#%BZPA.-.W#PGS]9MRWR[]SQ
MA;+%D0I-AZ';Y$BB,7;D_P!N(-K.HUSC&(\PHRH8[+G%;I%HEN"6!0I]`&`_
MDPE;IB(B'L=')$QR^/,4LC#JC?(W)V=LD,?>FXX*AO=V1Y1$N+4YH3P_HG)%
MZ%26:6/7X"`/6\K+,X#`@WI1+%%=(3_4R='=D:$C>W.R)VCS84^21OEK(^M3
MQ`5498#R5!$BDQ4Z0MVVYM,+,+<5OQ)A`$$W8=EC-X8*XESE^L_5F1&P>YW6
M_P!@JJ83JQY$],%DI^?$$PDT/^EE"&Z*4CZE!"(78SN2?]6X1YJ0IAG*0["?
MK?IO61JYF*PKW?1!$69NCL4C$?:%1JYI8H\RLS6M/4_6'K&YK;4R)$J.6>HO
MJS5"8@(Q&>N_DWOW?^G*P^>]EK7B8\1,W9.G>B.8Y)94=Z;KJJGM\CX*T>&Q
MQB\"GYUT=$URA<6$Y,D>]H7$3F1(S0@,7'-B<``##L0!&L?5L35SQQ2BI=BI
MM!Y%=N\U#8E6]..ML2M35$SMN7,=/1.M9.M(>"'R/*/C8Y+&K"8'%<J*3%K$
MVGTHQ.(L1OI@QF;I88^;>/B+Q:9U:9T['%>NJX"U5$F941;8O>'!#.KDG,"1
MO!#4@9-B-5+)[>GV<\UP+]GL3D['K>@F"V,>RF-E\Y\95ZX6[R*=UUT5S<]L
M9%-QV:VLNCS-]ME<,%*$]BU52C58CY'W5)(4,6ARY-'_`(?9HU&S!`7LWWZW
MO(L7GFG]IK'CZ;7[;#*P]I%+ML[M:I<HKUJBM8D-D>5RZ'7.^G1@$^)C(9$[
MK:K*L:?2%7LQ6=LTE_2%.`S"4#<663&(R:"\<QUMTS:C#6',=RH9A1K^!JM_
MH]VCSO3#M]B1/*9(KJ9G9X\YQK]9T7!)&YB.,1',:Q*TG[^3[H2;K8-"+EC.
M;U)X;YW=>=:FDK1)DI**6SVV;+L%P;2G0I[U&(>YRA<TTI6P7@@!:=Q3U!0[
M+&(F084'1/P,H-%:T7H.LK,S:YN$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>*WFE_S9X'_`+1WF#_2-7DE
MO^><^CVIRL&`P&`P/G]YE_O&'DZ_J0\8?X2\X:G]8\:OH"PR8#`T"UU<305;
M92Z>MYCO!D4`F*N:-1*<Q6<YQ--'7$Z1-Y24D0#5)BUG`<6$L(M"'L7IK>M[
MP/GGGK=/(M):#>'=ZO)'+S[@<JTF;.HNR$S6(.LWFD!5/=32:4.#-X_54=DR
MYKJ96C;D:I6^UM^7M)2TJ1>L</G5'QOI.7C/J]W^64S8BYCYR1LK@_.S,DH>
MH4S2ZRD3>*3N;817T>*0.$C$T;VU"?EB4`#%FTN]I]J!#^/]#TRL3F\<>@J[
MX7EUMR1+<*^[ZGGE@3;IFM2IS6UWP2*OFUJA2U'*)\EC(G1CLH^1-2PT"*+O
M+-'G_3`69M,M7@3&C!D;CE$89)/Y'7<TG&W=S<"H^BX`KK*EF+\\QFXU]<O$
MNCE4;D<VMBO9R^)Z]='EL;I%,Y=+7\^/%-JIY.VE8RAKRFY3L*<RI.5H8G4"
MBUT0%/%^F%77-E3UK>D*"H5=3W+6J_I&64_,P'7BV.$\V30W*=3,3([1*FG%
M$L:D2R5;5LQRQ$M7*%AP`@+=9,!+)SS;+F.&)8%#^Q5,>JFJ9Y71=P\_+:ED
M;N17O/$U2O[?7`6>PX<8;(9A>;0K2+EQ.F5,C0,N][TZ(SRS!;B56=.G"97Q
M31KM)U3O'^K8O)9_<U]S&%MUF7#5,Q4N:)F,YVZT>P0T:*82ER24YN;K69O9
MVF,@?]-Y;FXJCBRT1IRY-5FYQPR7%XOAW-%CFM;=7;'TM7XXV4GMF""M!9!$
M*2R8D]6CJ?F3J('PU4_"5Q/4Y#]O&%R`T.6T^_9]/L._FR)+U4KV$M-:P2'5
MZPGN"EDA$:98JTJ'=04K=#VYB;R&U&<XJB4Z0I2M,(3AV:8$HO0Q[WOVZ]?3
M*RW#`8%?NIC&8NAIZ!Z;W%SVK+CC;'4[0XIF5S*GSI+F!MK1Q0OJUBE*"/J&
MBPU36K"XJ&MS3H-D_4&I%)98B!B'@Y(7EH5VQ'HS$F:2F]#5O3EI)9B?/7&+
MKVM->RA0,;RXL]UQCBJ.*K-E$Z<3%`EB,RQ:]97$KVB(C*[6]%`-=,7T;5^7
M&R8'"2H:=M1$"HC&RXJH$,TP1\;`S(@L9PC#PA.,V:UZ*%L0]:%OU]=Z]<,^
MKYQK+45FZ4]9K[TRBZ(A\`.67)U5%IA1O1-#M=J3R&N#EKG]^>GUO4TSR[$J
MOEL%/GQ#VUEL#@YR!>:B),4O+LK"4@4QN+Z(V#27CH%9U:]3PN#]Q2NW*;H]
MQJ"',J:PX8@F=OS9DH&(3IT$^K!N(B+`OYC9+1TSR1Q?)"A1-LLB!I8R%!R`
MDXXO+=584M*BJF&\:T=4XFPCJN65Y;D4@_1EN7C:=_,,ROM@E_//VJ_:^J9(
M_P`GII_A%F63:;H0I8C`2=[B;<K1)SB43J6XC0E&5G.6B]16#S7=2WH%*?2/
M=])7'.&PJS;"E52R>E*,NNR$',PFJO#*+9+3A\KF+B]Q7[JG^)Q8W5P)9CSO
MD&6HV$?LR+%X94G7E:AN;[_D$WC*2N^K*)F]04].>=7!9-)/6A>IO1=MSFZF
M::,#`\1/<A,,WN?LIXW8XQ$SN#8_QM$6WJ5*,M0H<:DS,8X/3'EODVN>2(8*
M$UT_V-)49[5%6UR>[/EQDWECXHB;48SI7]_D:I"D<7J2.B,8?KEJ@1AJ@11?
M_1T#6L),VL_A#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`\5O-+_FSP/_:.\P?Z1J\DM_SSGT>U.5@P&`P&
M!\_O,O\`>,/)U_4AXP_PEYPU/ZQXU?0%ADP&!QG$DJ"34Z@HL\@\L9)Q)P`F
MDG$FAV`PHTL>A`,+,`+>A!WK>MZWZ;P*@KN!>1%B>!%%TA%$!U6.DD?JV6(!
M.R=3"Y!+1.(WQ^:-A<OB&['F.R@99JD)_P``C/T-!#K0<+RF%E8#!XQ6,%A=
M:PEL+9(97L2CD'B+,48::4T1B)LZ-A8&PHT\9AYI:!J;RB@B&(0Q:!Z[WO?X
MX3-7TSA?D`Z;Q"RE//%9+9_`7B=2"&2]>P%KW^-O-F.93S/E[4XK##STYTK=
M"`'J]:W[3!AU^&OY,+<LW47'G,E"GMBNH*9AT#6L_P"9`H%[,F5[<`%R[[=^
M84ZAP6K%:U<E7::D^M$GC,*(T7Z$A+UL7J)F9S::C\??&+>T31B1<]P1.U6)
M,R+"F24!3KZO<Q3$OB=.]&J!.>U20PE/)7`L)2<92?1:PT/Q^T>]8+EG95Q!
MR7-GDZ0R:AH$X/*B(SN!G+@(%#>89$;-<ONT^9!%MBM$3M-*G#]-4+V_(/7Z
M.A:!^C@N7'_09Y!^_-<H%SO5YLA8U3PM8W<^.)SUK*ID%9QNFGLQG-.V9]KT
MZU;$&QC/"1\83$"(H&];]OK@N<DV1&J:X@.V04,AC#&]QR)$P-BVU(@IMM4-
M3K]NA$;1>W>_A:BG'?S:*U^&A_CA$@X#`8&!E$8C\UC;[$)6THWZ,R9J7,;\
MS.!?RHW-J<DYB5:C4`UL(O8<0;O7J'81AW^(=ZWK6]!7%[XFYI=F^.I$=:MT
M770NO7.K81(HHJ6M$AAL+=PEA6ML?7Z//+(4#"7KVJCBSE)?KO81ZWO>%N5H
MT2-(W(TC>@3$HT*!,0C1)$Y82DZ5(E*`0F3$%`UH!9)!(-!"'6O30=:UK"*8
MO_CCX9E<<L6(R;F.K9!&+9DZ:96(Q/+,<XMDHDB1:!S3N*Q*K5FEI]%N185'
MP)]$I]G@"9LO8PZWHO*8QT2(_<><P2>#/U:OM(0)?!I.XVF[OL<VT_3HG!UN
MZ4G3:V7(8TAI"HE=/94I,6N!I9@!FFCWZ;T'?MP7+)ROE;GB=)*];IA4\5D3
M;5,960VO6QU(5*6R,1A>R)HXI9T;:)5]"<F$R)"DX=GEFC+"#6P""+7NP7+)
M.W-M#OKBO=WBJH:XN;FU31C7KE+46-2J:;%5G+YPA,-]="^"3+5`S56M>FQF
M"]WKK?XX2V9K"CZDI=L;6:K(%'X2W-$69H4WIV5,,O9$5CRUX<F9EV>>:>I/
M2H7&0KCP[,&,8CE9HQ"V(>]X,TJX#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'BMYI?\`-G@?^T=Y@_TC
M5Y);_GG/H]J<K!@,!@,#Y_>9?[QAY.OZD/&'^$O.&I_6/&KZ`L,F`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!XK>:7_`#9X'_M'>8/](U>2
M6_YYSZ/:G*P8#`8#`^?WF7^\8>3K^I#QA_A+SAJ?UCQJ^@+#+SL\D?*SKU/6
M-0L48CC](9'#NF^=).Y!8+5EE4G)*C)N*%@O_:QRC$Y@VWIO6TSIY3GH!FJ5
M*@DT8416UFR=Z-;9J;\I>4$OY_\`-A3T=ZN9N6E4BD$?FMR6%9E51&=WQ5@'
M9C:)#V!U&Y((G2\UE():IKUC<J.6UQ(%:"1@7$`(-7MJ8Q$K-&F0&[V3,7I_
MI)/D.Y?\HMO6SQ-9_.(RDUI5ESPO1367$6&UQ6F(ATJ?.J.DI[U-HD*TH^]/
M$$7-,9DB4S;;&IL<M;3S&;X&T+GM[;R;9VQ$WDP-I1;S;L_*<V045&KODEQ*
MK-,7TPEMJ_\`D1JN>$-2>O4!3ZXW2_QT+Q2EGUF[VH8O.C<?:5[4\E,FTP7)
M6E.`,O)B?#ECE7T2*R\]>3\=Y>-,=B2ZWK"K*KFRDY_T+(5-K4JV(F>U05'T
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M=+-J1UEWYU#-X\)Z+ECTO*0*$BQ,G]PSA\,;;&=17F2`^0><N3GTRNE*ZD4,
M!Z&_)=W\EH-.<H:[4E$KM9RYI8Y)(T<0BQTW8'="GJE9)"RU+(C3G)I,,@7Q
M#%#X>+\>OLDYKIKS,J;'J2:RVS[;&S1*5<N-ZNM8A8?-+'`9=6RNR^F5UXG=
M`NJ]K=Y8*?P:I2:Q+>UT/*6II#(=*D;.F^@6+'5JI\*FO/Q_EL_>%;^8(^TK
MXL'DEUL290-7.J+C5:4O';VH6E4Y]:):P,<;!GD(E,[@$W/8Y,V7<$DF0)7[
M9>WF-Z.(:RRS1A4!AMX8<O\`#24,%\UBVN8F*PEUP"N`Z6S]TLTZFK)Y/9:Z
M-G*\<.-YS<JT039X"\MO)$%9BG1+:S$XBW.GMXWL^/@4)=E^ZGPZ>/SIT1!&
M:9_\P2QUVXJGBSIW([4=J0GS:XI#K$YA-BC;<4MYYZ@&0YPDGZ)G,;T\6Z$1
M5J5&1KCC4Z)"O,VN"I(`M-2P^#<)K5OGIA\/O)OJN52BS52Q=L4`(L*W^>X_
M,5S#&>E+L9HZC@,S;8R-EB$CE/.Z>"/;PH?6LY,J,$N3`TB7'#3I*1_UW%^,
M/N[;I67G0+MUND$DD]GR&H)-+7-5=$-I6R^6HU)T$8B]5\W)("DYA5V0<W(H
M2;+;L>)ZNDH)(K6B/C;,<G3F)E)K6)>Q/A7FV7A&HO)!2_+M[PKKBQ;DJ!NB
M_,+"VU_;=E71SP_*:TG<;;703B"$@BCM;`%[0TMY*82Z83-\*6.:S8]:9TY(
M=&;ANG;.ZXK-%Y";S>="<^5Y;=<2V70FS[THX4SJ\N/36BF^E*+L:6OEC)W;
M?1K3-&LJQ+`@J^E10]9!-PI([&MDT,<%+I\S8,G&)\(N'H53C/Y+D7-%KSB<
MI)`=TO$+OL6:4I3,[G%-":+.J]/"&"/Q:MYE*:_4OT48VR0/9;FXMAXG).L0
M+C$YBX02@C(U69XWADI'/.;_`#63J$SN"S&W)0ZF.7.T%=3GNN9[4<#1NUL(
M6NC)*^P"N50MI9/';#36@FLE.<[NHDD56191&"`JM*"'(0C5[/=GJZK_`,T,
MYC'D?@-\PQY:(M9/(%\17G!R'T34+Z]R&\Y-#S62D4=:IX*W1-;09[1'7,Y'
M*E3R\N:15+R].3>O(0!+V(?"*F-=&D6!X\^U8E"G*O(,RS:Q+6!2L"CW*724
M&N`=:5UR%.D,)"CM4RQZUGW3+[,K`5SJ<;5+R%)":<%`TL`#1B4!7Z,.43-S
ME_GV;SQ_P#W'2G'_`%_0\HE,L;K$N+C6JDM42QFLX\INCG0*BKK$:9W%%ZR3
MV[=4H0V:WS%0V)I++T*U%')`WC1'M12)0G5##3=NB9OI:!JSYV\X-.49:"6K
ME%SO<EG^Y[,%,(Z$Z2YZ?;1;W9'>E:DM#'75K1X<XA4$F]D4D1(CREBDESCK
M6?\`!LQ.F5?]7,G1J9_G,KP]%\^>2FRT?%%B1>8.S/=M5\CV$*[T<-L2+QFL
MU74;@AHA$9I'%UYX4TB>)2PG3].PGJA+(XTNY+>:K-(3A^536(XXWE;SZ<.4
M/->LLP5J,ZJ["&Y#<E,N$4*FE_T`HOE)R_'><^MH/9T7EQ<8FH^>5W5"Q_M%
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ML8S-$KA(CPB`&-5&51=2L7*Z5\WSBQH)"UVI;*%QC%:PIJ8X*R6+S$D>I0I?
M+1ZP6"U8+@Z-BB,.=SUQ""J5#,G1$XH8T[(@28IATL5J$_PF;V>/I^6@-[YY
M<+FMCHW5-6%;CZUU3U1(:HNTQDF/.,=K-54\=J^GW*;UAQPRS4M!.HAT[J42
M!:I8)!./2&)TYX@JU0A;``(^,5I236N*>;1HJ/J<E>P7#/9<YM5:I>7&Q;?_
M`"C7$_C;,E<I0H+;)#*F=OGL&?[(9(WIDW8+\L"W-SZ^C7(&!%]M*3O*BXD\
M+CW7?\?E6=?5_-K(?.HT-G%.UBR683]8H)L>L9#3('9]I;B1D6)]Q)#)Y'.V
M*0;LF'3@,?3M>RH^W(2'<:L.S7)I./,[JK#QF]7<,F`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P*8^1*];`YDX?Z=OVJ@,0['JJII)+89J3MACU'
M]2!`47IO&[-);O']N*,!QNMB*VO1@'_((XL/J/1=L7,0\CA>9R_:]B\_C$RH
M2`3:YX"%QB"B(K+'2U_8T%L5@O>M:%+4]@UG!T%VQSFV'6X\6.%WKYP8938"
M.6,;<>K2G;+V7O<;X7EX]/\`>CT?\CG65K\H\HHI)6<>8GWJJSGV%U=44&;H
MQ8%NM"FRY)LM9+75MA,"8@6C9$5K*(-SS(EB9J;`NJIH:#1A3@%[@AK.V+GR
M><SSY[2$VZH6(:RJN.M4Q.YWC<L9[AMV20"W6B3W+6ALXG$DC-11ZKI\]2JK
MZ(D98XM*7!.HVM125"O1!2&#3AV::X(N2>?2T7!F!:L6I2MIG7LFKFK9LRQL
MZ:RR+&,K8T0WR46#>LE99B*"/+Q.$\CC7"1>X6W.$<C2CY''6G0Q$+9P4I?^
MN,NM_;[K&<^^7:T^B+KYB8$,/YX@U66G>EGTU8"]/<+K8XD+LUU)JQJVBC%:
M<?AR*E'JTWW1@0',L=?9.`*X(FXY0F5!WD9G;$1YTG[R(>16<<F=!<JU77$.
M/G$??I"U3OK-4UP&;SQPK/GN1S%LJJ,2!0MB"8]HK3[[,'1T="7Z2F)&,3?"
MW5+HW:LP@L5-NVXF7G'7_GYM%-7$1<I?#.5+(<9&<].2FQH/?CRRQZ*,B2WG
MN"L\.L6L6Z`SJRDG0<NC)2=UC,#B*:9/,@;DRM=H*5.4/9<M9V8]6BSG_P`P
MK:<4H3G\P;=S`IZ!M]HH6/2=ABTEMJ3R.NK'MVP6N*K3GZOU=:,=>HV>*E)W
M-L?FI18!$C99*F,1A0*BR!F[J\(N<Z>TW`_?$H["EMP1"7U.PULL@+0SS:+*
MXU.ULX22"`R2[NDJ38S9#]QB,0.CLQ^Z\VN"M4A(`O1EDKB@EJS1@,UHQNVU
M2!O-+_FSP/\`VCO,'^D:O)*_SSGT>U.5@P&`P&!\_O,O]XP\G7]2'C#_``EY
MPU/ZQXU?0%ADP&`P&`P&`P&`P&`P&`P&`P/P846<6,HXL!I1@=@,+,`$98P"
MUZ"",`M;"(.]?RZWKTP/Z``"P`++`$LLL(0```.@@``.M!"``0ZT$(0AUZ:U
MK\-:P/U@,!@,!@,!@,!@?S>M"UL(M:WK>MZWK>O76];_``WK>M_AO6]8'2):
MVQ,0!,G;D*=,6?I4!.2D3E$`5:,T;I2`H!82PGZ-U[M#UKW>[\?7UP.]@<19
M))/R;)***V<:(X[998`?*</00B-,]NM>\T6@ZUL6_7>]:U@<N`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!QG$DJ"AD*"BCR30[`:2<6$THP
M&_Y0C+'H0!AW_P#TWKTP.IMK;!&J#Q-R#9ZSX?JSMHT^S57TX@C3_4&;+]Y_
MP"#K8/=O?MWK7IZ8':&22:,DPPHHPQ.,1A`QE@&,@P18R1&$B%K8BQB*,$'>
MP^F]A%O7\F]X%:YCR33T_NR#7M+R9D^R*N!;71"&+9[*C*?:Y.!.>D23W]47
MW/4!46"V)%1I25Z,0B7I@&"T`S7KO"WA2PX69H"#186IM"6$'QA`%"ET`)?L
M4E^S0=%>F@?&L.#Z?R>AH]?_`&A>I']):&E.`HLAK;B"R%'U9)9*),4`E5Z>
MGU)00%!"6H]/_MZ]!?\`KP.R-(E-&888F3F&'$@3G#&26,9J<L9AA9!@A!V(
M9(!FB%H._4.MBWO6OQW@=`$?82]:T!D:`:T<!1K0&U&'6CRM"T6?K6B=?SQ>
MA;T$7_2UK>_3>`VP,6Q:%ME:-BT/1FA;;4?NT9HP1VC-;^'U]^CA;'Z_R^[>
M]_RX+=\E(D3"$).E3IQ##H`Q$DEE"$`)AIH0BV`(=B"$T\P6M;_#0ABW_+O>
M!XO>:7_-G@?^T=Y@_P!(U>26_P"><^CVIRL&`P&`P/G]YE_O&'DZ_J0\8?X2
M\X:G]8\:OH"PRT>?V;6U4,A,EM*P8/6L<4.;<R)W^?RQAAS(>\NZ@"-I:"76
M1+VY":YNBLP)2=.$S9IY@M!`$0M^F!O&!TW%Q;V=O7NSLO1M;4UHU3BYN;BJ
M(1-[<WHB!J5J]>M4C*3)$:1,4(PTTP00%@#L0MZUK>\#4*ZM*LK@C89E4EBP
M2TH@-P<&D$JKJ71^;1L;JTG[2NK8%\C+@YM@G!L5:V6H)T;\A)FO:/6M_A@F
M)C-N:I8D0D_4+529&1\R9/\`.J/*3D_4+%)2-(1\AP@`^94K/`46'U]PS!A"
M'6Q;UK`Q"25Q=>[!8$,D8%KZ-I^_@94CPW*'8;%]7]O^]!;25(U@FGZ_^8^I
MT#X?F_0]WN_#`[A;VS&N9C*4[MACP2$X9K26O2C<R@)BFT]0,Q`$W:H`2"'A
M(,>]@UH(%1.]^FC0>X,G@,#@-5)2#4I)ZD@DY:<-.B*-.++-5GEISE9A"4L8
MM#4'`2IC#=A!K8M%EB%O7H'>]!^?K4?UGV[ZM-]P^F^M^A^<KZSZ/1NB-J_I
MO?\`/]-H_?L^3V^SW_AZ^N!V<#JE+D1RI4A)6)35J$"<Q:C*4%&*D8%FC!)!
MJDX![.3@5!)'LO8]:T/0-^WU]-X&&>)A$H\L);W^4QQC7J&IX?4Z%X>VQL6'
MLD=)*42!Y)3+51!QK4QD'@&L4!#LE,`8=F"#K>MX'5@D_@EI1)EGU936)6+!
M9(G-5QV:P22,\NB3^E(5'H3U++(X^L<&=T3DK4II(QD'&!":6(&]^X.]:#8S
M5J).I2(SU:4E6OV>%"E-4%%J5HDQ6SU&DA`QA-4[3DZ]X_9H7L#^._36!JQ=
MCUZ<1.%)4\AAJ:LCU26R5!<H8QD5\I0LB63+D\X-"NV7$ST<<7D.!H%^TXBT
M)P#Q:T4,(MAW66:0Z2.3NS1V61E_>&!*Q+GUJ97YK=7)E12A$8YQE8[H4*H]
M4VI9$VDC4(3#@``K(#LPK8PZWO!4MFP.@M=6MM-0$N+D@0'.BH:%L*6K$Z4U
MQ6EI%+@-&@+/,+&L5`0(CC]EEZ$/1)(Q^GM"+>@TXJV:K/ED<@1-F5^=.9C&
MU4QB,+*F<<,EDJB"$SXELJCD<`Y;>'R-HS?T35R4DU*6+\!#UO!Y]$@8#`ZY
MZM*F$F`I4ITXUA^DJ0!YQ90E2K91I^DR8)@@[//V00,?L#ZB]@!;]/36\#\*
M5Z%$8A)6+4B0YS5[0-I2E2208X+M)52[:)"`T8!*U>D*$X[XR]"'\1(Q^GM`
M+>@[>`P.FWN+>[(R'%J7HG-O4A$),N;U1"U&H"`8BAB(5)AF$&A`8`0=["+?
MH+6]?RZP/V0L2*359"94F4'-Z@*1>20>4::B5#2IUH$RLLL0AIE`T2PH[0!Z
M"+91H!^GM$'>P[&]Z#K8A;UK6M;WO>]^FM:U^.][WO\`#6M:P.@6[M)VVT)+
MFWFB>4PUC0$M:F'MU2%E%*#%3;H)N]KDQ9"@L8AE>X.@##O>_3>M[#(8'23N
M3<J5KV]*X(E*]J$F`Z(DZH@Y6VC6$:5)`KTQ9@CD8E286C"]&!#L8-^X/KK\
M<#]+7!`V$:5.*U(WIMGI$NE"U22D(VJ7JB4*%-HT\99>SUJU0624#U]QAHP@
M#K8A:UL.FC?V)Q6K&UO>VA>XMYIY"]`C<D:I:A.2[("I)6)2#AGIC4XE16AA
M&$.P;,#Z^GNUZAE\!@,#'M[LU.P5(VIS;W,")8H;E@F]8F6A2.",?QJT"D28
MPS1"Q*9KVF%#]!@%^`M:W@<3Z^L<79761R5Y:H['F)O5NSV_/KBD:&5F:D!`
MU*YS=71P.3H6]O1)BQ&&G'&`++`'8A;UK6]X'9;G%O>&]$[-*]&Z-;FD3KVY
MR;E1"UO<$*LH!Z5:B6)AFIU:120,(RS"Q"`,&];UO>MX'4<Y`PLJID0O#VT-
M*Z2N8F6.(W-R1(%4@>0-R]X&TLB=4<4<ZN8&AJ5*MD$:,-TF3&F^WV%C%H,J
M,8"P",,$$``!$,8QBT$``!UL0A"$+>M!"'6O7>]_AK6!CF=Z9Y"VIGF/NS8^
M-"W1@D;JSKTKFVJPDG&)SA)ER(T]*?HI02,L6P"W[1AV'?XZWK`Z*N711`_H
MHHND\>12ER0B=&Z-*WIM3OZ]L`L*;AN*)F.4@<52$+@H+(V<`L1>CAA!Z^[>
MM;#8<#HMKHV/*(AS9W%"[-JK0]IG!M5IUR)1HHT9!NR%:4PT@W19Q8@"]HM^
M@@[UO\=;P.]@,#&KGEH:SVU*Y.K:W*7A7]O:$ZY<E2'NJ_XC#_HFTE0:68N5
M_`4(?QE:$/V!WOT]-;P,E@1XVVY5#U/WRIV>SJ\=K3C+<G=Y)6C;-(VNG\>:
M5>PZ2.CY#4KD;(FEN5;'KXSSTQ90_77H+>!(>!U%Z]"U(E;DYK4C:W($YJM<
MO7J24:)$E(!LP]2K5*!ED)TY)8=B&,8M!"'7KO?I@=O`T)PM6KVF4JX,ZV1`
MFR;-\86S9?#G"81Y%*44,;=Z"X2Y7'U+B6[)HP@%OT.7C)"D*W_TC-8&7'-8
M:7$C)\.6QD$$)9C9$;-1OS4&)%1\A.)6<^F2/:O3.!F)2`V:)5L[1`2];%L7
MIKUP-<07+4#HI9T39:U;.*R0PLVR&!(@G,76*7RNR-["=/6<A.Z&&N<+)%K>
MA.A.AH0[_E-P/PANJFW22Q2%MEM5FXS&>1Y7+H/$T,\BRN2S.)H-#VND\48D
M[J8Z2*/(M%B^5:C*.3%^W?N'KTP4DS`8&NRZ6QJ!1>0369O;?&XG%&=>_P`C
M?W4\*9M9V9K3&*U[@M/%^!9"9.4(0OY=[]/36M[]-8%8Z7[MYHOV8I8#74GL
M`J6.#.J?FAKL>@>A*3`_-B#:7ZXR-N5TU;7[5)%*("TH9R9`>H4E%&!,$7H&
M_=A9VS&:WV$,"HMU=T<U\_RX^"6-)K`-E:-F2O[HTUO0705W;8VM>-6!`;(U
MM*5=8+=&U"_2`X1"=><G4G%E"&`L0->["QMF<EE8;,8O844CTYA+XWR:(RQH
M0OT<?VH_2AO=FAR(`I1+4INM:WLLXD>M^@M!&'?J$6M"UO6B-EP-)L:QH94L
M)D5BV"]!8(A%6\US>G/Z%S=5!:<OT"$A`S,B)R?'MS5FB"4F1(4RA8K/&$HD
MHPP00["$J.[+Y^Z*D3O$:QD$XW)V5K)>E3%8M(WE23FK:3CQIMKV)+==<5Z9
M)DR8\'M4";=*_I=B#\WL]X/<68F,UH\(\5O-+_FSP/\`VCO,'^D:O)+?\\Y]
M'M3E8,!@,!@?/[S+_>,/)U_4AXP_PEYPU/ZQXU?0%AE37NJF[AO^AG:I*?04
M<X'S1R0L\[3WL"6:8SZY5"$5+4,770YK=G=AFCJV"&E0N@"_D:QG;5$_SY1>
M%BKQM;%B^^Z0BU(BV<I>%:XA)`QFK3D7VL*X\+/L8EY)!^EPFS16U(=:V6$_
MW:!L0-:WLC*'D$*B#DJHDI2F4E&$*$YY8#B#R#@;+-).*,T(LTHTL6PB"+6]
M"UOTW^&!Y441P!.*5M"/R=N>*K01]DIHR"&.\51R=AERQX.@3?$MQ\;"C*20
MG4$32%$9(P*ME_>#'129HS>P>F\+,W"K]D^)F[Y)(H`Q1>4<Q%T-":%B4,?(
M!(X=90IS:EGQRP]7,]@GEH(7TYV_5).[6)TO7(4Y'UZ41YIQ`_=H!.HUR];M
MG8YX\YW`>LN8I@#12]2YQNKF?HV90UOEB9C20+F!L<+(JZ*M\K=S2R0)W+H=
M,REZ;_\`WU>P$G?4@$#Y-X2\$US;QM.TGOFR[?85M:P96OM.3VU4<Q813C=D
M0Z:SVO.=(7,)<M&>J^PIY`=NI7DHL"?1R,U$X)O>6$P)OHHY84C[^'EUXW\2
MWSSVBN?FN1VY;5Z*Y^S26:4])%M.M$(%+VN0$A>:]1R`#DXV:N3(/>L="E92
M<;B$D\)>M%^T5(F+N<E38YX[.LVV).R=_C%/SA7*N@V]O<&J0O?0"9%.UL=N
MFYY$/HVW_HRR5[8=J.O37]H`T^Y"(DM/H_>B]:T&+RCSR6%AWBHO`$,@T/GE
MJ5Z,+"\5J;:#O&G.S5+AT6WL:5^23)ULTQX,3FMDD+:'L]G:?MQGQ&-JY3M4
M/0]%!"2VXO/B;3.W0-;R9:AJ=\H.*0.X(*Z1%Z=;3#,TL?62#[[SK#F':)S`
MRKHC51P`"-TM/TIT9K^:V9K*EX4A20^'WHQRNN"/2#H2OOZ/"&#P2+SBI'-N
ML$YZ*<6GX'"UG"NI(2[:,CJ*_G^0/ZF5IS=C^N]&W8!%?3[UJ4URBO-;RM_'
MC(JK(M1JB#A7#2"Q.0@<YM<V1J9V";PU;%7N5;KQE;`J5"M$HKU$Q2\TQ4>,
M[3P6O2%:+V84+8@5+O/5WJJ\>:B*)ULIDZ.JR[-+YAMGG^%'1D4Q7L=6H[0L
MJQ)T.,PMVD>MO0("VM\K;V_8C4^EYA;:'\-`"`&B7_E7J)>)B8/%!QVM;D?J
M[=Y:@K"MZY>UC9++4DS:Z%59#^ADD44*I$Y$Q%[<4R"QK1CS\27M$F$5]B^`
M6S@ED[$6=VB>JCX(GL`ZL1]#O`J?<2TEQV[,P.);G9KO8@(G9=5)(HJ'IU>S
M?LPGUSF:<2@QLT2!I9VH?P(AC'KUPEMSY<Y(NZI[KZBDUIR*HI)3]\RJ92,J
M*1Q+*7*3219)78Y,G76.?)T!#1I"AKTM$RDLB+YT"4:=4J`8,3D<64)F.BKN
M_%=:$:42157DVK=!*I5%7D;C<CPZ6(&V"I6H:)(V;BP5K:1IO5UK,T;@B;G3
M9@M+6YM)&%`7[]%[T6VXN7"=[/!*J]+4FD%9+W;F&?%OJRES;>ER#\C2.VKM
MMB4U?$VYR)2R.0,DR9IPT-1R8#=IPV)&:6C]/5.#!<91DP'+_/?2B?D"IG6K
MZ_I^J;$B'0$NN"`4]:B+H"%5BQP>20&25MN/&,DO9MWS"3M%R98[%(7="4J`
MNWL(RPIS0[P3,<L;I,O-?"-BLT[HJW>GG>OUL[Y^I%NIB'1JDI%.15JX?8)4
MZ.[+.7]NFK,WO"V2%MZDH02_F^F2*MF^P)A>P;")F,HR0_67CSZD9>IDU[VE
M-.:9BR-'2=B6O"T,58K/A1L%@LR2J&O?LA"1>?"IM=#LPI&U"MDCD,!:4I,<
M-,1LQ0,6H7%4W8WA[IR)6U(;EJ^7TD"6IETS`V&2UWMC15RDV">4@72J\RVH
MDU,V3""QHT\EC`QDF)!FZ!\VP`_Z(N*IGR_'5*$O'%<<T()XPI)&R70=:-D2
M\LV6_3SU&[3&4O4H1FGFK3GPIRD+!(0HSA_(65K81>W00[U@O&T1VEXM+*>G
MY(VU1/X%!X1'8QTK$J7D2MPL8VR.666WJ(E581%'2`"5*AA5:+E\L&\/!KL8
M,\G24O2(?N$+6A&ZO&:HD-\5';SI&;AK=TM&F*WL+5;ZBT>Z5@S-;+2:V/TC
M:6:0.-?5+7ZY<9$DG.[TLT-N?RC5`GHD6CRD_H`0=XI>47Y6L=`?%)=D.KM0
MN<9_3;Y>[^P-L;G:]%^M2-U=*H8WW!0EH:J!*TI7-:[QBIRD=?REJ3IDH1+$
MZ)_+*^40`&8I)W1.'1UH/XAK%5NT19+DFE-/%"L]3<Z0IPH"'M-AIX^2\5'*
M#GV5,R67+7A!('NLG'9@532WJP%*"'0H!QXQAU[-TY8W&:S<*\>CLQ1RZ8=(
M!UD[HKF9>.S)+,2#IZ"82)[YU:X!%9''Y&G&M+0?D[\N5BB/8CDQP%YBUT6@
M7Z$262(0O3HI$JX.Z#J"<42BE[C'>CWI;UH7/&94Q5S=+%&*D@B[H>N9J*>C
M?8IIWA;79[%738K0N:F1JDJ)Z3$A+(!OVB`.+$QCI3^2SPXWPYU(]Q:'S.@8
ME:095*'>&6HL<+HE#ZQ.D[AT-C\KM14N7J4QYLLT9"P-Z",%%@CB6/KCDNC/
M<``Q*(W8XY-_8/$_T<RU[492.]:?9;<;+TKRP+JD*&$3)WB#W7\&")8QQJHV
M9VD`5%=R"MW9W>?R@HW\Q+<E=!@/T=L`/0G*/HS(_'S=]4\H6A4+4@JJR9O;
M_0%4OJU`0KM9)`9DUH'-I02F7W>X(33IPBU,R$HUTETS"VG(V+84VM%Y5Y1,
MVR3MX\NLW2.2>L7Z0<U6)4*QB1NK%$I[(+P-(.DZB6\P/1M6/B%O2;+)I>"Q
MVB%;5'EB=2-\^(],8>`(QJ]C)$QYVXV+QCWNR4>@A;W)Z,M*0@W81TEKB<.%
MK(*8G`9S;45G#8S2)\92C;!&U0-@8/C;A^PPTU:G3A.#M/\`)K(7%WBE"^N'
M.H[5Z'Z+LI#/.=G"F+%J*(0:%4L_12=1IPFS@Q-+24[Q?HBQ(JL4ND@KAP>@
MKSTGVI,6X(2#"BM>_7OP1,5#0"O&U=`[4%,0M',,=2^V')4DXCTEODZRFDUJ
M_*I[=,$"%SV**BE=!IF-2RP,O8@IE;0KV)U%\WO"*EX4[T'\<?0,@>I'*;_G
M=5+99"8)6T'YI?Z^DEON"N&N]?HTK*JMF3@D^VU.3/9<Q$C*7$I"U*/WF;WH
M6_Y<A,QT8^I_%`]1A26HF!E-I0UQTI=ES<]IX2?9IA->,EBV_0LZCRLW3RO3
M;#-DT4K=^;W`&OJF_1SN7\&]E;.UND[ND7DQ?//#TPLKE/M_GFVV5$>PW!+Y
M!%HFZSV.6NPD3-4W!<-'VE*XE893;)0.CX]*R35!S>#;&X:2EF(A&$[%ZPNI
MB8S;TI\3[2^A1K):M@SX_HXM&F(E[T9.T:HA:P5GS36_UR4"%Y2)4X1-E,O)
M0-!*UZ$/`/77R?,+8C=TZ)#G?CA+D=.\Y05H7PL$KYM<[E51%W>OS:H0'1VR
M8S9<<+@.G`M:<^H8\^M$S3M#TI#L:X#5I1]*+1FP>M2V1Y]\?(J]B/2!%E)*
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M:>5-!CW%%X#5"I$8Y*0*0#WH`MQ8F(;%,N,;<3O7#-31^92P2B%0^P6*]+*8
MD;^GBB2-QIS;[KK>4('A0),U@GQ?3T%A8_HC-[7.+(-TUH&T@57I4M#<,\5/
M4OLIV.6E;//$DA,*H*Y*NG88Q$[(C[_)G^S;-:K`:F]E,T\B(:ZMC7T9P2&T
M9HE*<XW^;-V7OTU*:Y1C5IRZL\<%T]#]AQ2V$5Q0A+S$&L:]KZ;TJ_M,M!+?
MIX?+),JE+5"Y2P.:5,V1&V(9+S44B2FA^58I9VDS1@-)?QJ<L*ZH]0>+6XV^
M[>?Y;J54NLA%&IH*B8I$M6VJ=:<:C$5IY77#Q64-0&G'Q`N$R9Y4:<3SU9@G
M#?IOU'[LARPG5I<R\>,THERY#AM,H4;C'&"YV9R-BL=9KG61B&J#('SN18MK
M;E+48ZL<5DJE\IU^$DW*%)+4M22M22#>UV]!$+N[S66M3A"^[!F70)T>FM*5
MXS3+=U3&I+.:6"1NERD6!<%*2:H"X_991Z)`RG5O$!R3[F0%"O/5*3$H"=E%
M:WLS52XP5ML/Q7=;/]&DU_$KQHM!9Z=5S\['V+((U8JR,/K964531N94:XUN
ME=--R"BCEP3W:/ITZO:]&O,+^H$8$@&]QJ-T7=-P+\0CFAB;VH*D\%D5IOE3
MRV$ODDE;C9*MHE\AEE*]!U8\*Y20!S-&-ED!UEQO:[X2-'Z2,9FRM:.V5O"1
MNQ:4C\372[P\M1$KNBF66K!1.ZH\NJ*),UBN!$2;I_,"WJ+UY75@O#DWR5OJ
M0MF)"4^-AY&C59_K\)A9?IK!<1D],9-SI.Y7UA`+06&P-%1U;U>_0]OC!3G)
M'&02EUDZ,YH7IY+#UK*"(%H6AIT`I"Y`<#EGP*%*8Q/L!NAAJ7AYN*LZYOZM
M:)G%"QV+U6:MK^K&B.T=,9FXK5E>SV7NS/(%+LDF\39DBJ1,$+BST8B2"`$H
MP]:E&,18-^WTV,+M"U#\26C7\@J!7.7*I%C;'(Q'7BRG6.?FMQF+G9C1"OR*
M^QJ*N;^U)2-TO8'R'R!W1*=$'#?E)FP$:*]-Z$S%^3HM?&%]1*T>.'B)/U2@
MKWE]GNU4Z$'/D\9W:6R"PXO:#+#XX.)MD<4QQ7$(NX2]M/+5'+BE:("=5HA.
M9LT'H6XJ=7JD#W>T/O\`;[_;KW^SUV'W>FO=[=[UK>P^O\GK^/IAE^L"FWD.
MJN:WAPQUC4-<-OWB>6+1%BQ2)-.C@D"<GUVCRQ.WHBS1B"$)JD_>@`_'\1;U
MK^7>&MLUNB903'[S'U/T9SNMA5#]2P9IJLBQ)+,Y'?G.%J42R-Z9_8V5H:F]
ML=;+C;$DD#ZL6@'H21O,/,+++$,?H#TWLD[:CH]/\(8'F-);Q%RQTET$ZS:B
M>H9XR6JW5C((;(:"YQM2]V=<3&&B1M+RV.[C64;?R(Z]I%9Q7L2KQ$&'%G!&
M7ZA]V]&HBXZ)F\<]53>C^%^6:ELAK$R3N"4[%&*4M!ANC36UV)2B./1'C#L7
MHH3Z.T$P.]^H#-;#O\=;P;IO=,PNGAE4;N&-R22<\O\`^58\^2MRC$NK*?J(
M]%VQ4^2=U9:_L2,S%_2QMA0`-<']_&S,Q_TB%.`:A6?[2BP[&+6MEA!=:6>J
MZ9ZYKVR8G4'1=>PVIJFL)ADSK?M"6=1!:YWG3G'A,B.*DV9'X\HE1X"V(\:O
MZ,!H4@-E[,WKY`ZP3%:/2W"/%;S2_P";/`_]H[S!_I&KR2W_`#SGT>U.5@P&
M`P&!\_O,O]XP\G7]2'C#_"7G#4_K'C5]`6&3`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`\5O-+_`)L\#_VCO,'^D:O)+?\`/.?1[4Y6#`8#
M`8'S^\R_WC#R=?U(>,/\)><-3^L>-7T!895,[6OR<\Q4%)[NA$*99YJ"GH'.
M5,3L5:RH_P#*6E`2WI:SHJ?JNW9*<Y(R!>_1BIN2LZ4O0CUZY&E+,/`6(N:6
MP*'LPLLS8=@V,`1[!L0!;![@ZW[=B+$,L6]>O\H=[UO_`-&]X1T7@;L6TN@V
M`AN5/H&Y:-E2O"M2@:5+L%,;MM(=%R)$Y+$3<<LT`)YI2=0:65L0@EC%K0=A
MYR<I]V3RWC8Y&[FIAG@TIDK"XR)))JRL%--:F)&"'-]D-\,5/$X:JRL!-,2H
M$[)UBX\<=#'B3AB)*<CA`WA9C1'6_+S5P(>Z3S]2EENL5B3[8;/8SY"K%YCL
MMGK]/`W*BVM,ZN3S7%[RIHD)4M4]"L&T:1D/<W%&'9VW!.C]FO<7BWYJ\E")
MV=S(H1R]>Y4Z)88P]FPTZ0\_!<0FV)-VJ%56U:<P72..C66)MU"O3&Z6;2-J
M0L0'(U$H]I`B5YM('YA>?4\-'.'.$SZ/LY;]5$2&.4O].Q8HF87#-;/8(E#E
M;G(+/;F9#+E,(KI-,2VPY26M6Q^3L^D9:A>J$C*6O&>B2[Z\DD!I.YT'/[56
M$LMZVI%'Z\>(7`8!9?.+=.9*ML>3)(ZTM*V`V%=,*G$`3IBE7U8G>3-S,PJ0
M@VF2K5"[84HA&V\>C<)KWS7L&A?*TU=85)]D=7N2-EB;"*65`V2B-/*^)+)4
ME;71C>[(;%DM.]R$Q$<*+Z?BDQVM''"+2;THPE>R"U/EKK.-5\XSRTJ0MBHM
MD-D?7,L?FTNY[$IDJQV*@+BZL3?(H]=#W"&]ZCS!:#"L^%P<T?W8;D6B:MKG
M#0DH2\9NHQ=U]\HK>16SI,(US-<KE*G6+%3VGX2]OE1L8[<K?2DI&[V2VOY5
MB.;/%HU&#S?<L1/(T$@.`#?T;<I%L.MPXXU;MRKRE0Z`/+L387/MS0Z$LTEE
M+"MM)SD-#GP@I"Q2^X8&SRI5]ON!7(VJ.R^4TF[$)A+4"92WE"*/<RD)'RF%
M5*T:<G\ND/D\`DTYK3GJTIVE;:F_6#%G!KG7/Z^%S:3@C<PF3A7C!.([;D@9
M')2RQ"$+W(Y]2B41E842).@<%BW6TVB\:FI60M#M)XK*[76F=\\61,%Q-3QN
MTHVOC,HJ=.9+$:I=)RYXD1)Y1/H\E:P5JV1\*A6->H2FN(C_`(VXI7L'KLE8
M6Y9CWA!8>[LJ<VN;)>(X[54S6@=,FH$,^U-8I/7=BVA$X6K:5\N12M3)I%$Z
MI>S"C$K>>VD')0E*%1(SB=#%-AK+KE-=DRO*$5O6\D2ZI-"J0N=CSMWB3'6*
MN>:T(Y%#S#V=_D$\3!VV["O4.&F,:`E'O>M&B4:^#!2J-5>1JU959E`UQ/*4
MK:/"LI3%6*<OD;N8UP+1O%F2/L=!54GJ9BEL,ALEL.KYA%N/5CV0Z*TC0I7-
M\B1'-R5:2E<S49>,5,I/JCMNR)TLJ$4DJB&L#7)A1MFM';/.Y`]O$<E5C2U[
MBE=E5X@401K33J-%FM(3I"N4'M8F@!F_:4HT'UV28CHKBY^9&/U7(I(S=!4V
M\1%`X7K?]64\]1]W&RHI^P\^28M@EKFG.O9MI5/+)<!.N1*RFR%F2LAQ"H.*
M;5*T]O<2TI>-Y:)(6^3J9(+A:8(IXQN`J&*.7!]-2"3"L*A-R6+,@I&[$%(G
M&+:M+Z1<D(@S`H?#S$+@J5Z"H2I2TQBD2@M.*BL\;;=KR7%*4U?.+5RA?SJU
M61'`2Q@<"I-SD@]L?>)RZ0R"KU2!VO%O=-?GY.TF.J(LLDPU*BV$M<%*KWM-
MHE>;563RWUC+9W)X+!:7LBP%,3CK?8SRYP:Q.9I00VTRIT:)PM5^:FF]5,DB
M:-D`G-VHCSLB0R\6RAA*:C!:],+.V82R+R+UZGGU20USK6>,S5?]G-]>49,W
M:15`B;[4;%:+0UT_B\4-LL-C_EYA=S"D2Y`I9D\@(T9M9MO^WEG*RQQP=59Y
M$([&IVX0R95)/$;6D<)ZU%6&P.,->(A^8&"X+;J>$PA8W*I(V3U-*[`.J)8L
M*4:9AQ]$$X!:AR+%H7H2FK./D[C[6_RJNU'.=P&W="XS5SY(Z/0SCFMPGC2Z
MVI9,?KMFBKDH17F?%&QR3!E*%V"K4N)34Y(##"VY4L6)U"8HO'LQ#=Y3X=N6
M62GDE.SN-5O#"Z0<&*PECW!1D2"*W@RK')DGCN@W)BBX3$VYP3%H3]NAY"X"
MA61[TX-#WL)*[L#7GEJ@-\<SWM>]*5G)/S!2Q4,;UL`GSLQN#P3+Y?.'"N%<
M1E;#1:VZK`CDHA\P9%Z=<Q?9#Y(M*)3J&MO7IW!N-5%G;,34M01^8=@B4(AJ
MFYJ1=6.W):DL<*:G8I957-4_.?X"Z%-"2/(:PO>5TE=FA296<#_XDJBZ9E9-
M#U]X6-^_=K0C;?HM!-NXI'&ZCK6S6WG&>F.4TG5MUW+H5()K4R%SJ>4U)&[4
M<G%ME3NPSF2QQ^$[R&L#6Y.<P*W9*7]3HXXTH`-^I*QJT4RCRGQ>+PJ"K5])
M3)+:<YK2]94&I5MBT:4_QV?453ZVY'6MG+X;,4+'\N1Q]($"61,"9WCB,P\H
M+@L1C'H&%B+]&>GWE0INJI^DJBQZYM:,V4)NA9SI$@)(@]*FQYL6'P"10*.I
MU31*U:60K9G(9>Y1QK.;1*DBY[B;T66;LI*`TT1MF8N&Q0;OC<P!;BL==DHF
M^KFGJ)ST>5(S%1SO_1N>ZQ91@^+;02!,"4&6`:/W:&9].%('TT9\N_82G4A/
MD@9)NLA[4DYUNUO=K%8'2?U^C7N-.`+E]1,36)>^6L@6@M$:5MC[<I#]+]N<
M1(I":;O0BV\17J/0I$I/F6H42>XR5M?S!DDU%TLQ7//X=(+,YI8GMK2/D%JB
MS`1D\YTO%*SMZX,(N)K4I756J3QQW6$+FYN<5;DA4I"R\)PTE*;3Y.JK63VN
M:[>ZVL*&O]KVA"ZY@:.5O]0-CO(6V=1PA_9;&;8G^LPV8K8:<)2`D`26\;FI
M)`<O3I#6U,I6%#C+'OGD9>(ATC<U.R_F2R4%9TJMC`9A=[3*ZR>FR/1F3H$!
M[583_"T\P!,C8F\N+B%&C3-"5V?P&E#&K;DQ6P#$2HK/%GRO(["7[G@_I&!U
MO)Y="&?H9HHR6";Y;5Z\$=:3)XQ1*26<%TCLV?V>0,#`WO6E>VUM/5/GSAVC
M-1DJ2SRRB\<:EHME^45!6J"*O+ISG/DC6X[L(B7ZE=M<RUV.&N$2CR:4Q=L.
M?YY=4?K]R6V#'E05J+1;T$)!0OB4;+5:&G"(VVVV1^19O9J2=KQ::;ELNB^Y
M*S-3.M9)#"TK`RQR34)7UW,$SLB7O[^SQB.LRK\_IVD`&Y4[J%ZW9(&XM::H
M**V2L:1I,/+G!ZM8X>HM^@;+K>8/R^/M[]7CY9O,)4PCP)J!/^KUW:&4^]$S
MG935/35(-(P1@EW7H-"UIT3(!Z$`)>-Y,RD\LE:K;0U3::D[34V&UJZ^06&Q
M(IESRX[IA9,0HT[\&ZEC?="E'5J.$O2X#=I8\C2(Y0L]0QHUY#^E@XM^O[OM
M]JX,_9J[YPGEF2QEG;145='K)C6$.A-D6VZ/\$9E<4*=G*8GR>,(8ZAGA+DL
M<7%H3HS4J4XM*-0IV4282DJ6#U\.$SQ_KEHHNT+$?X^K96DXZ*/-3MK8X/JR
M%H[%D#4WGSFQHD?H41A+@0O5'*"B"%(3-$I!J%(1DA%86K6L\K<61P;=I"YD
MOT=9K8A))W&)E]YH,DB61B+*F^/N+DV,2FYR90@"*>R!I80`7HD@_JW,"D6@
MMY"M6G%,ZG\G#8&3*X.]\M7]'9OI,\&LD;7/G/ZXR2J(>\(&^PT+8\L=TND=
M3'01N7?<%(UBM,2M3E"+0#5J=@)$*2%4'?S#<<8N*8LE%7*VQ^N(>Z6)!%"H
MVL7APOJ!(99/X6BDU=,43L20/C`!Y?:Z6@)1RQ/'7`D!A8E!!.M&_&)CS:+$
M?)*5('V7HG/G"T&^,160+-GSIJF5(R./E5PT%0-/)K%7$-MG">ADQ)_GR9`N
M:T"9>Z&&@&)(2I`$>PB8I)%/=RM]O7=#Z=3U/,8F;/:!:^BXRX2-XA@E9U=O
M4P?HNRORI&S2)U1;2/Q+60J(2)U2AY2`4>B]"C_1V(3&%H:</+=1)$KF4*9(
ME()H_0^7R2$#,A%D\\2B..4BBLWA,7>&84R:KD41&-2-KCD@?)2X,[RM;G=G
MCD)?%#@F2F$$%*"\98>"^6*$6!&9A.6BM/HXS`':U(_*4RRYJ&7*"WZJJY,G
MSFVH+"CUDO7/P@KM@^E"J43-.B3"_24'$[UL.B3%33HD>6F-@<8XK>J.FS!7
MDR:G*?1&Q#9'")`W2"K(OR?!.J9TX)6*'O\`(9*1-8JRV$@;M-YJ0"%R,%LY
M"N4`PO'&NK,*?*>Q2:@J:Z(INEWVQX39-HOL4DPDUDU`>7"Z^@\*=[(G%@H7
M^*3B5Q&;G)H>RF:0-K4XJ%!KF/213M*,L_90XU-2L7!NSR)I*K6@RVE;&@4H
MI:K5=BV*1,7RK5+=&7'[I*TK/"52R%6!+C7)W>&6,!=PK&XI:TDHEA11JH"T
M!Z0HE86@R$^46/2,%;CE'-=[5P384H1Q72V9K*A:R6%2]KXBWPY:XM9UG`E(
MOSZ&3FN#2V%MXG\3$V*G50@3H`@/&*T9&2>4RGFJV9?1L8@LJL>V([(1Q%GK
MV&3Z@CYQ*I/J0J&`E!^3':WFJ505K<M)]JT#O*$;(SN*40=I51H]^S!QFKZ,
M#8?EJIRKZZ.M*85=93'$`VTVT"G<WZ14G%D:B[M0J1SN75N-QE5K,K6WN<+:
M8JK3C6*CR&Q[=-D(692XJE28HTL;9G)8BT.VH76C-,7,-?6++E<3C(9&4SL)
M430*)!LZFY'=*-H;'&52F/L2)>L8HV:B"-P5HTQ;@:6$PT!.Q&A)2!I7Y0(W
M'#XHM'1MC-\+^[O<9M^=RF1U8P,5-3V.-<A6.]7OQ'Y\6.KS+"UC*`K3J@(/
MAA11@SCWLHLL6\%=VR07R+I+9YFO#IFK>>K/D,9J2*?>V%$MEM*I2;1>TC4L
M=)(P1%];+->6@!$/3E)S%;DJ,);EY*LL;4<X?I:T7C4U*.FORRPADKN&2RZ*
M2L&I)'/7"``A49=)=4*Q-845GSL%A06%`GP5A(D:YG"[:&`IB<--TT5A!O:=
MF-]-X..F+ULPR@OIR\FGF;GBZ.@WUH6/[13E<2JPE[(WF%DK'4B--2AQV@3G
M&Z$`D:H1.@>_>M^W6_7TWZ>FRQ%S4*[UY>?84?MZMJ[ZBI_G&,,5LH)05%7^
M@KMLFRG)LD460MSHI1R=HL2C:D((:%B)<()2A$I6&Z.+]!DA#O0L$\>EK^80
MP*$V+=_8#_<-AUKRU4/.4G::K:XE^:Y!?]UV36BMPD,P2N[BA11AJKFCK>`I
M:42%L#]0H6'(S?E-UHLD80[%AJ.-8VGOEN]VOI[G>G.@F5F5QYLMR!L<U3,:
MXX"A4U?=4^AG(3%!80!/"G4!&$`_:#8P:UO80[WL.B3%32>\(@GI*WW&C:BD
M$^8X^AE$E+7QN,Q-B=G50Q,:^6S21-D3C1<@>D3:]+VF/A>7@D2U0G1+%!*;
M0Q%D&CUH&PA"H;SZ<378U4KU'6-"Q!RFT)?IE7[Q05LV'9J,XN)+4"61(I>5
M8=-U$<SCV6[)Q(AH_N&CMZ,T9HKVAV(LUTM>7"/%;S2_YL\#_P!H[S!_I&KR
M2W_/.?1[4Y6#`8#`8'S^\R_WC#R=?U(>,/\`"7G#4_K'C5]`6&417/0-(=%Q
M=-";ZJ:OKBAZ-V2/J6,61%6>7L2=Y0>_Z)T*;'M(L2`7)?D%[#-`]P?7?IO"
MQ,QDDQL:&ME)4)VAO1MI"IQ<W=22B(+3EGNCRO4.CLX&@*"$(U;DXJC3SC-_
MI&&F"$+>][WO"/Z[J1HVIS6%*F]"8D;UJDM:[CV!J1C(3&F@5.8PFD"`WIQ!
M]YV]&`WHO0OTM?RX'SU5#U6VBMWGA0LI+AAQD=C#14X_6A6(%#4X6+3$WO\`
MG%&UNIH4M2KD#@;"4T>B9+VZ('%6J"80J^G`!+\?R"-SMPG-K7ZD*#EKM63&
MY\M<G0%K;WV_H=((=`JZ1-BES>;7O]-1L;M/GIJ/T!$IN6M8_P`YQAUE"Y8G
M5A3HR2A$:*+*(V&%R_DHO&C.2D7050SWB>D0\>0&5QRD(6836"6#,-H6$[S=
MB6R2/O$Y>]N=>SB8R%S*&]E-*-I1&F/24*<9XU!@3`BIFM4IS#H=@"9#2W7Q
MS4'NH;.A,(Z$?T$NL.JD+HX3]G,E$'YMD"DU?'015,XM'/\`SN!00J6>]8V#
M$U,:8032-^X9]6S2?HZ`//0/ZVH[XWJSGEDJE[5'6*]WVQJ>C-DN(6A_I-LK
M<A4H>8JJE3.4*?7(V$%EF*1?:?I1JM^H?;K0K"K:0H[FY7NF8,[)#^-J)O&8
M<SN50/\`2;219E2JY=6##:2^4Q-XD(&ITBAAU)RN&@CK@G&TA-&J<=:$44:'
MURI]6\3GK_D)W<*]ADSY,J![K&\K4J"KZI%)WVL3Y!,-S-'&7%8J>ZB4,"YY
MA[W#SX%&%#>S.!@53VV-/UZ002FD.A0J<^K(7;=-+E.)]1VEPA5%M4#"Y0\P
M*5/&C8(--7L0A=V,\+K)`UU!(6->ZSLY5.%1+ALEK,3IVXP&C=!]P?7!%YWB
MU&6^0VE02752.G'M0S"]7ZM%D\3T\QW)4TL->A2FW7J)-.PRM-%3HLK@3^"W
M'5P=)*$PQ&VO;RM:CBC%1QQPAQ__`)8UZZRYE@T>7PR7\24W%.;$HJLKYZ;@
M'5\L1QJB+"KRZ6^WII-H6B92T<8KBIHPPR`E:D-*,`Z,)JW9/H$_V8(B<XS9
M61=.<Z=%QCIASDO%M5K;XYAY]I94^PZSFJ,6:_1=R?0J9%'Z8DK4T-3>]D`@
M<O?59S8D3*0E/12H"M&(CZO6@WH98=&@3+NZBJYE53-G:O,E!-%[3'F]0RIX
ML[-K=!;<-@K\WV\SRZ`1"K9RGEDC60Q?&X\UDN#-MUUML2/QGU(CR]"#D7C/
M3*UA5EE-4#Y1L*#5+P+3$"FSG8%64Y+.;'R1P=+4CE$K;2MVV"02*2Q1B3,4
MC:MUTY;/,:@I]'%F;^D$+^7>S/7-#]6]$417[574@K3QGU%7;_`5;96/.K%&
MIS2C)(6%?<$BA\CCS4T`;(R4IK"!R^%W`!_7.WM^@1NBDYK.#M4=[QFL;S6^
MH&Q&"]T<[GS'R-6M/W1SI"%8:,>94Z1.9I4R&R4$N4*"T#S#&YM=HE'W-_CJ
M@MR3$&`-4ECV9K?J+"9=<%;>O+RJL%3\62*5<V\EV`3-&)RZ1=(Y<B-`8BB,
ME<E%,J98UU"0>W+A(;6F"KH`:\A<HT,0R$I@C23]JOD++$3TM@EUWZL>.*6^
MZN?>3'V7UW;<O.51N3UD\IVW524FXKV&K()7:QVD\C2RF_91&94L,CHTIP&P
M.MKR=-Y6]"T(E8X6V"YNM&Z!=,I^?X13W)1460_ENI*V?)<K,^Z0-W3TFR]`
MQRQI@ULP$K<W\^1H<J,;3`H32#DZL(U9:KT,^#0K"VF\1V-3DFZ>M6NH1QKQ
MY`U+]`;LK]Z458R-$?LF<+J)8^>79]'+-C:?I#*6MUQZ8-%'0'Z,VD1H]'G&
MK/K_`&IBS%1U\?\`"4.2+,YQO&R*RF2KB"@X!8UDRARG3E9$>>JLE<E8NA8%
M"9.2Y.FD36SD2M8G9X:QFMZ.8%F`(5:-TG+]NMZUL3>5X0RZB]F\NBNOK/D,
M!XSL%XK/H!35=:2Z)EB25?,FB4RN+1]^?[`-7NTE?0.%;V#?,F12D9!J<E8M
M)7#)^`"WY=U*QB,58Z%N2(Q9>D41;E;BRL8TLH"'QZMW2OJR6GL2^Q()T)+8
MR0L6V`T/*-$QT%6;ZRE3(AO/;25R9,8I/(<!&I]B'%W9]6P]%W13U,U8QVFF
MY5XLDDYMF`SF,]$K7=I0M+%<=><<[BQ<6KNN%):)Q<Y&AE`%J99`BG<Q8F1(
M"B#`IS]#`(--L3,YI#9KM9((99H8G0O(;`]VG.T_15K2%@BJELCEFMS4O*?&
MRM9.J1K2E,D[E0+DI0P%JS#4Y:X&A!3ZWK61/5ZB+^8.6+0?X_;\EY^IR43?
MZ->X-$T>X#$WJ3M^I6(EQ?0I9`<WJ%98W16$(E>RS?0XP'J+UWK*ES"0I31U
M-SAH;&"8U=`Y.R,LT<;&:&E]B[.YM[;/G<$A+=9DB2*TAI">2N)<M=-'K`ZT
M>;IP4>X6_E'ZDN6K+>5>:'&;L5EKZ$J-;848125MCDU50&-'R=C;YFP:BDM1
M-3T8W"7H4LEC(=(%P"QA"I1Z^(S0@?AA;FJZ.1#RWS<V&1(YOHFIT9T"CU<Q
M.$G)X'&RSHI&*@6/#A5;`P&A;_D:VFNETA7G,Q!.PEMQBPX1&@;,%O8N6TMU
M)T^T$O"9KK""-Z>0)Y6D?24<79TY3PFG2AL5S1.Y`*2!"L)E:IE2&.`3/=I6
M-,5LSW;`'T(PCIS=S^]@AQ;Q2]9.1=>)$B""`6PM@4!AZ%"?M4C1QS1B$7V=
M*F4"V,!9'L"$6_76O7"W+1I9Q!QS/%<K737EVAI6MG<+CU<S16_U;#G51*X#
M$B"$T7ADA.6-)HW>,Q].E*`C1'[&G3@+#H`=:#K!<LE'>..3XD]HY)&.<*58
M)"W3=OLIO>VFN(JA=4-@M3$*+MDT1KB&P"E-)F^.#VA)6`%H\M)O901:!OTP
M7+;?Z.M"_GJQ[._4Y6V[$N%MB+-:LWW#F+<HL5I@`2@0AMF;UM%M?(D42`0#
M3>6J&:!)H.OCT'TP7.71PIN;>?4<"656DI6L$M:N$T36,N@2>$Q\F(JY\BES
M?/DDR4,!:`+8=)4TV:4KL!8(O9X7!.6?H7R`T+1+EHK]P_QS*8C&X#)>7J(?
MX1#G>3O\4B;Q5\0<8]'7N:$&I9<[,[2J:C43>X25,>,M::6`(U(!;T/>];PM
MRSLAY&Y<ED4BL%D_/=//\+@SHR/<.BCM7T971Z,.\;B;9!(^YL;0H;AH6U:R
M0MF2-24PH`1$-Z8H@&]%@"'0N<W#/N/>4[5D[+-K+YSI:?3"-[CVV"3RZN(J
M_OK+N)G%*8QML='-L4K$6X^H(`-'\8P_3B!K8/3>M8(F8R?J4\@<K3>5+)S,
M.=:8DTR<9'#I>X2E[KF+.+^NE->%FE020K'54V&+53Q#RSAA;5`QB,1Z%OXM
MA]<%RVD?/-$F3E]LTRGZX,L.4!:`R.;#B#&*3O>F!V:'YD^Z/(D>URS;2],"
M%4GV,>]E*$A0P^@BP[T1CYYS'SM:3NZR"R*0JZ<OCZ2PIWEWE4)8'MQ="(L>
M-3&REZQ>A//5`8SS!"2Z&+?P;WOV^F"Y9930-'K8ZEB*NHZZ4Q9"T.,?11T^
M(,9K*E8W=Y;I$ZM"=M&BVD);7%^:$JPXD(=%F*4Y9@M;$`.]!UI9SI0D[0KV
MV:4W6LI;W184X.2-^AK"Z)URXAZ220I6J+5HC0G*"W]`0LT,7KOZDH!G_2#K
M>"V=5TY4ZYLD;*LK>%*&B8,;I&94V&QMJ$AD,=>WI^DCNQO";:7XG!J<Y!*'
M):>09H19BI>>8+6QFCWL(XUQYRF&5-LY#SG3`9BS&PTYJDX:ZB^GQN-KQ.<D
M@IB1RTVZ5$"B*50,MOV$6OI0BWHOVX+EL\7YPH&$N#6ZP^F:TC#FR*UBYG<&
M.&L38L:UC@O6NJY0@4I$11J4Q6Y.2@\S8-Z]QIPQ;_$6]X&IMO&O)C,!T+:>
M;*1;`/<OD]@/`4-:1)+ITG$UBTQA$OER_1+4#ZJ1R>'V$^M:Y8/U/5(7A828
M(1:@T(BW.KHMG$/'3-`WRK6GEZAVRMI,X/[M(8(AJZ'I8F]NDJ1;;9*X.C$2
MT@;ERQ_;Q;(5F&%B$H*W[1[WK\,%SFYH_P`5<A124$3:,\S4:PR]-'T433R5
MIK.)(7HB,-T(9*T0Q\EQ3M9:DIG25Y&V]D+3A%HH+4B(3:U\)0`:$S,YMKB?
M,?.L$@#554*HZJHI6;&;(CV:`Q^"QQIB+4=+D+DV2DUOCZ)O);$ADA;GA40L
MV`O6U!2@P(_70Q:V+EFX11-+UHQGQFOJK@,+CRIF5QU2RQF*L[,VJ6%>YO#T
MM9U"1"D)).;5;M(5RDPD6M@$<L.'O7J8+>R(F1<(<6-IR=0@Y5H)&>D135N2
MG)ZLAY1B=#9#4D8I^D)&%JULHB8LR`E*XAUZ:5IR@%F>X(=:PMRR$%XEX^K&
M3HIK77,5%0B8-J=H2()1%JPB#(_HTK!__P`0A.[(&HA<44T__P"OK0_0K_[/
MI@N7-*N+N1IRGD"29\TT?*DLK=FE^DR:05G$G9._/C$[+GYE>'8E:UG%KG-J
M>G-0J(/,T(TH\\8P[T(6][%S#-/_`"CS-*K*27)):#J1^MA!#EU>HK&=H''%
M\R2P5S:E;$XQ`B0*6\QR+CJUE7')#4FC/A&G-&7L.PBWK!<U71_7GE/F>12L
MB=/U!U&\S),SR6/D2=S@,:6OA3',E[PZ2QI`XJ&XQ3I!)'*0KCUI7N]JDU8<
M(>M[,%ZBYR;"S\_T='JN?:18:CKIFIZ3LCM&Y%6#9$61%!'N/OS3]A>V5TBZ
M=&6T+6QV9?\`JB@DPH19J?\`FQ:V'\,%S=]6O&<I<S'12#P4Z@JA.AE:-\/:
M:\BQL`C)K#"6ROEICC!D$6:QMPDC(DB*\T1S<!.$L*0T6Q%Z#O?K@N9QZI_P
MB!>I*+;^G.<KMYZ=7I5'6^Y*UEE>JGY$2!0I:`25I4-VEY1!FPA.VF&=H6P^
MNO=K6]:WK?XX6)J;5SKJF>TI7<=;6%U//N8E4=J9#*5,98^?(#:4<=7B1RE"
MW-1XY"X63/)@G*8T*)$(1920LL\1H]>XS8=>FQ/'I;T&PA@>?UDTYVA%KDL6
MR.59[S*C9+6:XB.4,G0L"M"1N#1(X>D=VU(='%];3J'E#95Z%R"(XI6`PX)I
M>_89H(O31J./6U@.5*&0\O\`.%,<]MKVHDB.HH`Q0HM^5$!3'.PVI-[5"W:<
M`A:(+.4#'L`-[%L(/36][WZ[V29N;6!PB!.F*B=[OIZ002-O;9'95]PC,IB+
MJ^H5;G'B)9")(URZ-ER1O;E;>Y+(ZI>&8DM<6E4$*1)ACT48`?M%HL(*IVEN
MJG.\&BZNJIESVYK8)")##H`S<^P^R8R0<&8K6Y3(5DQ46--)>-7I,6SIPH@(
M@IMA$,S9HAZ]F@B:Z6OAA'BMYI?\V>!_[1WF#_2-7DEO^><^CVIRL&`P&`P/
MG]YE_O&'DZ_J0\8?X2\X:G]8\:OH"PR8#`Z+FV-KTVN#,\MZ%V:'9"K;'5J<
MTA"]M<VU>08E7-[@A5%FI5J%:E-$6:48$19A8MA%K>M[U@1?%.?:%@@(N7!Z
M1J&&EPA8^N,+!%*UAD>!$'"4G#429=%PM#*C"P+)$H-$8O-2?$-8,6Q&['O>
M]X69F<VU'5O7:EVC;^H@4+/?8:L?7&(/1T68S7:*.$HV/<F71MQ&A$L8EDBV
M8+ZXU*,H:OW;^78_7>$<CW7D`DS6J9)'!H?(&5:]DR58T/<9975K5R-.>4J(
MD"I`O1'I%#V0J(`8!6,&SPF`"+0M;UK>!T'^J*ME;-^7936L`DL?^D:&_P"Q
M/\-CKPS?01Y4<N8$7VQQ;E*+Z1C7*##D9?L]B8T8AEZ"(6][#*?D2#_-I1^3
M8I]1HX"G1_Y=:/FTH*5-:TH_1OT?OT<6L8T1P1>ONT:C(%K?N*+V$-58J)I"
M+N3D\1JFZJCKN\`2EN[JQ5Y$6AR=2T*E6M1`<ES>T)U2X"-8O/.*T:(6BS3S
M!!]!#%O9;EQDT)1:>0K9<12]3$2QR<XN]N,G)KF'ER%>\P=M5,L*=UKT!G"Y
M*G.(,ZX](UJ!FB-;TQPRB!%@&(.R6W,4*AHU!RL<2C(U:E3M8H5"86H2@]6)
M>%TVJ..VEV8:IVY@TIV,6]B^?6C/7WZ]<#2XS05$PI,UHH;2M2Q)&QMJIF94
MD9KB',*9G:%TB.EZUJ:R&IF2E-[:LEJDQT-(*T`HQQ,$I$'9PMCV+O-W5M*4
MTY&O9[C4E9.!TF8ORO)#EL"BJHV01G2%W;-1U[,/:C!NK%IMD"]/](?LQ/\`
M`N4%^SV'&:$+EGMU[`1.,E>!0>("=IF!M+F#IN-,NW&5ELQ99+07)5NT7U+Z
M!J)*"!-I4(W1`0ZT#VZUK`P\FIRHIJ_(Y5,JKKB6R=O2B0H)))H/&'Y^0HAA
M-`)&C>'5K5."9*(!P];+`8$&]#%KT_'>!LYD2BIVSMG1F/F[4JFU:HV8RMH]
MGK68D"9H5G>Y-OY534G*"6F,%ZC(`'00;#K6M8&M)Z?J5(_BEB2KJZ2RD3.W
MQX4E3PF-$OXF!I4MJUJ8Q/);8%QVSMBQF1FITWR?`2:E)$`.A%`V$-I;8Q&F
M;2K3/'F-JTN))3KM-K2@0Z6)T^U&TY"K25.5]021M6;[`C]0A^4?IK7NWZA'
M"3GND$CL[O8:LA2MQ>9?&Y\>-U8TCTF;YE$(-'*UC$BC;<\`7-T1<F2"Q%N;
MDXVHI'H!*;6_3WB,&(6[;50M&,38WLK'2]3LS,TSH^T6MI:JZA[<V-MF*E!B
MM38C>@2,Y*5'.E"HT1ICN6`+@,P6Q;-WO>]X+F6&CO,_/L6C+9#VJG*]-86B
MN4-0I27R,MLI7GU<W`"!'`75\DY+P^OL4*T#6]HEJE00,7Z0@[%^.!OC'6U=
M1A[.DT:@,*CTD4L#/%%$@8XJQ-+V?%XZ5\$?C9SJ@0)UYK`QDZ]B-&(S:=,'
M\"P!U@M@XQ1U*PAV)?X73]71%]3-(F!.]1BOXFP.R=B&8<<)E)<FII2+"FD1
MJDP6TP1Z)V(P6_;ZBWZBVD-?(_,#"Z%.T=H*IXR:!#/FY6@B\)8HU'GM+:*6
M)(9_J4Q5B1M\9ERB4(8(T$*#G1(L.^%"6``PA]VA%N6X(J%HQM7.CFW4O4Z!
MR?(*FJ][<$5=0]*N>*S1Z,TDKMT5D,Y:AP@J71P_C:#1#;P>[?M*UZ[PERQ+
M3S903(N<5[?4,"`-QD,,E>D:F/(7%G:)'7D0:(%!WB*L#B6J8X8MB\084B%&
M)H3HOB*)UO7Z>Q"V&Q_J7IW2,+=JIJTTW@G0K0`@_(D6^C!98S-G#L0*7[5\
M`9T,[?OV[Z#]PV+\?E]<#?V]N;VA$F;6I`C;&Y&7HE&WMZ4A$B2DAWO>BDR5
M,`H@@O6][]`A#K6!W,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,#Q6\TO^;/`_]H[S!_I&KR2W_/.?1[4Y6#`8#`8'
MS^\R_P!XP\G7]2'C#_"7G#4_K'C5]`6&5!?(Z[=9I>=7QAX_KB83>?2X#HRO
MK]7D_@D!G]=QDMD<'!3(X8HGBE,D<I&XJDA;:F"B^1Q2C6:4IP"-*#K#6VKQ
M7-@KZX2.+-+H\1]ZBSR(C:5Y8'\!?W%L=T`Q(W--]6G]43ND`M('].O2[$D7
M$^T\@0BC`[V99MY;0O3.ZLXUKDVA=FU<VB<69:8VO#>%<E-2[6M3B3_/(')+
MHWY"#@?I%&A"+7XZP/(WB@'7%:V)!ZMLE[Z,FL#45Z;+9<X7A'5TX-3/CQ%&
MM\5KP7ZN)1J=2$FP5"QG3PSXM@;FL@L\`MZ%D:FIQ4\L/NGR&QW4X7ML+OB+
MKV*S>H5U>P6P>2FDU5.:>KMYY/1QN63)]BZY8E@-6QQ%9TQ-02,T11SR6V`T
MJT`TD0!%F(\O%IS@-Y>1"60I5.MN5N:@)$59#T#Z[<;I8_:SVYR&TV%NF3JA
MIL]4:^'@K*$J5`F`HD@PJ4H?5<+UV#0=DP8"UN@/+3&U\3%"*DFTTC_WFGWU
MU4QFFX<F?GBN+9;&F%`3.S;+7E&3&IY6LUJM^E$U;2MB/9V*?MZ8O6S4)7OI
M$16*P?2=V]VE]0MM$T56UKL$+D-80/[UT#JI87.:,@<KE<Q3MDA>XXYKG-)*
MI%+X4RE''GM+B46T"2#"8(S1FO39(JK8Z^>ANZ:QJ?BA1!Z;NZU[?F2;X[Y)
M@E10E3#D3BCBJ0"A1;I;HZE/%9M+F_&&'DACNE2@!H!$[_FO;O98K%%$PLOR
MO5E7%M3$E/+[S?TT#7J81`(9SW`HW+4DB5/O-"\LZ+FN;Z!DDKVR1^?3=$F0
MN@R$BP<>$8:()@-AW,3XWHSDKGWD\C\'LN2KWJ;&K9BY-^XXRP/F.+2]^Y^8
M4EK,\=<CH>SE.ASA=KDXU\H/<ME.)90RMA&,@(P@UK=/CA@ZM:R[RIMB"*2N
M4N#X^($<,TI<JA=*08"758\(HI?C,F9G"Q]N87DUT5/]?1-S,5F$A^4Z2!*'
MH)(PBT,&*B=@^5JT:R8I"Z)9Q3CX_P!`3%G409ZI.![F[?;,DJ2TW>,3R1/B
M!W4LL<?X)8S`S(BF9#\S8N`N3Z4#",P>M#XI`O*T>TX^[T7+JVE'19\+GG-L
M-U(TC9QF3,9$CL9&I>'N6S2?5_[D[I5,_5H7%F1!C)_L(WLY8$&MF-X_2&&7
M5*'1UI]S,J*K"JECD@231^JR,+]L#+3X9_#)%:SJ>R)INQV;-C30IZ99H0B5
M&*VTXT8"W8W9Q6Q_]7]HJF%^3=N>;9ZCMN7OTQDL<GL#KA##;:1L%?V)2IU=
M/;O,V.SW-HA3FN6R`TJ2I"U$12%#3%`)^C<TQNE81_CK6%P^J@\JZ2\K!]B4
MS7T&K6WCHY8%3L*Z77(Z<S1YOCU=VFZ3V71VTF:81YW<4;JB3UJQ&QU;#S"0
M#1R=-IS.6&:`!,,46MN?FR-P%>2MZA5H1&&6?T&?(X#<3DH339EI)E@BZRXT
MQW#3IK5&8?\`$$U$3"'>%#>AF.K;LTQ0B^I)WOTUO>B8==$KV/T/WE&+(K1D
MBU:=#374KZ6L&"2U'&>>H234M;U4C5H&Z#R:76+)7-))7J*N$=7E/(7AD+/'
MMT"I0*-`+(_&D1#8..+;\@+K8%B02X8'8[]&H91LV>(/8-IUHP58RVE:Z6Y)
MNTQ!,!8VJA.C"M<HJA)TM;SR`(R&G[>N2#'I2;Z0FNC,U<Y=KSZ8TC.)7++;
M0PR+%='(Y)&':FT%2GV,O/A0"X$OL6*G&'ND?2Q.6&G(X]HKT*>P$%KQ;]3-
M:RIA7FT1SLWR*1.,3-V>S;#'&G>&Q3:-9%.;4EC692BIAK>AC)$\P^%-9ZES
MON0S*?SB1%F-JP@LQ$!F4B)`,"8?J7"Z:FFZ!\@R"!NDY>'*<M3#!J]LF>6$
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M*_3]0!&#/WU:G;<?M2(/D<67;$('87/M;N[_`!:L^60=`-]93UL2V$Y60I*6
MZ$6Z?G,^2OL192&-7[=+&L2Y<7^+:=L-,*?KJRV?(:0]U1"*?J6;?;)IS%9<
MIL2;0UD8UC-$KA:D*83#&USN<J_-3%)UB80SF1*@3G)U;EZ)U8@DZ$+!%=6B
M6$_>4XN&OLB@DPDB%:3"6M6TP`_GZ*O[GI[8ZEYS5NC43)E+B4[KETPGLUF.
MMGFE:&C.9ADE`WHC>Q#!QW1;GDAJ&(V[-V)EOJXB7DE,BJVKJBYXJIXG=:*V
M.2TPW%JDKQ,I`@2V2WRUJD$B.<#7;Z8](F1'&I="-)"'</C@YZ5O/R-;MFCX
MI.J^N%VC,^O^SG&XG5^I*/1^'4[6;XR@F4#K\,OVL*<I!'6)D=T1*.0(@'FA
M?=+F=?[!(@X)C;7T2&_=$=CQ:_I<U_E"ZY5!UEGUQ71$7:^57=3!J]+DEFPD
MI'+(M<#7[S[.@CU4)4D5R9\'K2*'.Q:-.=[-G`T,5%=&EMUA>3*M7BMIK.G>
M96Y7:%;&'2X(1'>8(^CFAD5=((;)Y<5%4\2=ESNX2**2$06E&B2EF'KC0^@@
M^_>]93!#4]Z3\FPC$I$#I#ITYSN6T;J0QE8DIR$D0JL:[/KJ*M50.MG:FC@A
MEU=G-;JJ,<0!;B%`E;P4K+7Z++UD*AD&>\?*HQQE[4LD.MNU&YMA=A60W.<K
MY\C=<63*&J%PQ36H(`W1%^6M[.R6]*;=D:.8Q]M5[`B<&&/J"=CT2L]VF)\5
M@7&WO)&?&>6G!@KUU1/%BU(VS2WFF2ULR&.%?/%<A?UL\C,[&R.![:Q65;;%
M-H_]F;&\1R).\QAR3D#$2HT+5,$$N]N>2(VP*S/CCIT(_P`6D]9]7-K(H=>/
MDT(2)I=$:?8I#5$ZMUD&9K\FOCE9"E6UL;&XC3I'O277LWH1HO0M15^B7D%V
M=SUE?_,51V?(7Z81&43.8PF2V'_1^9F-LM,Y%8CXC1NLG<8\X*&BG"T=;)DJ
MYIV1[RGQ2,0/4(OT=$PQERRF4>06KKBN[\MKK*M1@D=J6%(Z?9'*HD#G!UT;
M04G`@M=?K)0U&@!5<2B3^A5+&AP'[E$PD"M6D,]!!]-0P9'J4GO5GC/!4=KN
MZK9%-)K8C="[[GE<<T1V3-C4HDL?6*T5CV='4R@]K@4%@;D,(%*8TX+8N,+"
M6I-#[M;RD<<<'6YBO;R.OW85L4[>M/2E+3<`@K\"O;>45TQQ6L+?5L26.,T<
ME`I(F7J'R/V+,9<E?%+@P@*$T(V,;><E,$,1N"8BKA49PZD\O;76KK8B/G2]
M'"3/_0D9KT4,_5+"UDOA=5A9K@TEF;=#0.H8LZ1HZRRXTE?W4E2-<"'GB6$@
M^N+`#(M;<KZ)R>[>\@IMV4TXI3;^7,ZWHJ=U_9]1(^4S&&K(6WIJR3O$>5`N
ML!(ELWIDF0F!`EF&Q_0K5XC$HAA&5[=5)JDDUE:'D0D"FI)$Z!F(XVURM\+L
M2/S#G%%`GFP&=U?^>XX-O7)CUH'B`)*Y532;JFM>C+-U(FV.%J3=Z*'L6Q@Y
M+C>.[+-L&P:H@LSMZK8\X7%$6!1+8U1#:WH:_I<-CM*<V5UK;#UL;?8,AE\2
M^4#L7K0C8\088H"'6RM>Z&$=F`O6TN]3NUUL1K1%<S;4\7!:B%D1,M!#<:A>
MF@?-=?2B#3]WN)7H*.12A+>+N[-2>.?*`D[Z$0#/3\=[I%5BQ5A7MY%8W.;%
MABB,7$UUM$Z2I59N^()S(Q6R^N,[D1K3J5/M951'UJ]SFDJ+<CU".0QXXD29
MA1^U:EV:$LW60J/K;J--K>21K6V+#6X-HRQ^:99?##$)%+^9TC'&7Z+AM]V;
M(U9X)&4J*9B7&$QQ26"-1TL6TTJ9TQ:X0_0S>\IA]'H+R],+M5.UI0:\%4RE
MKE%YH<U0^QW"FC*IBDGCK'%(4G<%;40`9Y:T3E(W!4K`JV(*52,T\A%LPI"8
M+1)KHN'A#`8#`8#`8#`8#`8#`IWY"+8FM%<.]6W'7"XMKGE;458DNB3D:0%2
M!`^M$>6*6]9\`];"8).>'0PZWK?Z6M;PNV+W1"`8Q2;YRUT5SXAC7274]IL=
MLI["CDPC70=UOEO,IQ$?9&9X:G1E1/Q)(&!]3+#!Z&I2Z#\I1@@"#[?;Z"9O
MI#U"PA@>8LLI-[ZGZ/OMGDG2'4E5,%3MM:,,0CG/ETOE0-)8)2TR)W>'9\3,
M!)OW][4*DY6BU"GW?"45H`->FQ>IJ)J,H39X[;:F][<.<NV_9#@!VG<_I^*/
M\I=`$!3_`'%W/2B*4+3"@:"'1ZGX=#,WK6O<9O8O3\<)NBMTQ"YV$5)[>E$G
MBO/4@'$9$\Q)VDLKK6`&26-+-MDF9&BP;!C<-?'&-.P0&#9Y"F:'HX2)8$(A
MI5&@&AUO8=86$#5;6S[S/UI`JP9;UZ,MJ'VS5$_D,A;N@[>?;=VSNT%<V`#*
MKB![^4`^.F*"WT\"W10A`4A"7ZAUL&M[$S>CTOPCQ6\TO^;/`_\`:.\P?Z1J
M\DM_SSGT>U.5@P&`P&!\_O,O]XP\G7]2'C#_``EYPU/ZQXU?0%ADP&`P&!A'
M.,QMZ/&I>(^R.RDQG=8Z8H<VE`O/''WWZ7;VQ#-5)S3!,[QM"3]4EWOX%'P@
M^0(O8'T#*IDR=&G(1HTY"1(E)*3)4J8HLA.F3D`"420004$)1)))8=!"$.M!
M"'6M:UZ8'-@,!@,!@,!@,!@,!@,!@,!@,#H.C4UOC:N9GMM0/#0YI3D+DU.B
M-.X-K@B4`V6H2+D*LLY*K2GEBV$99@1`$'?IO6]8'="$(`A``(0``'00A#K0
M0A"'7H$(0Z]-!"'6O36M?R8'ZP&`P&`P&`P&`P&`P&`P-17U_`W68L%B.D)B
M+E8$4;G1HBTZ7QMF63&--+X$('MK8),H1&/3,W/``:TJ(3GEE*-:UHP(O3`V
M[`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`UB:PN*V-$9+`IPQH)-#I@R.,=
MDT?="OG;WAE=DQB-P;U9?J$0B5*<T0=^F]"UZ^NMZWK6\"ME0\.\_4E,FZ?Q
M`BXW^5,K0M8X^ON'ISI?H%+&4#EI(!QW%F>]K<L9EC"Y>4A)+.5H$Z=4:26$
ML1FP:]N%F9E;K"&!4FX.(J!O"8KI],";CC\J=F9"POKE3G3?2W/9<D;FS:W[
M9J4MM#6W6[7)UK:!Q/+3JG`A2J(*-$6`P(-^W"QNF,J[+&0:#Q.M(=&J_@C"
M@C$-AS,@C\:C[87LI`TL[:0!,C1IPC$,P02R@:]1C$(P8M[$(0A;WO9&U8&C
M636\-MV$2&NY^TF/,3DZ+:%T1IG1W8G``=#`<G6M$@CR]JD,>>6]24`](O;U
M29:C4``:0:68$(M!#-+<?4C0DH<IK!RK7>Y6YM`&';_</1'0?0CDU,X5`E1K
M?&5%]6?9`HBG7*-Z$JTU_1[5^P&CODT`&M%F;6?PCQ6\TO\`FSP/_:.\P?Z1
MJ\DM_P`\Y]'M3E8,!@,!@?/[S+_>,/)U_4AXP_PEYPU/ZQXU?0%AE%MMWC2]
M`QDF:7I;5;4W#U#FC9")3:,WC<"CQ[PX"V!`U$O,H<FMO,<5H@[T43HS9AF]
M?HZWA8B9PC-)B92G6)R%:0\E4E5$E*$RE.8`XA0G.`$PD\DTO8BS2C2Q:$$0
M=[UO6_76$=9U=6QB:W)[>G!$T,S.@6.KL[.:HA"W-C8WIS%:]P<%JD9:9&B1
M)21F&FF""`LL.Q"WK6M[P-!J:Z:>OJ)AGE'VI7=PP<;DXLX)A6$SCL[C`G9H
M4"2.K8%]C#BYMFW!M5!V6>3\OR%&:V$6M;_#"S$QA.:3<(8#`8#`8'$>>0E(
M.5*3BDZ9.48>H4'F!*)((*!LPTXXT>P@+*+`'>Q"WO6M:UZ[P.LUN;:]MK<\
MLR]$ZM#NA2.;4Z-RDE:WN3:O3EJD*]`L3#,3JT2Q*:$PHTL0@&`%H0=[UO6\
M`YN;:R-J]X>7!$U-+4C4N#FYN2HE$WMZ!&2-0K6K5BD9:=*D3$%B&88,00`#
MK>][UK6!P%/K(>YZ9"'AL.>=M9#YII*7I3'+;*J4&I$SOI"$W:G;8H5$#+`?
M[?B$8`0="]=;U@97`8#`C64W-4,';5SS,[1KV)M#6[)F!R=)),H\R-[>^+'E
MMCJ1F6K')P3)TKHJD#PD0EIQB":-6J*)T'9A@`["2=;T+6A!WH01:UL(M;UO
M6];UZZWK>OPWK>L#'M+PTOR`ET8W-O>&Q0-060X-:Q.O1'&)%)R)6`I4E,-(
M,&F6)S"C-:%O8#`"#OTWK>L#%.\TA\?>XW&7Z51UED<Q^]?E)A=7IN;WB3_E
MMN^[R'\OMJI04L>/L;5_UE9].`SZ8C^<,]H?QP,ZB6HW%&E<&]4G7(%R8A8B
M6I#BU"56D4EA.3J4R@D0RCTYY(]"`,.]A$'>MZWZ8'9P&!A'N2QR-%ICI$_,
M["4L&J*2&/#DC;2U1B%N6O"TM.-8<2$X:1I;E"HW0?78$Y!A@O0`!;T&9`,!
M@`F%B",L80C`,&]"",`M:$$01:]=""+6_76]?RZP.@6\-)SJK8BG-O->T")$
MY+F@M8G&YHVYR.6IV]>I0!,VJ(1KCVU0`DT0=`,&09H.][`+T#D^Y-_W'[1]
M<D^Z_1?<OMGU)/U_V_Y_I?KOI/?\_P!)]3_-_)[?9[_T?7U_#`[N`P&`P&!K
MI,NBBA^-BR>2L!\F(^M^>/$NZ`Q[)^VI6-:X_*U`4;7%_0HY.VFG>H-?&6O3
MB%Z:.+V(,LN<4#846>XKDB`DY6C0$FK%!*8LU:X*2D2!&6,X8`C5+5AX"BB]
M;V(PP>@AUO>]:P.Y@:Z5+XF?'5LO)DS`=$VU.[JW"3%.[>8P(4L?,5DORE6[
M@4;;TQ#*<WGA5#&9H*<1(]#V'8!>@9T@\E402I3'%*$Z@HL\@\DP)I)Q)H-#
M*-*-!L0#"S`"UL(M;WK>M^NL#EP-<ELQB4!C[C+9S)X_#8LSE!/=I)*'AO86
M)L)&8$H!J]V=%"5"C+$:,(=",,#K8MZU_+O`V/`8#`8&.3/#2M7N;4C<V]4Z
M,NT87AN3+$YRYJ$X)_JD&G%(68(]%M:E_G"OD"'Y"_T@^NOQP/R%[9AO)\<`
MZMPY`E;$CTI8PK4PG=.SKU2U"A=3F[1FU93<L6MJ@DHX0-%F&D&!#O8@"UH,
M='YC$I:=(D\6D\?DA\1D*N)2LEB>&]V-C4I;TR-8NC;\6@4'C:'U&D<"#34A
M^BSRRS@"$'6A!WL-DP*^3WK3EFJ]3?=F](457FJS4L".QMS:UX+%OR&KE1)B
MF,)IC][?47Y:42%.2,:("SX1*@!WLO0M:WA:F<FZ.UVTTP.T)87RUZX9GRRD
M)[G7;.Z3:.('.=MR9(%>H7P]`J<BE4D1D(1:.&8C"<`)6]"WOT_'!4L4R]$T
M#)"ZY.CUVU,^%7`I>D=3F-%A1-Q!9BN-[,U(4L"$D=C@RY0Q;)'I8!!\XDWM
MW\F@^F\(ZL@Z7YTB:Z:MDHOFG(XY5L)C!8:!\LJ'-2V"#DRM.WQP$P3+G@@Z
M-B?EZLHE'I8$G:DTT("_<(6M;#:(]<%32UWF[!%;-@$D?:S."GL9F8I>P.SI
M`U`TYBL!$Q0(%YZJ-&B2E",T%8$G>P!V+^36\#>T#@A=$*-T;%J5P;7!*0N0
M.")04J1+42HH)Z96D5$#&0H3*"!A&`P`MA$'>MZWO6\"!87UMRO9!D0)KWI*
MB9R;8#M(&&"%1&V8)(S)F]Q)4<AE+1%0-#ZK$_N<<6IS"5Q"71IJ0T`@FZ"+
M6]86IC-LCWT+0D:W8^I%=54L.Z>`RF6SIXL&*-NZR+DGQ_EX<^TL=2=Q`#Y\
MH/I-K_I]*?=KX_=ZZPC,1VY:BE\BD\1BEH5[)97"4#>ZS*-,$QCSN_11K=DP
M5C6XR-I0."A>RH7%(+1I!JDLL!I>_<'>]?C@IKK=TGSP[H(*ZM5ZU`Y-EGK9
M`VULXH+'B"M#/W")EGFRA##%1#N81)E<<*2F"7%HA'#2!+%LW0=!WZ!NM?67
M75LQLF8U;/(=8\24*UJ`B3P62,\KCYRYM.VF<$93PQ+%S>8J0J`[+.+T9L18
M]>@M:W@R;M@,#I.3DW,S>N=G=<C:VIL2*%[DY."DE&@0(4A0SU2Q8K4#+(3)
M4Q`!#,,&((0!UO>]ZUK`KQ3G9?(G0\@5Q2@^HN?+LE#>V;>UT<JBXJ^L%\1L
MP30$;=535%)`ZKB&[1QH0;.$#1?N%K7KZ[PL[9C.)64PA@5NN7LCD?G5\11F
M_P#J#GVD9&Y->WMO8+9N&OZ\>5S-HTPC;LD;)9(&E8I;M'E"!\X`;+]P=Z]?
M76\+&W=.43*P36ZMCXV-[TRN*)W9W9&F<6MT;51"YN<6]82!0D7(5B89J=4D
M5$&!&68`0@##O6];WK>$=_`U^5RR+02-/DSF\C8HA$(PUK'N22F3NR%BCS`S
M-Y(E"]U>7ES/2M[8W(DX!#-..,`66#6]BWK6L"(*7ZOY>Z/6/K?SYT71UY+X
MNG1K)*BJ.U8/8JJ/I'`PTE`I>D\1?'<UL3K32!A*&=H`3!`WH.][UO"S$QFG
M_"/%;S2_YL\#_P!H[S!_I&KR2W_/.?1[4Y6#`8#`8'S^\R_WC#R=?U(>,/\`
M"7G#4_K'C5]`6&54.NZ+FU[02/,M;O<;B<VC\N0O;5,GQ[MV-N490G)5;3(%
M<4?J5L"MY<WR%8R+STY?R+C&\T!@@*4YQ0A`V6%AH6W29HC;:URY[221[;BQ
MHC7Y*B&WC=TB4P1+>XN241QQ0'I6A`68MV3\:82H1FR2RR]A`$C:-ZT+6PBU
MK>MZWK>MZ]=;UO\`#>MZW^&];U@>9]"\(2:E[OA5GF2RN7A!$*L0P@3HEA#N
MW64Y*4D):8>&-GR3\PG-0:K(6M@GLEL^CVJ`[J##=G[UOTPMX4\UK6\5W42D
MR?D%O'.LO?Y7+^L[\:9[$:%5P1PK@V>O?(KA'*[JI+'98A1,UOSM+3+V4ZR1
M2$P#IIS.&>7LP1OS1KE'GXM8RM_%/)4D&^]24GF9NGSA#XTT-];M%-R`FC&`
ME%9L?L:2M*^,.4P7R=03:Y+6(J;%%N!9+NY^B@("R]?%NI;`6KX<9_.U\5=H
MQT#"88IC+U3\W1MBRFVN<1UHF+4W-D&O%KC+5+W%S`SP.5U)65>,D52:V)3&
MCXD!;HXU09H0)2QNJ%@>C_'597174C=8\DMJK57-H:Q@%<RBEWZCV!UL&>HF
M"9%R*:M4YNL*E/*Y9`YJVI2"!1]>(]L)4@VI^,1@A;W4B:CS8Z^_'7==@51Q
M75%2774%9-O+1&T3Z^/G/\>G$G<D*>*)XLU%T[)717I\HM>A2$;!M:RGE*S$
MV]$"'LO6M9")C&^J+9EX;$A=<6O':1F]75!/;,@JZ'GS4%,L\J;E'W%[YIDS
MD5+XB^+#V2;1][?J3>E"]N7EF$*QR48AZV,L6S%$;L;G%L$E\1#49"[":XHY
MTRHEMJNC<]6RZSVIA/K1>:IFM=FL!I1W80VO;8[S5N0LK:-K)T-4$U,`0-DB
M``O0,IRGL_D)\/S'"M,DE03"$E6\SQI2TAMU+`-ES`;VHCO0$3U(M.!KJ:H&
MI!'K68D>P&#&$:6-@)%ZEF!"6+UR8B!>'0""`19BM6PZZL>?M%&R>B72?)Z<
M9(P4&&SBJ;0KJ;1Z(Q9K4@88;#I2Y3A"Z+FE&4!(J4(#1&A$8HV/0Y3TU2->
MGC9DEMJ*-DJ-JY'2RF`4#%:5FC)(:7ESM7H440VYN#9':N:TD[0OD:K$Q]D:
MD\;2XK'`T(6YMV`[1A)PS87TQ;[T3X^Y'>*"L6+\]PH:2+57%JP=IC,8<Y2&
MR(9N.JF0]VEU&O1#XB;X9(["2MHT;\-80MTK2!)!KTT$>AU+QMNO/?'$Y@DL
M?[0N*45?*+5>8=;$%1R6OH2_,6F)AL&SG*=-Y+2LEDFE+\D+2HE1):U.!4%,
M>M+V:4`H&]%Z+?2,E"I7X;[2FECTR]NER4<TU3":FCE6V34C'1&Q(9W^69W+
M9"OE+/(W.1JWR*NEQ1R;K4=@$%&"2RE0F0&J0#"A3@!*6-U1YVE6=>(IJF;#
M8D/1JZ1AT05V>_6!3K'&:I5IT==&N=DUC.T#J:C.?S$/YS;D4!-;_KFXM$#9
M:D&]%A]@M"J<JFV3LKQJ7)+K$K&2Q.SN=8<S1#I>P[HG3^LYM9IE=%D0V>+$
M2H,7!:DF=%SS`94S-FU+'IU8OH]*X^%,D/*&$K?NA$_X;5R;XW9[SG9ED2E3
M;T*10F549+J<@T0J6LB8$YU?N2VS,)\D<6.5'.;HZ.+5'6I]3:;6]7LPAM=M
MKE"7112P9."=UMQIKQX%5\[UM,7Q14J:8UT5>C>QAKVO5K!'HNTV_&B8\<F@
MQ+N]O#S'ANZPH3O(=?5#+<W50<8`)01>F5+P18]>+1Q(9YJKC#]2SU*IY&(V
MRV"R676+L^5=>8H97M$P*)-%^QUFDK2ZSV)QX%:/:Q*F$J`:2<\$A"/V$FA.
M+R[0CM?XO9=#ZQD+IM+2[]*X-5]GML#AE2UBY1=+,)W)Z@DT$:+%?Q2*4/1X
MK7;#WH*!*Y)S2/1AT))O7N%H88<L?)P[\1DQD#!"&.2OW-#"T)F]H;Y5%J]I
M^8,\3B#*BE;^\2N$T<VO$Z<#XC![K:I"9^=4CB)<-U<"@&AV6#U+Q1R8VP/$
M/;$WM^W9^?97+NX6^S!F=Z1K<OEMFC*:K6M'7ZRHP/DCDD*>6!^LBTX-`'Q=
M^4WYR-&<TJPIRQ:,1!,3C4<L/-*K9XGTCO/CWJUG6H)]$T+)-$B4E16[B*86
M-.74T:Z&7C=3PXR!:VRNYHFZ#T;IT3)4OK[=?%HKTUZ5+P;1?'CBE5J6)!K+
M+5<Y3Z1M=$P6J+$6W_5,GG:VP'*O&V<-[/MP7,TS85)\+=7*S7)]7(%0E"C;
M\U-"@H\O1*@)Y;PILW1/C;3]$*:H*F$TC\C9*PI5TK\EIG$3')R5U@@.3N$+
MLH!)SB4E)6PEY3`4H@B+&<4,`=@-"+7NR$;J1=>'BTEMOPRWFINL&HH18TG_
M`%^+:YN1'4.Y!-T;]<MEU58R9TLX4@>UB*:DHT5;[C#JE*`F(>(L:6@.U\01
MA'5C=4^2#*I\0/1$&G::522\.6WY&DC-<M2;\N<H-,'?@R&"V[`;*0RE[<V!
M_3$SL,621MQ31MK?BE[6TFK"-Z)$21\0B<H2Q0GBUM^HN2Y)SY.[CIN^9,MN
MYILE(Y3^E1MU=3:*QN/$1=I8KIA<;D#>HGTN?$:4MPD+Z)26J?7L.UJKY#3#
M!"$[KF\FZ1_QS6^:_#BMDV93T^H5"IC<C9XXZ5_,U\W.DJ2TN8K%=61\4O4X
M<H.H@+`CYX"V1I,0U%+&U.>FV8<;L@SY1>F;JWGP'U7-.Q)5U35UW\Y1MN*9
M:^2U[7<GY[4IW!0Z0I*-.(-QVO74JAEEVE&-&&B.;6I4X:2M)WIM.$/I@B8J
MFD)?#NT.,V<Y])U5$%3YRJ"KXX3<T9J%23>$?MF)LM#19[F<?G3Y('4Y,P,#
M%1VC8F2,`W-M7OBP:E6I+^,&B\L*QJTC1#Q?K&V2029R*35:)^K.9E3""-L7
MKYV;XU%WS5CQR22&;LR1SD;DM;[&M>&-BULEK@6:$#D<N$,`"R?<4*,WT5:A
M7ADNU@LJIY_JY.;Z^:8VSV1JT*XIWG]W8XG+IC++`L"?()9!%LEFK_(JM+D8
M9Z-BEC<UJ2T+Q'$*-O`62G1)0%6FIW14PL1,/&7/)'R#S1S>U+N78L_TJ_S)
MR<'ALJ.;FUS$44O63(U1NC:W46`-NCCVC;Y5M,D6/8W@;:/8U2/X%82#2B<L
M9G%I$W\1D^/>*RB%0VS2M5<X09+=J=PJA!STP*I*H3W!/%<F5L43LH"Y/)X/
M"CF!7MO=V1`:6W/`]B./*WL6]9*.6N;@-\1$]:NBS[=C=G4:X0)DM:E))5%=
MRJBBR?U65U6*("!4Q"/B+]'VFTYC'V=(2T05QEB5V(A#48>%O(+.$$P-.6'F
MGV>^-=-:5NS*73[=)OL'DMP1*UEJ5962UQGD\1QVP8W-DM>6R]NCZK8Y3#(I
MMA]T>(*1$;;UNBSA>_01!$(FF:Z"X+E=O6G8=@H#N>WQ'-'F,.B9!;M82.8+
MTY37`&V#[0N2QLEC.0M)A"QK&^1+V%%[:GAU<#3/E^4'M)?1!C]X<(6Z5.CA
MR1RK`BPUU:/,0GEIK*P)62&?RM\EC"-QF4B5[<PN+@>X540[Q126<>9LYL>5
M!0A?`884.4O*;MFW_P`2<<;9*]26J3*9BR1Y>5QJZ`NM8*AUX[,YMIODVB9S
MRRQ]]935,CIYB<RB(B<`P"=M<"MGB*&7O16JEI?@'CN25E!NH&!F=H1*Y'TQ
M7_Y?G#U+6"1-PK(F:616BK23.XG>%R1@E<I5+(I-V]J5C2+D:K9+>/11I8#0
M@`+F:\E?X-XIYS$9.P/A4LYT92M)J24/Y]?TJ[0ASCLXKF$JHO(K6J@EKEFF
M.*61[C@IV%P4)50D39[RU6E1H]F869[)#I?QQ3VL.H4W0RN4T20A;9,_B4Q.
M%U?(6,VT$+^<YG;NFXW)=+7`,FZJ9DQX&Y')""R$);8M7D;2^AQ?Q"9PIB)%
MXG(L"3])3N%I*-+D-VV4EF32Q2VJU*Z$DQMQ4-[C,HA.6YB?6=QD:5YE+.WR
M(L2<]*'[^T(5)P3/A]-CE-4VF%^+2*16YXC>B]_C$ILF,V"T3=58CY#]*+#?
MA-,\G[YK;E)?K_F&ZJ85*T+&(_T]NB6[7H'XQ!`&%MDO;D#I&X;'N>;;GE(%
MDN@:W:><E6R.BH9-:=9(\0_%SQT4S&K;KAKF7-)>*4JR_K60346<E3(R%@%)
M9'IND5YHTM[Q^7GTQ)X>^V=84"BA,3'&J]D#CJ(HYO/9K`*,O!+<%/SZ/3!0
M)`;"9I.E;>67(TQI:T"(!@S4`R%FM*,A&ZHINKAQ;?K8F<9TVS"H9!8\F*U)
M+!BJ*.2Z)PM5)ZVUI\J%AI12.5.2FIFJ2R!J1)I:I4Z<A+49RC9(2Q;#Z5+:
M"#QS7;NZI%T*W6)237*E:BSY-#X8^U*8\-3?(.BW.LGFX6FRI`Q/3"YSQKBA
MD!&5%S$WT`AGFE*G+2LU,1L$6=UQ22^5O'.Y<]NERH9!8D6FD(FM9S*H(4G0
M5RUL$O+B$]NB[+Q?5]FR`!R@J92(F0W>M0%B**3)CTB0*E06:O5+%!U)W6Q7
MCU\=<@XH*:FXXSGA.UQ>NIK7C8;2]6R.OW6;)9%-&"11]SM(UVE\@1O:N(-,
M>TE2!2%)0`&X*Q!T$`P@")FT50KQCW7%Y=54X<[6JMS*K]PAKBL@942G4O3M
M3?3MM2*XJPB52V'<DZL&P(@Q.KR[E(70AQ7.21K3%[&S%(!>GH.72,DNM_&7
M0;ZF;9\^2NGXQ9+`7^>H-$#F"7RZ&M]B6;K\PW%&;F7AE+:IMR%Q>3.JU)$!
M)@MAJ-"2GV=\@M;]23*.*_\`'!;%)N]C*(Q-8#/6&Q29M7J8@$8+K^>1J"],
M7)!IY?\`,GJ>H3EJR42&O&V/J!Q-&4!)]>()87,Q0<$!P2\L&WS'QW6I8\4F
MK%*[2K%M7WQ%'R"7F;%Z]?@L,>CQ+0L:X>OH".O<I<D$,?S/D*%(-NFG-*[@
M^4OX@`'O6$B:6AXRYOL'FN(R1@FDLKB4+IK+ELUD9M?P$Z`M"1U10:K:TBZ5
MC;-.KAO:/46K?:AP,6#4*3%ZO0"!E)""B`EW3:Z.&3`I!Y*XE,YYX_\`L2'5
MVU.CY.)'SW9K5%F=DT/;LXO"F-+0I$C<$K>C!*S1_@#0?TM[_#7XX7;4;HO*
MU=HYU+S3U9T[R^CYGER6R%-;([.?9@>P0F7,26(1EVCL?:V]0ZK9'&F`A$0Y
M.!0"2B`B$:,9?I[-:!O>BSMW1&+UHPR8'E!*.I>;.3^I.EP],RU-6X[(:*F?
M(8K?X7+7U)+XXQ,DK;'4UJ6QV-OY"LIJ<#Q%'$"V$P`S=?H;T/6]FHVSNC!.
MOC(B4S@GC]Y'B-AM+JQ35BI*'I)"T/83`NR!=M((_P"%>`[>S0'_``&@WL(O
M06M;]-ZUO\,&ZIW3,9+U894P[]*/US/)'3296H:XO,JJF4I&C1JW$:&%Q"RX
MK(IBZGH$!*E:M1-4;;E*@\HDHTP9)8M!`+?Z.RPK_5O0U(]4]H5O+>;9<18<
M8K6FK(;+)>6:-2EA;H^ME3M&Q1%&Y*)%'V(I8>Z#;%FR"R=G#+^(8A:!K>MB
M$Q,9O4_"/%;S2_YL\#_VCO,'^D:O)+?\\Y]'M3E8,!@,!@?/[S+_`'C#R=?U
M(>,/\)><-3^L>-7T!89,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,#Q6\TO^;/`_]H[S!_I&KR2W_/.?1[4Y6#`8#`8'S^\R_P!XP\G7]2'C
M#_"7G#4_K'C5]`6&3`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`\5O-+_FSP/_:.\P?Z1J\DM_SSGT>U.5@P&`P&!\_O,O\`>,/)U_4AXP_P
MEYPU/ZQXU?0%ADP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M/%;S2_YL\#_VCO,'^D:O)+?\\Y]'M3E8,!@,!@?/[S+_`'C#R=?U(>,/\)><
M-3^L>-7T!89,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#Q6
M\TO^;/`_]H[S!_I&KR2W_/.?1[4Y6#`8#`8'S^\R_P!XP\G7]2'C#_"7G#4_
MK'C5]`6&6KRR;PN!MQ;O.9?%X8TFJ0(RG26/[5'6XU6;H0BDI:UX5HTPU)@0
M;V$&A;%O6M^FL&;9@#`8`)A8@C`,(1@&`6A`&`6M""((@[WH01:WZZWK\-ZP
M/U@==0K2I-%"5*4Z8)Z@E(2)0<63HY4I'HM.F*V8(.C%!YF]!`#7J(0M^FM;
MW@<FCBA&C(T:7L\LLHXPG0P[-+*/$<`DT9>M^\!9PTYF@BWKT%L`M:_DWZ!R
M8'&4<2>'8R32S@:,.)V,H83`Z-3FC(/*V(&]ZT80>6(`P_RA&'>M^F];P.3`
MXOG(^?:;YBOJ=%:/VG^0'SZ($,183ME>OR:*$8'8="]/3>];U@<N`P.N2K2*
M!C+(5)SS"O=\I9)Q9@R_8H/2C]X0"$('L5)32]^O\AA8@_RAWK0/JTNE6D.U
M*?2X2<2L*/YB_JA)0&!)&ITG]WS;3A.&$&Q^GMT+>M>OKO`[&`P.,!Q)@S2B
MS2QF$""`\L`PB&2(8`F@":`.]B+$,L>A:UOTWL.];_DW@<F`P&!U-+T.PK!Z
M6)-@;AC*<!Z4$["@,+3E*C"U@M#]$HRTIP#!:'[=Z+&$6_PWK>!V\#JZ7(A'
M#3Z6)=J"U`4AA&E!6S@*AI=+@)AE:'[PJ!HMZ.T#>O=LK]/T]OXX'\5+T"':
M4*U:D1B6JBT2,*I22GVK6G>[9*1+HX8-J%1N@[]I8/48O3?IK`_:M6E0)5*Y
M<I3HD*).<K6+%9Q:9*D2IBQ'*%*E0<(!)"<@D&QC&/>@A#K>][UK6!T6)_8I
M2T()!&'IID;`ZD:5-;VQ.2-W:')-L0@:4(')O.4(EA&Q@WKWEC$'UUO7K^&!
MEL#7F27122G.*>.2>//ZAG<%K0[D,CTVNIS6[-OTOW%L<2D*D\:%P0?7$?.2
M;H)A7S`]P=>\/J&<`>08::2`XH9R?X_G*`8`1I/RAV,KY2];V,OY`Z]0^NM>
MNOY,#EP.(9Q)0R2S#2BS%`Q%IRQF``,\P!1APRR0BWH1HPDE"'O0?7>@AWO^
M36\#EP&`P&`P&!%$PO2H:_EI,#FE@QN-S%16TVN!/'71;].YGUE7#A&VJ=3,
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M9FE46!S$-.Y.^M_]5('K1JC_`.P$6$9;]8$#^D0K]3:([0NCZ.+MBS4D9]I7
M&3%&GD&1U`HTL^)8^EGIC`"1E[$HT,L6M@]0[UH-:3WG2RI,8K)MRM-D$EL9
MJD1DXC1`D89.9LF.!7%'N19R$U]/ULM(`X(!J#-;`#6Q:WK"U+;76:PUB=&]
MD?);&69Z=M%B:FAU?FIN=',)RU,W$B;T"M42K6:-<%I)`=E@%[CC0`U^D(.M
MD:X;<U/DDOJDZUJV*3Q<"(R2GFSJ+EDQTMS4?2-PWTT3IH#2!P5[^(C:C9>C
M3/T0^N_PP4QT>OJDY8K6(8U:]?O2E`E4KE(&^5,YX`HD4P=J^6JBCPJ_@4IT
M4X8E32<,H0PE+R]$CWH8R]"#:=V'`-+SVK<YAVG1-(4414MNY,RZ7IY6Y)AK
M&Z,'H]K?J"I"O2%B-(1"#I2:6'8@@V'6]X'X7V17;6H*2.<]A;<J4*3T1"9?
M*6-(H.6)7):SJ4A1*A<688I3N[:H2F%ZUL8%*<PK>M#`(.A3('S*()G)H9E,
MKC:=WD`BP,+4>^-93D]C-1JW$H+0A,5!5.0C&]`>>'1(1[V208/7Z(!;T&M(
M+EJ!U(3*FNUJV<DJU\/C"-2@G,86$*Y*E(&J4QY,<G=#"SWQ.F+$8-(#>U`"
MP[%L&M:WO!4N-)==-."54N06W62U"A:C'U:L23V*J4J-D*/3)C7E4H)=1DIV
MHM2M)+$H'O1.AF@#L7J(.MAG'*Q:^9CM)GB=0YJ4"8U<FT0Y2=D0G;C:!(8O
M72'12I<4/;&C0DC.-5^GTY9(=C$/0=;W@?ARLBNV94%"[SV%M2T<=-EX$;E*
M6-"J'$R1_$=*`IU2XHT4=*,_1$MUKZ8(OPV/UP,67<E0G*&M(5:M;FJGM"V.
M;*F+G,8&H=VU[6B;&9P:R0NFS%Z%W<0;3I32M#+4'ZV`&Q"_#!4MA2S:&+7+
M[,BET85N_P!S<67[4E?VI0Y?>&@KYW9I^A*5C5?<VPG]-01[?E)#^(PAU@8;
M=LU7H\A+NRZ_TJ4NCPQIDVYE'-'J'J/"3!?V<@G[E\AKHQB6DZ6)PZV:FV:#
MY`A]P?4.XWV373LF;%C5/H6YI'IV5L#.J;Y2QK4SL^H"S35[*V'IEQA2]V1%
M$C$<F*V,XL(!;$'6M;P,"IO"FTJ5M6&6I7QB9YTE$T&I)<Q+].A2U:XMJ90W
MA0KE`U:0:YG6%[.+T(H`D9_N%K1)OM#M(+BJ=T0OCJ@LB$*6F-!:#'UX!)F@
M+.V$2#W!8E2AV&K"W:1O!I8RTQVC=E'FEC+`+8P"#H,JCL>OG$YZ3-LYB#DJ
MCC6%[D"1NDC.O5LC.,H9Y;JZI4BPY0@;S"2A""<:$)8@AWO6]^F!H4,Z8YXL
M5">Z0"[ZLFK8D<4K2K<8K.8Z_(4;BLBQLV3)EBML<%*=((R)IS5_J8((0IR3
M-[WK98]!+4QFZ<SZCY\KU_K.,3"V(DSN]QC$"M`[6'+F^5`#LL.E:5[;$ZUD
M1MQIAH`%JE2@A,:8((`#$/>M8*E)"*R*[<O3[=/86X>Y.TJP_12EC5>J5_:5
M#^Q*=?`N,]4[TQ)#5J0?_14I"AG%[$6'8M$8B1W+5,3@DJLY^L*))(!!XF?/
M);+"7I&XL[!#$R1>O-D[@H;#5FRV7Z-J5&!/UK98P)S-AWOV"]!4HJ_IJ\G:
M="&8Z_ZT1."BW;#H,L#E(4[8G#<U4%A-L*ME"]QTE0))7&"Q:V<E--`(SU_F
MODPM2EYYMNJ8X`PV0V;7K"62H9$AQCS-(VU@*525&I<(XF,&N<B`@4/Z!$<>
MB!OT$J)*&,K0@A%O1*="8W?3=>K$K?.K5KV(."Q8P($Z&12]A:5@E4K6Z;8T
M`258N*/)`_..]$)#!A"6>=O0`"V+>M8*EG5=D5V@<%K2NGL+1.K:N;FMQ;%<
MI8TS@@<WAO4NS0W+41RX"E*N=&I$<I3$C"$P].4,P&A`"+>@_"2S*W7F;)0V
M#"%INH\;+ME))6PJ#-10@X:<^3[`2O&+4>)4%B`-;Z?3!&'8=C]=>F!C$MS4
M^N2`7H;6K58A,+:C@+4LZBZA(,E]7*6QC-`H)=!DB+>7)&<G2"UOT4'E#++]
MP@BUH4DK`\5O-+_FSP/_`&CO,'^D:O)+?\\Y]'M3E8,!@,!@?/[S+_>,/)U_
M4AXP_P`)><-3^L>-7T!895-[/YG2]74Q^JX:>!:<2IU7DM:GFPH1'[`:X\;$
M9BSORUT01R2LSVU+'C;8A.)(+-*`4=LW99HPE#'O"Q,Q-PIW&N-;>=>9'.N&
MMWKY"TR^R(E,F:(1#IGH*00/5:`K%OB+DF8KOU&VJT"M/$@]TJ2(T2<#?]0$
MM*%0$@8CM"\6B+.&.AK>FB(J\[3AB%LK>(TO&F>#5;TET$4J-88'/&8L^RIB
M)N9ZY=$DCM.L6:0H%*91MP2:<!_HK%.RA*B8MN-#Q+UHYCIY)'[4J.1516:&
MK)?%7M[N"Y)LLF<DB]1(X.H2NS8;$]DJ8F<\$:=DSL7(U+DN,-$>+2<_>C,%
MQU4HD'BL\CA<-@RDF[^5(U>+BJCD2D#JANSM!FK8^`Q5;9CLAI^'1UR>'N>R
M,MQ.LQ?+B71P?Q.S6_Q!N(V%P9UBU,E4U&[;UR7NMSC"[RYS9\X<;RBJB&NZ
M5HU`X!-^@;DJ]D<B'96SV)=[S-I-&T*Y6Q*8=-HFF=(N%G(-(TS@4(%VTR0\
M[UK-X-`4>-WK=EDC*CAUJ0$N`(;`Z3G,V5F7/T)&[!MQ\N]E$XI98H.;6EZB
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MQ5=;0>V>/KMJ0*H"GD<PJ"#5*W5[U.PO4::^C>N9'8$::[I9`%UA!&V8NB"(
M_?([!7$6U*UT=2021O-#K2!7[-;`*%Q]69<O&O9+&&\E$`6UCJI;,L\Z?H4"
M[K#IV(_=V*02RPI^;=+]-&1@D#Q$)952>=$I6B(-#@?$9,G:@JW!>@-5FZ*+
MRCZM5NGAKO&]*[&Y02P^4%]E@56LQ-\D?;SZ>=8\SL;HHKESJZ1LLIJACKF4
M))0F60[3@XLRKZ]C1FJ]A!IR`8(>ZD3$3Y+027Q]/$NJ"F*Y;+/5I[(I-EL-
M]?9>FO.^S5;?T;8^X=(B+&4E-LN1*Y,V-ZL+BO2L4@+,9R"%Q!2=O+3"]H!R
M]T0D^/RRIY/U;=.+7C2-O:S6):IA\%ZMZ07OTMED=MJ)2*P[<DR$O<361!\G
ME8/RAM6QM"-3'V54Y(PIQ?&86>`EU#=HQXX[F9IW7DS66X$XVJHQ2;?!_@MB
M[!#1R6"-ZEBG;[)4FSTZ.QMR*/C*(3_F/[K[]@]Y@"AZT9A>6%(LYD\?/D2J
M6].8+!M3I2HI]7]95F^,EJQ-EDW0R=0.P27NVEC<\5LBD[X^M3Q'[-13YK.E
MP92->J2.+"GVR;1I0[3#+.[;,3$1BS=!<5]D5#*39O<-D45'D_W/K!07+HQT
M'TU(F*MF>Y=I=5(VPZL[4;D\>='EE=RPGNKF^OZLI`6,U(T(B]'A/(),Q.MJ
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M?;\]QBY+LDCE-ZR_(;5!96K=I0]QUDD\%L*?)4R@PUB9#1,3(`T)*!?H`=>V
MI?\`AT+Y\9TQM%)S##D:V.R2NZ5Z.ESFZIYC?703!*6#E65I%2/<0A\@CR1Y
M?YE9S8F.T4F5/3DC5IM;V,A\)&$.]B-U6R+%Q3T8SW%,&N3WU!7:G97RI>%%
M5E`W:960[6&BT_R=[+AZ9S1R<3I%9I$J[@;PUEGNRE`LD0'!4H`J4+DPT^"^
M]M,+\5\[K6N$L(I6=`4G)FFH&8L^471:5;I23H575D1ISE"1HIZ(M=?M"N,S
MF4,TA;6EGC+0WR`QC"G=1E:.&;N$[KS1G6'+5ZT!U-SK%[-MU8*+2^;K'QY=
M&^WKJ=8XC@];-QLJYTY[:W6S5;0P/SO%9Y+'B)AT3MRD\WB#"@=GLLE48:04
M6XF+ZLW=/C8Z:="9;(.?XSR5"YD=-K\-KMGFMI]"MT,C+-?;O7SW-;+E;E0T
M$IJ8V/.9".!#(+8G=0I$Q&NIBHB2K"DJ9NU2-T=;IP[\>/9CM/(#/(+>M+-K
M"]O]$R^YY:BL?H.0R*8/T'J]7#9Q,*R(1KVZ*Q]Y+=C`DLR9S$]L"Q#K:A8W
ME+`ZUL7$13-._C;Z&8ZGEE?\\WG$H[+E$<BT.DJ>9W3TK/&%6-IBM++BFY[6
M.$K<YQ%UQ,K33"1(UK>K2+SOO;>!5I2AV)*3$N+Q<Y_!]RU\GI.Y:Z7,G2]J
M<]NCK8-FUF]]/W(QHK;O]B1K(ZVKX](G7;Y'HK((_!'Y<2E9'!*U1US<C227
M0M.28)P3B^DY/=0&Q;`'8@^P6PAV('KK?M%O6M[#ZZ]=;]N_P]=967ZP&`P&
M`P/+?NNDN=;SMBL(58?2K%0-[R*M9C%:1")5'6V;/C=(K&JI#/D<3%(W%`GE
MB67M9A<2<F$K1AZQ+(OE(T6I(3G%FHF8CR14Y1_GJ*Q">M,\[VI5!0\)KR30
M:F7`"1@C+?33!+92*$RQIG5U'6BX16X9J=*8]MH(0"+97%,K)V`Q*<J'\NQC
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M)0W`D;NR.1WURMI0$:I&ZHJNMPUI#Q36\8M8AVF/D"YJDTWG($%!5=3$XXNJ
MM+`)._0>8LZY]&\U0VV`QS;H,#!%4X4I3JXNZQ%'UYHGKZO6@[)R%^4MZ_HD
M4E([EH>1U;>M"VE#V:76=:-AF5^OIF,P2+<;N%[W=<;U''=I:+%D;J_HWJ_0
MQY(.0MK82UFN%;KS%9S:H%]-@O#JR<2J?FB==(7+T&E\CO+$Y7MW2=&]3.#*
M*`4LWJJ?@=6,$EAI2=DD:6R$"5Q3V.@GXVG]9CL@=C"TQIR1`9I7HH]'4FZJ
MF.DW&54V?+>C+GE=KUQ!:QG-IR@=6#6,M?7@[#HJVFN%3FS'VN_R5+%IT/D%
MD7G*W:=1B1@.<E[4TRL!RAN3_.,L$+J%AZ#J3G]ALJ7=8S_KNAKG9>:B5O,Z
M67F1&&P>%42X1C;,TQYB=K">+"E;*1;D499GIC='5*>W&JS7@Q((A*,PU**F
M-5"I]M\<<@#C%6P&'>0[F[ER+;2Q.W)1"R*]YEBSC;T:BD`-CKM8`44L>&"4
M0DV2I!B<%\J9OI7$PD6PFK#"A>[(MS.-3*2KV\9/,>Z%#-X9?,5H9B>H[7L-
MB%V4]1=92QJ6$V*R\W4M#"-QQ`UR6)S^"3220@A:%M-2'M(E\CTL$,&D>E`Z
MES;5+6AW!<V4QZ-S/MZCF&)2:!.U!*WRPZZ9$S\[2WGM"=5TR;TMVRV1,T.B
M40<);-$R.0Q10E$@DAJD+8E/T$_VY%CET6?[*I?E>RIPX/BSK'FWGFVV.+5/
M3[$ZRELHR1OT);!N4FD[5!3&"=21K`L8K4:)ZG"5'%A6VY<24G/`F4;$#821
M,UADAQC\?G,M5H*_I.V>F:2EG1#)6[5'T#JZ5'3$6MUT87)YOF(0F41ZO&%T
M$_Q.*Q^>]$MIC9]K`2TMSQ'D9I(TYQFC$]69F<8C!R\W4KRK4EZ1*=LOD2Y[
MMJ43ZWKFL>O68]32SE:<P;-M!E=/5=U^^1RP3UDLW!G-H,2R)U2LKA(G-40-
M,M4DG:'O<2;TZ*33?E*K[&C]NOL6\@G'=NL$BL#H2>SBTC(=SE%G6LK/N1?R
MT?5O.["L9+DC9=0V),-<X.295('`DQU<MG*@KDFSRA#,-8Y3$Y+B!X9A=??T
M:S;+[8H^C[0K)T>^C%\$C%94[5L"E,1@<8-4KY$V5H]6,^G,)U>FJ`+I7.6A
MQ]CR`C>U^B4IHR]F;TAQ1GBNE.;*LHA3878?-DFD$JE(QQFTK!BE,TFPW%%I
M]..E9ON*URV1N4(&QP970?62=,F:8\X)$RU.D!L@P@;CK99;F9PAM45YEK2#
MPEUA$F[#Y2/0Q"I>>SH?J30NL3:Y*B'/DKM^+2"6SFF`62S,RVIC'JTBV)K3
M&/&RF)Z9B3SEZEP$,(JS?5(=<\]<<\B1F!223]#T^T!7++$K>262>1!HBHM;
M=W.JB*Q6(RN1)G]?I4UPU]0J4+.2X'JTA"H(R0_",(@X,90Y3'`_*"K<6@E;
M=+\GRJ6_:KY,40FGZWJZ-QZS(4MK=EYZ*13&M:QM8A]EK+5+8,E._J@N(!*W
MAZ<-Z,:#'/8`QJ9F<9MM5B<Z\.ZKIDKKH'L:C!OW(-`H*;E*M1.894S76<CD
M[LV`B$ZGM4Q>T&2/LJ<U6G)2L<;D)*Q":HV5L@1BG](=2.73JCZ7<V<5VVN?
M8=`>V>>(*CEBN$RB$5O7S#6S7=+`S1AE/L9JB:IL13M!-7HAIVTH`,S5IA;U
M+%`BG6.%D"(<C5*:$3,8RS'$Y_(T+H?HX5B]$\P!I:TYE852NB9!8E.?8H)4
M6H^M,A%7S63P>P)17]6)F@#E.G!''5[DL/3I'TL@:D!Z8U-NDW<14VA'GWE+
MQ[U8X=!?G?R0T!=*@%C53-.@XO;KO2`6&+]!US`U=1VS<,PATSF;J&)3F_+'
MTJ=U:H>DJ$H>BT:,)^B]*C(UNG=-83#=F'C+AF93>R9!*^XZ.MYFF#ZVP>&P
M:=--%.<9A,ZK7E'5/O14)-=';:J<O;"V6$P2H@9AS@.-&>B9"8E*<%(A$N8P
MB*6>L?D_FFQ7Y)UC*KVY=44')HQ1"95,W>OJOD3'9!U5N)":'.D@ON76`]QE
MZCRM<$)32W-B1`E3+!:,V-6I]H]7_"1<88VK$T<]\HF7/>R>R_(W1\YD"*"5
M[$%4;=(33$=?J4'S72,TJ)WG,HGB^1N2I_EB4SK1G7#>'TS:IN4[(;BCQ`&8
M6G+<U&&'C[-THKF;G:BDPX[&_(/RZZ6),.?FSD_]83A"^?C+8G%ES9I?G6MW
M%W*,L-3%71NTR)E"YBKQE8FEO=M(SU:D3AO1@PDF],$4PGQI4`=!)90;/Y%:
M?=.A6WIABEU@S*!UARVTS)$TN<FD"V-<V2*F4#@\,L61;6,+H5'P$)F]:WN"
M9P4MZ<M3]1L,69G.L'T:-Z(EM0(FY-L[:=`D3(B-J#S5)^R4I(""MGJ3QF'J
M#M@+U[AC$(8]^N][WO>5AXP^:7_-G@?^T=Y@_P!(U>26_P"><^CVIRL&`P&`
MP/G]YE_O&'DZ_J0\8?X2\X:G]8\:OH"PR\]?)FWPA3S.X+['F5!1:%-,HCI[
MVV]2&R(-!R\"M<!`E8Y\5$U:*0J`D*E(5C>$@?LTXIR=G!$3H>L+MS>-,\Y,
MJ:-M5:QZJNZN?Z*;Z9OJP9IT#&G:/N*G3W)()3W.;%?<TCK4Y.NE44NF'R!N
M0RAI?0!%]`CF6][!L*P>]QJ)GJM;QW3D%C_3%JW)%[]Y->$U4)Y"&XJWIT4Q
M.2(4<MB[M+4/3UB#>G5:<3TZ]1-]3HG)62'[+N/NBX`"PG&E;RI.$1FK/SER
M?&+#K!=&JUOOB27HC:W@MDQV&1EHMMKA=30=TJAO:$W1<0C3J\IW]@LVPU:$
MQ6Z#4Z`CTC-$'8-&^[8HLW>-VGMMH:LY]PY"8"5U%S-:KFU7`#I*MK?DRF1J
MHNYL,FKBR8XC==C0/)+Q]73D:1RMMKM2D-^$,>@3(6KT:,E>(=+^5]&GPBK>
M<NQ:0CM(TY=_)LZL&C)].[C<(PVL]B[KRKZQM9A=X$Z2ZKFMU<2):`3$UO*E
M8QN2@TYJ/>=C";H2?\,&,:OS35*4HP]%<1WM1?;O-Y7*$>;KGCE>5"VI37';
ML!)8]VVFB*I.7*'0>X@0@C-L%-\J)&'9+NCC[=O_`**<KVB9PF)C%6>X6KF%
M/"4L;HJZ.?[Z6G2F-E.$48HI9DNB5-R@V?3D#CTR[/<&<])ZKE<;?[+:VU')
M'\0F-*J5:`H!O9Y7MA%]<%KN>:>XV@;ORM/:WZ#Y(FA:VS7^U(_]<K>!)9FX
M%5(UTMT39-?C(<M&$V0ME4#6F`/4@^@$,Y42:#9P-;TP)Y93:(&ZJ.:H>UZ0
MP3J/GNN+5F=-3XBG9)4T$EDC*G]#F/?:%H;K^+-#BO5[M9$2IF"!?*HXET/0
M1M.@ZT7]P2!P8SZ?\+,430]1\92"NI%<765)H+;F=#MC#(GM,VJZW23JN&2K
MU<7:6N/Q(QQ&VQ>LHS,%A3HT-.@@TAT#90/4?KZ"9F</-5F6\PT)$..XS:+'
MTMS'+8#T8_1*#OL^F;#:,HJ3I*8Q>/=8QAH:I47`W$R1N:AD9Y(@(;20?&6!
M9#]$C]1#)#H8W4]&\.-)0'I%EJU+1?0?!%Q&VP?8\4KE7><&E]B'0M=$X+!H
MO9\.I6`C=D32+:UM:3TDE3O97U24A01HG83@BT,MU><2P,#YTAU1/'-;H_=O
M<?0A+772D:1V^KBL37(7.YKBJ"BJDYXMQB9U+^[G$5_935;415"0J$.MF(T3
ME]&9H1WR"Q@ES7T2^\U/RMJZ9]9C1TYRY7#[NV+$L^HY7"E#N18<',MVZ>:J
M+L!S&['NAC=J92&S:<>86I"C#HD]4[$DC+T(LW>QCEBZ]3<\4O<_,O.?,SWU
MKSE=DV,E'0%L053"VM8UPF5R9$[.NV62P2'MKI\:$JHI$=HX10#1%!4`'LK7
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M]"SJ50^9QF/6`W(5E/7-%XE=<>-<T<ACM8I*WHE_0DE%[*$D:G@D)`P^W7N$
MW%9K27CR]R*J;?'E8UX61R>_0F.U+#ZOCDNLIHD2MPEC='&]1+V`^@QI5Y:4
ME'*%2O7W'3F6=L+627L@03M[W@B9QJT6QI3S-%F'J";6%Y$N?9S3EJ5WQM`V
MQDC[0IT\-#'%&R/LBZ+R)U;%IDAG:6TB:8D":,MX]!-;?N#@3^/U`_<7'I&.
M*1>F.?F7FV*J@2"?M17(URI[.C#%5K+6-JS^6P*+R2F)%$H1%(S'XRZA9TM4
M0F,.:QWD>W'7R$A*W]+O0_3"1/7JBB9\F<F#G#/:%>6MR0TMK6;&I>ZP:W&F
M>(APIGNRTI?.J*F+>W,KND6QRPH9!9$@:XWL\.D0#D?J<#X1%ZP1,UU60YNI
MRFJJ[7E5J7'V'1]S262VI+(=0T?^`#+8;+:(XU%8FXJ7X]*X#:)5;!<9DA[6
MO<PD!&<E>$J??H+X];$S-89-4B%1\I5'>Q+-T7<G-J&4\GM"N<31E86Z8H_H
MEMTPQ+5$7O.<R&4+EK<T]`S0YM5DJ-H1:UM&+0BBP;]1[)C6&4N:*\XU11UC
M4G';5ZQH9RELS6S&S5)<A7OK9)3:L;HDA@<)44HB$\;8VY!,.8:HCT7FY[CH
MTAU*:%2I)[33QY29OT5<J3E6.2%_;*D@75W&]F2*8UE6[I3U8%PVS@P6+Q?F
MRQBC;`?##6EX*!93=!UQP$K`S2`X1",&A`.`8F]<C5]:6&M%EYCLWMYYG4!Z
M*Y,1.5FK*WNHQ9(4E@$V4J%#4R"$+93#96W+T<`>W6'L7,KJC9-;T8<E+>GS
M2H(RAHL,X\47WA4L)G2SIV6UUU_Q[6+/U2H9YQ$I)&H/*;&7S9IGO0="K(S(
M>B(L\.ID6?V4D%<.$8)5)2DH0)WH0C/4L!GJ6)UM]*D$0!:X3$6P#T=(PM\:
M9$09`H,$<>]A3-R<G3J::/>QF&+]`^7>]_COW96&UX'&<<2G)-4*#2R"""QG
M'G&C"64224'8S#33![T$!98`[V+>]ZUK6O7`J#6/D"XJN>QR:BJOIBIIU9:D
MUW)20Y@DZ=6\+CF$0PNY2`O80%+S$7Q"$+1(Q[V`.Q!]0ZWO#4[=T1<Q@N%A
MDP/.;L*5\DQ&VJY5]%7BS5))AUR_RB)II`4@3M:R*5%<M'6S+GG3PN;U($1R
M1RBC6@.+T<6,U$XG_'H1@0[":B)F,'GXDY.XWHV!5E'RO(4[AFUR1]W15%8-
MG&5Q:TDLBOI+(WB5;8HS%Y2RKV63H6V+FB:&A4%,-0V)$X3B1Z/]1[BW,S=.
MVHD7(EWR,$]A_7]>0BJZ\XUH"%1FT1R6#2M\>Z^<72QHI839+:MES6;J&JCT
M,LB>B7P\H"].H<!!2?&6)1L8FXC'.UF)%R[R!5+#7=23[H!(Q+K`A*2OX-^9
M#HDE?YHPAJF3U&2!(K,;OE6(ST<XTL$$0M)1+2RM;U[1;#NLX]%=*:A5?\N3
M)J[*,ZIJ)-SM9"FJ$;==$\U%44?ON268=/)#=]DUU&8.F;8S6K[9VCH#&D`"
MB`%$-D$V$`=)3T^&L9FJQ?JS>,N=9$YS";M?D_O6O(U=%]5G.D+3'['BZ^*I
M&"2@EC6UT*R"7-2T0:OM*7$&N(RCC-G#7M!>BC@!+WK<(F8Z1DVB%D<4L5TQ
M9Q,[);;:=#)&Z3>C(?'X3!5*NOX7SI/G0$]9%<QC##]\E12"8O)C>X/#RI$Y
M';#HH`QZT+>R3<]$@V/%>)KCM9,FCO8,4C-Y3"[+W;J_3(M060+"K?:(_1L5
ML^(G1&2-:AKF2B`1Z,HBA-SH`XL@^1A4>FS0)-A&-,-?7'_)%'.E4*;?ZN=*
M<CKY(9VD9V*3JXJF5V`Z*'LJVU22.R=P;CI%&G2*KV<2P:EK-).-;PB3GB$3
M^&"YG)@^?2^$>3*GG+!,.W03F1V%0L9;I[,^D5,7>[`-BDU4S221&0V`Q*VD
MHD_1[!;"-$)L6DA2C;4J/1Q7H<(9E)N<H8^$<^\9%P2M:CC/;K$]VQ`^DF90
MT67]MK!9*7VYWR*;>()6;K'"68N-+F=O9$)"IL8?C^E`F3E%:#[?;K<,?HZ4
M[HGEZI[.G=:6CWGM`094<YL.S*$,B58-DF"M=HG6S99=YD/[2Q`F$88T[#'D
M*S;(C-+9FI,K]2"0E!+]!%UDFJ&UQSO+JDM?DF-]H1&837H6V%\TA;T@A]1*
M91#3(Q$J1M)E8HG%4S+^6W^302NCHV^HI`X$'O(3'1,Z[,$>44,-/.E1(A7%
M/2?K6,5I#K>-?:=XIFD-9;X.G;74RA=/;KA==ZKZ(1&*[6-`++<MG.YFDSZ0
MC%MC.<=&$!!L[61<HQ7<<[%Y8COCML"42*^W^)<YV8XV`UP6S%\4)9)36;_9
MD[?-QP4-:2VH1QKY!;*<AKV$U0G%M.8D(WO^:)#Z$B^7FJO4-9>-FL[8E3X'
MI(Y[_HY19CB<QCU@-K9N!ULZHXT9"K`=W(YR9`(RI;>\ULMGDSKL`S!+7IM3
MF$^W01AVP7Y525&SA?E'FZU&F66=U5(W/=W5L_U-4,)MASBCA'$Y+95;=N5.
M5<FJVW9NG(E&RJY.(.S1`(4*CQ%>A6M!U4N99FUJPY`EL:J"^95V!&XU0EH5
MU4=,Q%\;4M?L15Y'UPZ"G<55*+=TV;FD@,&TPUS,2(RU.D:`HQ:K)#H>]CT,
M<HS1#"F*E:#J]+,^U[JC=86>.TY"<U1-'^JE[DK8C=+.DMW0*)E`JIB^Q*Y*
M]0]^)$I,:RRRUB383!BV9L8L$XX1DZEC<?5+*^&8;8?)5KK[3B<>8&!5';0C
M(:K6L"F'0ETZ+0V#8#X@DK3IFEPF^,75(&]2F(!IV`:WIC$.RUA/NR'6I9Z_
MC>7N@'&77,_]D3*'5-P;5LUHBW8(X5@Q2.CS9U=5/J(B%YDC5,XPO-G<HBS-
M*"O_`(4`PY$%4:6G5@%[MZPL7E6,L?>U/\>]>0"HF%Q\@T]B23GB1"XLML&W
MF-IB;PF;6I.KUX@-QQ&3,PFXV42!<S.IS:N1%)Q)URP"U&9HQ.FV$1,[>GF[
M\EY'YCK>[HG!I!W=.D-U0>@Z%A$.J=W40UX;8ZT0"\`IZ0NIXK)0TFM"]X2[
M=R(JM7+M?2NZ71ZA4$:DTXW!,S,986P:2/\`)=IS5RCS;Y-(5)7WH5?(WGFR
M*((%1YAL-DT.NJ>R2S'6-E[C>]V1HJ?N+VW')7WYR6\9.PD:",G6]4QB,8R6
M%X[KJGX_:13]SCUE7UVRJ0)(')[>)5QV(B=C><8W&+6J>$(H43#$3<1&5:^=
MQ)F*4N1VA:==1=88:$:A1LW(DS/5"AU!T7TQ<O2O44/\D,SD2F",:^-2"$N3
M!6$YKOEEN>5Y$BE+6KA,DC"I,:[*XBU*4`-N^E*AL+,$I3^Q0``\JWA5)%KK
MF7A^-TE6%OQ[HMJ=*M7A;X=";<'^4]IY4ZJ7J^61*C2O1;8!0I>52^WEZ#98
M?0S_`.#)P;UK0#/6),S<VAZP:G\?+/3+''==PUY!FJJ7:-0C4T?62J)6B;9[
M2];W(_'.;DPR)C4QXR<,L2?G5_"N,)&8@/82E10M"3BP1=Y.Y.J^Y)<87;A3
M%Y./U6!Z&9#I)'[&B(:E03.-1!DE\WD%J[)EJF/'+)7J761('8]:8\[-5(=%
M@1)M`((`'5(F<,$43FO.&('"I0Q2KR,:U$)^X456LX*3P2MG5_<'%_H6(OE*
M(AN[=%3'N.O5D-5&K9*!R*^,;R>M,3&F;))3@+B_*9N(Q6PZ!E=(S+EJ?T'/
MO(G&.8T3/?[37+%8]"N[#!93#XX0_(GJ`T6]%.Z=P;E+^]Q,!:!\,*)T2L`:
M/8?9H65(SPAV+MXTJ2A0HKWL#K\5*1F&O`5#!(I;7]2*V=MDSC5M!UHVB>%[
MU'S54M,&70ZETVE6"-"I6/RC8];`B1_$+O!IK95G!S)6(ZOD'3;>E4#E?2T]
M-E#^W1)E?)*L<*M=4-@2AC+(:0I3&*OF&8C=6H])K04^_0!/J`.P9"YG)6!%
M3]'U[=@+0ISOV(RQCBLI)M54]7S8#'.FJ#RF[BX8'D^K$$3;$R.0[A,,BSA*
MW2.FK31C`LE6S="T/0M[+?28?3.`83`A&`01@&'0P#!O0@C"+6MA$$6M[T((
MM;]=;U^&]96'BQYI?\V>!_[1WF#_`$C5Y);_`)YSZ/:G*P8#`8#`^?WF7^\8
M>3K^I#QA_A+SAJ?UCQJ^@+#+RT\M$B:&?GEA9-2%\A,YGTW*@E?S]E,?M:A2
MR1L3NBE+PYI(W270[LZMHH6->4-&"+FA5;'HL;BSA%MR3&MN?DJS9U7^,&Q9
MK9T0=.C[IBU@6FE?H>D>JU=;&B#E'9\YVT^3*136CY_&ZY`A+M23.,X*C.U3
M:X.&W-BC0$11)IK.Y'%C&EQXZ@XOXE2+)VMM*3-J"$'S2FUXGHM_F*_<G?8[
M6,RE+(6WQ:'*Y1(9BXH*W;W/_JH5!RQ:N5"UHY0H"$`QF:ZJ_<]+N'*33L2A
M!TC<\ICJV%H([7*^V(TQ*&/0K/KE'8#K82)#'J9CRUL?9Y&W$'U94L2D-AJ\
MD:1$W@,T,H4)F6HPJK.$)$%*4U=;='2QOHV)47#7\IWC!"5I32^\I%*3>;)H
M[JP\XLJ=-/&M1T>24S,34:DC4=9S6[2YC3H"M['3%8/GB2<<1UX`H9NII]<T
M\ET0=FIQL*P6UN0+I]NZ)^A)&L^JA505Q79TS_,S"6E^W-*)*8VIB]C4HBR]
M_-A)OZ(XM&JO'M6<8K]_L3I25P*$7U$(RTH2U[ZS`;[]A;!$:HIF&M+H8JKI
M>^;"R+I(PN).VPUJ7F.3H8<I&:@+&0G+%S.&;7KC3>-E!!YT@LJZK988XK.!
M%7E61![",6.`ELG@9XUL0)1TPXF2YH;G>@4^E;FU$.#:WD:5#4'%%FE&`$1-
MX(UNNG?'3.IA_28F=N]91TJJ;LL;D":H(:5/6J'RF>S"SYC,$B.6QIGKM6HG
M,9K.P)*X.L8?VP9J9B--^39_O";H)8G=$5A3<JUH;G&OJA<[-IWKRX6VLN?X
M^:SH)'(H.X/]C/UF2IN=6A=*K=<W2JTEX6M%9TY/D86)VV*C9F^2KFOY#S7,
M6R_IHEZMBMT_Q]OJ-G@<NZIL"+M:9GB$4G5=P5G5+6N;.5.&I)'&91,B%U03
M69,8(<F)VZ%JD;BV-8V4)BY3\Z,H:D`^6;8K(NG@J75&T521T1<,2:9?,;7M
MYDLR(0*5EO,;,.D=H[L@Q1()K3+Y`FQG=&Y;(6U"@<4)SBY,2@"UI`>#:9Q#
M2IAL595!PY9%_55<T`N.WC9A3,#D5S-D06NDV@=<OT`LQ)%&XA[L>+2*%1AK
ME((BNA+8X-Z5:9]R8%OPJ3BROF(V(7,171%UJL'CBN"#,W0LOOJ]&FOJ,LFU
MH\YEH&^V8P%XG=]OKS(FYHD=7+*M+ELP.B<DEQCM!E"-J']*886I)/4DBV(9
M8G=&$=6MTK4'C0%8;?:-?=&WPM6U!%:TBJV+2I\LQB@89;6BU[MHZWE<#E5=
ML3,?<LS24E(?S2_MI!1JM,!S3""G-4>W<P2YR:_"$'C^H^P*9Z6=KV['=7Y`
ME2*XW$9"Q3@=82_^D5(5>X&[J:PJVJF2EY&LK8*OX6=-&"=BB#:$/U2<K6A"
MP8S@R39`N!YC%Y%)0]F=%N#E8,HKNP4TA3,T<2/4+:)S+>F:DB\%B40B/.R>
M!LE?.CLRV*V.!0&=1HDM`H>E2L!AP792)O1)QU8<"\H.E[05?T#?:62W1+JN
M1)&8QPL>Z5])2$N)/EDUF@H9B05W/&B$L*A'7JN0Z2F)%[*>O;PZ4EBV,M.9
M3&7-%^A>":LB]QNJWH"Y71(_-$GJN=VD]P)\7.[^]2=.MOMXE$/C\0J1%M_?
M5Y/1(UQ2AECQ[0$!>PA3Z+3CV9"IF7/4O-?&EC(JTYQKGI*WIK9?*--RZ--$
MP<F6`K)=J-W.SM[DKDTBW)J#*I:6R=J;9TW&Z1D,PTR`2E,%P0;$/81TQS6_
MFG%1$J@%:PAEZ7ZAKAT@,")K%YM&"3.!E6Q:,)`G3A4-<\F4HK24'H%RQQ3!
M7#<XT5'G4M5O?PJ2BO0K1+]$/PWQ:U=`Z:%3L?OOI\P2^8V-*93:,AF\$F%L
MSANML]*=8D)ELFEM9/;<X1F3!;419AQ2$AZ)+0E:)7E>INS!=S:U<WY9J6TV
M*HXW;C,GMIFIQQV\Q]LL=@A4I:'EZ)CB^-M;Q)8^NBNXZL=&`A=]4@/3)$HT
MJTDLX&_4.]"%UDI+-?#S1$O%+C$%\]CUZ;-$M&-[H*L>@'*%DI6NBH6E@*)I
M9T#:R?;6MKLZ.-J$N9D%$Z+D0F]+L[0=$@UHO+T;<Y>*JD7:[ZCOQ5:_11$N
MIR4JGMA862>QR+UY((VH60)Z+K.9P*+0AECC_`4TNK-D??CV26Y*'IO(5J%A
MQA!'Q#E-4E*9\(1*73V?6`CNF\X8NF1[`YL3-%%U6[8ZODS6_2"1OLK@)<EJ
MJ1N@WF=.,H7?=0/BIZ0A`?Z(DZ/VAWHEMGG/$=.V!`Y'7#VJF!,:E%55#3K@
M6@=&LM65$:4=GAXB(D:E2QJ_B=#U#V:!8:((PFEA!\8"A:V+8MRPCD%GADZ1
M62?<MS3"8G,,FB<Y=94IK$6K1B3TETGCT;F2./5C'T:)%79@0G,Q[$6RKAC#
MH+@>O*V(L0MHSOX]:JE%;BJ^9V)=$L8`1N!1)"N52F.1U]:6&K4]CIJ[3-3E
M!H=%/HED1*L@W:9:$'UPS&Q"8<<::6<-0+QM'L?\5E'L%=(:M,M+H:2Q4H53
MN[T=,IZP2J63"P:3G".?UY:\KG[S"U4Z<[$9WE`2`2H+B4E.3E@T-/L999@!
MRG-Z3M*(]M:VYN5.C@^*4*)*D/>74+>%S=3DY("C'!P"TH&ML"M6##LPS2=,
M03[Q;]A8`^@=$9#`CVVVIP?:KLEE:4IBYT=X'+FUN0E;!HU:M7,"],E2%?((
M!?R*3C-`#[MZ#ZB_'>M8'BG6MX0*XH-XO><*_C5LJ+=Y_GU#N=K1A_Y\NN!L
M]9H:EYUGT!GBM?.IQ7L<KHXN.2AT(;0_:W98)8-1K:/1Y&Q&:-SMF+GH][L,
M&!YJ]Q.]9-=F4DJG!=](G*-1:T[23+ZX+@""K9,R4P.'6X;6EK2&<-SJYDJG
MV70EF=F=%&B0OJDQC.,,,"UDN`1EAY^)5/-R&QXQ(]//D&0P]FGWZO(8Z@9^
M8BZXB%&;B2.S/JXK+T[*7>K5S.[().!,I6)ENINO'OZ9:$:4.LB]+P:#..%>
M8XMT7T_7ED2KO](U/M?5*]?K11W3`4,>6/J^+3YQ5G51!89"V(F'*V6AN3F>
M"O;VL"$Z2LJ%$WKDZ@XLUT4FN4S$9+KGRRH.G*_!:KJ@NZ*QB$4[5455U?7;
MQ7SZYW_"+3-)D46J-V3RF')U*)U=GE@2)@'-;U'CAG*=A$N(*]PL,Y8(+ZSO
M,#]2]&4A1U=]/P:UFE5&Z<C$E>I-24(DK;7:&MW'72:1Z='R/WU$9LLJ%J@Q
M#7-FM*VM:I<Z"`%A>=$[&KRD1$SCDB1)5',,W9H)6CA-?)I5C1))G24F+A4>
MD=05>TPJLHX-;6E;[F/Y-7N4BDO-%U3BY/F"S/+K+G4QR,)&<2A3)]Y%NL8I
MGWJP^6@L#<M98WV8C*@7+<44`H4J5\DB<9]"I8TPUA26?+&-IE$ZLB,32L86
MVMYAQIPV1F4(P>],C=#Q;%@KIAGFF2JHSRY'J1O#I&-R+L[I1,W=<R)8\LS[
M,ZBL.QY59$FMCF+;7'J\/)>&&&F5RWN%4Q?3,B5O*-<UM!R]*=HE9H*9/2;F
MHFHP1KU!;+9>\?I*F)7.^EK%7,]2&/%NR3G>+<V1*9WS`.ID:BBBF-C@MC2R
M6`AGV.02`H#\6L+91E)R1FMBU<+6R]PC.\$4E<[\)W1<4>;(K>/D8H*R.JX\
MQULHA<'NN`UU^5R8A0,1B<>L!;'6Q:^F(W*[**CD:&I<F(+L6J2,[6!V);C"
MB"1#E-5-5#+1\_EB,2&N[&M95Y!V!RKBVW"84['G>0TF56UJ).<*\EA29FBC
M?72&$ML\AMAR>"H2`_FE$@E;[8BIG+V?LLLH\D8Y15>/'HL1TZ0-T[]5PV61
MZWE_,<RJJ<N]U+HU(ZZ>X`HL1RA%(Q".Q=9#7*O&^Q6*=*XPA;1>A#^[,BQL
M.V,91"@0BPDC+S:Q4S?QU570=2/+<+J\N:TS:]_TU7K2NE3"XQBUI*LM:LJV
M=C[!BII$;3N<AJ-/?QQ$1+(T)>V5M&7$\0S0IA)S"X^6*4+)?^1W'H%_CRJ>
M7[&[!I2TIW:$O9("_P!#31GLE`U+=6O((A(&Q*=8,AC,1:I,H^0A"<7$9:%7
MKV[-VF_3W4QB/5$6K3HUVY\DWCS>*Q[.I*F7C5K0XGHAJ646]/D>(K^S;J=3
MY*8L<=2)L1,T^.HMW+833(PZFG#`I2JT:/X2%JB+6-X6U>WX]S=9+)((N]LW
MD2;%5A(8:0HCD<EM&U5*Z3E,)MVDBQ'Q^9L+XW/##8MR2[\LN8P#=U[":G`(
MH!S&6,TO8BXQP25<5S\TW\]\BH%;=W9!)954`3WG5?*4+W2K`]6*L7Q)QC,/
MKZW:?ETF?$<AE6H>]:>&I(ZG(XY[!?&<MVI`K0!J1A>5:ML,+I6=\B<B5%-$
MG7BJ*[&]6.\&(%U,NUE1ZOH1.U,$FB:]9B)IC8(E!B#9X6V/:&N$Z)82S;-:
M48C&G1Y*@BF4&LAADLC94EAL7>M:LUP4[.;NE-KR:><G/DPNBEH$^$0V`4*K
MB$<I8]D!'93%T2-P"-`9&7QN-.^F-=U>M".W&JK1Z3Q'I6@A2F:\6MT?Z(52
M6?R176TQ@AXZ.7N=;O\`T!&++O&:O+Z<R392[QL$:8)&$E6-;I429\J`#00X
M_"Z'E$J:MP]2V!2?-]3W-SLNC_3+O$[,9)$NL&W*T*K96BIQ_LAG3LL2:W!^
MEQWO9WJ7'M@-,NBHO)$0%'NVM"$O?LW2,<<+A2"VY;Q?8"*"SLQC[MDSS'+#
M0.S6TUV]5LR3N=2EG2(>PI55RII&^-$,D\8976^US9,&E:Y("&U[B9Z`O0S4
M>E!T6+C1<=Y/Y][1N^U1!)Z;6`B-8,:QTK]K:Z>B%6V\KK577EEGLC>_(41E
MD2^;QA5/&=J-*?7@AG;MNIVFS96S3U6ZF4*G\[6#&!T75RF^VR\3[<OJQSU(
MHBZ3R!+AQB/RU3-.F86R269Q"M8C&Y"^1*%6$6A6FH6-*$2PO1`#!;)VK.BS
MY9)IK2>TYXRJ48381673=GQZ0\;,-WJY?/+&C<[7NJ6$RV/-L;KYQG#V:VR-
M]LDQ/?Q2`M:L1%-X&9E0)PF`T5[0$G'/5T^;951S,<\\O!EG6M,S7JU+9<=C
M,6=YC1,6F]'HHB>%F=9%'TM;-$97I;"?'U]!LY[(13IP*4A*/<70!`1&`$XX
MMEK)\HRN11SAQIE?9Z^:TITK^<VR]Y=..=K2F[A)+7E5U/BR9S&:;DLP2HH`
MH7'R".#)DS`UR+V"(((2F*`_4`$WGY(_M.*4NQ0WK"O6:3]3L]APE+;-<Q*4
M6`BJU$T-:?7-EWR9.;`$3(QIW1TJB.L<UD![4Z2!K-,<'_82@'+DZ<P)8MH+
M+&J1<[:CM$NS+W\\0*ZKB2V,\W&[AY;(K>Z+3DED2>8Q"X)6G8F)OF<?A"A_
M(/:&8;0C9AG:3:+6LGH$#@>7I>%I6[$I2+U!;T\>DSYV1<%@=<R"GE9XF*W:
ML3M%*1EFLEHYM=([`FN?UF^-$2K%\A?6D@^^$!3NRY1[]!0Z1K#@N:6I$W%8
M5#L6'&^8*RL^25:XL75DMD#(DEM;UK'6P^L4BD;)+:R"X!J/GE$M2QUUE;8L
M/+^%.Y2925HIZWL`G<PC^;U#&<4:7?VM';+IIO9)I*^FZD.I6UW^X)ET.77U
M!UT^P0+99JN",W/L42RB86Q`=7=7'Z_(=%W!<]MAD45(MJ70YS3#%L1!8C'"
MI8&*\]<<7C&7"WZP>^_*=C4>E@:9_,$1N2/P"-S*?='O+;`GN71PB$O$V;'^
MQ*2D3GI>W/@4Z734ZJP'M*H\OXC"!<QHP:OESD&.\=PJ_I39GDB;H"\V#5;!
MI`^W%45?7W&75GL)PC+JNM9:UND,<YBOG+L<`B:)'YWD,O/:RD[:%(0%)I`G
M)<S-13Z5D2-*W(TC>A(*2HD"8A&C2D`"62F2I2@$)R"2PZT$!1)(-!#K7X:U
MKTRLO%_S2_YL\#_VCO,'^D:O)+?\\Y]'M3E8,!@,!@?/[S+_`'C#R=?U(>,/
M\)><-3^L>-7T!890+?7/<9Z":8LWOLNLN!N,,D)DECDLJ>8GPB6MRU2T.#`X
MIBW@A(MV)M=F5U4)5)(B]Z-*-WKUU_+@5F7>,/F]:\(78+K;[>"-RUMG5=LS
M99*]$Q53+&63K9<R/=<MX$6],2QF>9`_"3;,$IT67)W4'IL*K6BR\IA)4RX;
MIV<W`DN)Z>;/`L13*.64G@#=.E:*K06=&1H`H[(_)P$@B]S):W-:="K4_/[3
MT902]@U^(MBV@OOC+YC?9=6<\&38[7+JETEU#WEFL%W0F`TWP5/7S9IY1[`:
MVR`+6RIM')M+"3=$+MB4!]![W@Y2ZTNX#CZ2G+U@%9SNP%,AN"CD]&-2JT+`
M>7R.01N"U#9!3:/I&YKTJ3SM*8J&]?7BT:I4NZ9.'1J<@(=%"\;9)/XY:+!'
M4S#]XLIJ+01&.L\?+B\S/86Z`3=C1D)S[DK9`2C-!%+6>3R?E5.NMG;.%O?N
M+]=[WL7;%])>+KE#K7GBE.9;X9IM,J\H53$54*<OSLXM<Y5CB$?_`"X2"22]
ML*3.+L2^I`%G.80_#I8J(*-W[1%A]"QNF)N'29/%;RE'[/LJVFXBTMR2T6-1
M&WEO6VE)W&+L3&JK%34A[="8\N/4(8DG-B"L>AZ2:!\BO?U`_<9^.$N4TR/C
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M6Y65&8HJ^B1.0Q_&`HHKWDCV#6\)$TZE'^.SG6A91,YE&=6/*9#8M1-%+SM=
M9%B/TU#*8JUJUJU0XN29R&%*"52`]<+[FO(`2-8$LH(@ZT4#01,S.#7$OC7I
M_P"LCRN0VMTO-],3ZURE8CF-QK71%+93&W@+E"Y),2"&=#]Z>8*V$)VAI.]2
MOIVA*40/1FP[,$+;?/\`@&D;!1C1J7NUHQ]3("WYR50N?K&%:\%B57`H<H\Z
M*-(U0E$:?R[SD)"]+K0=J$YY8/?K10=X+0R'Q%<L(YXKLQAD7046FVJ_C%=Q
MQXC]W2I*5`&Z'HBV]B?J_9U/UC%%I<G2@WHQP(2_(=L8MF:%L6\+RG+HVF0>
M*OD"2Q-9"W*-34#&JNNIKX)`VV!(6E8V2^EX`R5S"F9J7-IZ92C@>F9I/4KF
M70MHE[D\.2DT(AK3?4G*8RT2W;7$--VY;3)>JUQL:#6Q&($.O(Q,ZQFRV'+V
M!H-?VQY/<D"9,G4MHY$:WH#F;ZT\@XP#(XK$@-!"?L6A;5D'CPY^;WUF?`J;
M)4ZC)S8HBS,MG:]0Q1DUMI>-4.(3(W[3AVD^YPB*IC%?J,7RN0C5/Z(A[#H6
MP-*<2CJ7HRU[5;)&[1^!R"/0YB@T39;`D+\/:U`9`CYK)7=H>XX@;H>XRY/5
MK&W.1+<K<2WE$G]YHTQ@-:&+P>A&$,!@,!@,!@,!@,!@,!@,!@,#S@["G%#1
MN\Z';[DYS<+7.4,$B;$-J;=H>!AI]CMZ?5CSB[`<XX^R]G?WG4S7W$D1*#FI
ML<#$K;]5LP9(!;T86,GEC3_2G/*9A[EN2N^>$G2&PNSY>$Q21.=<R%UC"V[:
MM/4*>NH[,('=\\C,P=2(;%P*W1R0C*T8+04JE,E7A&GU&ZRB<%C.C^TN,Y%%
M&9^ZQY.?TKU+)15$FC42F<EJX3]+H62QV.YU-9K$XL=D::WX9)#E(0$Q<I49
M)`)E*L\YN^E+-,`9B)Z.*Q.LJ^@,5,IY=XVYH@B%C58TK["K=98-$,CN[U"R
MPU[7+5462IK1^&0M%:L?M$L7)EB=*7L_Z5$H.<=EIMBNMM]IF0\MR.VIC3\&
MY755JI;'A[Y\)OM$[1)X;(_,ZRC4JKZO&EI87>7*K&TY?JZ-/,^ZZ:?MQAHA
M%+5AAP@B$,<VHV<V\@<.C8JTCO(&I>/G2'H[726L8^,:1C8K,FY#@DB?W9J<
M9DLLAY53^:P\D)@T#4Z-;&>:6J-TG++V:`8SF@95TGXERIS8CRGY9J%9)9_)
M@\E3J0MEET&FG$^CD1C#*],$%21,5J)+$D+Z0:A1(P0=,AW,$!825"EN)1F`
M-$6MRZ/+70_&TCET%Y$@'/C)4+M;T2=>P)%4H'ZJU:R)3P^V9$%U.ED0ATT>
MW<<N13^N51[NXHB%#4S/*<I`M4$.!I:8528G/HKN@NWE&`S"96ZV>.-VC5V+
MXA]M<HPH>ZC:;?=H/2]KI#6@4A$XV*5$X0ACINM21$SO"]O?1:`$L*/9X@%[
M%>>"SM6O'.<RL"R[`,XG2UM/..V:Q)!2EAR1?6+RIED5C)\NH%TD<#/@LOE+
M_#FQS2\^`:_HWQ,@7Z1)B/5/H01ZT)PC-7V&_P!%VV8>_P!E-O-$GY]C+>[0
M[R"N>BB8/)5_2K3S3+$=A-CA%G!NF[R?606>XFUJ$L2."9J4O"7Y2-I_@/-/
M*&+KWCUSQ!,+`8W'HOE0@WH>64Q/H*76[U;-'K[=60&2N3:%OBK9%XQ<!ALH
MC=D[`CW^8VX"IM9#@?2N*Y">0,H$6(W5ADUN%S"CJGG?/D?7\:37FVNN6KTN
M>9E1B+R*G9ZG@LZ<:IJ^KB;`L1V9['DDU?PNAG6KDR_:H\2^Z.<`D.*L\@M&
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M).]0RT:$7JF>J:^:ZYGS,U[ESA<Z5Z3LCRY6NW$E-`U09&SJ]G`7IT@`[]8N
M.<SFM%2MB<1]&6G#^<&&AFYO?.8JO(LR*M+H[1TS]5K@VSU,QOL(61]@EBZ3
M!^W3)D*-*7K$A\?D`T9AJ%2L^G-V&I,3$6A*K.L.:[?EU44U9?#;C"+#D==U
ME6479M2"K)FP`A-Z$G/SW&XDZ1>:J5RZ,12`_#)WT(4Y9[>V*BPC#I5H1016
M&;)/EC^/6%=%]$\XQ^C8^P6WJ%G-4XL:G[`JQWLX;;$>9['&@<)&;')X[6=5
M,PBU<N3BRL!DI1MJY28XA/1:.3A&>"%343T5GN>R8G:74<%FEZ<MR)/S1RJU
MJX?NP%#S3\TE5@)#YG`(%&I8]B3V\WVDCC+:LE91;HRF19R6N2C>S$XPE^\>
M%Z83C*U3+?-!;L*'4]K@==#US)/)M-I0K>Y-3(H[6<NZ>99I;;F_#=(]8#PG
M=7J]#%3L>J4I1&(&X9INW$Y&7[-;)C5VKK0W9G-\`Z\G\B)Y_F\"ON\*3A6V
MNCS%U`QR0(X?L,N::]),/8[J?B+&16.Z53]."5E)D;-&TYK84[*BRW!&:(M3
M.W#];6B"Z<XQ^#\N],+.%$3A>5\P6*HRHA&)=7>E=9QN`P=.6H2J97+IO'(&
MO2P"(&[2@&V&G*EY1>P)]'^H=;)Y7@AN.^0/BOJUV1CJ_CZ4="IZ#AEL1J.'
M,3U4AA\/JB"NK85(D;C#G2R$#S&=O$[J*-D$,#RB)>@(S&UW&F+:3=J]EXS&
M$]6\1NU^1ZS=83,:AX&6/DOI=:KAO/;_`!F2THJ>U*2U;%:8)<@81+)#9_JR
M(VF4O^MN6G-4F,>2RQB;M*O0.LJ8]9=F^9/XU.0WJI^G/Z-E<J)KU<M%=+>_
M-TMK:#6C,9+&V)ZLB)O2>OY]/8Q*[/D!SG:;AO93,@<]LISD:J7A3)_0X,(N
M6L/EA<S6I-JV9I]X]U*"UK]Z&BDIN1!/+&JUX4UL^Q];7U4QNQI.[P.S)2CG
MPSV&]D[<VMD<,<4R;:\S;@4E)T<;HN77HE&52B@*+Z,GT8BO#NT+O,+JKI78
MUJOE@5O$6Q\%(V67NZ"U8]&I/8()81%V-Z2KFXM60V-[5]Q,4;`9KXS!:J9Q
MC*#ICY8.8TL<J"U)WS(,^L)!$($P538*RW*"7-Z";F6#<CO^JX$C/L[486_1
M*N.MN[,[(7):VOSJ4W-J,XYS5I$QY8V3/JDWK2<\TK;!MZK-\[N!705W5^#;
M#9:J,0*>&R-FDU2F":)/N.2FSH<4WQ@3SO4+^9P6L2`+Z9KW*"R?51D2.D]&
MFPQSX@CW-2RA!<J.5T(4K`]5I/8-)$5>M9TX=)$Y<S1VRVET'(IV*+IVT]ZL
M%G)#L3HH1FDQ48$BI3[$AJD8S.:9KSM^M^*7!DY9KGBYI65:BHFR.D(6VLLN
MA4<CR^P:*;4LO98,TL:IW&XM3N!7'$PPNZO1#>2867L)@]A%Z4J\9GJC2!R[
MABX'2C?'[;'),(CWU[]:UUPNG':7P^6(87(:QO":LNY68VIY:=)IJ_*9U'5R
MYQ>F<IW9D"PS0E"W03RA&0Q_9[L967BMYI?\V>!_[1WF#_2-7DEO^><^CVIR
ML&`P&`P/G]YE_O&'DZ_J0\8?X2\X:G]8\:OH"PRIIV-W'4G$;36#G:3#84E.
MMZ:.T%AS37;1'7)>:[L4)DE@NZAT52N5PUB:VU'&8HL-^0U9HPTT(2B@#,&$
M.S6W;.[)$=&^6[@_H&'L<RA=QC;DTB:;&?FIDE$3E#9(SV:L)O(((_*1MJ1K
M<RR7)R<HV<K:VD1NGMR;#"E1*,19GX"=NZ,VYA\GW!)S5*'I%TK"'9NAC?&G
M&3&L2&5OY[4&6JQHF)M,1,L>7KCY&><2;L]I)+,<T12<XU2G)*(.&`<=SA?_
M`"=<50^?.M>3BY6J%.*64U_#X^^2%(L!$IZ[V56#!<$?,A,A;"W)(Y,Z>#R=
M$H6KU&DB)(,_01F_^G!QW5;2IMY<^%H!;KU3C_:Y_P!WC$DCL0E<N0,#BLKJ
M.2:11_H>1%,BZ7!"!*M7MA?,[^B5`0`6;T[*F]"5\JI0840(VS,7XZ?=NTX\
MF_%T!5,3:\VT)0\2"75=$$;&WQ"9">BU%OO:!@B#V>VKF)`IW&0N#D4%<L*T
M:!$,6BC-:/V$H0C;NEV[`\D_']>U8RW6HM`J5U@\6ZJI(V5P5I<)*D8YPCA\
MLG9P'U,042X)&,R,Q`Y40O+).3JTRI&I(V:D4E*-CC,X=61BWD4Y&D-:5_:C
MS:B*MF"RH5`[$CC=:*!=#)&7#+.F26`P>0O#0M*,VU-3Y*%Z<CZ@TS1"8"@L
MY0,HD7OPE3D_4%\C_#UE.L?887T;!'B02AYB<?98\,+ZU2%2\SN5R*$0MO4,
M3RS-SLVGRN3Q-P3M_P!422%6%-LXO8B!EF"+QW:,7+/)7QK$;R;^;U%NH7BY
MS[0/J1\A,?;'1P7PV4HZDEEV.)TH.,2I4A30TP2)[-6'(QK1I%#DW$G%@$M)
MWL<9J^C8X[Y"^+I7,:LKUAZ"A:N;744^&5K&#BWYO=Y"9&W_`/*KTA.2N3.C
M$P.Z.3;TW_1.?T:LU8())98S!!#LG&6I0;R><.V`ZL#`T7JR-T@E%IV!3K$Q
MR-HDC"O5S6N)>XPAY)5"7-`$;(SND@;!D-2]P-2)7(_?TQ(Q+`')BAQEL-R^
M0[DJAY4I@EA6=M'.$,WK&!N$1;8S)W)\2.ELRYDA48<@D$M`2'&/)7F0)M."
MQ$8I+0Z,"`S^?,)),$1,M(AOE:X%FM6CM])T/%V6((ZK2W,]ZDR!^9WJ/0-4
MK1H=KG9G,:S57W),I<4WR(DWU"OX%:=0$`DRE.<:7CNNJ9=L\F_%DDLBJJJ@
M]P)+#EMNN+JWL!<&9'U]:67[+5MEVZY'R]Z`WDML?/216J'4!K>,P;N0NV02
M:D!L[0M#C-6K:A\[OCD<(K/9819\O+2P.,Q:3B0+:WE+>OEP)?'4\C:6.%&K
MDB=G=Y*,I2%+I$:K3#/6>I:?9X?0>R\-RYDK[YX\A$#<;0E-]PMHKYJN-XY^
M72XS[PI907''6QU>9#!2%2)K4A6N3"VL2\U::1HQ(DTA4Z--`).=H!FI:U'O
M)5PE*'!*U-'35;[<5CL-F+2.:IU8#B56F\;FE4+POS6V?:V9W3!T%N<5/Q-[
MFH&`A(<<>8`L0XRA07F<\?*BPXW63%<#E)Y')%L92>]H@LO3-L>)DJ6QW$+G
M+E,@:6,Z,MK.T5<Y+58U10!_2#3F$`/T;^B7CN38V^2CA9WC=;2UMZ5KU4P6
M[+D$$KU8`QZ"<_RMT<X>S-K4-N,:`.;-]>ZV$PIR3UY*5,8:\H@A,WM23[R<
M=UU6*\6$,!@,!@==6J*1)%2T_P!WPI$YRH[V!]P_B3EB-,]H?77N%[`;]-?^
MG>!Y=?Q`+L:T<:MB8\C-D;Y1E-K0^LF^Y2NAV=WL(DJR+6:Z1K^1+*/+K)&:
M66]V/(6TA0D!(3#4*%4)2(1GQ"*V:XQTGY/4W#)@4MZ&Z?LFNK:K^@J%HIMO
MJXIK`)I;BU@DMMHJ6C<?K""O\1A[P_?FI7"9\)U>1RV>M*4IM+1%[$2>8?L[
M6BM@$:B+BYPA)W-]UOUVPQZ<II78JIL&&3*1P">P4N5)ITV,LEC2X:51ICFB
M1HCY,E:%9'QG$J?H$@MZ'[1%!V'?J25A,(8#`8#`\BN[8TJ<.P^+79AYVK_H
M%^^BF#6[ZGE1HK0#6U?@L^D'.1SYB=E4IC&JN=F!:G1K"W\13T$L]*4F"WB,
M4`/(-1E*H]<=-\D[;+LC"^E^(&#E5+QNSVA>D8KVG8/,H[)Y%+8]J7R6#S3\
MI3M86Z-:5Q<!EGQDV%.JM0(8CC5Q9HMD9%J<,[MAZPZ_AE^U`WRJ34)Q,6R5
M=RI:+DAJHVJE$P<X[T-S2U3L4,B;:VR5WA;W6-4L]-N;:ZLB%PCA)QS?)E29
M,ZH@I_<N%5-8W:QT=E;!,Z_YTN4%;<+U?T!TO5<?<[8OBYZ/:F"&R>-(_IX^
MKIUD3LUPNTA4RER9'+9;4VK)P])4Z$DX0@*`Z^#53RQI5J\WR(QR5=0V\Q\\
M\QV38D^=K,`R1=J:Y#%>@8(S\T=(U37K[%I1/87(6J6IVJZ3F51,6UK1?9DZ
MI_.]%`G0E2:(46.D3.#*33H8RZNU7JTZ8Y1JR]R5\]H?FFO9]9%5)YO+72NW
MVFNDIOT"M@LC,EK,76\!7.[.AC"][%IP2!4(7<"QJ6_3%%[%5MS;2^613]PS
M6@6:'\X\$N\LMBL)U>MDN4GHV&VN"-7K]J4HU;:\KVZRH8_160C3H-D.!PD4
M@?5@/^KF$I`E[-V(C"TN<3V8Z(^E*MJ^;U5QO`1,?!E86*@E%$4.&M?L)5S6
M1*%[16,/D\BN=V>XK`TQ@"Q?8BH^M)='M2>KTN2BV!(;28BKB\T7]AQFJ23+
MQYB1U5S_``:!'S"B'HROZ/I.IGZV97#YM:S1^?760JI*DE43:W63R(X)B8(8
MTTOK<IV%>E<33@A."2)K%F77R#+:F3K)#)XQRO:%?Z8NCF:^+*HR&.Q,7A)J
M9HJ.RZ8:CSDT\L4RR8)(93T$N1RYQ!M'\CV^D'@1(_<N]Q:B<,;6LZB=6Y%S
MW4\%K$[F"BW&^61PH)^FUE,'PU_4L1F%6O\`/)=$6M-%YA7JIL='14U%)VQ$
M8YE)].1Z<TT@_>M`&2,\;>4,+ZVYWE"N0U[S]REPA6]ATWS3"Y'S_P#GGGI^
M>FI!-]NS))NGH20HC;)7K8T1R(2V;E%DHVEX+<U;XG6J%903-_&"-5/[3<Q;
MTMK*UXBPW]V>5?-<<WL3/0L(8[3M>P8'2"5H?)K,&2&5S,)M83I(G*S93*GX
M*4F-M`$+>='1*TVF5N_^,+#2R22:S.,13SDAGD$HZ7T>O^NXOY(=JQ@R*Q7B
M_6AFKL:2'UN^:MOW<Z6*YUS,8>PO!4+LI[/+?G8Y6F*/9#A"<"U*G6O=D7C4
MUBM[))3'[\<;EK&UH)R?*(&G@MZ_88M7L-"79U90[C*W84Y,M:7\K>WJ8LZF
M'6L\LY"Y*A(:V(DA"3_-$J1;T>23+*T8<M=8V=;LPH#EQXH?EZM&M1#NM&XF
M#+N;7&,-4%%`FZ.M$$:TU=.%_F**XC4@:IV8%T*0)I*7(T(]@3C;"SS!$UJ8
MBKC-NE/WA$ZUC\":[`IGA)GMKHB/UU?+FRU'6&JR3S=SNO=M#<W+4:D+_(Y-
M+),U,5&,B=T=Q'*=FFIOD,"64!*669GRND,<T>1>;()_+I78?)5%5T\J9[2?
M/SI;T4J]TJJ8-KC>EF0IWK2$V+''&3S1^U#I0P3!^7-+R%\&V+I$)O\`:D+,
M=#"4\6=L=+3C:\'WQ_V'%YQ6M&4*12%1LL9F%<T/S-0@H?=;],^@'<=#35]V
MH:9K'(+-YN&,,GTS84>D0D`0;V6/U,`$W*1-Q766/IEYHKM+K.2UW<'"7-:"
M'V32<BMJPH_<W+-=K+L?YM%NBKGI6/);7>W>R)`E*<&N*5B6:-N%''S8E*HX
M079*64!.;#]8N)QB455OUO;J65<_RV2<7<^0HWH>S(9';2GJ/G9Q875[J6)6
MVTUE4BUU<`VDZ+8(@A9S@@W')$]F/S:N5F%`(;&<O^=`68SQPAD&CIE@K9EB
MB6/\[\"N4*L:N:[GKQ7%8UX*-O$3;[N%(6)K;I>`IQ=VA>#GA.-U/GQAK>A$
ML;I$2$!+/KYA+*S4K.T%65>LRZQX;,^(.,/CYBYSD;.YN=!T#&FF/V["+<0'
M2:#1OGYK5K)$*,5I+HFQR%ND4:7*'#2MT&C-*4"3'F%X)F<[E5/JNYZ7J7G_
M`)J>;0CG"]W-M>W8E0\]\U5/6+\KI&&5TUM,>^],;ZR-^K<;HU;E+10P2QG<
M@-[$U)%9?M^C3_\`V341,SA;\PWH^.SV0=)IX72'`=71RZ+5AC7#+HMOG_;!
M75L4];9-_"?+"M%U26>UI[[;)TFYZ0(R70A>Q)]NBX*-2D/TG3'*HFEVL,3;
M[P3*^4WNE^.:)"LZ$@C;9W13NRTJ2YK&F.U^\I&-ED)\R22>$&Q2/QHX&EK,
MN<D$D-'H)28A.2+>E(2=$-5YTF=TY47-\VN&A^'XU-("QZ>3F2_J2/:'`Z/G
M:1->Z3YKAS_8S^\5K;"]AT0<A).<7I.XLSBS+`(0D.02DY9BIF,6N2?OP^0D
ML4B1\;\_HN@:Z-ZDNR,IIA7YLKD,1JV#4'9D@HRPHD8A4,+@@LVR;(K=K9G5
MK(=$BG[0VKOC.)&!.852(C5+DHDDN8GZ2W#?',_"$1;W*AZOZ$OQ+8%#G,EP
M/M@MU@+JKA4HF,W=[#=HO'2(FU&+%Z=*[">'!A)7_0A<A[+.4&PPJL;_`--R
M21"I'>`WPZR+C#A9=1_"]4VZV0QQ)I&*K8E(WPM4Q])0W]3Z7YW)KAE/LD-T
MV.4ET6`TQZF"H"M"-&!N%I54N=9N49V5>;1(;JF/02M#SK:52R"G[XY>_+K\
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MPWK>LK#Q7\TO^;/`_P#:.\P?Z1J\DM_SSGT>U.5@P&`P&!\_O,O]XP\G7]2'
MC#_"7G#4_K'C5]`6&5<KUY4I7I.34E)+FBB*<D4+-9)/HA$I$W,3_!W602:O
M)56BDR7QB0L[N@?2&UDEZE2AUKX3$KB62>$?J7[=EB9C)YEN7_E_N&U-H/5M
M,4LZC@4B?Y_.K97-5>7R[0Z'%VM.)3(9&"RV^)-+.4S-DUA3?(S&1A6IRRQM
M[(001O1IA>SQ&N>ZJ8H?_E\.,#H(V0,^V.QP$171AE=2AEO[\FS6MG-P?WM_
ME$FC<A@L/C!KS-)KN2."%V?)"![=U#8N/3`4EEFF:%*.<W>"9W7PK\:.;$5&
M0'7`V,::M&.IDJ!MGZ8($T-CU&0'GMO2!.6QU:I/5;@=<MYAIIPS=FN(SCQ:
M]IFBP*.<L')_!YQK+79^<W5]O<*9=:,,MZ(,*.Q&A,QU/+J]?^B9Y#-UJGU#
MAJVUK8+;ZAE<R*(<#W/8I$<G&,0T9.T8Z<YRP\5]FV.?A_H%_L:<6_)[IZQE
M5IS5)6Y9$XD-P-C@Y0-TJVT8S<$;D5:MNX27&H<[*9M$TAZXLA")`K!H7N3:
M'[1A)RFJZ.M7_A=XTK&CUO/L/,N1%`%MT.-X;$NLQ4]R%(_GTF_\[L,50O3R
MU+S4L`@M1/@&=C;=`]4"1M0EZ-&4GT`2EY[KN<_$EQ^+6MKMN'EXN;,S4]\Y
M\Z\I6WS0Z,CM,Y&?-;6BEEP-EJXN!SI@11M!'7**(8^BV\_=P.I+B0_(T_P)
M`EC&:62-TQEG;GCOAVYI9+?AM_NEA]$S:Z([8%:V)+;%F-@QM:^7(Y4J<Y;I
M=GM<EK@3.SNL?JM$YB2-136E:%`DQ9859RH8=CV.4^5(Y;?#E7LXZ;NCIV^I
MY.G25N/2%PVQSLUUU.!LK%5\1NSF>`T#/QJ6]7#$ZY)/I:9&?K%QA2]>D"-@
M8CDXRA%+"#B\_CQC*D@55X:.4JD<X4^-,MZ"E+_"+!;K.3R"P+2)EK[(I>V=
M`M?2A#C,'=;&@+Y&,=B-!(#!G&?,)M]2?DT/T.T3G+/J/$;S(IL*0SLV57?M
MOFUF'618%;[G#&.N9\23<,@Z-CE>2=L-AQC^974+Z,FLBG;6E2.21>5()$O^
M98>A&2B('.7>G_BBY^L:\K0Z(?;(Z.+LNR`P@QL5)K43JF&H72O;>K.\8T]4
MS&GR,/#-#'`JPZE9U:D`REB18$H83R#-["(`Y3$4@-@\`_"L=?%D@3.W0RU>
M=`$-;-Y3E;QBAKC\;976%F1LQB92X\0T)'N-0VMX_$TJ\9)JH<89DB10,\PK
M2C9?^S=E@G6D?$QSIS]:D2L^NIU?25-#[UMGIM)6+I.V!QK!UORZXW:4,GMG
MOC0*$DR)9(%\.M=8V%``Z%(R4J!#Z$[,*-,/)RFJ1B\>#GCM_I2S:`=Y3T"M
MKNSK0HVSE*0VQF3;C$-<YE)$M2P"$K=0G06ZO8X@1`3_`$RLM<N-*UZB6>_6
MAZ'.4WR3Q<<Y2VNY96C\_6ZJ89E?EK=%.AY,R:T"M',K=IRQZ)?6)@1M\72Q
MZ/0EI@%GN`42%(A*,&X@+7K3EBLQ6:J$;IA`5X>!O@CHJRVNT+90W)('=#`*
M>JUQ8DUJN3+$I57]&L)K1!(M+F5G;T7WQL3.NDSX;H9NA:?D"580(D17MV6-
M\QHU6`_^7^XNKQ:2Z-MD];/[NM<`.4Z>IU>OYX?+54-43GT,@X+%>9+$W!S=
M$]9LMF/`6$",U"%,-1KYOJ`%@!H<Y\G4NKPQQ)XF],N]$R5ZAR9MM^LII=<U
MDUE*MR=YKRK'+E)Y0UPUPQ%5+PRS5JDJ_CN(GBTI>(X:TO)&G,)ZTH`FH\O/
M73[_`'>TL"BI\'A<7AZF6RV>*(TQM[*=-)ZN;G.:2@Q`G`G$]RAQ:&IB;%KX
MX;!\B@PA&F*&9O>PE@U^&'-MN`P&`P.FX)-+T"Y!L>RM+4:E)LS0?=LO2DD9
M.QZ#O8="V#0_7T]=>N!Y#./*W;$OKF$\JRUFY:;>>XC=]76(;<<?N&V7"YG&
M,T[T)'.B(TG+IE?SXV0=&_2!YAZ)H7%[FQJ=*E/.4EFG#"`@1JXC&+M["X9,
M"A?0=,]$E=)UCU+S6T4K-I;%Z5LN@9+`[RL:=53'=Q2P9M6UB:EK%*X#4ES.
M*N0-KY6*5']`H:TZ<Q*L--^IT84`HPU$Q53DE?EFLK.KN)31SN3<%3619MF3
M"RI(PUH]/TGA$7.DK@(U(P,4JD\7A#])24*$LOY%BAF;1&F[%Z$!#K6]DFKP
MR6=PA@,!@,#RH\BG6DZYBGE&%0UVKB/@EL4NUQ6N$U:*T6.KZMAT>971C@\>
M76)>](KBM2%S.`8>EC1,NDBO:4O2=D.*">J2FHB[4KJ^ZX\US$,4=ZLX9XJM
M:-6)$:PNFVG&CXN*',$B=*CBMGJ&9@?U;C58'AEO]Z>C?RFL<G1M5#(T`6D*
MU3H908LXZS";9QTO5;['Y))6^S^&*:N!785OU;T1?UDPFOYLV1%EC;ZX16N*
MCN!@#8D0E""2=!UW%D6F8EY>0%+4#4+Z5(LU]&F%4B)\U;IOU6N:&F/55)V'
MD&-0%NZ0J]BBM2'U)SDY0WGN`K(XX.[:Q/JFR>HJJKF,7`]NI99Y2)UU$W]N
M3K@_9&B1&?\`3+$>N2Y?.]VNTKG?3\B5.7-5Q/2=UZ(.7FU35+3'9?2QU!6C
M,8=7E?7_`"-OG$]=I])9$1%RU:4TY.R+B#D)^PMQ8-DC$2?K"AT"\@_3`JD2
M2*LXCRZ]FOQ53UG![):8;`4D7K#I[H*VW&)P1FG;/0EX7G$$5<KA/;HU*E`)
M4CDQ$B>TQ:YI1B7*2RXLQ%XVWQ;U)'E%E\GV?6-9\S02NN@^A[A10<V3\^55
M#;</<JWJ5$ALGX5UJVY2DE3RZ5V\D=OA<HPURF2.#%HD`&52'8U.B8UBWM^Z
M,IR]I'4DE:E?%DQ6IH?Q<UN+"WQUHDUDVC-7^\42N?5C6L_@\R(E,-UR?)XB
MUR=QCJ9,_C0'!*T\I$"003SZ8Q@UNB^KKL(N/F5UZ.C'.-1K^EE4O?91.7.N
M>>8!/;1C<*DIS=`FY:X23K/2Y.0QHQD*&LUA4S^4*2][.51UE+T+8(LQ&-=/
M&CW3B])TQ"&97'H74=81&/N`W$Q<QQ>!11@9EHWC:$3L8K;&EI2(E(W3;8FV
MHV,`MG_3E>_W?&'TK-S.;#CYUHI2T2N/.E3020Q^<3U1:$I899'6^7LCM/U*
M5J1&2@;1)RG=O3.1:5D2`*V064`CX`[+"'?KO8N6^[@L($C*;A0Z*B;TZ]U=
M2$.X\T;1DNC\X*'=\<BDNT?P%KWEU5&JE9V@Z,4*#!F&;$,6Q;(QXZOK,R3/
MDT,KN"CF,G9B(Y)98.(L`I-(8\E.+4I6)\?1-^W1V9DR@H!A:50:80`8="T'
M6]:W@<Z^N*\=5,I6ND#ACDLG+6E9)LK7Q=C6*9@RH2!ID31*3U"$PV0-:-,8
M(LI.KV<46`6PA#K6_3!<N!HJ^LX^\2^0L-=P5D?[!V7N>OC1$6!M>)OLHDU.
M5N7N:-O)6R799!XP!^M&=Z`&(.OPWO6!PG5-5:B6L<^45I7Y\ZC"94CC4T.A
ML<-EL>2+DVD:U*QR,;:)X:4RQ)KXC0)SBPF%_HBUL/X8/+H+*FJMP?(W)E]9
MU^NDD.0#:HC(%D,CBE\BK686H*&VQMV.;1KV-`,I6:'9*4PHO831Z]/06_4,
MB=7T"4%JRCX1$#REYL8/7%G1IF,+6GPIP(=H:<K`-$(*@V).B4I2V"'K>T"@
ML)A'QC#K>@S2IB9%RPMQ6LS4K<"?H_B7*F](H6%?;U0ER#XU)I(S@?0K1[.)
M]!:^(W>QA]!;]<#6R*PK1+,4]AIJ\@R>?I&A;'DLY(B3`3,4S`Y.9[VXL:>3
M%MX7HEH<'E4:K/3!/T2:J,$:(.QBV+8N66'#HB8G)2&1:.#2IT>VXA,-C;!)
MR&_:DM;M`22)+LLM'M84$[90=:!\H="]/=K6\#74-/U*UJ7%:V5=73<L>/S%
M]W5H83&DBET_-Y2(F6?<3T[86:N_-!+8F`X_+L7UH4Y>CO?HL/H&WMC"QL@=
M`9F9I:`Z0MK9H+8W(T`=-K,0-*T-^M)"2M:0M288BTQ7_LR`;V$&@ZWZ8&J1
M>I:JA&W?<+K.OHCM_6.3B^[B\,CC!M[<'G0-/"YWVU-J3[DL==%ATI-.]XS_
M`&Z]^Q>FL#'.M&TH^19'!GNGJM>(2W-Z)I;X<ZU]$G"+(6MM.+4MS:CCZMH.
M:4S>WJ"@F$$@)"64,.A!UK>M;PMRWTIB9"1$C)9VHD:9K^QIQE-Z0L2=DULO
M>F<D0"=;*:];*!_U</H3^CK]'\-81I[E3]2/!S,I=ZNKIU41Q_0RN/'N4)C*
MXYBE#6TMC`V21F-5-AHVM_;F)D1(B%A&P*"4B0DD`]%E%A"+EF1P*"FFGGF0
MN)F'J23$ZDX<<9QFJ$YI+@G-(/,$CV,TDPAW5@$$6]AV!4;K>O0P>A!^I/!(
M1-VQX9)G#8K+F:0L^X\_M$GCS0_MCXP;.$IVQO"!U1JTKFS[4"V9],<`9/OW
ML7M]?QP/VAA,,:X^IB;9$8PW15:W_:5D:0L#4DCZMJVV%,NVQ2S)TA;<>W_9
MR`)/A&7LOZ8`2O3V:T'`U)IHNDF`+*!BIVJV4$<0O;7'@-->Q)N"PMLF.^HD
MC<RA1M!.FM#(#_TUQ)'QEJQ_B;H>_P`<%RSC[6-:RAL<V635[!Y$SO38M97E
MI?8FP.[8[,SFZ_?7)I<T#@WJ$J]L<'S_`*X>0:`91JO^>$'9GZ6"V2:(7#H^
MP,L388G&62+1K2'4<C30PM;:P,&FLX*ALTRLR)*2W-6FY0#0R/@++^$>M"!Z
M;UZX&#DM253,VA)'YA65>RMA;S&4Y`R26%QM]:$1T:5'+HZ:D;71M5(TQC`M
M4&'(A``':4TP0RO:(6]["00AT'6@AUH(0ZT$(0ZUK0=:UZ:UK6OPUK6L#Q7\
MTO\`FSP/_:.\P?Z1J\DM_P`\Y]'M3E8,!@,!@?/[S+_>,/)U_4AXP_PEYPU/
MZQXU?0%ADP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.%06::G/*(/$E/
M,)-+)4A++-$G-&`02SPE&Z$48(D>]"T$6MAWZ>F_PP/F[5^3OMVB^F8K4%JU
M<=<T*=NN!\7DR:!U-)D_YB?6MYJR5FV")P9$^FZ)O+Y4W2+8M!M9O\MZ!64@
M*!O2QR0_&=.,3%^7C_'N]>^#NE9;U=1)]JS:-L,6?"K-M"$[;8J7(CXN8WP>
M7N$?;5\?D4B(2BFS<L1I0B^\HBBVU:=[_IM>P/XF-T5-+GX1Y6^2SISISFV1
M\B*><XR5-&J66;;*^\H>&(*Y2]RFH*IYZLNW)&QPHU$#:AJL-8"'?_N_KW!+
M<'<*=&;H99PP"-;8B;M4[Q5^4#IWK1\I"O;RJZ.)WR6T07*+%`T1^5Q:U:K?
MXS'V`;;:MSL+BE2PAGKWJ=0N-=8(B9P!4)40]%JMB$$>@&MVV(QC5]`>',P&
M`P&!$DWM.E8Q*4D,L&809JEY4!F-NH8_)%;<!W+KJ`+X\T3>=)$BS0C@,,8<
M):VD+50->T@:XK0M_IZPM3GT0[*^S>+HR1<RB87?4C:FH4YD-NPYU7I!$0`Y
M>:%"Q*),8),8`&]G>A11@=F:*W^CO8?Y,%2VFJ^@N6KY?)C%:HGU;6&^QDF#
MO,V:&0"14I;M3F.AED#5/!9Z,H)BQ[C!VER0(MC/TF%H?H'6\$Q,9I'8994$
MX^GU'WR`24U[)"_$)D:MB7+7(A&:<E+>=(?<)8H*3F)1@"HV#>@_'OT%^&$=
M&$VQ1\P<)2WU_8%:O[FPN;LBF".,R".JUJ!R:1[^]?>2$*D1WO0'&BTH-,UL
M(#/>$0O=H6M"I;!'WRM778VJ+N<+7;VL.'MN95+*=HY:T_;W$\\M*C%O2DUM
M&X)3AF`"+X1FEBWO0MZP-;W:%%*WE2P#G-9'O44=-)%3>8]QP:B//:IM1NP4
MIGR'["V.RAJ<R%'Q^H#A$G!%Z;"+6\&+8ONU7M9N]?<X$W'MYCBJWKZR/)#4
M1J?Z7;NHWKY"QIC"-*R-J1_H[#\H/?O7N#ZAAR+$I5^7N+>1,*X=7&%K%:%U
M3?>(\I/BK@E6D-BI(NT,X6V16!>I+)V6/XQB&/6M:WZX&^MTBC[NJ6(6E]9W
M1:WA)&O1MSFB6JD(%.A"3C6)TQYIJ8*C0-[!L>@Z'K6_3UP-*0W54#G,UM<M
M]H0%9/VXY<F<(4GEK&;*4*EM/:4JY.K8@+=N28].H?48-@&7H6Q*2_36_=K!
M4MI%,H@!`E=1RN-@:URL3>B<A/C6%`L7@/$F$B2K-JM)U"L*D.R]E@%L>AZV
M'T]?PP/S^=8;I6H0;EL9TN1C7%JT?WYJ^K2F-B;ZUR+4)_J_F(&WH_YT_0M:
MV45^D+T#^."G`7/H.:M6MI<PC(E[<YDLBY)]\;='I7E0ETN):#B]J=;"Z#1"
MT;]/_P"U^/>A>WTWK>!R'3B%)TK<N43"+$(G@*H;0L.D#24E=`(AA*6C;E`U
M82EP4A@]!-V5L6BQ;UH7IO>!V$TNBBPPLE')X\J.-3MZLHI,]-IYAB1V5A0-
M:HL!2D0AIW)<+1*<>M;"<;O0`;V+\,#%?K*KO[P./?GJ(_?"VED?AM6Y$TZ7
M!99(:X$QYT^GVK^3:%\-:E.DAGI[5'TYGQ[%[=^@=X,WA8QI2P2^+B,7(ESD
MB`%_:1#6-S8$T;DO2ATKV)0B;P$#V>:#U`5H`MBWKTW@<@9E$!@/,!*HV("5
M&@<%0POC8("9`Z^GVM<>+2K>B4;E[M?3FB]`'>OZ&]X&,:[,KI[:AOK1/(>X
MLI;\ZQ8QV1R-H/;@25C7*&QX8!+`*]D:>&UP2&$G)O=\Q8P;UL.!RRJQ8#!V
M9QD4QFD7C#$THE[BYNKX^-K:A0H&HGZAS5J5"I06`M.WI_TSA;_`H'XB]-8&
M3W+(MI&@<=R5@TWNJCZ1L7;>6[2-Q5_-M/\`2H%7U/P+%'SZV#V%B$+WZ]/3
MU_#`T^,793\U=%3'$;0@4D>42<Y6K:V:5,K@O(3IE3JA5&F)4RPP[04:MC6%
MG_AZDC3CT/V^F!E7.SZX9F9TD+G.XBD8V1IT_/#J9(&L2)L8]G_2Z>%IY:H8
M$S7]1K8/J!>A7NUO7N_#>"I9M/*XLK;BG=))6!4TGIMK"'1.\MQS<<CT%6+:
MHI:6I$F,3:"@/W[]"V'T),_']`7H'1;)[!WI8)N:9A&7%P`<X)]H$;XVGK=G
M-.]Z<P!2%J1*!_0>G\[O0=Z!K\=[],#D'.(46G*5F3"+`2'`1FDJAR!I"G-+
M<5!J1O,*.$KT68!<J(&63O6]Z-,`((?7>MZP.POEL5:E"E(Z2:/-JI&F3+%B
M9>]-J-0D1K#])4BI22H4EF$)E2G>BRQBUH(Q[]H=[W^&`4RZ*(E+BB62>/)%
MC0G*5NR12]-I"EK2'A*&0J<2#5(#42<X!X-@&;H(1:&'>M_CK`Z^IS"1;*"&
M8Q80CUX&L@.I`T[V<YF"T`MN*UI7ZF+QCWZ:)UZF;W^&M8&/D-FUU%$+FY22
M<Q-E1,H%PW8]P?VQ/IN"UA"8Y[5@$I^0C[<6+0E'N#K9(?Q'Z:_'`V#<CCVD
MVUNWYFTCT>B2[5[=$.DVE+DF2K&Y/L_Y_BT>O2+B#20>ON-+.`(.MA&'>PQ@
MY[!2]%B,FD3`$U6-O*V.1LX=&+R][T8B+V)9K0U8-ZWK9>O4>MZ_'6!_3YW!
MTH"C%,RBB<L],D6D#/D304`Y&X#T6@5E",6!"8F6F;T$DS7J$S?X!WO>!M>M
MZWK6];]=;_'6]?CK>M_R;UO`\5O-+_FSP/\`VCO,'^D:O)+?\\Y]'M3E8,!@
M,!@?/[S+_>,/)U_4AXP_PEYPU/ZQXU?0%ADP&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&!Y>=R\^TKT#;5;1:2=&L%$7XZU3/8M39
M>P,&IN],4AGU7$V81'TK\Z("Y:QR:-D[C+HSE@,-&4_`5DB)5I4QQ9J)F/1#
M+@T4+'EFZ0FG>5!IHJOJVVHMS,Q-B%$T2>$0AM=4C7;CM;%F"MMYC=F*HXZH
M`H/G/21<*9:68$T"A<$P>AEC2=JJB%;5UT[?=IJNJ^>I8V7]<56R".UTZ/DC
M7R>&RPNDFIE;H]&]/_2TCK%',IG&5"!Y;E<<@T>=EC*M$%7MT)-1J$PG*(I$
M56U1Q14'6<10+.A.=E?4T*W&8BI1.4?KUAN1\:5]?SJ)LU3!F*MW-E!XG8V6
M:=R8X6J4&["CT/2/8!?,"$W,?_*+&OQY<[P:%]'S7?2/,E>+GOHRUU[/><`K
M&LZ[5T?#960_H5W,DOD;A8CZS/:=LG#X->_-JH34U/"O0RE+(6,T8]B9NDX<
M'<Q\_P#/^J:6M735(WW+4$;NFMX+*H\UUBRNDD>94LK"7V"AKH$;E#Z!H+8$
M,``<XL;)Z)2$JL`S"B2B"];I,W*B:?C+F-HKX,2DW;/!#[^1)!6-S+G];1L;
M%7I30SP&-4U%;3MYK*Z141:86$Z/<"4JRI/(5IC.>X';"I:U.RRQ;BW/2U@Y
MGP32U]0-RKJ)=9\V$6';,)MAWIBS(+4-)S&PWB-V3=%5VA()\L;Y%+YBS7,C
M^JJ0Y@<5*9"D:'!K,*2G$Z"AT$VI$U.3^,7"5([L!\4PKJ'DZ3.KY.#69K@4
MJJN"3Y#/K66%)Y?8J&_HNV7$QZO2=M25J,<8FE^%H70Y.7HT05Y9.MZ%^J2:
M:HNE^/I%2+I65^<N#D;!8<OH[I*3RA\B,`F-FIY;L+S'HTO6M$C7K9#<]<OB
M=G0,K*]&GC+;'57LK2<9A99@S8"R^'N37VR^A.BI#>'+D';YRZU_+]6LU02I
M(Y;E:R%[LJ"N!\D?NBE\N./7J9,KJ;['$3Q)&PUJ,.7`":XC_FBQ<U$8J[+.
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M_'48906,^<\]9TE/I8GXPC(>7ZXK:!4A%1U3JO\`HN+VM673DJMI/.M_F.B*
MHL-N0C&F6%JT+6A(4G-I)YWN2&Q8G#'59YII[ABY7QMM*C.CN1RJKIFDZ-B!
MR(Z'5G*I%"=4XGM6.4W8$RD\AE;<F01=&W6&E"P%.K$%.:!!HQ(K,2K=%@J8
MQG=H?I_Q[\]Q.*$(+/[1Y7OVWBV.W8.58#[6%.05+MG'2EJM%SP1LA53V5#A
M0N%?EZW4C_,&:+KV'W-Z,)JDPCZK2PN%S]'8J?C>!2N]UL79.WN9[LFA'*_,
M9;+5D:Y:KL^%;@-$V&86AFU@;K>?(45@0J4.8?MS4Q+7(K3&`H`T8S"@;UNG
M_CEU6RGWC')F%1ZIMLD5`1B/!Z7GMZ)W=+R\D6/36R6>0>IFJ-L0"M-/"CKD
M5.SX[IT4V<6=P^WLAZ-.4U?7(0NAHOK.=.F/QFR:2,D@;;/M:GK#62UHO"*O
MJQTYL,4I$<5M<YJTU:B;9)KAE94?E#6V-($+VN,&L22%(::7I&A"/TT2]$IS
M'Q_-3E&X%%86ZU$Q,$"L6[)8S1J5T&US"(1UBN>PT<[$EKZ+MTRB#=!)[`=(
M_IV*0D?/]&::8HTCV(>P8+5T+\-<!TS6`UDS:%QUU?&&W8'7UAP*D66'6K!8
M%<%4W%7LF,7SQ%*U"]^LIZ?+?,>7E_1%LQ3T8SH"SD(3"?J-REY-NYY\5*.F
M.=;RJB5VA![(MF](<5#)!>*3GB#UR).S`2A&;'2Z^A[N0RIZ^5/XCEXXX@4M
M[5HQ2;H!8!#V/=)W7/DU5M\4<M1)7%F,N"D$\*?HD8C>*OCG,#S$JM;Y@EB%
MM01CU!84Q=`I4,*J%*R6LI5K(D0(T2]Z^I5"<0$K!I0"V[QOQ4QQF13%T768
MVJK6D<QBD@8+E9JICD:G=?QUH0$H)/`X8O;W4P;%%IJG*^-8B2B(0&D;^-0F
M4ZV+8B6BB+>'A?'JYA4(<K7HV;NT22568;*IER2T+BW.4UQ8UB3XN8`A;7:[
M1!6M2V_K"4IXVT$-X8TPGF'JS&U>>)+M%%Y8I'Z=\94\Z'Z$G5W[NRF$K7(J
M7A5316$V#R/%[%,B[E%+,A%C#L!]E**Q8.OLYU3*(@/3,TR`E;'6=8I^?Z!0
M5HY*HI$Q$4QED>-Q\OWI+I2>SI=6$5K:P$08FC^"DF)XLNS&I[I*EH:M5S:P
MS9P-$_Q"(OT`4[:6-?'PA1*A;.+-]N@['"ZC#-'<@\5DQ'>%<.3*X\X$P1`R
MOJ9Z=2N56LHJ/MT=E;<XQ5V;$!=QICB.I7U#)%@R[+*)&!&8S!%MI]32P@I>
M'FWR*>(UCCSUU#*9G;":U'F\F*?L$->'FGH<CF]7L<Z,^G=RD4G0.[>;+)8\
MQCWM+H]G_0.3X49ZKU!FO76"=UMHHW@N0#Y(A5<RO[#"YJ&\WJV5S9/X,P6`
M21`X\DDE.4%#95'8])FECU.ZRY9;(:UD+D[HXE-4DCI"LLU>$@(C23.+',_B
M7A:E5.W&?.%%R%<_58JKJ$DQSF./1IE@;^!6>:VW*0T/,WF0%URF)51@7-^3
MF-ZIP-WHP.T_I[,%H!D'@Z$MOFP+8:;UK)=!)/*8_,8-2-D\JQB>PNG7R.G-
MK>T?D-0DL.)J_P`LQJ(L2)*QQ9<%7#&AST>YELXU)^_;*:Y85U>^R(@Q*C2)
MC5`U9J9,008J,+)*&I,)*`6-0,I.64G*&<(.Q;"`(0!WOT#K6O365AXO^:7_
M`#9X'_M'>8/](U>26_YYSZ/:G*P8#`8#`^?WF7^\8>3K^I#QA_A+SAJ?UCQJ
M^@+#)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"D
MO27'JWH.W*8LHJU!09LJU9'U#U&4]=1>3.<N)C-U5#=;<2U3=V4$OT!--=*D
M*0*3$`3/J$:\WWAV(!>%B<*5<KCQ*,-8PM*T-M_R^9V`S'Z'&[/M6`06>.C8
MC1V,^SUD8US*H3MS<\Q]I3/FVSZ88R_JB20''C&?ZBPL[KEPR'Q#0]TF%#S5
M@OZQX8ZU#:S]9,K3,4?B?VNX&V8(J(52N!RE&H3#$V1\^9<_,KHV&I1_5,J?
M6V]*/20/M$(W35=$SV'X[8M970=^WB_3E(%'=E+1ZKFN)IZOAFG2M96Q'#T.
MVH[80O\`]Y5<M5H![3EZ,T7M*#\2S?\`T82V,A'C5B,8JZ>U9)+9F-F-,ZZ!
ME=Z'+IRQ1IR4(4SY$W>&L$`,2A3`0O#-#&9P("E6*2Q+#QHBAG"$9[A[%Z8-
M:/\`%9`OU@U;+V>XK#B,:KH%GEN=;0QNC<;B<Z_63"X#%]*GS2%)I8WN47=*
M\1NR-2B&2:8J&,!VQE;V'9>6'FT:+^(6/,D)C<$?[^DL[;T++&DLS>9165>'
MR>R7Z,W9([C3/DH=$Z8D@Q$KW(/M9S7I.)#LDG1P0Z&+8=#DW!CX;D4#[>J2
MT8/I675D7C4S>)<N6,-9)&`IW42:\G*$0F%_;W0FPXO]G+Z#=_J$J5M#'UZ-
M&E&<<%6F)+$+N/-*U+\",=56;";.=K"W,W*L0O[17Z`NO(G%$[;%'QB6M&TL
MA4-6U"B53-*>K^7\QG?$XG$Z$G'ZEF#]26C:)>,5.CMZ[+<M/HNP;U66JYV\
MKBD>L6(04]HII!9QR,;&U03[>WIQB_5B0A+*9UJG0W#18`^\_>PZR+,X(JKO
MQHV$=RA==$(;FG7,3Q9=O)%L*F$,2P*<6-!*!@:Y".!54O4NB=]ARI*J7[>U
MX_BVH$G*D!@=&!4>_P!@O&W7FGC%ER9V9(I&+&<Y;#9>*H$4BE3Y#JZ3/==A
MI=TD,X6R>3/RAP+F%OJ;(F+_`*)1,IY)C:RHBQD>X!/L]RCDDDSQD/ZF2F.2
MOI(T45ES-)?UOPA)1\%1-DXF3S6]S5>U2.+G`=3"ZS8F*/W*J'MB1$*4:Q2G
M$88/6U1_K3EA75+AGCLJD:X:L*QM**528,G=D)==P8*-\5$6;JRT!3R3IMT6
MYZ;%(=(DQA^C!D)]:V#81:PER@>5>(:#2:658_`O&>M,;KI='7!VKA'&HD.#
MSI3&(E5\6;3WEH,3>UN4G;K]:K5C2;`%>=(%7U(3=@+%DI>6%+703B^*5Y;K
M_8\??&XB-R2'6Q#G&N]0"*E-Q2&S97#9,F2MSR46%:ACD4+B9B8AG"7M`?\`
M7#-&$(PZUNI>"GC?X?H^EYHB]%ZZ`DC'.HZAL5`JO>O:QK^`2J1)YO)4#LU)
M7V.-A2MA<VV&,*(32B2J=GD_3G",#HH>@^A>6-QDYY%X?(HX%T6GB72=PUJW
MTW&Y`V/3%"VR&HH]<4@5K#72,22S&U2UJ3G0+.NV60Z(RCRRY(S@$W+1[3C_
M`$91R\EMJ'XY*HV2F3I'8"9ZG+TWJVR9O26N(M%D$@1.EANE@.R1O96<[9<=
M1&GN>TB8@HXTM&4#0@:V+>\J6NQA#`8#`8#`8#`8#`8#`8#`8#`\5O-+_FSP
M/_:.\P?Z1J\DM_SSGT>U.5@P&`P&!\_O,O\`>,/)U_4AXP_PEYPU/ZQXU?0%
MADP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/%;S2_YL\#_V
MCO,'^D:O)+?\\Y]'M3E8,!@,!@?/[S+_`'C#R=?U(>,/\)><-3^L>-7T!89,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#Q6\TO^;/`_]H[S
M!_I&KR2W_/.?1[4Y6#`8#`8'S^\R_P!XP\G7]2'C#_"7G#4_K'C5]`6&3`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`\5O-+_FSP/_:.\P?Z
M1J\DM_SSGT>U.5@P&`P&!\_O,O\`>,/)U_4AXP_PEYPU/ZQXU?0%AE3+JWI"
MU*6E_-E9TK3\'M^QND+%FL&9T5C7"\TM$8XD@E0SFW7=Y<)-'Z@NIV6'GMT(
M&D3I2VD.AG'A$(X`0[ULU$1,3,Y0U']9ODW_`'..,/\`B!V__P`N_!6S6>WY
M/UF^3?\`<XXP_P"(';__`"[\%;-9[?D_6;Y-_P!SCC#_`(@=O_\`+OP5LUGM
M^3]9ODW_`'..,/\`B!V__P`N_!6S6>WY/UF^3?\`<XXP_P"(';__`"[\%;-9
M[?D_6;Y-_P!SCC#_`(@=O_\`+OP5LUGM^3]9ODW_`'..,/\`B!V__P`N_!6S
M6>WY/UF^3?\`<XXP_P"(';__`"[\%;-9[?D_6;Y-_P!SCC#_`(@=O_\`+OP5
MLUGM^3]9ODW_`'..,/\`B!V__P`N_!6S6>WY/UF^3?\`<XXP_P"(';__`"[\
M%;-9[?D_6;Y-_P!SCC#_`(@=O_\`+OP5LUGM^3]9ODW_`'..,/\`B!V__P`N
M_!6S6>WY/UF^3?\`<XXP_P"(';__`"[\%;-9[?D_6;Y-_P!SCC#_`(@=O_\`
M+OP5LUGM^3]9ODW_`'..,/\`B!V__P`N_!6S6>WY/UF^3?\`<XXP_P"(';__
M`"[\%;-9[?D_6;Y-_P!SCC#_`(@=O_\`+OP5LUGM^4/QGKKR$2N[;:H1MXMY
M/+FE,PRHIU*UJSO:T"HXJ9[J566DB1+$N)X#4.*MQ2&U4Y;7EGI$Q9(3$^RA
MG>\S11>.VKN>WY3!^LWR;_N<<8?\0.W_`/EWX2MFL]OR?K-\F_[G'&'_`!`[
M?_Y=^"MFL]OR?K-\F_[G'&'_`!`[?_Y=^"MFL]ORTBS>B?)#5=;6#9[]Q?Q^
ML8ZX@\LGCRD:^_[8-<U35$&%?(7%,W%JO'ND3&+CT;<,)(3#2R]F;UH0PZ]=
MZ+$;9FKGM^5[ZCGQ=K516-HE-@V4JR:\A<^+9C%6EPVDN8QMMD(&P:X*=(%8
M-`%QT5LW11>C-@]WL#Z^FC,Q4TD/"&`P&`P&`P&`P&`P*/=!=)7Q">@JHYSY
M\HNL+<E]B4W<-UNSM:]^R2C8_&XW4DVI6"GMR`Z+T%>Z^0/#VYW2E-`$9"`D
M@A&9O9@Q""'1J(BKEA?UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!
MV_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`
M\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!
M6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>
MWY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/U
MF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?
M]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC
M#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY/UF^3?]SCC#_B!
MV_\`\N_!6S6>WY/UF^3?]SCC#_B!V_\`\N_!6S6>WY1-6G67D+M62WC%8WQ;
MR:F<N?[:(IF;&/'>]HID:V5J*EJJY@*HT:CX"<#5[%J*7`UE;.4EHS]+RE)?
MP_&66<<68VQUG'R_*6?UF^3?]SCC#_B!V_\`\N_"5LUGM^3]9ODW_<XXP_X@
M=O\`_+OP5LUGM^3]9ODW_<XXP_X@=O\`_+OP5LUGM^6ARWK3M*G9=1*2]^3>
M=(]7]SWW7="GR>K^RI_9$JC#O9)KDE9WTJ%R7C&K&Q\;T:IO]%!>WM&9H`_<
M'8MZ]NRQ&V<IFZT_+TWPP8#`8#`8#`8#`8#`\5O-+_FSP/\`VCO,'^D:O)+?
M\\Y]'M3E8,!@,!@?/[S+_>,/)U_4AXP_PEYPU/ZQXU?0%AEYW=8?_6=XLO\`
M]//2'_ZD]_8:C]9>B.&3`8#`8#`8#`8#`8#`8#`8#`8#`\\J4_\`VEW??]7/
MQ^?_`'UVAAJ?TCUG_3T-PR8#`K;V7_\`2!U9_5MO/_Y82C"[?VCU<_'W_P!)
M/+G]72DO_EI&<&[]I]5B\(8#`8#`8#`8#`8#`\_IA_\`M4.=?[/[L[_]8O@S
M)U:_\9]8_P!O0'*R8#`8#`8#`8#`8#`8#`8#`8#`8%!.+O\`^,WDY_K]MO\`
M^H1PKAK=E'I_N5^\,F`P/./R-_\`NG#W]HYRC_\`?4DPUMZ^DO1S#)@,!@,!
M@,!@,!@,#Q6\TO\`FSP/_:.\P?Z1J\DM_P`\Y]'M3E8,!@,!@?/[S+_>,/)U
M_4AXP_PEYPU/ZQXU?0%AEYW=8?\`UG>++_\`3STA_P#J3W]AJ/UEZ(X9,!@,
M!@,!@,!@,!@,!@,!@,!@,#SRI3_]I=WW_5S\?G_WUVAAJ?TCUG_3T-PR8#`K
M;V7_`/2!U9_5MO/_`.6$HPNW]H]7/Q]_])/+G]72DO\`Y:1G!N_:?58O"&`P
M&`P&`P&`P&`P//Z8?_M4.=?[/[L[_P#6+X,R=6O_`!GUC_;T!RLF`P&`P&`P
M&`P&`P&`P&`P&`P&!03B[_\`C-Y.?Z_;;_\`J$<*X:W91Z?[E?O#)@,#SC\C
M?_NG#W]HYRC_`/?4DPUMZ^DO1S#)@,!@,!@,!@,!@,#Q6\TO^;/`_P#:.\P?
MZ1J\DM_SSGT>U.5@P&`P&!\_O,O]XP\G7]2'C#_"7G#4_K'C5]`6&7FUY**I
MW,8-4=I-CK9T2E-!V>.8L]BUG92VLSZZ99=$W^M9]*),Y--.7P\.<;30:6+@
MFDD1P\LD8@J%*A(F)-4`-;9K#5YGN\J>4#E9J-IOCR_S%!6SO:,5W(8IT-QD
M0R2J=5E)(0RC@C&";Q.&/J=_D+983:O(5+D25B*ULX@3A\I8=&+:ORV^[K3J
M=A8G4B)5]T_Y5+7L=RJ^$V4Q5TU]2<5QF2N@Y)T)`^=)'"E3?(X@C<XM)8;*
MYT`[2YY3M\8>`I#2T+L=O0A!67K$4V.PY3&*WA!%AO?9'E@!%$]>'V9*W=?>
MG)D600>-$U-'+:T=(5\R@T>0BWMODI3<,Q(:I(3KBS!'#+2Z"H$+OI#!7\OL
M*M*HKVVJIZM\@-H,]C4R?:32W._1T5-=PNQUN4)5S)&VILHKC2]5T[:5A5PK
MUPW*.`=M*=M27[<6N1KA+$XB8NIB/'U91]2V\@A]=O:#HCR0D2J:=&O5#/,+
M=[V2RA=%$48:37U_EBA!2G"MK30Y4%M3CV$DQF);&[7H<ZKD!`#QE0N-(\?5
M&E>6FY7>1?8*)[5['L%VH/HQ@J^3($_:53R3[;1#J^.D8/Z,F:"H.0[2D\2"
MLD<3>2&]@^W*30I"4Z]P4(4FU1B:DX9Q$1Z)]J"O+QN:F;SM:+=,>0Y8X5W)
M92T5?&$5YFDH;29V`Y4D2/\`^:Y'P9'6J1I%PT)BC9U>;GJ,XG>B$IRA?KZ0
M0F8CI'CZHF9WRQY0UM#M&^ONS!-C8`J16A(W3JC2R,-5>&7#+Z9(D-<I(7X_
MI98<E=%KW$#5?L?F&.-B)*>5]4M+%\NBA<=8CQ]79K-^G]GH;<CC3TIY%D=\
M536O3]CJ*5/ZGJ!2X/*6D['5P2H-(7=+RN88;&NAR$9QB5W+3#+;71O<&\!2
ML:(TS0F:Z12)Z)OYVZ%G5AP&!=3=\*'6!=`0*MRU"KKNL"$,EHRX&TDBG^FF
M(\''BDUTB$SG)WV4TA&6J(3#`(PM2?O]#"SA$81EHR;S:-K5A!7URNZ_O(:F
ML-#')(^,;-1702ZWJJ6'16Y[)IQT3SZWC_'S&FNEVP]96YZUO<),0A2N>U`4
MJ<0E(#`!EF'2(KQYIMIE4]6C?(^>I!U[Y$X#-UUBS9BBA1W3=//`I?5$0JMN
ML+]<3`F_HO-XEZ4$A<R(Z\-P1:VR+%241IXQ*2RMU)FHNH0W54^NJVFY>F9^
M@.[6&;@=+$>V=@G'4I5?,+M3]=0.#SY?-6UZG?C_`(X_2UT<4TS^W)5D>:G>
M$*EZ(X1$@,(V68,3ATBO'FW)]=[;232/PU@Z9[E7F29@YYM9M<WOLJI6U*"B
M[UEU:P,Y4K3,W)$@=`7G&)).E!X8\6G,CJMG2D*0OWR''$)Q<:0]4M>/J3[_
M`!_B)>1G]L%0?]P.&>7E#^_P^9/_`.(EY&?VP5!_W`X.7E!_#YD__B)>1G]L
M%0?]P.#EY0?P^9/_`.(EY&?VP5!_W`X.7E"@UW<G3:@NARI!!.G.SY-J>TV.
M7]$VB\]616,V;JNJ6FC9&X'&Z[@;=R-+HM/WUJ<KM=U"5"H<8^:I,4"(+&I.
M.*"`URBJF(\?56IGZ1A#TU3F8(NP?):LK.M:W=YI-['9NU?'Y)XM'Y2GFRN'
M1NN5<KB[6\UR)SF&DFU)*X#\)"V&"TD=!H5/J7BUQB:J+])>LD%XG>)_"(=.
MVGR%^21*US6*QZ6MJ9?;M-EKT[?)&A&\HR%I9%#'D@5DIU@0F:`,8=#UO6A;
MU^.&.7E#:OX?,G_\1+R,_M@J#_N!P<O*&!E/C3536,2.&RCR!>15WC,M87>,
MR)J.N.IRB7-B?F]0U.[>::FH8A264M;U9A8A%C`/6A>H1:WZ;PL;ZFZAZ%0&
M%LE;06%5U&0J01N`Q*.0N/@6J/JU@&2+,Z-C:@JU6P%[4J0H$)>C#/:'WC]=
M^FO7#$XS;;<!@,!@,!@,!@,!@,#QF\E52*HM8L([!;[/Z7ABB*0&45*^O%8W
M2FKJ&P*`/JMMFKX@:F5+SS=ZE1,;?FL)C:'ZIVVVLHE34@),<$9A@"U9O;.%
M8*F/3](T%CFURQ7/YEIH<H(F2N-26.WYQ*0Q2Y#64A41VTES0EDC*PR9O3P0
M]&:<:%S;T!S@0#_J):DS>@;6MX74-1:[=9I+-EL8A75_E%F+`S.2`V136/\`
M6W#$@3,\)?:LN*S8M+SXE$8Y)9XTN$C%2[DUEL#VV,STF4B]ZE.2`.O>+\H]
MV0L>WJ^K/]9"U][2\J":+UH\QF).,XD'2?%5?0UUGLJ-:U#;!6U_LJ.1!&G?
M!QUP,<@#6;2HU`$HTI!QJ\PA*:LC'I':4VVQ&A53M6^*NX/)`]UXB<Z;CZF3
ME7M5K=("Y+<+%*),@90PY1S&,X)J)F1L'PF'J4Y)JE^&6H&E`A-,$2_*$/22
M62B-!F*(^Y/,,X2NNY8AB\^@;=TCQ`7*H<7JIIW=4ED3PO>8^T5\YL48@L&&
M<(+(^N[BJ-4A+*2[$`?H6_+:D_<)M=QB$B>V'I?R-M[[OJMTY7K%/8'5O/[+
M#K$<$;\YL"&RE3]$.=YM)HK%E:AI.^1`>S#>`&A]@$Q@-A.V3E&D(`A70%<O
MDQ35A+>T?*G&;.+M5]I5Y8V"Y:'ET?!8#=9\'K..$1MX_4@TOD@8K("]2I]8
M#Q-B90>QUI+#5!"8YJ$28M<:NHIM[%:$*7N-6QJ2=B>6*!3FUIO^4V6"2B_N
M/-R$EI7H7-PBTW2[98B[-<N89.E;!&:2L*ET=VL@6CW-&B)"88`7I$5]6U5`
M;*+5<H$A=.@O+14(9[*ZMC3>1:O1W(B>0*$5NUY-;#BLNCS!`*^GPG^)!2P=
M4A.7".2ISUNQ`0#6[2K_`*43/E#T<_A\R?\`\1+R,_M@J#_N!PSR\H/X?,G_
M`/$2\C/[8*@_[@<'+R@_A\R?_P`1+R,_M@J#_N!P<O*#^'S)_P#Q$O(S^V"H
M/^X'!R\H/X?,G_\`$2\C/[8*@_[@<'+R@_A\R?\`\1+R,_M@J#_N!P<O*#^'
MS)__`!$O(S^V"H/^X'!R\H/X?,G_`/$2\C/[8*@_[@<'+R@_A\R?_P`1+R,_
MM@J#_N!P<O*'FNZT3*J/N^XB6WI?LYJK"6W>",3NRD78]8M-JSN_D?*3'82:
M1OD+G7+3-5;-$MU+63+&2U^I@E^F,0%*%*4A(!0KPURB8RB_3\HM27U%MP(J
MV7?K#RFLU4O$7HIYA<T,ZGXI4E3"1W4K>"C8"WA!$`,RF20]$R'*@B0+UZ.0
M`UHAG.6K!DIC1Y5%^DO7D/C[DPM:%KR)^1G>A:UO6_UOU#K\-Z]=?AN@?77X
M89Y>4/[_``^9/_XB7D9_;!4'_<#@Y>4-5DWB]:YPLA"J=]Q>0":%UW842M**
M('VX:R^@;IQ"%^W".O(BFND6TU3M(8,P`BC!B*,+-%H0=[]-Z+SK*(>H>&#`
M8#`8#`8#`8#`8'BMYI?\V>!_[1WF#_2-7DEO^><^CVIRL&`P&`P/GGZ1)M3Q
MZ^56<>0E-S_<'0W-75_.4"I:Y'2D6`N:SBBII3;H<?$7=1!$QA#L\Q66M:W9
M0U!(_P";6;T#>M>FM[.D1&[;5Q&Z$Q_QU^>OW4O(Q_L?3'_*N,&>,ZQW1I:O
MEQXAO.-D0ZY>"^Y+1BB5Y:I$GCD[X<?9.RDOK$K`N9G<MN=EBI*%P:UA832#
M?;[RQZUL.];Q@<9C*8[JYC[HX.4=,;Z56<<=YF.I<5E<:30])X\F1K;CCIRN
MB[I*WF12IN;$\YF"MS=XDF6`*<W!2G3*?490`[]/0M357'=(CCY#_&4\/4OD
M;IXP^KG!_L"".=7SAZ5^/<\]TEM<O3V"2NT&D"XP0E+K%7*0EA7'(3A"3F*P
MZ-V'8]>N,"MVL=W4B'D`\7E?QN90^$>+CJ:*12PSWA3.XXP^/(QM99@?(&1+
M&GPV1MJ;9:1W&[Q]"2B4?.$?RI2@%B]0!UK&!6[6.[<%GE,X:6R.N9$/B/R'
M$`JB#.M=06+(N1IVB@#/%W)^KR2D)OR$E>RHFK6QUXJUF-9U1J0:AHT08%(,
MH)YVAL$XSKM[M)FG?'BVL>3R>:S[Q:]2S&7S5>QNDODLC\>9SL]R5RC)@#8\
MX/;DL$:J<5C,84$28PT0AE;UKV[UC!:W:QW;2\>2_P`<TA9XW'WSQM=?.K'#
MVZ$-$5:5W`2U0WQ]KK0]2IKUN:4HS=E(D4*4+#AM90-:`B&:/96@[%OU8)QG
M6.[C1>2KQQ-L?MF)M_C8Z_0QB^%JARNB/I.!'!.SVFO5IS$BI9.V\H\"62J5
M"8T18QJ@F;$`6];_``WC!:W:QAYM=DG?GBYF$2A,"E7BWZED,)K=U+?(!%'?
MQY&+V"&O!2T#B4Y1MK4;&C:%A;@6$_1A(`"T;KW_`/2_'&!$;HRF.Z9F7S#<
M91R0_FU@X7[K991]E6QO\PMG#[\B>MQ]RD*R6+V7;DG6%J]M:R3N*AP,(V/X
MQK#AF[U[Q;WM@G&=8[M*AGD^\>5=?)^0O''V)#=FHX"WF;C/`BYEV8AJK9@J
MT1CV@-(V)+`A'"VT`W^B@V+>R=`]<8+,;ISF.[8UWEMX<<VM\9'#@;M]:SR9
MO,:9"V*N%WH]`]MALE>9F:WNB4Q4(E<C,ELB7N6RS-"#M<L..]/D,$+;!.,Z
MQW=E!Y>N)VM^9I2V\'=R())'1OAC"_).&GM.[LXY.C0M\B$VN!2L*I'M\0MB
M<E7\8@_.606$?KH(?1@<9UCNB5-Y`/%XC87*+I?%SU.GCCS,S;%=60GQYFEM
MCA/#S`G'RY6C"+1!\@.-!H0E0M;-%O6O7>,#CNUCNRU@^2CQ]68WI$,CX)[[
M2FH+:AEY(WB,\=36)R)-:<%W'4[++B9!'7AN=P."A@BR1D7^AOL<6#Y&U3HQ
M&:82)@M;M8[K$?QU^>OW4O(Q_L?3'_*N,$XSK'<_CK\]?NI>1C_8^F/^5<8'
M&=8[G\=?GK]U+R,?['TQ_P`JXP.,ZQW/XZ_/7[J7D8_V/IC_`)5Q@<9UCNB*
M=>5G@NSYC$+"L7Q\]K3B=5^D=&^#RZ4\)O#W(HFA>U;8O=T<?=G!4>M:DSFM
M9$9QX"1@":8E*$+6]@#O3`X[LKBO5%2+N3Q1MK'J,M_BBZ511S14M(^Q)?'*
M40T;(GJ8E'-2A-Y0`I1%RM*G`6OUL.]*@@UHSW>F,%K=K'=:1K\X?-+(V-S*
MS\B>0UK:&A"D:VIL0<;RQ*A;FY`G+2(4*)*2Y@)3)$B8H)998-:"``=:UK6M
M8P3C.L=W>_CK\]?NI>1C_8^F/^5<8'&=8[G\=?GK]U+R,?['TQ_RKC`XSK'<
M_CK\]?NI>1C_`&/IC_E7&!QG6.Y_'7YZ_=2\C'^Q],?\JXP.,ZQW/XZ_/7[J
M7D8_V/IC_E7&!QG6.Y_'7YZ_=2\C'^Q],?\`*N,#C.L=S^.OSU^ZEY&/]CZ8
M_P"5<8'&=8[G\=?GK]U+R,?['TQ_RKC`XSK'<_CK\]?NI>1C_8^F/^5<8'&=
M8[G\=?GK]U+R,?['TQ_RKC`XSK'<_CK\]?NI>1C_`&/IC_E7&!QG6.Y_'7YZ
M_=2\C'^Q],?\JXP.,ZQW/XZ_/7[J7D8_V/IC_E7&!QG6.Y_'7YZ_=2\C'^Q]
M,?\`*N,#C.L=T1VKY6N#+SU%PW-X^NU[2#"G@<AB`)[PF\2@$:?3$9[>-W90
M/"I6%O<!(5)A6S2]!'\8]Z]?3>,#C,=8[H/@?>_#D)Z2L[I\?(G?CS/+&BIL
M(+(#X^&>-$1Z*K716[.Z#[M%FUJD$K6O"A7LM0M>%*U68G#HO8_;ZZR8+4U5
MQW9MI[F\4K"8YG,GBEZ8:37E8B<'<UN\=`49CFN;6"=Q5O5KAIPEB5*$4:M"
M1H"A#]=@2/JXK7H!2=H5P*W:QW;"E\B?C,15ZIJ5)XQ.KB*O6+6)Q5U^7X]C
MM1!2X1@[2B.+3V#>]MIRMC/#H:0P1>Q$"UZ@WK&"<=V=QW9^3>47@R:SE/8<
MRX/[UEDA0-+4TM(9'Q;*'AH9/M"22MA#NR,RYQ.;FN0J626*VY0O)+"I/;OB
M3#'LHH`=,%K=K'=QQ;R;^.V#L@XU#O'!V'&8^:2K3FLS)P*O;FTTA>P/<56D
MF)$IQ9)A:N,R1P;S-;UO0T:TXK?Z!@@[8)QW:QW=US\I7C^>FVQ69W\=W9SD
MTVZZ-KY:+:MX-=%"*P7EF:&Y@:767)C5`BGYQ;F1H2I23E&AF%D)RP:WH(=:
MTP.,ZQW=1M\G7CO9WAHD#3XX.PFY]8!0H;(\(N`UJ9R:3*X;IZT0`QO6E&A4
M)3(8UVG)4[8(`M;1DOR\)6PZ5':&P..[6.[G4^43Q[K'6*/BOQS]D*7F".*9
MWA;J?P.X&N$4=$;4I8TKA'U8SMGM*Q.S+#4H#"!`$%.8(&M^W>]8P..[6.[5
M&WR(>-MCES=.XWXX^TXM*FZ7Q2?;=XOPL]Q]6Y3&!PU^KV"O[T>U*TIKNNA<
M*E+DVM>S]C"B2+C@%Z#H6,%K=K'=9?\`CK\]?NI>1C_8^F/^5<8)QG6.Y_'7
MYZ_=2\C'^Q],?\JXP.,ZQW/XZ_/7[J7D8_V/IC_E7&!QG6.Y_'7YZ_=2\C'^
MQ],?\JXP.,ZQW/XZ_/7[J7D8_P!CZ8_Y5Q@<9UCN?QU^>OW4O(Q_L?3'_*N,
M#C.L=S^.OSU^ZEY&/]CZ8_Y5Q@<9UCN?QU^>OW4O(Q_L?3'_`"KC`XSK'<_C
MK\]?NI>1C_8^F/\`E7&!QG6.Z`I!Y+?'++)Y*;1D_C:Z_D%C3>)C@<QG#QP&
MN<)1)X682!.9%GUZ5'&+G-B&G+"7M,<,16P:]OIZ?AC!:W55Q7JUPOOWQ<E,
ML8C9?BUZC!'H5$V""1!D#X[Q::HS#(K*DDXC,68T'_NS8Q,$Q0$NB-,2$!2=
M<4$X&@F:T+&!6[6.ZT'\=?GK]U+R,?['TQ_RKC!.,ZQW/XZ_/7[J7D8_V/IC
M_E7&!QG6.Y_'7YZ_=2\C'^Q],?\`*N,#C.L=S^.OSU^ZEY&/]CZ8_P"5<8'&
M=8[G\=?GK]U+R,?['TQ_RKC`XSK'<_CK\]?NI>1C_8^F/^5<8'&=8[G\=?GK
M]U+R,?['TQ_RKC`XSK'<_CK\]?NI>1C_`&/IC_E7&!QG6.Y_'7YZ_=2\C'^Q
M],?\JXP.,ZQW/XZ_/7[J7D8_V/IC_E7&!QG6.Y_'7YZ_=2\C'^Q],?\`*N,#
MC.L=S^.OSU^ZEY&/]CZ8_P"5<8'&=8[G\=?GK]U+R,?['TQ_RKC`XSK'<_CK
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#?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g511574pc2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g511574pc2.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@#*@)Q`P$1``(1`0,1`?_$`+4``0`"`@(#`0``````
M```````'"`8)!0H"`P0!`0$!`0$``````````````````0(#$```!@,``0$#
M!0@/!0<#``L"`P0%!@<``0@)$1(3%!476)@9(2(6EQC869DQT[34M=4VEM=X
M>=D*&CHC)%56=D%1,C6VMSEA<3.10G)#HS0E)D4G*!$!``$#`@0%!0$``P`#
M``````$1`A(A43%!89'P<:'1X8'!(C)2L?%"8H(#$__:``P#`0`"$0,1`#\`
M[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!Q;X]-<:97B1/BPMN9
M6!K<'IX<#0F#*0M;4D.7."PT)(##1%IDA`QBT$(A;T'[FM[^Y@8I5=I0&[:X
MA5N57)4<QKBQ8ZVRR%2IO)6IT3_'7<@*IM=$I#BE1+RB%9`]""$THL>M;^Z'
M6#@S_`8'"N$ECK2ZL#$ZO[*V/DK4KT<69G!U0HG62JVIM4/+HE8&Y2>6K>5+
M:SI#5:@"<!@B4Q0S1ZT`.Q:#FL#AG&11]H<6!G=GUF:W:5KU;7%FMQ<T2)QD
MKFWM#A(%[<P(E)Y2EX7HF%I5+3B4X3#"TB8TX6M%EC%H(8E?4_/D&M!XI:6V
ME'&&TV&HWJ]W.$KM.(7DNI(XH.3/TU2@`A&0Y-[0:G'\04F,.5%`#[>RM`]!
M86D\4IP&=1*T8+"K,@+TFDD%L2)1R=0N1(RU)*1_B4N9T<@CCTE)6D)5A29U
M9W`D\`32BS0A,UH00B]=:)PT8QJ[:L-?*WCR"8H'Q=;JF6HZ\51E.Y2A@D*B
M"MR]TEA>I5'43I%VKY&3-AX!B6K$P1J2]IR]C4>A6RTE*F$5DZ.[(YKY)#!]
M]"V<DKP=D.SBR0@@V.3&2K)`XL[8>]O!:5%#8[(E9*=H94IJQ4H.`4G3)2C#
M3!A+`(6BQ$SP3]&)/'9K'&.7Q%[:Y+%I,U(7R/R!E6D.+0\L[DG+5H')N7)A
MF)U:-6F-",`P"V$0=X1SN`P*G6#VC2-67@[T).E4L9Y4RU/7MPJWE-$7601D
M<<L^SY-443;$PXR!YD:B0'R^*J/B"]-OPJ5&,L\U0$'M^P6DTKU6QPA@5QF?
M4]2PV?<_UYMQ6RIUZ1M">U!`G6$A:I'&T$UK2`SVPYDAE;LF=BPM(&9LK=T1
MG:*`I.(="])C2R]Z,$66DS7HL=A$)VST?1M$R"I(K;UF1J`R*]YSJM:B:7Y0
M>2JG<XVWGNGX/,^B4YX-*@H4XA[&<(HD.]@#L>AF`"(M)G@FS"(^L:TH35#<
MQ.LZ=%;4BDLJ9X4RF)&-_?1*Y*_Z5;:4!Q;`V.8VU.I^#,T)8KT0A(]->].+
M]H/J&&\W=!0;J6FXM>5;I9&BALO73)N:TTL;DK2_%J(-.9+7SU\:@1.+LF)+
M&^Q52(C85`_>)]ECW[.Q;`$LQ2:2X"F^JJLNVMK(M>-:D[/#JJLBX*OEJF2L
M0DZ\M]I"4.L3FR]L;652^JW-EVY,YPD0RP[4*2M:W[D(]^Q@F*<6"5CWKSQ;
M%@R&MHRZ3)._,\Y@-?M9[Q`I.B;I8]V3S[%^FXXH:1$H5;@PM8:KEB8U6=(D
M[)M(X`,1F!T?H`1B;9A;2/2./2YE;Y)%'YFD\==B-J6I^CSHA>F5S3:,&5M0
MWNC:>I0K2/>EB#[99@@^T'>O7UUA',X$`[Z-@YW2`^76MIF#Y8C;6R&U9:YM
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M?Y%'XHR.$EE#ZSQJ.M"42UV?Y`YHF5F:T8=AT-6XNCD<F1(4P-BUK8S1@#K>
M_N[PCEBQ@-``PL6A`,`$8!:_8$`>M""+7K]WTWK>!@[[94-C4W@E=/+FJ2R^
MRPR44+;2F.0+DSH&'M6GJ0[4O2!K5,3)I"VBT,/QZE+[\0M%D^\,WH&Q1@-P
M]%0*D9C0$'F*62*'GI&UQTY7YC$V)5Z!++"X1+)\(^3'J'%"8ULOR'#%8??E
M`4C^($6#W?H+8PEB*IJ=71"R-;D\N9_PS:TH%;FX*?=FG?#H4*<Q4K/]T0`T
M\S11!0A>R`(A;]/N:WO"(=YOON+]/TQ!KX@L>FL>@ME-0)+!]3UG0L+W((<O
MWLZ,S-*V(79YT5'9DSC)<FP9QA:@U`I*&:24,6R]%F*33FG'"*UN_5]0MMN<
M]TZWN:R6O'33=:#K6$JAGR1(X`I1U&Q%O\L,=)0A>-E$^J4SW2;:8I4$Q1K8
M![+]/7"TG7HLIA$)S[H^C:ML^H*7L*S(U%+3OQP?VNGH2ZJ#RWF>KXPU&/3Z
MG9@%IS2-"0-Q6Q[V>,H(Q["6#8C!!!LM)F*QPA-F$,!@0#&ND:[E%Y7AS\B+
MD*6:<_02J;$GK@X-B<F,#CMPF6.7%]L3D0O4K'%<D^:US$O+&E)T0$1'L"-V
M8+0"TTJA?7DLX6WS6\]@?E'PG7-L?G)M:/-JB2R8#*@GI$E31`R*FMPF'4A$
M[ZD:TI-HL*,7M",T/6]E_?X,9K3FNNUN:![;&YY:U(%C8[(4CFW*RPC"6J0K
MTY:I(I`$P(#`@/3FA%K0@ZWZ;^[K6$?*]R*/QI.B5R-]9H^E<GEFCK<I>W-$
MU)U\@D;DF98\Q(CEYY!:IY?GA:2D1)0;$>J4F@**"(8@AV&.P6RH99(96.&N
MBESU")M):[DWQ+(_L@D$NB*\;:_MI07]K:Q.:=(L!O1:U)H]"J!Z#(.,!O0M
MAG>`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!'MN,+I*JHLZ+L:<*M
M[DE>S1A9THSR4P%+H\1MR;V].-2H&6G3A.5J`!V,P00`UOU%O6M;WA8XNL14
MGBY[=9:XK]KE,;E+!)(#$?%5!V%NCG0+4VMC-&JZG]E-7>#6F1L<RTR"+5T[
M)4Z0X7N]C>`&:"W[-4$ZV".F5M?K/PBN6<N=11_I2'\IA@UF3]U;>?N\%]$1
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M/8'ALMZ6RR3-#Q!5L>%\6J`T+W]*8#0FE.K*.*+A-UM-.-)3X@\<M[*$/C;F
M]L4NLN.5\==H]$N;G&UETMFI7'N:9W);80T4]LTF7SIJ9']%5H'.)/REN/6G
M/9S<U#;_`':@0SDAHRXQ'"89/Y)O'WU)?O2-V='<\L+4ELB)</LL!YMECE*8
MT@12&T3[0>'*SJ;D34Y.R)0@BMHUF>!M5N*H)2(K1FO0WV@BUJI;,1%)W8="
M>`>X&N7<K-3NF7IVZ$U-Q-!T]A([9;4T7YPJ>IJ3B\"Z[YL>ZT:9.F':;C?[
MZB<-I'YO3K""0J@&?&(]H$^U)9NC6G"K"J%\:/7](PWGNK*=A*2@GZF9?Y#2
M7BYV^T6J30AZ=[QI6V8]SK<K?"/PO7R-6SL4OE302:TJFY,M2J$PE1B;0=>^
MV@FZ)F9GHQ>RN`?(5(XA2[=4,6FU!1Z(MBQGL&"@L*L[KG#GT2-T1*G;LQ@E
MLMZ%AK'\BRD(`;*;5*O;FE"G-]IC+V?H.A$V\]9\:+Q^2?A#IOK0[BQBKJPY
M/&7FK8IT0V69?D4?8C$Y.P2J:<D6/7$6?-,+OMP"ZLL\LQX1M[T@0$*-A:'%
M2'1A(->_+);=%M=/%5185P?Y'DO1O/L_*<'BA:QC<'HUKC41K1?5<I8^8H_7
M]3DQN?TJ]GN5Q,RAT@,MFQ6U9Y,;8)2)Q!O1@EB06]E!+6VE.,[[JB497O4%
MF6[.8;4$=)N*T(#R==E7=1S=7T<*;UM;M[2KJ2A9*9)A)6*<@CE=VD^5E#7<
M;5&'I5&U*0E+M&J$B1FA5*(<(VU]URJB\?/D"<P47`K;=I*T0"M+W[0D;8Y)
MK*8XZ@C$`F-6.)7,@7.%0NS)LK5QIBLTU./Y!)=7@Q!HL0S3ME"]<I,VZSSI
M'R@:+>,[NM.C<%B.BGZ$SC?/W$U<3R:NW2D0EKM<]U4[UJ^69T-;[:ZZGJYU
MC,>L2/.!S\2W*-H?;`N$D^%+/]XF"6;K:QM6>U%QU/%W=D<O"T;>@<D?JX>+
M"Z.\BYZRQW"TTLG9(OS[9?,;BAY4?_F_,DBTDQ%&>BVYI<BVM&C"Y(-IA#.`
M6G&/U,UMI'E'^^S[O"<W/SU(^U5"U$_#K$:OGF#-*E1;!MPPU]FS%0$7;[J=
M(9.T,@?F9>%YGIJP]R+0J-"0KSAIS@E'@$6$74I&Z!JR\2-DQ@FG*;<N?BV2
MN*[[Q["N"?3F-W2A3M\\J6X::Z+24Y(8N1J<#GT?<(T^6$P1QQ2B3(5YB@@Y
M8()Z;9BL46;JUG_R4_PIY7"+XY`L>Z+4FFT\5BO.2:7O$6>:QE+A51-=)%I-
MPUU,G=\MV-&NL:M,0""W$<<898:Z%BV,2E(9K8<03-M)B%E_(AX^^ONV[_L"
MP8G,Z_JR%430C7&.64<J@\;M!UL&Z'.3MEP2J9-BU3,F`^E%9$LKZ(Q].[&%
M'*_ADB\6B=ICPB,J6W1;#&6GC[R%.EJ58@.2)XSS[%8Q.^P'"(26[U+FL/[=
ME%='QAAYND+I&G-T>"Z#A=GJ?PO0JT(7!%OU&29K8@E$[%8IU5FJG@/R6M+Z
M)+((N)BK-RNWC.YBX(VSJ#QI!%I%"9A<X>BC_<-EW68=)2%L==(\;LX2Q/IZ
M)$6'3>6>2<47%F;<>M'*+>#O)*P5;Q1#*^@#/%WN@I\?/G*2,%B0X<G95<A[
MND<]GK`K<%5EQUA;F!\YTD/Q03D""3GN.A*VI00B-$28(96S,ST^SF*X\?/<
MS!95AGL5<NM4%.]H>02?36QB;OB3E'+]KR^")#JDZF101FF"U3%G]-)7%.['
M.*U`WE(?=B$)5LT8B0TF8IUI#WT;XUNP6R;TQJTX%O\``SYV.:7.Z1_.ZR'F
MO$(AWAWAG)]DFOIK#+0ODDTFZ$:#T`BRQG*E>R0N16AD>PHP3=%=-I_VJJ5/
M<+W?03WQ[Q!"&PZI'N^V27TKWC7$>MA5+@*Z"K2RTEJI>JHL*(320BK4%J0>
M/*X&W'*/D)80I?-%F$?$^Y"9%FZM;NWCIQ;UO(=SW?=P3.E'^#Q=[NFD(?%;
M::+!YSC%H(:>>I#9,H01PFG[5U+G60Q5O7(*P6-R\1B0:\LXOXS1Y!"L>ME:
MK$3'U0YPCP)<=+=C2_HWHA(BG4^>..N>ZY<KT(EQZA3,;?8Y9<8K*3*(L!^&
M9KY&K]RB39MP4MY*9<8A$H3:`<:J]2S,8Q$;RIU8'B(O&:UYY,;$6AL51?\`
M8E]=>S7B2!HKFB['7T627FN;D"2V8N8U*T!T(LJ6QM+LH]0YNI1B4`=`$07O
M>_6-1?%8KP2Y<_CNZJ0V"P1VC#)$;""8;S>ST-9"J[%Z0OD26QNV)%/NQY;8
M$;=I.2^V^LZ;CDD-;@C0D/'NQ^I'NVY,$H[1F+HIKQ\4[,)6\KWM!:5\@JR_
M'63\YP.<U$P.?*-G2/I1OE(^5/P#=37.&TVI"AD@@DN!5BI$C^!Q3'NB1R(4
M?!J5?O`:3;+6*QS^ZT%#TQTO;WBMZ'E%D,"PKL#O*NK<M]\KUR=ES*WP^36G
M#36*HJM0E2]6D3Q`B%URW1]J5A.`A+TO(4'GE@,,,WN^:32+M/UB6MM5XB.S
M@-3#6HF%J=J.YQ=N/[#Y2@.Y?!$VHY/Y);O)TEZO+&8-Z`6B3TO$:<EQ;*8+
MW>G<$O7`2[/&,(=FLX^LU^/'1ZKG\87D2Z(?NB62;P.$,<#O6H^A6B81-#.&
MPJ!2"XVI;''KG.8?A"7;;Y,Y:W*QIW!,G&NC<:VV''^JU)LG03-1(NMCSA:&
M.<3>0$OL&@K095\DIV@(TKH59%*Z;CZPG;ASM6\)8$2"W*!G,G<;[(62ANL5
M>G<Q&.+"U2D0M.R<>E!8D>P[J5MI3C*,Z^\;?;M4U/S.ZPR%FO\`>A$&[C_*
M/(L[HE>[LCC);'JZ<0F@H\H=4DJ<]K6I`0\ITC?IKULMO&/1JL\G8-GEQ9NM
MFNS@8SX]/(8H8HK%I:S31'"X3VP?<$"#$9_4L,GE8T_)^*GNN9&97J(RV[(8
MH_)&ZXI"J3@2C?U@%2TTYPT(E*HWLIR*V^GK5M)Y`Y<N9H\;$@YBZ9@L9*EC
MS$[/AR2)-$I7&N;S$WQ"K1Q@VQ'YMFDF;&VR7P1PCGD;-(5[6%29[PA3K0A%
MEUFZ?RK#5U7?C&[>JRC*9JV%1MR89FV\X<SL=2S1CO1*UQ[AKH1A;XZX]02F
M1,NYDL,M5/9DU`[+RC65*])=%J]("4R9(6`S#4W6S=7C'^MN'&?*,]A4E[CD
M_1J=Z?GB].@9RAABERGJI]:G3G1RKNN&M`6Q,C4_*D\!2OTO)?SC$6M)G`G>
MPBW[`=E[V9F8I$1LT_55XC[VBE5\J4TLH4N,$\Y,'>+9+YA&KM:$[?8%@6/`
M7A%1=FPD:2;_`(5QYGDDB/3E"0GDMQJ`0?>+$Q9?J+<HU-T3,SSFB7>>>*/*
M0U=A<]7/?]JS)>VH6&DWFPY+&EU8O:)H01WEZ&0NU:)GJU?;;2^+F&27L0\/
M(M1V*/*50L$6OTZ`T8).`3-E*1'BOLS3M[Q]=T]0=%WQU%!957,!>*2B=:,?
M$L!DL1BDVD$V?JKEC5>2N1(K'-F;5JC3;!MB),S8,PQ.><-I*4%JP`)-^[2V
MZV(IKU<K97&/9\QZTG_4D<C\QBCT_=4<63"(-I-\-.FB+42R\LM4)Z@8RHP1
M+!1O8MV.D`A6$?#B-=]I`+$0!`V(\P91C3I]T,0WQR]\(*,M>M$J^01.17EX
M^NKJ]GCL\WL8]D#ZJ>.EQR'G580O;Y2Z.;*I2TD].9);HU^Z1H@'!3J3`'`!
MK4H96UB>L?+U6;R)Y*[AWT2Y+Z6;X:UW%>4+FL19GFWXK94NKIMB?*<=KID>
MV9@3W'!8"2EU9S29MV+`^Z/3G"^.2(G#UWL5*Q%/'->7@GFGK.O9Q=5@]+,W
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MCWLAE]GT4A)!]S<E,H](^4:.L:Z>9O(-PS&K?E#_`#:\'BP./)/*0QNV4BM;
M65803C6RV;H>'3FK8W(A`>XF[=&I!2`Z6[1&LZQ8M2HPJ?>:*+%3\:33A\NP
MGQ_!UU=T1&HJXU,^4BH1NTL4:K>16<GN!V9"7"3.BTDX^=I75[3N('8L_2HL
MD*HW20!VB?76P>SHQ.L[K.X0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&!^>R'VO:]G7M:U[/M>FO:]/7U]/7]GT]<#BWU"O=&-Y;6IZ61IT<6IQ0ML
MB;TK8N7L"]6D.3HWI"B>D3BSK%C4H,">44K3GIC!EZ":6,&Q!V'6OC'0/?45
MN:KT`;OGG83W'O)?TWRNV5-(AT?S>QSR#5-QC:DX1.DUE58U2RMRM6F?QE/*
M@I6A5(OB&PC:5,0:$(LCK2VG"FGW7&JCS15#<MZ4344+JR;K&FYHM1RY=(=;
M>%DE@TMZ$IJ.WO`&YSAS3#G%F40)#!90E`]R10_MX6QS%M/\$<'8#AUF;)B*
MHY[5\A5]\U7=Y!8ZG=X\V5%5/"D%F5-2QP9&0\=:]83:$]92R"ZDARI+[MTA
MEB[I$MO#IR$H(+?B6Q"06';D;[8BV)B-YGV?/='F#L:#<W&75!N?F9U8[0Y]
MFEN\C67*;&3%LMTKJRA9$XG'X?URACS5(JF0EQT)RE"68N5G+30Z(%I-O>A8
MG18LUI.^JQ+5WG9VIY;U-Q:F7NS>H45L&QUAH.2VG`H;!8RAB'+O*MO6>@C-
MTM%8@`KB44<N@6S0#GM$XO3FZN:O:<1;<20G2$QCCR_Y<[S9Y0()T=T<Z4(S
M0@QM2"!*4,6F#:]2B1G+Y/`$^S)RS2YH'6;%'H2B;U*182WK?EYP"ZB3Z]@L
ML1H0Z)-M(JBV]/,'$*1M#H.IA5M&+`EE41)9(Z[:X5<Y*I=93BQ6%`:UEL=E
M)JZN4<=JU=%Y%8[>6JWIR?A$C`H*/+(.($7LL65B)17UOY-[,7\M])U_55.N
M$6ZPB'-O=+Y:[<S72@0).93>:ZY@OX43J)V:FB)'SDRF.+[^A;FT(D*-J-4!
M4G;]^08D]DPMMNL5_6L>J2^[^A^F*[??'M`Z(EUN(7.\FZT54R14_5M66S.9
MDY06JHK(XNF?D]M-;H@CM=BD#J,R1NJ`9+H0F,#[DS0A>T$EL129GDRAB\BU
MZOEH6+S[%>1H],[QK]]'!4J(F_6B#Q&PYS7]-4':W0*IN<G.!2!3#XE7:CI"
M,-[88MVM6/@UA@P%%`3&CV,8I$UTGQ]GA4_E@+O=%)@U+S1.9'(6"A)'TBC9
M'";1IG)D%<`3O;;7B9K<PH''>IC.)XPGM2EN,("%F3^RL,/4!%HG9)MI-)3L
M]=*VOT5S;T'/.)&:-O<@8GUKC%`6"ND;*\1BU6H+7`7"P9I&"Q-ZYI0O,/5O
M,C9&U$XA6)%3^P%B4_[L>(H`B(B?R5`@/D$NR)6=&*@4-(+E@4>Y&ONWYU='
M1,K@%"W29=E26+`(695ECUY6M:(8)6BAM=;!9VLX*-L5F+Q/R=6F"+X(U.LB
MS;%*]4?Q3S6O4OL>!)T-*0%JJ*+MG2A_5DE;+8=94Z5LYTI`8C9K03!TRNMH
M.YRQ(N@<U:G%48:UD;,/<-HB=>VD&<=5FRD5YN1:?..%_-6M,>Y=52*0Q:E[
MNZ0L8;5;BQ!"8G1U':JQ<_2)MF<QIZ)"F$K5,=@JS1,R)!K2-4UEIS57^^E&
MEPP9?._-$WUDTGM$]YX416X%E@0N,Q:`N-J_*,8>HI.:=77VT2IQG\4K63+&
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M5V@<B&_(FO2I6Y&J6]X&:`9'MFE;)-L1;UT^ZOE?^06^8S;?53_.=]`VJA9^
MR)GQ_P`X5$*MJ2K;EN035=;9]<55'V[HI)$W"V`R@(B-!D:MU$M0MYFQ^[3&
M["'0BS;%(IM58N?>5)Z@:W\%C^9UCI8D`KKK.Q.DXFGN!B3(:92\F5O3%ER)
MICTE4Q`*2VU\P9N@8K\`)"2A+)"M/$?L(TII6$QKSYN7YN\F<FNRSZJ@,XYE
M,JI):5@SVDDTH0W-&K("SW97=)J^A'V'*&MKBC$H6QH-:H3!A?"S0E:<_1)M
M/]]HW)4FRE>C.^C.@>@*:[9I&+M[O%'?GF<\N]<V`LK5LB)Q]E/5G4$WUE(6
MQ89+E3@<3ME6MLR$D2MR).E,$I$(9YIP=EA*J1$3;UJBBMNV'6C7.)27K6Z'
MM\K*_>=">GV=Z=JP9F])0"U9+*_CZ:D@`J:(_+CTD6D625\&>\%.3GL]C7[-
M6;`'0=%I7]>3W\2]17ET_P!$7[&I':+-'8!S=T5TS`F^'IHA'4LEO:*-=BO$
M>@#B%8O:=JVB!U$T>Y:SE+:,MU=9"D-,7'_#BTF$2Z*0Y_ICRGPSF*_GFG)/
M"H]*6=I@=A2<Y\B-GFN4W122OJ&L?H)5$Y'7P:^VRQD#E$*V/`6H/D@E8!KT
M1HD.R#PF8(MF8K"-J(\OQ-K73`:4L'GSYKGZ7O3!$']O;[+=K2DD+F<P:4;Q
M$FUT:8S4*2+*&!8E<D^E[H)]3@;!&_[0H6M;W@FVD53G?7D<:J.ZKAO,!<`C
M<[<YXG/96!1'+4'^'">RU5=RFPHM"9%`0UZL:(VADB.-@*"O52$"DDMP3*-(
M#"30"$(MK;DKS;GFBAU9PQ79#?5\1DD'8F%E<Y(K-O9(BD8GUHCDB?+T@\.B
MT>K69JI-**-7-K:UK_BC6E`J<7E.4)2DWZ>V6+*^:)V_R)2J,])]+3S\+767
MU]5M+VHQQZM[AL1BK"(NUAPOON\*;3Z9ET*K]X0ISM1V(E-K(9M@=9(M:TA(
M%QZI2$Y0*+AI'CD^^G_*'(ICT'*;M98F\33DFPZA\=[(\&%V;[*:@K$O+J#K
M/EU0[Q"#.$9*,L,B77"RM38[+4XF4\#4SDK3"C-@`F#2;=*<]?M+&N&?+44F
M:N/>8K)9I];UGS*(5,WVG:ISI)9'+T,NOQ^>Q5<XZ8"8@\DRB'$MA03)(^K7
MUI#'DI.Q[(5!#D@NLXS'!L7OCOMNI+JVHN7PPF,RYQN<A0P1=S0V@-!)T-JJ
M8C/)C&89(85J!.3>R1Y^;84'VWD]\`H3Z7EF!;CB@[&*LQ;6*L(YN[WL68\*
MT]UST!3[)#'.=V;'X1-&>"S9,\1F#1637>74`K/7O3PE1`)BL(`JVXO?O!_[
M%N0J%01Z!O181-M+L8177GF0@]FQ9OG[!2<D:('#[PL:L>H7N:S=@B;ARU7T
M6E$EC4&NN>,JUL-,=HW97R`6I)1ISB3D!2H.QFF@#HP8FVG%]L>\R%6."R!;
ME-3RZOH\HEMUM%_2R62-A1,?,D/KU/'7"II_82K9.B7%JZ49;"BKA%2THP@,
M1O)HA'#,0G%#+AXW3ES'Y$6;I-.J3%4Q.J^E$/K"=S6Y8K)7!K4KJ<G$$FSA
M#EE.2H]&2`LZ:N)"#Y53#*#I*:UF@.+$,(L)-M%;4/EQFY-$Q2X9;Q\X1=ZO
M"HZLN/E2O@WQ%'E3<T:LVR*4K#X>629+#2&FG5\;>^A(J>H"M`XA.2+31%[]
MM,<6$N&M*\.+)Y!Y6)%#VR&SR4<MN8:<LS4])K6=QRXHV^/<I<*2B\XL.^4A
MT&615B6,A4+KNJ)2M9C#EFQ2->V$(@@1_'%G@)CIY,TE7DP<(]7,4FR3GAT<
M'ZZ::1VKRY7JZU(HRR6_GIXE4G`R5<U;-:EA$=FPJI0LTJ<"]Z7`;0O(D(_;
M,1F'&DH]#1Y+GRT9,77?-_/R*YK*6P9LEK8RJ;M8(3%#72-J-M70T+<YV*'R
M5`TR:@9+((LVK$PDQBAT.D81E%$%I#Q;+C'&>"IS7YO'14ILJ9ZI**J*:=R^
M<=\U/+W93K$I'*G6ZZ09;H=8Q9:%G@-C*8PI98RY;7%+4R,]/O8PHA`V8':D
M1K#ES;"WGO)M4<^<ZVY6]7/DYGW54V#5=-50\.ZBNB'*SD4.LZ<R%FDLTE,:
M"HBT::X_34B,(=CF8>UWN$ONTP=*P[`9QUF-F`.WD6?X_(F8][Y[4%U*AN*&
M\OVI9;9:C2X.-?=2SF01F%,U9-<"41)M<IQ$4\XFK4A5RDE6C3E$*1J2TIH"
M1APN/757FO/,--I"Q0.;V'Q\96=>R.I.;NCY;)=="1>7*X;SIUP^K(514Y2L
M3?`FX^4S!UG[0N;GB.%&IALY!)2KXQ0$\!>BS9'*:S[-XV',P/'V`>U[?LA]
MOT]/;]G7M>G_`'>UZ>OI@>6`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P(,;>::*:).WS-MK=B22AJMJ:WLWO)0W'XI+;EC0ERKB;3DO0EPBMN
MTBA#NI;C];#LCW!PO9+"+T%HM987!^*>:*REL!FM<5TI@;U6<+8Z^BB>'SRR
M8W&/P4C+&DC$=0R:$-$P20J>+&.--R9N2+GYO<G`A`E(3@/T404``K+(;0Y.
MYSNE!<35:M212=-O0,3@4'N1"_DK%2:>Q6KW5_?:]:7<H*PL!1<1>9.N5HC4
M_N3RE"C9GM[$$&PB)F.#!0<#\B!DUA2PZEV9>Z6C#W>`RY&[OTR>HO\`@E($
M?R=(&>+0AWDBV&5^!^0:T2N.8$#8H6%:T$XP>M:U@RG@]3SP)R:_0!ZK5PJY
M5J-2)_8)4]*VZQK599NODL8KZ*U4T/IMG,TX064!U+KV$-+6>>!V"8M3H2]J
M-FF>T,0BZ8FJ0ZYY<I2I9^^V77D=D,<DTC94T?=4I5EV@X0O;:D^$]WIOK-W
MF;A6[*O&-"6,U8B:4ZP\SVQF&C&88(0K-*(J<?'5QB\3"23IUI!J<I#*W2=/
M;O\`'2J?JF$+M9TLB\\L5P9H@=+!Q&,JIO-H8VN[H)M0I-K7)/M2;[1IIPS!
ME+WV_P"//CF]VN2L]H4LWOB*9R^93F7B:Y;8,,72A^L6.QV)SXJ0.T(ED<=7
M>-S2/Q%J3NC(H.,95_R:E,.2C-(*&$1=,<%B5]1UNYRBLIJOB3<JE--(9&V5
MB]&"5_%0Y#+F5%'9(F;-!4A)$!V9&XA.9[X)N_8+U[.];]=[(B:Q.,N:[39)
MRP3"M_;2618HK9F:^,S">P*2NUB&Q",P%1)RIC`I3&I:TJU<-AC6WGE(EJ9.
M>G0E:,+%O7KLL73'!CC1P]0%<$">J&KJ%U)9;/\`ARX02;E-<B?T,:D$ZCBR
M-KS7B+DS&/!E\.(3+!&%QQ0M):DYWJ<E`E4[T?H93S<E7/&U-P+DY@X[VS;,
MJI!%=Q]]1PM:^U(-Y<')X,E4J?&E16SZP/D*,DDQ5JG$938X%")$I$7HP8=B
MV(5FM>;%G7QT<:/;="6UTI@A457L+G=?Q9;N=6:4^)XQ92IB<9D0[R0B:%2&
M4N[D[Q=K7DNCJJ6NJ!R;4BQ(I(5)B30%REZ6+QP<81YV8Y`BIKXR0QZ6JYRB
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M=HP[8C-BL\&&HN'^7&VC77FQ!5I2.E7::J+&'"T\OGQ7R3.#YHGL4J2Q.1`E
M6I9"7-JG24IU;A,Z]#IL6EA,2:(WK6#*:UYN,8.!.08Q'91%6>DF`IDFS<>U
M2TA:\2UW5R%"IMV27TH*=79XD*]W5F'W!+W)^$:(_P!Z):L'ZB]W[(-"LN?K
M_B_F>K+OD_1L"K(F/7!+FV5,[M)2I5.%K:F;9T]Q^339'&X4Z29=`X85+Y)%
MD#BZ?([8AVO7)]*#]C-$,8A-TS%)X.;D7*'/4JKJPJH>ZR:3H):<[D=H39I1
MN#^T+7"R98\ZD3W/6N1,[N@DT6F!S\'2PAQ:5B%6C4:T8F&4+6MX*SQ<.W\8
M\R-L9:HB34[2J9&:L[6IY(%X>)2_.I]<WCN.;MJ.N\B?'UQD3_\`AWJ(MFER
MQ>J4KQ!1%!">'0?3!6:U9#&>6N?X<[QI_C%7Q]G>(?84EM:,KTICGLYHL.85
MZ;5$FE2;WJ\P&W!XKL\;4;H>A%?#BWL(-#^_P5E(;[6,"DTXA=E/T8;G2<UV
MT31AA<B5:/$K8&>Q2V`F;-Z0L)P4AB>1%19O"?HTLS?HE#[.P^HO4E=*<F$5
M%S;2U$.LX>JKA>HPYV*\#?)4I,D,JD/OU8SU"KX1G)E#X])XHP@5*S30-;2!
M"VEF#V,)&A;]<+,S/%Z6SF.B&5_9)2SUVUM4BCUA6%:;2\-J]\0KD\YMAZ<)
M'8[P<<E="A+D\O?W0]8L0J/>MXU(_>:(T((=Z%91C.N`.1K*L22VG-ZB*?)?
M,E+JX2O8YO9"&+2)X?*J=Z.=Y$\5ZV3!%7Z^4N%1/JF/&NIC6)Q$V"`5[_T)
M)V66+IB*,[:.4*)CUH1ZX8[%7R/3B+L)$::AL%DV>R1(QJ3-/R$2%ZK9KF:2
MMY,X`:=!)^-<FE6MWH`=[-]H`=Z)6:4<(_<5<S26\$?1SQ6PC[?12R.3T$A3
M32P6UG5SJ(Q(4"C4U=H&V2Q'7KY+F:%;"U$N2UJ4+0H222=F;`25H`K-*(ZE
M7C/X;F#%N-.-`L;2R&KK=7KD,'E%@5MIZ'?:EK77.BD9]>2V+JI,RV6N9$2A
MW;W`:E`K/2$F")]LH`@B+IADDB\?O'DIT\"=J29`K'UX,D2UX:'^9QR1$R`R
MRY%<0GYGDT=DK5((\]_.7+G-VTK;U*90$]::'0]%"V7@RECT8\:G$<,FL#L&
M,T:B:9/6Q"%/%329O9AS+K338$]M=E/D<3530^)SA?'[,LY]?FU2^(7%0W.S
M@)2F&4:`H19<KJ4Y,\B7$G,D!EM>S:!UPH@[_5["5&8F*&SVR8LS#8TQAXT*
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M&^2)LU6:Q2RA8"_L5S1"G8#:#(XH%)S-,H;S^X'NE.QUU:OBPH--L%6G[$E`
M467LP("P';-`44$`K+FW;DNBER^R7]JA*>,2ZUI%!YG-)/'761LRU]F-8QU/
M&*]>GA.TO;>D=$T<:$9)0VXT/R<XEE^RL)/]L>]BLJ]<U>+OD_G&CXQ32:$"
MG8T$%I&)S"4RN13YU,E[K1:R.2*,2-L8I!-I(@KHD^>QI._&M;$-(WB7!![P
M!H2P>A9NF9JDU_\`'WQ_*[%>+5DU,H'^9/KRS2!<8[RR?N$:*>6-Y1/A*]I@
M:F5F0-@.=E:`)3OI`V)@OJ`U0B<=*D:I20:3*:4Y./.X<J\-LT/,FILB#56_
M.SS:-A5O6?X%FNCE';DMEY<G*1SF.3UXDZXZ),!"1Y5)TD>;6Q.B2@.]V286
MD+(2%"KF7S@7D5]K]TJ_YF6N-PQYLF4V^Y(J]DDWJYV/LJ<&[/F<L!*ZWD\5
MEJ9PE9WH)Q"4N`0LV`'O0#]@/H(F8U>F4<`<B2U2<M65`G8EAL)B==@5U],[
M%JU4BB4%("BB3>U**TET2.9EC&UEA0E+T@B7#;<`*01XDP0E:&4LFFW&?.MC
MQ%3!YS"WR3,"B+5W$"A.EGVP:_M+95)TK.@[C&Y@&<`ET6F#:7.'5.ID#:N2
M/SHB6"2KEBE,$!01%TQ-7&[X9Y9,G\*LY35WQ\QKYD;F&,+'2:V(ZM!)3.D$
MC9WIYB;E+E42E<U9RQ:&DD+LA6OR50`!Y2P!Q8#`C*:4Y.8#QIS`&.IHEJG(
MMN.(ZLIJDDS0(3L-(55//<E53"F83H(G+8Q-$`DRTU8C]=[-$:/?O1F!^]P5
ME.,*A4=KR-HHE%$RY(QMZEV5I2')\?9&L`>^/#@_.0C'B2N3N\J`&N;F<,L!
MB@8""Q!**T`D!9823-=658#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8%2[8Z1M2N)NOB46X:ZJO!E1HFQ618U6/G(Z&%N9R]/[]
M2W(4UM=3U;.0+6<S_9*=J&4@C9G_`.$PX'W^&HB*<8]7(TUT'9EHRX^-2_B_
MIKG]J)8USN"=6^\\L.$44K4BQM2DQL@BF.F+>E^GMQ)7&*"1&-0$&B4AVC5)
M9FR2SB3$1SB>Z,%O8=XI%R](3XR^Y'$A&O6HR')')>!PHG,A(J-3DN:$*WN%
M&N"A<2B]'$Z/)(/T4,.C"BQ^T`)<8WCU]DM5+?=CV21-S95Q[TA1@XFR)W9E
M3VJ\<QKCK&6G@=!&1V%[J/HZU"$SRDVWE!,$^#94.]K2?84#UH_9))B(YQZH
M9*[-O<PLL8O%YW@2(8`#$49)_'WLPH0@ZWLLS97=IA>Q@WOTW[(A!]=?<WO7
MW<+C&\>OLF(V_;)+I1/:P>.>DSID>_;9S.=RGCE_5R)$.GH]JU)U#B;TB526
MV(2,D+AH!<R,</@S`Z^%^)]I.$E(K2L>J'3>S;W++,,#XO.\#A``,822Y1X^
MM&&B"'>]%E[-[M+*T,>]>FO:$$/KO[N]:^[A<8WCU]DRW#?=CUBIBB>)<>](
M7V5(V0]V=%E2/',2!-"%I1B0`(Y*0W'T=4JH]Z4A4C&`326Z(=!('[2@.]EZ
M&2(B><0BQJZ^N]Q=6EN5>-+M]E2N3JV-RI[=)+P8-K8TJ]<G2*7MU`U=N.;L
M-K9R#A*5(4B54K$04+1)!QOL%B+2-X]?9(5P=$VA64SW%HEQ/U#?3/IF;G35
M@U(]<HH(>)8N.7%*(_I/<?3]2S3Y7:0)`&*!;9](M@4E^Y4&BT:$LD1$\XCN
M]51=&VE9<U3Q25\0]2T2S'-;DX&6):[WR8NAJ52@^'^&93T]0=1VM-]N;O[\
M7PPBV8Q+KW0_?'$_>>V)B(YQZ^S!GOKN[&E[>VE'XV.VY$B:7EV:D4C99)PB
M6RR)&VN"E$ED#*6^=L,SX6SOB<@*I*%<B1+0IS@:/3D'>V4`M(WCU]DH4S?=
MCVDZR)NF''O2'/R5C9"W9O>K@>.8W!LEBT:D9`H['P4OT=;[J4]%%AT:(3DE
M;T/NQ:]%&Q^H-$F(CG$]T-`[,O88`#%XO>[R]B"$6RQR?Q^;&7L6M;V`>P=V
M#![0=[]-^F]Z]?V-[PN,;QZ^R8T=^60JI9TM4[COI%OF+>^`:$O/*QXYA%<C
MTB$[M[;N2-C@BZ064F!D+2+3%^PJYBE7_")3=:3;4;)(-)2*TK"'#.S+V``8
MP^+WN\T00"%HL$G\?>AF;#K>]`!LSNP`-"'O7IKVA:UZ_L[UA<8WCU]DS6K?
M5C5VUP%PB_'_`$==BF9,RAU?6:KW?F1$Y5@L)3LQY<?G0[7Z,K!K5/"HQT.*
M+%'U+ZBT8WJ/;4`!M,-02(B><(A3]BWD>I3$&>,?N=(6>I3D&*U$FX$VG1EG
MG`*,6*=)^Y3U.TR0`]F&:*+,-V`._8`,7H'9<8WCU]DL71?]DU7*4$>AW&_2
MO0K8L84SP?-*<>.7F^,-BY0O<D9D97$W7TG3TJ$^(R$!:HP2=L/0;(6$Z`I&
M;HXHDD1$\XAPM5=*6M8DX:HE*.%NK:397%.YG*K(M!\Y#6PIE,0(#EB9*YIJ
MHZKL^=#4/!Y04R;:1E5%Z/,#LX1)7M&A+,13C'K[,<EO6%S1N526.M7CI[.G
M+6POSLSMTUBLBX?(B\O0MJX]&EDT<)EW9<5E9+&^$$A4I0N;6W+PD&!TH3$&
M^T6$4C>/7V9'7O2=JS7\-/E_A;JVJ_P5@KY+F?\`#Y\Y#5?.&]M'N/@JVAOS
M>=5SWX>;R3WPO@C'OY'80^Z%\4Y)OO?:%(WCU]D=Z[*O7>M;^R_[MU]S]C<G
M\?OKK_Z;].ZMZ]=8,8WCU]DR,=\V,[4Y*[06\?\`1T;ET<=]MK70+T[\R&6]
M-TFAL0-/L67L71KU3)#4(+N>+07:7-:ST;5/^P]=I=*24BM*PAO?95Z_HO\`
MNW?_`--2?Q^_=_\`I]WNK6L+C&\>OLF6Q[YL:"Q"MY+'N0.CK;=ITTEN4B@E
M=N_,J265&J&U-;B)CL0^R>C*\AZMT*5.!J$0HT[2))\4B.WH_9&R#SB1$;PA
MG?9=[:UO>O%_W=OTUO?IJ3^/WUWZ?]FO7NK6O7?_`-=X7&-X]?9,ET7U8]5O
M;&TP[C[H_H5$[L@G5;(Z<>.8V]EC:P*L:;4=>R[KZ-IY\,>1%!T?H2%$M0^Z
M%K6U&C/4&B1$3SB&+5ITY;4\G+!$9'P3UM4#*\FKBU]D6._<<K(5%PI&I>XD
M'OR:LNM+&G1I3DJ1@1$?)[*O'I4I*V:$LC1IY0F(WCU]G&S;JJXXG,)+&&;Q
MY=CV*TL+NI;&V>PR0\3IXC,$A&@>[?8X1..Q89,26E7[6_=A<VEN6:]G?MD`
M^YZEI&\>OLYFN.EK7G3N]-LAX2ZPJ1(U1%_DJ-]L-]Y`5M4A=F8*3:&",Q=;
M=76$[ERR3[4CT@,6I$;.'9`_BUR7U+]L4C>/7V1X7V9>XRP#%XO.[RA#`$0B
MC)/X^]C+V+6M[+'LONPPO8P;WZ;]D0M>O[&]ZP8QO'K[)BBE^V3(ZLGUANG'
M/24(D\-4'$L5+2EXY@/LZSP%H&]8!5!5L3Z1E%5)2#SUIB4'X02=B,]^E-V(
M(2MDFFDI%>,>J'_RRKU_1@=V_P`Y_']^?5A<8WCU]DP36_;)BE<US.&;CGI.
MQ)#."2#)#4T->.7T]A5,,YJ$XC(L)7-ND8;6ZLU,J#I$/\&Y#(`;5;UL(A$>
MIVB4BO&/5#AO9M[EE&&!\7G>!P@`&,))<H\?6C#1!#O>BR]F]VE%:&/>O37M
M""'UW]W>M?=PN,;QZ^R9;>ONQZS%#@Q/CWI"]]2=D4.SN.IGCF)`&`K2=M^B
MXY+OG@Z.J<:AZ5?&&;+$S:=T.OA3?;4!]2O>DB(GG$=V%P+J6X)C-(U%7WQ]
M=A5BS/SCM"XV'.I!Q8IAT03Z2*5'RM(T\`Z_G,V.;]FD!(]&QG<5/O3@;]U[
MO0Q@+2-X]?9[+"ZBMZ%3:21-@\?_`%]:C,Q+24C=8L!?^,$L,EI)J!&L&XQU
M/8G7D"G!*).>J&E'IR9FX_WZ<S82Q%;+-,$1&\>OL^^L>EK7G\KU'9)PEUA3
MC7ME>G7\-K*?>0%D7TL:DP3T<>V15_5MDRSY8D)@MDHQ?)?P03-;^)4)P>@]
MDF(WCU]D=E=FWN866,7B\[P)$,`!B*,D_C[V84(0=;V69LKNTPO8P;WZ;]D0
M@^NON;WK[N%QC>/7V3'!+]LB80&R)D^<==)5H^P5&<JCM83AXY@4SNW#BFDY
MR`WUVJ@72$WK](L4*BM(0;DK['B=*C`[$8$CVCPDI%:5CU0_^65>OZ,#NW^<
M_C^_/JPN,;QZ^R89+?ED,-30>R&[COI*82J6KBTCU1T<>.82;4K<D:5W4"<I
MJNDW2$<J12B*-;2B1:8I2]'^]7$;T7L&E`R"4BM*PAP?9=[!"(6O%]W>/80[
M%H`)/X_/:'O6M[T$/M]V`![0OV->N]:]?V=ZPN,;QZ^R9[1OFQJ]8Z]=HSR!
MT=="V:LY[H_QRLG?F5$]58K*1LJD#!/C+3Z,K-C5.Z@UU.(`*.K7Y%HYN4;$
MH"7M,8H)$1O'JC^&=67)*9=&HT\>._LJOFI^>D+4XSJ82'B11%(@C5FZ+.D,
MC(A?8\OEYS.VAW[9X6QJ<5NP_P#XDY@OO<+2-X]?9S5H=,6Q7\Y>XC&N#^LK
MF9&GY.^"LFM'WCY'"9'\<U(7%1\BIK2ZPK6=E_)*I6-"H^.9$7JJ3&;)]Z1L
MH\PD1&\>OL\ZLZ5M:PYRT1&3\*=7TJRN93F8KLBSWWD%;"6(2!M5+TQ#LFJK
MJRS9T8:\*$X4B;X-E5@TI.!LX1).AG`$Q$<X]?9'PNR;UT(6M>,'NP6@B$'0
M@R?Q_P#LBUK>]:$'VNZ0B]D6M>NO76M^G[.M;PN,;QZ^R9:SOBQI[&+&?Y)R
M#T;3SE!V@+E'H=9#OS,LDMLJQ-SRNVQ5Z=6/1=CQ=([`4-9*38I(Y1Y'\0X)
M]Z/V3I0:G)2-X0QKLN]MZUO?B_[N#O>M;V'<G\?OKKUU^QOT[KWKUU_]-[UA
M<8WCU]DS/%\V,V4S&K22<@='/TP?G@38Y<^M+OS(7<$/2:6/:73_`"-P>.C&
MFECF@1+22HT%LF#BL]RXIM;(]YI26G)2*TK"&ORRKU_1@=V_SG\?WY]6%QC>
M/7V3'85]V/"856\K8./>D+5>9TVE+Y%7D`=^8TLRJ-28TH'$318BBQ.CH#"5
M;B2J6#0BW&GF1)OBDQNPG"(V4>82D;PCB,]:70_R2/,3EXX^TX<W/;ZT-#A+
MI)(^&CHY%$+FX)T2N2R`F,=H222FL;"G/$J5A;FYP7B3E#TG3'G>P4,M(WCU
M]F5VQTC:E<3=PB46X:ZJN]E1(VQ4GL>K'SD9#"W4Y>ETH4MZ!-;75%6SD"QG
M-W[E3M0RD$[-UZDF'`^_PD1$QQCU]G'5QT];DYG$>B4AX%ZZJ1E>U*LAPL>P
MW_C57"HJ6F;%R\I6_IJVZWL*<FIURE(!&5IN95YFE*DO9@`$Z-.++2-X]?9B
M2SL.\4JU<D)\9?<K@2D7+$A+BCDW`X4;B2E4FIR7%$%;W$C6A1.!9>CB='DD
MGZ+&'WA98_:`$8QO'K[):J:^['LA-.#Y5Q[TA1QD29$[LRI+4>.8URFR%IY;
MJ,R.PK=2='6FF3/*43<4$P3Z8RH=B6D>PH'K1^R"3$1SB4,E]F7N,LL8O%YW
M@2(8`B$49)_'WLPH0@ZWLL>R^[#"]C!O?IOV1"#ZZ^YO>ONX7&-X]?9,1U^V
M252J6U@<<])J)DH?A,YO/!+QR_JY$2'3RI:]294XG=(DTD)C$C("X:"5,35_
MP9P-;3:4^VG`2D5I6/5$'Y95Z_HP.[?YS^/[\^K"XQO'K[)?F-_63%ZTKR>-
M'''2<^D<VT3^$%01%YY?(L>J?>MJA>/4_63+I&(UDKVG4DA1C_!R1O\`_O)H
M=A]HGVS@DI%>,>OLB]IZ^NYR=FAM5>-/MYC2N3LV-JM]=9+P:-J8DK@O3HU+
MX[`:>VW1W,:F8@X2E2%&D5JQ$%"T00<;[!0BTC>/7V2#;_15H5E,QQ:)<2]1
M7RSA9VYSU8-2O?)Z"'&*UQBT"AA`GN+J"IIK\K-(4H!J!;9](]A4%^Y/-%HS
M19(B)YQZ^SPJ+HRT;+FI$4EG$74E$,QK4Y.([#MA[Y-70U.J0;3:3,AR>G^H
MK7FVW1W^(%M.(#,-)KW(_?'D^H/;$Q&\>OLP1ZZ[NUJ>GIJ1^-?MR0HVIY=6
MM'(6>2<(%LTA1MS@I1)9`S%O7;+.]EM#VG("J2A6HT:T)!H-'IR#?;*`6D;Q
MZ^R4::ONQ[1<I(@E_'O2'/Z9B9"G9N=[?>.8W!NERTQ0:2*.1T%,='6\YDO1
M)9>C1"<T[<A]V/7LJ-C]H.B3$;Q*&B^S+V&``Q>+WN\H0@!%LL<G\?>QE[%K
M6]@'LONP9>Q`WOTW[(MZ]?V-[PN,;QZ^R8DE^V0II5RM4WCKI)#,4#Z!G3\\
MJGCF`5R.Z$3N@;-R5N<$G2"JDP,8$BP:_85,Q3K_`(1,;K2;:C91!I*16E8]
M4/\`Y95Z_HP.[?YS^/[\^K"XQO'K[)CD5]V.R5%#++;^/>D)7+)2Y`0O%$1]
MXYC*MBODXR7HW;O,%TCZ.8*?4-Q8VHDL6F65O"GVW%/Z$[#I2).2D5I6$1I>
MQ;R4*DJ<SQD=SHRE"I,G-6J9-P)M,B*//+),6J@INY%*H25&`>S3-%%&F[`'
M?L`&+T#LM(WCU]E],,F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&!J+7>7JJBZXJB4-%3S]ZL.T&WK%U-I@#I%T$Q@J+DB'SR03!7-%JM>%F;$<
MED$99F-N-T8(/QLJ0#,]"0GB`:QI.LZ/UX\M<*CLEA<2=*7E+D]3?E([IIHW
M!Y_74\:7!9^$3/%T5:,#TPNXV^2+'!V?"2RWM,/Y(T(H_6S/4@>*KC_KSEGE
MB8X@@*7./,UT;`AADF<ID9I9#RT$*L2/%=.C!7KHZ#=O@U;<JUR1+##I*GV-
ME1)1MIYIGNUY7I*IBR6<^4NNH?S1S/T<GKUS=2^E!PW397ZR>P.-R*)?A<T:
M>2T3FM>7,MM=G_1'J4A;D>QJ78_T+3:%L6LICK1^S7RCUY`)"_0>31!G:IXU
M]&-O/K<RN-SU@@8W-:J):')Q=5LU4.6HY&Y&RL+RG6'1A:86]"TH3E@!L9X-
M8,9^CV'^2%\C<WL"(63S%+($WUM/6=A?YH=;=12&*GP1<A6J7B<,ZYD?SAN<
MCBR@"(E;#RP_A*'3B28%/L&A;T2G!9[GCJ1HOU]L".`A[C"76&J$3DUHG-_C
MKXLD4"?#EI$8F*Q)'U:L^&K'DQM4:&R.FB'5'[O7OB@^UK!,+480P&`P&`P&
M!A\XL*`UDQ#E%DSB'U[&2U)"(R13B2LL38BUBKV_AD@W=^6H&\*E1[L7NR]F
M>T/V=^FM^F!5_P"T:X(^F-S?]S>];_\`]O0K]G6_3?\`_E_^_"XW;2?:-<$?
M3&YO_&]"OXWP8W;2?:-<$?3&YO\`QO0K^-\&-VTGVC7!'TQN;_QO0K^-\&-V
MTGVC7!'TQN;_`,;T*_C?!C=M)]HUP1],;F_\;T*_C?!C=M)]HUP1],;F_P#&
M]"OXWP8W;2?:-<$?3&YO_&]"OXWP8W;2?:-<$?3&YO\`QO0K^-\&-VTGVC7!
M'TQN;_QO0K^-\&-VTGVC7!'TQN;_`,;T*_C?!C=M)]HUP1],;F_\;T*_C?!C
M=M)]HUP1],;F_P#&]"OXWP8W;2?:-<$?3&YO_&]"OXWP8W;2?:-<$?3&YO\`
MQO0K^-\&-VTGVC7!'TQN;_QO0K^-\&-VTGVC7!'TQN;_`,;T*_C?!C=M)]HU
MP1],;F_\;T*_C?!C=M)]HUP1],;F_P#&]"OXWP8W;2?:-<$?3&YO_&]"OXWP
M8W;2?:-<$?3&YO\`QO0K^-\&-VTGVC7!'TQN;_QO0K^-\&-VTGVC7!'TQN;_
M`,;T*_C?!C=M)]HUP1],;F_\;T*_C?!C=M)]HUP1],;F_P#&]"OXWP8W;2?:
M-<$?3&YO_&]"OXWP8W;2?:-<$?3&YO\`QO0K^-\&-VTGVC7!'TQN;_QO0K^-
M\&-VTGVC7!'TQN;_`,;T*_C?!C=M)]HUP1],;F_\;T*_C?!C=M)]HUP1],;F
M_P#&]"OXWP8W;2?:-<$?3&YO_&]"OXWP8W;2?:-<$?3&YO\`QO0K^-\&-VTG
MVC7!'TQN;_QO0K^-\&-VTGVC7!'TQN;_`,;T*_C?!C=M)]HUP1],;F_\;T*_
MC?!C=M)]HUP1],;F_P#&]"OXWP8W;2?:-<$?3&YO_&]"OXWP8W;2?:-<$?3&
MYO\`QO0K^-\&-VTGVC7!'TQN;_QO0K^-\&-VTGVC7!'TQN;_`,;T*_C?!C=M
M)]HUP1],;F_\;T*_C?!C=M)]HUP1],;F_P#&]"OXWP8W;2?:-<$?3&YO_&]"
MOXWP8W;2?:-<$?3&YO\`QO0K^-\&-VTGVC7!'TQN;_QO0K^-\&-VTGVC7!'T
MQN;_`,;T*_C?!C=M)]HUP1],;F_\;T*_C?!C=M)]HUP1],;F_P#&]"OXWP8W
M;2?:-<$?3&YO_&]"OXWP8W;2?:-<$?3&YO\`QO0K^-\&-VTGVC7!'TQN;_QO
M0K^-\&-VTGVC7!'TQN;_`,;T*_C?!C=M)]HUP1],;F_\;T*_C?!C=M)]HUP1
M],;F_P#&]"OXWP8W;2?:-<$?3&YO_&]"OXWP8W;2?:-<$?3&YO\`QO0K^-\&
M-VTGVC7!'TQN;_QO0K^-\&-VTGVC7!'TQN;_`,;T*_C?!C=M)]HUP1],;F_\
M;T*_C?!C=M)]HUP1],;F_P#&]"OXWP8W;2?:-<$?3&YO_&]"OXWP8W;2?:-<
M$?3&YO\`QO0K^-\&-VTGVC7!'TQN;_QO0K^-\&-VTJDZF7AF)6/KFU]`4!&W
MF0MQ#8LD$.ZGD$*DJ$HAGFK%\;&I)$K/97V'/BEML)UTH<FA0A<%1II!QQPS
MD2(Q.6E^T]G$OCMX4I,A3M4COB@GUJ)B.H8J:G?J^5.+6_(P*$RQ/)9<VJ[5
M-136T$2U&4>GF3N6MER8\L)A3D`>M"P4OCA$O@,^PZ,4Q=<*W>9@KX;'#XU'
MG`KI9V(<4A9RJQUY<F5+R;++6.]E-KC<4M5(9:L&HE+<JDSH<E<"35ZD9I?S
MZI.KNXO#U5#XPRR!7AR>R3A@1#;P6,=<S$]V?(4PV8V/ZW/[.?Y4Z3^SE)3.
M=L@H^1N3J>4'0=@&$00BT2E^TL;43WP]K4;@D<.HJK<S7:<@L%S>G;M6QG65
MKW<"E4ITPJIDXW*IEAU8C$L,+'#-K=Q`Q/O1`FS9(0@T6E^T]GV/MB^&F3*(
M>H?+PY>7!@MS+>AF)%N_24[0HNA>C`A-G\I9$LY(9YV[D)BB])@/A#BF1B)*
M&046,HL024OVEG=0])>*:B5UE.M7=+<W1]YN&?/-GV8^KK]0RM_E\V?AZ&O=
M7-^F$R?WC24H(=%I$!1Y;>WD!T4E()*UH&A,73QB4U?:-<$?3&YO_&]"OXWP
MF-VTIRJWH"BKP*4FTW<E7VGI"G+5KRZ_G<9EJEN3'&[))/<DC&YK53<4::'8
M0[.`7H6_V,$Q,<4O80P&`P&!U=KFH"!^2WSR7/S-UR!RLCFGC+E"G[3KVA%3
M@L3UO*IQ;*L!;R^SYG2J4X'U2UCUK:3VO78=:UKUUK6];-UQMTXS\^S9T#PA
M^)0```!P%SEH``A`'7X%`WZ!!K00Z]=JM[WZ:UA,[MWE]B-XEOH!\Y?S*!^^
ML&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*
M!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y
M?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH
M!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-X
MEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]
MB-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=
MVY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^L&=VY]B-XEOH!\Y?S*!^^
ML&=V[P'X2O$D7Z>WP-S>#U^YKVX84'U_^WJKUZX,[MW[OPD^)+0@AWP-S?H0
MM;V$.X65[0M:_9V'7Q?KO6L&5VY]B3XD_00OR!>;_9#O>A;_``++]`[#]P6A
M;^+]-;UO]G!G=N_->$OQ([!LS7`_-VR]?LCU#"M@UZ?L^HOB_3!G=N_=>$CQ
M)[#[6N!><-A_9]K4++V'_P#3I5Z8,[MWCKPF>(_>A"UP1S;L(/\`QBU#2?0/
MKOTU[6_B_0/KO_OP9W;OS7A-\1XM>H>".;1:]K0?74-)WKVM_L!]=*__`!;_
M`.[!G=N\A>$OQ(A]KVN!^;@^SZ>U[4,*U[/M>OL^UZJ_N>OI]S!G=N_->$OQ
M("UK8>".;A:$+V`[U#2MZ$+]GV=;TK^Z+T_[,&5V[SUX2/$IO>PZX$YPV(/_
M`(M:A9>]A]?NZ]=?%>NO76#.[=X:\)?B0%[7L\$<W;]CUV/TAI6_8UKU]=B]
M%?WOIZ?]N#*[=Y?8D^)+[W__`(&YO^__`/!__9A7W_W/7[W_`'O[[[G_`'8,
M[MS7A)\2>Q"!K@7G#8@^GM!U"R]B#Z_=U[6M*_77K@SNW>(?"7XD1BV$/`_-
MPA:_9"&&E;%K_P"^M*][U@SNW?H?"5XDA:%L/`W-XM!]="V&&%;T'>ON[T+>
ME?IKTU@SNW?GV)?B1]CWGY`_-WN]?_O/P-*]C]G6O_%\7[/[.\&5V[S^Q'\2
MFM>N^!.<=:]/7U_`HOT]/^_U^*]/3!G=N]>_"=XCM:T+?!/-F@[WO6A;AQ/I
MO>OV=:W\7Z>NO7!G=N\@^$KQ(C^X#@?FX6]AT/7LPPH7WF_N:%]Q7O[W?_?^
MQ@SNW>&_"=XCM>GKP5S9KU]=Z]8<3KU]-[UOT]5GW?3>MZ_^^#.[=YA\)7B2
M'OT!P-S>+?IH7H&&%"W[.]^FA?<5[^YO>OV<&=VX'PE>)$6Q:#P/S>+8?_%H
M,,*WL/\`^UK2O[F#*[<UX2O$CL'O-<#\W;+_`&?>:AA7L>G['K[7Q?L_LX,[
MMWZ+PD>),(?:%P+S@$.ON[$*%EZ#_P#IVJ],&=V[]UX1_$H+6MAX$YQWK?W=
M;U"B]ZW_`/;>E7IO!G=N\=^$OQ(A]K8N!^;M:!O6A^L,*U[&Q?L:%ZJ_O=[_
M`.SUP9W;O+[$CQ)^UH/Y`O.'M;#[6@_@67[6P_L>UK7Q7K[/K_VX,[MWCKPE
M>)(0M@#P-S>(>OV0ZAA6Q:_^X=*_76#.[=Y_8C>);Z`?.7\R@?OK!G=N?8C>
M);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?
M8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G
M=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?O
MK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R
M@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.
M7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z
M`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>);Z`?.7\R@?OK!G=N?8C>
M);Z`?.7\R@?OK!G=NT\>1KBWGKQ==*>./KW@VO6WF>1O_5D=I2YXG5RA:Q1"
MWJVGQ*@M:RRJ-_$&MK@ITL'K_;C]!!(U[(/9%Z"U.#5MTW1,7;.VIE<S`8#`
M8'7DYM_U)WDE_J&\E_PD##4_K'C=V&\,F`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&!UH+V(Y=L?R6]GQ3RE3`,?K*O:=H1[XICU@S&5Q*MBX>YL,^,N&RJY`@5
MHV)5=#;-B=(S5278WY*B*3:(U[L8LG/5TBL6Q-N[5Y%VCKNW;*\3]I-\HEX^
MLZ)XG[-O*G&Z;N#B5(;I@5;WK'2Z_@EE;>M">S06W4Y!#<H4':TIT!2`P>_:
MWO#4XQ$[5915=^H+@YTB%@.+U/X+X^.FO-%V;)NO9<R/<KALACE6S1V73&DH
M39"V(F)95&X++9@[Z12303""2!IRB56PE#%A)TN_]4A>_IR.\1Q"<<!4Q7LA
MA\6\3$XN6_0=);JR;O)5'/%W)ZD5K*I@5KOL6<CVE)7T@>2C3E:)6<!G4N1*
M<*K7W^_5_B176?\`M12NRI^Y0J;7+5//]BV9'?#09VWS9#;(MBM)=80VBLX8
M^UJTN%U0^M9FUC4R)GI];9!@4;N8S#VVH1&F@`+0-[]341'_`,Z2PCM&Q>8H
MYR!Y6N=^>.=:"JR,M%,\[VL7==%7J=;,#M2)O/:=<1*.:L(U*E;D<5LY0%&>
MM?$9YASH0G4D[-.%HT/H+:Y1=.O_``D6Z^=ZS>^2.+Z:JB4<=5;)[I\H'-S)
M*9OX]'20)XY'Y(Y1/9,)>),I?9?*GTBT4#6$.A>BHL`R/498-;$+!$S69UIC
M/%2;K7H-^Z2UY!76X&*.0>XXK;/ABI'HR&3W2ALKEJMZ#V!TS![%$\@(7I%@
MZ;EKBB-<]&E'$&G1E=K99@1>AFBVQ2GU;G.BH#0=<>*V)M-4&<N,?3;9TVUN
M_%`O'SM0LA:KN=7(VQ-$$M?H9.^3!PT<[IA?#3,DU2:05'C5?O?9+PQ69NUK
M3G79>/PL/S/**[Z0?+.7J#N^S^BILD[Y9WT9'R]$K:;S@)(K%HZ062F"73+5
M7A3;J&C(!\,:SB`/0A&[-%M"7\8I^M-'7NY(Y?MA_IWR<]:Q@,1JVG:[WYNH
MK:TFCTR<76:]3J9(RV.UPV!SZ(^Z)88O'*.=RC7MN<!F*%QJI1[HKW!(S]''
M3*)F(XSI]$JQ^;]%P:+_`.'7G744FYHC_.,>F;%(:S=:Z*G[7.F]G9N:7A;M
M5:+Q,)>\19T"?&"Q".^34J707#V?9]DK?N\,Z4NQKXEY^-7K":Q/O,CMF^(9
MT969'E(Z#E%:@5V%68XY0:^GY!$8DOX6=4EBK'LXA+/6-#$W=E$C^'+"Y%R1
M/Z;]I,'WA;HTQBFGB42^/%B-CW8'/%@KFECHV-SGRF]PPI5U/')F>JE5]R"+
MI):%EX^M",%%HFV,Q9X<0;`TJUIZ\:\TCW"<M,8;ZC$_KKM#&>1+.LSFJHI[
M2L`5.#JJ\R%EW/7U(JTYXSD<?O\`AO6MH\^7*G4*/>"`A0H^<HXUN6C`_L*M
MZUOT^[ZENB)F)GE'V>F&.<27>/+GGQ.L[3=EJP>7=6==+.@TG/$2/LNSV;G'
MERT%43AS@:PHY`QJBAR^X11<8#!J2_4A$J%K8M@V$3H?]IOTB=/5>%1VE9E^
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MQI,03'=%W9WA9\P;XN(Y?HE<FCDUB<\TJ$C'H.C`+OOM>N.343,?_92NE/LM
MIUC'9KRGU]Y-85P'#A0:3UCX?>;DM:0VJR/D]U@L-7=+RDFQW^O&A"$9J>2Q
MB`+GAS;`)P:-$X)R_=[T9L.\)%)B,IYRF6Z;?\>7(O#L]DWC8=6FS^H^J(C7
M]!QW<'E+W95]V,_6<X!1;D\]99,]F2]XE[4U'."L\YST4XE#"$`Q`!Z:T2(N
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M(7V%T#2S"!WFW<_$'B$MNGH7(3=Z)47">V7&^O\`1%K,IGN_<+I-+:3<6UT6
MA+"/14AV:FW]^'>M.9IC%?UF6SWQZ2WQ,432L'ZA8;I@"&Z5E)Q91T7;UGV7
M(7"Y%T@E3Q$6&9#NK\,G55)DSI\[KL4W$DN)(0(E1^DZ302=ZUNLW93-)X-_
MJ=00K3D*TQH#TRHDI0G.+W[19Q!P`F%&@%_V@,+%K>M_]V\,/=@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@==K_$+_`,D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!@
M=>3FW_4G>27^H;R7_"0,-3^L>-W8;PR8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8&"3>K:RLT#079%=02P2X^OTZL`)O$8_*P,;IH&R].30%^;UX6U?HO?L^^)
M]@SV?N>OI@<N=#8@HD;9,#XK&SY<RM*Q@9I2<QMADC:6)P,).7LK8]C2B<T#
M2N-3EB.3%&@)-$`.Q!WL.O0(%O2=<J<=<^VK:]T)*_J;GJ-IU\JMA8GK_:^/
M*=2!P3I'1S>(9"XT\.<K<GMQ7%Z4:*;UBI2(>Q#"+6A;T-99#64'YHFM'LB*
MK*[J-PY]LZ/H96U1F/U]&F^NI4PRE&G<T[@KAGR&B:COE-,:6,XM4C"=H>O9
M-`$8=AT6:UUXI49X-"8]%BH,P0^+,<)(1GMQ,.9X^TMD6);U6S-J4!4?1)"&
MDM&HV</9A6B=`'L6_76_7>$1\V<V<ZLL;D4-9J"I5IB$P-"HEL5;*L@R"-R@
M\"Q(X@.D3&E8BFQ[-"X("#]"4E&[T<26/_Q`#O1:SQ><5YQYY@J4E#"*&IB'
M(4\I;)R0CBM70B/)2)LRIQ)&>8DIVAC1DEREI2BV4F<`ZTK(+WL(#`Z^Y@K,
M\95W8I5R==G4/57+#ASY%7FQ:TB=!V)=L@F-65LYQ.RTED(YV56WOG$\QT?)
M<\0])%G`H6W="2%"!4$*4PP)AGLEUB(GDX&BKN\;LMOJR^/Z%2TFBO#D)X7S
M:<U5&Z7'!OFB?7I$T('>8L#@K@4?B`G-P02)(G6.3$L4&#+4:+.,]/:#H3%U
M,IX2SWC[J[BSLTNV;>Y`ET.L@UBFZ:L[<G\>K^10]V7S".1YH<6]E>GJ5Q&+
M.TP*:8X\I-I5)0UJ(LDS191OWH@A),3'%9QMK>NV>.O\0:(%"VJ)RL^0*I3%
MVV+,:&.R55+/??A2I?V1,A*;7@^2_$&?*`U!1@EGMB]]L?KOU)6>/-`EGN'*
MZ)`\UG(*ZKRT9!1-9&6>VT!&ZYC-ASF.009"Z/H%,%J\EL6*4GR[I`<VH2$9
M!.U>P[(+UL/W,+K]$K1QGKFVJLK1>Z5:D31!:Q0"=Q2N[*KQ&T.<"4IFUM?8
MDC<8%(&[VX1,8.(91>DNR"53.L(V6'W8R_N#A/5R(*;J$I`D:BZJK<MK03(5
MC(6T$&C`$"*PA+/E$4[2(PM>DZ>9"<-^_P!N@`Z7;.^_][[7W<)67XFIJH$8
MHD-)5-;)10%Z>Y)!!)H-&"!0J124Y2HD;_$ME-8=QQZD!ZTX:Y4C]R>K&:/9
MHA;$+>Q65;.BK1YQX)@Y5UBH\I1)9K.8=343C=%5K"B;1LZP+?FR9'&8$RJC
MU$/:35DJF"[XD?RFZHD0U/M'&&^\]-[+%;F07'<G)W+=:N]LWBWQ.H6&XW=G
M(EK8HKD;].++FK\VDH4D>=H/74?E<MM":?)Y6DHTZ9(['^Y)V'6]DA]<$1,Z
M0X!LAWC\EL=IF%DU1S8>Q7.FDLWI2N7ZFH6S'RPI`UM;S-)'':WD<1;W-(I;
M6Q0A,=SC&\@Y-HQ.%3L(A%AV*W<=4_N-`4.\1.+P)VI.HW2"P?9&X5"W&MX:
MMB<0VE$$:;<7CBEF-9X_M.,.M@^$))]C>M;UZ82LH4[%O*B.>H337SW5D=8D
M3LSH2I*0A,>;HA#I0@C]A2X]S.@\E6M4M<FEM;&B,J&`1GQ:3WRU&/W8DY(M
M^OLEB)GARA]MC7G2E0]8\[U,[5TK.N[KI!8T2BME,$6B>]I6.E8*^VLY,D]E
MJES;Y:%CV@:U&FU,G(<"=+S=>T`D(A&Z$1,Q7E"66OGF@&24;F[+1M/-$TV[
MBD&Y>UUG"V^4;?A%"($][?TC(4Z[=Q$"V#:GWOOMAWO7M>F"LH+F-F\X2WLM
M!R/-Z;;IA<$KY9E=L&3.2P&"2"*J*9CMIPB,NU>.;X[JU,H.$MFLB;W(#7MO
M,:C-I=GC-">66$0UI7JCRNC.()5T#T-PG%^4ZV97&G&"I+?L=O,I&HV^I96I
ML=L<@1!T;F]N+//>92R-[>:0<>O:DXDX!:`2<8'>_0LY4BZO%<%AHVIHO:<E
MNR/PAI:K0ET$AE8O\L2B6A4JH!7BV0.,,BB=`)4)H:VEB72I>86!(G(V,2C?
MO-CT$&@DK-*<G)KJAJ9S%*!N57UVX#G#JPOLT$NA4:5BE[W%CR%,8>)0(]L,
MW('6.*4Q9B!0K]\<C&6$10@;#K>B5<[J$PS4L_#W41C&ISMG#'OPTTP-6I9\
M@`.$I"Q_A%I)\L?(X5`MF:3>^]SH>]B]GU^[@8"OYRY[='"4.SG1%-.+K-PI
M`31S7U?"%CA+PH'%(\(0RA:H8S%+^%$[H"%16E8CM%J22S0^@P!%HM93$666
M26`HH`"BB@!++++"$!998`Z"```!UH(``#K6M:UKTUK"//`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`Z[7^(7_`)(^/+^T`IO]T#R2W9S\I=B7*P8#`8#`Z\G-
MO^I.\DO]0WDO^$@8:G]8\;NPWADP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP-)GE?JOK'J.S.3>;*!J6)RVK&66/'1=^R6YRY4V43(4\`3[CM>TU(9#$#=/
M:A?)7:1K7-2@(`(?NFY,9O[W>\-6TBLRULP;F3NA+R33/#MNTS91:SF[RJ4$
M29,*?)D""O))QC8]BK)C)'J"3'XXEZ6PVKV!\=&IZ-/W\0WD?#Z-UL6_N1NM
MLW9;QZT<RAXPZ--0U%S\HJ"]$O/<"\U-TI6=C(4R%,@C_";@WR#<=7A>`.GR
MD&EW$XTLH@P1@@B`;[&M:UO*E8F:_P#GU<U45)]@TI'N"K!=Z'Z`F$.XZ\A?
M>#""JVDI:YV$W\U60R6?67.#FSLBUQ]Z_5HSZ?T!P%)PQA1-6]*-^@2_746L
M5GAK"C+CR%W\Z<MTM4<JYEO%EDU?U'T+,*FD\4AD>LV>D]`K[97R]AADS<9R
MO.9*7;!L@PF,\H3_`.^*3=:))WK6]:QJM;:UWEO!\9-:=*M/6-\7%T+7D^CC
MK9_`WBZ:GR93%F$V$R:Z(?5-C"N]B][LP>AR>)2Y^T!W(]/5,H4:#O>_7#-U
M,:1O+6)=W'_>4(Z`[SZDY7I24H[HM/LB>T,RO#@PF%!E_,G1W/+17X;?9511
MP3'*+4S<I3/(CCA>@"P,QVMZ]/7"UMF(B>%/\^&+2#Q\]:TA5G2-04'SXJ=N
M;8UY&VF43&I),R3PM'T5S9%>7Z=AT1<8^P5DM22^Q(:38#(M$Z-R(P)RU4G`
M+6M^X%@RB:3,ZT^[CKGY)\GKM0/*K1/(Z^7?5S35%[,S1$AQ7H,4UHFSIU8[
M,NI*8KJZBCNEM$Z:4O#C%**,NKN<<D8T27_>->],+P1-E9HEN4\`W?`>B+=M
MB9\_3:W+IOGQ/[A`+_JR/2%<UG]E(V)<1:J]Y*6.!;S7[W8;4,A.W_&>HE9H
M1EA]DP>]X3+\:?\`IC70/#_4D\BT9E)%/=$JIW3?@'Y5C-5IX^ND:`:#N"N)
M\]/.HR8A2.A93O<L+(WH0B#_`&C`)UIP1C$$W>L-5MK32F4]E:O*$EM=.#N(
MB\XA<LSZ)LN+<=LW($VALK7M26!5_)$T&9[&IA:W-+B4<W3223XQ<8ZLGPXE
M$@"<'>AZ"#[KS2RD4_GF['WEDJV\[.K^@05]&9O9]%Q2]VB1]?T;6"Y0@L:X
MJ-)C[TE,C<=*2*D2R1I$$E/2*ES(2:`UU(![`=_>_<K%M.?&C2S/?'-;EV5!
M`BIES/:BVBR?*CSD]\R\_P`X-=G6R>?.()(Z01IZ*2S=`)S-5PZ"OBAI5+MM
M9YIBAD1`WO6];']V-Q=$36-)I/=N,\KE$1.84G3:YCJGJ*1671,S_"KG.=<@
M-B=^M:C[!;HV:T,4A+97-2%N=8RYI=Z;5Y:P!R?X8P6S-:UKUQ+-DS$\J2UN
M7SQITM:$P\2?7'5G,R>U^EX7"+,KKIITIAD,>_F_LY^5,+MR/8,BB+6K3$'Q
M"I)H-4YR<U$'X1"I./'L(TP2PZ-91$3;;P1;2O*/D`1/M$HJFK2\Z-[?B*>W
M==Z=:VE)%SC3?0HGB#S-OB0(P\*'-8U688MFZYK5LXT:<K49))]!_P#A]<J5
MMUVY.'E/)71<I\?-)5)0W-/0]'=O1KKSD*2=#W%:,973M#*KPC4)L)JF_3;>
M[NKHO03JNF"6*2E:MS3A+*(2K4X`@V,K7I.358BZ9TFVD^.B4J]X>F-T2OQB
MUC=7*%U1R,UE:'=;/VR\RA7)5[5,Y]**8F*(RXU=G&.FG>1UY?LL/2A:SM&:
M#\.H"V;T$!.M94RB*S$ZZ,*9J`[>=^6/'BEZ<I'I6XZBKRA+X@EJ<_,!KH5<
M+'T8;(G1'SE9$R:"').Z.\?B\5)3)T:X9Q@&11K2PS6]"^["L93,4JYJ;\D>
M4MT;H@7L,P6]6I/"19=+/=[-SEHAL'>*_J:EY>566[%+,T3NT'JE6-:WA7Z]
M-*%Q!JOV_N^N"MNM>%?=&D)Y+Z^W&/)(/C7FB[>8PV?SEQM$JI9KL%(HF_25
MLAH]@Z#AL6D1#DI?6F2.D=VK2I@%F@,`>?O8=Z]]K6A,QI6:TJ^:I^'NM;*?
M>7858576A!N4I!W!+'%^I:N8]>52M=`5&GYJ+9G](-18KV.;M54S^THVE5E>
MAVR37)P5A+T$!VMX)F-=Z+U<)<\VU47DRL][9:.N*854Z$6,FF?374L==XC9
M4$3$(6EOKJK*9EY"\;'>=1[+:2RDQAA6SVXH8C=[]O6]Y6;IK;#L=X8,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#KM?XA?^2/CR_M`*;_=`\DMV<_*78ER
ML&`P&`P.O)S;_J3O)+_4-Y+_`(2!AJ?UCQN[#>&3`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8&ISNCRGL?#O47)?/DFIQ=,(OTDM7"EMM)YT1
M'T5+QI`[$,9\J=HN9$G@<F;275P2%&^CBW:+VI#OVM^GW8U;;6)G9P[MY;H6
MU>2I[X`'52L45B582R=3+I`<W#IC8))`8>7/9O`]0!-#UBUQ6Q>*NS0I5*"W
M;0PZ=2PZ3^T'T'3'\<N=5E4ODIXE40I^L(^\T#+$XO.(;7<D72F%65#UK#)[
M#=BF.$A=V&50QGD#?'Y,ZG@)2O1J4+,9L>M_%:#OUPF,I^9;\K:8R>[8!7CV
M">V1S\)K065"&0A80M99+(HD1-8Q%!O+FE11LU\?&%:F.T64K,^%"I+^)]U[
M6L%)XM:\$Z;@TA[QB]8=9<#UU0O1CW3TVM^DKT5O5:7+)1576ZQ"FE`I98"6
M`QJ14\K:MKP"TFVN7-Q@M;"4K&+6_0LQ--)_%*/`ODRCG?-H=/0J(5'(X%$:
M#?(05#)W)7X"@^YH/8D>U*H98[7%-Q]L4Q2.RJ-GIG%M"<K6&J4*LHT?NA;V
M7H3;2(ZK0])VW?\`5S:RF4'S.#HIW7%.BUY)<[@CU-1Z.H&H2`0@*Y"\1N8*
M%#JYIU1PD9($&DXA)A:/4I]""/"13FU3-WGIKN<5VTV73W.4^L)DB=#)^DNE
MD*Z8L<0>J-JTR6+H8<H9D:IF=";2?].32K5ITQ)K2E5M1.E):KU'HK4:PF)I
M.]%IIWY1&".]E\:\J1*B;!F,0[`2+W%BZ25.C9&JK;D?S-O=T,A,/)$D>76R
MG15'VH@*\LOY+3-NEY`M*%`_;)!4BW29F=8>U\\CTAA7=L)XVG=!LZ9GM.4/
M43KR?0&^XE9ECDJ&B.+9.3*;7YY8HPEE51UR[MK>;\,]KG105L6@Z&6'V@^H
MQK;DVF89,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@==K_$+_
M`,D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!@=>3FW_4G>27^H;R7_"0,-3^L>-W8
M;PR8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`U+=R^.!Z[(Z%
MB]C.$CAB2MFWD#H_GEW8'@EZ')PS>VG"(O4!FC*:B1FMQ2"'OD4+4*-C-`IW
MO0=%!%K8LC5MV/FH#$?"3U.UP*AU+CU3#63HYFJGN9OZ'Z`C;?(G22S.Z^J6
M"H8?$YK$=/3.D">S1N'5$C;G#3@`@X)9@AIRA;WO65K/2E--$?N_B<E7/L*[
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MRXWMFE#O`>>JOKH+%94GF3(L109KE$U2*6-&QQ+3*,9K:RG!T82;L)F]1)NB
MZVD\H6_\I7,7=O64-@-3\H7/3]4U,Z*GG?2;)8"B?LLHM:,^^90M=<L,N@;(
M]+HU$9&W;<T[\8`(%9Q)I19.]:V9L-E+9MC6>*D3]XBNH9.W31:VR_E*EG?H
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M!@==K_$+_P`D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!@=>3FW_4G>27^H;R7_"0
M,-3^L>-W8;PR8#`8#`8#`8#`8#`8#`8#`8#`8#`T56-UUY/(SY)(%Q`P-G#)
MD5M:`V3?T/F#Q$[U.D3/3%>V0TQ<V-2$I%:21N762X1]Y*,"M3$$MH5FA;^&
M]WKV,-Q%LVS.M8>CACRHZE5J6C0W3[Y,ELXD?>U^\\45.2*T:V:J4C?#V".R
M"!4\X3*.IFU&HG;@V$O"E'\2G/5JRDQGOU&M@+UL3;I6-DD\\>5"J5K;3U?3
MVPY?>]UWS=G1T-@#?`:*W7CLFAM+W!)*^?7Z00U=-'8*>(UTH:PMRM[)5FGN
MHB=JRT)83/=@)-M/*BZG57;-1<A+ZG9;(9[)DLFO!ZE4:J^*5A"SYM(Y7)HE
M'!RE='T+<0M1;TYK6DHP24(Q!+,$6+VA@T'8L)$3/!7%U\Q'&B&*<^2YI7VC
M-$?32><!K!I@U:/,DDAK[6A@2)_$)"PI#0KV&51!3HPI>G-#L!`B1[V9[.O:
MV7&>S)F#RM<FR6U&JM6M98HF2362^4K![P4P56EH"P+ICJQ[;'6IX99IRP*%
MVF93M'5B,L`B2D9ZH@19:@8M83&49.WFKX[;8K,Y(F9;\?G*J8C;LXO*!L-1
MKED^H./TJ\(&67G7$PG.R4F(J%A[FG.:ROB#QN*,SX@O_9`,$"57&:T76K#K
MJGKDNJ;T97:J02*25Y659VG*9(E9=[@2)EMU!MZ@S(7*-*=E*)8Z1P13IM$$
MK_9H#RC=C^_T'*DQ,15K\C'E@J*LDUEMUMV',;KG;EVI>'.].UQ6M%:AT]5[
MJB)UG)I'!65I=IP:TV`&`H)P2K4R(2UM$Y%K0EDHO;3BV,U-O/E2J[?3'<M(
M\F5/`K8MT$U1E6E)HM!ZY@#/&M+K)F$[F(-#9(4UL"MP;F\F0FZ]K0P*EJ<D
M&P"ULS]CU,Q$W<$,6?Y5N;*G5MK3((U>;M)"*U9;BL^*1&K%LED7/M7/VW33
M?-[U1(',14)9Q_(BP7H6:M4"*3C-`6,KT'L1;,J)WQY*[!C'0G4.XAT$S1SF
MV.<]^.BSJ:ES;3#1<"0I;U%T0"OWIX1M2!PB$FD:.Q(^M2MQ)RIU$F8-G_'!
M3&;)&29&HMBD;Z^BY,Y\EE4S:JNOGBCGJQFAOYNKJQG59U`.E5,[HHN7UXH4
MM$J:(9[4C8MVE(H6])3"UK60-(4:(L0`*O76]ZJ8\*H1K_S+P!-?9=`VC7=L
M-\.A'&%:=1V)UJYU^3%*M/9917BF?.=@.,=+D+PX06LU;8UC3)#Q&KU!LD/,
M9P$^TDVI4%FSRK7@F<7F+Y(2P62REX:[OCLQ8I?!(4T4._U6N;K[L%VM0E.L
MJU175>C<QBDS58;:J`J;%&E10=D;]3]$B^\PF,SP>C@/L:P^I>I/(C&GI?($
M]54M8-"L-00>805IA$QK]-*:&B<EG[!)BDR,MZ<'+YP5"\>Q+E*SW8=Z"G,^
M']WK!=%(B>:JW&'E_;3-6M`^M'.QGN?_`)6'5%84]*6.I6U#!Y0@JY:-U@=$
M1I[C1+4WOUO.$62*-H$B@G2AP,+$$U5LS0?57DMUND3&S8_2'D0YTZ(D_/,2
MJE5,Y$Z=)\[G=/Q`P$7$6WQ6K`+T[,F/LE:%>:5$GYRD(E#:F1;]^(U<WJB_
M:U[G8MDFV8KTE1CJ_P`LTE@UO]W<DUO15V1:RN=N&[=OV(7\OA;&\5^AFC+5
M%D32)2A:A<5JM"76Y+A$"$J!Q6$*BGE]&8WC2%%D#,.+%E:3,Q299CS+YB><
M9#2$>=;[F$RA<XBW*D"Z*F4RG==&0J,VM&'5`A;7^9U&2A"`$F0?AF8-!I.G
M1(Q_$F`"63[&];T)MFNF]%^>7NNZOZP:9LH@[5/X5+*SDB:*V35MMQ(Z"V?`
MW9R:$4A8M26+G*U^DB21QYQ(7(3BSS0'$&>F]A,`86`S,4:+N/\`S:=)7YU5
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M%BW"Q2$M05'(G-)$W[$RB/2+?E!/KWHB`E^N2JQ9,^55Y(OV!$:GX)H#J?IZ
M8A1G2ZDN?WF4.B%G)$ZS*T;5B$2^%88K%F%.24LD4QF+[[E"W(B@%^\.T$&@
M%!WL-28_*8MW:\.Y_,ZR0/B?H&QN<HC;\8Z1K9SB,'>J]LFH"B9U1+E8^R#(
ME85FPAT>3VU'%'9L&8-H6;&Y(E;A[E.<5Z#'H);;:W1$\$\]I=I7]R#P-0-Q
M0-N16%==BV9S?2RE3TY!C((XC=[G>TT452.Q:_JIWCR&,2=O<E19RYN;#RT1
M!FC2R@Z#H'H2V(FZG)6?I?R>]/\`(Z6QJ/[#2531=K*Z%E-XTGT_1<)D]UU?
M*6^O)7&6F=LJKGV52ILF2)[9FZ0DF[).D@P&EG:$`>MZUAJ+8G6WA5=6W?+]
MQK0]Y6MSY:#W8S+-J29X(\V0]D5L^.,&94=EQ9FDT"&*3-PE2;1TN,>RFU$2
M((3#74(R-:]`^\V9PNF(F.;*T'E*Y9'2TUN63&V37BBOK+CM,RJFI]`UC%?*
M"VYJ6A40*NBJW*6+E*Z3SQ$Y$*&HLE084H)$(0C`>Z.T63&4"._F+B+'UK3/
M-DBY>Z9@D?L^CW"[Y!9=A05OC9%;Q]&J((7K9FQ;D*@QEBD*)T>*2NXCS0M:
M@L"<!!^S/>A57'2M8XI:K_RW<H6%\K#3);ABJ8RG["ONL5T[K%RBJ'H.I:OC
MA4LF$QH=0M6"#.$2!B4DJ`%&?!*#"CRQZ+]V+V\&,L-@'FHXTM)'11L!2W;(
M7?I-X&CIN*`JIP;)/,XXA1$KY'8K6W/;DV%*H!$23M:<5A)IAX!:WHH@[[F]
MC&8K7DVW89,!@,!@,!@,!@,!@,!@,!@,!@,!@==K_$+_`,D?'E_:`4W^Z!Y)
M;LY^4NQ+E8,!@,!@=>3FW_4G>27^H;R7_"0,-3^L>-W8;PR8#`8#`8#`8#`8
M#`8#`8#`8#`8#`I/+>-4DJ[]I_NP5AJT*VIN=+*Y^*K$,:3J$3\18LM8I49*
MS98)Y*4MQ[0)DT0%&%`<$[1GM[-!L/L[+$TMF-U6(SXFVV.'00T-[NJP,(\G
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M$!9M[BEP.,KFD^:PO=J$R`MZE-;QN;SI:X)&/Y.1'[%O0#%PP_=U4SGCSF&/
M1;Q9NG-<HLSI*-324=-VC=\"N1E[=J<<0@\:2]V*;!"85$D:'\-+*98/2SE7
M;=L#:W[&L5H5+5L],HV`2C9Y9<JZ<(39X?.%9-PCR<WPJSE1CG=,\?5,QL9>
MM>P2=S:$!!!+#6M<*Y*4(Q,]`JFMVUM80'IQB2F;1B&3O8!Z%LE]V4U0M87A
MT=9;6MU5BP]),+(UWOU+>/1TH>9%SHQS23Q9-=D.KV&J(]5TB%93`]5[-(>D
M@YIS?*4:C9@CE_\`M4`])P>T6+HTK'"%N[^X<=+4Y2K[EV#VXWL"2!-L78OP
MXNRK&_HYW?VF.-86KXYP(>9;!G))-S0ATH3OB9Q*5)5>M&>R9KU!LS$TFJH:
M'PP_-PQ.#'SWU_;59BL_GJ$<S],/LTC;9<DGNZOH(AE[4S/25\D3^SJH)8*1
MFG+B@3N>OE4E.@$45\*,16C-FLZZSO5XS_PD5U(4,XC,#NAZKN"R&D^%Z-BL
M9W!44G/AT<XANION)H7G/)\I:!R%PL0Q#M`K]HA*%"(T2@'OM^A.#.?KKZI%
MC7BM>H-2O3_*D*Z=>&SE"^8I<[;!:D=JK:'M]I.6WC(G662N0-=AAF#:KF$=
M1/SZM/1,RA`C$5\0+0E@_37H2;JZSQ<!8?ATBMAKXZG77S*6^%O?#,,X-Z$B
M26&-9IEOUO6C0Y&5U*XN]G/VS*IF49G3CMXV/2=\3*BM;1C+T$6SM%RUKSK5
M!<;\`T!BC7N51^]3H_TM#K!KJ=TET6U02;/+Q!05>X`7QE@FL1LR^['062WB
M]CV%.R%C`$P(MZ+`27Z%Z&<_2C8IQYQ3*N9K6ZIN>?7ZY7Q.^K)77$NE+BOK
M]M@1+`MKRNVJO$R!L2MDC?RU+6<WM!6TQ8O=C1IP`)$,\0=G#)-U8B-E,*[\
M/;G6%C-$\DO1<HNBKJPZKM#NBL^<F^MXW`C=="2TI>;'_B['5SEQVXLK`:O.
MV2E/3(R3UA@#C3BBPB+%";JQPUI1F'B/X#?^3]])W#84(5UI*>@+:E+M65-N
M\GCTR<^<^>]RA]E4.I(#[#W)ZA@4R.5REX=Q)V=8I0I]N020FF>Z]=4NNK]$
MK].^-Q;?5VW-<D/OYUJK71G&E@\77=$3Z];IXV2>%2&,V(W0*4QY<HE$:4Q2
M15[)[#/<C`Z`L*=DY>T@OAO>?$`$74ITFJ$;E\*-87\FK-ELVXI2NC%<\/)^
M-RFUBC*5A=%ZQLD#?(F2VDCZ7(59C*X-BQN"'Y)`0<6,&_N*@;T'>BYS'#C6
MJS_C_P#'K$>%D=K."21-,ZL.XG:/*IM/&YCL&/J7IHA@'PF&M;HDL&YKJ<5B
MQC)D:W6U@7`G:CW^_:+T$)80$FZJG'/WA35U)9E=O,\ZP>[/IBG.H+/[`JZG
M&JGV>N')KNJS7%P7JELIM!#.I(^2J+-&G(P`&H"-O(5AW[*G9I7^RPLWZ4B-
M:42-4?AT@U83&J"UEZ3N2T;S,IOMTY.IPMA:X^XTD^]$`?")<[J+(2N2USFQ
M\6225<7&]&($&VSWVA&"5"#K>2AGIU5C3_X?1@*AMZQ0WJ5:-5<W+$EY/!(T
MU$19O>F^(N-QUY;L?G$U7HIH4YVI9Z`^%J4#J[N2DHQY+6DF:"CTC]TH46+Z
M4Z35:_L#Q1K>D)[;=@5CTY*.=W?HOFA+RYT$%KKMFL#4[@S#\HCA[LP&.TE8
M=0N1L`WA668:$"XM6F/V7L!8O]IN\V8NI])6$M;@"%6_QM2?)DBG$@;%W/J+
MGQUK"W(ZWI$#_';1YM3Q[<!L5-'U2E>W#]7)@T8H;33S2AIU!A.CM;]DW0RG
M*;HY_=4Z>^'I3;]6=9-]O]0/4TZ*[";Z>C5C7ZEJEICK.R0>D'Q(]PJ'P^I$
MDS4HVYOV>0,:LTYZ4''J3/>ZV#6O=[+%]*;0N!Y$>*E/>-#L5.MUL**6>8M<
M=675'IT1"DM@:122IG_\)F!,HC*N118E:C/=BRA&_P"^`W[!>P^GWWKHS;.,
MU4@NCPO./3L4N)VZ9[`G%M]#6;3BZCXI:QE91Z-5Y2D+>90SRB1ZK&DV^3*=
M(G.2G,I2=<>KD:H9Q/W/77IK(U%].$:533<GB;K>^I)WNXV+9LE/CW=#/SNB
M7L<?9RX^Z5B[\Y11H8(L]-4H3O9RJ1_*+DT:6&D&$(O<!.&469H?LGAI%\Q2
MG)$4+\(]7QBF9+$#;.-0W@Y7S4G2$=Z#A<9FB%V8K0H0^0BJ1W=8M9]S7&?)
MRV!!+G5&L`-X2_*"9>9K>RMA*$6)OF9Z)<M;QERJ])=2-EVQTR?(;'BM,69S
M7T2Z-E0MS%%NBZ!MQ<)?,H8DB1<Z6F5._>^T7\"[IU[QM-[O7MICO7>$BZG#
M@CZ->()P$@AS/;'5TNMIEH+FNY^8.14*NLH[%S*3AMT5<W5`[R.7JVN1*3;>
MF33"F=(C3J1Z9"!$E;T(G1@]FX7+73>KF+,\1Z&S:`XOYQ77RH8X9R:TP=J7
MRJ/U6UM=K2[<$4,*MO<*]L9%,$KW2"YR-80DKM)?EA,K1'#(,)%]Z/1,N/5N
M/PR8#`8#`8#`8#`8#`8#`8#`8#`8#`Z[7^(7_DCX\O[0"F_W0/)+=G/REV)<
MK!@,!@,#KR<V_P"I.\DO]0WDO^$@8:G]8\;NPWADP&`P&`P/$0@@"(8Q!```
M=B$(6]!"$(=>HA"%OTT$(=:]=[W^Q@>M,I3K$Y"M(>2J2*B2E*54F-`>G4IS
MP!-)/(.*$(LXDXL6A!$'>PB#O6];],#W8#`^=4K2HB=J%JE.D(T803L]4<6G
M)T:I/+3)BMF&B`#WBA2<`L`?7U&,6@Z]=[UK`^C`8#`8'SG*TJ<Q*2>I3D'+
M3A)T11QQ99BL\!!RH9"4L8@B4'`3)S#-A!K8M%@$+T]-;WH'Q:3XO:#XI/\`
M':3Z5[1>^+^+TDV9LG2K:?VO??#[.UL'M^GL^UKT]?7`^C`]"I4F1)CUBU00
MD2)2C#U*I4<6G3)R"@[&:<>>:(!1)18-;V(0MZUK6O7>![M;UO6MZWK>MZ]=
M;U]W6];_`&-ZW_VZW@?N`P&`P&`P&`P/P0@A#L0MZ"$.MB$(6]:"$.M>N][W
MO[FM:U@>E,I3+4Y"M&H(5I%1):A,J3&EGIU!!P-&%'D'%"&6<2:`6A!$'>PB
MUOUUO`]^`P&`P&`P&`P&`P&`P&!\Z16E7IB%B%2G6(U)83DRI(<6H3*"AZ]0
M&D'DB&4:6+7[`@[WK>!]&`P/G3*TJTK9Z-2G5DZ-4$;.3'%GE:/2'F)51.S"
MA#![U,I)&68'U]0&`V'?IO6]8'T8#`8#`8#`8'SI%B1>0!4A5)UB8P1@0*$A
MY2@@8B31D'!`<2(98A%'%B`+6M_>B#O6_NZW@?1@,#Y]JTFE84&U2?2X2<:L
M*+9Q?Q8DA9@"1J@I_:]]M.`XP(-C]/9T(6M>OKO6!]&`P/G3*TBP)HDBI.J"
M0H/2'B3'%GA)5I3!$J4INRA"T6H3&AV$P&_00!:WK>M;P/HP/A(<VU4M7-J9
MQ0J'%LTGVY("%:<U:WZ6%[-2;7)2S!'I-*BM;$7[P(?;#KU#ZZP/<>K2I1)P
MJ5*=.)8H"D2!/.+)$J5"+-."F3Z,$'9Z@1)`QZ`'U%L(!;]/36\#Z,!@,!@,
M!@,!@==K_$+_`,D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!@=>3FW_4G>27^H;R7
M_"0,-3^L>-W8;PR8#`8#`8&E.ZZ:BKSY2MK%TAN@*%-P98=^:BC=T5T&SUL=
M:D&N"#Q*-R%;5K39J*LG!(ECKNI3*&I0TFM#@`[8E:4\6M"T=(G\/JHE3_D,
MZ.Y+X%YEK,:&N)S*B.0O&I*8!8[?6NF.(TU3O0U2V;'VU5<3)9?45;1&?R"#
M._.B@E<[*Y]63(O_``@2^@DBDHI(OBXQ==/G/CQ5N=:.D>@'GQOR;J,%2,*3
MH]OYNM"SHW4;<^,-@1R06#$8S*G&#M29QK:;2EC=6R=JV9"H^#:I&Y:3`7_"
M%N2@97Q(ZQ2,J5TJH])O)S:MGN\XBO*TWYC>P![3X]Y7@UM"9GN]("@0WYS^
MRVI8;L_L]?7+!`R.0Q65*E+>G3)WQKTE*#H*G1AH1;$:BV/^U>$JH=+=_P`X
MZ6K*O*YD\OI&EV11:'`2EY8)>PN26==-6*E\K"VBI^GYQ5.5MLJ:+LE8.W-9
M<@=$`VZ<+]-$J1D*34/NRUBTL6TU\_\`/EFM>>6?MFX&"4&1>KZ8@;M+KQYM
MJ>OW*?-4=?B:1?;QZ":*A<J\MJLZ\ZS?[HFCTT1)>8_)WI_8Z=.$:$",QA]H
M6S0DFR(\>/ND&V^_+JA?2\+J&P'FC+D?HMT<PMD9K'GTJ7-<K5)V/GCI*3.J
MM[DT&ZPDQI<VE[_7Y25)!K`A36T(#78LL@V2*$`7-*(MBE>C&S_*+U$3/4]>
ML%O\2V@^6!`>>9:Q):_K*;N#ASQ+KI[:YUYD75/?#>V=02/<AD;!'+M4C//(
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MK$A-=+HQ6O+?84`FTFCK1#*Q?4BJO^>)1*&CH!@BDHZRG-XOE=6=)C4S*C8B
MJZ`WM18S7`$P=`$"386VV(I/5:4?D[N>LTPU+Q8?,G1]8-C1%XP;>/--93MT
M@K?=][`*B]!4FXMS+>%JN*=^A$ICK@X3)6<:F).8GII%[#,?HW1IG&.K95U;
M=5U4)R='I^TCKL%Z.,VY1J]S4O$4D+]6J68WE>]0TO+%Q47;IU'I%IA1*)\K
M.1A^6QFI`@*,-$KT6,LZLQ%9Z-?"WR.=`DP]_8I/8O*U%32K9WTK#)3>MP0&
M0HJ+NB2<]71):J1595D,<.CX=(8=:=B(&$IV+2*9+)/D]*M+]R4XBT(&G)K&
M*\YAC,6\@W>5SS>*(8.AYWHYBMKH>K>;(I%+6I2UK#L"I9;8/CB@/>KJ]6*)
MLO6I")>"*.2EYB1K64AC:H9BI*J--3F(5"-;%QMCK2/O1A=6>13H*[;=@K=2
MJ&J:PEG2+33BYVD-GQ>Y[>CB$A#R1>EQ/6FRO4O04"CL0,*?:ST4G^2/A-KD
MRGV'`2E4$M8`3;2->7NSIG\N,]F=H>.N*1U36;&9VA5E)CFU>/,):USW75GW
MK14GM]BD+%+%_3\,L.8PE@,0(R34#95[BV*`!/)42EM6Z$G)J8\>BM=$^57K
MYFJWF...C]7'1-@R-3.E%A2I-'Z+AY=GR5%T',JZU046=+*[GHTJ!6M$FN.>
MVITA8YVN3$.K62H9P&:^(7Q9MBLT\>C<%P[U//+[FG04,LV=TC))16<L2%H(
MS136@>HY#8TZA.$WMCQ;K!>]MMD^D))A(BE.E[%7KP484(0V("<91YE9F*1'
M%2>P/*]/(O?_`&W6$/75I.F6C^/.O>B*Q0JX,TQE^CDUY89:Z+/B=@@9NHY_
M8LI97^2S8W8SG>"5<:8D)*VU[="#!KBI58MTB9WHX2<>1+HJ--BFBK-L7EZ"
MSW\,&./V%U9+ZMED#YLB<3LGEUQZ&A4<50.3=)[7,\TDAI'X*I7%?/"DASD:
M!02A.%_N&[R7&)FL=EH>;[N9^>O"ORO=;C(DD710SA'F1<BD+I%SIZA0NSQ5
ME?,4=,<HX3,:X*=TBE]=TQ1XU,@8D)(#!'JW!$F+-4%DF*WS'5K^K7R_=`6:
MK@D3=[IXCYX6[8^JETIM.]X:G'$9X_4',*'8XQ$H1'ZS[<FL'C3[*VZVU1B@
MI'8DV]T%&`TCWP]C29%FR(WGQY)&Y?\`+3?]S&ZG$D;J-5JG*XNA*M/X*A\=
M>$O9]6,M3JIUIBL>S7Q7<S^C.8"]0XE*\%HX.67I0ZIA)5(Q[^&V2ZV(T]>3
M[D7D3M2?U'`7*3/=$WF"QI=Q7-W-9S]JPZ];.8W>RNS.9*[6\Y7JZ1CH.42M
MTN=B26>J4DA&;'T#MN).B=[CVD!YK<<6;8KIIQ_R4*N7D@[9EM3\Y.S[;U!5
M3);<<.+^E5<^C]&2MHKBM>?;?Z-)IF;UU;1<SZ`D`I"B;3=!4N4B3N,4*,0&
M[*`6A-T%3MRZK%MM9VUYMLW%76$WOBX>L:JL:8TT^2&CYT0F8H]2K:D?&-CK
MI[E5AL,+<9!;3/=-DM\JFKTF@YH'IB71^#/<6=TBI*<WK$1C>ZK:Q=%(B=U,
M>B^D&OD[J^];!3*5?5]M"I*Z9K6E:UOT78"J5U$NJJF939I%5V[R7$WURK]H
M@$O:H>J)9I^8QG2`;^N2M@TZ@Q4F4EEMMK&T5<W9'D%MF%1!2>S];<"R@EB@
M\@M1+T$EA"WYA[L<FMZ>&Y-R34:1O[%=59?011#*2-4X;?'7>BWM"80P'BT:
M1@QBM*3XY\."K3SVOVJJISH^R%O3M04<XQ3R'<#-1L#M"I0AEM#<\=$*.3R7
MZ/35S=K;AI*"M5$EM16F/=W-K0G*$C+(DA:U*I6ICX\7&VM*<I]&VCNF2GHT
M=!QV;S5QKCF6<3U8W='VW%IL\UNK8V--'C%\)854Y8#27:"0:P92'2-V?$[N
MSJ&Q,$`BW`G8_:$8CU5\LSI>'<],'+U3<E]!\\0*B[(BUZS1NZOZ:LN>]05$
MJ6U=+*U;B:4;+.?NAXX^2*R;,=+2<E+8H5S)Q/;T457$I6E>`L84)J(K69X[
M*_OWD=[4ETADA4`9J2I]`;//&]3T>B5P4U/YW-(G,>U9>0T3"83)7%N@(`UO
M;)%F3>SFME2DH%`_?E&*''TT(K98MMXSU]'$*O*#TM7T60N5SS7G9A46L;V3
M7E4/L?HF3)F2#VCPK?:*BYN^S\=B]>0*&R&(WF9LUV8TKC*H$CBGM@1+7UT,
MT6<H&,<J\O7Z,HXV\I%L]52QDA$JL'G/F]=7=THZAF[Q<,*9BQ]?R;Y2CBQT
M@O*;3"^QI?$H5,FMADJ%&I$7*[/`4X.J$U.0L+,,(*A-D1UT[>>C-/!#?TEL
MOC.F:SFZ>.5Z^5/2L`9(W4C@4XJ+,?:Z1I?D^)="F2)4XHVM]KRWFX!:I`G;
MVH06-5[UN6.!ZXDXHNI?'Y3,<*L$[)\NDSYTZ5MJI8"=")TT0NM[O:DT>>:T
M;F=?$;ZK3D6R>L8^ED<QUU.&Q9A$7J-0$LL9:.JVMH4:6&%I9,8K1*DP"Q96
M*SX\>;-0^0/HB/M;O4]CV-S+!;1CUCU&R3'K&755)X5RQ7<1N2BU%[174MK2
M1=,`DA+VNTAW$T2D4\3IEKXJ3F[*(!OX<1)B.,<-N:4O&FO>9EXQ).Z%6Y%(
MG()79/D9<";XBR0D4$C3N^]A=.J";<C""1/*E+N&LZM5IY0$KG$PKX`LL)JD
M0?:-V+OV[?XKCSCV7#.;(U1$#2S.OGNN9)?<TKJ^^HWWIVP>CJ=F3N+F.U+7
MB$\K>Z[#GSPSPMUGUC5\A0+X:6I/0L*IV+:T6C#U"8S8F)FLSQB.#TUCY:K#
M7(T,FO*=<\5\QR'Q[5]U:P1VMH:9=$D;Y<^U174LFSE/!,W2[&\P".,<NG`=
M,S,ZL25ID$?.2KB9F69\80D&.VZ+H]Y<^K9_5$@D4(#1B&84=5'D`LZXC9?4
M"I>UV)^13&>4K%0,L$05+V-:D2KPV?1?H\#?I05,I\E*-"6Y%F&`)&VGRJS9
M$3KPFGWZ=&X3J]TFTKXV=[7KDQT:[`B,1B5_1-M:Y*]QU.N>8<2W3P,;>U[&
M,"IQC2].0:0M2'%*$RPGU`<0:#>P;K$<:2T_5K>]N6[?,;C)TXM%WJCRISVN
M>G*!%'9I)VEXJNB^>[#L'<PD$/<2A,Y<2KB;TC6-)+')H(#HTUXLMU`H+5E'
M*#A&Z13K'CW3=OR`=I3SIRD^6ZT-Y[C$F3758G/?44PGM'7"ZLC'8L?J^;=#
M1!34[:7<T(+>F%\IRO5J8XWY1<B`/"DHS:@L!>TAI*6TF604-W'/)#="&D/P
MSH?G*.GW3U([#D=X&6%/%70BQA[TZAI!13]$K9S?<2.C]C-3'5*1_7%)E4C;
MVHB0I4C?'&YK+1`%";=*^.$/'PT]%`.H%^KBS7J(U8AKNU;G9H#%)H+3-+IW
M'9;U_;$8C5NMDL=)$G9'N)3N=R`B*-K2F;2W!$^I`E'G&"<V\G:"Z-=%I?)I
MV<]\=5C"'2$2N*1^R)[)75!$VV9UU&YTRR9%%&,Z1RAM^.G74W'\&BRXMJ+T
M(D]7+3EIV]["A:W$X.R<J6VY3T\>:J%`^2;HJV[)IF1."&F2J-MGHJCN;#(6
MV069)[)8G^XO''%.WCIFGM`RU72*O3$POZU0T%)=1<@2U(N*W\028A&-PBS;
M&N]/O1A'"/3DNZI\DC+8L[E]1BDBG@6WM'4;7Z!:V6%S:G#U-5J,JN+[`Z6#
M*W1SL)00A*5`5',L0]2O>`TV[]/>!JW12W3=,]D>2"\8?Y"Y=S<CK6,$TG6B
MI`WS5Q>=P5).%T)4\_MEW2+H:'#<^B(]:\UC<!=G<,</BD7J:4DN9Z8XW4H1
M*RE36D)C&->:L]1>8NS;3;WZ)#FU!P)2*[:^BI'6-HUVR1B@:VJBVJ1Z%N2O
M)=/X%".UK7;E"B0.="EQ-(8X69%%)KU)$I:EM0K2@M:LLV<^7CHR;QS=`73#
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MPJ-R<2:7@\L\<4TLN.JIY7[+=C%+9I"WA%+5",LX;DR;<9,D=7!.L`D-*96P
MU&,17E-OW2=`O+AT':E_\Q5W"J<BFHI8\9IA=-$KZHKF+.E@BGULSNK+5EU8
MR"Q.FZ\DS,@I%#7:N0;8(_"+47/0%:9M5+&0XTI4>3"(B9\>.R/H'Y2>X0UI
M#;KLDWF17#R^1^:NV9K#X92EI()&^0+H*S'6H15)&I.[]#N;?%I?&WIC,>/P
MA4MCNE/3*0H-M0!D[7&B;(X1QK3C\.RMAS,!@,!@,#KM?XA?^2/CR_M`*;_=
M`\DMV<_*78ERL&`P&`P.O)S;_J3O)+_4-Y+_`(2!AJ?UCQN[#>&3`8#`8#`P
M!+*8NXS*6,JED=FUXB"%D;UDED41<V5@>T$H2'/`&V(3-V0)F>8)T7P7_P#4
MR&]2H"@4>P!0$!@@ZV$$=*7)3=#--6,\YK@,W;+ML2.T,W1B-Q-FDR@1.H58
M5A,R=1$Q%&+)`Q(44!6$H6U$G5*#5ZDDI,0(9F%B)G@F<,UB<8@D2>FV+R9(
MP/*N!L#/$H_7[\*0L6YTZLC,VIWB!MC5\LQ5#&MOH%+[M2E(*C[>G5*EWN"$
MIXP"FJ'WRR*1I^[:-YU:J[8&QZO?=M2]D5Q5@B;7'H\ZTLQ1IV=G*1D)=(U)
M#RO22@HI$H+),,T(L>AB!KT]1K,53DYPRL%RMB,>8I`EB^/KE)\:,<V*/*%;
M(YJUA#BL.8A*DHSFU<J<!%GF"3^P8,[81B]1>F\)JI=Q5UI0'8:B?/U;5&9!
M'1`S4K8TC7R6.PY"Z297;$77SN,+#U;(>M4N;Y'4[6+:@X\6QDG["(H8M:V+
M1JZ)CBM[(&>H8*S3*T'IJ@T/;F]J<)O,["^2F)I.1-\?:7)<LESM(P)`'>TR
MM)RH[2PTP0B2AF;T+T$+U,ZJ$\<1KE]KO_H6+P!WG5NV`U1"B['<+JMR2Q:>
MBE<)OHZ7V#!FBN7]"WMRPR.-"^`:7[":1OV3_A32S3!`]H!JZM(JV).<(KF5
MD!1/,0A4D3-KPI=@)'-@8G@A!(%*C:M8YA(5)%):5X4*A;-,.UH)XS-^T+>]
M_=PRPZ6NU!5JJ^=&8FU;$')=)X="Q3UU3QIM=U4LG;^UUU"8\.1#*`X&NTC?
MWU*THR=F[&:8H"4'7IO>L+K.CDXY-Z<M-))7>-O\#FZ)CDLEJF5."10S.Y"&
M3PQ[/;I1!790/WH=+F!_3F%J40][]TH#OU#[7W<%)AS)L7K-,\/;X?'8*G?W
MG2$N2/!K1'RGAUTD&F4M@'MP&G"M7:3&-Y)A&CQB]@1`!`]-@#O1-7L7Q.N5
M#TKD#I&H2?(GAE.:ESVO9F(UZ=([[@91[:K<E"82Y:R_#&B",D8Q$>P+>MZ]
M-[P(TE'-M2RQS@!P6L<;::TG)EA$PF$&H8M"I-,!-Y:=N<K`C30A)2R@YF#L
M*E&%1Z>Z/]DS?M>@?053<LTS.`MM:_38N&`Q,MVW+/A5(@&H5!2Y&KVD.]O8
M3$:M.`XHSV?4LP`1AWK>M;T&+.T8K&1M^B'V/0-^:R'K;QHEV:8^Z-Y,B4F^
M_$Z:+6)STY;T>>+V]G^FCQ#WZ^UO>#5X2Q_K.",LJG4Q<(A&V6$-SQ8LODCM
MMK2$QUOCL=.^6Y@[K#0Z,1Z:XLG&`Y8/>A`1!V#8O=_<P<='O8BJX6,S'+XZ
MGAIC$X-K>Y1V1-:5G`WJ6MP;AE-BMK<B"PE;2*FIP$`H18O9$0<(.OO1;UL/
M7N'5B)ZCSUN*P/<B9T"=%%';;'']O34UD@.`E21Y?\+\<A0%%F&:++3#"6$(
MA:UKTWO"ZH&63*AM]+POF$55Q9QESA4UD]*L;^3%H<JCT?\`P-L:L8/(_9W[
MH3BW31Y?;$0J]'E$ZV:!(8(PWW@`:V-:56%C[%`8D)Z#%F:'QD2Q6)SD08^W
MLK,)4N]/=#<'K3<2FV>K]`^SLT_U']ST]<(^0$0K(IZ>'PN,00N0R=M/)D#N
M!ECX'J0LZ@D!:DIX<`IM+G9M.3I0A&$\9A0@%ZUO[@=>A:R][U$Z[D*1Q:Y%
M&H6^(%>FY<[-STS,;FD4Z:P!`T+'%&N3'DG:;BP:TF,-#OW(=:T#>M:PCE5;
M7%]-!457-S!IA4H@,Y$<5I&[30H;RB@)P-93.<7\&:B+)T$&B-%[!H/IKV?3
MTU@:\J79N7NAK]NJQ6^@FUA*Y!=IYR8WRU^)KWYM9*L='"N[-M=5'H"@4K#F
M93&'Z*,90G=S1H35`?>:3"-*T8()J<HBF[E.7I9R"T7;(JXY^8V=]<;5K53W
MBDNY$?'7YKGC)UQ==I/#@3&9B$P4A6HUTJ9%JXE('U1)VY2F+*%O0/8")BZE
M9\NR\C+#:\;`.R:.Q6%MX%[N2\OB=E8V-*!:_$+/E!.ZNQ2%*7I2[DN`/?@/
M.T(X)VO;T+VM>N&7L61R`GMVT"]AAYS2<UD-(D:QK93&XUD+5Z4)FS:<XC:8
M;6!<'0P$^FR=&Z]K6O:^[@1Q9DPJ[F>H+DN\J+,:!DA4#G]P2I%#&V/M#Q,P
M0B-.\N=_AS"_DY*[O[DG0&@+-4&_?'&ZV,>M;WO"ZS-'-U^KK&6M#+<3-&HN
MR/5A0J-R%P=E#6P))=MEDK4@=T+9(W5,#:P[11:LL`BS#AE>\#][Z_<W@UX.
M&D3'2470PN+CJE@>6EUGC4@8V.'U2EE;5%Y&\IU:]-,GMNCS$O1PMF*"U?[P
M_JP)DJ<T1(3#PB,+UL:\6>N3#6SR%\,=V6#NH'X#<ADHW)N85P7HMH--5M*-
M\$J)-TX@:S@#-3EJ/;T0+0A`T'>M[PFL.><D4=>T)L=>$C*[MKJC$6<Q.1"%
M>A<F_P!->T6:V*@FD+$?H'7KK8!`^Y@5N8Y?1TLN>;\AI:OC2@NFZOJ*\AIS
M(Q$5->IB+;F=UQ%B2L3066<!#)V=SJ%T/5#^%)T`M>5L`Q"&9H):33)8XUIC
M.SSC3FQBVJ$K9U"@PU$W[/$N;1!TP'G#&7[S:M`+6O@Q"W[96]:]WO6$0K/)
M]S^PRIHJNSFV.-&YBH:&6+'3:&E)Z_FTKLQUEZG5>1F3N[7^"<DL-V45^M<7
M)B3GFN0$X4ZM23H"@@8RQ$\88CS).**Z=IV"7!"ZLC;`RAE,X/C+"^1>(A>H
MG(8)8+_7J]\1IVPM8F9G!:Z0;WY"@@8#]D!)]K81@]D(FL327+T+<<&N&3VZ
M*#P!(QQZGIW(*&:[$`K@^T\Q=*X<E+984>86MC<5,ICS-`9PF5MYB=S3(BU"
M@D2A,`P@8#1"8F.*$H=U70%H]AR_FPFGQ&V?'UMS,;I83M&X<J;7,JE:^Y4D
MK_HMVT<H?E")WCO:#4C1A,+]!:2.(!Z`6(OWQ:32O)=ITC-?R`IQ8GJ/PY[(
M<_@]NS,Z-+*Y%.'R0$`6_;BWJTYP%?R6`L.B?>@%[C0=>S[/IK#+[&]OAZ5E
M%'6I%&D\="F7I!L3>F:R64*0WVAN:838F`%#I,;\9O9X-@]D7O=['K[[[H<#
MJ`U.WQM/%0PNO$40*6$.:6.:CD;31LMP]L)Z9P3L^D8&P"SWA>AEFA+]OV@Z
MWK?KK!7N]R6OJO3K7#2*$0(AQ6,*...FDL:CQ2U5&$J4I$@8G#1*()Y["G0D
M@*)2F>J<!0`A"'0=:UA:RAR\[!ISF.F)A8ID%BS@W,`V2(MT(C*6$Q]1*99:
MTIB=91&!)U3N<SQEH.L"8.C,U#-<3TR`.O=#5&!)(]H`BLRGYL<"E+`S&/;8
MGC9[JUI/B(TX+&E5MO-4(P"4L@SF]0I:7#:+0]E"VF,-('H/J#8@;UO9$'W!
M<M:4(\<X-3M%BE)MOV^U<\U^K84;"G30E1)*]GL^`M/-4'(]M41.:*C-3&`1
M^ULP[28.BQ!!O8"Q$S5S-7U%6%*MS\<WO2Y]7R6722SWF9V))$TEE"MW>$QB
M=<O#(5X"32&II9/5$E`7[)25`'W6M^Q[7J&!ME[<F3I%`)08O@BB-2:;Q!!1
MD]D\72(8?9DPMV"HK7CSM1$O>VPIHG1TDCK@,X]P8CS]:7)5:<XS2E,>``I,
M,UN-FYR;F.)/-S%5VR1YFL:L"HLOD@F=I0!L1_LEB)JEN2GF:(T<XNULKFP]
MM3ZWL)SR$@[0=FEA$$:SP9:4KKVVF]:DDT-^-1LLSD<;3M%IP(]K$N>8FZJF
M50^QIJFC42-ZC[B:0(UK=T99B-R2#">F-,*&$6QP9<W,L.+V!,TM,:+VUK$R
MPLAN0-8=MS@B;=,2-4`I,5KX18D9R?@RAZT$9:8'N@[T#7LX1@ZUUH^N+%C3
M4L'7,,M2\7%\;8R3I(PLLTLYRCC&LEL@3)3B2"':2*&EB:CERC0A&[+*)V/?
M[&L+K,=(9@;'((\/A,P/88DZ21H1GM2>4FM;.M?&MO,T<-2VDO8R#5Z)&/2@
MS8R0FA!O1@M[U]]OU)T<&.O*@2LCFQ&0:MDT<=]MYKPS#C,8)9'/:=0<N:C'
M-O$B"A6[(5;,.3[-`+V3/:&#TWZ[PM9?!%Y72JR2R^%1%UKW<JIYR;DDSCS-
MMD(<Z^=)VP(I0W%NB-,`LQC4RJ.N1"L.]Z!M40:$6]BUA-67R.-0J1`:W"6L
M$6?2V%82[,JV1M32Z`9EX3"3$[DUJ7,@\+<L":46(!Q0@#T((=ZWZZU@4[*[
M@JMKZ\+XY00>3$35YF:5C-E2!*P$Q%4\O=!2KH83NH,)<`.:G1T9B!J0PW9`
MC!KC"_V2_4>C6,TKR62L&2TC4J%\M&R7"NX,D2+8MN13B1A8VHTI>M<$D,AY
MKL]J2RU7OQ+Y"4W(1FC]0;5Z*!O6A[ULFLZ0R,42K92Y,S@.,0=0\1(H\^/K
MA,K":Y1DA6:%4I.9E.TPE3,4I/\`0PP1`B]#'Z"WZ[^[A-4,H[>JA=T6[<MI
MX:B$],_/40N(U_"V1T4-.A+O94N@3-$4X@#$H$L:Y#$U*G2?9.DI030[!OWF
MQ:T6DTJL]A#`8#`8#`Z[7^(7_DCX\O[0"F_W0/)+=G/REV)<K!@,!@,#KR<V
M_P"I.\DO]0WDO^$@8:G]8\;NPWADP&`P&`P-+=W>.*77KW$ZV_9$4IJRN='F
M<1>3N$&L5$CEIB@F,\A6[3:06XL_1QR:`*`69,FT_80FZT<@+,&/8MAT4(W%
MT1%.?RHFZ^*3LIP;:89))"J+LJQF6,5$JD'5LFM!8*SZO20#QO'<CR.@8F4Z
M5H\RZ30257J%;.#5Q+\THC#I$I.-;1+@'GJC6=OTV^OB$[R'Q:]&NTAI1`6L
MIH-:5++.$NCT+84I>4TO*ZXJ6P::C'3<V,?-(#$;A'I3S7#7EL;/]W*6K'!5
MHL\T"<P6@QG*.O-#T\\3?2<T?BR6JH^>H;-(?2_1T*E?722>DZN#LZP+#7UN
M[0^;V^PL-6LBF*N#XLA:H3B<J=GT;<:LU\/H1`-$[+%T1QX?XX^^?'9Y!;O7
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MN4PYS1.2^M(CR?;;B[]2)(5*FZOXT?&TUQ5ZN4`&E0ITX'G3@H0KA;*&8,9J
M;XGRU]4^^+3@:^N.G&YW:U']4Z3>2PJ(PK<JU*ZG<H!<\PBIS\K77_*H/65`
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MZ)W31H!Z&<1$TXMH'CWU?44BE<N-SUZFE=K=5-TRO?H6[(^E6PIA8E4?:X7`
MJ#:W*&R+Y8DJN22FG6)L2J23UP36LUG'HS6PF@+*K,TY<E(>N^$NP;,ZON6_
M6U;3U+0?=?7_`!9EZ'@B2N&:Q&"KI;QK<-:1ETEY,0Y\+ZHG$S@EOS)*\C2@
MM`4>,1H4QR%G(<4I1PHU%T1;3QQ\<E"*ZX:L_L"/77,^=Z`JZDJ-UU%#7U/1
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MBW;/3L^3R.MW5@JR(L==GM'*UIQQJ+31IK:F\U4@&V`3DH2"186;XY5IS[1]
MUT^)N&[,I3LL-X/'.//]!1)AY:G]#R24U1-DDCFO2ED2&WZLFZ>\;&:&NLX$
MD:'R0-D(7J5FE*EU7%JW'90E1Q8`;"2;OQIQ^S74F\;UY],![5-B=%U'42";
MWOY&8C(K.DCJ%NG'8S-9O53L9#8[;L;1UZW.J:N*G96`\^.J'9TDR5R2J"S$
M1"(L_6PQJ;HI$3KI'T7?GOCOLMMM^ZE-?\X\WRAAD\L89Q3UYKWV.1*?5E2T
M2K.`15=X]&6%*JFE`&6@;7401[:G,U(Y@8D398;DI"QFK2!FJ:SE%/'=79!P
M9:$`L6IZ%D"6LI+-+TESW%>AYTJ;[&GKY;G!BU.?.I35CU*Y$-6&%`H^7C2Q
MB+%.;PZ)W1M'O:5O1%[$06*\U^>T>/+:N+H]+9\:JZI+G9'RE8A5E=RBS)6F
MCTKX7L^-3&T)"\].4>W.<#G)#Y.Y:BG;$6:6VGQU?L4+2%*EJE,822F$3%*>
M)Z)`XNX&CW/M8]>U7.8'4+M'>C[UL^4N:-LA\<,9;!K>:PB+1H1%DQHE@;F5
M8HD+H2]K'!JV4>A")U/T'>]'F:V2ZZLQ/.(:P89XC^CD-!P9"A@'.=3=%TYP
M!S]SG1\W9G5!,%53]*5A>UARFQ.@('*_FWC[A%'6R8A)RW90L1$$NAR]4<C5
M'G^SM49&YOBO2LKS^.'B&Y>8+AO.9V<<>G(E:-0T`>&1VYO(8;L=%<M4O^[5
MFL7IKE2C)V5/F].`9"95+)1-7`*5U4DB5B%KW@JQ=,3$1"F3)XM^HGZ44W6%
ME0:F7SGOG9BYNJ$AYEMBAL%7T#6U5]6DW-,9;(:R7UFB;($].4&*VG);QN#J
M(:L7N]*BP>H]FINMIUE]EM>+B_'"CI-5(Z%YNZ9:G>"=;532L&L^;(H?">.D
M5E]$="3^I;+I_P!]5,Q4EN1M2V=%8ZL:FT+1\AI(8C1H5'PNQ!V,M:\/OP0^
MV^%SI9_?X]&K?6QJQ(ZDG7+;G;\V<WCGEOC_`$S75;V;5SW8U>6G&XOR9'>@
MI8SL\/BZS;&GE-E2-&8O2IPB***'O0)YF<4TXZK"7%XU[>5]!2&9TG5%)\X5
M2TVI%)XLM=))8[(;.61F&U?<T-;%L$!"Z9AMH0EA@HI@UG((<XRV1,R)(B+3
M,1;,$G>CB1=2*<50.$>(FOI.X4[SOF;G4CF:M)]RTCN(Q-&C7>L^G9+5'.'?
M-8V/:0V">T?6+FZVS+9[=4/<Y0D<VI2(2-5L)KRY^V:4$U==IQFO_"P].^*3
MK^+7?S-.K(L`]U,K*DJ3B!5A0NP:U(>:@?:KJ@J!R2"(W&<\_2Z^)95MGRHG
M;V\M44GL#9G3VPA<&]6IT:J-$WVTFFZ<.#>9NAN)+<TZR+E*MVAOM2M^2N3I
M!)J.L!K>C)[,:62]83JV^WKM3_-O##H\LM,Q_9RU2=0?('M4^N18%3@=OU.R
MI=,71IXX:)>[8\?=R]#7PN?ZME4.KZKI[`D,TLI^^)=TUG!ZKY\!\I\7S:/?
M"%B8U<8KF8"`O=$KD6K3K2TP"1$#`+>M&8FBK,K\5U\S&P:.O">P2AK1E\36
M\W71:=>2R2*G)A>;L!T+V/>71,2BLCE$/DOP,(C#UTRS'1=4>C,^*31!(C^&
M1Z)2FIS471&D+/<!^.Z<<E6E6,_4L56QLQ72O6L;Z$7P,SW+U9MHVGU=#+<I
MB1R944Q-ATW'"ZS1O+>4M<#-GM(EQB9*'W*@W>1+KHF/JADWQL7'2K=(+,H2
MJZ:>[3'T_P"0:<@KMGF:&E6.=5AV`H>HS7CU*["0UK*SBI)3\!+:R4[8-K5%
MA))^#(4%%$E[V7*)TGA2/1E/`7CHZ%YJO^MK0LQP@"MCC%3V-#GO\'Y&Y.CH
M:_2[FGQ;50B.(*5LB`"E-^%O'4N&<:(P(M)3D!GL[$>8`FEUT3%(\:S[JNP?
MB*_+QMOL-UK^KHAS9-'+OGH>0,/D/3.3:'I0NO4#JT$CI]@@S]6ISBOJNP41
M1C6)<"2?)NVTX9Y2(1^@CR$S$4YZ<&9N/C`Z'?IN[V55U$\N<?II`V0/G:5T
MM`YH[2.#2>B)F_RU3VA=07.%PJL3&Z[>@()^!\<*&80>[%%Q%.H6NRK84H$U
M3+2E9\>/5A%E^)'K1WCJ-,O?(]<39`G0BF(-7;H_48<E?N?*J12!KYTL=V5]
M)\O=-5W%+;B<:F"UK<=M,83N:C:5&JTZ[.+%O<6+HKX^U&T+ESAV04Y8_7UF
MR=>TK+-O!AI&#P&_UY<=DE[DQ&M^6*LJE:*9RI'$XVE,5I[4C+L]%HD9)34>
M>H^)"G)$<(L-9FZL1'*&N>9>)6U+93J(](:"YCA+6PH*@C=DOH'AGEZCO*1L
M/6?+5J2_H6]6,BK(^C8IXVTU4,\9R4CB*1*5@;'7-Q*U&W&*RE1J+Z1XTXK_
M`/>?(DPO*9<X+JGI*J)2KK!<K;V^96=((<HA%-LBU.!M-<62E974=@%O+F4W
M?>$KXJ[0J3)2BPD$.Q9&]@V9B:0UJ2CQI=DR]142.;\_<]VC7W,$>X-J&/UC
M8M]'/['T]7_'K!W%%GV9SDM72QS/`'2?)NA8ROTS*4;^0%2C4E'G&EE@]Y):
MRCEQFOTK1-\+\:=F:M"JG"9<S<XN,%7H;,:9:R3=_KJVZ\YXHZQT*MO'R=2]
M<23G\I\3QB/(AF?#O,9?8>A<E2X>W=L<4A04FZF5(XS[]55JV\,]_(^9*^K^
MQ>?^7UTSA?0'-$A#$R)NVO#(E@D,X4AO)E^SYBECC3NBFZ8V+84;U-E#9\E[
MV[GIR0+%@E.M*0FIOBLTVG_:ILD/C9ZALRO[#16M0//\T>*Y)\543HJ(S>WD
MTZ;[1:.";JG+C;<X>9$\4O\`#4V]7E2,T5M.T0&]^%HIQ6(52@]*>/0HF41P
MG?U?7*/&#TZL=;\(-AE+3Z07KU-<EM4/?<DFQ:&=>-R,32QCY,U2"AD8:Z52
M=]D[^3OY37E-+[&E*=<H,3@6B3:#H*A%T?3_`%/%*<BVMPG*$%^0:E81)G>4
M.'9`>@XE3!;.TSR[I=T;WY#YIRY)Y:_#CC89)TE%4G.9,:Z+G`PTUG1[4)DH
M#R]AV&I-V6GE_B<?(/Q7/.E[7Y$M2K8U73?/*D<;PC#Y;3R8QI+'IR/6_24M
MA4<L6M%[K"Y/^$KU55H+VF2I688VXI0M;BCRU!!Y)8]$MNI$Q/!QO(7%\HAT
MWZ,=9O0-)\NT[;]-0^E5W/-&2=++XA8DF:'&RSIYT?+CT,$KYK)G5E1:>-[`
MJ+5H7)W,21\D2QS5`]P40)G2.<^-%6VSQS=!,K,*97/1_+_:CPG6/55BYHFC
MPW0NE9%2=?*@(.39T]N<SK2TR#;4I*%.4A:MIQMIC>,$F4&I@D'%%F86)UTF
M85SE7ASZ=9FUZ1I&NHKG?)#!N81V38#F=3)$ONU]IZB8O4TFKN:I.D.;>G8@
MOCF[`8%DX3.KNW.YIZYU&':<I:$Q<;&IOB:><^-*-I-L<KW2X>.*'<P1MDC5
MOR]*SPYGFT2O=31<QTZQM&[F/BN+MCQ+N<9;SP)?"%VD*=G/6U>J9P-C6$HA
MM3'[3J$U8B8RKP4YXC\:_6=-W-RC:]SN=<*C*G8JZ26`!EEJAZ<M*8KQ79//
MJM*TB30Z,M+B6FF$J1:*V2F;TVT!8QE$$!`!/HU==$Q,1P^7-]D^-FU>B[WZ
M\D,?H^AUL$NFL*Y"?)[;D<6G,IM.?5=):(?6.'1\Q33NY]0M;RB'P!\B\A:C
M)+)(PL-4IWA.S)U:AVVO%MT1$;PCYW\9'2D@?X!J.UE1M//E>NK],[2OV-39
MH-L3M.MG>-2UN3<*V^UQ6I(68P4HD_"-M;!.(EKB@3H8Z2H0-*18,HY,(NB(
M\:=6<%^/2]-W]2O2\$YPYQH2%4_0I]:JN`H?/D2GGV=/[CT;8L]<W)V5Q6JX
M3$"G]J9I$FET?=C8VI`VR=>O*.2J!F_&X)NY5GS=@3#F8#`8#`8'7:_Q"_\`
M)'QY?V@%-_N@>26[.?E+L2Y6#`8#`8'7DYM_U)WDE_J&\E_PD##4_K'C=V&\
M,F`P&`P&!K(NKO*>5Q<-^1Z*5'%9+3_(D9K.0=&REYG,E;K34BMMG52&*HZ)
MK&,UU,$-CG)&E((*PEQ>&%6:LV$A$2L'O#6.E><L`\;,AN%HY`Z8N6Q(NR22
MY77J#O:5.+3"K,G5BIYC(JOOFUJ]:(DRK+#8XD5'FAAU71$6CZ9$D1I%#$VH
M%ZDI,X*UI!1;J94CA2/\4UZ$Z!Z/H3EEFZ8A?3UC69,NI^?.O9@]Q]UU7ZRO
MN?'^L>'^@N@8U(*68V6-EJ8[\W5IU<U1]P`\.D@2*C59@?:T<82`<Y+;$733
ME7[O`CM?K9CM9TH*<V9\F3N!\P\XPBY9Z".15/#81+;0Z,LB#'=FEM2M<044
MRS2JF1H<TS4-=OY,.=B"CD^SB32Q$I%*]5\)U6UFP.7T;R,DZWZB!'KZ7W+-
M7[HF42BIE]T('2O(_#ED7HVM9"76;7'6,V1DN+C(-C-C;L:)IC;H2(TG9Y1I
M52L<=/)7F"W!T7?;TW\QN5R6G7+#%)_U]%6V[Z]%6C7=O1R;FV<)H?`87$);
M,4PX6Q3UT9C=R%_<@L!K6XHDXRRQ(@C&:`M(C5%'.5\77?W8U1P&)2+R%+*G
MJJE(HJL9F>+$XX;G>(6O%^Q.UJ+MM5UV?M3ZV>Q+'>AT[.V@K$UP%I&U"-V'
M>E`#Q%F(BVNGKTX*53#R,=Q0ODB$K)/=KB&S[$:/)+=U<6,T1R*I@R6I*HYF
M[+>H;$EJ,;<L3ER"@+8@$3-,4')TORGI2E]`G$EJ=BBQ;%:<M/\`6Q.SKEZ=
MY4YRI^R6!PZE?;OD,[EL;1\W]:S"B;4L"<1&1(D&Y%:"MRY4:91&T\5H!C1[
MDP##%3>C)1&&)78](:J3>RX,TBZ>5%W[LF<SJCQ87I:$'OMXLFP(CQ7<EK0_
MHM0A8RES]*RJEE,\CUB-3.C;3F1"U)G0TE0UH!$*@ID)1!!HE(@#,,J1K=&U
M6L&K>H._:9O)9`)!5W5]\PI\X-=+CAM:S2QN*7&_ZZD!=F+&ERM2XITGLVM*
MADC:X[,`3'T4:7.*Y(U!"!>A`H]=Y&J6SKI&O6C\7>1.[6N'^.>7`E5Z2E%"
M.6^5[RZU45YSC.['A5^/71<,C;#(&V?V[$(,YP:@"*493UUCO0GA0SE*V]6D
MT2+02QE"ICQX<9]%?[U['[*B4V\@TWBUY7!%&"&.?D+BU2/,K=J0=.>W)OI+
MD9]L>M(M0,49FY;;"2]H%-!(),Y+9.`#`YQMO<-)!JA[``$:BVW2/+_5B.L>
MYNF(?S+":DAUP(HEU1S2Z5K*.V[1(3Q(PU'6$,NN$U4F?GF**0K]Q1!V:S.B
MR21XS2?0T+0F.]\%.(1>\K$1$S7DR^,>1^Z(],.ZYL:WW7,VYVH[IBX>4*VM
M'G&RZ@@$*DG)<==B(_4</L600]I9>@'KHUN0N4W`JC+B\A3,+0(`=%CT'1HQ
MX5IW9]V"@OFBN;*ZG-5=6==W/+^G^E.480H0Q"8<[()&ECECRC0I3'N9G&90
MV,UQ`SI6F5>Z3GR5W<$B=&6$&UFA_P"V%"VDSK32&2R"Z^AJV8_(A$"IM;*1
M_HKQ9T;;U3M=LJJUEEJQ6\YPG[N)5.S^\5PE5P>6S=U?JSCJ+W;:8L:U"AL*
M+3!'L9FS*1$:3/";O94&<SWJ2NHSY0K:2]C]-*WSF'D.FK)K*"RAQJM5!F"=
MWA0$DDLE<')B(J1J>UAL3DC66J9B3G#V$:@(M'!/!OW>HU^,TBD:RVG<];FE
MU2F?]0V+T%<$";ZIOSJ6J%?/+$^P=GH]LA5#W'8U615[L%I<X4YS18_2F$19
M%+#U87M`F$!T($06)($LT^L32-&K=5Y';[459Y(IA^$U\0Y=*N4NB^B.3B;.
MYSF-3L]!O%(19Y9T4*@5BSN%M,+Z$.G;<41/&]6S'.Z5*V)S_?#V#>M:C6,5
MB-..[9MU$Z7;#+MHFWY-9-I1/D&-L421S5%2CG"FQX1VV]2A4C/?+^:IA&W=
MWEE%.C(X-B$E-%C2WI"[!---+$F-T876=*3'-9WMJ<2JL>,NN+)@CP='IO7O
M,5]SB&R!.4F/4,<JB=52M^CSP00L)4(SCFQW0$GA`:686(0-:$$0?76R6Q6Z
M(G=H9A?=78+$XGDSBTG&1QRW/*A4](4>X(F*,IES3$HE:T%8+@YZ>CBTFSEN
MIM"!N#NB<1IBOATHS$X5.U&@^AO&/2K;IQ8PS^V&.%==3OHJY'M[LF-R(Z0<
MZENE?I**J]Z7OZA.?`0QEJB:^4[GM-B;-QUS6"DR@E6\(URCW(`G`)),3/)8
MSIF\_P`G*LR+7<&5O=(>S3NMFFR'5S?T\;00*M97.V"+3BTG%P6D&HML]81U
MW/?5Y9@R?>(4!V@#]OV0[$16:-%5\>3*Q.L>%^J1UY6RJDYY4$@DL<LY&Z6(
M]L\VKDYKO^%LW.:Q.>Q1<(EB2\HN`2YX$G4!VS-Q^AI?E4@XDPV-Q;$71LL(
MY>32QP]-U9SX"L6PWI*0F]0T"IA[9;\A!RFENRKG/E*>I'&63%71(;`TQFU9
M<"<3;(?DY'M.ZJ%3*!I<5+@B4$DQTKR]6.PKK#I&E^[N@4-HPF`/L)G5O>.:
MC;(;X[<TY>P5'<%^5*W1TE+1[$_U@S-LSK8B3*P+71R<AQ)R/*'LT#><?KW>
M5<8F--I3;Y/>@>AJZD:.G:P_`5#6-F<%>1^RK'?W![DK+9<>7T?7-9EQJ2UP
ML9&-<E)?(^[66GT2F/4I2EH%AYPE20YO2EKQ9$3K/&L(-KGR?7%6-#LE>S^C
MV9_Z&BL8Y&CT0009[Z`NZ,35LOBH'Z=L<@F!U4<Z3V[44D:X_7CD8\D-4/D!
M`%IQ.BE9Y0CCRA-L5TX+\R'M261[A%5U\NHB:-LQ:&]ET\4M+F2P*Z?@.YUC
M-5=O9B=OL*`1BPT,="-8<Z-I[I'&Y8K:PE&FI4_O=Z`9IK14R[_*K:=?V#T7
M#X!0%>RE!R^P];6'8:F8V])HB\O%7<C0'E:Q98[0UO:*FEC8ME,E:NCC$B!O
M6K4)'QR!-[Q2%.I//1EBWAU^]?9"'>'?-IIT-.VVS0YNBW+%5^16DJRELE:)
M_.T70\ND\-?'%-+8T12Z&O26&15A(G8P)"<\F2JU+HWZTK`W#*$7ZBV(UB>-
M$VQ;R?='2EBJAL2<A;06C:W1L/J-A03LGIZB:Y>X9):3NF[UCM#95T9RI44J
ME5A-#32"YK&WE,((Z%R<V\1CV4E-,4%#&-==*,49_)C;1-P+HQ/*G1L5T%5"
MH0-%*,UG6*GKY@G$XZ:KBE:M%<[/8/,T"L&('."Z6EJ%<Q;@.L73L92TQ#\J
MD^[6!A333@_5_E,ZJ9['FU+._-?-Y=F4[*N@Q6ZK0=*V,XUX56W/-(<OWK(W
MBO7XCF_\(I#.G6-])`2$,[FTLR4E<T&`.7`T9K8+JN$4K%:?\O&*^:!ZGNAS
M.%<P6*\4S8!$88Z*GZRM^HH^U'3F>+HJR0H=X6(^\V(>>H)7+I()260I=X[-
MI<I0%@V8<C#K0]`)A3S^GNLCX^IO>$PZ+\E*6^R(HRS.+7Q1;(&&UU9,EM"M
M(HDWR;3:X1$,?Y3$X&YIR7A4J&M6IA,K>,M<>;[8!#V(8B74I%.O^L2XA[=M
M>WYG%X7*Z[)B-5RU_P"DFV"6/:MDS"6659DHJ_H.W8:XL<071:@F"D36EI:H
MCLQ"S.,G;)@F9TPMZ;%R5&8ZGENBGG\,DM/R1RJ%=NJ^4X=SG/K%BL(/JMHM
MRQHY$;FD&X>X70TGOD8E.WB%4_+:6C==0IH($KDZB7S.+O128`AM+8Z_>Z$,
M/QR4YF/E8Z^?N9E\[A%*\_0:UW2H_'ST["S%EK3Z>0530G:%V.53?"NFSZ<B
M3ZGLA`]1@\H*+202(MH<RU_Q>UJ<36.+A%=:TU]$"=/=Q=620SRA4NS&,L:I
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M%$)L=N/D$<5<ZQ9SJUQ8)_+=QTGVG)`X/;,T-[EZHPN9P]"V$LVQE3M\MG79
M71=D<_--!MM15S#K+L;H+HV(<_1IJL">.]<PYD,D$(L>?.<I?9&PPJP'C29H
M9*W4Z`G3M9QB@TT`=;#AB(K7I#6+$/,A>%EQE>^P+CE06GF-ETS7-'S"PU=_
MUQ3CPZVETQ!^8U3/.[=DG-2>(.4F2/LL4OZ`JNCK";E,?:SQJ5B-5[*;#>$1
MQG7Q+EY=YAK4AY<]<%G-4*6L_/=4V'+>D3VRV)<XN:2=P/L"X.*@Q:BF-#3Z
MERM-B?+.J!4Y)U:X#"Y;95``Z;Q.7LH!PP]?^6>P_P`GU_:;8[,[JY,.HNJ6
M==8++9MC6&AZ=A*63/,+BS=+$`*#C-C<LP>6GMTG+7B:FP^T$58:>WY,8B:-
M.)FRMF5)MB.>J.HYY;^CIG*H!7D=Y)8V>86@BM:;0YZMK785%UDMK>L*U#82
MHE/+K>XMARZ2V2,L(RE"!A0.S*61[)Y+J>'8@AAA%*^WNM5QQV->?3W2LY1N
M$1KB-\TNO$O#W4%5)4S[(%UNM2WJ-!;KL<CFY(HRGBIBH1L"6(CTR1Q.)0)V
ME"I(.5F.JU.U5+HB(ZUE&'7OE5=^7;>LF$(JWA=@0J+TU=DNC<O3.M[-1.K8
MHZE)9<\EK6=2\//#C1S=O;;&=)S4C!,9'+D(%&E"EB*)`,6BVVUBO5E;+WST
M3(IO(><FZ@Z?2=6,%O/<%-:':YIX7S]N),5#4KT4L?5-M-U'N,I12P4*OAG1
M$M`XS[M4ZI''W*HQ&E^+&2D1$3RF&,\-]"SFOO$M4?0\N))F[M'G&822V%\G
MG#FH2QZMT_3\O16]+2YFI;'=4\H*FK#3HY-VU!2=.O(:"233D1)@CB"W1&=(
M<0N\J5BKH#8EZ0BCZ[D5"TNY,<FL&3KK9E+3*)I1MIJT3M1%D4"V%U.NB=D+
M)E7T@:W%T(5O30VMJ\U0@(7K34^Q"&,5IS0DC\L/5%=U7`QS;G)GO2XK`LWO
M9RC;!0K#T;.CGFC>-.CPTPYMI$3JKGBSY0T7&].,C;VMETZ)D,+4_#`5/4A8
MU#@0AT7")G2=-/5M4ZBZ3E%+T8PV)!(HPNUDRU1&PQ6J[!1W::_O'R@E+=Y&
MS(8CSO271%Q/4JC;'HXXU(V15<62(@8E1J8D(C@F(B)FD\%,/'_Y`;U[1Z-G
MB%?"JSB?/S5S364X:&Y&OLPFT6BUMWGTE1%F)WEIGE8P)>F:#;!H%[2)4+@F
M;G%$U-S<K/)"M<U[:T&KK8B.M5?>P.F>Q7"\^B*;;TM3-,2I7K+P^;H;;'/)
M['7R1JKTZLBB9QC]OOJ&#'B0Q6<IV)6C>B6\AU"W(`%EEDN>EAX$Q;;8I7I/
MI"2HQY=YW*K/;JS8>8Y/,'*M[$=*:ZB%6$(ZJM9+$;-C4W=(!*RJDEM?\NO]
M9O\`#F5Y:Q*-KYR_5^>8@]3M)M>GILF/C1O*PP8#`8#`8'7:_P`0O_)'QY?V
M@%-_N@>26[.?E+L2Y6#`8#`8'7DYM_U)WDE_J&\E_P`)`PU/ZQXW=AO#)@,!
M@,!@4+Z?6\.5U?/+-A=$UI!G2^+`LEOI3GBRG*MD\IE<<EST$]V;V\$L*;E2
MR',ZI8DT$*LXPI,%4,L'M:$/6&HRF*1P6?BB^E8(W/T:A;I6L5:V5YE,HDS(
MPND;:TC0^S"8O#Y,7U\0HU)0&]QD,\>%RA>>>$`U#FH.$9O9PA>I-4.QSFCB
M-"JMF:1:G>>23[_C,J27/)&:-PD0+5B"XKY+FA,V<$I(B))'U!*CX=R^($8G
MWH?L'?L^F"MW9A?54[Y@Y]KV\^@Y16E>V),833+%#;!CS,FAY]CR"G39*0%E
MA#K\8$Q=^!9#G+35A"96'X/0CAC!KU'Z[$5G2$>1RI_&HIG-H^,]FYYIA$8U
M0R%]/3BBS*F9$E>2%HG#^]Q%JG25(-N^0WQ^0NT'TG7"`'XA($Q)[>_9.!A:
MW:7.=K=Z\>/9]![KADA5/3KG>&V],*`C$$F</CR&!N<]IMY''G1LKN//1):)
M];T+@G$%$>A+%I0`&Q`UO6#\K9KS?)+*&\6-(IH-9<LJWD.O2N:WR*P>`2Q1
M'*];%%,O\PL5P5Q2-LJQ,1I7$5SS9DR6JB"->ZWMP7*5&]:V(X>"M\Z:ZI.8
M:^XVMZ#5S&'REZJ;VM(CL8JOZELB&0ILD,?;;.;YK#K"TT0A4)68WM]H1=Z>
M0*_A@[+=FEQ.V9[99P]836&14E0G&%+/9L6Y_K2@:]DD?(>T9T>KAHAC4^LJ
M=S5@.D*8UJ9]!<6XI:LT':L`@`T,?I[>O7!,S.LHHZ)M+F/F+D69M47KNI;!
MK13*H]1"/GV.R&NXO"9A-^E;505T97SX:[&BB$<:Y%*[&5+9"8N*V2E;M."Q
M07LHH[>BQ$S/5D\ENGG^-7RWPE=44A>[(+J=)&+%LF)UN1(X12]6.2=1+4<0
MMVSR=IT40B#D!">N3)S?:2GA*$=H.L)2:59/42'BB15(W,=,):#5T[TU"FAS
M;XW$BHBFC%R09?5D;K9JV&.$:(#)FGYH8BV,7N1$#]RT-I208`ED>["/RCC6
ML(=LW\B=ADE+<RJZ1IJ=Q+H:V;1CKRU-C-`W.&0J913GR=6))7Z?M&RCR"5[
M]`ZW-:![,"%0,H8`F>I`1:PL94KLY>/+.0.G+,[/I*6TY4SXZ,CG7U-W(GF#
M9!7P-^07=*5C=$;5N#6:6<ODD!B[1:Q"$G2T!R<E2G-V7O0=ZP4F(B65SVQ.
M<V";<25XB@L'L!#*;EF%:T>_1K\%7>/T=+*\Y=NR8*W1J,(VI+8S0U9$7>-A
M`B$6>4G>-E"UH@9FMDUU5@@%<>,&TY[V32&N8^9$4<9K%IEOMA\=8[6!\'OB
M<2R%MUPQ59K00;2OC[$5;_L.@G;,4E+?:&7K7KK>31J9OBDK0NG.7`+LOJ5K
M>*JYC<'3GYR*C=,-Z]G@![A53M\HEN*>/PQ*=[2F.N&G1"$XM(0$!FCB]BT#
MVM;RI6[K263N[EQK,9ATA6<A/HYXF1T9@2'J6*R`,8^/<(@[LS@FKQ/:A#H$
MLMT8CF4U20ATLV8266,9>O9]KV=D_+2=4%=21_B"#V+0U\6IS[3U@37H2RFO
MFMMNUQ8X0:L9H]8-666]'N3W,W8OV5D)<8I%%;::6`_>E);B`&O:`+>MEMRG
M2.6JS4NJGENRF2$5!-H52\U8F6*.J.O*X?VZ)O2-#"I#6\BJQY)BL95Z/T&-
MO%52=T8S_AB=ICF9:H3B]21C#LE9XJ,<XT#XV;F12TVO^5Z(JR4<V6KTI0D<
M^2XW`FJ=5\&O+/FD%F$YAAK02!SA37*I`0M=4A^@DF`$IT:+?M[]<-3-T<9T
ME8-AFO/T+44UPDD:T$\J.8\@W#(RY=()"RS"#/%5T:Z4O4,R99V[.!ZLN4K)
MBGN<LU>K/,,)4?#K-J=[$9A*3^W5P-&R_CVZX'9+X35E3PRO:4[/G;<E<9(F
M@A<4<KXI^5MY2"[XVY`T!H3R-Q?`E*&YPT9\H`-+UOV_;U@F)B?HR!!6/COD
MG0EJK6R%<TNW23G39#Q<#FB:8:?8#E1]QDO3-I7+G,@O:E;"YRCARH!_O3!%
M'ITX!FZ]V:4(8_*G1P-2=/<@=:N%L<I1$FLK"IIHIZKFM&E$Z1&05A<%<7"U
M6;%U4&CL6$89\IM,<;:T6M[FB-($7L@\`?8]CU]1,71KS6'04US$_)+;:&JO
M*;>$4\D#(9>#<W,<47D2:40AK86F/_..F2E&A6O469XPW$)@K];.2$(B`AT$
M)8?0E95+Z@<.((LTQ]<\4SSG<K]U!;SC2IZ)T=:K9FV9.\N9H_/;@4RV9R#2
MAJ&%LK[GMO=G%.H$(]S41EJ1:_WD2+6BQEV<7Q[+^1+AKMCD,$YDKZLJB(;H
MC9-6S5"V5\Y5BM@E`OA<)HJ3G25FT2AA4XAB!N"<UL2L.ET;0E@ULT`];`$7
M5YSJN+9$.Y>O,4:3VHS4O:)D<9Y%,(F3+]1&3F-$>D#$YPV5R5F`O,5#3L+O
M'7%6W+E97HF.3&F%&"V'UUA-88S+Z4XRFM<R4R;5]S_(:IGC3`X_*ESXV0E7
M")2S5Z$YJK=I=7)1ZL[DBB05HTS24(P04OO1%DZ#[6];%9^J((Q>G.K5KH_F
MZ*5Q!R>;.0:8;$MEAC;I$G"-M38YUP58*RLVJH&T!SLIC::IWE"J"N"#Y.5&
MJS$)>MG)SM:+2=)YRP/CR*>/6:48S.E2\D13FVM+69YW"(Q7ULT9&J-=[*@]
MT,<#63HIEA#L$M7(X9;#0T,0%H=`&%TTW$%G%B^'!K0NRKK-96`=>;N$I?<Q
M5H/%2<VR.^8F?&V8N7KF"!N=C1U8TD&,<3;MK#0'/38M1)PC2H2Q>P:'6MEE
MZ^YZ82MU*<G'(:`XQH*"I@UMSC61$>#:!+ZW1*I:]BZ]:*R)<,=&R*8MK*WZ
M3`V[-$<G*Y`^+"MZ4)&0Q:`SU#[98A69XJMV97'$-4+H-RU0]84A4SOU.1?5
M-K;(K2N:1DS+5:=CK]\ON=);$B4L97N+O#7*1PT1AS:Z)C$YJW0#SB]Z!O>B
M_E/Y3R<*U5/P5XR(1`X/-*_;IJ_W>\6`2[RR)T3$=$K&B>(ZFJVSI.]1&NV1
MHAU<U0J9@PAB>`-Z0EO,+T@T84/[H@M%K-R=K#@'CIHBR9V?.Z%J2$R"5\HV
MO-;/L,VIV@F-K^;*610F/S^+3"4)FP2=0WM<;>$)A3,,(Q'M;>>86#8$HO0E
M;IBG7U>/'-E\$1BJ*EE'(-<1*J*AZ;@)]^I'.%5PW5U%VZ.-3,SM::2V^:22
MW)H:Z')P$M*7Y3WHP:A$8E#O6R=ZT)RK2>++EL%\<?+,L-Z(41?E^F)N<C;6
MXVTTS=!X[)?DFZ+';V]$;MY1@`XELD]LN:D;,5ZWI*H6K]FFF>@ACP1E,4BM
M'.SELXVE'6$2%-JP@DIZ>@]"R"YX58J^!M[O(6"H$,H0Q)W,8YUM*8:1[]Z=
MRPA1EF^T:4/8]:]GUP1E33A54FX[]\;#%0=#KI-S8HM&FNM>7&%?$(;"^<`3
MI(7Q]2B.'V,VFV-%240"HI3U.EVZWN.DRH.T[4>O&(HK1GM86(NKIQB5MCJ(
MX$FH89,'"K.;7<V=P2;K(0Z/,:A`'"45[=L0CS78PV@#FG*7.4?L6%-+8G>0
MZ"(M:C3$`4:V$L.M&?R0K*6_Q81_G"[NX5%><\R.A+EK`4KNJU8C7K-+4UO5
M\(6GTM+(DS&TK7&5[.6GZ'I$<4(XM4+>C``'H7H7\JX\X9?3UU<(<[*>5.?Z
M-C$8J+\MU&\6=1U>5[6YD8:9&455&K*=Y5)269M3M$?<#H'&R@"&M,TI.,3E
MD:T+V/O1,7369Y*MUS/_``]2-B<)*U<_U?!X9QU%I/T[5\GE7/J&.1SYJUCV
MI>9!T=SF(#,I-D]?/$LV9ZNS:0`9[B/_`/'L0P[$6<]]97)M+JOFD5`<V]/2
MB&2FS&*TG>N9_P`O0YEK-1,+CD5@SVK91,HB"O($;H+FEL=/5!S\I.+`82H2
MMY2X.Q^FA!$3&:S:C2RN$N%.A&-;'7&J*[J^17?85+]"7##M0^$QBQ;>+JJ?
M1NU"(M<437)CW!Y8WI;&@(WHHXL8PD;-#HP(M>UH971]%C([6?%\=C;='8O%
M.>&J*/L$+Y_:FEI3P,AF>J]9E[HY@J1`00+29S86UTDRQ1MI+]X`M0N-,V7H
M9HM[)6[ZL(AW(/CT@,MBIL'HCF&,S:A6QV5Q$#)%X&CD-3M"XGT>EC<F)+TN
MBC>>G7?[<WV22_9-UL6_06O4M;NNJ(^<8[P/JU>J6FF><Z7A1O.$J:%<QLR'
MQB$&-$L=+HHUBETJD#.Y,!!I@#SH2[A9W78Q^\4@)V6+U+WK6"<J15*/*$BX
M@NF&UCU_SW"Z]CR=RI194M=SI7"&VO9RU<]U/*%2,B$$)')*W/[%5\:=``7(
MT1@2D2=,M3J`@`%0#8B3$QI+FYKS;P'-K0F%NS^I.8I+;RR**(7.IY)V&OG"
M9F0V:,IT/4QZ3.S@`QP`RRE@>!MHB5`M%K4RG9/WX1^SL5NB*:T9M/N?.1KJ
MCKXCL>JZ/LF+V6]L]GOX)&P1.0-$W?H+&&:)LLZ7&J"ST[XMBL0:D#>2OV(S
M:5`025H82P@U@K,<&90J%<_L,&,YUK^/U8W5ZRQ-4PG4S%TT:+CK9"9&2=\8
MV*(2W>J5+'7PAX,]L`TX2%`5._7VM&?=&O%52TD'CT9>HN3J!L2HJL<>A&J"
M3*=\S)5%6-KE\U,!IA$E-='ADD.VO;;`6MIT>$AO+`87L9H!!*!K0=[T6,J3
M3@A1QEOBGL8J;EW!2-602/EW;&+%12._J?8H/%K@M*PY.U59&KIJYW?TON9]
M^$LFV@;?EU/K0Q;$0,W>BO9,T7\HX;+'Q=_Y=\@L5MFJ+,J6`SQ@I"_Y]5KA
M6=EHXI,2S7JDY,6Q-U@H8X=I48V-"]9H!S:<84`P(-A^^^[KU)K;KS5(J+HC
MA&'V]6:NAN+I+`W-??$]X2BEZ`H1LJF%EFAG72UB6VTP&=J22#)9"6ZZZAE2
MMW3HP@+,>7,2W?M;.,'N+,74UGJV!/-=\;/\K<>B'Z-\^NTO=38'&72Y'($&
M5.2]34LP2V#6[&LFAY@_?JZ^G"`EV:B!G[,;W`H)Y6@&:T+*SKP?,JY>XPDE
MGQR2J:7H1WM^LY`]V3&G/48B"B=PR2SQ_<I>_P`U1;*)V\M3G*Y*]JW!0N]`
MC5JE1ANQB$/>]BL_25K<(8#`8#`8'7:_Q"_\D?'E_:`4W^Z!Y);LY^4NQ+E8
M,!@,!@=>3FW_`%)WDE_J&\E_PD##4_K'C=V&\,F`P&`P&!JMZ@\?M@];W+9\
MRE?0=I4C#"J>:J?J5NHN50T(Y0SO2LJ83Y9;+)8E-S$<>=4LY:D!34XQ5V0.
MWR6`T.U1`A^QHU%U(IQ4'7>(/HB958TKI8GY6CW0%EG]>NW4[I$$:\V)62JZ
M([(IKHR'QI>YG5:U.-@1N!1"'OS<0)Y;RC$J]<$X@'O%*E0&-9QRK1F5Q>+?
MHQHC_52'G!IY\,2W[$>Y>?H'73]/913=<4U1?84&H4I/*8\@A=*V`F#+898M
M+F*3(VC0M[8L3NRA1IQ+5&&:$(NMTKT]'"=/^+GL.^N@[0F[6[\_,,,EU$3:
MI$LF(>65AD<H2.B>K"H`SS&/1GEE#9+A^!1<*5%'N;W:,K0*-B+-;V-H]L11
M0B^(CG7QXX+;].<(=!V#T+??1]#63#:SL>P*JYHIJ`2M4H=2GUEA3`KZ;BO1
M"=S.31UR"C-+B-]MDGB02!*"U$SB+;\<$E(`>S*S$Q2(E1&SO"3;3S)$B.'2
M>/M=3#M/II8WPN!V?'JE?*PBUVVD@L"/6]`)1,^2ND_D*ZF1L3FMY@HFF@KV
MGV<(2>5>XWI*&4;B^/2/'%])7ANO842NUKE8JUMZ8J7:J9%`)':\^IY1$[PE
M4"Z'A]K/,VN2(U[X[Z]F4'G[G#V%U:D+VOEMFK4*>2N*+U&E4&[-)E&E-/'F
MD:E_$1:T':V9^DB;G=):48FG`<A@<ICB54N?*RCG//4DVN>]H7"YX?7#'*6]
MFE5=2S\'FTI.%(G<TWOD:HE&A.,+%4RCEPU1/S=S#*)KU]'62`UY!8B5S]07
M6U&6]VXQP"XJ_OZ]+#N1MAL=B=D6H?8W.E#HIC,27>-+G@TV.RB9MI:XP1R=
MQ)+/+"&+6EOGR2NV>)"?2NLJZA,VJ7D:NA5._<P)%S'"!E3^)]'KZ>Z+I*Q+
M%Z<M\M_H2%+F._)C55=29C(3!^7C%*>>/*!R>UB50,W=,]:Q5?'J+EZW;KON
MIW:`0ZJ*_@\9"4AL"[?G0EIL[F-:KD2INFM!R/FLBK/FOL2%3-I/VD(='J4B
M51T8MJVY*6HUZB,Q,1&O%K,9/#WT`CY[BG.J.+<P5_(Q,=.1EF[!@DJ6$7KQ
M^"FFJ#QMVDW+["CYUCAC@XWN.OU4I?$Y\GCIR.1SE[`M6R!.6':R-9169U3!
M8/BVM^WFRB&)%!N9N5EE!]'*+E=Y_24D?Y&X]3F--`V97T?DO0\614_3JEZ.
METPDJ%)+HZJ?GD#Q&EKD2%X+V,)!A,J1SG3L^VQO%M=UGN,WLAG4T9SO<=D=
M+\[V4OEM3#&[R6`\^U_R55526OS9$+%755&9`JKZ9V370D_R<%(VMJQ@/^*,
M(3+-[3!IE'#6E/NQ-[\4=]6(X2=[:6_G?BM#+#IHSH:MYFDDH?H+6BEUXD[C
MYI!>T.4HJOI`@VUI]-NJF)P>TQ+4UJB&Z(D>KXO4:3?#ESCAQ\1[(`=?#;U%
M(;8LVWR8-SC4,8G4DJY`R\L47;E;-M311%!JZ8XB]7PWR6V_&9;S6TW.^+T!
M@BT[%#V-6G3@+WI_]Y]T,7.W2/'EQ6%A'B.G5.1CE$=;USS?(+VK#I2[+4MG
MI*Q7QN?Y0_0>Q^AOP\(,EL2?>;)47?-IO%3%I40)!IV@#U$9$W%GM+D)N5.*
M!94SB:UX3'!-%]>.FP)/U]<?244J?F"Y(M9+;5;LZ5K<;B")H;,70"%2BOUU
M2VFL)HBW#U==*E4E(F2->`2D!4C9DA2EH5%^BDJ)%WXQ#YK`\?-VJN/N:ZE;
M(%S=;TFJ/LN7=02?GFT9>]L/.`*\G3YT0^H^<(K)!TK99IT$IM#=#:QQT1\*
M3H36^/DB);FPOW"1-5BZ,IG6(H@CF7Q%]#TA?5+3:;VD*Q8W#)3J=FRYHLFK
MXK(:B;M264RUMYTKUF?^'9_<,MHF/%/H8_\`#D6Y#4J]G$9KY+2EZ+2!$W1,
M3X^_V<[9?A]M&5?.V\0*75A5EC7)8/DB?9I;42"Z-MAO\-ZGFI$IHF.OL@21
M<E>^%PA&FVD6HUQJML:AJ!F)R%X?>$G"+]^&GHQ*->(*\T$&8TI"V!Q=P3Q&
MV#9)6#S:;%.Z^>7R3=#>/:W4%0,QU6<?\LUQ#*`LV$<:.T>D;:VUV2G2G2=4
MM.0/GQR\@P9Q7QU\TIMOCVZ<0<6V'1B2L.28Z[6AV+:-\NM&1Z01-^JB$5M.
M9,!\C49KF=W%Q5;4":9'"CB2U(1*J=5$'"T(E,-",6E@891E$ZTIXY_=D'CL
M\:]M<MVH^RB[HESE8;5/N9#:4FDU;36I=8.CHQTOTO*(7%E[2BH"O8Q,8<]\
MU6C#(TYG%B8DR/4,2-1#2<UI$&TU+KHF--U?>9O#1:%3-"AR?83RA#;*AUJ\
M++*IFM;_`!:][;*XYFZFEMNVR[)9$93L+>(#*+=JF2EQY0TMVU:980DT@6N!
MJ`6M`A-\3.E::^J5>._%#==%5CTC!Y;;3ZRSRS:HAM1M-OQ*U(<^)K`'"W9R
M>5%K2RNH_P`FTH[QFQIZ>X&I'ASDLLM64*&H\*53(%HDI9YE2ZZ)Y:>.KSCG
MB>=9O<]?6G:W/'%595PP7A7$ED?*U<H2+/IA1#H!0W8<`DD_1$2:C:X9%EE7
M'/>@HFL>&XU@*+)3P1`H4.[FJ3(=)2YZ4BM:<>R/HOX>[CKZKJ3C$83\]KQU
M+SG2L)F54:6O$0JSH&P*VZA4WM/(;8JMLK1X+*KNXV`W2%W=U3$]J3U6]B6-
M*\OUT*&=:UW^ST/WB2MJ4W])[<D=75+J#2$AME4=HRN^D&&JJZKA2V48P4T7
MS>2Y-7CS?+8EO/REW:5DJ4(TDJC407.[B`2V%*U)"M:YC.*4Y^->/%8]RX*O
M5=S5R+#9!5_*-D.W-]D2Z62/DJ1KVN)\RV5%91!9K!(W'I=*(3S,@A3Z_P!5
M+Y6GDJ%Q*I]L1.#LUDZ`WMRCV7(NIE%9XZ\_'N^SE7QE2OG^!^1A(M^:`5@]
MF">E$#>V!G3%;KMADU`1V&%4VL?RH2S.ZBJJULHMR`Q$[+5".:=@6J"=+U*H
M&Q-U:;0K7)_#-8K&W<PQRN98[NL4@%9UM$IZWNO0J$;W6-A,@(T&>VS1LXZ6
MY([=GB!<\"9"-MK7&G2M"&\+80`DXGX@P147/C7Q_C(Y]XCKB^47:QJ=7\\P
MR\Q]#]Q=$H[)<&`[;O*)G9TK>IAQLOM)Z:84DDDZU2;Z\C5J4ZA7[#:=ZZ;Q
MF!^YE)OK%.D0QR9^&6[Y#6EKU4S7-&8TUN[564GI>5-;I*0/M37C:UVT)<G=
MU@,*-P:G9.E"^3SGY/+X-M2>YJT[])75(::B0"#H<H9Q6M/')G<X\8-RV6HH
M7;=5_)G.:CGF\95:KR\U>^.LL2]@G_,-,J^CSETQ%=T;6HUY$YD[NG13!G4N
MT@-61]8NT4[:,V$DRF41%.-8[+*=H<BW_?T@H6P81$::-F-7PH!,.:Y%;<LB
M#!S+;[@8D4O5FPS3324Q9>DF`U,F2-1D6E#-'VT]*T$JB!H5IP#41F)B'(3C
MC_HBP*2XR:G5^@&K@IRVFI5T0GD$RE<\@MLTA8'X5P7I.%EOKS#$,C>")A7$
MT6.3$TK4A"1O>$R!&<J.2I1*#Q6*SLHG'O#5?L&XLM;E]@M2"N;>S]6+;`YV
MAP5OP#8;RDS6A);&C_.-GS6R*OO.+JT<H>Y6L<%I3M`)FPM?MEH?DYS*(*4:
M-9QE7IKYL5E'APNE?"$<`BE7<YZ1:B$$63F47I;[-?\`*[<>8/T7$^A=TTN<
MP<)U<YU=5[L-A/BY(X^L##&V-*/A@0$X00&EPB^*UU\?7QNV:6M0O3J;J6N;
M]IJN*">8VIY!?^8+`A$IN:7UMJO#GR?QN;$O=?'1Z@)\BG;0S$-!B(I&I)C6
MQAT`>A%ZWLL)F)BE)W5,JSQHW39+9X_ZU[+@=/I:GX9YOGU"*2J:Z<O5:\7(
MK=8;SU$HS)7I)'ZPH)4T1EQ)J5S^68LM=GUH5D+R2E&EH0^H#6=*S;QF4L]Q
M<)WQT!T!RK(*O9J#2TQ1TTI%S/#(006.RJ)PB!VU#959$(;$#ER];LSE\>G$
M#C6VY&V,4]K9L),#HET)>$9HR05+;HB)K6LIPY5Y"F]%^.0GC1:PU+$II'*9
MG-/-TBK=8J!%9TZ+HRZQALN&4E%0:)KF.7V"I4`>']-HAV/2KE!P?E%R'KXD
MTDS6[)RK1R78K=#/%G&C'V*[.XA>HHYVELI:[?"2(,?XHN;FTW\"P[:0[7G;
MF%D)E)6UH4/HV@.%ZZ-]DD8RX]?=!_(W`UB5+-K$L&5((]6*!/SP\\LT72D6
MNARO>$5[6!\U=IVV&MLV>J$HB5M*8IR7%D:;7%-)EA))>O5W.T$(,0LW<NM4
ME+>6;-C/CPYFY>35-3-^673E2T76SP3,;LGM$QZ-O];U:FA3M:%7VU"Z?LNP
M6.6-+FC$%J,2-;2K.1+3]#5IM;&2<2L3=,\(EKFMCQ`=:6S-9>NDW0ZY4^3^
MM'ID+Z.8)_7<,L:K']9!G:/,L.9HZ7QM)+NF%<H%2HI,X:07;#2W=*(X\2`@
M\8@B-1=$1P\=_LEY^\=]S2>:I)T3QWX_X`DD56`J4JLHQ8;HNB/+\L2S.>R=
M7UM0*L'(<>0O%X3!'.4Z9<D`T1147N.H!&ORTOV22"912E9\<N+%)WX?;;6J
MW^4PJ6U.79LFZY<+9LNSW1$!LL'HOG%IY7AM<(>>KLF#?7R]U<8I;]SUZA4R
MUL#M2VI6E8H4I-&JBRTPH912G3UW257/COOUOKGM&$IH5SQR@S=H6[2^W"%<
MIV$]$-U+4W&:RA]=V7(*YD"J@(.RGVTX[CARM`G,C*9J4&'_`.\&`^^]:3=&
MG.F[T37Q=]`()D_$5W=[/8\/F<[AKM.)STHGC3Y9+_5-J,K/6W;='((S4535
M97,8AUAU=157A8/@4Q:7;HC=#G%&:8,M0:,H_P"/1`7V,%P+K=2*)*]0V85D
MQ7S2<]6.DNF-2.*>Y:J@=QQ*5O\`75JU4R<)1F?NNV&OV09$;V^6[+2$CJG3
M&`"F!KVBY1<XQIS^ONG>6>.+HR*P2,M%.I*+?#HLH\J=>Q^NW^=2RKH'%*5[
MVM?\,JM(C#A&ZFG@6L=-Q%D;FK4:3LZ=L*+.$4C6%$(R@'TSB>/3T1MR]X_.
MGN';-A5LN#6X]!.$08JLK(AYBERU&POT\#./F\IN0:M&/%<+1.U'JL:285ZJ
M1$GNMN2,SW,<*/3M19Q@4I1)F)BG/QU^S:IT+S1);HZ%Y:LU*ZLS?#*=CW3<
M?G:(]8XD2%:3>-7-L$9C8P%(A&F.,;5B8TQ0(Y0D$67L(B]C%][HS$TBC6]=
M_C+NZ[:BA,.E<`YIDS]R3&J9K'E1JFD\E4IC%D06ONA:"LJ72:UEC]2KL95,
MVEE5445%O]Q;YF;HEX<P&+AI7%6G,-Q=$?7BGJB_'W8M0]*Q^_D(ZBCRUZZA
M[#M.Y'*)I3"9K.J;NV-+@TW6#M)M0UM=)0BK:9#2J_@%BDIO1:2%F)?:$`)>
MHDW5BG1`$N\/LW=:CC+)#K)'!K?6^0>R.L;+F*6T[:?HNMK9PM;JZ=PN%0>"
MR90\02"O4BBMX-D?E/R(RLX%Z4]R--4+%`"#3JN>O2E'&L7C3NMFL*PKK4\L
M\(/45F;5$X>V>.!;/'(/&,9=XL.1J%W4B!_-Y-6(M7S,=O9:)6D!7I8`MI.P
M'.JP_P"'4)AE&\^?/_4Z\;<:V=PC*5SLXP^&]'V/<;OR?44@O8M0:R6*Q5#2
MG*-7U'.YG-Y4_P`>D4F="1V'7RQR;X[\J*"5?RI[\:LE0([6R771=TC5N6PP
M8#`8#`8'7:_Q"_\`)'QY?V@%-_N@>26[.?E+L2Y6#`8#`8'7DYM_U)WDE_J&
M\E_PD##4_K'C=V&\,F`P&`P&!JWN_I&W:*ZO=G^\;!+I/C"+P=*Y0E6EK%!,
MF"ZY`7%75XFK9.+7-5!4TW+XZ\)"DT?:-EZ_"8L>_<;&8$80FZ1CI^RN0?/%
MSIJJ9+:)[##R"85*(ZEEK0+J;F`9+=`I,W*71OF[;*063N+R1[*2MB[1\20J
M3I.28ET`230CB?;E3_\`.:T^SW1SRH=%3*[HY6\=X]*=Z[F/;4GYBC]F(+CK
MY`>Y0-LY0=>DP2](P.K\0XII:P,J8MT7DGEA0*&@(DR(9SH,I/NKA%*UUHPW
MQO>86M[<BW&W/U@2<F:7!/:6JYBF5EK[)K93+7Z^5%?M;O*&5WI]*^:M@@H]
MR`KT-^$T`9!FE[]#]!$'>X763$S,<*K6]I]37O1E@3VJJY=(LHL&]Z.@3=Q6
MQ.T9^42VR]17@PTO9DMEPB50%$HAD2+Z"@T@7H-:*$C9F%S."(03#-EUF(CG
MP02/RNN$>ACE?#\U,"BL857U(0^8Q*7S:JJ!VIOFR6LV62HYJGUVRV(LQRN'
M-2(U"?&"S!N`3Q:W[.S/O<+%M9I\L:Z<\H[S/J0LHGG>'3F#R-H@O$-VP2;.
MTUK2*22P8KT!;/.+DG8X5!7F0;FBF+2&.V.LB:^6&(-1E&^)G%":K"<E,]!%
MM)UZ^B2IAY6RHW,6)$CJ2TWNQ-H%-72+EAH7TL8>UW\Y]6\X<WH&)TNM9-T\
M9(=V)TOUI.$%,H-9#FM><<-0%4F`2(8_\N;L3R^1N&Q(A]C?-=HV)(8A%Q2;
MHF&,4VJ%J7<^?"WQ,.979E>WJ0S-NCU@/3-=E>/K2H)C:AQ]DI`%5K>R%!`A
MB+*^/JQ"K_+C.WZFIQ9LXY%E)BJES+AG=^DUY:%5.K?5W-]<6I<$$:[J-1O,
MM0O\D/=V^D9,+4=0$'/BI7'U>TJ<9!Z(9T)LBM(E9BI/(W&[4Z&14?JG)S&H
M]*;.O>GZVM]7):_>HM/)YSRV#D$\;"H]'Y&X3.,D`CI0U!1[HB3%^^!M*/V5
M'H#=3'2K/^H.U4W.[M(F6.U#+[M<:RK`F^;U20V20:.*:@H8U;+48;+<2)P^
ML1DMTH^;V0B2M#-\6ZJ]LYP2R=B$7H0B*HZHCR1Q.\;U4U.544XA,+?;"L&J
M*>N.12*!J6.X;"K&"(;/ET?9H2T2!;8<4^#K]0>Y%GO3<B*-`C,+UOWFP!$6
M;*150=1Y1NCRN:N]BD;5`E75U77UT]#^26A8UC"QS:I8);=VP2"3N5L#>K.5
M!:8HOHF4,;BKV(`52YD`:9HO2L.L&,5C;1*<,\TT$;9+4=469"&Y?/I[`*5?
MR7B%730[ZX/)DSA4"G5DR]VJ-HGBNR*QB==0-Z?Y.L$^(4OO&V.G$IO>J%*,
M!PFS2L<*K77)T/,;!Y0EU\U+:AO,J")327EQV8/\!AEQ%VU%XE)E\?BA\58S
M7\E$%FN@2=.<U&!,TYDIU9?M$@-]K021$1-)U0Q-^Y;\9+@\<U.*H_!H;++.
MF-4Q[N1O4&:=BH-,+3YEO>R&FI*]<#E1*<]Q0SNG5QKDK]3%")`!K#L&PNP!
M:57'29Y<NZWW=$IL2`T%(["KB[SJ0=H1H;Z<N;Z=:;Q?IX(I.<4U5O&8*Y.3
M<H<9'+GDPA*C`A]ZN./&$LD&Q"UAF*5U5`?>KNH&=6\65+QM\&:>9U_+U==%
M<\L5?@F"JSK#Z!@M2R*8N-=V&>J)>$;-6CU;A:-$-&0I3+1,RW2@8?8%[!:1
MW<2P]$=;SBB.T'N4V,K@5C<]]TSFG6!;S!S`_P#4+V.IVQEJQPB,?::H-),E
M<P>=)+"`J>G0*8.T8@*!!!\(1HW<68B)C:82JK\A"NIO''07:EQ,E=2!^G]:
M5/*ILUQRZ:IKR%?'S2,IGJ0.,-G-HRF.Q.0)&_>QF)4*96:M7ZWH"8!@LIC6
M_&"L>^;8N6SNF(S7/,Z]YA%:<8<_=3T)(#9W%2GZZW>_HG:<FAL,<8Z4XG+X
M7J3N$"$T(?B2M'I536N/6:+3JFL1Y)MI$3U1-R]W39TEFUF5VHF"?K=XC4'B
M=H2QUAT#8:E;>>U3S*!1JP*>EJLQW.;I)(ZA)+&X+47O`R92G*$6!(8:(&MQ
M9MC3DAFEN[NL)DV5M`I7-HR?-NP:4X7O^K+'CU4I3T'-(>X4/2#NNKQTC07`
M398<3I]OYX]RTOKL>B5O2]Z"4L`7[)7M59MB/I,QV7+3=P/U0\O6O95MIF*=
MS#GN[WGGZ42!]EU:<UQNT'..ND>0GV"SO-LR>/5]'T2]!(-'[2!<3`&*$QR=
M*(P>@APF,3=3?ZLOGOD%8F;E[E[I6K*>F]UBZ\DE/1:GJUC\C@41D"YUN:+.
MLN8M.\CG,A9(:UIFUK9C]*#!K=Z$9H(2O;V+6$BV:S$Z4>'(OD&9.JY<EB9U
M-3NH1RJ$S^?5:NF4A@3YJQV"F+$9*=O(Q(W0V1/;E&3:QMB1HF<>G0M-IU">
M%6AV<F]1Z$VT5\=.V;*JOMCJ^F$$,GO1,ED=C4'#^<J.CDAA<1):TJ/F5+:]
MS.I4NG[I'8@P(4:$P3F:6M7!/7G^A*4`S/4.BXQ-L3P3-5GDA8KS^=5^J*FI
M3)*MH91/81=UL2"P*KKZ+5S?-;PYEETKI5Q33.5-3LXK&?<C1H%4A2DF1Q,N
M$<`:OV4YP@DFVG%"'(??ZCM#KBO'.!."QCJQ5RATM^%E8HYK!K"C15R5/T10
MD/\`EYNGE>.TAA,N`D8I<J2IE[8X'I!`4F@WOVP[]"W6XQKNARK_`"_6B[3)
M<V65S+83;/W^T`T1`.?H?*J3>VA=(#^K.PJ&:9BIMHZ;)P)GI&HYH5-,A1*-
M!9RU"(+BUGJ4:OVPEFSKI\1[I@/\SU8QN#NMAVA1]@U?%E-?RR85T\O\WJ5P
M9Y^\0'HJL>3YS&%+RQS%>W5ZDC-\6^QMISZ_C0L@VT:ET`H$A1GFAB83,TCB
MOER#UO`^QZ$07Q`D1S6TB?)I$WMK4O<??D+;*Z]?%\<E2-HF\:<'*%S..DNK
M<9\$^M2Q2TN*;85"<X90M"RI=;C-%"XWYDH9.'U_@%=T<MLZV6ZZ8+3+)`ZT
MZ$YMG*.1.%B1GH:31US_``^8+'5PAA6%$<VO87!F7+"7AO*/3J#B-$"$,)9L
MF./!$O7?E0DTZX;NJPN1*MM)2^-W+8K1FMGM$LK6-N7*SC-T+X5!5\D8Y#("
MWN8+RSH\O5B_!Y,Y@"D1[,V+6C"_65(M_*EVZW/:WDJC_(MEM%-Z@[+,)Q.*
MQF\J@.]W!532O/F48A-@3A)'GNK5TI36T&,FLU?J3U+ZE:S6TK0P$Z-VH$$&
M6J1;6*N8??(`Z5OP33_9=O5(Q0B0V+#*]D;U5<AORDX$A9UDX:R',DAKLNPI
MBPP-U"H2'!5(TH5NUYI!H2Q%:.`8`)<:W8PP&`>66!6?8+6T0NF)TZU!(MTS
M'8K?7X8UB1&9/:O0=%1Z_*AK%GAHY5\X!ZR7QF2$(RW;;?IH*7:$$9^@:]O!
M-E(UXIOBW>L5F%66Q:[9!%C:PT_4M=3R3J998=8Q%@26!+29:9-*0=IH^2=+
M%8U-:A-CR,I\5N"DAJV:\)@ISS=A-]@E-:*DQWS757+6N"RJ+TQ*I/7QM<3:
MU+\LB,VG2C_">>8A6UK(ZBG;@X/;9-CR+;*C\A6:.V.'_*P#T@=B+V(7H'9<
M)]691KLVP+I\A?/$$AD8F\+YS/CGD3B!LE=7Z(&Q^][`YDL^DZ??W!+$6UR6
MS..IZOL-%)4",]V3H@.1*GXI-HX@TL>#&ELSST]407;Y1$TWMW7,]8'%PBR*
M]ZXXO;)!((5<%/VDFDM42?M[GRE;,C\G;:XD\F>JS525LLSX`;7(4Z!>H2G'
M[+#ZE"WJ$6<YX4G_`!]\#\EZOF_QN^/^^KX"@M&0W/15>/MD3&6WG2%1/ORD
M?"V!W>Y06AMB71!1/W-Q-7'F;0,1:I9L97L^[ULPO0BS9$W3$(NZ7\I\PE35
MS===!Q6UHCRA*7_I25L'3;`OJR1LEX1BKN"^N+&&S,=0O,C32W2^.V5`4CBA
M32(AI0."Z-B+,-"2/0MBVWE/';ZPLRX^7F`1:O6^W9!35FK*-F](S.Y.>;G;
MG>NEZ+I%MK.&;G,S1,$,:),JDU>./X,)SEB04A3MZ19L'NB#!#$7H=3"?JF6
M0>1%"5U>CY#@-!V79-@`M:9U[)7EL?J^CL9BL<KNG>7+GF5EKE4IDC8J7Q]J
M8^L&!&6C2EFN:I<F4A*($'18ADQTRY>/97AB\R+2_0!OEB;E*V29/8CW7)'/
M%<'6%2GX0WK$;(Z+C?+Z"=('$N<#8*\:F>T)BUE+4LC4(%Q9"P(PE"V$>@Q9
MLI-'XZ^:*NH-'3Y+<]&3&DV]Z66M"ZO4SZT:33-EC7-S]-5=;7]58GI!-U;5
M`A5E/$!R/;^_&H6!W3@TK0*CDYA8Q4PGEJ\ZQ\T=8VN\!U%*4F#W!(O)>;X-
M=5HQ6RZ9FL/J*;=16JY4U6[(,R,31P7V,A,FP6T![G'"G!O^%<1'@-$!$L]U
M*IC/^^CDZ8\H=H3%R8X_:')+G7[O*NN;UYL;'$RZJ90Q-F0U+8[W`DASG(9!
M,D".1V2I5M6R38TR"6N"TPLQ2A+.1[`;NK-L1SY52I??D[A?/Q_2LNDM.6"Z
M<[\BC7QJ^^AD#[`T<=B5K%5I$+0::R0P=UD*2PY$I?F>RXNC(=T;>8S@<GP"
M<9X1IE/NR1;6F\ON>_(%8#-7'*S_`/D8VZLMSKN1R)EK6AR[%I$B2-S<P5=(
M[@W(95,U$Z+KYH1JX7&C3?<;<!*B#QA*,+"/0M:&/'72$?K?+=7^HJ_6/'J/
MM"8UA3DL15GUM+(R[P1P=.8[@4.C?'%M4N\%#(=3"U9:URAY0(30Q%*[$BVM
M*-`,0-[WH1;,Z<Z(:M_S%SNLF&NK#+X\?EE<*)]T]'K@]B\Z+>YY"&?FKG2V
M+^=V\J*1J<KS6BP7..UHH<#F=X$D4-Z%$>E/`!Q5(232Q97A.JP27R7O0I$U
M4ZZ<FV8Q=73V)#LVEN8W"S:1W++:J-*64)WL=NFR>;FUU%&YA/$,A8B>'%(X
M%G`T'10O;#O9,8WT8ZW>6^%/3Y&"&2@K/<H;L-*(+<FX9'6R<JDI7=/4=I\:
M-\7DL74RDN524QAZ"JA:UG+F9*L0+$)FG%(:<D*-,"7#OXG_`!&,3\Y]$60.
M;(*IJN:6;(FFPJBA-?1>*36KE+W/T5Q78ST$Q/#Z0?*B"Z9>FZ=O`!*(Y+Q-
M4@$W%F*RTHR0"%H39,<7+N'FFKJ&Q/4MN*BIA2B"4'VE&:>-L*U*10MEIV=0
M-B"J3H&O]OZ6<*66N]598Q0T(GJ0G(&1X3ATK0*3R!@$(83PC5]I/F<K5U9*
M^E<2I273>&+JKMVZKRFT4LRFG2(<_5O0\U@$-M>1.3^"9A;[63QC=B(UP?P1
M&[?&)"S?<;&9K0-C">;FJB\GEC2V:)(-/^5G&*"D'7W0G-L6G(;DJ!G@JYCI
MNT)17J%W"KEDN:W!ZL8Y7'#DJN*MA:IV/-2F+D9)K<>F.&)MB.?)N$PP8#`8
M#`8'7:_Q"_\`)'QY?V@%-_N@>26[.?E+L2Y6#`8#`8'7DYM_U)WDE_J&\E_P
MD##4_K'C=V&\,F`P&`P&!KWZ/AW'K99;/:EVFS6PI,\V)1M!_-J=;]HS2K6"
M9W;*$->U2[/?,ZNQ!TK'754[2("@$A''`.I82_C"SAFD@$$U%:4A]S_XT.4I
M6QIX]*T=]RE$C2S]I0*Y+V!UL_/S;%;4C;-$[#KYLDSM=JN1-U7RYCCJ`M;%
MR%1<?--1DG;1^^+`9H92RPOQ^\JI7)*[-D$DC$N;YE`+#:38W;=P1HMDG-;P
M758,LK84S%.V],Q/C[6^OD"2J$@"3)>S[VC?-N"?>R]C*4$VMQ?S)S/0<TD]
M:3:^>6(Q7%1%Q9N54U?5T)(U&F)G+:$9*YIIASL8RFY#9+X2W%(0OCHT'/*E
M4K$::MT<8,[!69G=;=13E2WTHYLNVPJKD"&=4HK-LJHD5@JE[?.*ND\N@3G#
M'@B3-[/)')I<G\F-2-2E5D+%#HF*6:"H`(2@DD\!*TK",7SQW<EO:)4D*@$F
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M<W4[]%25L2R"+=`1&KY'%W2S)&O="F">1*;,#8M<UIJ%$F$=K8"VWT\UG'KQ
MN<B/I+JA4P>;H&602B62>21>.WM?$5ALG+G;KM]F<(E$-C5E-47DE02A[/5+
M%T)7)#XBI5.3@:-MV-P6B/)E/U1EU%1/)54U]('E4[RWG^8B/Z=N>&V]7!LP
M62FOYM8T/4++UG<;7J3E\,8'Q[C8QDHR'0:9"$XT)3>`LWTUH1,SU3#8U%<[
M]0P^H7Z\(I8T"7RME;8XTPN16U/Z9L&2(G9E521;2EN(ZQLYK*MM`8TM2XQV
MBCPMD+2J*+7;-).*&I$,D3,<'"<OUKQ_<$+J?IRD*X/:&DZR;6N^N5B\R0,J
MMFG\\9'VE+"?BXWI]5-*,AXC")2@(0^P)O2I=@&F))'H.PEG*-)XLU'P=R@-
M_:Y2*I&_\(69LZ59VUVU()<%8F;>O98OG'0J;1H7_6S`SZ4.BI5H0_:$UB4F
M@;]I2S!A$3*5=YSXI><0U\HC=,,*N'OC+&Y)%JL:;)LKH&VZ(JQNG=22+GZ=
MCBO.[S<R&L6T;]2\V>VX9*5&F2*'!;I<L*5'!'[PN4OJZ.YHXQAE)\;4=;3+
M:C17==6Y35*<Z(*6MBY:8/BMEN[<;#:U<U2^D;%K=>2C8RD8])5!YJ@+4:/1
MB8`#-^U@B;JS,<4U3;QZ\:6"_5Y.YCSK5<RM>IUD5=X%<4]BJ*=VT0_0-B6,
M<'=IA9DJ^59W9AD:^*"M*!(G%T`-T3)EX]"6IDZ@HF5U*1.C%99R=05E1FE.
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M")/J?GZNN7PZ:+(LHEE,IJI!/.ZT8U,9%+AQQ7(H27(W`MOD1J0<C3DK3RPK
MO=FC"(DS,\7K@_(E+U\SJVAAU:JTQSF;%.7J23"_[XL">2-PC:_3@SQ^3V+.
MK'D4ZDU<IAZV0**+W%1&3D0QI3$`TPQE"&4SJPR)^/[E6#0^>0>+0&0M;+82
M:.-KBJ#:]N*91%8]"E#DKK^'5--5DY43"DX'6JIZ7&1AAB"YD9XV-<IVVIDN
MU!WMEFZ9FK+7_CFAY%5$3IM2SSEJBT'>")'%G^)7+<<(MEIDA1:DA5)2[RA\
M\8[F/D;VD7*$[FO-?AJW5,H.)6&'E&F`$2LUJ^*&\2\X0*'U=7\=AK_J%4G)
MJKF%2QI[LVT92TU\_P!+P$BLZ]519))YD[EM*=LBI.]*DQ7LIG5P//<%Q:E>
MH/4F%FZ9FO-[F#BSG.)FPE1$H8]1);7;?,VB'N45L:RXVZM+-8UY0WHV?,NW
M5EER%P7LLTMJ!-BUT2*3#DZY"6<V'`&UJE2,XE98W;?'G)]E3=>]3MH7L%JV
MG*665)9;"KDLRG[7<Y!7<$W#]&0285M.X=.6),770-H'M&R*DR5U:_4#D4H*
M]=86+ICR?(?X\^41N+VN10:61]-*(VECDLC,1N2Z(=!)><@;FMJ03>7U[%K`
M:(/*K=0(F)OT1-7!O42TD;<D,`XA,2D"+)6634/Q%SCS;(A3&K(G*2IH<BL!
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MK]1-[RO6S2H*74T;MN'ULR0U%8]D2I#%XE#(S>DI1(&9"60TD$.?LZ3_`.[I
MO<EFZ9XN&E_C`XMF\-CE=/%:RQ%`HW$SX*&&12[KU@T8D\0.>5$@+8+(9(79
M#"W6FW-[LK--1@DA;I\#[P04_NP;V'"936O-(MF\+\SW%;31=-B0R2/LP:'!
M(\;:B[5MAGK)^?D$.?J]0R.:4PQS=MJ*>29'!9,L9RG)Z9%ZX#<8%/HW1110
M0"+IB*1P0O/ZEXJ:6GDKF!U+L!V3,MZ2.N>?C(9=]QGS.K[/BU#VO8K_`!MX
MM9BLY)9L<9"J.;GUK.:53F:C&R+RFLQ+\GG`*"6MVLI1A?C^Y5K"*1N+5S5B
M-C20>34Y.X6!QE-@/Y37..>JY;:KI=]7GN4N.=7C4.A3*D1"*.4["O`5LQ3[
MT\0CMDFZ9FLL9J3@&I(KS=8-`6,Q1E_(NNW)+?MR+:N126F6U[N603]GL5/.
MH<.+RT<U@[]'9%%F94WN*9\&[$+FPI7\7M1]_A9NFM7)-?C?XZ:8_8<9!5KF
MZ-]L1FQ8A8ZJ36=;$M?Y>PVU-DEBV&G>93)YP[212KDLS1%KC57Q>E0!A]DL
MP!>Q`V,I?;`^7>/XWT2FZ"@HQBN1U^?Q-'&]->MC/D(;%DGG3$+IE97U'++!
M7U+%'UWLYI2&S-8RL*18.0#&8X&?&*#A&";KJ4G@X>*>-/CN%R5%*&2O9:)6
MSO3,_P`89GN[;QD\*@Z]@NF&=#M9=>5_)+&=H/7K63<E?-#V-"RMZ!&<>E]T
M84,@TXHP3==*.NE^8.'Z2YQ8Y-8D2LZ)4]S75**HVQMIRY;QKYX/J)Y/;X0D
MKB5&UY9\,<+1B!9KV'V&^2*W%*08:8H`$)PA#V(F9GK*%K5\9_&=G\\2ISI9
M6OJ%`T5W8E6PZ7V'/>BUU0T3$`5[).7+LET2HB:6M$:XBDM)I,<B0II`8VEI
MCW(9+TNTZ$^W\5%BZ8NU7,B?`W+3`[JY25"W62JG:!.<#3MTDL:QI17,=CLI
M82X_+#:MJIYESA5=0+9HR^I#DLB30SJ%R<>RS3!E[]G*SE*-*`YOXPH[I^15
MU5\4L<[H&O:U37F\3>R;8NBX7E1%NES6ZDSSE$\MVQYP_/[@Y-W%#0WB2JAF
M%MB%C2:3;+T>=H19FZ8UX>/=+#=P'R6U;J_:"I4J?YF&Z.M5:^DHFH]1I!%+
MJB_1#`07HR1CTX_`7##&UYT)7[\0QIM$#V),(9(B5EQ\\XMXZ+8FQVFT.0Q=
MMA$BO*7,$QW9,W@SE!Y?U'.BIC;TKCDX;9@RO$1D\SFZL)J9P1K$RMM-/V2W
M&)@&;+$*RP"F:#XYLW=]Q..1JR)DX5G;=,4M;;_;UJW+8LP?IOR>]1KIVF!&
MV!8MBRV:2=!`9/;"=P3*U"[VU1IAB53HY,4$O"S,\6<G^//EY0^OCT-BM,M+
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M8Q>LE:W385Y#K,TCZY%N)12S1^E)19H1E,<$,=`>*#FNZ.?[2J!"99K1,YLE
MLMYBURRV]NA+)L**V-/*:L>DT#X[RV66TKFLU@+#$+1=T?X%N#J.+GMZY2E^
M#"6>/"Q?,35D:'A;C^!-,9I1R(N0Z6V04,;!.`WMU6OM%OW7,>;OCV^$W\GL
M=?8%(Q5&V^QM.R-DC9&L_P!H1:=.:/0PX*S.OL^V'<[<1J[+M7F>.50J12>N
M*HX^D\[(&Z3$AO=(>QWQ>]S\].6I#N3C<'^6-E\0Z72)Y<3M[<G9T6C.<U*X
M2@>M"MU*\M4J1OA?FV*$FMS1%YF*,EV5`+;C\!=KEN:05C7\YJZ6HYU!EU45
M@^SYQK^HVACE*`I5IJC+:U-1_L^[.3&%;$#9)NF7J?.#.5Y`AC*)96RM&9"7
M"]WF$O,?GMC1>4PM^Z6L-/:ET2*(2Z-RUJD\8DDNG2;2P#BA5D+6T(S"$)J9
M.884(5E]+EPYS?((PIBDOBTPL!&OH:P.975XLJX+BLB:O=)VD\,S].H:_P!@
MSF>/\Y?A/CG'T8_E!8XG.B<!`2R%!9?J#8K-:]6-N/CSY><YZYV`>Q6HG/?)
MZIL]^@#9T?T6ST5(9VX.YDB=I%(>=FJU$=$ORQ^DAPW-Q"KCIQ;BYC$K4A-4
M;V9LN4THNWADP&`P&`P.NU_B%_Y(^/+^T`IO]T#R2W9S\I=B7*P8#`8#`Z\G
M-O\`J3O)+_4-Y+_A(&&I_6/&[L-X9,!@,!@,#KZ]0^-:;6UUW?LT2TP?)8-T
M+;/C>F#U9+9:B:,ID%:\Y7)'GF](6\,PY^R2Y%*CV1&-V:UC0VCV),2).0M*
M4B"G&=(NB+8C:OJBQ?P/WTGN'GL@B2V<S4O5-I6.AK$R#OL`LA_HF&H.W[UL
M&&R1W7V9T[4BS<9FO)#]"(>,6D%G/A;:VGD'M*)8F+4+8N5M)X5\??7DP2<>
M,OMI%#:/-BB^SVN1R62=+22^UD#FT>M:?PV\IO=9[O071T:*N#K&A8"VEU)4
M`UR1L(;U[Z4A/<"2#XPOU[PY&(NMK+E+W\;_`%A=$,LNO%E3RYPG#W24QB_1
M=T2>[XXEKCNFSE;S#C:RD]?UPU7.\N=1EPI:@>'4Y,Z-,43(RUP$Q(G$0=>Q
M2+XC7KV;_:ZEX%$=MFM:IKJ1L(N=U9-0PK5C"<VJ*39Z:*QBDJ8-L$C6*7V3
MO<)2$2A`W*WLPHX0UA*L`-J#DQVM'.=W76BG&'D!0P^;)G+FFPU&D76,#MFD
M*?4VS5\8J$LD%9N#99+A<Z-F[LG<R!62J7*-&-2YFD+J_$.GNG(<1V46)%LZ
M5MWY>.3:9V[Q!+[YZ:@5XUPR%H)9'N'NX*-0V6.>/D=-A]GV@W5DDH)2G96]
M_3^V!$K5RTXY<G;S_<^V`2D0C"F_W1F+J12>%8EK,O/ASR`]*PN?[=Z;F48<
MS:F^;>,1.S;EIM^]^]IO&)V9S&\2ID5Q2TI@SMA,]NRW(^%4)0<E5&ISBEB@
M&M$J=IXU%UL>.L2V,<F0N6._;%]%`D+3(Z)YK>98&N72/65)9,Z)KXZ0-3S[
MI:O[!:A'F1P`:[D)A!+.A"H6Z9BE`TY92+8-DY6*Z=6N.P^/?(#,KCZ,DLJY
MMG6ZJM-ML-P6UM2%F5<@99M:,1MB![H60OJV>]VPAZGL!=ZP-?%[JF!\URM$
M[`VF$E5D@3F*#58I%)U\=%R?)'QGT]U?S'1E50V#("E#=25YL%J5DR6PI9X:
M1-I-2A,<K5H4.3S)VA1,FYFFVQ:3FJSEA28S7OS!BUK1NT]"V;8FLK-=N<>$
M61%N%VVO:J56-%^2^K*GLA17J6?'L$B^;:,0"?P(E0PR663:-%.KK"Y#(V-[
M4!<'?2I<VM*L@.U9I^T:LS;=QKSAJ>9/&1VY5?/;="Z:;'.%/LVI%T,Z/C3?
M9R"5)[(G23M6!6.N@S-&WJWX1%"7.:<R`E#"F^3Y##F@>G0:58\H#!EJB8WG
M;,Z[_9L9(YGZB2^*URH=CD%BJNA"E!,FBS9+G&$5[-(\SMM\-UG-U,M3Q"KH
MN&'M37'("A%%6(TZ;NP1MQ24+BX;$)0;JLUC.L\%.K`XB[,Z&.Z)G\NKFS(`
M^2"%>1"><Z1.0]#1Y%)*TOV?Q7C<CC\H*FJ+C?8*-N:I/5<G7E@4GJFUI<`F
M;/\`83J=;618F(I]/NX?J?A;M"U[4B[[$*GDR[H-EZHKRXXYVTZ7#"T]10"D
M8\)>I;*J,H@^X2WY\E\`9E>FDQ61$RRW-9K:X#CKV]["2)B(G:C$Z-\:'3CS
M,8PMOE@Z&04O"JGZK4)ZDC,\KFF)$W]!R-CHMKK:RJ\<8/V]T>@DDFFB!JD@
M6TZ4/+:T,+LA+4*4*4I5[0BS='+CIXX,@;>=^MJIHQ!(;?3D\^477G/=A1NT
MXI,^A8?#OPUBGY4]:SMV9Y[*%W0LW@-7W%==$,[TU*I(DFZYC8%:O8BG)*`[
M9!5)F)FD<:H5YVX_L'IPZ?V/5]4SV,\OLTPZ[G',,+<NN!SQF:;)<.=.+66A
M))')_7%]3"+SMA^?6N9V<7LA_>XVW*%*H(Q>[."(46;HCCQYZ=92E">(/)V=
M(9M(K,D4R56,_P!=QA1<\CBK?53'">GF3:>$FV-SNR6`'LIPF4"D3\S(W)J:
MI`76D21(7#T.$X_#[T<,E;::>/1:7FKB*U62H/(VQ,=+V'R.GOZP8%-N=H&^
M7I&I[8[0JKRB*MC9(W>Q8C9-IHV0J06#"%"?W)KTL"E0'[UKU*]G6ZDW<.<H
MH@?%WDP?FOJ@ZQY@;&G.QUD>Z[IOXBQR9<IK_I>XJ]45I>'/#2E:)BSMKO6E
M2U@G=&)G"M5M;`Y+Y&C7$'$GH#G`H3-NE/+Y16I\<G=4RH2N8G'EU@UG)H=*
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M'CAP9G8O`?D.L"W)\ND`Y2+<QLFFG2<26$KX=':VL.ED%^TH_P`HJ-NLH[LA
M#<+>*MZU85RA"L#5$=/=#V42<U0?I;[M3$RMIU^/+[I_@_C]M^$=+<8V.^T]
M()Y$>;NN.W6J&N>KF0.+C3_*=J$.2SGMT&5*[,1.$HC[`[C!\4AUIWDI)`PD
MF$&$!$7JF43$QTAQW:/,_>MH]ERBPZ;J+;)%TL7L.!QRR8W,HPVMT[@4HY`M
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MD3O/6EK>4D9&2UI9,A7)7H`T(4J8U-T4T[?=!M1^,_JY14/&=%RRJ)A6])5[
M6/+==7_4Y?1*),W.3S6G24SE5V2IN55O;2Y2<TSB#*T;@F`A6DJ3$1A:`:<@
M90T8(N5M9GGJB'J:'7%6KQ0=5W@N6S2\E<GYRAG)L#@W4L-9;,HR*P#R46NX
M/LU<*A#=T>M.\F"S^-5\$:UBYH9ILH1IH>YC>2FXHA4H.I$QK,<.?;W;C.[^
M?[?M&^:CF:6H[`Z+I=AK661QGK>N;FCU.KJHZ&<)*SN$5Z&E"B1V751<GBS+
M#TZUJ$E1J'Y<4<HT(+0<$0CBS$3%)CA*$.%N(^N*$N*C[0N)]72B<.R_O=#U
M[/T=CN2R,6@&570RR3EB5-M<.TR?FZ.I'*/B=G(A"UIB3&3;@8E4A)#[L@$6
M;HF*1T1:L\6+O*^HI7N:T6N54[,_)'*>K)U8+5<9K*VR^H9+Q!:E0QAE1-K-
M92&R&65Q&X'<@MW`G;V_2U$[%;*4*TQ!^DM7.D:<:?=B#/Q;Y'EDKX?<['D,
MY4O-=5#0D6?I]%4=5V(Z4K-X>Q($=M.TT?)9U]2P9)J;.Z8_9JAJB%A#&E4:
M&`(3`^[T2MNOC[+1=K\*7%T!T7:EJ,39*')J%"/'W#ZK$VW9(H,TI6^,=2VT
MM[82&QAEF\>2%G2/F&=Z;3U2A/I0O(4^Z0&;6IR1$"+HB*>?PHG?7$/D33`5
M1>DZ74"44=8UR&<960BL:.2DV,TT"=-CU5,#FKU.^Q*J?8HI+;`J`(5I\7L5
M2)/K6G#:06@D;C43;SX2_"/%=>4$;*R.ICG-?`YA35Q>4*.0:1ZN1B?-,T?Z
M2O!EG'.E_,B%PO)&>[0I'1S6LBKDR.:M-)#7Q:2K7MX_9&ZDDFZ)B>M/1+%2
M^/OI]?$*"9[,8KL:X'`>CK0M62U6W2VO*=E<2);.7+DCD%D4%<H-V3TFT3`Z
M77T^1MR0IGZ4:2-SDC+/6-B=&$X6J3=&N]/')/L>Y*OMY\8EX\UI:,/K6:R2
M6@^;N$S.>1QVFC_'$UE1.2#>;#=4EX7Q!6Q_5(&U5O\`W*7JR%A)19PTZ!0<
M-$43+\JS-57)WX_.QK+!(81*:XFDP>[*Y\[GJ:3V9;-U1QWIZO2+4F'7TBY[
M6URAC5X#L'4\&;.8<WR1$ZP9X8%,94$!*<D*EC$@62BQ=;&O6/LR6!\.=IM?
M4'/$SCS1;%%TS`:TIMEKF,MK_5-CZH-K@T)`SVE2UE2ISZU(<38U;\Q(^+5J
MF")6:I$WCT(MS;S][3%U<K<9CC*7?'WR!T[4DQZ(>W^L)30M@R[B#GZCU-XV
M#9L)N<FX^O("_=*NMH=',+)'[4L%]::_DDCLEH>D;:[)HT<8$TPK;6C,T:6$
METVTBG"OIHC$/"?3\L=G=G9J<L6H:^?)!S"V=&M,LZ/0/9W3LWBW6%%3FT^C
MJX60ZZY8\5NP-='1&8)MM:@^,KUIKX6C`RJ@!T(H5BFOCBL/9W"=P3_Q==*\
M=.L<%)GU9<=ZJJ,ADBL4Y>-91"#J1^G=%PH,X5R42I*<.CR$+6@^5G(LY":(
MD"T\D90S03DD71%V2O8_'=U.S/MLW!SO''OG:[;8Z%O`]@?W2Z2UYD$H&6^,
M5RIVHDLK:6>:3N%.;C#.NVF,K%2A*C=WO1[*2M":H1!%[TN4<]8^5L/'SS-T
M937,/1\.L0VSV*56"=)!US6TW3UK'V^"NIT`VPJW*!N<`ZAZH,"W6!,-#>E)
M[I)DB@A>H'L"%&3H)8:EUT3=$PU]PGQ?]<L;]SC7KFNLR,0,%!5%`9=8$,=(
MW8KI43D[TL5'NHV*3V#/>VX).EB^RK(=Y&=\IL,'FAB0#LG4(5)(B-`(+-T3
M6>KGK9XF\C$]AL=EDV8%[C)G&:N;!-:EJJ2QFSM)H]5I2^&\WVXQJ[-ZNY(C
M;4[DP)Q4GOA);TL/-=32AG-ZW8-F%PB8KKX]&6(_'?>T.H),OFM?7ITCT]*^
MQ;4LN=NNKGB[?%)K#D]WRQ?3,OM&(N_4U7L<4CB.K%B(TEHA[NXJ&)0>=HQL
M<QE`(%3**Z:118#QF<J]FTKT!=,^ZBDDY-4R1EEJ%]-2"@CS3UO2)^G[3(83
M,FB6`Z$FMI.[O44!0[B[8-QKBMB34*E8,]*J.]P>*%TVS$1"O3=QCW45<4N<
M*:B5E4;$5ZGJE<LLVV[AA\EGLZE]B5U$&J"/DCC$(Z#M.*2E@4/"!R+;'#:6
M)KVA2>$1C*F*+"K.%;::ZJRRSQS]?+I_<4WICE&T:"H.:0[GE@<.<9#;M2]!
MVS.9W6X.@AK)N@D"_NNJXXS1Z*G602(DI98A!BA0L"H"VF[^(+3ERC2)GQIT
M=E_G1+9D;@$>KFT$<R>7V`0F`-BJVI:57K5NTWA9'@*9`J31>#S^>J8XX19>
M'2!P+5G?#FJ=>VA4KD_^\[KG/18#"&`P&`P&`P&`P.NU_B%_Y(^/+^T`IO\`
M=`\DMV<_*78ERL&`P&`P.O)S;_J3O)+_`%#>2_X2!AJ?UCQN[#>&3`8#`8#`
M8#`8#`_-:UKU]-:UZ[]=^G_;O]CUW_W[]-8'[@,!@>LLDHKV]E%%E[-&(TS9
M8`@]X8+_`,1@_9UKVQB_[=[^[O`]F`P&`P&`P&`P/6<22H+&2>46>29KV3"C
M@!,+&'?[(1@'H01:_P#IO6!^$DDIRP$IRBB"0:]`%$EA*+!KU]?0``:"$.O7
M?_9K`]N`P&`P/$00C"(`PA&`8=A$$6M""((M>@@B#OUT((M;]-ZW^S@?H0Z#
MK00ZT$(=:"$(=:UH.M:]-:UK7W-:UK`_<!@,!@,!@,!@?,8C2&GE*C4J8Q23
MKT)4F$%#/*U]W[A1P@[,+U]]O]C>OV<#Z<!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@==K_$+_`,D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!@
M=>3FW_4G>27^H;R7_"0,-3^L>-W8;PR8#`8#`8%>IGUSRC7$R45U8?3O/4#L
M%()M`K@DSNFMXO,DPWKTVS@41A\DJ%[)$[>NOAM"(UL_U^\]K"TFE::.6B'2
M=$SBJ5=XL=GQ<BHF^22Z(.-@2=4;!HVW2."6(\5-*6QQ6S8B/?`&-UC,*II`
M,[0"E2D`?AQ&@-*&,4FM.:;0#`:`!A8PF%F!",LP`M#`,`]:$$8!!WL(@B#O
MUUO7W-ZPCRP&`P&`P(NB=T5E.;%M:IHK*2'>PJ071-MM*.%MSRF.B:V<Q-LG
M$5(/7KFY,U.6W:*O"96':(]2$H)OL&;`9H0-%I,17E*4<(8#`8#`^%T<D3,V
MN+PYGZ2MK4A5N3@I$`PS2=$A3F*E9^RR0&'&:)(*$+V0!$+?IZ:UO?W,##*G
MM2`WC6<%N*JY"5+:WLN+L\T@\F(0NC82_1E_1E+VAT*;WM"V.Z,"Q(<$>BU*
M<DX'KZ"`'?W,+,3$TGBD'"&`P&]ZUK>][]-:^[O>_N:UK7[.][P&!&*JY:T1
M7&R4`JE!)5O2.NI-;++#=MSP)0NKV'2**1.2R,+J!N$PDDM<@G#4F$08J`K,
MVKT(LH8`&"`*:5Y).P(WL.X*NJ=(>KL6>1F)B)B4ZG9+8Z.9&I"ZQ&L68J0V
M$^QZ,$"/D<F20YE4%*'#3<E5#3@.*]H.MFEZ$6(F>"-ZQZZYVN5/.E5:V2CE
M">M(7`K#G!A+#+&[3##;/C3G,(*]FA>&%N$L+?XVS*5(2DVCE!.BM@.++,V$
M&Q282I5MFP:Z:V@5O5B_%2FN;/B$>GL%DI")R;B7^)2MK2O4?>"F]Y1-SNB+
M<6M84;HI2G)/!H7H,`1:WK0F)B:3Q9YA#`_/:#[6P^NO:UK0MA]=>UH(M[T'
M>]?LZUO8=^G_`-L",KEN2M>?*PF=S7#*"876E?,RB03"4*&YX=B&5G2^SH]:
M8W,#<[/"L)?M:^\3IS3-^OW`[P1%9I'%E*V9P]NE+'!G"5QI!-I,VO#S&X>M
M?6M+*9`T1X2$#^ZL<?/5`=G9M8QN:;2P\@DPI-M05HP0?>`]0R7`BU'=58.%
MR///Z.5$'V_'Z]9[6=X:%N>0GHZ_D#ZX1IGD6W8;<&/G$K7QJ4$:(+5C5!V7
M[0B@@V$6RTFE>24L(8#`8#`8$(S+I&C*[L(RK9[9<<ADS3U3(KQ7)9.8J8V1
MJJ:)/2&/22<O<Q<4J>&L;,SN[D04=M8X$&AT/V_8V7H0M%I-*IH3J$ZQ.0K2
M'DJDJHDI0F4IS0'IU"<\`323R#BA"+.).+%H01!WL(@[UO6_3"/=@?FA!%Z^
MSO0O3>P[]-ZWZ"#OTWK?I^QO6_V<",K&N6M:E<:Q:+"E!,<<;EL9)4M:)C6Y
MX7[E%A+HO*IHECA)C2W+RFXXZ,0ET5>_6"3I-!2;!LW1@RP#%'JC-UUA,;0L
MZF(U*B'.S*;30U9946`VO*<^,)K`:#'Z'FG.*QM3LSCIY:2A'!TC4*-E:U[)
MNBQ?>X6D\4IX1^"$$(=B%O00AUL0A"WK00AUKUWO>]_<UK6L#'HE,(E/XVS3
M*"2F.S6'R-"2Z1Z5Q)[;))&WUM4A]I.XLSZS*5K6Z(3P_=`<0:,L6OV-[P/R
M5S")0-D/DTXE,<AD;2JVI`JD$K>VR.LB9<^NR)A8T9[L[JD:`E6\OCFF1)"Q
M&:&H5J"R2]",,"'881!KTJJRYO9==026%2:5T\[(V"QTK>TOVVN-/ZU/\4%A
M,DY[43%W)[2%?<5I$:Q2H0F?>*`%#^]PM)XI:PA@,",;2N6M:5;8J[V=*"8J
MW3>Q8!4L74G-SPY:=K"M*4MD*@<<`6S-SD:F.D$G>$R4!YX2DA`C=#.-++T(
M>BQ$SP2=A$&5ETQ0MQ%MNZ[M**OJIZD=K11C:%"LY@D3\^4=+OP$MPA@C,E(
M9Y"^)(!+1%HG%6D2G(RAGD"T;LL\D9A:3"<\(8&,QF:0Z:@>S(=+(S+2XU(7
M*(R,R,OS6_`8)6S:3B=XP]B:U2H+5(6H*HK:E$?[M21HP'M@#[6O4,FP&`P&
M`P&`P.NU_B%_Y(^/+^T`IO\`=`\DMV<_*78ERL&`P&`P.O)S;_J3O)+_`%#>
M2_X2!AJ?UCQN[#>&3`8#`8#`U#=6<UCG7DT\>-KHJ*22Z(19CZE3VS80((W.
MS.R&.U-N;;!"9N^&(C0EC6OINB&S2D0M_$#]"_3>&HG\9AJ124IY"JRYPDU?
M0"'=-*6BV&+MV5/U:'QU6X-4`G;+Y18Y**?40AK/1G;CCA;-+SF1/IH=^W\K
M-@-J@ZUHG0LC<8S.M.7^-O7$ZCKE-V7UTTW*FN&64B<CCSI5MB3A/(*_@L65
M`*8T1-/0>K7I$E8W[;8ETM7'3"/FJ4J[[I"T0#]$!W7.:8QNTL<Z6GY/[CX9
M=K(J":]GSB32[AF7K9/.ILWFKE;CT0.>-"*EWWDLXE`$N1C-AQ2LR0#(T8G,
M"#6S_95;,#HZS%L7ZTI5?FXX3Y'H#:++7M:S;J2<EH8]S&3S=-].9CQ7,F>I
M-:3XZ]T+^RY$!'M.QB9*V=BR8(2LV2!O^'));?>J"MZW&*VS%9\;?+@F!3WX
M[5+W>)UL'JJKWR*5G$YSPO/KG;TD39!0*`J-OH&.VC=%!,475*I,V'(9&G>0
MDN"UC4E>[!HG>Q;&E8]5P>!.K9W,(+0\RO=%8>K1\CDCM_HRK:N4&F/C%0="
M1=KAZ>&QX2W992=C:0P%PCCFK*T(?OY!(E@R_4.Q>S4NBDTCA#7Q=DI\QU)V
M[<4AK^.7M=]2\>6#*IC7$296X+T\]JP?IU]BT;B$$TH&G+^7!<C1U?(790(O
MV3M*R6_VO4L`LC419,4YSZ/1`.<O(!0?2LIL%BE72LVD@[]\9U:V)*5B$;A!
MN@X2CY%B<'Z4N*>ITJ;X.2IH_,672=2X%;`4Q*PF>QZB,%E)F)CE6D_ZX-N=
M_-0E:>^S9.NL@B<MM"]*.,#C$3AEL/@'NSRYW[/-J_GV5.+&74;>Y(8"G]TK
M98PK6?'B5:/7:`K*]G)J?A-*<*Q\K%W+-^SN?^'/+V)_G]Z(=TQ`FZ6<L7;-
M1>[L$T<EI"-2N:'Q*6'I0$O">&V8L6H$>O8$%",OX??K[.4MB)NA%Q#3Y';/
M98E&X?->W811\]Z^Y9:]S^5(C6?I*/5L^T1>)W73@XC,0^]8:3(L$R,`C+@8
M#1:-Q,T8E$,@I-L1(QXS2M$C'N?DIB70%@&N;G=*9IB\NZ#!-W60F'*.:$W&
M#!3S]^3U)JTD9R<+:OZ>56$E;CGD:<P3N,0E&UQ):?TWB"<:==._-4.F[(\M
M]D<MQRS.=W.^)ZR3KD3C^8V4_P#18)*W/L@M26))`\75(.55T=;12A?'G*OS
MX^J1',Y*@!JA2<,GU5;$'4:F+(FD[RM=S)&O)+8EA5\T]%R^[$]3,O+?2<K3
MD,$>LJ&-,REZ2=5BPTM7EQ&VFRM4^<[%$P2"3*#2591)KLA1$C%K80#UE9G'
MD@7QJ(NY8':G'/!<QDUF1FL(;SU1?9%@:='CY+F]2,;%7#;7:CD"4M)A(EB.
M-.UW(EZ@YJ4:#[AC*))`+U#D:NQI-T<:T\?1;'I!W\I"3R%D@B'R@U<P$2*O
MAP=9$6&[I:QO5.:C7MWJVS-NKU@<H*U6N>LVZ:C2QZ4$*"5939I,$7O1Y68P
MIU5?*6>8PFGKT2IB>BULQ4+Z*<J1'-DZU&M2<;JI^8"TFV3N=<IELFUVLC:1
M>KKM(0:_!:]AVUDC,#OUA^%=?$ILJ=?Y%E8>2/REWKI9RJ9<S3<:1UYZA%HQ
M2T";<56S+$U81WJ]EEK(GL5-4S!3NVDM2[.R5,2X.(#E3D(L8@:W2<=:*D6)
M7_E`Z0Y\N/GZ=,G9B*0QCQR='1E\<5#DYP^.6]U>T=5QB10-OC\J1%I@S+3W
M2^S&U,808%.\,9RI(5O>P&"U&HFV)KIQCLL,VK_*?KK>HT]8NEULW.AL<J4F
MH5G0,1N^3N[Y6Z>F4YMBLO4:9NCXHE%KA=K/V(*I\EYZ)]2FA&%&4(C8194_
M&DU_9@G/$PZ+H7K"-=9]@0OK]Y.A7%5J55<;]8L75K*Z*Z5MOKWF2.12MN<%
M!9!2,V%2XHY&8U`)$)*8E2&G^W[TE9H`FDVTBG'W7+\A<4\D<@OR)0'DB;VG
M$*FZKKV.1N86.PEE+0<C2ZJI4DG$DE[0(Q.8G95MO5NG41I.6;L9!KT:`P6P
MX2W&FO&/53EO;/(YT0PP.ZKJJ?H*+.=[4=Y0C)9SV^1X)S?0JS7,E&TE3%;?
M!)TPE+2.U+`@,EDS"4,S1KB?(SMZT(/L:T:_&)I%-)A8[QT4)=]>L7:)$\J6
M?0XZ9<B\2Q.)%2*.K&T<DE$+YZL6/R^/LP3@ZVN=HR^N!"-:2'[XA0<``ON[
MQ+%TQ3ZRUOU8P^8"`<V4]7O.T2Z1BU55WS7R5$.EXC?+-8\6LR,SEB0O;?8,
M>X[+B3,KG(H>RPY&R$.7X/DJUY1P/=I`B4_&!!&[L*S,\:SP;<TSOY"8!PG0
M'2ZHRP[RZ/HQ'8<DL#G*-162PIYZ5@$E13"/0V#2&%3Y$WRQ#9,#-61YV"M5
M%D.:P+0L"(&SW`0<:L:94Y*G6!'_`"\0>`4HVGRV]YO:KCS6DF<)=ZW($X17
M\OF7SH;\_P`(Z;+^&^$9>:(?#%A:%`0Z^X9R0%&`V;M2$`<-1A]*^GNC'H"H
M_([3O0G:3[11?43NGN.]Z.M*4O"&46Q)ZY<.?]\YL[!/D=0.,":W:7L%CQJ^
M(X-K3M#`G'("(DF;2]$;1#,.W2,9B(EA7<\(\HEM<AQ2O;(1]&6O^&W#<C0?
M(W.]92UDW,^E5%E1W9##T3!WQO(D[6Q#IK2PL`',!'MNA?O?_P"<$$&XMN,7
M?5L;\L+#V6IL*-R'DQJN73D@X^Z4:DDIJ1B$YK6*T76S><00<M,J"D4;*E)L
M:!(34)'M:T>F)5^NMA#O>JS9CS?;NE.O;+X[\L/+\ID]ZR-[,5VO">0)Q.)`
M=%)U/V>0\ZPV0L*1)89?P7RC#':Y7-R9SC/4!)*`2A#L?NP;%H1,1=$\FOP^
MH^R(FXIN@.?XMVZ@GE4>/+E*.10-CL4G53BS[0CG1BTJR*GLIOD*$+E-$C%$
MG!4O^`'H.]-YFE&A;!O6]Q=.$TI7[+Q4@Y>4@WR62]+:PRFCGO5C6\4)"!EN
M=ZK=[Y[+3J=TBIASX)C#3,8M-.<!L,==:7;<E7OG`LT&O=E^M2<,=*U5\=(!
MY+)A.EP5MD]JQ6-3^\O(M&GPF-J%+2DAE6UI"EDJY#?(>KTVC,C1$VFS>G0(
M%@=C^6DYPTFOO1^N1?QB.5:0X^(VEY9G>YN-YD^U7?T9&Z-'+C'TJRNR2=KX
M0[-DVY:+=;BEB2"LK6=4-?'L5VDG)'0I<M+DS*Y%!"`CX92'>Z3%E)^M'`,:
MSRT1;G"V1%G]:26S;`\=U]6*W[D3(L<I3!>M8=TG^#51PNO"O@`#8I%):=>3
MUVFG6AB<$R0E1^P7@I;7I6/E[.C@>7F&*;-@-3NM[R6CX!T.XZ9K(>&ZS7RX
MI%&930<'ET46,:BH&1VL>=UW$[P=W5O/2H4@V\)27:-P,`07H60C'GQ;*>0X
MWV<_=66!(>FIY9XX7`^8.1M1AL:V=;!Z1L6[)I';/*OU_;V!8E+5C=(ZIC[*
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MV\N/54*`P7RR4;RIR14%3MU_QQ%73!)XE<"^Q`7U-YHQ]*,LO.2MH6--7#(^
MO,WY2,CP"!MAWWT<4`--$(_[W#4S9,S,\_'=89R@/>L[[1YV/Z+C72,QE%<]
M\P&>'J(1''@_B"*\\I>/+!CZ"<Q95\-\`V3L%Q2I[0N0CSMN)*5:E*5`![1&
MQ5-,=-OKQA)E_5'VE$>].K>C>>T%Z-6W>Z/&Y%HTRQIH4'U3;<`4LBF*7H_R
MQ'[H1<H9*X956REIVA``R[WL_P!?:P1-N,1.TJ[H%_FW753UREEZ^PX_9YT2
M@R=N15K&[F>G9IMT_J&M4@I'S]()G'DM;.%=I:942'Y7;&!0J($@)(.,WH0C
MO2$85C;X65BD<\I]?=Z0NNC9=,9-S;&)9&6F-3><_/38":Q>>QLYJR?*+-?6
M"/:J=GO,US5+/DY:\*DZHD9*,@L`B?7>R?C-O55RG&+RKQ"EZZ>DJ;J]@E5.
M\I<$/3!61L=4$1N:7))[TET:Z4CLXBX6\L+VX,%8GIG%W0A]CX(&BE`M!UA9
MQK2*4K/9M5\DFK#Z<X8ON#UW1ENJ9C$NI><8FVQ)VA"TMWG[+5_6W/4S?[*@
MS=]^.15MN+HUB\MR+_V6T[<J%OT]R+*ENDUZ3]T1\=<\WE0%'^4EP:S>C`6)
M->F.N)'2J&<OSP^N#^@^)<AUU85>('!/H:QRG9NBE`G$OV]NAV@#],%TUF.'
M"%?8,/RFQFJ)%%W%9TO)6975_C>LFRI1(FQ4OO9N#8U>V6F[DA//ZWX,H9ME
M0B3Q>*F;:``&>T_*2\1.A*3B0[$XUK&\_"?CSN_#/'=U%LF47C$)T"U9*#DV
M0.]?2J=]2*>>`O<?_!=)9D4BK<JGZ:=/"3Y03&KBDFW]O2&`4C*T:6'6$_&L
M>JLUC37RB,S*WE)*OZ^85]L4!X[R8TP0E_4VP*G9W%.A'D[K8V:SD",1Z>2O
M-6.S:6Y#6:TL=4)9F]!").=Z&HQ]9_S1[[IK/K^ZW1[A]JLO7JNW4OD4Y6E(
MC8>UR$[F"!<W1/K>`.41LBA7PI%^#R68PZM"1.LC5^]&Y(C"%1BL`2RRM[)%
M(\J3_BT8'#R$A\=CXTE@N,RZ(;T[.X`\/I[6:#HF2\D0V_I%'$$X@H1)]&2&
MTI+3B%$N;5VB_5PV=L\.O4>L)^->E&MV+5AWQ5G/5=+Z5K'I]CES%6WFKFC,
M!XACD&R16#/;SK25\P.DX3+$0G$%C6,QF.2Q$2/V!N)HUF]AWO6_9G)J<9VX
MQ\K,7BS>7.!W%S_$J@E<L?JY25S4JB.6)-TUT3A6]W`Y&(E-Q)>CV6KH^OCZ
M"-&FF;(0A?#4K<UI]CV2/8P94C"FO%@?1%0]DWMRMT^RV<;WU^4O$.EH;8;Q
M&:K=95&*B>*0@W4SJX0U+RH.-)=-LQ?TO/I*!S6H$)QSB;(T:<TT'OB]`W%B
M8BZ)THSR,MW:K`@=2Y`T]IL/-S]V'U.^2!75<:>2>N%\<<(A5JGEQV&C*;/E
M\ZN'=4![W)E>B1'#>PA`M$$CWVPU)I2*<:,)J9'YBD\]CUBW8]W_`/ABP7KX
M[HB^5U$VXM;1CM7$WH)B)ZTE)C0B3#;G5''YL2/Y74ISOA&9[]\,K>_>;UHL
MX<NOP[0&',P&`P&`P.NU_B%_Y(^/+^T`IO\`=`\DMV<_*78ERL&`P&`P.O)S
M;_J3O)+_`%#>2_X2!AJ?UCQN[#>&3`8#`8#`U87'Y-(#SC=G2L+MSXYQBM/_
M`),;%$V&$P,:>9.TVZ("[)VAH5S>4V4@KU>C7KD9>P*%Q461-0-""H5*=C"(
M!J+:T67Z5[,K3EBKZRM2P(Q9;\WVW/896D.B]?1MME$R4R^=QU^DK$W*&P4@
M;V\`/@XZH+.-+5FEEG>SK6Q`WLS1(BOT0?4GE1YMND,M_!!CMQ*='J45=!1X
MB3Q!GC@;/K)HE6H%*WFO%[C*@-*H4*GQA3*ZZ=%#460M.`(`S$_MGAE5FV85
M>G'E1Y9A/%GRER3&)5&Y*[UKTDCJ*IZEJ^O7!;43QSHVN:2P7E\B4:?%U7IH
M=6DDT3\8>TJGEO/`9H:8"LO8LJXSE2?%4I4CY7N>$R+E6EKHM%$LZ!LJI.:"
MK$D6EU>-3"W73>-41:91V,/C,1(V60(Y%8:EZ+/1$-+`>W$[<$Q8QI]&E@PD
MVSK,1HL%Y+^@X3R]QS:=RV)SJIZEAT8+8@O%1::XDZM#J!P>T*),Z28J:%+&
M9-'F56<`\\[X1:<6((?=DB%OV@BV*S2M%1J.\DAS?VET'S_=;):\7B3W?'-%
M0\\,SI7$*;X_33];?&]7W"DIRQ)'$G,]07-9!*S)$847HU]3IC4YA.EA24*7
M0BS;^,3&WW29S+Y2*]MIPY_K"4IWA^N>_5=R+F;4+@94"A[)$*LLUWKXQ^?4
M<\M)]<-BVL3)TXT[,N?W`TP0E8D:1+[6B23;,5Z)AZ!\D=`\UVE*JKL1DM4]
M97L$K^T+,F$9AR-X@E;UW9,O<8+'9A+W@;^B7I6D$D;#25.DR-4>4'[_`$6,
M&A["2+9G@X8SR@\Y[4VBE;V6VGDRM+A:N>T8FJ%H3@6G>KZS(9*R5347Q$C3
M#ETL<HJN^5=:,TD2)V\DTY0>2$&_48RP21^2[D*R&<NLIQ5]GS`BS)LJY],J
M:7U`RR8F6W4FD>XU->=GY@7O+I&-SF%@`)>])W,PIE`U`VH*6GA]-;+283;%
MN_*!?K3;Z"CK;.=683?]A<UK8*5&&U*OB;U55=L-E/DW>4(7P/P-1CADOCQJ
M)V("=L8I"W%"3EB-'HHF,TKR1W<WE$Y#J>:2.F;:%,$<H1WW6_-$@B+C#$CD
M!0ON2*NLM8)VL1F.AI"FE`PQF<5SJ]&!V6B1(CQ'D:T'6A%BV9U46Z)\EPXY
M4?041XU"CJ&,T/S*UR.IR]4HSL>F0ZNNW9!Q\\+(3M>_O==*ZE7(:[6$1YM#
M%"-Z;MDKBE>BSB4R<U%M9K//VJF2%];]"._"OENN)?8`3K(YDEG9+71\C%%X
M:2&$HJJYGB%@0$H343'RV20Z89>Z'J]B=4RT2GV_=*-FDZ"7HS$16WK[O;57
MDYX[K&KWRQ;)B#U55\O4>HEZLII?JQKNJ[0Z"D-KLZ1JKV>MBO;ZP1E^8):O
M+.(0N;ZZ-2="`'NE'P?IHO0QF9728_(!SU*><H#U5$W"32VG)W8L=JTU]BS,
ME?U$*ED@L/=2F`FA#8ZJ2$K0P64(MH7KD!SBE+-.+4%#.1B^)T3&:TYHV6^4
MOFTZ83*OH,S6S;DYAM@S.OC(M5L/:I$YR,=8IBC;6F$5$KE#2A=8+6"\\IO=
MUPSB1Z<C0)DI2DP6M8*3Q0BS^:GGEQL*X2E4$LE!SA5O-=+=(M_56R8Z.MID
MQW>[.;+#&-&W'O:20,RN3/!!+<SFJB=!4N29T+7!;2$`%*LUA-.M:49*X>7[
MF66U=MWJ+=DSNT'SYW8^EJNO8]#I]8\%?*BC21]GC[*4;%,W>"*8W!4;XW*5
M:QN>'5*=\6401[]0+9&B8S'%Q]6=KV@V^/'QI7U.9$SR"T>IE_&T'GD@?(!I
MR(D,AOII;M2%6G8X5(JY:8<XN"XX8REI12EO;1;W_P#TU0#T+U.2S;^4Q'*J
M=*`\EG/G1=O_`#+1!EMB.25<YWZRQ5XGD)3L$3G;QS)9*2K[F;H<\)7UV-<3
MHH^NK>HV,TA.2<A<2!@'LWWI)52;9B*LIFWD$Y\K7I5-R]8:U^ADQ<8=)9FS
M2EYU%=PMX10Z/'RR4H4Y;=*U\]0*V:-I358E"]B2-9X2]ED*S3MA+V2+9F*P
MP-O\FE.O%?5G/F6JNAW8^^'_`$W\ZP!)`XV78O0<3"P,4K/MBKX^NG2-(?5B
M.+R-(X'N3LK:324YH?:(T8,L`RXS6C$IIY?.1X"R3"92#5H`K>-L]L*(]:*2
M&(E,!M67TA7\DLJS:KJ]XU(0*7ZQ8Y'8>Z!^'5)T#>J6(#B$ZPT8-X(MF=%>
M^Y/*X@BO'+_+J`9[G@E]3RKUUI5@F?ZTB*M^@=8-UHLL$07E8<:D#L_M##6$
MWVH'\CJ%2=6L/(4!$8B).#LL!8M_+7@NQOR#4C'NA&;E.9;DS1;;M$%S\Q*E
M7X$&,TW71ZMQ6A(&R.MC;,U,X)6E1%&L5EG+V-O;#]HSRB5(C`>QLS2L5C@B
MZ#^7CDJ;5W)+)]BU(FV,]>US:,98YC"$[7*;4AUN/PXC7*ZKFA$_.89,IEDT
M#IF2)S#4IPW`6@>SHOU,U*KC-:.14^63E%BM*"4O8*R4U19<N7PV/2*(V2HK
M=@?JEF]B@&=`*_LQD3V.Y/265S!.).8C"S)WI%[M<EV:I*]^#UIC,\&7=3>3
M#FSCMWLR/W0&Q$3[6]6Q"W"6>/1`#ZY61&II8['4K8WU6B+=B%$PDZ6?29N0
M*4&@D&EC6EB#[8/:V$1;-W!`]L>5R%,5F-<>I^/2.T(ZPMM]J)4B:X"-:IM!
MRJ?G.HNBDJ*F[#.L:/QM`D:HY;*4IX4KFIS")02J3DZ)-1;^)$6S,55U:/+Z
M[%VUSQ<ME02Y*NY<M;QZ2_HV;U>KAD&D3U7#^"ZJ&CC;<$CDS:M`^'5?&H=-
M7+VEB=46%4D/^(,:@GA*`7%QXQQF)]VQ3M#N37(N^9-MU$6A>I72E[PJE6\V
MMC(T0&*"F11IZ1Z7:DCNU!<%RDHOU1(0B)+4^P;LQ2G]V'WE2VW*O*D*8\9^
M5.*K6FV(CUA*IDURR&VGY`WUEM%^@#.Q5H\T]RA?C]&G>/1=TB)*<]\>JLKU
MVC^EFS&L)ZS2D&_?JU>S=86ZW73IZKQ<J^0"@.S6&SU](O*HZ0502T*)9$WY
M5%%CNV()8QJI!!GTX^#2R8Q\QIEK2D$H(+"X:7I@ZV6L3I3O0O#,Q,<6I3QY
M^<"775!I?8W6I=*M<'CU`U1<B^2TG"+7@ZB)SBUK"D-;Q^@1Q.UY5*GJU)>]
MNK2E-0/L>,+81C7:2C,T80:9J5;NLII%:MB\L\JW/L)A,BE,DA=O,LB@<R:X
M5:=42!%5T0LNJ%KXT+I`QNDW1S2UHW$PLSZPMBA6@&V.[D>N*(,"G),-+&6&
ML8SW8ZO\Q?(21?8HDA-M/D*J^H:RNF3VNR01.KK/<5NV!1B?TNW-;X;($SBX
MRBU$DM2M[0A"BT(3EHP!XB"=!/$JN$_5]/$G8DON"2>1*8W2JE%<5GS_`'BR
MM\6B=N1F(PB44K6Z'FBJ+%F#7-_P8-<2#A-\B=W9S,5*7)S%I*>'V#_<!++`
M+HI2(V1AT9Y<8,P<O])V!2T*M(JWH%S5*^AJ88)S!6MN)M"LD"D,?2WG$DA\
MJ]V[U5''U<F/<]JQHW8I$/1P6\T.]!$+;:S&U7*WWUGT_2''G#LEKO32]7MT
MC>M%48_O?6->ITRMJ#9\<FKZ]2.3U_0TR@K*A?DID9+"G3-SAI(`DS[\(Q^N
M]->2Q$3,UX1#AJR\GTL>;:AU*6E&XG%)[$>@.EZ#O)+$(U(I8QRI?1'.3_?K
M;)ZL?UDU8Q05$^LS:`XQ*[))$;K98D/ME&'!6$O]3'GTJY\?G`X?1-%6R"0K
M[%AK';$8CM@L;A-6**18;;5DQD/X)0^TG%I=YPF?W2(RB2ZVE1ELJ1V=A:U[
M\:("40#Q#"[@^[J+RZU_1,;MJ05=SS?W3C=2UI5[3<^F58M40;ZJ8K&G$MKR
M.J88?-I+*T#DMEC,ELMK&6E1M*E,L7KDB3:M.`XY6E$6UYT3B]>2CG:,VDVU
M3*$EBQYR`]5C";!E3E&6[4&IBU[G;$CK5U.6L^I)"K.9;%F*=>0$@E"G<FX@
MPX`%*PG8M>HQFE4<H_+CS.XHJZ7H8I=HR+=O.6\]UD:OAT:CR2:SNO9`MC%A
MGLSO)YPRL8F.%O"`PI28:J*5*QA&!`G6&%'`*)C/HGY3T)8](4+U3T'UO#6>
M,Q"A7V[9U'$-5%*W]^D/-]<,NI%&9`L;W9[V2JL5Y:42SWZ4L]&EV<$L(0E:
MWO>%I$S$1S5PDGF/X^@QE7I[%'8M;+;/:&N7$-4_98E%WR(5Q*IZOKJNK+E3
M`XS@M[41>S7M"$YG3LB=Y>](%!*A:WHP#W[*IC/+5(2[R=\]DJ)6-HCMN2V/
M--@)J=@,UBD2972*7W=@UAZ)PIVC%@Y8F7S&<,(D2HQ=M0F;VL@E$J,TL$%,
M?L`QE'T^\QG(M;Q>/2:1H[@V)>YW,RS:.-T"2K933+OSV(D%R-]LM.I$7IB/
M@NSP[4[1&N0#@[T(@1H=ZWL1;,S1R\A\L_.4:B3K(UT%O\YZ9^BX_P`P+*V1
MURVG6/\`.-,J?<[W@ZPMC'+26_<5F=8MP'!"KVL"<'2L@"@@@6S-%RIC,[<*
MOCBWF&XVD46G<T<G2?0"+PVJ8C=;.]V/&&Z)MEG5S-Y@GK=B?JV<%<A-0N@3
M+-6D1T9;@8V#TZG@"'0B/4_5,98]OS2\<*&9J=6(JSYDJ-:;6>Y>Q0-CADW<
MZO;J24135FGV$MB\_=(TA!&&>;-KJ8)`X.(#&Q2$XL0][T#:IC+"^RO)@UQ^
M>453?-K[-5<O?>G_`!\,=GSYC@;`_P!9LU4]56[&2T,+DL@DOQ2EB?K5JL+F
M<WFI6[9Q!6O:"J2J=D^I;;><\*2S&_?,!3--QGKS<?JRSK&M3D.'MD^D=4(E
MT`;'"90ASE0X9N;,STVRV5:CL8:I`4(E:!Z1H'LK7LF%MII0]&9*I%DS3:60
MMODOBC'8-QLMI,$IBA,5B'(:BNJ<%77PMZO]C]/I+K6-5;`/)LV01.92]V(J
M<XY*WI"6HEI2HU!ZI<J+.]4=,=&/ROS1\CPY:I:'6.7P<_QJ&6;.;8CK;7+<
MM>*)9Z8F+9"[4*MXD$L"GCZZ%+'0"M0%(:X%*$`!&)3%`O9+$,9E;>,=JTW-
M.I'SDB)@E#Y9$7KJ/6;)G@E"RH8@S1^6MR1XBY6SGB0-TJ>53VTK2SP'-C2N
M;R?OBE"DD\(BM$II5;G"&`P&`P&`P&!UVO\`$+_R1\>7]H!3?[H'DENSGY2[
M$N5@P&`P&!UY.;?]2=Y)?ZAO)?\`"0,-3^L>-W8;PR8#`8#`8%"KH\=-#WD_
M]!R.4O-G-+AT\R5=&;;+C4I;$S>[QNID+DVQ]D0-SQ'7M&W(G-"['%N&P@$<
M?ZZ$6,D8="PM9[).L#CFE+$KKGNJG%!(F2#\PS*N)M4C3')&N1FM2^J8:]P*
M&MKJX+M.;@]LR*-OQQ1I9YHCE`P@&,W8@[V(5G7JK>7XE>3BX:TP;0K5VS,?
M/\CYO:C/G!4`<$L#DE[,71ISC\64W%Z/E3=9T;1G)E)H1I]HB]I3B#B1C"(N
M4L:5>&_D4RN2:Z:U]QQ4LJ2W^_\`X8PZ?I8Q-]MO3IYBBYX*6YM$<3-B.OY4
M,>M:;$Z(DM,$L.BA`UK?K*&4_P">CGG'Q,\P)9)'Y_`2WZ"6-%:W@\#;),!'
M#Y.0^.M3UVAKBHY]/$4@C"ESDDL@#6R-AR<Y(X-?OCFQ/L>];!K>J92LC*^1
M*_LWDE5Q_;[[,;)@[W7B:`2N6.KR-).Y#LDLH9DG&]DA-VCD.W$K2HHS03`E
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ML#8?1Y_6"*3M<HVDF%87@*.QF*(994KW\`/\#M,\?BQ*5*1[I06$A0I+'[PL
M\8<)691NK\47,:PN-&[?+K2O<3F:ZVFJ5(;.5HY,*_'F8?AC(>AE[D0V`"X7
M%)#MB;ER\TL2,YH%M+I($'IO1<I<S4?#8(WY`+_[WG*:#I9E8%=1>FJ\8X6H
M?'`"&),RS:V2S^5J'IM:"$MBS]*V,#6N(1%*""F^,(O16;[>RR1-U;<7+W_X
MR^4NEK8GMU6?&9$IGMC\XS7F"1N#+(SF=/\`@!.4"UH<7UM3$IC/D^Q&ME<U
M2)N>@"^(1HU1I0=;`/>L)%TQW8<J\3?)ZJ!$5P+5H%QTGE"L>-Q"+GQXG154
M]4669;3`Y+7$YN-.56`Z34XQ0Z.X_4:T)HP[+#Z^N%SGU3<S<.4@Q4MU+0J'
M<TW`^P'6VWBWOB),(Y[^,NFNFFKYIJ*.FT0=Q\G\&&8GX,.BSOAE/M&??>OL
MX2)F*=%>P>(#C]7`G^$RU-95DN+N36B)HLBRYF1-+)@[737LBJIDAKX[L9K:
MA8X*=K9J1&J0K"##A"&H">+?KHN4KA0/F.L(%SR#F5,G<G^N#(N^Q5U.?1-!
M4A?4LD&O-=G1S6QMFCK<!]..<!F`5)4B81)@`#+T$0`[T29K-55(CXGN5ZYJ
M6EZGK%3;%:BHE#-&B&VA#+`,;KA<6&R5Q[C8C!+YTI:EI\G:YNK-`8X:4$>]
M,,(*,`8`T&AX)NF9K+Z'KQ-\9.Z<YB3PI_8*\<.=X3S'(*D8)&8DK*55S5TA
M,E=3JY''5*1:>XRVL']2I4LZ_2D'LB5GZ4%J`F"UA<IX\ZU?(5XH^:B(1"8F
MED%O-C[`UMA":;4CDKCL.M)9'K50IFNP8*\/\-AD?:ET+D[4B)3GI-(`&:`2
M`8#0F@"9H92F<CA&BT]`\N\V@%-]UQR')J,EE2"%*1"D0G;GHL@JOOPL>?@?
M60I=A3A^4`;+*^,WZ^NP>N$RFLSNX^K?'_0=03RK[%B(YZ*0U"Z]6/,1"[RT
M;BW:6=D63';5N'3HBV@*TN)U*HNF^2`^T#Y.3>V5_M/:]K0FZ9KU86\^+[E:
M0]'G=.O35,7*<*Y#-9.O8%TE*60IP<[$@2NN9D2L;U34<^FLKS'UHQ[;=.(6
MXA9K1Q)!8M87*:4Y/B1>,*C6NO:ZK]HL;H9I'2#UM?SU.T5GD_.+SU&QL+)%
M5-:5))E,<4:9JT6QB/)&\]J6D.`34Q0="'L00B",IK5CLN\1'($X:9I%9$BL
ME5`)6S6HC9ZU+G)I$#K&4777[_6EG6=5S$!L_P#[7L:4QJ5.?O%PS%)!*I>>
M>2G+&9O>"+IAG_1OC6YRZ<98JSSE194<.C-:(J94OU>33<6D,QJ=O>661IJ^
MF[C\F.`7^,@?V(I9HC996]*!F"T+7M[PD73$UAP1/BQY73=&M_4"5-/D]DM<
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M+J="2T6DWSA4>D)52-'\@I2F]K#[9.V]$4`L.Q>SK>%REQ8O$AR\IKU?6;M(
M;P?HRJY6LOC!#\LV5\6Y1_GRSI?#IBMAS"N`Q$C2#BRJ"MZ-D4C"::B;P#)%
M[W8_;T,IK7K5:KH'E.M>CX/7L)F3C-8\.IY_`[0K>8P*0@CTVA\WKE0$Z.O3
M4[GM[FDV/97MD*2SDQI9Y!PP[#KUUO1(FDU04@\8/*B8;$4Z,TQE+0R:[-*'
M')-+5#@PO:+O&7LLVOUM?$A*1(<K0JGEA)TT!+-)&UD[&$`A[WH6BY3/IZ).
MY:XEISD.+S6(58=)U+--U2<:H,D'%1J65J0-PVEJC3$IC,3BXP,30@'L"<*O
MXM3K]D9PQ>N]DF9GBJI3_A:XNJ.O)'6AY=N6NQO-<PNI&%?<5CGR]_K>N:ZE
MJ^P8-%JV=4;4QBC2&+V`YGO:0>P'G@<3-BV/9>]EX6;YG7@R&0>(/DR7JDC_
M`#)1:LSL(Y\='F9VE+IBV26=6BG=6;<?%'[).>(PKCD@86QGW[EN`6VIE#:'
M8MI3BA&&['*&4LAAOBBY'A=.6E1"1JG;S7MNU90-1RA#(9D:X+TC!S/7$<K&
MHWB/KRD"0QHE;"RQ1"K&M#H7OG(KW^P:UO8,JS?=,UYIEH/B&H*#CM[1U.[V
M);1?2[_N1W:ZWC*29^[SQP/KQBJYP+=CODEI2"0.T/CJ<A2G"1HHS>Q[UH(1
M>SHS,S*%R/%+RU^`]J0)V4VQ)6RSZ*DG,:5RDE@G.C_5E`2I4%>Z5543F)L+
MW$HQ\>44<7[P"Q2$1!0=G"`#0,+%TQ-4V]/\5U;U;5=95/.)+:,.;:?L2`VG
M7\JJR9!A\Z89G6S2[LL9<2G\QJ=BS2RT+VHT<6(C>C1"UO[GIA(FC`6+QK<Q
MQLZJUK.W31,\55)[JG)$@'+E"E^GL[Z!J^05%9LULUT4I3E,ND;O$I(?[DX6
MR0)E("AE@T$O0-C*=>K!G3Q+<DN"+G`E.AFK4[<QU36=&PN5)W:..LFD]2U*
M(HZ'0B?.$IB4A(>&Y.K+V><>C);UIQA@M;.T#00!+G.O5E,X\9G.<Y%?Z!0Y
M6M'(5THXHI;9%81"=B8ZZ#;32YP1[8[RC,?"U*#8_;3"]5DQ*TK@6H$E`<VE
M;$E'KVM")%TQ3H^UQ\:_-KY9[-:LCU8,D>"'6MIA.&!ZE_Q$.N2TJ>;4K56%
MQVXP$MB<$ILV%ID).TJTHQ&F$84`1R<W8=>A<II1PTF\7O-4MHRLN;WI=:"B
MGZRMJ97*1%MS!&(4PE$WN%[O5R13)U/8#G92R(+%?35*(#><W*DY``$?$"+]
ML(QE-:\Z+>7?2D)Z`H^T>?)X%W+KVWJWE=5RP,?<AM3X7%)C'UD:=PL[OLI4
M-O<@MBX>B3]@,V69Z"]-^F$B:36%8+;\;7-5Q6'5EL/K?)66PZIC4*A#?*6!
M3&C'&4P6OW4Y\C,.F/X3Q63$K69&[J33Q#1`0+3!&;#L_P!C0`A$73$4Y.#<
M?&!S@I5R_;0[VU$&!_G:>W(A"HC.BF>(4G=0'43NON:D6OY$4'P.PWU0>I+7
M'A/4(SR%RHOX8(5!NA*+E+&99XC>19G$BXF\I[,V)4P=#M$LE*6=FD3"PG;J
M0A$5<<YG;WML,^6YP_&(`&DK`E$EI3!"]V5H.]!T(OF-4D/OCCYVD,S>IXX&
M6)\O/W1=>=0KQ)YD,E)\YU9<[G<PQK1"?Y/%[J-;K(\7Q*+VM^_<O]Y]O7_@
MPE9I3E2GW8"1XE..MPIGKUYCTPEL18N:VOEAO9Y;)P/J0%>L%LI[MCCT<2I:
M]$GSV/6*C(6HW,0=Z+T0`&RA:UOU+E/J,_B=Y89VOY."=8RD\ZG.@J.<G@#]
M&V)S>X9THBB;78*EX#$H?'6M;)433"6Y(TKMIM&(4Q&@;T9KT]%#*7U2+Q5<
MQ2&?5K8>G*WF%SK=PY9>A,\<L(QLC%@/W&;DB<*`?K+9]M)X92ZQ$M(-*(>C
M$X5"52:`8?:V`0!G/^^K@HWX?^-(VINH0&:>O+9?-.2&B)NP/LQ^-;=5W(9T
MXV*)$WJB6I(_GN[-)7'8D#@X+5ZQ.G)*)]X(`-:V,KNS,SO&/STY`EJ^2R*X
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M(?>FB$+TUZ^F$<S@,!@,!@,!@==K_$+_`,D?'E_:`4W^Z!Y);LY^4NQ+E8,!
M@,!@=>3FW_4G>27^H;R7_"0,-3^L>-W8;PR8#`8#`8&G6EF?LGJ65]3RM#WY
M:%+1JN>O;SI&%5W!:*Y5D#&QPZLG9M:V3VGRQ:;ETN=7)66>(U0<J7&;V8+T
M#H(=:UAN<;::5TZIY_)-[+_2H=!?5SX>_-UPF5O\QZ^Y^2;V7^E0Z"^KGP]^
M;K@RM_F/7W/R3>R_TJ'07U<^'OS=<&5O\QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F
M/7W/R3>R_P!*AT%]7/A[\W7!E;_,>ON?DF]E_I4.@OJY\/?FZX,K?YCU]S\D
MWLO]*AT%]7/A[\W7!E;_`#'K[GY)O9?Z5#H+ZN?#WYNN#*W^8]?<_)-[+_2H
M=!?5SX>_-UP96_S'K[GY)O9?Z5#H+ZN?#WYNN#*W^8]?<_)-[+_2H=!?5SX>
M_-UP96_S'K[GY)O9?Z5#H+ZN?#WYNN#*W^8]?<_)-[+_`$J'07U<^'OS=<&5
MO\QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F/7W/R3>R_TJ'07U<^'OS=<&5O\`,>ON
M?DF]E_I4.@OJY\/?FZX,K?YCU]S\DWLO]*AT%]7/A[\W7!E;_,>ON?DF]E_I
M4.@OJY\/?FZX,K?YCU]S\DWLO]*AT%]7/A[\W7!E;_,>ON?DF]E_I4.@OJY\
M/?FZX,K?YCU]S\DWLO\`2H=!?5SX>_-UP96_S'K[GY)O9?Z5#H+ZN?#WYNN#
M*W^8]?<_)-[+_2H=!?5SX>_-UP96_P`QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F/7
MW/R3>R_TJ'07U<^'OS=<&5O\QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F/7W/R3>R_
MTJ'07U<^'OS=<&5O\QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F/7W/R3>R_P!*AT%]
M7/A[\W7!E;_,>ON?DF]E_I4.@OJY\/?FZX,K?YCU]S\DWLO]*AT%]7/A[\W7
M!E;_`#'K[GY)O9?Z5#H+ZN?#WYNN#*W^8]?<_)-[+_2H=!?5SX>_-UP96_S'
MK[GY)O9?Z5#H+ZN?#WYNN#*W^8]?<_)-[+_2H=!?5SX>_-UP96_S'K[GY)O9
M?Z5#H+ZN?#WYNN#*W^8]?<_)-[+_`$J'07U<^'OS=<&5O\QZ^Y^2;V7^E0Z"
M^KGP]^;K@RM_F/7W/R3>R_TJ'07U<^'OS=<&5O\`,>ON?DF]E_I4.@OJY\/?
MFZX,K?YCU]S\DWLO]*AT%]7/A[\W7!E;_,>ON?DF]E_I4.@OJY\/?FZX,K?Y
MCU]S\DWLO]*AT%]7/A[\W7!E;_,>ON?DF]E_I4.@OJY\/?FZX,K?YCU]S\DW
MLO\`2H=!?5SX>_-UP96_S'K[GY)O9?Z5#H+ZN?#WYNN#*W^8]?<_)-[+_2H=
M!?5SX>_-UP96_P`QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F/7W/R3>R_TJ'07U<^'
MOS=<&5O\QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F/7W/R3>R_TJ'07U<^'OS=<&5O
M\QZ^Y^2;V7^E0Z"^KGP]^;K@RM_F/7W/R3>R_P!*AT%]7/A[\W7!E;_,>ON?
MDF]E_I4.@OJY\/?FZX,K?YCU]S\DWLO]*AT%]7/A[\W7!E;_`#'K[GY)O9?Z
M5#H+ZN?#WYNN#*W^8]?<_)-[+_2H=!?5SX>_-UP96_S'K[GY)O9?Z5#H+ZN?
M#WYNN#*W^8]?=63L:(]Q<I\WV1T&Q>2:X)RYUD"*/)4.EO//'*>-R4A;.(RR
M+V=X4QNBF1_2HUS>Z&@$:C5IU!6]Z$`>A:UAJW&Z:4CU;K,.9@,!@,!@==K_
M`!"_\D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!@=>3FW_4G>27^H;R7_``D##4_K
M'C=V&\,F`P&`P&!J?XRM>MZ2K;O>R;9FC!`8-'O(UUF-VDDC7`1("#%4P8TJ
M%&1K?M*%[FY+#0$)$B<!JI6H&$HDL9@@AW&[M:>4-A=.W57E]0\,[K-P?W&.
M;<5;3LV2P2>UR[%+T.BA*"3XQ9$9B4G3@]V>`8##$82S2QA&6(0=ZWE8X)5P
M&!`-#]&0GH57>*.&-<H;#:!O62\^S'<F1-:(#C,HM$X/,7!RCFVQX=Q*XV:V
M3]&64<ITD4B/*."(@(0@&868HR.87K4\%4.2%]F"90[,DCKZ*R)@BS<]3N2Q
M9XM5R+:8!N6QF#MLB?XFT2-69[1;DY)DK<2G"-0<>60`9H2);P&`P(ZFMM5S
M7NGTJ52MO1NL=KN76RX15N`KD4[.KJ!Z1:EDJ9:_CB9VF\E;VA0YI4X@MK>K
M.-6*R$Q0!GGE%C%*LMC[\V2AB9I*RFGGL[^V(7AK/5('!K4G-[BF+5I#3VUU
M2HG-`<,@T.Q$J"2CB][]D8`BUO6@YC`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&N'RY?_`!U=,?\`3\+_
M`/="#X:L_:&Q[#)@,!@,!@==K_$+_P`D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!
M@=>3FW_4G>27^H;R7_"0,-3^L>-W8;PR8#`8#`8'7I:^:[%Z/IWHX=3*8VHL
M*B?-):G1L:ATV4J4<*LE73]L1J4F0"2JTP#=H4\C)2B*(4C`,I,I]V8/7LAW
MO1TF:3%?Y9-V?1??W2`6JV8%SY'X5-77DWL[E=UJ)VZ`CA7X/NE[M=:F02V%
M4MCQA,?=4S>HA:M+I.GUMQ2#4EF>NB_>82)B-)WCT1>?XQ^CI=U/64^L"/$N
ME4I%7&,'L@@-P&EEO5+5[Q?>U=7_``]PCR1:6)V:7F]G6'[4)P^ACL23M2$7
ML$CWA<K:33CK_L(T??'1Y#P<RUA$2D+;+[3DOC@1<6V<E<+K)0F5S-H_>95H
M-D^!)#5&DTP(5QHSY+`8CW\65M-K0Q;+%K6XN5M=.%:ONZ!\=?>LHH;IBM:X
MA-=[=K;ZQOB\HH[JI7$'"6,"A;S)1D1HZ91U3)3TT>CB\-HP%U3K5?M"?&7T
M2+T01?[3"1-M8KRA]]F>+GHI=T(\6PR4["91)KK?/&W.K%N)/9S='Y)#W7G2
M4,QO3T=D2%:H*6S-59"5.:XDJD(1$*M@]T/T,%@BZ,:=)<RN\8/>*J-=<05D
MN!NB;/`V-[JGQYR$$F.=7@RE[7OM5T#=3'8!)Q^PH3EL<4-5<MB99L9.VB,$
M[-&%.L.]1E;%)IY^/5<_D7A*R?R!;3Y?Z3DE@QUPLR43MQBK<6\5\A=Z%;W'
MY.-A1-5JZ=6&12--<0D#8!X:4:4X6D:H0O:^Z,6LK,S&585$(X4\@<\!)K^Z
M<;(I;<^G71:Q5;_(D2LTB/UK9?,]?1!K@-'Q-DF3DI2-;8)F?&M7-5:!=[L*
MY>]'%*A;,*!K)JM;>$;<40R'Q*]2HSFN?O<#AEY7))>`/(#S,DFRBRDS)):(
MFETER1UY@;PR21J0*IHQUY"'I=7_`,>E]3D@7D2O?M)2-##=6HOCAPBL)O@7
MCU[!A]QL=R)D9#/+F+IWD!6WR-+:Q2H39S+&.>T<#Z3:B682D2%0%=,RA;VV
MB+V<YZ#HTO>M;PS6VE//X<#X=X/8K%V%T#^$&E,E30+G*MZVMJW6R8K9;%+;
MZ1*OGH5\F\Z4A-.&DC4_D$36,QKHRA"$YJ3A2EBUH`B\%U*13>?L[)V&#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8&N'RY?_`!U=,?\`3\+_`/="#X:L_:&Q[#)@,!@,!@==K_$+_P`D?'E_
M:`4W^Z!Y);LY^4NQ+E8,!@,!@=>3FW_4G>27^H;R7_"0,-3^L>-W8;PR8#`8
M#`8&N'QP?^7=N_VCW7/_`*I9L-7<O*&Q[#)@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M:X?+E_\`'5TQ_P!/PO\`]T(/AJS]H;'L,F`P&`P&!UVO\0O_`"1\>7]H!3?[
MH'DENSGY2[$N5@P&`P&!UY.;?]2=Y)?ZAO)?\)`PU/ZQXW=AO#)@,!@,!@:X
M?'!_Y=V[_:/=<_\`JEFPU=R\H;'L,F`P&`P&`P&`P&`P&`P&`P&`P&`P&!K;
M\N57V-=7`5QU/5'SE@FT_EG.\:1KJ>V]AL9D9'#IFG03.31PV.F%.B846A>G
M!R5'!$$DE"E.&?O1`3=X:LFEU9Z_XZWMJ0#S&6H^=-T#\QW3#C9C;=5-38^]
MH`\K*JKJ<Q_F>DA1VN)U4E@6.[1>N7%'+;<2-S@_Q5"L&Y.2<L[WA`];$+(Z
M1A2.#FN@8-Y);MM/M"<P"DNO8+`O)!4]>UW*6L;#9L>>^:I#3G!-+W7'W>(,
MZP*<YB#+;J5RNNW)4A*)`>^)OA=B,5FZUH?C2(F>'O*^7%-=WO'?)?"9)>%$
M6FK2+.0.86F&VY/H[U(J;Z[D3+SY82"RXNROK'$G3F]G=U;LJ3HI`3,'AK?=
MKS20)2E*GV=`K,S&&F[LM8<S`8#`8#`8#`8#`8#`UF>760]21SAZQ%/'1<V'
M>3@^PQE8MUY'HS))44VNCZ0G=CD2*426,IDJ<!6P_$*DIBI>F3^V,A*<+6]:
M-6TK^7!`W1==]*+^-N'F?H%LM>YFEBL"(O?D2A5'LKP;8<[@ZVH[1TL9&:'5
M2Y.\UF4:C=[O$6-5H(V<:ZK43>%5L`2@*0`+%*S3Z*?\K<P=8/\`W5S_`#FR
MZIDZ^A:OJJR9'3YUZR>Z8PYTQ6:N_4"RE(N6A94BI@DO1[#`R1%.33+S"%)3
M6((AC%[(P;+,QC2./CT=FS#F8#`8#`8#`8#`8#`8#`8#`8#`8#`UP^7+_P".
MKIC_`*?A?_NA!\-6?M#8]ADP&`P&`P.NU_B%_P"2/CR_M`*;_=`\DMV<_*78
MERL&`P&`P.O)S;_J3O)+_4-Y+_A(&&I_6/&[L-X9,!@,!@,#7#XX/_+NW?[1
M[KG_`-4LV&KN7E#8]ADP&`P&`P&`P&`P&`P&`P&`P&`P-5OE/O-IIN$T65-[
MWWS]1DFN5.FZ@GT;L[586E':+30R7#T\P-\9W9KGS>3NVAQ9`[KF#>UZ)J7'
MC#O7K]TU;NTW\R]5SNQ^YN8RGCIB03_G"&5?:TOC#P\=]JZD;G&GB.LK8B_/
MUO75#$T@/2=+3.1TLWLP5#-(M%."E*,I<M%[T0@B-S'XZ<?+QS6*\@7D)JFJ
MNC+,?I[U8\1Z+03GRM)?P5`J5Z",C$$Z)ZK.DMJ%3&OK6U6$P2G3("9U;H0F
M,9)-L#!ME<E)V]"V,W>DLQ;IUF5%8)W=T0Y\70WG5UZ^G]:]CUWY".6V>0SZ
M\+'@C=/%%07M,P3AM:9*M8IW(4$\K..-YQC`XG&*CDRI&`L"PDL.MZW&L?RK
MRI*OE?\`DL<[#GTYE]K]N7?4-OO]1V]/.-Z':.G)'J,N'0KGY`NPFZ+U%/8L
M@EXJVF3!%X0@CD=/)DOM(4D51IQI/]D4DWAJ;:1P\4CY<]*O();15J7BGG7<
MMBQ>]FEB[#4\JUS7/0^E<$E_7S"[<I!KNKC885+A59-JT2+WF0)D+=(0C8"6
MH]>>FU[P`MZ%(B(B8V^ZQU2^2*47M='9(;?Z#MN"T=V%4UQOW&KW';H0577\
M4,Y?:%XXE,Z2GT.LY%/8([7###6IR=6=42UZ5NB=4/>C='&E[)-M(C2*Q]WR
M\2]BQ""]U\5P:X>V+`F;#8_CYY;MQ9\[ODAL,$917I/XY?KG::A[K)VD<CB-
MLNC@)M:BC&5X6-P8[H"9247L02B]BZ/QG36L\G<@+,+.++-*,`:4:`)A1I8@
MC+,+&'0@&%C#O81@&'>MZWK?IO65Q>>`P&`P&`P&!KO\HLRE=6\DR.Z8-8IM
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M'?(7:<SGK)*WNXILURV^9S<[\]QN-](PUO8]$&O<>G2<(F!K93`M?L>T+2@S
M,<8Y^7^?"W'0WD8YDJ+MBX)=U7VH[5Q7571JK)1Q/!ZUOUR8*GO)9N*K%EHH
M9NPU/(U#?9KN38@"VPUOEI`D29&,L1`=A$(>JE)I2.,M9]<^1*WEW*G2=:]8
M]M/_`"Q:F[2J'J^/O-V6T*).TLIN\V>1FS'E:K[9HB?O-BP&',5P0EY)CSNT
M*TKHSLHFY,<5\*:(!DU;FVDUB*QXU;%N/KK@MN]\\M2O72=\Q.'V;P6XV^FY
MWGO=\SL2/I;Q27'75=Q=D?8X&S%D<FCR\0J3J5!*!4D&)QVI*5&)OBR?4JLS
M$Q;,4Y[.RSAS,!@,!@,!@,!@,!@,!@,!@,!@:X?+E_\`'5TQ_P!/PO\`]T(/
MAJS]H;'L,F`P&`P&!UVO\0O_`"1\>7]H!3?[H'DENSGY2[$N5@P&`P&!UY.;
M?]2=Y)?ZAO)?\)`PU/ZQXW=AO#)@,!@,!@:X?'!_Y=V[_:/=<_\`JEFPU=R\
MH;'L,F`P&`P&`P&`P&`P&`P&`P&`P&!%-BT11]OKF1SMJFJIM%RC1*]-''"Q
M:\B,V71].Z#2&.9#(KDK.YGM1+B8@($>$@183A$E['K>P!]"Q,QP1H;Q!Q:?
MH83^0N7C@F'"4C";0%4&:&H$'0!'CT.)[T(X0=>FQ;^^WK_MP97;R\TW$G&"
M,)@4?(O,*4)P=A."FH.J2`FAWK>MA,T5$PZ&'>M^GIOU^Y@RNWEXAXAXN"7H
MH/(?+X2@@.+"4&@:HT6$M3__`#!>@:B?LZ`?_P#KZ]/07_;ZX,KMY?1KBWCG
M19I.N3>9]%':"$XK5$5;[LW02P$AT:#\%?9,T$DH(->NM^@0ZU^QK6#*[>7@
M'BCC4!(DX.2>9`$#+`2,@-"U6$D9)>A:+*$7J*:`(LO0Q>R'>O37KOT_9P97
M;R\!<1\8"$<,7(O,(AJ1EF*!BH.J=B/,)%[90SA;B?J:,H?W0[%Z[#O[NL&5
MV\OT?$O&1B92C,Y&YB&D6#,,6)1T)50DRH9WILX:DC<4V4>,WV=>UL6M[%Z?
M=P97;RLR222F)*3IRBR$Y!99)!!)82B222@Z`4444#00%EE@#K00ZUK6M:]-
M81[,!@,!@,!@,#![`K&MK98BHO:E>P>RXT0Y(WDF.V!$V&9,1+PW:-TWNQ33
M(T#D@+<D.CQ^Y/T7HTKVQ>R+7KO!68X(:*XEXR(-./)Y&YB)/4:%H\XJA*J+
M-/T/?J/1Q@(IH9FA[^[OVM[]<+E=O+Q*XBXO(V7LCD/F`G9)^U)6RJ"JDO92
MG8=!VH+]B)Z]@_80ZU[>O07IK]G!E=O+WF<6<<&@/+-Y,YG,+5;UM2`RAZM&
M!1O6@ZUL\(HKL)V]:!K7WWK]S6L&5V\O6EXGXT0A&!#R1S&C"9OU,"EH6JTX
M1[_8]1Z)B@-"WZ?]^#*[>7Z1Q/QHEWK:7DCF1-L)AANMD4+59.]&FZ!HTS7N
MXH'T,,T6'0M_L[]G7K^Q@RNWE]['Q[R1&7IJDD;Y:YSCTB87I!)&-^8Z1K-I
M>F:1-2@*ML?VIT01A.N;GIM5`":0J),`>29K0@"UO7K@RNWE8S"&`P&`P&`P
M&`P&`P&`P&`P&`P-</ER_P#CJZ8_Z?A?_NA!\-6?M#8]ADP&`P&`P.NU_B%_
MY(^/+^T`IO\`=`\DMV<_*78ERL&`P&`P.O)S;_J3O)+_`%#>2_X2!AJ?UCQN
M[#>&3`8#`8#`UP^.#_R[MW^T>ZY_]4LV&KN7E#8]ADP&`P&`P&`P&`P&`P&`
MP*7\]]FL_0,TZ\A:*HK7@B_D:SD5:O*>9L12%]L0:^OF6PD$EA48+.$ZB8WA
MN>BRVW:C18U^O9,+U[`PX68I2=V3<8]4LW9=%-UXLD"F=8$K)M:,$706P24:
M:8Q]XJVQ9+7;NF?D:$X\EO7G+HV,TQ*(7OD@C-D&ZT:6/6A,4FBU6$,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#7#Y<
MO_CJZ8_Z?A?_`+H0?#5G[0V/89,!@,!@,#KM?XA?^2/CR_M`*;_=`\DMV<_*
M78ERL&`P&`P.O)S;_J3O)+_4-Y+_`(2!AJ?UCQN[#>&3`8#`8#`UP^.#_P`N
M[=_M'NN?_5+-AJ[EY0V/89,!@,!@,!@,!@,!@,!@,"JS#R=&(A:-O6U"K&M&
M(2.\[CK"XK(1LZ^&'LSVHJ^OF:MTT#`G>H0[+4<#EC&Q$&NQ92@+H-5K8DBY
M(#?N]%KI1FG._/D*YG@#G74#7R-R9G>S;>M98LE*U`O=122Z+-E5JRA.`YL:
MV=(!J0OTM4)T!?N/>E(BB@FF'&Z&<,3-9J@J0VGY%4;^])(OQCS`^QM,Y*B&
M%[=^\9U''5W:2S-A1N#E'T_#4A3LBU25Z",3`7K0E;^YHX?[.%I;O/;Y</\`
M.YY,?H.<G_K"K`_,#P4LWGM\GSN>3'Z#G)_ZPJP/S`\%+-Y[?)\[GDQ^@YR?
M^L*L#\P/!2S>>WR?.YY,?H.<G_K"K`_,#P4LWGM\GSN>3'Z#G)_ZPJP/S`\%
M+-Y[?)\[GDQ^@YR?^L*L#\P/!2S>>WR?.YY,?H.<G_K"K`_,#P4LWGM\GSN>
M3'Z#G)_ZPJP/S`\%+-Y[?)\[GDQ^@YR?^L*L#\P/!2S>>WR?.YY,?H.<G_K"
MK`_,#P4LWGM\GSN>3'Z#G)_ZPJP/S`\%+-Y[?)\[GDQ^@YR?^L*L#\P/!2S>
M>WRN+63M9#Y"61SMN%1:N[`5%J=R"'PN?K[/C3.:!8H+2`;9PYP2M%KX!0A`
M4:,0V1%LHP8B]:'H&C!F?)GN`P&!26;6=Y`FR829NK_C_FJ809$[J4\3E4E[
MAFT'D,A8P>Q\(ZO,-0\535'&'!1ZB]M&4\.0"O37HH'Z_<-4MYS-?+Y8O\[G
MDQ^@YR?^L*L#\P/!2S>>WR?.YY,?H.<G_K"K`_,#P4LWGM\GSN>3'Z#G)_ZP
MJP/S`\%+-Y[?)\[GDQ^@YR?^L*L#\P/!2S>>WR?.YY,?H.<G_K"K`_,#P4LW
MGM\GSN>3'Z#G)_ZPJP/S`\%+-Y[?)\[GDQ^@YR?^L*L#\P/!2S>>WRD*K;%[
MD?9NUMEQ<K<^5M7QY2P3Q,(/V-,+5DK:<65H2$I#!W3D.KD3J6J.]0F#$]I=
MDA^^T$S_`,.$G&FDS7R^5P,(8#`8#`8#`8#`8#`8#`8#`8&N'RY?_'5TQ_T_
M"_\`W0@^&K/VAL>PR8#`8#`8'7:_Q"_\D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,
M!@=>3FW_`%)WDE_J&\E_PD##4_K'C=V&\,F`P&`P&!KA\<'_`)=V[_:/=<_^
MJ6;#5W+RAL>PR8#`8#`8#`8#`8#`8#`8&J.DNF.@I7+_`"=0B\;+HVJ]<W6[
M'(G34]:6=<IB,"@TNI")6.TNL\-EZV/#E\@;5#X:>N!_N:7V@[)),&4'1NS4
MQ%(F.:5O&K=US=`<^O-@V_)8_8:$=JS-FINX&&$BK'5V4JV)6'46M5?6@G9\
M_`G<C?#W4MO)"J.*<&1,A<RA;*7`W@NB(G1L&PR8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&N'RY?\`QU=,?]/PO_W0
M@^&K/VAL>PR8#`8#`8'7:_Q"_P#)'QY?V@%-_N@>26[.?E+L2Y6#`8#`8'7D
MYM_U)WDE_J&\E_PD##4_K'C=V&\,F`P&`P&!KA\<'_EW;O\`:/=<_P#JEFPU
M=R\H;'L,F`P&`P&`P&`P&`P&`P&!!-A<N\U6VVS!GM3GZEK):;#D4;E\];)W
M6$+EC?-99#6I*Q1&32M&^LJY/('^+LB(E&WK%835"-,4`HH8`!T'18F8X2YV
MG:%H_GB-+890=/5A2<0<GI3)'&+51!(Q7L>72%8D0MZM\6,T4;&IO4NZE"V)
MB3%(R]G#*3E@V+80!UH3,SK*M4BY;ZC>']Z=FCR7]*11J<G)4M;8NU4KPXO;
M(\B/,V,AG;UTAY;>'Y8D1`W[`#%BM2I%K7J,P6_NX6)C:/5P_P"25UI^E.ZC
M_$5P)^:5@RM_F/7W/R2NM/TIW4?XBN!/S2L&5O\`,>ON?DE=:?I3NH_Q%<"?
MFE8,K?YCU]S\DKK3]*=U'^(K@3\TK!E;_,>ON?DE=:?I3NH_Q%<"?FE8,K?Y
MCU]S\DKK3]*=U'^(K@3\TK!E;_,>ON?DE=:?I3NH_P`17`GYI6#*W^8]?<_)
M*ZT_2G=1_B*X$_-*P96_S'K[GY)76GZ4[J/\17`GYI6#*W^8]?<_)*ZT_2G=
M1_B*X$_-*P96_P`QZ^Y^25UI^E.ZC_$5P)^:5@RM_F/7W/R2NM/TIW4?XBN!
M/S2L&5O\QZ^ZY%8Q650F$,D9FUG2:Y),V%J0.=C3%D@D<D4C&<L4*"37%FK2
M*0F%(Q(TYH$X-(FQ,$1901#T(S8AB,L^P&`P*0S?F;IB33&32*,^1KHJN8Z]
M.ZEP98#':<XK>6&'MYWL>Y86=VFO,TFE[B@1^SOV#7)Q6JQ>UOVS1?<]#43%
M-8CU8O\`DE=:?I3NH_Q%<"?FE8,K?YCU]S\DKK3]*=U'^(K@3\TK!E;_`#'K
M[GY)76GZ4[J/\17`GYI6#*W^8]?<_)*ZT_2G=1_B*X$_-*P96_S'K[GY)76G
MZ4[J/\17`GYI6#*W^8]?<_)*ZT_2G=1_B*X$_-*P96_S'K[GY)76GZ4[J/\`
M$5P)^:5@RM_F/7W2'5?/'0T%F[7)IUWS?5UQE"4L+75S-*HY$C,=>C%!6BTY
MZUYJ_GB"S5,-`9KVR])7,@(Q?<,T,/W,$S$QI$1W7#PR8#`8#`8#`8#`8#`8
M#`8#`8&N'RY?_'5TQ_T_"_\`W0@^&K/VAL>PR8#`8#`8'7:_Q"_\D?'E_:`4
MW^Z!Y);LY^4NQ+E8,!@,!@=>3FW_`%)WDE_J&\E_PD##4_K'C=V&\,F`P&`P
M&!KA\<'_`)=V[_:/=<_^J6;#5W+RAL>PR8#`8#`8#`8#`8#`8#`8&F"C6Z84
M%;/E!26]KJVR*]M/IBLD-3N;\PVS8QRIKL/G6'&/*.OE=:0M4*+5/'91I8A/
M<&=#I,R*`B`J/$LUL0C<TF(G2K/?#@U62U\MS+5@Q"T*^;%U^3Y=5L%L]?;S
MD**U@-@A"9I;8,MZ)8(AT2?!C9$F=%)6YPRM#Y\IGK?=I]MOP!YPOXML6&#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
MUP^7+_XZNF/^GX7_`.Z$'PU9^T-CV&3`8#`8#`Z[7^(7_DCX\O[0"F_W0/)+
M=G/REV)<K!@,!@,#KR<V_P"I.\DO]0WDO^$@8:G]8\;NPWADP&`P&`P-</C@
M_P#+NW?[1[KG_P!4LV&KN7E#8]ADP&`P&`P&`P&`P&`P&`P(M@UW5#9CW9D<
MKVR(=,WRF9*5#;7;8X^H7537TK.9DD@!'I4%*:8%I=OD1>2IV2;O0PE&:V+6
ML%)?=5EMUC>$-26'4$[C%D05>YR!F0RR'NR5[8E;I%7YQC$C0IG%&,Q.<>SR
M!H4I#]!WOV#B1!_[,$Q32549'XN_';+I`]2N3\9<]OLDD;FK>7Y[<ZX853B[
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M,-'H.ONC'O?_`&X9XZRS_`8#`H[./&AX_P"RYE)[#L#C^@YA.9H\*9!+)4_U
MZQN#W(7M;['Q;HZKSTXCE:U1[L/MF"WL6_36&HNNB*1,T8M]DSXT/H.\V_BQ
MCW[VP9W[R?9,^-#Z#O-OXL8]^]L&=^\GV3/C0^@[S;^+&/?O;!G?O)]DSXT/
MH.\V_BQCW[VP9W[R?9,^-#Z#O-OXL8]^]L&=^\GV3/C0^@[S;^+&/?O;!G?O
M)]DSXT/H.\V_BQCW[VP9W[RD2J?'IP[1DX:K,I[E:DJWL!C*6$-$PB$%9V9_
M;27`K1"XI(XI2`'D@5$ZT$>M;^^U]S!-UTQ29T7'PR8#`8#`8#`8#`8#`8#`
M8#`8&N'RY?\`QU=,?]/PO_W0@^&K/VAL>PR8#`8#`8'7:_Q"_P#)'QY?V@%-
M_N@>26[.?E+L2Y6#`8#`8'7DYM_U)WDE_J&\E_PD##4_K'C=V&\,F`P&`P&!
MKA\<'_EW;O\`:/=<_P#JEFPU=R\H;'L,F`P&`P&`P&`P&`P&`P&!J)!Q+?\`
M6[GY$@<['T961?:]S5Q((=)"4;BD2U=%QTI$X!:EBOE<QV,LB&:ST4F951Y+
M26\-FGTM3[]0\HC_`%#ANL3$5KHE;Q5<@6CPOR6CYVM225C)%L;M:XGV&"J:
M/R:/QEFKB6SUV?X@S'E2M_D#HI=2TBP:DP/O`EMQ*DIM]XN&B&Z+R7S%UU89
M1)/)CR/$Y"]Q=[>KV+>(ZYJV=T+;N->S'U`!<A,V4H"B>V*@7)D=DVAZ^\4)
M%!Z<W7W0#%K[N#">G>'#?:H\:?\`'>@OJ0=P_FZ8,+NG>#[5'C3_`([T%]2#
MN'\W3!A=T[P?:H\:?\=Z"^I!W#^;I@PNZ=X/M4>-/^.]!?4@[A_-TP87=.\'
MVJ/&G_'>@OJ0=P_FZ8,+NG>#[5'C3_CO07U(.X?S=,&%W3O!]JCQI_QWH+ZD
M'</YNF#"[IW@^U1XT_X[T%]2#N'\W3!A=T[P?:H\:?\`'>@OJ0=P_FZ8,+NG
M>#[5'C3_`([T%]2#N'\W3!A=T[P?:H\:?\=Z"^I!W#^;I@PNZ=X/M4>-/^.]
M!?4@[A_-TP87=.\+HU=9\/N2"L5CP,]^4Q21EJC6HZ3PN:UX]C`C6J&\_P".
MB%AQZ+2]H%I4E'H(5B`@1@/08-"`((MF9BFB0,!@,"C$Z\CO*=<3.40"5O%W
M$R:'/*IA?2F/D+KZ7LY;DC]CWX&R51"BGV*R%'KWFO95-ZU4E,__`%#!>F\-
M1;,Q7[PQ7[5'C3_CO07U(.X?S=,&%W3O!]JCQI_QWH+ZD'</YNF#"[IW@^U1
MXT_X[T%]2#N'\W3!A=T[P?:H\:?\=Z"^I!W#^;I@PNZ=X/M4>-/^.]!?4@[A
M_-TP87=.\'VJ/&G_`!WH+ZD'</YNF#"[IW@^U1XT_P".]!?4@[A_-TP87=.\
M)%JCOOFB[)TU5Q7SK<*F5O1*P]O)E7+/4]<,@BT!6CU.U4OLBF(G$&X>B]_>
M!4KRA&[^]!H0ON8J3;,16?\`87,PR8#`8#`8#`8#`8#`8#`8#`8&N'RY?_'5
MTQ_T_"__`'0@^&K/VAL>PR8#`8#`8'7:_P`0O_)'QY?V@%-_N@>26[.?E+L2
MY6#`8#`8'7DYM_U)WDE_J&\E_P`)`PU/ZQXW=AO#)@,!@,!@:X?'!_Y=V[_:
M/=<_^J6;#5W+RAL>PR8#`8#`8#`8#`8#`8#`8%3JY[>YHMHGII77MB%21OY!
ME3I"KX=4;,^::HO)6.))9L\-K<XFMY:24C;6%8#9PVT2H`#_`&B-[]Z'8-%F
MV8I7FS'F?I.O^L*J:+FJUGL]K@DBVD.C2RU*HL"H'63,SDPLDE:)7'6"QV".
M/+S#GMH?R!HG4@D:)4/1H"S!#),T$3$Q-)6`PA@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:X?+E_P#'5TQ_T_"__="#
MX:L_:&Q[#)@,!@,!@==K_$+_`,D?'E_:`4W^Z!Y);LY^4NQ+E8,!@,!@=>3F
MW_4G>27^H;R7_"0,-3^L>-W8;PR8#`8#`8&N'QP?^7=N_P!H]US_`.J6;#5W
M+RAL>PR8#`8#`8#`8#`8#`8#`8&OQNY&LJ&V3U]/H18%8N"3K>W:MF,BBUEU
MD\RQE::\A]+QVJ)C"3R&Z<L!;PZRDY@TJ3+3`A2I$YPB#4J@7^UPU72(V<SX
M^./W3BRE9)6CO)X6]+);:<GL\4;JB#JZPH^L"Y"SQAD!7U(5JOD<O6P:ODWX
M+[=!(C7-8(;TZN"GVPZ/T6`77935Q4E[MDD=D3XP%<#]_P`D*9716V%R&-51
M5*R.O8$ANRPN;&K6WDW+%+6KUKVB1FIR1B#OUV`._N8,>L.%^T&D_P"CM\C/
MXGZ@_I^P8]8/M!I/^CM\C/XGZ@_I^P8]8/M!I/\`H[?(S^)^H/Z?L&/6#[0:
M3_H[?(S^)^H/Z?L&/6#[0:3_`*.WR,_B?J#^G[!CU@^T&D_Z.WR,_B?J#^G[
M!CU@^T&D_P"CM\C/XGZ@_I^P8]8/M!I/^CM\C/XGZ@_I^P8]8/M!I/\`H[?(
MS^)^H/Z?L&/6#[0:3_H[?(S^)^H/Z?L&/6#[0:3_`*.WR,_B?J#^G[!CU@^T
M&D_Z.WR,_B?J#^G[!CUA=>JYZILZ",4W65_856J'LM489!;4:6ECG;%M,M4(
M]%OK6QOTF:TIBH*?1Q6BEI^A$&`WO8=[V'1E(6`P&!1&=]NR&$364PY/POW=
M.B(R\JF@F9P2KJO=(5*`)O8]'B+.3I=;(Y+F95[?^R,/1IC!>F_4O6&HMK%:
MPQ3[0:3_`*.WR,_B?J#^G[!CU@^T&D_Z.WR,_B?J#^G[!CU@^T&D_P"CM\C/
MXGZ@_I^P8]8/M!I/^CM\C/XGZ@_I^P8]8/M!I/\`H[?(S^)^H/Z?L&/6#[0:
M3_H[?(S^)^H/Z?L&/6#[0:3_`*.WR,_B?J#^G[!CUA)%2]AOMJ3MIA"WC/M&
MIT[H2M-'.K:KBN&""-6T96C0DNSHPV]*'0@Y9O?L$Z+1&Z$/[F]AU]W!-M(K
M6%T<,F`P&`P&`P&`P&`P&`P&`P&!KA\N7_QU=,?]/PO_`-T(/AJS]H;'L,F`
MP&`P&!UVO\0O_)'QY?V@%-_N@>26[.?E+L2Y6#`8#`8'7DYM_P!2=Y)?ZAO)
M?\)`PU/ZQXW=AO#)@,!@,!@:X?'!_P"7=N_VCW7/_JEFPU=R\H;'L,F`P&`P
M&`P&`P&`P&`P&!JM;?)<8P1GR53B[*/?*LC/CVF)+.-(GE#/.I79D265=&['
M:9;IJB1;BVL!SZ&1`*2MQ2UP6!)]D1P2C][3A-X<*:S*P_"G4R_KRC]VD]LL
M6B<E12]WBDE@T<6648XP9R1MK&^I(W.&FW*LIV=1J:A89$B5J42ED`GVF5IU
M*10J2*"5`R712:+EX9,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,#7#Y<O_CJZ8_Z?A?_`+H0?#5G[0V/89,!@,!@,#KM
M?XA?^2/CR_M`*;_=`\DMV<_*78ERL&`P&`P.O)S;_J3O)+_4-Y+_`(2!AJ?U
MCQN[#>&3`8#`8#`UP^.#_P`N[=_M'NN?_5+-AJ[EY0V/89,!@,!@,!@,!@,!
M@,!@,"H,SX9YZGBFZSWUCE8"NBY]!+%NAN:9_,65IGSS7<*:X`P-;VV-KPF1
MG1$^.,J4*]HT#3>XJ"0GJ"C#=>UA<I[,]YNYEJOE6".$`JE-*#$3])U<UEDE
MGDTD]CV!-Y<L9V..&26;3V9N;Q*)2\DQF+MC84>L4FC*;VY,G#O19(`Z$S,\
M5?I*B\J0I$^"A\F\?I43VZ*]QHJ2P?HQ1(BV79N_@`/A[7829M.=`D^GOA)R
MRRMB_P#"'6L+^'5PGP'EU_YI\<7\P>FOZ2<'X=3X#RZ_\T^.+^8/37]).#\.
MI\!Y=?\`FGQQ?S!Z:_I)P?AU/@/+K_S3XXOY@]-?TDX/PZGP'EU_YI\<7\P>
MFOZ2<'X=3X#RZ_\`-/CB_F#TU_23@_#J?`>77_FGQQ?S!Z:_I)P?AU/@/+K_
M`,T^.+^8/37]).#\.I\!Y=?^:?'%_,'IK^DG!^'4^`\NO_-/CB_F#TU_23@_
M#J?`>77_`)I\<7\P>FOZ2<'X=3X#RZ_\T^.+^8/37]).#\.J[55`M<N!L(+O
M55XLL\):K\)U-5()(VP,P[XU3M%MA12YQ=I"27IN]SHWXA09O9^A[#Z!V'6C
M/EP2'@,!@4.GB/R=CFLI'6,CX.35R)Z5;A*>>0OH-;-28]]Y\$7*5D?GR!B4
MO6OOO>C2$%$;^Y[(=?=PU&%-:U8G\!Y=?^:?'%_,'IK^DG!^'4^`\NO_`#3X
MXOY@]-?TDX/PZGP'EU_YI\<7\P>FOZ2<'X=3X#RZ_P#-/CB_F#TU_23@_#J?
M`>77_FGQQ?S!Z:_I)P?AU/@/+K_S3XXOY@]-?TDX/PZGP'EU_P":?'%_,'IK
M^DG!^'5)%2)/(L5/&D=[O_%2VL-$K?EU-4D1O-KG@S]DZ^3MM*V8S=WCQ1(3
M_7WVCDXQ;!_X?3>"<::5JNKADP&`P&`P&`P&`P&`P&`P&`P-</ER_P#CJZ8_
MZ?A?_NA!\-6?M#8]ADP&`P&`P.NU_B%_Y(^/+^T`IO\`=`\DMV<_*78ERL&`
MP&`P.O)S;_J3O)+_`%#>2_X2!AJ?UCQN[#>&3`8#`8#`U/517WD$YLE/2;17
M5"<I6S`K8ZEN.^XC*I=UY:%52DMDM)R;G1.R/\+:N,K3;&YR:#$HRQC(>U99
MVO06O9]=AT;F;9I6O#;Y3-\YODW^AQQA^L#M_P#N[\)2S>>WR?.;Y-_H<<8?
MK`[?_N[\%+-Y[?)\YODW^AQQA^L#M_\`N[\%+-Y[?)\YODW^AQQA^L#M_P#N
M[\%+-Y[?)\YODW^AQQA^L#M_^[OP4LWGM\GSF^3?Z''&'ZP.W_[N_!2S>>WR
M?.;Y-_H<<8?K`[?_`+N_!2S>>WR?.;Y-_H<<8?K`[?\`[N_!2S>>WR?.;Y-_
MH<<8?K`[?_N[\%+-Y[?)\YODW^AQQA^L#M_^[OP4LWGM\GSF^3?Z''&'ZP.W
M_P"[OP4LWGM\GSF^3?Z''&'ZP.W_`.[OP4LWGM\GSF^3?Z''&'ZP.W_[N_!2
MS>>WR?.;Y-_H<<8?K`[?_N[\%+-Y[?)\YODW^AQQA^L#M_\`N[\%+-Y[?)\Y
MODW^AQQA^L#M_P#N[\%+-Y[?)\YODW^AQQA^L#M_^[OP4LWGM\GSF^3?Z''&
M'ZP.W_[N_!2S>>WR?.;Y-_H<<8?K`[?_`+N_!2S>>WR?.;Y-_H<<8?K`[?\`
M[N_!2S>>WR?.;Y-_H<<8?K`[?_N[\%+-Y[?)\YODW^AQQA^L#M_^[OP4LWGM
M\GSF^3?Z''&'ZP.W_P"[OP4LWGM\GSF^3?Z''&'ZP.W_`.[OP4LWGM\GSF^3
M?Z''&'ZP.W_[N_!2S>>WR?.;Y-_H<<8?K`[?_N[\%+-Y[?)\YODW^AQQA^L#
MM_\`N[\%+-Y[?)\YODW^AQQA^L#M_P#N[\%+-Y[?)\YODW^AQQA^L#M_^[OP
M4LWGM\GSF^3?Z''&'ZP.W_[N_!2S>>WR?.;Y-_H<<8?K`[?_`+N_!2S>>WR?
M.;Y-_H<<8?K`[?\`[N_!2S>>WR?.;Y-_H<<8?K`[?_N[\%+-Y[?)\YODW^AQ
MQA^L#M_^[OP4LWGM\GSF^3?Z''&'ZP.W_P"[OP4LWGM\GSF^3?Z''&'ZP.W_
M`.[OP4LWGM\GSF^3?Z''&'ZP.W_[N_!2S>>WR?.;Y-_H<<8?K`[?_N[\%+-Y
M[?)\YODW^AQQA^L#M_\`N[\%+-Y[?)\YODW^AQQA^L#M_P#N[\%+-Y[?)\YO
MDW^AQQA^L#M_^[OP4LWGM\GSF^3?Z''&'ZP.W_[N_!2S>>WR?.;Y-_H<<8?K
M`[?_`+N_!2S>>WR?.;Y-_H<<8?K`[?\`[N_!2S>>WR?.;Y-_H<<8?K`[?_N[
M\%+-Y[?)\YODW^AQQA^L#M_^[OP4LWGM\GSF^3?Z''&'ZP.W_P"[OP4LWGM\
MGSF^3?Z''&'ZP.W_`.[OP4LWGM\GSF^3?Z''&'ZP.W_[N_!2S>>WR?.;Y-_H
M<<8?K`[?_N[\%+-Y[?)\YODW^AQQA^L#M_\`N[\%+-Y[?)\YODW^AQQA^L#M
M_P#N[\%+-Y[?)\YODW^AQQA^L#M_^[OP4LWGM\GSF^3?Z''&'ZP.W_[N_!2S
M>>WR?.;Y-_H<<8?K`[?_`+N_!2S>>WR?.;Y-_H<<8?K`[?\`[N_!2S>>WR?.
M;Y-_H<<8?K`[?_N[\%+-Y[?)\YODW^AQQA^L#M_^[OP4LWGM\J]=5P?R5]5T
M)/.?G'FOCBNVVR=1AL<YLD[=MR9+(VV-DRCLA<7%%%3>$(F4_K0(F<824PW-
M"`PP0=".!KU%HL3;$UK/;Y;@,,&`P&`P&!UVO\0O_)'QY?V@%-_N@>26[.?E
M+L2Y6#`8#`8'7DYM_P!2=Y)?ZAO)?\)`PU/ZQXW=AO#)@,!@,!@,!@,!@,!@
M,!@,!@,"NO5J:7+*/D*6%E/9SB?)ZM+>RH\>2F=#*^W:T)^=(`#3S"@Z0CK7
MY6TL"$6C1HMFA+_VFPX6.+6;S97O:)`^GKED<B?$=F?DI0^%\]#MR!%:01R5
M[4V5(3=_*BEP2*7EL(7MK$)U1'%%B-W[@8S0[UZ;BS32'%5WU5W_`&FHJ^PX
MO%)("%W1$I#;=;P\=`K%D3+HZPVN<S^LG:R;@1JCVV'717+,I8&`Z*>WHZ0&
ME"6%AW\5]X)B(3A^47VTNXIM^V6RDK#4W@T61`X_!H*"J!1ZQU%<+@TLV6;-
M(Y6LT6-A$B?XW\N2]R9T:TY.F7F-Q"<P02_:'E32O15UKZJ\K!-2V.\OM!V*
MYS!&HJ`4+3QNA"$,I'%I/-U;/>#^AC$C=4C*Z2RHW@DQJ:6=2I)W(HN23(RO
M:+5!])JU2UF\)M#R:.M6I76X-S9@G5A5=?TCC<'KKFP\?R'8#-&I>QPVKI+,
MB5;@KKE,D6,#:_L3^YE$&ORM\$@"'T2!]NII71B"KI[RJ-LLK6)12CY_8"):
M[OA<BF[Y18H+"3%J=ZC:`B'OYLC<4$T8HTV0]2Y+TLITCV!V?$Y2?80HQC,T
M*6[ZIBH>7]?Q_FKM"VD4?MNQ[C?;BCCY6GSFT0LI*9R**):OHF'2=_C]#.ZP
M/PYD33M3X<A;2S-;D*]M]0^IRS?J.?1\.[[\@[I(QUQ&&">F[7)HL^M-N2;E
M211EM(A4SO+G"'I%SNWNQB*/)+`C-=/E@.+M'!G%K4"5"G5GEE@!Z"%(XL39
M.@?*#!Z?W)K&@LBG$J,50Y/HF+<W/)\D)>+(JVKW9O9P0:*+'56.-U]9#E(D
M+V\C]"D128'Q/N]!]=BD5HKS,)_Y2*]5Q.HZ7C-M12O$,]G:B?/BCG>1V9,V
M2+CZZG=D#M2NYML2B)31*LIIF,9?P)<#"G9>%T1C1`$6>7O"QCQE)THOSROP
M2K:S_!.J+-GK@?`*KGT\<@4^TNUB-D<?!G5I9,:2LTE=F1(Z7JP3-T235.QG
M^Z(U'$QZ4>];!L6B:<UZ+CL?NAMK#E1ZJV$(5UD6A$&V,6]&_P`$A+FROK<>
MX["9^FE<N4+U:4Z(U:S)85+XPX#%[2@IWDK0+6O:)V$1(HIA:MG>2Q_A[$_P
MQ5=*/13UT9'C6!HYF%%I-('L?.%NOT%3O1"DU8[1F&PBU&=H9X](P%_"R=<X
MIU&]^\`46(NC$;3Z>\FM*5G6\GL=T?6Y#*ZFA5ISJ?-7*:=[*K&TI3*8?$D'
M-3Y&D#Z9I(UGF'.2QRDJD0#VDLXKVR]`T'>RQ$3*]W7W6$H:ZGH.8\YR67I$
MEK]-KJ8>WZ&4.]WC/DS1$66Z"9CJ+U$64G>'I0WR^K1%J5("C`)6HI0MT$9(
M/:V2(UI.S7?!+R\JL/Z#9'Z3<O68:R7'7G/<UMPV)PQ!((JVV"W0(N,V9"4Z
MI_>$OX"B:&9$2YHA)`G$J'X0T2O8`;]O"TBG'F\(;UYY<2(S/#Y)4]BV%*&"
M*K`PIGB/&DWK,<L1*IS$U)MB.3G;1K$P(9M'J[EJY`BAJ<X9CB^Q@Y0;L#>L
M)-%-2EOT77LVT/(4JYEYAFE?,3W'+G=(]8TMNZ,;I5!)W1P.B=4S:2PB"O,;
M6O"0->NT\F;6TMYYB4:D:=6J$01H8=A%E317R[>@_+!#%,*K^L:_?IG(@R"U
MX?,+).YS6K8V[QI=T',J\JZV&;Y%<#(^QO\`#:SC260KV5<<4A>F]V2'D&?_
M`)-!$1'T6^XB3=,Q6\.NH5>K=*AQ`^WG.351.UL4^&CUJMFJ^IAHDDU)<4RA
M6A@PC942L`@CP1!(4%"5')O>!2';")I2**[1/H?R.NSY7Q;E`+"0N#P21NP8
M>[<UK&Z,Q*8'NSNCGD-06:!;\F.T0K=D)3K8])"A&)I@>+1(!Z]O>@B8A@:N
MX?+7`F.O71X9I];ALDLBC88[HX=S3`V-QCB=UIB"V--I--F]9,='-U;N]C3A
MUB3TY-VE"J,;B@#20&GJSP@+^+V5=UIWP\=#U14LF#.%[DLTM?I2R+>17ZO8
M=-X>5?D6ALMDQ,BDZQ-,ZJB->UXYK1-*UZ1DF2M<2`9`=EBUD2D4<D3=7EE?
MX"V/S#%7%LF#`7)7Y;'9'SV%I33]\2LW,XA56O$YNB)PB,;9YK-9\W-DE2%J
M!/3;'RU^M;*UL8J?BC%-)_)&?:;Y,Z_+NLYPGG3?.->2J437FMQ@K!$JJ31N
M^F2RSFZNW-4!%+X+6[A(FLTB5:.**>C@I%`A;"4$.QIS69I#IOL!=U9S+5-\
MZ?82V6A4[NZND'641ML:I0ZQ>B(%*Y3*%MI%.1Z:%2]HM5W=$)L6"`ST1%`'
MH>P^@MBFDRK'![4\C58+)U`(\R7ENKD5E].N,XF3OR%(I1+J*;%_03"]4X?0
MJ`1IJGL-NL2+3!Y-6"2@%^#Z,@/H#V4FM"DU6D<9X^.R\/$MU=S3Z662U=-U
MX_QEL;H`-^JM6LJ99!VV4R0#R:AEC-(70Y0H+85L1==)T3(G'L(Y*SGFNH-;
M`3OTJ3$4TXJUQF^O*0]%1521&YJ<D2;,?K*U(^6#X:YI9B7(:);9!1T00N[B
MCW(*^CK9+9&J;)T3HSY;+0J/=:'I%L0D56EJ:>Y8KV%,>E*LBE0S^S&.I7=H
MIR2EBBE,MLMB$$L&$]A\]K'R2RF8'+$P59QU7JG=4-J6C+)$TH%P@:,#L[V2
M12C[^7;[[^FO2T,@EYTM*X?4GY/4%D$GFCA7C>RQ5WL5PJ^!/<E-)?TSHI=(
M[.$EINC\TJ8X<1\$0V(4YY1PSAFA")I33BK0^]$^6V%3AB3?-3.K&B"-');D
MDBIIH&.(2GB`0RU;D<I?0#,-#)%#FAN5WJ2KHVW090<5HE^73DQ0IT68D2%F
MS5:6L@2W5Y9WBR'*I%L*DT'.`.@F%RNGYAHQ*:F;F>7.A9\[LFOST4F$XR:5
MM+4;HA_8'4*5$R"",:8T[>@ZW4T<Y$NF/(RIO&I(0LJ2XI%7CQ==E,\JL]7S
MBWP"OE4-2BCBUE025+(GE/9$#AC#'7H1;/(]-YBB1/Z-:2:46B+)-'"D49OT
MC;7=[5>\F9JJ:[/4UK&)28MU(HISZZ/;#&(".D;`-=U3:2Y&)UO04V1S'X%:
MWM3;H*$UQ)3H-&B4'!!L12G5"7(=W=Y06TX=";*IOH9RI%T47?8DAL!\Y_TV
M$2XF?W_.G)G>'MD1."RQJHL=,0]HQHX84W&-2:/B^($<`)/IJDT;:N5TKZBK
MZ2IW!.ZI8T"UK,%7)$A`J+DH84;)E1OM/X5N]JOB#98-U&DV+[@FP278?O-A
MPDK*X0P&`P&`P&`P&`P&`P&`P&`P&!UVO\0O_)'QY?V@%-_N@>26[.?E+L2Y
M6#`8#`8'7DYM_P!2=Y)?ZAO)?\)`PU/ZQXW=AO#)@,!@,!@,!@,!@,!@,!@,
M!@,!@<4^,3))V9UCDE9FJ0QY];U;2]L+XWI'9F>&I>0-,N;75K7DJ$+@WK4Q
M@BS23@#+,`+81:WK>]8'VI$B1O2ID*!*G1(42<E(C1I"2TR5(E3EA*3IDR<D
M("2$Y!0-!``.M!"'6M:UK6L#Z,!@8;8D]CE7066V++E0T<;A;`Y2%W-)`$Y6
M8E;4PU'P;<E$87M<[.!@0ITB8._>*5)I90/48PZV%95G:4;4V8QUI7])]!7"
M8>M8VB?3:LHE#G*`4H_OA2!7J-6N]R*P(RM:Y$RMCB6J<T;6D=SF\K?LG:"=
MZ%;-8Z5E97=FUOJ2R*&;L&$:F$/9BY'+8IN6,/X2Q>/')P*R7Z1,7Q_RHR,Q
MJ4T)H52DHH@18M"T+TWK>&:2BF5=>\N0RMRK@?>@*B*JTZ=Q*L]6`AL"+NT1
M+G,WDK+$H_'5$@:W-6UI5IKS($OQ'O#0@0I1#5*=E)BC30%I,S3FY1/TO2R=
M&-7,+!A=:",D[]&6I)8<]KU@52+;+,7*#HWM@T5+5Y"]DD[VUC"V[]X!4;L6
MBC2"5.C"`"D\DLG2R*IRW$Y1)8^04SO*"..YISRW%%M<A=1-86MB<1C4A"A>
M7(3VBTG2F[">=M61[`=^]+]HC&]V_4VDD^7[M&N](:I4GH[16[FT:TDK96F2
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M9[B00>(B9C3@DI@L*`RI\DT8B\XA\DDL*6%M\RCS!)65X?(DO."(12&3-+<M
M4+V%8:$.]A*5%E#%K6_36$1C7G3E,V=:-OTM&YBUEVE24W%!9C!G5R9T$I4+
M"Z^K:RC7^/1[;D:]O$/)8+5:2AN84X$X5PC2-[]HOUV68F(KR2C%Y]!9N:_)
MX7-8E+SXJ[&L,H)B\C9W\V-OI`?:.97XMJ6*QL[L2'[HDRC19P=?LAPC!SK[
MK)2XHFF)29BL9PW9*&JY(D@$KA#\I@,H6(G=:,J<)1RA&J9]H=,XRST@`'N@
M3!A]E(,.C!%EI+VINA*"6LLMDB.\*?5QV`KR6J=OZ:RX6>RPIT4+#6XAMEKH
M4]#0QQ>>X$#(`2L,),$<`0-:V+6]8*2Y=3<M0(XS&)HKM6MDL.FRI`AALL4S
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MZ1:0V;7S%)V.+K9P]1QYF<<:WYHA;:0>I<9>Z-"YR(<&^+H$R4TPYP-+`D*`
M6(0C-:#O>B4EB;2;S@YRO5QL9E).$X=H`W/6K4:1P17*W*K5QPT[0[:G"/9C
MNL@"Q0D$!,?\4)N,&5L(!;V'>M%U9(?<M0)?PUTIM:MD_P`VQ+,HL7W\YBY7
MX`IY&F+6QX^:^\=`_@L2_(S0&HA+O<!5%"T(K8@[UO!27PLE\T;)E!Z6.7/5
M$@5)8@18*E,R6)$'50G@2DH:A--SR4#P>83$%!!8A@<A:TB&`.]Z,WK6]X*2
MRQHGD'?X@78+#,XH]P(YM5O1,W:)$T.40-9T&C]KG8N2HUAS,-M1:2F^^/T=
MLHOW8O:%KV=^A$?(>A:I=3TBUGE\;>("JKF26>*X6J8P1?5"6-Q5X:6AW$JE
M*>5#,")/MU^(&I`F&V$ITYOOE11GNRS"TGAS8-"NTN9YXNM@IEMR$$L5/3V"
M5I(YTZ2V*H:]>)A9$`B%D1%KA\S$^#8Y(<YL4W0E!`4;HT2[9A``"$#UV*3"
M8(3:$7GSY8\:9MN"=]JR7%PZ5MCLDT@5EK%+$TR)N=D!.SC#%L<=VYW#\(MU
MH)1YI!Y8?OB1ZT1(N`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.NU_B%_Y(^/
M+^T`IO\`=`\DMV<_*78ERL&`P&`P.O)S;_J3O)+_`%#>2_X2!AJ?UCQN[#>&
M3`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`I1Y#8%)K$Y-G37$RSSW*+36A;>7H
MT9*]6X.43HCH*K;MG;2TMS6G5.+P]NT(KYP3(4!)8QKU9I:?6M^]],-6S24,
M4.AN?F^=6&P1+G2P;WJ;I_H>:]*(KFA,OHZ)-M5HKM7-#D\1VR85:%IP6P%:
MJ(#)V:$U@;'LQ4E]0[++4A]P(328KSB%09!Q'T*XHKEKANHMJ1S0Z8=[V1OK
M7\+ZZ,%?<*Z;>KZD%3\\`$.4AMLDR*MUJL34Y:DS8@CK/^#)8&M0>ET0/47*
M)FO+1B"WQKVS'ZILV+1SGZM7%B107P_RV,TZW#JMOCL]L+C2TW>Q.GXHTLSD
MI1P-JF4^C2<IB"[.XD3:^[6ED*UNT(#A%5<XKW]605AXY;/7V+T9+[9HB!+&
M:94]VJ@J%IE9]8RTR-V#='<_0=\UH%(G+6/2-@=2H+,F!66M)&`AL4"&5HTL
MX!H=#+A3I_CAFCEGM6*U<.AW.BI18;G<70GC2ZFM&\P672.V"(/=#(.&HQ>\
M*>6R0V<USJ4S9H<N6W!^^.0MBEI=D3D("=48MT%,9"L3->D_=`59^-?LF-,$
MM5V77[G94HK:64'ITAS:U\\PB`=?US4W2[)=DW)U+`=#2&07-9D[C;+IH(=;
M;88`2I3FF)UVBB3C,46;XKIP\>-&SWA>D+GJ.O>_I$?S!&:#=[VZ&FENT7SR
M[R^O%;&!H-YKI6O6!KESG4#[,8?%291/("N^4"$"E0!"6>,1.AE^[V*L3,3,
M>.:@'-/`O74RZ2@$^ZQYWJMNIICOUCM@^LS(-SG%Z^BXG#C7JNKIHM;JBKBU
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M6`AND!4^/1GYL9X*N9F24.%V*G1-=*X#EIE6LZ:-FHF#:LQ26J^#"H-1,4UV
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MT!C3]3QM]]@_(M,M=7<Y7`?!H3;U_/$WK*TX`U75T;SW!*X+;:Y5IT!)+8M5
M/3-[KV"&\'J(`B96S-9XIN@_'%VP&W^2X<IYD56&MI?KQ;==A]\/\KHTA]FM
M9KJ.O>(LR%]2#GIMYNDQCSA/FAB4-_R2:T:(2Z4)CS2P[$"I$Z3K]$L]V\HW
M5;<PO1'"J::KA6=%4VVU53]P/,D@[*EXEF2%J=VU982L,CDK)82)B>'%V(=#
M%L#2.LC"I;@`TGUKV!ZDI;-)K,Z.*@G"UH0ERJ*?,E;Q!BMA'Y6.H;\M*?MA
ML%1S-RY1M:SNHY(PH5<H1CTZ+V20M$PARE9'B5`SOBP:&>G]\0;L-7*.'*CA
M^QN'KXM2Q>X+1JZ`UYJ7SUF\>)E2RYS8H'*)3/X[SE;\GL:^*C7M4LE<4;5[
M#*XW[AL`QOKM'8[(Q.`T3@N)1&J5)`BZ(I$\-4)-WCLZ.U6/-,<:(:,MNM6?
MW-">Z8_.4M1UC+8ASK;ELOMXMS)6K+4MMW'`V.+U?8BP866.LDE="P-"[W`?
M=>R8#1<HK/HA-=XO>LIB=?<5L6$AD9"NP5J..K$,7H"*5G=-0V3Y)^<>G9$1
M-9^CON07%:;[5]%U0)F94LO@T:3LZ33FU-IBDA0FVLBY6Q2GC286+Z&XMZ/4
MSWH"/\7T$BI""R8F-/<A?K$CG+\Q@EG-\-7-"Q36'.L9CEK1ZQXXPVB0W[2/
MD=G9T9BFB1#-3*$FQ#(-K,3%(RU6KI3F^>(N#+JKNZ*GLN026UG67ORRA8:S
M<X4/(F/2WY$;6UAJQF@W0UJ\_P`.),5,(7XH*J8F(5"Y4?M:2'WQB41)F,M.
M"D$FX=[!GC?3\O>J(8BFVLJ;9V5;2QKO141D4]B5>=]\A=&@H^?,<!E*BAA6
M1<-0TK)&YS-0N`X&M6+""ERQ,G5*"RC6416.OVE!]@>/KLJ7NMKV97G*;?0<
M!L'J&;RD/+R-IY/N60%0"=<IT)33;9*&#//1E:\ZMDMBDWKEW7Z.#,-.+$-5
MHUJ2+O?F:`6+K>$\:?=N&XDJ-Z@]X7H_%N$M<X5$^=.'>3$+K.PJRY9)+!YI
MB]QOE@29T.&>XM,A$L;+P84I[PWKG!*K=D;@1I0;\)H6&)FL4ZRV8X9,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,#KM?XA?^2/CR_M`*;_`'0/)+=G/REV)<K!
M@,!@,#K*]F+KU\:/EDD7DO;:)LCHCD[ISGR%4=?9E0L`9-.Z4?:Q5E:B3SJ.
M)O>.;BQ/.Q:,,,*#O9IHO<:]G>O:$;B(NMIPNA)O^9#Y5^B[W]]5B<_M6*P8
M7=.Y_F0^5OHN=^_58G/[5BL)A=T[G^9#Y6^BYW[]5B<_M6*P87=.Y_F0^5OH
MN=^_58G/[5BL&%W3N?YD/E;Z+G?OU6)S^U8K!A=T[G^9#Y6^BYW[]5B<_M6*
MP87=.Y_F0^5OHN=^_58G/[5BL&%W3N?YD/E;Z+G?OU6)S^U8K!A=T[G^9#Y6
M^BYW[]5B<_M6*P87=.Y_F0^5OHN=^_58G/[5BL&%W3N?YD/E;Z+G?OU6)S^U
M8K!A=T[G^9#Y6^BYW[]5B<_M6*P87=.Y_F0^5OHN=^_58G/[5BL&%W3N?YD/
ME;Z+G?OU6)S^U8K!A=T[G^9#Y6^BYW[]5B<_M6*P87=.Y_F0^5OHN=^_58G/
M[5BL&%W3N?YD/E;Z+G?OU6)S^U8K!A=T[G^9#Y6^BYW[]5B<_M6*P87=.Y_F
M0^5OHN=^_58G/[5BL&%W3N?YD/E;Z+G?OU6)S^U8K!A=T[G^9#Y6^BYW[]5B
M<_M6*P87=.Y_F0^5OHN=^_58G/[5BL&%W3N_-_XD+E7?W-\N=^[UO[F];Y8G
M'W?_`.%BL&%W3N:_Q(7*NM:UKESOW6M?<UK7+$XUK7_VU[K%8,+NG=^_YD/E
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M]TGY2FI!?M;_`&1>P40$/M;]/N[],5@PNZ=WT?YD/E;Z+G?OU6)S^U8K!A=T
M[G^9#Y6^BYW[]5B<_M6*P87=.Y_F0^5OHN=^_58G/[5BL&%W3N?YD/E;Z+G?
MOU6)S^U8K!A=T[G^9#Y6^BYW[]5B<_M6*P87=.Y_F0^5OHN=^_58G/[5BL&%
MW3N?YD/E;Z+G?OU6)S^U8K!A=T[G^9#Y6^BYW[]5B<_M6*P87=.Y_F0^5OHN
M=^_58G/[5BL&%W3N?YD/E;Z+G?OU6)S^U8K!A=T[G^9#Y6^BYW[]5B<_M6*P
M87=.[QU_B0>5`^OL\M]^:]=^N_3E><:]=[_9WOT*^[O>*P87=.[R_P`R'RM]
M%SOWZK$Y_:L5@PNZ=S_,A\K?1<[]^JQ.?VK%8,+NG<_S(?*WT7._?JL3G]JQ
M6#"[IW/\R'RM]%SOWZK$Y_:L5@PNZ=S_`#(?*WT7._?JL3G]JQ6#"[IW/\R'
MRM]%SOWZK$Y_:L5@PNZ=S_,A\K?1<[]^JQ.?VK%8,+NG<_S(?*WT7._?JL3G
M]JQ6#"[IW/\`,A\K?1<[]^JQ.?VK%8,+NG<_S(?*WT7._?JL3G]JQ6#"[IW/
M\R'RM]%SOWZK$Y_:L5@PNZ=S_,A\K?1<[]^JQ.?VK%8,+NG<_P`R'RM]%SOW
MZK$Y_:L5@PNZ=S_,A\K?1<[]^JQ.?VK%8,+NG<_S(?*WT7._?JL3G]JQ6#"[
MIW/\R'RM]%SOWZK$Y_:L5@PNZ=S_`#(?*WT7._?JL3G]JQ6#"[IW/\R'RM]%
MSOWZK$Y_:L5@PNZ=S_,A\K?1<[]^JQ.?VK%8,+NG<_S(?*WT7._?JL3G]JQ6
M#"[IW/\`,A\K?1<[]^JQ.?VK%8,+NG<_S(?*WT7._?JL3G]JQ6#"[IW5"N;H
M*UO.'T=Q?5W/?)W0E6\V<Z]&1^^KYZ`OB)G5RT&-461G:;X7&H^[$A=CY4K7
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;,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
